Unnamed: 0,Unnamed: 1,Unnamed: 2,Unnamed: 3,April,May,June,July,August,September,October,November,December,January,February,March,Total
District,,,,,,,,,,,,,,,,
Bagalkote,1.1,Total number of pregnant women Registered for ANC,TOTAL,3641.0,3450.0,3853.0,3828.0,3470.0,3603.0,3251.0,3767.0,3457.0,3533.0,3428.0,3658.0,42939.0
Bagalkote,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2562.0,2400.0,2700.0,2610.0,2453.0,2535.0,2372.0,2765.0,2565.0,2482.0,2528.0,2647.0,30619.0
Bagalkote,1.2,Number of Pregnant women registered under JSY,TOTAL,2330.0,2224.0,2628.0,2538.0,2280.0,2374.0,2138.0,2460.0,2239.0,2275.0,2294.0,2445.0,28225.0
Bagalkote,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3748.0,3603.0,3811.0,3917.0,3780.0,3385.0,3597.0,3557.0,3664.0,3832.0,3351.0,3512.0,43757.0
Bagalkote,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3005.0,2990.0,3276.0,3272.0,3115.0,3099.0,2843.0,3304.0,2938.0,3017.0,2847.0,3063.0,36769.0
Bagalkote,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3682.0,3622.0,3785.0,4008.0,3886.0,3782.0,3534.0,3823.0,3783.0,3698.0,3541.0,3563.0,44707.0
Bagalkote,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1759.0,1696.0,1900.0,1812.0,1829.0,1415.0,1454.0,1762.0,2092.0,2121.0,2160.0,2075.0,22075.0
Bagalkote,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,89.0,71.0,58.0,62.0,107.0,65.0,77.0,92.0,44.0,74.0,58.0,56.0,853.0
Bagalkote,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,29.0,27.0,34.0,4.0,23.0,12.0,15.0,10.0,12.0,22.0,24.0,28.0,240.0
Bagalkote,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3625.0,3855.0,4143.0,4142.0,3833.0,3738.0,2932.0,3791.0,3094.0,4091.0,4260.0,3691.0,45195.0
Bagalkote,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,198.0,159.0,136.0,252.0,197.0,123.0,431.0,110.0,79.0,115.0,139.0,158.0,2097.0
Bagalkote,1.8,Number of pregnancy test kits used at SC level,TOTAL,436.0,383.0,491.0,457.0,446.0,421.0,436.0,436.0,467.0,477.0,475.0,481.0,5406.0
Bagalkote,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,7.0,8.0,10.0,9.0,11.0,9.0,5.0,2.0,1.0,3.0,1.0,71.0
Bagalkote,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,5.0,8.0,8.0,4.0,3.0,4.0,5.0,0.0,0.0,1.0,0.0,1.0,39.0
Bagalkote,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,10.0,15.0,16.0,14.0,12.0,15.0,14.0,5.0,2.0,2.0,3.0,2.0,110.0
Bagalkote,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,10.0,21.0,8.0,10.0,10.0,12.0,11.0,4.0,1.0,2.0,1.0,1.0,91.0
Bagalkote,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1516.0,1350.0,1410.0,1440.0,1532.0,1566.0,1640.0,1673.0,1448.0,1521.0,1473.0,1304.0,17873.0
Bagalkote,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,87.0,36.0,68.0,48.0,34.0,55.0,63.0,100.0,34.0,45.0,34.0,39.0,643.0
Bagalkote,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,552.0,514.0,545.0,500.0,438.0,419.0,378.0,404.0,586.0,527.0,627.0,449.0,5939.0
Bagalkote,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,24.0,92.0,8.0,0.0,4.0,8.0,2.0,24.0,6.0,4.0,7.0,7.0,186.0
Bagalkote,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1670.0,2134.0,2249.0,2067.0,2130.0,2463.0,2214.0,2354.0,2132.0,2131.0,2203.0,2055.0,25802.0
Bagalkote,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,4.0,4.0,5.0,0.0,4.0,0.0,4.0,0.0,6.0,0.0,4.0,4.0,35.0
Bagalkote,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,24.0,3.0,13.0,9.0,9.0,12.0,7.0,10.0,7.0,10.0,7.0,14.0,125.0
Bagalkote,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,53.0,63.0,58.0,59.0,44.0,75.0,34.0,44.0,39.0,49.0,34.0,31.0,583.0
Bagalkote,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,77.0,66.0,71.0,68.0,53.0,87.0,41.0,54.0,46.0,59.0,41.0,45.0,708.0
Bagalkote,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,430.0,522.0,590.0,626.0,680.0,708.0,820.0,916.0,786.0,690.0,661.0,562.0,7991.0
Bagalkote,4.1.1.a,Number of male live births,TOTAL,1647.0,1772.0,1940.0,1803.0,1893.0,2065.0,1951.0,2050.0,1812.0,1935.0,1862.0,1753.0,22483.0
Bagalkote,4.1.1.b,Number of female live births,TOTAL,1529.0,1702.0,1736.0,1704.0,1768.0,1909.0,1896.0,1959.0,1748.0,1698.0,1798.0,1597.0,21044.0
Bagalkote,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3176.0,3474.0,3676.0,3507.0,3661.0,3974.0,3847.0,4009.0,3560.0,3633.0,3660.0,3350.0,43527.0
Bagalkote,4.1.2,Number of still births,TOTAL,23.0,32.0,23.0,22.0,24.0,56.0,28.0,27.0,28.0,21.0,24.0,17.0,325.0
Bagalkote,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,29.0,20.0,24.0,20.0,18.0,25.0,13.0,19.0,18.0,27.0,21.0,14.0,248.0
Bagalkote,4.2.1,Number of Newborns weighed at birth,TOTAL,2929.0,3191.0,3459.0,3316.0,3470.0,3973.0,3840.0,4004.0,3423.0,3633.0,3491.0,3221.0,41950.0
Bagalkote,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,401.0,408.0,400.0,381.0,432.0,398.0,441.0,544.0,446.0,403.0,420.0,365.0,5039.0
Bagalkote,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3141.0,3386.0,3545.0,3440.0,3616.0,3940.0,3790.0,3927.0,3473.0,3591.0,3592.0,3283.0,42724.0
Bagalkote,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,1.0,7.0,6.0,5.0,11.0,1.0,6.0,5.0,6.0,2.0,3.0,62.0
Bagalkote,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,2.0,0.0,0.0,0.0,2.0,91.0,0.0,0.0,0.0,1.0,2.0,98.0
Bagalkote,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,40.0,48.0,44.0,44.0,31.0,23.0,66.0,145.0,107.0,34.0,20.0,17.0,619.0
Bagalkote,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,49.0,51.0,51.0,50.0,36.0,36.0,158.0,151.0,112.0,40.0,23.0,22.0,779.0
Bagalkote,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,1.0,2.0,6.0,3.0,45.0,69.0,44.0,58.0,32.0,65.0,8.0,335.0
Bagalkote,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,146.0,199.0,181.0,80.0,65.0,69.0,88.0,84.0,53.0,61.0,81.0,47.0,1154.0
Bagalkote,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,13.0,20.0,11.0,17.0,10.0,17.0,41.0,35.0,28.0,20.0,20.0,24.0,256.0
Bagalkote,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,445.0,355.0,186.0,47.0,47.0,38.0,46.0,169.0,144.0,17.0,28.0,24.0,1546.0
Bagalkote,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,53.0,50.0,77.0,51.0,29.0,43.0,61.0,41.0,52.0,34.0,48.0,29.0,568.0
Bagalkote,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2446.0,2683.0,2582.0,2511.0,2632.0,2766.0,2937.0,2909.0,2734.0,2784.0,1948.0,1988.0,30920.0
Bagalkote,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2114.0,2429.0,2357.0,2374.0,2172.0,1600.0,1612.0,1590.0,1447.0,1656.0,2309.0,2442.0,24102.0
Bagalkote,6.3,PNC maternal complications attended,TOTAL,7.0,5.0,7.0,4.0,8.0,3.0,3.0,14.0,7.0,5.0,7.0,3.0,73.0
Bagalkote,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,2.0,5.0,4.0,1.0,4.0,2.0,0.0,3.0,6.0,1.0,0.0,33.0
Bagalkote,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,1.0,1.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,7.0
Bagalkote,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,5.0,3.0,6.0,6.0,1.0,5.0,2.0,0.0,3.0,6.0,1.0,2.0,40.0
Bagalkote,7.2,Number of MTPs conducted at Private Facilities,TOTAL,5.0,3.0,5.0,12.0,3.0,8.0,9.0,6.0,8.0,5.0,7.0,5.0,76.0
Bagalkote,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,398.0,454.0,467.0,420.0,486.0,528.0,477.0,558.0,518.0,455.0,458.0,423.0,5642.0
Bagalkote,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,562.0,859.0,845.0,625.0,602.0,773.0,777.0,910.0,863.0,777.0,691.0,798.0,9082.0
Bagalkote,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,960.0,1313.0,1312.0,1045.0,1088.0,1301.0,1254.0,1468.0,1381.0,1232.0,1149.0,1221.0,14724.0
Bagalkote,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,15.0,75.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,90.0
Bagalkote,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Bagalkote,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,0.0,21.0
Bagalkote,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,7.0,0.0,0.0,14.0,1.0,0.0,0.0,0.0,0.0,22.0
Bagalkote,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,88.0,27.0,66.0,38.0,25.0,56.0,32.0,109.0,0.0,21.0,7.0,38.0,507.0
Bagalkote,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,57.0,0.0,76.0,130.0,86.0,115.0,48.0,150.0,54.0,190.0,125.0,30.0,1061.0
Bagalkote,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,124.0,190.0,133.0,116.0,88.0,122.0,27.0,160.0,114.0,70.0,78.0,169.0,1391.0
Bagalkote,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,269.0,217.0,275.0,284.0,199.0,293.0,107.0,419.0,168.0,281.0,210.0,237.0,2959.0
Bagalkote,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,109.0,183.0,185.0,241.0,223.0,195.0,174.0,220.0,157.0,160.0,98.0,88.0,2033.0
Bagalkote,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,44.0,19.0,46.0,41.0,22.0,12.0,13.0,20.0,12.0,31.0,12.0,8.0,280.0
Bagalkote,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,79.0,69.0,99.0,58.0,91.0,89.0,65.0,130.0,98.0,45.0,22.0,68.0,913.0
Bagalkote,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,227.0,225.0,180.0,162.0,173.0,270.0,191.0,238.0,165.0,198.0,139.0,185.0,2353.0
Bagalkote,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,350.0,313.0,325.0,261.0,286.0,371.0,269.0,388.0,275.0,274.0,173.0,261.0,3546.0
Bagalkote,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,66.0,97.0,90.0,164.0,222.0,52.0,39.0,282.0,56.0,53.0,50.0,56.0,1227.0
Bagalkote,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,5.0,4.0,0.0,0.0,0.0,9.0,0.0,10.0,0.0,0.0,30.0
Bagalkote,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,70.0,12.0,29.0,31.0,66.0,37.0,23.0,20.0,10.0,298.0
Bagalkote,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,41.0,39.0,101.0,85.0,36.0,79.0,53.0,76.0,47.0,50.0,157.0,64.0,828.0
Bagalkote,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,43.0,39.0,106.0,159.0,48.0,108.0,84.0,151.0,84.0,83.0,177.0,74.0,1156.0
Bagalkote,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,23.0,17.0,18.0,45.0,31.0,46.0,42.0,34.0,51.0,44.0,32.0,36.0,419.0
Bagalkote,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,379.0,350.0,374.0,451.0,367.0,413.0,373.0,373.0,400.0,374.0,381.0,362.0,4597.0
Bagalkote,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,115.0,161.0,102.0,130.0,94.0,68.0,93.0,92.0,89.0,88.0,76.0,67.0,1175.0
Bagalkote,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,66.0,78.0,71.0,59.0,107.0,99.0,104.0,115.0,95.0,84.0,92.0,83.0,1053.0
Bagalkote,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,86.0,69.0,59.0,114.0,39.0,50.0,46.0,55.0,53.0,66.0,81.0,44.0,762.0
Bagalkote,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bagalkote,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,646.0,658.0,606.0,754.0,607.0,630.0,616.0,635.0,637.0,612.0,630.0,556.0,7587.0
Bagalkote,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,7.0,0.0,1.0,0.0,8.0,7.0,7.0,0.0,3.0,3.0,11.0,8.0,55.0
Bagalkote,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5.0,1.0,4.0,7.0,3.0,1.0,3.0,1.0,3.0,0.0,2.0,9.0,39.0
Bagalkote,9.06,Number of IUCD removals,TOTAL,210.0,182.0,179.0,164.0,112.0,335.0,146.0,133.0,223.0,136.0,205.0,111.0,2136.0
Bagalkote,9.07,Number of Oral Pills cycles distributed,TOTAL,6057.0,5720.0,5904.0,5692.0,5935.0,8007.0,6872.0,6214.0,6329.0,5655.0,5954.0,5511.0,73850.0
Bagalkote,9.08,Number of Condom pieces distributed,TOTAL,41987.0,45872.0,45234.0,46900.0,44529.0,46498.0,53011.0,52938.0,46543.0,46823.0,48149.0,53204.0,571688.0
Bagalkote,9.09,Number of Centchroman (weekly) pills given,TOTAL,54.0,8.0,10.0,120.0,280.0,0.0,125.0,23.0,135.0,0.0,0.0,5.0,760.0
Bagalkote,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,4.0
Bagalkote,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bagalkote,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,7.0,11.0,7.0,11.0,13.0,12.0,10.0,11.0,9.0,12.0,14.0,-1.0
Bagalkote,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4540.0,4364.0,4518.0,4859.0,4413.0,4651.0,4340.0,4973.0,4424.0,4206.0,3996.0,4034.0,53318.0
Bagalkote,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,421.0,572.0,35.0,0.0,67.0,38.0,34.0,45.0,14.0,37.0,0.0,0.0,1263.0
Bagalkote,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,381.0,558.0,31.0,0.0,33.0,29.0,36.0,45.0,3.0,54.0,1.0,0.0,1171.0
Bagalkote,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,383.0,564.0,23.0,0.0,17.0,37.0,24.0,37.0,8.0,34.0,1.0,0.0,1128.0
Bagalkote,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3289.0,3572.0,3513.0,3547.0,3662.0,3475.0,3578.0,4167.0,3714.0,3817.0,3443.0,3614.0,43391.0
Bagalkote,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3309.0,3402.0,3538.0,3654.0,3536.0,3415.0,3379.0,3771.0,3629.0,3688.0,3620.0,3555.0,42496.0
Bagalkote,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3467.0,3569.0,3686.0,3668.0,3608.0,3578.0,3489.0,3857.0,3596.0,3740.0,3638.0,3746.0,43642.0
Bagalkote,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2898.0,2721.0,2700.0,2967.0,3181.0,2938.0,2813.0,3018.0,2724.0,2538.0,2428.0,2406.0,33332.0
Bagalkote,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3362.0,3565.0,3513.0,3542.0,3611.0,3475.0,3579.0,4135.0,3703.0,3466.0,3343.0,3657.0,42951.0
Bagalkote,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3396.0,3462.0,3536.0,3658.0,3497.0,3397.0,3378.0,3767.0,3617.0,3383.0,3546.0,3582.0,42219.0
Bagalkote,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3557.0,3602.0,3687.0,3663.0,3563.0,3573.0,3487.0,3856.0,3600.0,3457.0,3560.0,3740.0,43345.0
Bagalkote,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2646.0,2546.0,2514.0,2881.0,3068.0,2754.0,2528.0,2692.0,2515.0,2201.0,2403.0,2306.0,31054.0
Bagalkote,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,144.0,274.0,73.0,64.0,40.0,45.0,56.0,53.0,13.0,87.0,7.0,29.0,885.0
Bagalkote,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,167.0,280.0,75.0,77.0,33.0,38.0,36.0,56.0,0.0,96.0,3.0,24.0,885.0
Bagalkote,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,161.0,262.0,67.0,59.0,17.0,47.0,24.0,43.0,7.0,75.0,4.0,18.0,784.0
Bagalkote,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3090.0,3238.0,3365.0,3595.0,3480.0,3533.0,3392.0,3781.0,3193.0,3420.0,3140.0,3378.0,40605.0
Bagalkote,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1800.0,1769.0,2197.0,2488.0,2232.0,2500.0,2499.0,2874.0,2670.0,2573.0,2338.0,2551.0,28491.0
Bagalkote,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bagalkote,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1750.0,1552.0,1843.0,1817.0,1860.0,1792.0,1729.0,2004.0,1660.0,1745.0,1723.0,1679.0,21154.0
Bagalkote,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1618.0,1430.0,1704.0,1691.0,1676.0,1612.0,1596.0,1842.0,1473.0,1623.0,1486.0,1544.0,19295.0
Bagalkote,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3368.0,2982.0,3547.0,3508.0,3536.0,3404.0,3325.0,3846.0,3133.0,3368.0,3209.0,3223.0,40449.0
Bagalkote,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2458.0,2552.0,2827.0,2990.0,2819.0,2954.0,2893.0,2954.0,2912.0,2755.0,2534.0,2741.0,33389.0
Bagalkote,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2578.0,2513.0,2770.0,2940.0,2841.0,2928.0,2877.0,3140.0,2915.0,2780.0,2553.0,2722.0,33557.0
Bagalkote,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,57.0,40.0,38.0,40.0,43.0,13.0,108.0,188.0,38.0,36.0,218.0,61.0,880.0
Bagalkote,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,996.0,736.0,802.0,874.0,946.0,886.0,955.0,1108.0,841.0,858.0,862.0,818.0,10682.0
Bagalkote,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,900.0,712.0,772.0,838.0,888.0,826.0,885.0,1062.0,759.0,787.0,771.0,683.0,9883.0
Bagalkote,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1896.0,1448.0,1574.0,1712.0,1834.0,1712.0,1840.0,2170.0,1600.0,1645.0,1633.0,1501.0,20565.0
Bagalkote,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,304.0,329.0,645.0,2049.0,2699.0,6215.0,810.0,5877.0,3269.0,2542.0,1576.0,1464.0,27779.0
Bagalkote,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,616.0,813.0,1064.0,2697.0,3301.0,6551.0,1074.0,5884.0,3171.0,2689.0,1646.0,1942.0,31448.0
Bagalkote,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,644.0,1123.0,972.0,1710.0,2428.0,5083.0,1078.0,4912.0,2950.0,3031.0,2242.0,1614.0,27787.0
Bagalkote,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,1.0,1.0,2.0,9.0
Bagalkote,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,2.0,2.0,5.0,2.0,4.0,2.0,4.0,4.0,2.0,4.0,31.0
Bagalkote,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1246.0,1299.0,1293.0,1307.0,1330.0,1335.0,1298.0,1303.0,1323.0,1290.0,1323.0,1306.0,15653.0
Bagalkote,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1190.0,1223.0,1300.0,1248.0,1236.0,1264.0,1184.0,1245.0,1218.0,1187.0,1204.0,1218.0,14717.0
Bagalkote,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,818.0,825.0,822.0,904.0,931.0,875.0,848.0,841.0,763.0,809.0,825.0,782.0,10043.0
Bagalkote,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2984.0,2996.0,3204.0,3454.0,3203.0,3147.0,3037.0,3195.0,2744.0,3063.0,2759.0,2942.0,36728.0
Bagalkote,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,513.0,400.0,603.0,3085.0,1922.0,995.0,906.0,522.0,294.0,346.0,455.0,458.0,10499.0
Bagalkote,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,160.0,95.0,140.0,3190.0,1382.0,556.0,596.0,130.0,77.0,112.0,88.0,47.0,6573.0
Bagalkote,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,5.0,3.0,4.0,12.0,14.0,8.0,8.0,14.0,0.0,1.0,15.0,89.0
Bagalkote,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,50.0,84.0,69.0,91.0,73.0,80.0,85.0,84.0,94.0,128.0,92.0,97.0,1027.0
Bagalkote,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,44.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Bagalkote,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,4.0,2.0,4.0,4.0,6.0,6.0,19.0,4.0,6.0,11.0,3.0,5.0,74.0
Bagalkote,13.1,Number of Patients operated for cataract,TOTAL,236.0,308.0,297.0,230.0,161.0,258.0,171.0,261.0,272.0,257.0,224.0,170.0,2845.0
Bagalkote,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,236.0,308.0,297.0,233.0,161.0,258.0,166.0,270.0,272.0,276.0,246.0,159.0,2882.0
Bagalkote,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,0.0,9.0,7.0,11.0,33.0,3.0,90.0,269.0,15.0,74.0,53.0,569.0
Bagalkote,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,3.0,2.0,1.0,20.0,0.0,90.0,110.0,0.0,44.0,114.0,384.0
Bagalkote,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,4.0,3.0,2.0,3.0,4.0,4.0,3.0,2.0,2.0,4.0,33.0
Bagalkote,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,1.0,2.0,3.0,2.0,2.0,4.0,2.0,2.0,2.0,2.0,2.0,24.0
Bagalkote,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,15.0,15.0,16.0,17.0,13.0,15.0,16.0,15.0,15.0,15.0,14.0,14.0,-1.0
Bagalkote,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,37.0,35.0,35.0,35.0,36.0,35.0,36.0,37.0,37.0,36.0,36.0,35.0,-1.0
Bagalkote,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,305.0,222.0,313.0,298.0,267.0,382.0,292.0,326.0,286.0,285.0,261.0,349.0,-1.0
Bagalkote,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,10.0,11.0,12.0,11.0,11.0,12.0,11.0,12.0,12.0,12.0,12.0,-1.0
Bagalkote,14.05,Number of RKS meetings held during the month,TOTAL,7.0,8.0,11.0,8.0,10.0,14.0,10.0,12.0,10.0,16.0,12.0,13.0,131.0
Bagalkote,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,34.0,32.0,32.0,30.0,30.0,33.0,32.0,30.0,32.0,34.0,31.0,-1.0
Bagalkote,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,528.0,559.0,654.0,605.0,504.0,647.0,499.0,667.0,625.0,597.0,619.0,605.0,7109.0
Bagalkote,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,15.0,16.0,16.0,15.0,13.0,11.0,14.0,13.0,14.0,14.0,14.0,14.0,-1.0
Bagalkote,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,7.0,6.0,6.0,23.0,3.0,23.0,24.0,6.0,7.0,5.0,5.0,5.0,-1.0
Bagalkote,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1035.0,877.0,921.0,648.0,955.0,1183.0,896.0,863.0,877.0,870.0,978.0,949.0,11052.0
Bagalkote,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2937.0,3035.0,3120.0,2604.0,2599.0,3009.0,3092.0,3136.0,2543.0,2894.0,3438.0,3360.0,35767.0
Bagalkote,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,816.0,707.0,755.0,871.0,1064.0,1142.0,742.0,834.0,644.0,721.0,819.0,728.0,9843.0
Bagalkote,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6141.0,6780.0,7451.0,6767.0,6666.0,7708.0,6677.0,7476.0,6837.0,7245.0,7674.0,7827.0,85249.0
Bagalkote,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1851.0,1584.0,1676.0,1519.0,2019.0,2325.0,1638.0,1697.0,1521.0,1591.0,1797.0,1677.0,20895.0
Bagalkote,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9078.0,9815.0,10571.0,9371.0,9265.0,10717.0,9769.0,10612.0,9380.0,10139.0,11112.0,11187.0,121016.0
Bagalkote,14.10.2.a,Number of death cases of Inpatient males,TOTAL,74.0,51.0,33.0,35.0,44.0,56.0,49.0,53.0,78.0,58.0,58.0,53.0,642.0
Bagalkote,14.10.2.b,Number of death cases of Inpatient females,TOTAL,19.0,22.0,24.0,28.0,32.0,31.0,25.0,30.0,680.0,688.0,36.0,30.0,1645.0
Bagalkote,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,93.0,73.0,57.0,63.0,76.0,87.0,74.0,83.0,758.0,746.0,94.0,83.0,2287.0
Bagalkote,14.11,In-Patient Head Count at midnight,TOTAL,13842.0,12472.0,14066.0,11264.0,10451.0,16336.0,13760.0,12876.0,13710.0,12938.0,14441.0,14024.0,160180.0
Bagalkote,14.12.1,OPD attendance (All),TOTAL,159601.0,153251.0,172883.0,164810.0,170167.0,188999.0,153861.0,172929.0,160190.0,165988.0,166133.0,153822.0,1982634.0
Bagalkote,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1098.0,1032.0,1135.0,1272.0,1155.0,1273.0,1450.0,1432.0,1226.0,1110.0,2039.0,1202.0,15424.0
Bagalkote,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,18.0,8.0,14.0,4.0,5.0,7.0,9.0,7.0,7.0,0.0,5.0,7.0,91.0
Bagalkote,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1136.0,1430.0,1365.0,1262.0,1484.0,1685.0,1663.0,1813.0,1647.0,1479.0,1552.0,1631.0,18147.0
Bagalkote,14.14.a,Number of patients given AYUSH treatment,TOTAL,9459.0,8001.0,8007.0,8800.0,8994.0,9658.0,9281.0,9353.0,9754.0,7472.0,8074.0,7969.0,104822.0
Bagalkote,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,635.0,683.0,649.0,1023.0,789.0,705.0,783.0,537.0,826.0,571.0,691.0,701.0,8593.0
Bagalkote,14.14.c,Number of Adolescents counselled,TOTAL,278.0,278.0,216.0,203.0,238.0,173.0,175.0,162.0,128.0,148.0,136.0,118.0,2253.0
Bagalkote,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,16587.0,18931.0,16546.0,18610.0,8759.0,19231.0,15865.0,18092.0,16054.0,20374.0,21230.0,17954.0,208233.0
Bagalkote,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,6766.0,7018.0,3562.0,7877.0,411.0,3766.0,3231.0,9738.0,6560.0,8617.0,8577.0,4482.0,70605.0
Bagalkote,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,4200.0,3580.0,5260.0,2311.0,1308.0,4881.0,3651.0,2798.0,2413.0,4281.0,4725.0,4603.0,44011.0
Bagalkote,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,129.0,120.0,105.0,115.0,78.0,115.0,105.0,96.0,92.0,78.0,82.0,68.0,1183.0
Bagalkote,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,5923.0,5314.0,4628.0,3433.0,2014.0,4898.0,3486.0,3679.0,3103.0,4934.0,4767.0,4281.0,50460.0
Bagalkote,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,157.0,133.0,125.0,134.0,83.0,117.0,78.0,98.0,86.0,65.0,82.0,60.0,1218.0
Bagalkote,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3765.0,3427.0,4070.0,3908.0,3322.0,4067.0,2854.0,3758.0,3057.0,3740.0,4013.0,2982.0,42963.0
Bagalkote,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,12.0,11.0,14.0,55.0,9.0,11.0,26.0,8.0,11.0,8.0,11.0,15.0,191.0
Bagalkote,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,13888.0,12321.0,13958.0,9652.0,6644.0,13846.0,9991.0,10235.0,8573.0,12955.0,13505.0,11866.0,137434.0
Bagalkote,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,298.0,264.0,244.0,304.0,170.0,243.0,209.0,202.0,189.0,151.0,175.0,143.0,2592.0
Bagalkote,15.2,Number of Widal tests conducted,Number tested,1418.0,1116.0,1049.0,863.0,877.0,1815.0,1466.0,1571.0,1355.0,1577.0,1755.0,1642.0,16504.0
Bagalkote,15.3.a,Number of VDRL tests conducted on males,Number tested,326.0,291.0,446.0,356.0,208.0,506.0,152.0,285.0,591.0,191.0,361.0,529.0,4242.0
Bagalkote,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,301.0,298.0,602.0,344.0,237.0,450.0,413.0,382.0,345.0,217.0,421.0,524.0,4534.0
Bagalkote,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1300.0,666.0,1366.0,1546.0,1228.0,1697.0,1077.0,1714.0,1087.0,1640.0,1470.0,1307.0,16098.0
Bagalkote,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1927.0,1255.0,2414.0,2246.0,1673.0,2653.0,1642.0,2381.0,2023.0,2048.0,2252.0,2360.0,24874.0
Bagalkote,15.4.1,Number of blood smears examined for Malaria,TOTAL,24061.0,23403.0,26587.0,31156.0,29113.0,31743.0,23847.0,26830.0,24999.0,22928.0,23860.0,22658.0,311185.0
Bagalkote,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,572.0,45.0,49.0,131.0,71.0,52.0,48.0,85.0,40.0,24.0,24.0,28.0,1169.0
Bagalkote,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,9.0,13.0,21.0,15.0,19.0,2.0,4.0,5.0,12.0,2.0,0.0,108.0
Bagalkote,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,800.0,800.0,800.0,2500.0,7000.0,3500.0,3500.0,2500.0,3500.0,500.0,3500.0,1000.0,29900.0
Bagalkote,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,,11200.0,10000.0,5000.0,10000.0,10000.0,5000.0,5000.0,6000.0,2500.0,3000.0,77700.0
Bagalkote,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10000.0,,9500.0,5500.0,8500.0,10000.0,11000.0,4000.0,8000.0,3000.0,5000.0,3000.0,77500.0
Bagalkote,16.1.1,Stock position of DPT vaccines,5. Total Stock,800.0,800.0,2500.0,7000.0,3500.0,3500.0,2500.0,3500.0,500.0,3500.0,1000.0,1000.0,30100.0
Bagalkote,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1500.0,2000.0,2000.0,5500.0,4000.0,1000.0,1000.0,0.0,2500.0,2000.0,6000.0,4500.0,32000.0
Bagalkote,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,10000.0,5000.0,16500.0,10000.0,8000.0,6000.0,11500.0,10000.0,10000.0,10000.0,10000.0,8000.0,115000.0
Bagalkote,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,9500.0,5000.0,13000.0,11500.0,11000.0,6000.0,12500.0,7500.0,10500.0,6000.0,11500.0,7500.0,111500.0
Bagalkote,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2000.0,2000.0,5500.0,4000.0,1000.0,1000.0,0.0,2500.0,2000.0,6000.0,4500.0,5000.0,35500.0
Bagalkote,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2500.0,500.0,500.0,800.0,2800.0,1300.0,9300.0,7000.0,800.0,800.0,13800.0,6300.0,46400.0
Bagalkote,16.1.2,Stock position of OPV vaccines,2. Stocks Received,16500.0,1000.0,23800.0,20000.0,22000.0,25000.0,20000.0,2000.0,30000.0,384000.0,20000.0,12100.0,576400.0
Bagalkote,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,18500.0,1000.0,23500.0,18000.0,23500.0,17000.0,22300.0,8200.0,30000.0,368500.0,27500.0,13400.0,571400.0
Bagalkote,16.1.2,Stock position of OPV vaccines,5. Total Stock,500.0,500.0,800.0,2800.0,1300.0,9300.0,7000.0,800.0,800.0,16300.0,6300.0,5000.0,51400.0
Bagalkote,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,1500.0,5000.0,5000.0,500.0,4500.0,500.0,25000.0,2500.0,2000.0,2000.0,7500.0,4000.0,60000.0
Bagalkote,16.1.3,Stock position of TT vaccines,2. Stocks Received,15000.0,,11000.0,20000.0,15000.0,42000.0,5000.0,12500.0,15000.0,15000.0,10000.0,12000.0,172500.0
Bagalkote,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11500.0,,15500.0,16000.0,19000.0,17500.0,27500.0,12500.0,15000.0,9500.0,13500.0,10500.0,168000.0
Bagalkote,16.1.3,Stock position of TT vaccines,5. Total Stock,5000.0,5000.0,500.0,4500.0,500.0,25000.0,2500.0,2500.0,2000.0,7500.0,4000.0,5500.0,64500.0
Bagalkote,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1000.0,2000.0,2000.0,2000.0,2500.0,500.0,6500.0,9000.0,4000.0,,,,29500.0
Bagalkote,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,5000.0,13000.0,9000.0,10000.0,12000.0,10000.0,0.0,6000.0,,,,75000.0
Bagalkote,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Bagalkote,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9000.0,5000.0,13000.0,8500.0,12000.0,6000.0,7500.0,5000.0,8000.0,,,,74000.0
Bagalkote,16.1.5,Stock position of BCG vaccines,5. Total Stock,2000.0,2000.0,2000.0,2500.0,500.0,6500.0,9000.0,4000.0,2000.0,0.0,0.0,0.0,30500.0
Bagalkote,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2000.0,0.0,0.0,2250.0,500.0,1750.0,1250.0,1000.0,2250.0,1000.0,2750.0,750.0,15500.0
Bagalkote,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2250.0,,8250.0,5000.0,6500.0,5000.0,5000.0,5000.0,8000.0,8000.0,3500.0,8500.0,65000.0
Bagalkote,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4250.0,,6000.0,6750.0,5250.0,5500.0,5250.0,3750.0,9250.0,6250.0,5500.0,6250.0,64000.0
Bagalkote,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,0.0,2250.0,500.0,1750.0,1250.0,1000.0,2250.0,1000.0,2750.0,750.0,3000.0,16500.0
Bagalkote,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3000.0,3500.0,3500.0,2000.0,1500.0,2000.0,1000.0,0.0,500.0,0.0,1500.0,0.0,18500.0
Bagalkote,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,1500.0,3000.0,,2000.0,0.0,1000.0,2000.0,3000.0,2000.0,0.0,2000.0,19500.0
Bagalkote,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2500.0,1500.0,4500.0,500.0,1500.0,1000.0,2000.0,1500.0,3500.0,500.0,1500.0,1500.0,22000.0
Bagalkote,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3500.0,3500.0,2000.0,1500.0,2000.0,1000.0,0.0,500.0,0.0,1500.0,0.0,500.0,16000.0
Bagalkote,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2850.0,2850.0,2850.0,9800.0,9600.0,775.0,500.0,500.0,500.0,500.0,10100.0,10000.0,50825.0
Bagalkote,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,10000.0,,0.0,0.0,0.0,0.0,0.0,9600.0,0.0,0.0,19600.0
Bagalkote,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,3050.0,200.0,8825.0,275.0,,0.0,0.0,0.0,,0.0,12350.0
Bagalkote,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2850.0,2850.0,9800.0,9600.0,775.0,500.0,500.0,500.0,500.0,10100.0,10100.0,10000.0,58075.0
Bagalkote,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,23190.0,13110.0,13110.0,201600.0,201600.0,0.0,302400.0,302400.0,302400.0,302400.0,141600.0,98160.0,1901970.0
Bagalkote,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,7050.0,,0.0,302400.0,0.0,0.0,0.0,141600.0,90000.0,0.0,541050.0
Bagalkote,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,10080.0,,20160.0,,201600.0,0.0,,0.0,0.0,302400.0,127550.0,92160.0,753950.0
Bagalkote,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,13110.0,13110.0,0.0,201600.0,0.0,302400.0,302400.0,302400.0,302400.0,141600.0,104050.0,6000.0,1689070.0
Bagalkote,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,12500.0,12500.0,12500.0,1600.0,300.0,100.0,,6800.0,6800.0,0.0,54000.0,1762.0,108862.0
Bagalkote,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,0.0,16000.0,,0.0,0.0,54000.0,0.0,0.0,70000.0
Bagalkote,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,10900.0,1500.0,200.0,100.0,,0.0,6800.0,0.0,18458.0,0.0,37958.0
Bagalkote,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,12500.0,12500.0,1600.0,100.0,100.0,16000.0,0.0,6800.0,0.0,54000.0,35542.0,1762.0,140904.0
Bagalkote,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,7500.0,7500.0,7500.0,11216.0,11216.0,9716.0,9716.0,9516.0,8816.0,8816.0,8816.0,7816.0,108144.0
Bagalkote,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,1000.0,0.0,200.0,700.0,0.0,0.0,1000.0,500.0,3400.0
Bagalkote,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,7500.0,7500.0,7500.0,11216.0,10216.0,9716.0,9516.0,8816.0,8816.0,8816.0,7816.0,7316.0,104744.0
Bagalkote,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,550.0,550.0,200.0,200.0,100.0,,1600.0
Bagalkote,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,0.0,0.0,0.0,0.0,0.0,,0.0
Bagalkote,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,0.0,0.0,0.0,0.0,0.0,,0.0
Bagalkote,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,0.0,350.0,0.0,100.0,100.0,,550.0
Bagalkote,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,550.0,200.0,200.0,100.0,0.0,0.0,1050.0
Bagalkote,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,0.0,14250.0,0.0,,14250.0
Bagalkote,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,14250.0,0.0,0.0,,14250.0
Bagalkote,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,0.0,0.0,0.0,,0.0
Bagalkote,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,0.0,14250.0,0.0,,14250.0
Bagalkote,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14250.0,0.0,0.0,0.0,14250.0
Bagalkote,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,0.0,,0.0
Bagalkote,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bagalkote,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bagalkote,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bagalkote,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bagalkote,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,5000.0,500.0,500.0,2365.0,14365.0,38941.0,99253.0,99253.0,25253.0,23253.0,23253.0,6253.0,338189.0
Bagalkote,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,2865.0,12500.0,55176.0,66812.0,0.0,0.0,0.0,0.0,0.0,0.0,137353.0
Bagalkote,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,4500.0,,1000.0,500.0,30600.0,7500.0,0.0,74000.0,2000.0,0.0,0.0,0.0,120100.0
Bagalkote,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,500.0,500.0,2365.0,14365.0,38941.0,98253.0,99253.0,25253.0,23253.0,23253.0,23253.0,6253.0,355442.0
Bagalkote,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1200.0,0.0,0.0,1200.0,1100.0,3500.0,0.0,4500.0,3800.0,2100.0,4300.0,700.0,22400.0
Bagalkote,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4400.0,,6600.0,3300.0,6600.0,3300.0,9900.0,3300.0,3300.0,6600.0,1000.0,6600.0,54900.0
Bagalkote,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5600.0,,5400.0,3400.0,4200.0,6800.0,5400.0,4000.0,5000.0,4400.0,4600.0,4000.0,52800.0
Bagalkote,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,1200.0,1100.0,3500.0,0.0,4500.0,3800.0,2100.0,4300.0,700.0,3300.0,24500.0
Bagalkote,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,17400.0,17400.0,17400.0,86400.0,67200.0,64800.0,9600.0,118800.0,106800.0,54800.0,32800.0,12800.0,606200.0
Bagalkote,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,19200.0,,96000.0,,0.0,0.0,120000.0,0.0,0.0,0.0,0.0,48000.0,283200.0
Bagalkote,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,19200.0,,27000.0,19200.0,2400.0,55200.0,10800.0,12000.0,52000.0,22000.0,20000.0,15200.0,255000.0
Bagalkote,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,17400.0,17400.0,86400.0,67200.0,64800.0,9600.0,118800.0,106800.0,54800.0,32800.0,12800.0,45600.0,634400.0
Bagalkote,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4400.0,3400.0,3400.0,6100.0,4500.0,1900.0,300.0,4100.0,3500.0,1900.0,1900.0,1700.0,37100.0
Bagalkote,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,4600.0,,0.0,1000.0,4800.0,0.0,0.0,0.0,2400.0,4800.0,17600.0
Bagalkote,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bagalkote,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1000.0,,1900.0,1500.0,2600.0,2600.0,1000.0,600.0,1600.0,0.0,2600.0,3400.0,18800.0
Bagalkote,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3400.0,3400.0,6100.0,4600.0,1900.0,300.0,4100.0,3500.0,1900.0,1900.0,1700.0,3100.0,35900.0
Bagalkote,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,1.0,,,,1.0,,,2.0
Bagalkote,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,1.0,,3.0,1.0,1.0,,,1.0,,1.0,9.0
Bagalkote,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,1.0,1.0,,,,,,,2.0
Bagalkote,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,1.0,,4.0,2.0,1.0,,,1.0,,1.0,11.0
Bagalkote,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,3.0,3.0,3.0,4.0,2.0,2.0,2.0,2.0,1.0,,3.0,26.0
Bagalkote,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bagalkote,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,3.0,3.0,3.0,4.0,2.0,2.0,2.0,2.0,1.0,,3.0,26.0
Bagalkote,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,1.0,2.0,2.0,1.0,,3.0,2.0,1.0,,,1.0,15.0
Bagalkote,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Bagalkote,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,1.0,2.0,2.0,1.0,1.0,3.0,2.0,1.0,,,1.0,16.0
Bagalkote,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,6.0,2.0,2.0,3.0,1.0,9.0,5.0,7.0,6.0,5.0,4.0,52.0
Bagalkote,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,2.0,1.0,,,1.0,1.0,,,,6.0
Bagalkote,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,3.0,6.0,2.0,4.0,4.0,1.0,9.0,6.0,8.0,6.0,5.0,4.0,58.0
Bagalkote,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,1.0,,1.0,1.0,,,,,4.0
Bagalkote,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,,,1.0
Bagalkote,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,1.0,,1.0,1.0,,1.0,,,5.0
Bagalkote,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bagalkote,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,1.0,,,,,,1.0
Bagalkote,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,,,,,1.0
Bagalkote,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,,1.0,,,,,,2.0
Bagalkote,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Bagalkote,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,1.0,,,,1.0,,3.0
Bagalkote,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bagalkote,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bagalkote,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bagalkote,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,3.0,3.0,2.0,3.0,8.0,5.0,6.0,6.0,2.0,6.0,1.0,47.0
Bagalkote,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,2.0,2.0,5.0,2.0,2.0,4.0,2.0,2.0,3.0,3.0,2.0,4.0,33.0
Bagalkote,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,4.0,5.0,8.0,4.0,5.0,12.0,7.0,8.0,9.0,5.0,8.0,5.0,80.0
Bagalkote,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bagalkote,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,1.0,1.0,,,,,,,3.0
Bagalkote,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,1.0,8.0,4.0,3.0,7.0,2.0,8.0,2.0,1.0,1.0,4.0,44.0
Bagalkote,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,3.0,,2.0,3.0,5.0,2.0,2.0,4.0,,1.0,,23.0
Bagalkote,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,5.0,8.0,6.0,7.0,13.0,4.0,10.0,6.0,1.0,2.0,4.0,70.0
Bagalkote,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Bagalkote,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,7.0,10.0,10.0,3.0,9.0,8.0,14.0,8.0,5.0,9.0,10.0,8.0,101.0
Bagalkote,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,18.0,20.0,24.0,25.0,30.0,28.0,27.0,37.0,26.0,32.0,19.0,30.0,316.0
Bagalkote,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,25.0,30.0,34.0,28.0,39.0,37.0,41.0,45.0,31.0,41.0,29.0,38.0,418.0
Bagalkote,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bagalkote,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,1.0,,,,,,1.0,3.0
Bagalkote,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,3.0,4.0,1.0,3.0,4.0,2.0,1.0,,1.0,,,22.0
Bagalkote,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,2.0,,3.0,,,,1.0,5.0,,1.0,,14.0
Bagalkote,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,6.0,5.0,4.0,4.0,3.0,5.0,2.0,2.0,5.0,1.0,1.0,1.0,39.0
Bagalkote,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,1.0,,1.0,,,,,,,2.0
Bagalkote,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,20.0,20.0,24.0,22.0,28.0,20.0,21.0,20.0,18.0,13.0,11.0,14.0,231.0
Bagalkote,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,3.0,2.0,1.0,1.0,4.0,1.0,,2.0,1.0,2.0,18.0
Bagalkote,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,20.0,21.0,27.0,25.0,29.0,22.0,25.0,21.0,18.0,15.0,12.0,16.0,251.0
Bagalkote,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,2.0,,1.0,1.0,1.0,1.0,,1.0,1.0,2.0,,,10.0
Bagalkote,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,33.0,37.0,31.0,40.0,44.0,49.0,53.0,34.0,33.0,43.0,47.0,37.0,481.0
Bagalkote,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,44.0,40.0,38.0,40.0,40.0,42.0,47.0,61.0,50.0,51.0,48.0,55.0,556.0
Bagalkote,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,79.0,77.0,70.0,81.0,85.0,92.0,100.0,96.0,84.0,96.0,95.0,92.0,1047.0
Bagalkote,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,1.0,1.0,,,2.0,1.0,1.0,2.0,,,8.0
Bagalkote,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,8.0,7.0,18.0,12.0,15.0,9.0,10.0,10.0,14.0,8.0,8.0,8.0,127.0
Bagalkote,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,22.0,22.0,16.0,24.0,38.0,18.0,32.0,30.0,24.0,41.0,35.0,20.0,322.0
Bagalkote,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,30.0,29.0,35.0,37.0,53.0,27.0,44.0,41.0,39.0,51.0,43.0,28.0,457.0
Bagalkote,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bagalkote,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,1.0,,,,,,1.0
Bagalkote,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,1.0,,,,,,1.0
Bagalkote,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,1.0,,,,1.0,,,,3.0
Bagalkote,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,1.0,,,,1.0,,,,3.0
Bagalkote,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,2.0,,1.0,,,1.0,1.0,,,,5.0
Bagalkote,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,2.0,,1.0,,,1.0,1.0,,,,5.0
Bagalkote,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bagalkote,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,1.0,,,1.0,1.0,1.0,1.0,,,,5.0
Bagalkote,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bagalkote,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,1.0,,,1.0,1.0,1.0,1.0,,,,5.0
Bagalkote,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,1.0,1.0,3.0,,1.0,,3.0,1.0,3.0,1.0,16.0
Bagalkote,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,14.0,24.0,19.0,14.0,15.0,14.0,19.0,18.0,13.0,13.0,15.0,190.0
Bagalkote,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,4.0,,2.0,5.0,3.0,4.0,2.0,3.0,7.0,3.0,4.0,40.0
Bagalkote,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,16.0,19.0,25.0,22.0,22.0,18.0,19.0,21.0,24.0,21.0,19.0,20.0,246.0
Bagalkote,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bagalkote,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,7.0,10.0,11.0,8.0,8.0,11.0,8.0,6.0,8.0,7.0,4.0,90.0
Bagalkote,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,2.0,,,,,,2.0,,,,4.0
Bagalkote,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,2.0,7.0,12.0,11.0,8.0,8.0,11.0,8.0,8.0,8.0,7.0,4.0,94.0
Bagalkote,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,1.0,1.0,,,,1.0,,1.0,,,5.0
Bagalkote,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,3.0,3.0,5.0,3.0,3.0,1.0,2.0,1.0,1.0,,,,22.0
Bagalkote,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,1.0,1.0,,2.0,2.0,1.0,,,9.0
Bagalkote,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,3.0,7.0,5.0,4.0,2.0,2.0,4.0,3.0,2.0,,,36.0
Bagalkote,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,1.0,2.0,,,1.0,,,1.0,,1.0,7.0
Bagalkote,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,15.0,10.0,22.0,13.0,19.0,16.0,7.0,20.0,20.0,21.0,13.0,15.0,191.0
Bagalkote,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,20.0,14.0,19.0,21.0,31.0,26.0,20.0,18.0,17.0,23.0,11.0,17.0,237.0
Bagalkote,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,36.0,24.0,42.0,36.0,50.0,42.0,28.0,38.0,37.0,45.0,24.0,33.0,435.0
Bagalkote,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,1.0,1.0,,,,1.0,1.0,,,5.0
Bagalkote,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,15.0,17.0,18.0,23.0,23.0,19.0,16.0,22.0,23.0,24.0,16.0,18.0,234.0
Bagalkote,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,21.0,20.0,38.0,31.0,39.0,42.0,32.0,45.0,60.0,60.0,34.0,43.0,465.0
Bagalkote,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,36.0,37.0,57.0,55.0,63.0,61.0,48.0,67.0,84.0,85.0,50.0,61.0,704.0
Bagalkote,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,4.0,1.0,3.0,4.0,,,,,3.0,3.0,3.0,23.0
Bagalkote,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,53.0,39.0,36.0,47.0,65.0,43.0,30.0,56.0,63.0,61.0,73.0,55.0,621.0
Bagalkote,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,150.0,126.0,142.0,178.0,185.0,198.0,157.0,217.0,174.0,197.0,188.0,178.0,2090.0
Bagalkote,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,205.0,169.0,179.0,228.0,254.0,241.0,187.0,273.0,237.0,261.0,264.0,236.0,2734.0
Bangalore Rural,1.1,Total number of pregnant women Registered for ANC,TOTAL,1347.0,1244.0,1559.0,1390.0,1467.0,1517.0,1209.0,1382.0,1283.0,1341.0,1327.0,1211.0,16277.0
Bangalore Rural,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1075.0,989.0,1189.0,1083.0,1154.0,1186.0,956.0,1038.0,954.0,997.0,989.0,884.0,12494.0
Bangalore Rural,1.2,Number of Pregnant women registered under JSY,TOTAL,1013.0,928.0,1215.0,1073.0,1110.0,1130.0,918.0,1032.0,981.0,1593.0,1008.0,906.0,12907.0
Bangalore Rural,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1238.0,1214.0,1442.0,1476.0,1511.0,1160.0,1151.0,1505.0,1332.0,1381.0,1282.0,1205.0,15897.0
Bangalore Rural,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1271.0,1131.0,1523.0,1509.0,1546.0,1641.0,1470.0,1509.0,1504.0,1360.0,1299.0,1132.0,16895.0
Bangalore Rural,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1269.0,1209.0,1443.0,1726.0,1525.0,1452.0,1391.0,1461.0,1273.0,1113.0,1060.0,1026.0,15948.0
Bangalore Rural,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,746.0,649.0,757.0,1104.0,1317.0,1193.0,1196.0,1563.0,1334.0,1157.0,1238.0,1093.0,13347.0
Bangalore Rural,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,5.0,61.0,104.0,37.0,21.0,30.0,11.0,25.0,48.0,48.0,50.0,38.0,478.0
Bangalore Rural,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,12.0,11.0,8.0,4.0,4.0,0.0,4.0,16.0,4.0,3.0,5.0,76.0
Bangalore Rural,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,830.0,952.0,1521.0,1124.0,988.0,965.0,738.0,1108.0,1231.0,1645.0,1686.0,1265.0,14053.0
Bangalore Rural,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,12.0,18.0,44.0,1.0,19.0,21.0,16.0,56.0,64.0,24.0,315.0,66.0,656.0
Bangalore Rural,1.8,Number of pregnancy test kits used at SC level,TOTAL,0.0,23.0,24.0,28.0,32.0,21.0,14.0,16.0,13.0,15.0,7.0,32.0,225.0
Bangalore Rural,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,1.0,0.0,2.0,2.0,0.0,2.0,0.0,1.0,2.0,0.0,1.0,13.0
Bangalore Rural,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,1.0,0.0,5.0,5.0,14.0
Bangalore Rural,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,1.0,0.0,4.0,2.0,1.0,2.0,0.0,2.0,2.0,5.0,6.0,27.0
Bangalore Rural,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,1.0,0.0,4.0,2.0,1.0,2.0,0.0,0.0,2.0,4.0,6.0,24.0
Bangalore Rural,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Bangalore Rural,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,339.0,483.0,463.0,408.0,439.0,443.0,361.0,443.0,387.0,450.0,376.0,394.0,4986.0
Bangalore Rural,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,158.0,50.0,67.0,92.0,52.0,157.0,114.0,134.0,85.0,68.0,113.0,129.0,1219.0
Bangalore Rural,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,138.0,158.0,239.0,385.0,187.0,198.0,198.0,210.0,149.0,220.0,297.0,496.0,2875.0
Bangalore Rural,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,30.0,37.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0,74.0
Bangalore Rural,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,441.0,388.0,435.0,376.0,437.0,372.0,262.0,347.0,354.0,367.0,374.0,353.0,4506.0
Bangalore Rural,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,63.0,63.0,67.0,68.0,60.0,45.0,24.0,40.0,38.0,47.0,33.0,27.0,575.0
Bangalore Rural,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,63.0,63.0,67.0,68.0,60.0,45.0,24.0,40.0,38.0,47.0,33.0,27.0,575.0
Bangalore Rural,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,241.0,221.0,244.0,244.0,226.0,131.0,170.0,212.0,213.0,207.0,210.0,209.0,2528.0
Bangalore Rural,4.1.1.a,Number of male live births,TOTAL,410.0,461.0,456.0,421.0,441.0,413.0,307.0,392.0,393.0,408.0,383.0,368.0,4853.0
Bangalore Rural,4.1.1.b,Number of female live births,TOTAL,374.0,405.0,439.0,365.0,431.0,402.0,317.0,398.0,332.0,406.0,367.0,382.0,4618.0
Bangalore Rural,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,784.0,866.0,895.0,786.0,872.0,815.0,624.0,790.0,725.0,814.0,750.0,750.0,9471.0
Bangalore Rural,4.1.2,Number of still births,TOTAL,6.0,6.0,3.0,2.0,6.0,2.0,1.0,1.0,18.0,7.0,8.0,5.0,65.0
Bangalore Rural,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,166.0,168.0,86.0,122.0,109.0,123.0,21.0,29.0,41.0,54.0,95.0,61.0,1075.0
Bangalore Rural,4.2.1,Number of Newborns weighed at birth,TOTAL,696.0,828.0,895.0,786.0,871.0,814.0,624.0,790.0,722.0,788.0,678.0,672.0,9164.0
Bangalore Rural,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,57.0,124.0,82.0,77.0,48.0,54.0,25.0,73.0,48.0,86.0,80.0,75.0,829.0
Bangalore Rural,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,689.0,862.0,888.0,783.0,870.0,825.0,622.0,790.0,726.0,806.0,703.0,683.0,9247.0
Bangalore Rural,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,9.0,10.0,9.0,0.0,0.0,1.0,1.0,30.0
Bangalore Rural,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,4.0,19.0,26.0
Bangalore Rural,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,0.0,0.0,0.0,0.0,1.0,9.0,10.0,11.0,0.0,0.0,5.0,20.0,56.0
Bangalore Rural,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,132.0,85.0,85.0,85.0,56.0,57.0,0.0,0.0,56.0,0.0,8.0,42.0,606.0
Bangalore Rural,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,132.0,82.0,85.0,85.0,55.0,51.0,55.0,80.0,68.0,29.0,36.0,36.0,794.0
Bangalore Rural,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,12.0,16.0,11.0,11.0,42.0,12.0,9.0,10.0,32.0,1.0,1.0,18.0,175.0
Bangalore Rural,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,121.0,83.0,85.0,84.0,51.0,58.0,117.0,107.0,77.0,78.0,96.0,158.0,1115.0
Bangalore Rural,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,47.0,46.0,44.0,45.0,18.0,16.0,19.0,9.0,22.0,2.0,15.0,34.0,317.0
Bangalore Rural,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,358.0,509.0,561.0,498.0,515.0,388.0,325.0,474.0,431.0,502.0,376.0,576.0,5513.0
Bangalore Rural,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,786.0,805.0,793.0,794.0,817.0,875.0,711.0,814.0,762.0,752.0,740.0,735.0,9384.0
Bangalore Rural,6.3,PNC maternal complications attended,TOTAL,8.0,134.0,18.0,50.0,0.0,42.0,2.0,23.0,56.0,20.0,48.0,65.0,466.0
Bangalore Rural,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7.0,15.0,10.0,15.0,10.0,19.0,12.0,13.0,11.0,11.0,19.0,9.0,151.0
Bangalore Rural,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,8.0,2.0,3.0,0.0,1.0,3.0,1.0,1.0,0.0,0.0,1.0,20.0
Bangalore Rural,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,7.0,23.0,12.0,18.0,10.0,20.0,15.0,14.0,12.0,11.0,19.0,10.0,171.0
Bangalore Rural,7.2,Number of MTPs conducted at Private Facilities,TOTAL,74.0,69.0,61.0,93.0,70.0,80.0,0.0,0.0,65.0,59.0,74.0,68.0,713.0
Bangalore Rural,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,82.0,62.0,80.0,80.0,73.0,88.0,92.0,99.0,107.0,106.0,100.0,104.0,1073.0
Bangalore Rural,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,200.0,220.0,250.0,227.0,201.0,262.0,223.0,240.0,229.0,228.0,248.0,236.0,2764.0
Bangalore Rural,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,282.0,282.0,330.0,307.0,274.0,350.0,315.0,339.0,336.0,334.0,348.0,340.0,3837.0
Bangalore Rural,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,15.0,0.0,5.0,0.0,0.0,0.0,5.0,0.0,0.0,7.0,0.0,32.0
Bangalore Rural,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,0.0,13.0,5.0,3.0,0.0,0.0,23.0
Bangalore Rural,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,0.0,13.0,5.0,3.0,0.0,0.0,23.0
Bangalore Rural,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,22.0,26.0,19.0,11.0,43.0,26.0,23.0,25.0,31.0,33.0,25.0,20.0,304.0
Bangalore Rural,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,246.0,312.0,333.0,186.0,208.0,216.0,171.0,296.0,150.0,201.0,186.0,178.0,2683.0
Bangalore Rural,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,268.0,338.0,352.0,197.0,251.0,242.0,194.0,321.0,181.0,234.0,211.0,198.0,2987.0
Bangalore Rural,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,11.0,16.0,14.0,12.0,37.0,12.0,12.0,10.0,0.0,7.0,9.0,3.0,143.0
Bangalore Rural,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0
Bangalore Rural,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,15.0,25.0,19.0,22.0,22.0,11.0,5.0,12.0,2.0,3.0,5.0,2.0,143.0
Bangalore Rural,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,15.0,25.0,19.0,22.0,22.0,11.0,5.0,12.0,2.0,3.0,10.0,2.0,148.0
Bangalore Rural,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,27.0,20.0,39.0,26.0,14.0,24.0,27.0,30.0,17.0,11.0,34.0,20.0,289.0
Bangalore Rural,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,27.0,33.0,23.0,31.0,32.0,15.0,12.0,18.0,10.0,19.0,10.0,6.0,236.0
Bangalore Rural,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,27.0,33.0,23.0,31.0,32.0,15.0,12.0,18.0,10.0,19.0,10.0,6.0,236.0
Bangalore Rural,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,33.0,31.0,17.0,36.0,35.0,10.0,7.0,20.0,15.0,12.0,4.0,7.0,227.0
Bangalore Rural,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,91.0,75.0,85.0,92.0,94.0,88.0,87.0,75.0,55.0,53.0,77.0,42.0,914.0
Bangalore Rural,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,46.0,45.0,53.0,58.0,43.0,50.0,41.0,46.0,38.0,61.0,39.0,44.0,564.0
Bangalore Rural,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,7.0,8.0,18.0,13.0,17.0,10.0,8.0,11.0,26.0,26.0,17.0,170.0
Bangalore Rural,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,26.0,20.0,38.0,32.0,26.0,24.0,22.0,40.0,31.0,27.0,41.0,29.0,356.0
Bangalore Rural,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Rural,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,172.0,147.0,184.0,200.0,176.0,179.0,160.0,169.0,135.0,167.0,183.0,132.0,2004.0
Bangalore Rural,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,0.0,1.0,1.0,16.0,15.0,7.0,3.0,11.0,3.0,2.0,3.0,11.0,73.0
Bangalore Rural,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,117.0,111.0,118.0,125.0,105.0,29.0,23.0,123.0,25.0,64.0,71.0,60.0,971.0
Bangalore Rural,9.06,Number of IUCD removals,TOTAL,100.0,122.0,125.0,141.0,138.0,127.0,122.0,109.0,56.0,114.0,84.0,106.0,1344.0
Bangalore Rural,9.07,Number of Oral Pills cycles distributed,TOTAL,1715.0,1707.0,1995.0,2090.0,2191.0,2603.0,2286.0,2333.0,2362.0,2325.0,2600.0,2592.0,26799.0
Bangalore Rural,9.08,Number of Condom pieces distributed,TOTAL,18652.0,19625.0,22324.0,25984.0,23531.0,25744.0,26417.0,25818.0,24649.0,23524.0,23124.0,23593.0,282985.0
Bangalore Rural,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,4.0,1.0,0.0,8.0,1.0,0.0,3.0,4.0,3.0,24.0
Bangalore Rural,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,2.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,6.0
Bangalore Rural,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Bangalore Rural,9.12,Number of Institutions having NSV trained doctors,TOTAL,19.0,14.0,18.0,18.0,18.0,20.0,17.0,17.0,18.0,19.0,18.0,18.0,-1.0
Bangalore Rural,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,858.0,917.0,981.0,902.0,871.0,879.0,722.0,842.0,785.0,800.0,786.0,886.0,10229.0
Bangalore Rural,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bangalore Rural,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Rural,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1327.0,1331.0,1317.0,1270.0,1140.0,1202.0,1082.0,1205.0,1072.0,1124.0,1174.0,1237.0,14481.0
Bangalore Rural,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1287.0,1282.0,1348.0,1264.0,1126.0,1188.0,1043.0,1205.0,1033.0,1078.0,1125.0,1358.0,14337.0
Bangalore Rural,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1268.0,1223.0,1366.0,1303.0,1161.0,1199.0,1068.0,1198.0,986.0,1059.0,1150.0,1220.0,14201.0
Bangalore Rural,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,674.0,757.0,711.0,722.0,813.0,685.0,633.0,765.0,678.0,841.0,763.0,818.0,8860.0
Bangalore Rural,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1324.0,1336.0,1321.0,1278.0,1146.0,1212.0,1077.0,1205.0,1072.0,1126.0,1168.0,1233.0,14498.0
Bangalore Rural,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1291.0,1286.0,1357.0,1269.0,1190.0,1197.0,1047.0,1210.0,1033.0,1078.0,1123.0,1357.0,14438.0
Bangalore Rural,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1267.0,1219.0,1368.0,1299.0,1163.0,1208.0,1071.0,1205.0,986.0,1057.0,1151.0,1219.0,14213.0
Bangalore Rural,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,400.0,522.0,418.0,507.0,540.0,648.0,617.0,618.0,601.0,470.0,489.0,424.0,6254.0
Bangalore Rural,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Rural,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bangalore Rural,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Bangalore Rural,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1288.0,1284.0,1276.0,1261.0,1054.0,1169.0,1065.0,1218.0,1122.0,1178.0,1121.0,1190.0,14226.0
Bangalore Rural,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1034.0,1002.0,1120.0,1167.0,1028.0,1146.0,957.0,1202.0,892.0,958.0,965.0,1033.0,12504.0
Bangalore Rural,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,675.0,683.0,704.0,675.0,572.0,628.0,561.0,657.0,602.0,637.0,596.0,616.0,7606.0
Bangalore Rural,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,628.0,607.0,596.0,605.0,488.0,560.0,513.0,587.0,519.0,540.0,525.0,575.0,6743.0
Bangalore Rural,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1303.0,1290.0,1300.0,1280.0,1060.0,1188.0,1074.0,1244.0,1121.0,1177.0,1121.0,1191.0,14349.0
Bangalore Rural,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1123.0,1170.0,1214.0,1312.0,1095.0,1269.0,1005.0,1266.0,948.0,996.0,989.0,1046.0,13433.0
Bangalore Rural,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1123.0,1169.0,1214.0,1321.0,1094.0,1273.0,1010.0,1266.0,948.0,995.0,983.0,1046.0,13442.0
Bangalore Rural,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,536.0,552.0,601.0,643.0,499.0,614.0,487.0,575.0,458.0,486.0,496.0,518.0,6465.0
Bangalore Rural,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,496.0,473.0,539.0,560.0,448.0,560.0,440.0,563.0,423.0,467.0,412.0,486.0,5867.0
Bangalore Rural,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1032.0,1025.0,1140.0,1203.0,947.0,1174.0,927.0,1138.0,881.0,953.0,908.0,1004.0,12332.0
Bangalore Rural,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,37.0,29.0,33.0,345.0,1713.0,4096.0,222.0,2908.0,320.0,666.0,249.0,70.0,10688.0
Bangalore Rural,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,32.0,27.0,34.0,414.0,1667.0,3962.0,180.0,2894.0,328.0,605.0,261.0,62.0,10466.0
Bangalore Rural,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,27.0,20.0,14.0,263.0,1406.0,2843.0,327.0,2514.0,710.0,348.0,372.0,42.0,8886.0
Bangalore Rural,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Rural,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Rural,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,601.0,612.0,566.0,619.0,632.0,604.0,593.0,598.0,584.0,573.0,568.0,574.0,7124.0
Bangalore Rural,10.4.2,Number of Immunisation sessions held during the month,TOTAL,572.0,592.0,584.0,623.0,637.0,588.0,569.0,588.0,527.0,520.0,520.0,536.0,6856.0
Bangalore Rural,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,352.0,356.0,371.0,370.0,386.0,387.0,384.0,405.0,343.0,354.0,366.0,337.0,4411.0
Bangalore Rural,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1079.0,1029.0,1056.0,1349.0,1279.0,1175.0,1042.0,1127.0,937.0,988.0,978.0,1086.0,13125.0
Bangalore Rural,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,7.0,10.0,4.0,479.0,6701.0,48.0,3.0,13.0,46.0,38.0,9784.0,1500.0,18633.0
Bangalore Rural,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,3.0,4.0,292.0,6279.0,65.0,0.0,0.0,0.0,0.0,11743.0,1083.0,19469.0
Bangalore Rural,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,8.0,6.0,11.0,0.0,1.0,0.0,15.0,4.0,2.0,3.0,0.0,1.0,51.0
Bangalore Rural,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,261.0,219.0,204.0,282.0,317.0,316.0,228.0,225.0,208.0,219.0,229.0,218.0,2926.0
Bangalore Rural,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bangalore Rural,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,18.0,18.0,23.0,23.0,19.0,5.0,13.0,25.0,13.0,13.0,39.0,40.0,249.0
Bangalore Rural,13.1,Number of Patients operated for cataract,TOTAL,146.0,134.0,186.0,147.0,156.0,133.0,124.0,102.0,175.0,107.0,123.0,97.0,1630.0
Bangalore Rural,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,146.0,134.0,186.0,147.0,156.0,133.0,124.0,102.0,175.0,107.0,121.0,96.0,1627.0
Bangalore Rural,13.3,Number of School children detected with Refractive errors,TOTAL,151.0,230.0,45.0,36.0,51.0,40.0,498.0,48.0,261.0,0.0,49.0,21.0,1430.0
Bangalore Rural,13.4,Number of children provided free glasses,TOTAL,83.0,192.0,0.0,0.0,0.0,0.0,32.0,0.0,120.0,0.0,0.0,0.0,427.0
Bangalore Rural,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Rural,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,7.0,6.0,8.0,4.0,5.0,6.0,6.0,6.0,7.0,7.0,-1.0
Bangalore Rural,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,17.0,20.0,21.0,24.0,20.0,21.0,21.0,22.0,21.0,21.0,20.0,20.0,-1.0
Bangalore Rural,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,167.0,159.0,175.0,184.0,382.0,356.0,181.0,297.0,337.0,371.0,424.0,416.0,-1.0
Bangalore Rural,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,5.0,5.0,6.0,5.0,7.0,3.0,5.0,5.0,6.0,6.0,7.0,6.0,-1.0
Bangalore Rural,14.05,Number of RKS meetings held during the month,TOTAL,4.0,3.0,4.0,4.0,3.0,4.0,2.0,3.0,3.0,7.0,6.0,12.0,55.0
Bangalore Rural,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,24.0,26.0,28.0,23.0,26.0,24.0,21.0,22.0,24.0,20.0,19.0,-1.0
Bangalore Rural,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,46.0,50.0,54.0,75.0,38.0,52.0,53.0,80.0,48.0,50.0,50.0,68.0,664.0
Bangalore Rural,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,6.0,5.0,6.0,7.0,8.0,6.0,7.0,6.0,6.0,6.0,7.0,-1.0
Bangalore Rural,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,14.0,16.0,18.0,35.0,7.0,8.0,8.0,11.0,8.0,5.0,6.0,4.0,-1.0
Bangalore Rural,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,328.0,291.0,334.0,365.0,368.0,351.0,389.0,411.0,409.0,409.0,407.0,393.0,4455.0
Bangalore Rural,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1695.0,1717.0,2178.0,1931.0,1850.0,1904.0,1459.0,1857.0,1752.0,1785.0,1934.0,1828.0,21890.0
Bangalore Rural,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,268.0,260.0,343.0,329.0,302.0,334.0,338.0,317.0,351.0,385.0,420.0,438.0,4085.0
Bangalore Rural,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2464.0,2529.0,2677.0,2431.0,2802.0,2963.0,2149.0,2570.0,2547.0,2227.0,2575.0,2619.0,30553.0
Bangalore Rural,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,596.0,551.0,677.0,694.0,670.0,685.0,727.0,728.0,760.0,794.0,827.0,831.0,8540.0
Bangalore Rural,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4159.0,4246.0,4855.0,4362.0,4652.0,4867.0,3608.0,4427.0,4299.0,4012.0,4509.0,4447.0,52443.0
Bangalore Rural,14.10.2.a,Number of death cases of Inpatient males,TOTAL,15.0,21.0,17.0,20.0,10.0,20.0,11.0,22.0,18.0,17.0,20.0,21.0,212.0
Bangalore Rural,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,3.0,13.0,11.0,7.0,15.0,9.0,8.0,12.0,11.0,11.0,13.0,123.0
Bangalore Rural,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,25.0,24.0,30.0,31.0,17.0,35.0,20.0,30.0,30.0,28.0,31.0,34.0,335.0
Bangalore Rural,14.11,In-Patient Head Count at midnight,TOTAL,3110.0,22524.0,23430.0,22705.0,23613.0,24330.0,21836.0,24593.0,22400.0,21543.0,24789.0,20812.0,255685.0
Bangalore Rural,14.12.1,OPD attendance (All),TOTAL,76533.0,99140.0,111222.0,116887.0,104642.0,112563.0,91133.0,106818.0,104513.0,107302.0,125711.0,111805.0,1268269.0
Bangalore Rural,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,528.0,1070.0,1216.0,1316.0,1071.0,1130.0,903.0,236.0,1442.0,1140.0,1116.0,1037.0,12205.0
Bangalore Rural,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,108.0,0.0,17.0,54.0,3.0,2.0,0.0,17.0,1.0,0.0,4.0,208.0
Bangalore Rural,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,2820.0,2732.0,3094.0,2987.0,2521.0,71.0,356.0,394.0,2995.0,2686.0,2840.0,2564.0,26060.0
Bangalore Rural,14.14.a,Number of patients given AYUSH treatment,TOTAL,3.0,2.0,2.0,182.0,152.0,262.0,82.0,316.0,470.0,416.0,472.0,453.0,2812.0
Bangalore Rural,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,361.0,273.0,401.0,431.0,374.0,512.0,275.0,444.0,582.0,513.0,637.0,482.0,5285.0
Bangalore Rural,14.14.c,Number of Adolescents counselled,TOTAL,171.0,94.0,226.0,226.0,181.0,209.0,156.0,170.0,144.0,146.0,166.0,252.0,2141.0
Bangalore Rural,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3018.0,5675.0,2990.0,6613.0,5961.0,6538.0,5035.0,3388.0,4443.0,5654.0,6137.0,6311.0,61763.0
Bangalore Rural,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,97.0,191.0,95.0,78.0,135.0,149.0,169.0,187.0,144.0,158.0,166.0,176.0,1745.0
Bangalore Rural,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2066.0,2383.0,2604.0,2547.0,2175.0,2379.0,1800.0,1700.0,2019.0,2000.0,2020.0,1881.0,25574.0
Bangalore Rural,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,25.0,18.0,27.0,20.0,11.0,22.0,20.0,13.0,20.0,11.0,11.0,16.0,214.0
Bangalore Rural,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,973.0,1198.0,1280.0,1347.0,1094.0,1158.0,799.0,870.0,842.0,852.0,823.0,1017.0,12253.0
Bangalore Rural,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,18.0,19.0,39.0,10.0,7.0,20.0,19.0,11.0,11.0,5.0,6.0,6.0,171.0
Bangalore Rural,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1393.0,1787.0,1816.0,1943.0,1992.0,2102.0,1704.0,1710.0,1936.0,1905.0,1943.0,1970.0,22201.0
Bangalore Rural,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,5.0,14.0,5.0,4.0,1.0,3.0,3.0,3.0,0.0,1.0,1.0,42.0
Bangalore Rural,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4432.0,5368.0,5700.0,5837.0,5261.0,5639.0,4303.0,4280.0,4797.0,4757.0,4786.0,4868.0,60028.0
Bangalore Rural,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,45.0,42.0,80.0,35.0,22.0,43.0,42.0,27.0,34.0,16.0,18.0,23.0,427.0
Bangalore Rural,15.2,Number of Widal tests conducted,Number tested,475.0,518.0,626.0,1110.0,1172.0,1118.0,713.0,822.0,728.0,807.0,1346.0,1172.0,10607.0
Bangalore Rural,15.3.a,Number of VDRL tests conducted on males,Number tested,73.0,116.0,77.0,76.0,85.0,41.0,48.0,40.0,70.0,35.0,48.0,47.0,756.0
Bangalore Rural,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,92.0,126.0,139.0,154.0,109.0,104.0,55.0,52.0,66.0,45.0,64.0,65.0,1071.0
Bangalore Rural,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1293.0,1377.0,1386.0,1372.0,1117.0,1029.0,950.0,875.0,1074.0,1012.0,1104.0,1138.0,13727.0
Bangalore Rural,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1458.0,1619.0,1602.0,1602.0,1311.0,1174.0,1053.0,967.0,1210.0,1092.0,1216.0,1250.0,15554.0
Bangalore Rural,15.4.1,Number of blood smears examined for Malaria,TOTAL,12229.0,12517.0,13519.0,13601.0,12932.0,13296.0,11476.0,11887.0,10864.0,10662.0,13163.0,12834.0,148980.0
Bangalore Rural,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,11.0
Bangalore Rural,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,15.0
Bangalore Rural,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1550.0,550.0,550.0,1550.0,3550.0,3550.0,17000.0,13500.0,13000.0,18000.0,15000.0,14500.0,102300.0
Bangalore Rural,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,2500.0,5000.0,15000.0,17000.0,0.0,0.0,8000.0,0.0,0.0,0.0,47500.0
Bangalore Rural,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1000.0,0.0,1500.0,3000.0,15000.0,3550.0,3500.0,500.0,3000.0,3000.0,500.0,500.0,35050.0
Bangalore Rural,16.1.1,Stock position of DPT vaccines,5. Total Stock,550.0,550.0,1550.0,3550.0,3550.0,17000.0,13500.0,13000.0,18000.0,15000.0,14500.0,14000.0,114750.0
Bangalore Rural,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4500.0,2800.0,300.0,3300.0,2300.0,10800.0,9300.0,6800.0,4300.0,4800.0,9000.0,6500.0,64700.0
Bangalore Rural,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,0.0,6000.0,6000.0,15000.0,0.0,0.0,0.0,6000.0,9000.0,0.0,0.0,42000.0
Bangalore Rural,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,1700.0,2500.0,3000.0,7000.0,6500.0,1500.0,2500.0,2500.0,5500.0,4800.0,2500.0,3000.0,43000.0
Bangalore Rural,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2800.0,300.0,3300.0,2300.0,10800.0,9300.0,6800.0,4300.0,4800.0,9000.0,6500.0,3500.0,63700.0
Bangalore Rural,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,10160.0,6160.0,660.0,3160.0,1160.0,10160.0,6160.0,16160.0,2660.0,3500.0,11500.0,1500.0,72940.0
Bangalore Rural,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,0.0,10000.0,10000.0,10000.0,8000.0,20000.0,0.0,10000.0,9000.0,0.0,10000.0,87000.0
Bangalore Rural,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,4000.0,5500.0,7500.0,12000.0,1000.0,12000.0,10000.0,13500.0,9160.0,1000.0,10000.0,1000.0,86660.0
Bangalore Rural,16.1.2,Stock position of OPV vaccines,5. Total Stock,6160.0,660.0,3160.0,1160.0,10160.0,6160.0,16160.0,2660.0,3500.0,11500.0,1500.0,10500.0,73280.0
Bangalore Rural,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,6000.0,4500.0,1500.0,8000.0,500.0,6500.0,11500.0,9000.0,5500.0,11500.0,7000.0,4000.0,75500.0
Bangalore Rural,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,0.0,8000.0,2500.0,20000.0,13000.0,0.0,0.0,10000.0,0.0,0.0,12000.0,65500.0
Bangalore Rural,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1500.0,3000.0,1500.0,10000.0,14000.0,8000.0,2500.0,3500.0,4000.0,4500.0,3000.0,0.0,55500.0
Bangalore Rural,16.1.3,Stock position of TT vaccines,5. Total Stock,4500.0,1500.0,8000.0,500.0,6500.0,11500.0,9000.0,5500.0,11500.0,7000.0,4000.0,16000.0,85500.0
Bangalore Rural,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3500.0,2500.0,1000.0,4900.0,4400.0,6900.0,8900.0,7400.0,5900.0,6900.0,5400.0,4400.0,62100.0
Bangalore Rural,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,0.0,5500.0,3000.0,5000.0,5000.0,0.0,0.0,3000.0,0.0,0.0,10000.0,31500.0
Bangalore Rural,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1000.0,1500.0,1600.0,3500.0,2500.0,3000.0,1500.0,1500.0,2000.0,1500.0,1000.0,500.0,21100.0
Bangalore Rural,16.1.5,Stock position of BCG vaccines,5. Total Stock,2500.0,1000.0,4900.0,4400.0,6900.0,8900.0,7400.0,5900.0,6900.0,5400.0,4400.0,13900.0,72500.0
Bangalore Rural,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3500.0,2750.0,1250.0,2325.0,2825.0,6575.0,7575.0,4575.0,1575.0,3075.0,10000.0,7500.0,53525.0
Bangalore Rural,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,0.0,5000.0,5000.0,5000.0,5000.0,0.0,0.0,5000.0,10000.0,0.0,0.0,35000.0
Bangalore Rural,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,750.0,1500.0,3925.0,4500.0,1250.0,4000.0,3000.0,3000.0,3500.0,3075.0,2500.0,2500.0,33500.0
Bangalore Rural,16.1.6,Stock position of Measles vaccines,5. Total Stock,2750.0,1250.0,2325.0,2825.0,6575.0,7575.0,4575.0,1575.0,3075.0,10000.0,7500.0,5000.0,55025.0
Bangalore Rural,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2000.0,2000.0,2000.0,1500.0,3700.0,7800.0,11300.0,11300.0,10800.0,8800.0,8800.0,6800.0,76800.0
Bangalore Rural,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,3500.0,5100.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,13600.0
Bangalore Rural,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Bangalore Rural,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,500.0,1300.0,1000.0,1500.0,0.0,500.0,2000.0,0.0,2000.0,1600.0,10400.0
Bangalore Rural,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2000.0,2000.0,1500.0,3700.0,7800.0,11300.0,11300.0,10800.0,8800.0,8800.0,6800.0,5200.0,80000.0
Bangalore Rural,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1400.0,1400.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4200.0
Bangalore Rural,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0
Bangalore Rural,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1400.0,1400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2800.0
Bangalore Rural,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12000.0,12000.0,12000.0,0.0,0.0,0.0,0.0,0.0,15120.0,15120.0,0.0,0.0,66240.0
Bangalore Rural,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,151200.0,0.0,0.0,0.0,0.0,151200.0
Bangalore Rural,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,12000.0,0.0,0.0,0.0,0.0,136080.0,0.0,15120.0,0.0,0.0,163200.0
Bangalore Rural,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,12000.0,12000.0,0.0,0.0,0.0,0.0,0.0,15120.0,15120.0,0.0,0.0,0.0,54240.0
Bangalore Rural,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2700.0,2700.0,2700.0,0.0,0.0,0.0,3000.0,3000.0,3000.0,3000.0,0.0,0.0,20100.0
Bangalore Rural,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,0.0,0.0,0.0,0.0,0.0,16000.0
Bangalore Rural,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,2700.0,0.0,0.0,13000.0,0.0,0.0,0.0,3000.0,0.0,0.0,18700.0
Bangalore Rural,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2700.0,2700.0,0.0,0.0,0.0,3000.0,3000.0,3000.0,3000.0,0.0,0.0,0.0,17400.0
Bangalore Rural,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3240.0,3240.0,3240.0,0.0,0.0,0.0,0.0,,,604.0,0.0,0.0,10324.0
Bangalore Rural,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,3240.0,0.0,0.0,0.0,0.0,0.0,0.0,604.0,0.0,0.0,3844.0
Bangalore Rural,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3240.0,3240.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6480.0
Bangalore Rural,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5000.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,4000.0,4000.0,2000.0,2000.0,21000.0
Bangalore Rural,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,10000.0,0.0,0.0,0.0,0.0,20000.0
Bangalore Rural,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,5000.0,0.0,0.0,0.0,0.0,8000.0,0.0,8000.0,0.0,2000.0,0.0,0.0,23000.0
Bangalore Rural,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0,4000.0,4000.0,2000.0,2000.0,2000.0,18000.0
Bangalore Rural,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,18045.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18045.0
Bangalore Rural,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,18045.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18045.0
Bangalore Rural,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,10000.0
Bangalore Rural,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,10000.0
Bangalore Rural,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,79.0,79.0,79.0,79.0,119.0,119.0,119.0,119.0,0.0,0.0,0.0,0.0,792.0
Bangalore Rural,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,500.0
Bangalore Rural,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,460.0,0.0,0.0,0.0,119.0,0.0,0.0,0.0,0.0,579.0
Bangalore Rural,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,79.0,79.0,79.0,119.0,119.0,119.0,119.0,0.0,0.0,0.0,0.0,0.0,713.0
Bangalore Rural,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0
Bangalore Rural,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0
Bangalore Rural,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,1000.0,100.0,0.0,3300.0,2000.0,0.0,2100.0,0.0,0.0,8500.0
Bangalore Rural,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,3300.0,0.0,0.0,3300.0,0.0,0.0,3300.0,0.0,0.0,0.0,9900.0
Bangalore Rural,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,2300.0,900.0,100.0,0.0,1300.0,2000.0,1200.0,2100.0,0.0,0.0,9900.0
Bangalore Rural,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,1000.0,100.0,0.0,3300.0,2000.0,0.0,2100.0,0.0,0.0,0.0,8500.0
Bangalore Rural,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,800.0,800.0,0.0,38000.0,31200.0,14400.0,20800.0,14800.0,16800.0,31200.0,0.0,0.0,168800.0
Bangalore Rural,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,48000.0,0.0,0.0,16000.0,0.0,20000.0,24000.0,0.0,0.0,0.0,108000.0
Bangalore Rural,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,800.0,10000.0,6800.0,16800.0,9600.0,6000.0,18000.0,9600.0,31200.0,0.0,0.0,108800.0
Bangalore Rural,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,800.0,0.0,38000.0,31200.0,14400.0,20800.0,14800.0,16800.0,31200.0,0.0,0.0,0.0,168000.0
Bangalore Rural,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,0.0,0.0,600.0,600.0,0.0,4800.0,3800.0,3800.0,6000.0,0.0,0.0,19600.0
Bangalore Rural,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,2400.0,0.0,0.0,4800.0,0.0,0.0,2400.0,0.0,0.0,0.0,9600.0
Bangalore Rural,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Rural,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,1800.0,0.0,600.0,0.0,1000.0,0.0,200.0,6000.0,0.0,0.0,9600.0
Bangalore Rural,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,600.0,600.0,0.0,4800.0,3800.0,3800.0,6000.0,0.0,0.0,0.0,19600.0
Bangalore Rural,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Bangalore Rural,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,1.0,1.0,,,2.0
Bangalore Rural,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,1.0,1.0,,,1.0,,1.0,5.0
Bangalore Rural,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,,,,1.0,1.0,,1.0,2.0,,1.0,7.0
Bangalore Rural,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,2.0,,,,,,1.0,2.0,3.0,,,9.0
Bangalore Rural,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,1.0,,,2.0
Bangalore Rural,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,2.0,,,,1.0,,1.0,2.0,4.0,,,11.0
Bangalore Rural,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,1.0,,2.0,1.0,1.0,1.0,6.0
Bangalore Rural,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,2.0,1.0,,4.0
Bangalore Rural,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,2.0,,2.0,3.0,2.0,1.0,10.0
Bangalore Rural,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,,,,,2.0,,,,1.0,,1.0,6.0
Bangalore Rural,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Bangalore Rural,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,,,,,2.0,,,,1.0,,2.0,7.0
Bangalore Rural,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,2.0,,1.0,,,1.0,,,5.0
Bangalore Rural,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Bangalore Rural,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,2.0,,1.0,1.0,,1.0,,,6.0
Bangalore Rural,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bangalore Rural,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Rural,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bangalore Rural,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Bangalore Rural,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Rural,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Bangalore Rural,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bangalore Rural,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Rural,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bangalore Rural,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,1.0,,1.0,,1.0,1.0,2.0,3.0,2.0,,13.0
Bangalore Rural,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Rural,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,1.0,,1.0,,1.0,1.0,2.0,3.0,2.0,,13.0
Bangalore Rural,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Bangalore Rural,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,2.0,2.0,,1.0,1.0,2.0,1.0,,2.0,,,11.0
Bangalore Rural,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,1.0,,2.0,1.0,1.0,2.0,,,,,8.0
Bangalore Rural,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,2.0,3.0,,3.0,2.0,3.0,3.0,,2.0,,,19.0
Bangalore Rural,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Bangalore Rural,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,2.0,1.0,,1.0,1.0,,,1.0,1.0,1.0,10.0
Bangalore Rural,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,13.0,3.0,,1.0,4.0,4.0,2.0,6.0,1.0,5.0,8.0,4.0,51.0
Bangalore Rural,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,14.0,4.0,2.0,2.0,4.0,5.0,3.0,6.0,1.0,6.0,10.0,5.0,62.0
Bangalore Rural,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bangalore Rural,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,1.0,1.0,,,,1.0,3.0
Bangalore Rural,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,1.0,1.0,,2.0
Bangalore Rural,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,,,1.0,1.0,,1.0,1.0,1.0,5.0
Bangalore Rural,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,,,1.0,1.0,1.0,1.0,1.0,,,1.0,,6.0
Bangalore Rural,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,,1.0,,,,,,,2.0
Bangalore Rural,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,,1.0,1.0,2.0,1.0,1.0,,,1.0,,8.0
Bangalore Rural,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,13.0,8.0,8.0,7.0,6.0,4.0,8.0,8.0,9.0,11.0,13.0,100.0
Bangalore Rural,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,10.0,10.0,17.0,10.0,10.0,12.0,5.0,14.0,12.0,17.0,19.0,8.0,144.0
Bangalore Rural,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,15.0,23.0,25.0,18.0,17.0,18.0,9.0,22.0,20.0,26.0,30.0,21.0,244.0
Bangalore Rural,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Bangalore Rural,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,1.0,2.0,,2.0,,3.0,3.0,4.0,1.0,1.0,1.0,20.0
Bangalore Rural,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,3.0,7.0,8.0,8.0,4.0,3.0,3.0,7.0,3.0,11.0,4.0,64.0
Bangalore Rural,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,4.0,10.0,8.0,10.0,4.0,6.0,6.0,11.0,4.0,12.0,5.0,85.0
Bangalore Rural,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bangalore Rural,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Bangalore Rural,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Bangalore Rural,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Bangalore Rural,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,1.0,,1.0
Bangalore Rural,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Bangalore Rural,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,1.0,,1.0
Bangalore Rural,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bangalore Rural,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,2.0,,,,1.0,,,1.0,,,6.0
Bangalore Rural,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Rural,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,2.0,,,,1.0,,,1.0,,,6.0
Bangalore Rural,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,,2.0,1.0,,,,,,5.0
Bangalore Rural,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,10.0,6.0,7.0,11.0,13.0,16.0,7.0,8.0,5.0,4.0,7.0,8.0,102.0
Bangalore Rural,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,,3.0,2.0,2.0,1.0,3.0,3.0,2.0,1.0,4.0,2.0,25.0
Bangalore Rural,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,12.0,7.0,11.0,13.0,15.0,19.0,11.0,11.0,7.0,5.0,11.0,10.0,132.0
Bangalore Rural,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Rural,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,13.0,8.0,11.0,7.0,16.0,12.0,3.0,6.0,6.0,4.0,7.0,9.0,102.0
Bangalore Rural,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,1.0,2.0,1.0,,1.0,,1.0,1.0,,,,9.0
Bangalore Rural,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,15.0,9.0,13.0,8.0,16.0,13.0,3.0,7.0,7.0,4.0,7.0,9.0,111.0
Bangalore Rural,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Bangalore Rural,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,1.0,,,,1.0,,1.0,,3.0
Bangalore Rural,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Bangalore Rural,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,,,1.0,1.0,,,2.0,,1.0,,5.0
Bangalore Rural,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Bangalore Rural,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,6.0,8.0,3.0,3.0,4.0,2.0,7.0,2.0,4.0,6.0,6.0,54.0
Bangalore Rural,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,17.0,15.0,13.0,22.0,12.0,15.0,12.0,5.0,17.0,11.0,14.0,12.0,165.0
Bangalore Rural,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,20.0,21.0,21.0,25.0,15.0,19.0,15.0,12.0,19.0,15.0,20.0,18.0,220.0
Bangalore Rural,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,1.0,,,,,2.0
Bangalore Rural,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,4.0,2.0,2.0,5.0,4.0,10.0,4.0,4.0,7.0,8.0,7.0,8.0,65.0
Bangalore Rural,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,22.0,6.0,11.0,8.0,19.0,14.0,6.0,8.0,13.0,10.0,18.0,16.0,151.0
Bangalore Rural,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,26.0,8.0,13.0,13.0,23.0,25.0,10.0,13.0,20.0,18.0,25.0,24.0,218.0
Bangalore Rural,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,,,,1.0,,2.0,,,2.0,6.0
Bangalore Rural,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,13.0,9.0,22.0,21.0,15.0,20.0,17.0,14.0,18.0,19.0,14.0,19.0,201.0
Bangalore Rural,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,70.0,46.0,38.0,51.0,52.0,65.0,68.0,72.0,54.0,56.0,80.0,71.0,723.0
Bangalore Rural,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,84.0,55.0,60.0,72.0,67.0,85.0,86.0,86.0,74.0,75.0,94.0,92.0,930.0
Bangalore Urban,1.1,Total number of pregnant women Registered for ANC,TOTAL,13335.0,14587.0,13395.0,13694.0,12747.0,29546.0,21947.0,15529.0,22390.0,22038.0,19909.0,23039.0,222156.0
Bangalore Urban,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,6765.0,7471.0,7206.0,7541.0,7014.0,19571.0,14713.0,9059.0,12342.0,10871.0,11997.0,10928.0,125478.0
Bangalore Urban,1.2,Number of Pregnant women registered under JSY,TOTAL,2365.0,2580.0,2531.0,2703.0,2411.0,2736.0,2074.0,2714.0,3779.0,3997.0,4643.0,4105.0,36638.0
Bangalore Urban,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,10138.0,10752.0,10145.0,11284.0,10486.0,22936.0,18993.0,12864.0,16392.0,15395.0,16225.0,15922.0,171532.0
Bangalore Urban,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,12714.0,11776.0,13193.0,14211.0,13141.0,30355.0,22098.0,15637.0,15700.0,15329.0,15152.0,16052.0,195358.0
Bangalore Urban,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,12124.0,11708.0,11810.0,13615.0,12039.0,27951.0,20791.0,14995.0,15809.0,15357.0,14954.0,16102.0,187255.0
Bangalore Urban,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,11971.0,11731.0,9107.0,11425.0,12603.0,29058.0,21795.0,13465.0,16111.0,14385.0,14349.0,16977.0,182977.0
Bangalore Urban,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,147.0,156.0,113.0,164.0,77.0,776.0,699.0,382.0,988.0,1187.0,904.0,807.0,6400.0
Bangalore Urban,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,6.0,2.0,2.0,5.0,68.0,73.0,22.0,89.0,87.0,31.0,198.0,583.0
Bangalore Urban,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2944.0,3782.0,3996.0,4908.0,3761.0,6369.0,4912.0,6854.0,13450.0,10665.0,9459.0,9975.0,81075.0
Bangalore Urban,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,81.0,66.0,86.0,110.0,116.0,292.0,253.0,214.0,286.0,407.0,336.0,562.0,2809.0
Bangalore Urban,1.8,Number of pregnancy test kits used at SC level,TOTAL,135.0,136.0,169.0,207.0,195.0,235.0,204.0,241.0,298.0,319.0,403.0,429.0,2971.0
Bangalore Urban,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,0.0,4.0
Bangalore Urban,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,3.0,3.0,0.0,8.0
Bangalore Urban,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,5.0,4.0,0.0,12.0
Bangalore Urban,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,11.0
Bangalore Urban,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,5830.0,6767.0,5021.0,4933.0,4249.0,8615.0,7733.0,3412.0,5735.0,5205.0,5099.0,5513.0,68112.0
Bangalore Urban,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,100.0,105.0,171.0,160.0,138.0,299.0,424.0,368.0,795.0,551.0,1288.0,941.0,5340.0
Bangalore Urban,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,398.0,478.0,524.0,519.0,281.0,646.0,472.0,719.0,1512.0,1673.0,718.0,646.0,8586.0
Bangalore Urban,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,21.0,20.0,37.0,14.0,0.0,148.0,0.0,19.0,3.0,22.0,16.0,18.0,318.0
Bangalore Urban,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1684.0,1897.0,1613.0,731.0,978.0,9799.0,7796.0,2914.0,2994.0,2700.0,2517.0,2463.0,38086.0
Bangalore Urban,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1098.0,1580.0,1139.0,572.0,907.0,983.0,590.0,472.0,416.0,408.0,315.0,389.0,8869.0
Bangalore Urban,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,29.0,147.0,124.0,122.0,166.0,918.0,2133.0,260.0,1003.0,1062.0,953.0,988.0,7905.0
Bangalore Urban,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,1127.0,1727.0,1263.0,694.0,1073.0,1901.0,2723.0,732.0,1419.0,1470.0,1268.0,1377.0,16774.0
Bangalore Urban,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,540.0,431.0,407.0,231.0,189.0,872.0,4934.0,586.0,706.0,541.0,614.0,715.0,10766.0
Bangalore Urban,4.1.1.a,Number of male live births,TOTAL,3942.0,4401.0,3321.0,3058.0,2685.0,9214.0,7660.0,3266.0,4506.0,4508.0,3839.0,4104.0,54504.0
Bangalore Urban,4.1.1.b,Number of female live births,TOTAL,3660.0,4252.0,3358.0,2826.0,2668.0,9144.0,7775.0,3060.0,4298.0,4046.0,3866.0,3947.0,52900.0
Bangalore Urban,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,7602.0,8653.0,6679.0,5884.0,5353.0,18358.0,15435.0,6326.0,8804.0,8554.0,7705.0,8051.0,107404.0
Bangalore Urban,4.1.2,Number of still births,TOTAL,7.0,14.0,12.0,8.0,10.0,44.0,29.0,17.0,23.0,23.0,48.0,31.0,266.0
Bangalore Urban,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,120.0,194.0,205.0,201.0,135.0,263.0,273.0,153.0,347.0,298.0,284.0,311.0,2784.0
Bangalore Urban,4.2.1,Number of Newborns weighed at birth,TOTAL,7541.0,8618.0,6135.0,5738.0,5244.0,18371.0,15245.0,6019.0,8806.0,8279.0,7668.0,8049.0,105713.0
Bangalore Urban,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,331.0,379.0,307.0,324.0,289.0,449.0,355.0,352.0,790.0,620.0,784.0,729.0,5709.0
Bangalore Urban,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,7479.0,8616.0,6131.0,5688.0,5244.0,18298.0,15236.0,5985.0,8184.0,7553.0,7143.0,7156.0,102713.0
Bangalore Urban,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,2.0,4.0,0.0,0.0,0.0,5.0,0.0,14.0,0.0,3.0,28.0
Bangalore Urban,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,18.0,57.0,120.0,21.0,33.0,230.0,222.0,103.0,181.0,175.0,93.0,19.0,1272.0
Bangalore Urban,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,15.0,17.0,80.0,49.0,39.0,71.0,35.0,35.0,746.0,788.0,559.0,421.0,2855.0
Bangalore Urban,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,33.0,74.0,202.0,74.0,72.0,301.0,257.0,143.0,927.0,977.0,652.0,443.0,4155.0
Bangalore Urban,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,11.0,9.0,7.0,8.0,4.0,64.0,42.0,19.0,27.0,17.0,7.0,19.0,234.0
Bangalore Urban,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1141.0,1633.0,1358.0,285.0,1008.0,1629.0,3500.0,866.0,1489.0,1505.0,1152.0,1260.0,16826.0
Bangalore Urban,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,40.0,182.0,18.0,111.0,57.0,57.0,68.0,8.0,321.0,336.0,250.0,289.0,1737.0
Bangalore Urban,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,4183.0,4253.0,3284.0,757.0,2259.0,5011.0,7755.0,1697.0,1827.0,1830.0,1721.0,1942.0,36519.0
Bangalore Urban,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,59.0,50.0,32.0,103.0,15.0,46.0,23.0,11.0,101.0,177.0,159.0,194.0,970.0
Bangalore Urban,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,7047.0,8197.0,5766.0,3352.0,4742.0,18007.0,13716.0,5350.0,7152.0,7070.0,6829.0,7356.0,94584.0
Bangalore Urban,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3432.0,4308.0,3931.0,3166.0,3859.0,11578.0,7654.0,3928.0,4247.0,4333.0,5204.0,5890.0,61530.0
Bangalore Urban,6.3,PNC maternal complications attended,TOTAL,4.0,12.0,12.0,4.0,12.0,138.0,118.0,25.0,135.0,190.0,17.0,21.0,688.0
Bangalore Urban,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,96.0,141.0,140.0,175.0,109.0,145.0,107.0,120.0,193.0,199.0,237.0,202.0,1864.0
Bangalore Urban,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,15.0,12.0,20.0,14.0,32.0,30.0,33.0,107.0,55.0,56.0,46.0,425.0
Bangalore Urban,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,101.0,156.0,152.0,195.0,123.0,177.0,137.0,153.0,300.0,254.0,293.0,248.0,2289.0
Bangalore Urban,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,85.0,102.0,85.0,72.0,51.0,71.0,71.0,537.0
Bangalore Urban,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,558.0,586.0,732.0,855.0,681.0,1353.0,1323.0,765.0,867.0,889.0,1005.0,1030.0,10644.0
Bangalore Urban,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1257.0,1415.0,1344.0,1371.0,941.0,2141.0,2021.0,1639.0,2164.0,2180.0,2397.0,2348.0,21218.0
Bangalore Urban,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1815.0,2001.0,2076.0,2226.0,1622.0,3494.0,3344.0,2404.0,3031.0,3069.0,3402.0,3378.0,31862.0
Bangalore Urban,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,19.0,6.0,0.0,0.0,0.0,0.0,44.0,87.0,38.0,40.0,41.0,275.0
Bangalore Urban,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,1.0,1.0,0.0,0.0,12.0,1.0,0.0,0.0,0.0,15.0
Bangalore Urban,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,5.0,9.0,12.0,17.0,4.0,3.0,5.0,14.0,13.0,15.0,16.0,20.0,133.0
Bangalore Urban,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,5.0,9.0,12.0,18.0,5.0,3.0,5.0,26.0,14.0,15.0,16.0,20.0,148.0
Bangalore Urban,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,3.0,1.0,1.0,1.0,0.0,0.0,3.0,1.0,2.0,0.0,0.0,12.0
Bangalore Urban,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,71.0,28.0,30.0,41.0,0.0,43.0,32.0,70.0,43.0,49.0,33.0,48.0,488.0
Bangalore Urban,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,1206.0,1090.0,425.0,387.0,355.0,323.0,245.0,325.0,280.0,269.0,385.0,373.0,5663.0
Bangalore Urban,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,287.0,482.0,396.0,444.0,379.0,3448.0,2621.0,1011.0,1174.0,1078.0,1242.0,1112.0,13674.0
Bangalore Urban,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,1564.0,1600.0,851.0,872.0,734.0,3814.0,2898.0,1406.0,1497.0,1396.0,1660.0,1533.0,19825.0
Bangalore Urban,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,324.0,644.0,576.0,527.0,400.0,4619.0,3808.0,1100.0,1633.0,1866.0,1506.0,971.0,17974.0
Bangalore Urban,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0
Bangalore Urban,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,132.0,143.0,124.0,207.0,68.0,138.0,54.0,71.0,155.0,180.0,103.0,122.0,1497.0
Bangalore Urban,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,78.0,189.0,141.0,136.0,105.0,545.0,562.0,310.0,430.0,336.0,476.0,441.0,3749.0
Bangalore Urban,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,210.0,332.0,265.0,343.0,173.0,683.0,616.0,381.0,585.0,516.0,580.0,563.0,5247.0
Bangalore Urban,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,344.0,313.0,237.0,398.0,387.0,962.0,771.0,629.0,653.0,678.0,769.0,690.0,6831.0
Bangalore Urban,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,5.0
Bangalore Urban,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,137.0,148.0,156.0,75.0,124.0,88.0,134.0,190.0,10.0,52.0,64.0,65.0,1243.0
Bangalore Urban,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,10.0,4.0,8.0,16.0,6.0,3108.0,2325.0,242.0,209.0,131.0,122.0,198.0,6379.0
Bangalore Urban,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,147.0,152.0,164.0,91.0,130.0,3196.0,2459.0,432.0,219.0,183.0,191.0,263.0,7627.0
Bangalore Urban,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,298.0,422.0,202.0,309.0,164.0,722.0,541.0,293.0,115.0,70.0,228.0,92.0,3456.0
Bangalore Urban,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,353.0,361.0,387.0,424.0,334.0,365.0,271.0,316.0,317.0,290.0,237.0,240.0,3895.0
Bangalore Urban,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,378.0,405.0,470.0,566.0,418.0,459.0,419.0,406.0,454.0,364.0,372.0,466.0,5177.0
Bangalore Urban,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1232.0,1141.0,676.0,784.0,653.0,627.0,540.0,529.0,602.0,562.0,629.0,614.0,8589.0
Bangalore Urban,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,49.0,62.0,36.0,51.0,132.0,3588.0,3349.0,340.0,612.0,582.0,538.0,574.0,9913.0
Bangalore Urban,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bangalore Urban,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,2012.0,1969.0,1569.0,1825.0,1537.0,5039.0,4579.0,1591.0,1985.0,1798.0,1776.0,1894.0,27574.0
Bangalore Urban,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,16.0,37.0,8.0,71.0,57.0,56.0,123.0,59.0,71.0,78.0,63.0,185.0,824.0
Bangalore Urban,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,201.0,484.0,524.0,277.0,401.0,1695.0,1171.0,638.0,722.0,656.0,582.0,471.0,7822.0
Bangalore Urban,9.06,Number of IUCD removals,TOTAL,369.0,646.0,541.0,1061.0,474.0,781.0,731.0,741.0,785.0,929.0,911.0,1033.0,9002.0
Bangalore Urban,9.07,Number of Oral Pills cycles distributed,TOTAL,18521.0,19587.0,17424.0,18377.0,21273.0,22979.0,24195.0,24725.0,25782.0,25665.0,26527.0,26339.0,271394.0
Bangalore Urban,9.08,Number of Condom pieces distributed,TOTAL,166204.0,165987.0,164018.0,167340.0,201332.0,189623.0,202918.0,222980.0,215727.0,219396.0,227389.0,196627.0,2339541.0
Bangalore Urban,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,7.0,4.0,1.0,2.0,341.0,357.0,4.0,11.0,10.0,9.0,746.0
Bangalore Urban,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Urban,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Urban,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,4.0,7.0,20.0,7.0,7.0,8.0,7.0,11.0,11.0,13.0,12.0,-1.0
Bangalore Urban,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,9002.0,8895.0,7362.0,6764.0,5751.0,18230.0,15608.0,8561.0,11443.0,10839.0,10415.0,9887.0,122757.0
Bangalore Urban,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,1.0,0.0,1.0,356.0,27.0,0.0,0.0,0.0,126.0,186.0,196.0,232.0,1125.0
Bangalore Urban,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,2.0,6.0,362.0,34.0,0.0,0.0,0.0,100.0,128.0,124.0,202.0,958.0
Bangalore Urban,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,29.0,7.0,10.0,417.0,20.0,0.0,0.0,0.0,84.0,123.0,132.0,72.0,894.0
Bangalore Urban,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,7330.0,7545.0,7717.0,7777.0,7207.0,9940.0,11383.0,9037.0,9901.0,9211.0,9481.0,9474.0,106003.0
Bangalore Urban,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7323.0,7348.0,8044.0,7809.0,7233.0,10079.0,11337.0,9192.0,9930.0,9323.0,9437.0,10029.0,107084.0
Bangalore Urban,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,7599.0,7645.0,8115.0,8312.0,7567.0,10261.0,11498.0,9295.0,10056.0,9614.0,9545.0,10169.0,109676.0
Bangalore Urban,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,7825.0,8231.0,6596.0,6156.0,5441.0,18063.0,15451.0,7841.0,10094.0,9021.0,9122.0,9532.0,113373.0
Bangalore Urban,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7308.0,7727.0,7748.0,7747.0,7204.0,9961.0,11396.0,9042.0,9845.0,9231.0,9483.0,9516.0,106208.0
Bangalore Urban,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7346.0,7541.0,8091.0,7798.0,7217.0,10084.0,11345.0,9165.0,9859.0,9334.0,9425.0,10033.0,107238.0
Bangalore Urban,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,7586.0,7849.0,8142.0,8319.0,7532.0,10310.0,10564.0,9247.0,9983.0,9641.0,11993.0,10180.0,111346.0
Bangalore Urban,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,7395.0,8612.0,5967.0,5150.0,5135.0,18252.0,15220.0,6324.0,8123.0,7873.0,7272.0,7362.0,102685.0
Bangalore Urban,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,246.0,218.0,4.0,0.0,0.0,155.0,192.0,170.0,142.0,1127.0
Bangalore Urban,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,2.0,5.0,201.0,111.0,1.0,0.0,0.0,131.0,128.0,80.0,68.0,727.0
Bangalore Urban,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,7.0,13.0,260.0,2.0,0.0,0.0,0.0,117.0,123.0,80.0,127.0,729.0
Bangalore Urban,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7677.0,8108.0,8799.0,8949.0,7805.0,13547.0,11508.0,10218.0,10761.0,9976.0,10225.0,10624.0,118197.0
Bangalore Urban,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,5529.0,6484.0,6822.0,8102.0,7036.0,12631.0,10398.0,9587.0,10045.0,9123.0,10388.0,9684.0,105829.0
Bangalore Urban,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3877.0,4093.0,4342.0,4373.0,3930.0,6884.0,5768.0,5142.0,5907.0,5945.0,5856.0,5911.0,62028.0
Bangalore Urban,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3753.0,3846.0,4161.0,4129.0,3730.0,6574.0,5674.0,4829.0,5632.0,5523.0,5736.0,5526.0,59113.0
Bangalore Urban,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,7630.0,7939.0,8503.0,8502.0,7660.0,13458.0,11442.0,9971.0,11539.0,11468.0,11592.0,11437.0,121141.0
Bangalore Urban,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,7147.0,7478.0,8114.0,8322.0,7166.0,12802.0,10705.0,9632.0,10030.0,9236.0,10001.0,9794.0,110427.0
Bangalore Urban,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,7147.0,7476.0,8046.0,8335.0,7157.0,12800.0,10707.0,9590.0,10018.0,9218.0,9993.0,9780.0,110267.0
Bangalore Urban,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,391.0,490.0,323.0,104.0,37.0,103.0,90.0,28.0,55.0,303.0,72.0,292.0,2288.0
Bangalore Urban,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1841.0,1591.0,1801.0,2489.0,2154.0,4789.0,3679.0,2914.0,3783.0,4350.0,4113.0,4371.0,37875.0
Bangalore Urban,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1825.0,1538.0,1706.0,2142.0,2077.0,4612.0,3597.0,2891.0,3520.0,3875.0,4014.0,3992.0,35789.0
Bangalore Urban,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3666.0,3129.0,3507.0,4631.0,4231.0,9401.0,7276.0,5805.0,7303.0,8225.0,8127.0,8363.0,73664.0
Bangalore Urban,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,4682.0,5485.0,4760.0,5698.0,6930.0,13128.0,7390.0,9872.0,8302.0,8625.0,7831.0,5338.0,88041.0
Bangalore Urban,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,3841.0,4267.0,3771.0,5195.0,6150.0,12774.0,6486.0,9106.0,7628.0,7858.0,6733.0,4505.0,78314.0
Bangalore Urban,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,2488.0,2660.0,2588.0,4460.0,4125.0,10345.0,5231.0,8327.0,6439.0,5944.0,5751.0,3711.0,62069.0
Bangalore Urban,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Bangalore Urban,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Bangalore Urban,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,1.0,7.0
Bangalore Urban,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1634.0,1626.0,1837.0,1795.0,1748.0,1875.0,1798.0,1898.0,3054.0,1894.0,1996.0,2006.0,23161.0
Bangalore Urban,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1486.0,1500.0,1711.0,1726.0,1643.0,1777.0,1693.0,1803.0,1887.0,1757.0,1866.0,1886.0,20735.0
Bangalore Urban,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,566.0,587.0,654.0,530.0,599.0,642.0,579.0,574.0,556.0,505.0,538.0,614.0,6944.0
Bangalore Urban,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,6973.0,7936.0,8481.0,8571.0,7780.0,8739.0,8262.0,8533.0,9517.0,8793.0,8726.0,9769.0,102080.0
Bangalore Urban,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2260.0,3396.0,2580.0,8832.0,53520.0,4933.0,4491.0,3699.0,4569.0,4151.0,42417.0,8588.0,143436.0
Bangalore Urban,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,798.0,929.0,877.0,7321.0,40666.0,1823.0,930.0,945.0,1273.0,1978.0,34208.0,3133.0,94881.0
Bangalore Urban,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,0.0,26.0,31.0,0.0,4.0,2.0,67.0
Bangalore Urban,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,394.0,359.0,321.0,542.0,310.0,713.0,1009.0,697.0,1102.0,947.0,637.0,756.0,7787.0
Bangalore Urban,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,2.0,0.0,5.0
Bangalore Urban,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,154.0,20.0,11.0,31.0,35.0,702.0,615.0,296.0,386.0,413.0,476.0,442.0,3581.0
Bangalore Urban,13.1,Number of Patients operated for cataract,TOTAL,238.0,281.0,243.0,110.0,202.0,37.0,139.0,203.0,380.0,279.0,275.0,286.0,2673.0
Bangalore Urban,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,238.0,268.0,243.0,110.0,202.0,37.0,139.0,203.0,289.0,254.0,266.0,285.0,2534.0
Bangalore Urban,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,24.0,48.0,36.0,0.0,69.0,153.0,75.0,301.0,87.0,793.0
Bangalore Urban,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,27.0,90.0,0.0,23.0,1.0,1.0,109.0,224.0,475.0
Bangalore Urban,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,4.0
Bangalore Urban,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,0.0,4.0
Bangalore Urban,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,5.0,5.0,7.0,7.0,8.0,14.0,13.0,20.0,11.0,-1.0
Bangalore Urban,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,23.0,24.0,24.0,29.0,20.0,18.0,16.0,18.0,22.0,19.0,16.0,22.0,-1.0
Bangalore Urban,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,323.0,322.0,337.0,374.0,348.0,357.0,363.0,374.0,379.0,346.0,374.0,370.0,-1.0
Bangalore Urban,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,3.0,4.0,7.0,6.0,5.0,9.0,6.0,10.0,12.0,13.0,9.0,-1.0
Bangalore Urban,14.05,Number of RKS meetings held during the month,TOTAL,20.0,26.0,23.0,24.0,20.0,20.0,27.0,24.0,30.0,37.0,54.0,35.0,340.0
Bangalore Urban,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,29.0,26.0,26.0,34.0,25.0,26.0,25.0,26.0,25.0,33.0,27.0,30.0,-1.0
Bangalore Urban,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,174.0,205.0,157.0,133.0,86.0,132.0,124.0,101.0,292.0,255.0,352.0,353.0,2364.0
Bangalore Urban,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,1.0,2.0,2.0,4.0,5.0,3.0,3.0,4.0,8.0,10.0,9.0,9.0,-1.0
Bangalore Urban,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,13.0,10.0,4.0,7.0,22.0,11.0,10.0,13.0,23.0,29.0,15.0,20.0,-1.0
Bangalore Urban,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,420.0,282.0,86.0,369.0,367.0,1306.0,1138.0,798.0,2773.0,2019.0,1613.0,1592.0,12763.0
Bangalore Urban,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1623.0,1674.0,679.0,1565.0,1635.0,2921.0,2701.0,2312.0,3568.0,5282.0,5293.0,5542.0,34795.0
Bangalore Urban,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,482.0,341.0,93.0,340.0,363.0,1234.0,1044.0,1006.0,2207.0,2971.0,1532.0,1470.0,13083.0
Bangalore Urban,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4510.0,4966.0,3953.0,5375.0,5389.0,6343.0,5994.0,5608.0,9083.0,10475.0,10730.0,12141.0,84567.0
Bangalore Urban,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,902.0,623.0,179.0,709.0,730.0,2540.0,2182.0,1804.0,4980.0,4990.0,3145.0,3062.0,25846.0
Bangalore Urban,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6133.0,6640.0,4632.0,6940.0,7024.0,9264.0,8695.0,7920.0,12651.0,15757.0,16023.0,17683.0,119362.0
Bangalore Urban,14.10.2.a,Number of death cases of Inpatient males,TOTAL,18.0,7.0,17.0,4.0,5.0,7.0,3.0,28.0,280.0,474.0,330.0,293.0,1466.0
Bangalore Urban,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,6.0,14.0,1.0,2.0,2.0,64.0,6.0,373.0,149.0,161.0,178.0,961.0
Bangalore Urban,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,23.0,13.0,31.0,5.0,7.0,9.0,67.0,34.0,653.0,623.0,491.0,471.0,2427.0
Bangalore Urban,14.11,In-Patient Head Count at midnight,TOTAL,12985.0,12687.0,12607.0,11168.0,8250.0,15817.0,13989.0,9563.0,53730.0,52566.0,56540.0,60063.0,319965.0
Bangalore Urban,14.12.1,OPD attendance (All),TOTAL,197242.0,176021.0,202298.0,183395.0,204411.0,210940.0,196909.0,204529.0,325884.0,321714.0,334822.0,371162.0,2929327.0
Bangalore Urban,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1247.0,1368.0,1110.0,1606.0,888.0,8470.0,9286.0,2561.0,3485.0,3260.0,3230.0,3420.0,39931.0
Bangalore Urban,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,12.0,0.0,6.0,24.0,1.0,227.0,216.0,419.0,364.0,340.0,534.0,525.0,2668.0
Bangalore Urban,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,614.0,127.0,74.0,621.0,241.0,7586.0,11163.0,720.0,4714.0,4436.0,3978.0,4901.0,39175.0
Bangalore Urban,14.14.a,Number of patients given AYUSH treatment,TOTAL,771.0,0.0,0.0,812.0,851.0,837.0,85.0,841.0,1163.0,1576.0,1183.0,1150.0,9269.0
Bangalore Urban,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,657.0,195.0,204.0,183.0,257.0,1352.0,1197.0,696.0,1483.0,1333.0,2077.0,1569.0,11203.0
Bangalore Urban,14.14.c,Number of Adolescents counselled,TOTAL,274.0,238.0,285.0,249.0,258.0,842.0,942.0,584.0,546.0,573.0,574.0,637.0,6002.0
Bangalore Urban,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7207.0,10423.0,8640.0,77957.0,17269.0,21240.0,30624.0,19133.0,25784.0,35984.0,36325.0,23647.0,314233.0
Bangalore Urban,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,47.0,301.0,127.0,361.0,117.0,692.0,478.0,208.0,1037.0,555.0,624.0,629.0,5176.0
Bangalore Urban,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2559.0,3443.0,3308.0,4079.0,4946.0,12096.0,6083.0,4587.0,5464.0,5490.0,5148.0,6053.0,63256.0
Bangalore Urban,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,20.0,39.0,61.0,180.0,27.0,56.0,25.0,26.0,108.0,86.0,85.0,80.0,793.0
Bangalore Urban,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2638.0,3288.0,2405.0,3292.0,2873.0,8311.0,5990.0,3996.0,5457.0,4559.0,4819.0,5946.0,53574.0
Bangalore Urban,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,24.0,303.0,23.0,29.0,54.0,19.0,17.0,45.0,48.0,54.0,62.0,681.0
Bangalore Urban,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,4735.0,6446.0,5614.0,8094.0,7774.0,16499.0,8990.0,7000.0,9567.0,8394.0,8482.0,8579.0,100174.0
Bangalore Urban,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,7.0,10.0,232.0,10.0,4.0,57.0,9.0,6.0,9.0,18.0,30.0,6.0,398.0
Bangalore Urban,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,9932.0,13177.0,11327.0,15465.0,15593.0,36906.0,21063.0,15583.0,20488.0,18443.0,18449.0,20578.0,217004.0
Bangalore Urban,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,30.0,73.0,596.0,213.0,60.0,167.0,53.0,49.0,162.0,152.0,169.0,148.0,1872.0
Bangalore Urban,15.2,Number of Widal tests conducted,Number tested,163.0,189.0,497.0,881.0,531.0,15087.0,16105.0,2034.0,3971.0,3406.0,3807.0,5157.0,51828.0
Bangalore Urban,15.3.a,Number of VDRL tests conducted on males,Number tested,373.0,284.0,385.0,466.0,475.0,8889.0,7959.0,877.0,1476.0,829.0,1151.0,2717.0,25881.0
Bangalore Urban,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,189.0,435.0,427.0,756.0,627.0,5839.0,9111.0,817.0,1897.0,1752.0,2005.0,4188.0,28043.0
Bangalore Urban,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1946.0,1849.0,2095.0,2080.0,2128.0,13163.0,10197.0,2810.0,5892.0,6508.0,5238.0,5785.0,59691.0
Bangalore Urban,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2508.0,2568.0,2907.0,3302.0,3230.0,27891.0,27267.0,4504.0,9265.0,9089.0,8394.0,12690.0,113615.0
Bangalore Urban,15.4.1,Number of blood smears examined for Malaria,TOTAL,13511.0,15168.0,17779.0,15289.0,16576.0,15995.0,15798.0,19253.0,18629.0,16384.0,18605.0,26801.0,209788.0
Bangalore Urban,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,75.0,0.0,0.0,1.0,1.0,1.0,1.0,0.0,67.0,0.0,89.0,9.0,244.0
Bangalore Urban,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,2.0,7.0
Bangalore Urban,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,440.0,4320.0,9820.0,16580.0,5680.0,18480.0,23130.0,14530.0,32380.0,22610.0,17010.0,32210.0,197190.0
Bangalore Urban,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,15000.0,10000.0,10000.0,20000.0,20000.0,0.0,30000.0,,0.0,24000.0,,139000.0
Bangalore Urban,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6120.0,9500.0,3240.0,20900.0,7200.0,15350.0,8600.0,12150.0,9770.0,5600.0,8800.0,6770.0,114000.0
Bangalore Urban,16.1.1,Stock position of DPT vaccines,5. Total Stock,4320.0,9820.0,16580.0,5680.0,18480.0,23130.0,14530.0,32380.0,22610.0,17010.0,32210.0,25440.0,222190.0
Bangalore Urban,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,33370.0,23330.0,12430.0,28450.0,14400.0,24460.0,12710.0,14460.0,19710.0,8430.0,980.0,12600.0,205330.0
Bangalore Urban,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,,21000.0,,20000.0,,12000.0,15000.0,,0.0,21000.0,,89000.0
Bangalore Urban,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,10040.0,10900.0,4980.0,14050.0,9940.0,11750.0,10250.0,9750.0,11280.0,7450.0,9380.0,9750.0,119520.0
Bangalore Urban,16.1.1A,Stock Position of Pentavalent,5. Total Stock,23330.0,12430.0,28450.0,14400.0,24460.0,12710.0,14460.0,19710.0,8430.0,980.0,12600.0,2850.0,174810.0
Bangalore Urban,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9900.0,10240.0,6040.0,13300.0,14740.0,35540.0,48540.0,22240.0,32240.0,10000.0,1400.0,23300.0,227480.0
Bangalore Urban,16.1.2,Stock position of OPV vaccines,2. Stocks Received,20000.0,18420.0,25000.0,30000.0,40000.0,40000.0,0.0,36000.0,,0.0,36000.0,,245420.0
Bangalore Urban,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,19660.0,22620.0,17740.0,28560.0,19200.0,27000.0,26300.0,26000.0,22240.0,8600.0,14100.0,11360.0,243380.0
Bangalore Urban,16.1.2,Stock position of OPV vaccines,5. Total Stock,10240.0,6040.0,13300.0,14740.0,35540.0,48540.0,22240.0,32240.0,10000.0,1400.0,23300.0,11940.0,229520.0
Bangalore Urban,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,37090.0,25420.0,12590.0,23710.0,15490.0,23490.0,31490.0,20040.0,33190.0,22060.0,13910.0,23170.0,281650.0
Bangalore Urban,16.1.3,Stock position of TT vaccines,2. Stocks Received,,,20000.0,10000.0,20000.0,30000.0,0.0,30000.0,,0.0,20000.0,,130000.0
Bangalore Urban,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bangalore Urban,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11670.0,12830.0,8880.0,18220.0,12000.0,22000.0,11450.0,16850.0,11130.0,8150.0,10740.0,10850.0,154770.0
Bangalore Urban,16.1.3,Stock position of TT vaccines,5. Total Stock,25420.0,12590.0,23710.0,15490.0,23490.0,31490.0,20040.0,33190.0,22060.0,13910.0,23170.0,12320.0,256880.0
Bangalore Urban,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,0.0,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8990.0,2780.0,7010.0,11240.0,7740.0,17490.0,20940.0,19590.0,18590.0,12230.0,11840.0,15740.0,154180.0
Bangalore Urban,16.1.5,Stock position of BCG vaccines,2. Stocks Received,,10000.0,10000.0,5000.0,14000.0,10000.0,0.0,5000.0,,0.0,10000.0,,64000.0
Bangalore Urban,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bangalore Urban,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6210.0,5770.0,5770.0,8500.0,4250.0,6550.0,1350.0,6000.0,6360.0,390.0,6100.0,4850.0,62100.0
Bangalore Urban,16.1.5,Stock position of BCG vaccines,5. Total Stock,2780.0,7010.0,11240.0,7740.0,17490.0,20940.0,19590.0,18590.0,12230.0,11840.0,15740.0,10890.0,156080.0
Bangalore Urban,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,22190.0,12785.0,6230.0,18450.0,9175.0,13675.0,17225.0,11025.0,20150.0,8520.0,2820.0,9645.0,151890.0
Bangalore Urban,16.1.6,Stock position of Measles vaccines,2. Stocks Received,500.0,,20000.0,,10000.0,15000.0,,20000.0,,0.0,15000.0,10000.0,90500.0
Bangalore Urban,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9905.0,6555.0,7780.0,9275.0,5500.0,11450.0,6200.0,10875.0,11630.0,5700.0,8175.0,10050.0,103095.0
Bangalore Urban,16.1.6,Stock position of Measles vaccines,5. Total Stock,12785.0,6230.0,18450.0,9175.0,13675.0,17225.0,11025.0,20150.0,8520.0,2820.0,9645.0,9595.0,139295.0
Bangalore Urban,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,0.0,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,6690.0,5070.0,3600.0,11900.0,10800.0,10200.0,9550.0,8700.0,21950.0,21550.0,18950.0,25050.0,154010.0
Bangalore Urban,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,9000.0,,,,0.0,15000.0,,0.0,10000.0,,34000.0
Bangalore Urban,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1620.0,1470.0,700.0,1100.0,600.0,650.0,850.0,1750.0,400.0,2600.0,3900.0,1100.0,16740.0
Bangalore Urban,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5070.0,3600.0,11900.0,10800.0,10200.0,9550.0,8700.0,21950.0,21550.0,18950.0,25050.0,23950.0,171270.0
Bangalore Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,7700.0,6800.0,6100.0,5550.0,4050.0,2300.0,1400.0,850.0,480.0,180.0,80.0,5.0,35495.0
Bangalore Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,,0.0,,6000.0,6000.0
Bangalore Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,900.0,700.0,550.0,1500.0,1750.0,900.0,550.0,370.0,300.0,100.0,75.0,300.0,7995.0
Bangalore Urban,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,6800.0,6100.0,5550.0,4050.0,2300.0,1400.0,850.0,480.0,180.0,80.0,5.0,5705.0,33500.0
Bangalore Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,8000.0,90520.0,47060.0,23560.0,100260.0,780.0,26760.0,18290.0,4390.0,0.0,,,319620.0
Bangalore Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,90720.0,,,151200.0,,105840.0,0.0,0.0,,0.0,,,347760.0
Bangalore Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,8200.0,43460.0,23500.0,74500.0,99480.0,79860.0,8470.0,13900.0,4390.0,0.0,,,355760.0
Bangalore Urban,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,90520.0,47060.0,23560.0,100260.0,780.0,26760.0,18290.0,4390.0,0.0,0.0,0.0,0.0,311620.0
Bangalore Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2050.0,400.0,,,,0.0,6900.0,4650.0,2650.0,400.0,200.0,100.0,17350.0
Bangalore Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,16000.0,0.0,0.0,,0.0,,25000.0,41000.0
Bangalore Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,1650.0,400.0,,,,9100.0,2250.0,2000.0,2250.0,200.0,100.0,3050.0,21000.0
Bangalore Urban,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,400.0,0.0,0.0,0.0,0.0,6900.0,4650.0,2650.0,400.0,200.0,100.0,22050.0,37350.0
Bangalore Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2100.0,1500.0,1100.0,700.0,550.0,550.0,400.0,350.0,150.0,0.0,,,7400.0
Bangalore Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,0.0,0.0,,0.0,,,0.0
Bangalore Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,600.0,400.0,400.0,150.0,,150.0,50.0,200.0,150.0,0.0,,,2100.0
Bangalore Urban,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1500.0,1100.0,700.0,550.0,550.0,400.0,350.0,150.0,0.0,0.0,0.0,0.0,5300.0
Bangalore Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,376300.0,361300.0,345300.0,335300.0,319800.0,295800.0,268600.0,194600.0,189600.0,517000.0,437000.0,423000.0,4063600.0
Bangalore Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,0.0,0.0,327400.0,0.0,,,327400.0
Bangalore Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,15000.0,16000.0,10000.0,15500.0,24000.0,27200.0,74000.0,5000.0,,80000.0,14000.0,16000.0,296700.0
Bangalore Urban,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,361300.0,345300.0,335300.0,319800.0,295800.0,268600.0,194600.0,189600.0,517000.0,437000.0,423000.0,407000.0,4094300.0
Bangalore Urban,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,,,,,,,,,,,0.0
Bangalore Urban,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bangalore Urban,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bangalore Urban,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bangalore Urban,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bangalore Urban,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,143090.0,133584.0,128840.0,123140.0,128690.0,11390.0,8790.0,4730.0,4690.0,79202.0,78520.0,76102.0,920768.0
Bangalore Urban,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,60000.0,60000.0,,0.0,,74512.0,0.0,,,194512.0
Bangalore Urban,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,9506.0,4744.0,5700.0,54450.0,177300.0,2600.0,4060.0,40.0,0.0,682.0,2418.0,4900.0,266400.0
Bangalore Urban,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,133584.0,128840.0,123140.0,128690.0,11390.0,8790.0,4730.0,4690.0,79202.0,78520.0,76102.0,71202.0,848880.0
Bangalore Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11425.0,8095.0,8290.0,5410.0,7760.0,5710.0,8410.0,2060.0,0.0,5900.0,3650.0,970.0,67680.0
Bangalore Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,3300.0,,6600.0,,6600.0,0.0,,6600.0,0.0,,3300.0,26400.0
Bangalore Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3330.0,3105.0,2880.0,4250.0,2050.0,3900.0,6350.0,2060.0,700.0,2250.0,2680.0,2050.0,35605.0
Bangalore Urban,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8095.0,8290.0,5410.0,7760.0,5710.0,8410.0,2060.0,0.0,5900.0,3650.0,970.0,2220.0,58475.0
Bangalore Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,53240.0,16650.0,17400.0,17400.0,26750.0,1500.0,94350.0,54650.0,9050.0,31520.0,2820.0,20470.0,345800.0
Bangalore Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,36000.0,,50000.0,,145000.0,0.0,,43500.0,0.0,54000.0,108000.0,436500.0
Bangalore Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,36590.0,35250.0,0.0,40650.0,25250.0,52150.0,39700.0,45600.0,21030.0,28700.0,36350.0,43800.0,405070.0
Bangalore Urban,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,16650.0,17400.0,17400.0,26750.0,1500.0,94350.0,54650.0,9050.0,31520.0,2820.0,20470.0,84670.0,377230.0
Bangalore Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1150.0,100.0,2100.0,3800.0,5300.0,2500.0,4400.0,4100.0,2100.0,1750.0,1400.0,1100.0,29800.0
Bangalore Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,2400.0,2400.0,2400.0,,2400.0,0.0,,,0.0,,5600.0,15200.0
Bangalore Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bangalore Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1050.0,400.0,700.0,900.0,2800.0,500.0,300.0,2000.0,350.0,350.0,300.0,1500.0,11150.0
Bangalore Urban,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,2100.0,3800.0,5300.0,2500.0,4400.0,4100.0,2100.0,1750.0,1400.0,1100.0,5200.0,33850.0
Bangalore Urban,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,1.0,1.0,,2.0
Bangalore Urban,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,18.0,13.0,11.0,11.0,53.0
Bangalore Urban,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,7.0,2.0,1.0,5.0,15.0
Bangalore Urban,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,25.0,15.0,12.0,16.0,68.0
Bangalore Urban,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,1.0,,,,,1.0,2.0,3.0,17.0,15.0,39.0
Bangalore Urban,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,1.0,2.0,3.0
Bangalore Urban,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,1.0,,,,,1.0,2.0,3.0,18.0,17.0,42.0
Bangalore Urban,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,,,,,1.0,1.0,24.0,8.0,35.0
Bangalore Urban,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,3.0,5.0,8.0
Bangalore Urban,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,1.0,,,,,,1.0,1.0,27.0,13.0,43.0
Bangalore Urban,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,1.0,,,,,28.0,18.0,,5.0,52.0
Bangalore Urban,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,12.0,2.0,,,14.0
Bangalore Urban,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,1.0,,,,,40.0,20.0,,5.0,66.0
Bangalore Urban,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Bangalore Urban,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Bangalore Urban,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,1.0,1.0,2.0
Bangalore Urban,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Bangalore Urban,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Urban,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,1.0,,,,1.0
Bangalore Urban,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,1.0,,,2.0
Bangalore Urban,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Urban,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,1.0,1.0,,,2.0
Bangalore Urban,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bangalore Urban,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bangalore Urban,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bangalore Urban,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,,1.0,1.0,8.0,4.0,2.0,6.0,22.0
Bangalore Urban,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,,,,,,4.0,3.0,1.0,6.0,15.0
Bangalore Urban,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,,,,,1.0,1.0,12.0,7.0,3.0,12.0,37.0
Bangalore Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,1.0,2.0,,1.0,4.0
Bangalore Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,1.0,,,5.0,6.0
Bangalore Urban,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,2.0,2.0,,6.0,10.0
Bangalore Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,,1.0,,1.0,,,1.0,15.0,8.0,,8.0,35.0
Bangalore Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,1.0,1.0,,,,1.0,4.0,2.0,1.0,4.0,15.0
Bangalore Urban,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,2.0,1.0,1.0,,,2.0,19.0,10.0,1.0,12.0,50.0
Bangalore Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,1.0,,2.0,2.0,1.0,3.0,1.0,16.0,15.0,5.0,29.0,76.0
Bangalore Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,1.0,4.0,2.0,1.0,,1.0,3.0,17.0,14.0,8.0,17.0,73.0
Bangalore Urban,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,6.0,2.0,4.0,4.0,3.0,1.0,4.0,4.0,33.0,29.0,13.0,46.0,149.0
Bangalore Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Bangalore Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,1.0,1.0
Bangalore Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,,,1.0,,,2.0
Bangalore Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,1.0,,,,,6.0,4.0,3.0,10.0,25.0
Bangalore Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,4.0,2.0,1.0,3.0,10.0
Bangalore Urban,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,2.0,,,,,10.0,7.0,4.0,13.0,37.0
Bangalore Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,,,,,,1.0,,10.0,11.0,1.0,13.0,37.0
Bangalore Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,1.0,1.0,1.0,,3.0,6.0
Bangalore Urban,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,,,,,,1.0,1.0,11.0,12.0,1.0,16.0,43.0
Bangalore Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Bangalore Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,8.0,10.0,8.0,5.0,18.0,18.0,12.0,16.0,22.0,23.0,17.0,31.0,188.0
Bangalore Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,13.0,7.0,8.0,11.0,11.0,16.0,16.0,7.0,32.0,45.0,21.0,34.0,221.0
Bangalore Urban,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,21.0,17.0,16.0,16.0,30.0,34.0,28.0,23.0,54.0,68.0,38.0,65.0,410.0
Bangalore Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Bangalore Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,2.0,2.0,,1.0,1.0,,1.0,16.0,18.0,6.0,10.0,58.0
Bangalore Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,3.0,3.0,3.0,2.0,5.0,3.0,2.0,2.0,17.0,28.0,4.0,22.0,94.0
Bangalore Urban,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,4.0,5.0,5.0,2.0,6.0,4.0,2.0,3.0,34.0,46.0,10.0,32.0,153.0
Bangalore Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bangalore Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Bangalore Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,,1.0
Bangalore Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,2.0,,,1.0,3.0
Bangalore Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,2.0,,,1.0,3.0
Bangalore Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,2.0,2.0
Bangalore Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,2.0,2.0
Bangalore Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Bangalore Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,,,,1.0,1.0,,3.0,6.0
Bangalore Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,,,,1.0,1.0,,3.0,6.0
Bangalore Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,3.0,,1.0,,,1.0,5.0,5.0,4.0,19.0
Bangalore Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,4.0,5.0,5.0,4.0,4.0,4.0,6.0,55.0,63.0,56.0,67.0,279.0
Bangalore Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,2.0,1.0,2.0,,1.0,2.0,4.0,12.0,13.0,16.0,6.0,60.0
Bangalore Urban,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,7.0,6.0,6.0,10.0,4.0,6.0,6.0,10.0,68.0,81.0,77.0,77.0,358.0
Bangalore Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2.0,,,,,1.0,1.0,,,,2.0,,6.0
Bangalore Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,3.0,1.0,6.0,6.0,6.0,6.0,3.0,15.0,15.0,35.0,22.0,126.0
Bangalore Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,,,1.0,1.0,2.0,,,3.0,2.0,3.0,13.0
Bangalore Urban,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,10.0,4.0,1.0,6.0,7.0,8.0,9.0,3.0,15.0,18.0,39.0,25.0,145.0
Bangalore Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,2.0,,,,,1.0,,,,1.0,5.0
Bangalore Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,,,
Bangalore Urban,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,2.0,,,,,1.0,,,,1.0,5.0
Bangalore Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Bangalore Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,3.0,2.0,3.0,2.0,2.0,2.0,2.0,3.0,34.0,21.0,7.0,31.0,112.0
Bangalore Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,6.0,3.0,4.0,10.0,4.0,4.0,,34.0,33.0,10.0,27.0,139.0
Bangalore Urban,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,8.0,6.0,6.0,12.0,6.0,6.0,3.0,68.0,54.0,17.0,58.0,251.0
Bangalore Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Bangalore Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,2.0,3.0,4.0,4.0,5.0,4.0,4.0,54.0,37.0,15.0,56.0,191.0
Bangalore Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,9.0,7.0,5.0,8.0,13.0,10.0,6.0,13.0,42.0,32.0,30.0,45.0,220.0
Bangalore Urban,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,12.0,9.0,8.0,12.0,17.0,15.0,10.0,17.0,97.0,69.0,45.0,101.0,412.0
Bangalore Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,1.0,,,,,1.0,,,,3.0
Bangalore Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,18.0,13.0,12.0,13.0,21.0,16.0,17.0,12.0,33.0,40.0,14.0,27.0,236.0
Bangalore Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,30.0,32.0,48.0,49.0,44.0,45.0,43.0,60.0,60.0,86.0,63.0,51.0,611.0
Bangalore Urban,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,49.0,45.0,60.0,63.0,65.0,61.0,60.0,72.0,94.0,126.0,77.0,78.0,850.0
Belgaum,1.1,Total number of pregnant women Registered for ANC,TOTAL,7694.0,7010.0,8472.0,7915.0,7687.0,8074.0,7625.0,8181.0,7970.0,9332.0,8072.0,8659.0,96691.0
Belgaum,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,5986.0,5388.0,6385.0,5963.0,5892.0,6028.0,5888.0,6196.0,5958.0,6689.0,6347.0,6348.0,73068.0
Belgaum,1.2,Number of Pregnant women registered under JSY,TOTAL,4259.0,3897.0,4660.0,4414.0,4157.0,4295.0,4156.0,4357.0,4305.0,4376.0,4405.0,4463.0,51744.0
Belgaum,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,7587.0,6982.0,7589.0,7300.0,7402.0,7740.0,7403.0,7710.0,8035.0,7960.0,7933.0,7659.0,91300.0
Belgaum,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5787.0,5398.0,6372.0,5818.0,5852.0,6350.0,6206.0,6487.0,6117.0,6367.0,5865.0,6260.0,72879.0
Belgaum,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,7575.0,7220.0,8096.0,7662.0,7470.0,8080.0,7685.0,8464.0,7556.0,7864.0,7524.0,7673.0,92869.0
Belgaum,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,7057.0,6938.0,7466.0,7093.0,6465.0,7814.0,6771.0,6852.0,6422.0,6780.0,5939.0,5430.0,81027.0
Belgaum,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,237.0,2692.0,372.0,359.0,189.0,289.0,315.0,259.0,213.0,301.0,340.0,367.0,5933.0
Belgaum,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,19.0,26.0,31.0,9.0,7.0,17.0,23.0,34.0,18.0,23.0,35.0,21.0,263.0
Belgaum,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,7477.0,6904.0,8682.0,7833.0,7215.0,8956.0,7306.0,8545.0,6676.0,9008.0,8663.0,9421.0,96686.0
Belgaum,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,226.0,371.0,333.0,550.0,197.0,314.0,251.0,357.0,297.0,374.0,376.0,395.0,4041.0
Belgaum,1.8,Number of pregnancy test kits used at SC level,TOTAL,312.0,301.0,214.0,484.0,129.0,292.0,398.0,489.0,281.0,359.0,496.0,730.0,4485.0
Belgaum,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,7.0,7.0,4.0,8.0,9.0,5.0,10.0,11.0,8.0,12.0,9.0,9.0,99.0
Belgaum,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,1.0,1.0,0.0,2.0,2.0,4.0,5.0,3.0,1.0,2.0,4.0,26.0
Belgaum,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,8.0,8.0,5.0,8.0,11.0,7.0,14.0,16.0,11.0,13.0,11.0,13.0,125.0
Belgaum,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,7.0,9.0,7.0,8.0,11.0,7.0,16.0,16.0,9.0,13.0,13.0,14.0,130.0
Belgaum,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,5.0,1.0,4.0,1.0,2.0,5.0,0.0,11.0,0.0,0.0,0.0,0.0,29.0
Belgaum,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,3353.0,3132.0,3491.0,3296.0,3676.0,3565.0,3479.0,3519.0,3330.0,3399.0,3617.0,3336.0,41193.0
Belgaum,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,299.0,253.0,284.0,372.0,356.0,350.0,443.0,390.0,301.0,471.0,438.0,479.0,4436.0
Belgaum,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1034.0,935.0,1502.0,1055.0,614.0,557.0,452.0,3407.0,2523.0,866.0,602.0,685.0,14232.0
Belgaum,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,4.0,0.0,0.0,0.0,13.0,27.0
Belgaum,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1788.0,2336.0,2600.0,2301.0,2338.0,2533.0,2741.0,2808.0,2659.0,2878.0,2107.0,1993.0,29082.0
Belgaum,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,43.0,37.0,40.0,40.0,50.0,44.0,59.0,49.0,53.0,49.0,56.0,43.0,563.0
Belgaum,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,357.0,278.0,333.0,324.0,336.0,377.0,349.0,351.0,346.0,350.0,417.0,409.0,4227.0
Belgaum,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,400.0,315.0,373.0,364.0,386.0,421.0,408.0,400.0,399.0,399.0,473.0,452.0,4790.0
Belgaum,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,326.0,604.0,1188.0,366.0,311.0,896.0,549.0,751.0,465.0,630.0,639.0,540.0,7265.0
Belgaum,4.1.1.a,Number of male live births,TOTAL,2640.0,2796.0,3111.0,2845.0,3136.0,3192.0,3332.0,3311.0,3072.0,3315.0,2969.0,3114.0,36833.0
Belgaum,4.1.1.b,Number of female live births,TOTAL,2478.0,2598.0,2953.0,2715.0,2856.0,2928.0,2939.0,3116.0,2901.0,3078.0,2789.0,2871.0,34222.0
Belgaum,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,5118.0,5394.0,6064.0,5560.0,5992.0,6120.0,6271.0,6427.0,5973.0,6393.0,5758.0,5985.0,71055.0
Belgaum,4.1.2,Number of still births,TOTAL,47.0,146.0,58.0,72.0,58.0,58.0,61.0,50.0,56.0,59.0,80.0,73.0,818.0
Belgaum,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,127.0,190.0,135.0,129.0,111.0,141.0,110.0,113.0,122.0,176.0,176.0,209.0,1739.0
Belgaum,4.2.1,Number of Newborns weighed at birth,TOTAL,5130.0,5478.0,5964.0,5633.0,6146.0,6199.0,6422.0,6482.0,6023.0,6409.0,5659.0,4695.0,70240.0
Belgaum,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,563.0,808.0,919.0,955.0,641.0,1277.0,691.0,728.0,827.0,798.0,731.0,957.0,9895.0
Belgaum,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,4974.0,5330.0,5894.0,5497.0,5829.0,5685.0,6141.0,6203.0,5684.0,5995.0,5392.0,4781.0,67405.0
Belgaum,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,13.0,11.0,38.0,16.0,15.0,6.0,9.0,13.0,20.0,13.0,15.0,13.0,182.0
Belgaum,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,21.0,26.0,39.0,30.0,41.0,21.0,24.0,24.0,35.0,36.0,60.0,67.0,424.0
Belgaum,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,394.0,307.0,300.0,343.0,366.0,379.0,339.0,317.0,402.0,367.0,354.0,256.0,4124.0
Belgaum,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,428.0,344.0,377.0,389.0,422.0,406.0,372.0,354.0,457.0,416.0,429.0,336.0,4730.0
Belgaum,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,32.0,360.0,361.0,37.0,50.0,459.0,48.0,302.0,33.0,230.0,130.0,278.0,2320.0
Belgaum,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,802.0,1378.0,1628.0,1387.0,893.0,1507.0,1830.0,1615.0,1124.0,1457.0,1723.0,1519.0,16863.0
Belgaum,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,124.0,256.0,158.0,123.0,107.0,124.0,169.0,356.0,185.0,319.0,130.0,231.0,2282.0
Belgaum,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1444.0,1987.0,1693.0,2072.0,1545.0,2009.0,1850.0,1988.0,1626.0,1919.0,2118.0,1678.0,21929.0
Belgaum,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,72.0,274.0,281.0,121.0,81.0,158.0,132.0,101.0,96.0,96.0,215.0,205.0,1832.0
Belgaum,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,4094.0,4864.0,5112.0,4691.0,5248.0,5085.0,5273.0,5681.0,5273.0,5046.0,5739.0,4985.0,61091.0
Belgaum,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,4041.0,5066.0,5054.0,5037.0,5282.0,5105.0,4944.0,5854.0,5422.0,5921.0,5520.0,5979.0,63225.0
Belgaum,6.3,PNC maternal complications attended,TOTAL,51.0,58.0,61.0,57.0,48.0,56.0,51.0,44.0,47.0,61.0,50.0,48.0,632.0
Belgaum,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,28.0,33.0,42.0,27.0,29.0,16.0,34.0,22.0,26.0,32.0,28.0,30.0,347.0
Belgaum,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,19.0,7.0,24.0,17.0,12.0,31.0,16.0,11.0,19.0,15.0,17.0,5.0,193.0
Belgaum,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,47.0,40.0,66.0,44.0,41.0,47.0,50.0,33.0,45.0,47.0,45.0,35.0,540.0
Belgaum,7.2,Number of MTPs conducted at Private Facilities,TOTAL,50.0,79.0,170.0,184.0,56.0,67.0,68.0,85.0,76.0,108.0,89.0,76.0,1108.0
Belgaum,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,1249.0,1377.0,1547.0,1521.0,1389.0,1555.0,1334.0,1339.0,1313.0,1335.0,1303.0,1308.0,16570.0
Belgaum,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,2241.0,2369.0,2532.0,2881.0,2196.0,2054.0,2011.0,2157.0,2307.0,2110.0,2262.0,1889.0,27009.0
Belgaum,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,3490.0,3746.0,4079.0,4402.0,3585.0,3609.0,3345.0,3496.0,3620.0,3445.0,3565.0,3197.0,43579.0
Belgaum,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,76.0,92.0,42.0,0.0,73.0,186.0,39.0,45.0,1.0,14.0,5.0,576.0
Belgaum,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,2.0,3.0,4.0,10.0,14.0,9.0,1.0,0.0,0.0,3.0,3.0,2.0,51.0
Belgaum,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Belgaum,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,36.0,7.0,6.0,9.0,3.0,1.0,0.0,2.0,1.0,0.0,65.0
Belgaum,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,3.0,41.0,17.0,20.0,18.0,4.0,1.0,0.0,5.0,4.0,2.0,117.0
Belgaum,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,3.0,2.0,3.0,2.0,1.0,0.0,0.0,0.0,0.0,3.0,0.0,15.0
Belgaum,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,144.0,113.0,88.0,103.0,77.0,51.0,16.0,15.0,8.0,11.0,13.0,10.0,649.0
Belgaum,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,116.0,138.0,128.0,143.0,100.0,163.0,191.0,190.0,189.0,171.0,179.0,151.0,1859.0
Belgaum,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,312.0,194.0,274.0,273.0,166.0,282.0,179.0,303.0,247.0,183.0,255.0,248.0,2916.0
Belgaum,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,572.0,445.0,490.0,519.0,343.0,496.0,386.0,508.0,444.0,365.0,447.0,409.0,5424.0
Belgaum,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,167.0,122.0,117.0,116.0,84.0,115.0,104.0,23.0,19.0,76.0,110.0,131.0,1184.0
Belgaum,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,510.0,427.0,408.0,414.0,336.0,414.0,303.0,495.0,489.0,447.0,495.0,481.0,5219.0
Belgaum,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,144.0,111.0,127.0,102.0,140.0,147.0,85.0,190.0,172.0,93.0,113.0,83.0,1507.0
Belgaum,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,389.0,289.0,361.0,380.0,244.0,417.0,337.0,486.0,376.0,361.0,431.0,341.0,4412.0
Belgaum,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,1043.0,827.0,896.0,896.0,720.0,978.0,725.0,1171.0,1037.0,901.0,1039.0,905.0,11138.0
Belgaum,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,141.0,192.0,271.0,279.0,249.0,300.0,223.0,178.0,200.0,165.0,206.0,233.0,2637.0
Belgaum,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,22.0,28.0,33.0,33.0,41.0,29.0,49.0,18.0,15.0,65.0,25.0,22.0,380.0
Belgaum,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,11.0,10.0,6.0,10.0,2.0,5.0,10.0,10.0,13.0,6.0,39.0,124.0
Belgaum,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,50.0,33.0,46.0,40.0,77.0,72.0,61.0,72.0,55.0,58.0,75.0,46.0,685.0
Belgaum,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,74.0,72.0,89.0,79.0,128.0,103.0,115.0,100.0,80.0,136.0,106.0,107.0,1189.0
Belgaum,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,111.0,126.0,121.0,134.0,45.0,155.0,148.0,65.0,45.0,131.0,142.0,159.0,1382.0
Belgaum,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,444.0,443.0,433.0,802.0,476.0,481.0,488.0,466.0,367.0,395.0,390.0,382.0,5567.0
Belgaum,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,622.0,576.0,621.0,974.0,622.0,685.0,634.0,620.0,544.0,573.0,534.0,563.0,7568.0
Belgaum,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,93.0,63.0,76.0,109.0,83.0,73.0,80.0,66.0,61.0,68.0,73.0,76.0,921.0
Belgaum,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,52.0,64.0,52.0,50.0,63.0,80.0,49.0,62.0,63.0,61.0,75.0,76.0,747.0
Belgaum,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Belgaum,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,1211.0,1146.0,1182.0,1935.0,1244.0,1319.0,1251.0,1214.0,1035.0,1097.0,1072.0,1097.0,14803.0
Belgaum,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,82.0,92.0,81.0,79.0,67.0,86.0,74.0,82.0,85.0,75.0,97.0,86.0,986.0
Belgaum,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,133.0,225.0,140.0,131.0,181.0,293.0,226.0,87.0,197.0,135.0,110.0,160.0,2018.0
Belgaum,9.06,Number of IUCD removals,TOTAL,595.0,600.0,630.0,838.0,585.0,739.0,526.0,613.0,527.0,517.0,622.0,540.0,7332.0
Belgaum,9.07,Number of Oral Pills cycles distributed,TOTAL,4339.0,4143.0,4323.0,4804.0,3859.0,6156.0,4277.0,4276.0,4592.0,4458.0,4228.0,6010.0,55465.0
Belgaum,9.08,Number of Condom pieces distributed,TOTAL,29531.0,29134.0,24480.0,31492.0,23933.0,30417.0,25833.0,26940.0,28217.0,29207.0,27213.0,29629.0,336026.0
Belgaum,9.09,Number of Centchroman (weekly) pills given,TOTAL,86.0,27.0,55.0,41.0,134.0,153.0,21.0,104.0,143.0,30.0,44.0,34.0,872.0
Belgaum,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,633.0,174.0,162.0,161.0,184.0,185.0,296.0,152.0,260.0,181.0,203.0,185.0,2776.0
Belgaum,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Belgaum,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,9.12,Number of Institutions having NSV trained doctors,TOTAL,46.0,55.0,44.0,44.0,54.0,52.0,55.0,56.0,53.0,53.0,54.0,50.0,-1.0
Belgaum,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,7612.0,6945.0,7679.0,7500.0,9160.0,9241.0,8810.0,9223.0,8729.0,8724.0,8831.0,9033.0,101487.0
Belgaum,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,73.0,75.0,123.0,56.0,69.0,102.0,170.0,132.0,179.0,181.0,105.0,104.0,1369.0
Belgaum,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,75.0,65.0,106.0,61.0,81.0,91.0,146.0,122.0,168.0,213.0,101.0,97.0,1326.0
Belgaum,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,79.0,78.0,113.0,55.0,91.0,113.0,148.0,104.0,164.0,211.0,96.0,110.0,1362.0
Belgaum,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,8024.0,7806.0,7937.0,8090.0,8090.0,8209.0,8210.0,8585.0,8399.0,7914.0,8074.0,7726.0,97064.0
Belgaum,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,7741.0,7596.0,7681.0,8002.0,7790.0,8100.0,7759.0,8422.0,8219.0,7750.0,7901.0,7662.0,94623.0
Belgaum,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,7777.0,7427.0,7576.0,8001.0,7783.0,7808.0,7754.0,8244.0,7923.0,7755.0,7855.0,7659.0,93562.0
Belgaum,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,5051.0,5316.0,5097.0,6099.0,6424.0,6390.0,5769.0,6325.0,6215.0,5683.0,6614.0,6206.0,71189.0
Belgaum,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,7967.0,7735.0,7928.0,7843.0,8112.0,8073.0,8120.0,8280.0,8321.0,8085.0,7958.0,7823.0,96245.0
Belgaum,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,7689.0,7545.0,7764.0,7830.0,7709.0,7936.0,7668.0,8061.0,8143.0,8076.0,7850.0,7556.0,93827.0
Belgaum,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,8088.0,7318.0,7618.0,7854.0,7669.0,7657.0,7672.0,7887.0,8000.0,8118.0,7801.0,7577.0,93259.0
Belgaum,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2845.0,3098.0,2541.0,2956.0,3131.0,3118.0,2922.0,3212.0,3057.0,3368.0,3283.0,3580.0,37111.0
Belgaum,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,178.0,129.0,190.0,163.0,157.0,109.0,173.0,133.0,157.0,491.0,94.0,385.0,2359.0
Belgaum,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,172.0,96.0,155.0,173.0,133.0,111.0,171.0,140.0,133.0,514.0,45.0,51.0,1894.0
Belgaum,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,173.0,222.0,210.0,172.0,172.0,117.0,193.0,138.0,134.0,453.0,74.0,94.0,2152.0
Belgaum,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,7019.0,6774.0,7422.0,7772.0,7507.0,7689.0,7498.0,8174.0,7622.0,7228.0,7135.0,7432.0,89272.0
Belgaum,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4527.0,4371.0,5190.0,5370.0,5401.0,5418.0,5051.0,5638.0,5842.0,5397.0,5618.0,6052.0,63875.0
Belgaum,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,25.0,5.0,0.0,26.0,12.0,0.0,43.0,111.0
Belgaum,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3635.0,3233.0,3604.0,3877.0,3688.0,4169.0,3634.0,4101.0,3653.0,3515.0,3487.0,3630.0,44226.0
Belgaum,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,3313.0,2964.0,3283.0,3559.0,3440.0,3828.0,3383.0,3810.0,3310.0,3210.0,3307.0,3375.0,40782.0
Belgaum,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,6948.0,6197.0,6887.0,7436.0,7128.0,7997.0,7017.0,7911.0,6963.0,6725.0,6794.0,7005.0,85008.0
Belgaum,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,6391.0,6140.0,6795.0,6891.0,6623.0,7120.0,7107.0,7348.0,7376.0,6626.0,6708.0,6901.0,82026.0
Belgaum,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,6328.0,6099.0,6836.0,6812.0,6635.0,7077.0,7067.0,7277.0,7324.0,6599.0,6618.0,6966.0,81638.0
Belgaum,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,469.0,415.0,388.0,702.0,527.0,602.0,557.0,509.0,561.0,416.0,386.0,454.0,5986.0
Belgaum,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1868.0,1404.0,1544.0,1584.0,1586.0,1622.0,1850.0,1889.0,1732.0,1664.0,1603.0,1781.0,20127.0
Belgaum,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1725.0,1316.0,1460.0,1419.0,1503.0,1534.0,1748.0,1784.0,1522.0,1480.0,1506.0,1656.0,18653.0
Belgaum,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,3593.0,2720.0,3004.0,3003.0,3089.0,3156.0,3598.0,3673.0,3254.0,3144.0,3109.0,3437.0,38780.0
Belgaum,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1306.0,1137.0,1431.0,3390.0,5702.0,9427.0,2511.0,7840.0,24835.0,11261.0,8306.0,4379.0,81525.0
Belgaum,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1194.0,1106.0,1712.0,4414.0,7138.0,12127.0,2083.0,8924.0,17083.0,8146.0,9166.0,3424.0,76517.0
Belgaum,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1342.0,1084.0,1455.0,3210.0,5442.0,8313.0,2162.0,8139.0,14457.0,6470.0,9839.0,3816.0,65729.0
Belgaum,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Belgaum,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,5.0,0.0,5.0,5.0,2.0,0.0,16.0,11.0,12.0,0.0,0.0,13.0,69.0
Belgaum,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,2354.0,2280.0,2458.0,2381.0,2381.0,2378.0,2453.0,2397.0,2414.0,2424.0,2422.0,2454.0,28796.0
Belgaum,10.4.2,Number of Immunisation sessions held during the month,TOTAL,2339.0,2245.0,2395.0,2364.0,2366.0,2383.0,2407.0,2387.0,2402.0,2391.0,2387.0,2410.0,28476.0
Belgaum,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1941.0,1929.0,1996.0,1996.0,2055.0,1989.0,1979.0,2054.0,2057.0,2023.0,2050.0,2128.0,24197.0
Belgaum,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,20.0,25.0
Belgaum,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,4600.0,4230.0,4390.0,9130.0,6427.0,5029.0,4700.0,4911.0,5080.0,4878.0,7808.0,6652.0,67835.0
Belgaum,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,798.0,465.0,284.0,26477.0,13336.0,542.0,495.0,674.0,408.0,295.0,13024.0,7260.0,64058.0
Belgaum,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,366.0,453.0,54.0,24852.0,10989.0,305.0,187.0,86.0,214.0,50.0,10035.0,7073.0,54664.0
Belgaum,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,21.0,4.0,47.0,4.0,25.0,39.0,62.0,67.0,55.0,44.0,118.0,137.0,623.0
Belgaum,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,652.0,634.0,822.0,784.0,673.0,791.0,689.0,719.0,642.0,709.0,809.0,598.0,8522.0
Belgaum,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,10.0,0.0,0.0,25.0,12.0,16.0,60.0,23.0,157.0,43.0,347.0
Belgaum,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,546.0,123.0,223.0,451.0,231.0,342.0,243.0,208.0,143.0,391.0,273.0,308.0,3482.0
Belgaum,13.1,Number of Patients operated for cataract,TOTAL,276.0,415.0,991.0,666.0,215.0,618.0,316.0,482.0,694.0,1011.0,693.0,514.0,6891.0
Belgaum,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,277.0,440.0,958.0,666.0,188.0,618.0,310.0,449.0,653.0,973.0,457.0,507.0,6496.0
Belgaum,13.3,Number of School children detected with Refractive errors,TOTAL,34.0,80.0,159.0,97.0,142.0,200.0,108.0,129.0,277.0,301.0,126.0,142.0,1795.0
Belgaum,13.4,Number of children provided free glasses,TOTAL,139.0,5.0,0.0,0.0,15.0,0.0,0.0,36.0,0.0,0.0,2.0,0.0,197.0
Belgaum,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,4.0,2.0,0.0,4.0,0.0,0.0,12.0
Belgaum,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,3.0,0.0,0.0,5.0
Belgaum,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,16.0,16.0,15.0,16.0,14.0,14.0,15.0,16.0,13.0,15.0,14.0,16.0,-1.0
Belgaum,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,84.0,83.0,78.0,80.0,84.0,84.0,90.0,86.0,89.0,90.0,90.0,89.0,-1.0
Belgaum,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,811.0,789.0,805.0,787.0,867.0,877.0,928.0,838.0,852.0,878.0,823.0,925.0,-1.0
Belgaum,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,17.0,14.0,13.0,17.0,13.0,13.0,16.0,13.0,13.0,14.0,14.0,17.0,-1.0
Belgaum,14.05,Number of RKS meetings held during the month,TOTAL,34.0,29.0,34.0,31.0,35.0,38.0,31.0,28.0,38.0,48.0,47.0,44.0,437.0
Belgaum,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,60.0,64.0,60.0,69.0,65.0,57.0,61.0,62.0,60.0,58.0,58.0,65.0,-1.0
Belgaum,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,331.0,364.0,248.0,317.0,315.0,358.0,311.0,328.0,274.0,315.0,396.0,384.0,3941.0
Belgaum,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,13.0,13.0,9.0,13.0,12.0,14.0,15.0,14.0,14.0,15.0,13.0,12.0,-1.0
Belgaum,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,24.0,21.0,29.0,25.0,28.0,51.0,39.0,51.0,44.0,29.0,31.0,64.0,-1.0
Belgaum,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1029.0,2103.0,2206.0,2267.0,1327.0,2267.0,1905.0,3035.0,1870.0,2294.0,2162.0,2060.0,24525.0
Belgaum,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4074.0,7266.0,8034.0,7142.0,5273.0,7679.0,6255.0,10576.0,7468.0,6988.0,7900.0,7501.0,86156.0
Belgaum,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1067.0,1925.0,1688.0,2106.0,1314.0,1860.0,1713.0,2299.0,1715.0,1914.0,3433.0,5384.0,26418.0
Belgaum,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,10465.0,12995.0,14268.0,13058.0,11404.0,14908.0,11445.0,17001.0,12896.0,12517.0,14007.0,13379.0,158343.0
Belgaum,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2096.0,4028.0,3894.0,4373.0,2641.0,4127.0,3618.0,5334.0,3585.0,4208.0,5595.0,7444.0,50943.0
Belgaum,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,14539.0,20261.0,22302.0,20200.0,16677.0,22587.0,17700.0,27577.0,20364.0,19505.0,21907.0,20880.0,244499.0
Belgaum,14.10.2.a,Number of death cases of Inpatient males,TOTAL,98.0,167.0,152.0,182.0,126.0,230.0,213.0,203.0,208.0,191.0,202.0,188.0,2160.0
Belgaum,14.10.2.b,Number of death cases of Inpatient females,TOTAL,92.0,95.0,61.0,95.0,68.0,116.0,98.0,123.0,106.0,94.0,105.0,114.0,1167.0
Belgaum,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,190.0,262.0,213.0,277.0,194.0,346.0,311.0,326.0,314.0,285.0,307.0,302.0,3327.0
Belgaum,14.11,In-Patient Head Count at midnight,TOTAL,29240.0,36026.0,25532.0,37420.0,35266.0,45404.0,34988.0,32851.0,40263.0,38070.0,36975.0,42905.0,434940.0
Belgaum,14.12.1,OPD attendance (All),TOTAL,231159.0,296974.0,330403.0,246232.0,262753.0,364224.0,297704.0,334558.0,328319.0,318768.0,267388.0,313283.0,3591765.0
Belgaum,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1234.0,2653.0,2286.0,2444.0,4079.0,3159.0,2151.0,3242.0,2011.0,1934.0,1966.0,1849.0,29008.0
Belgaum,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,152.0,140.0,185.0,164.0,132.0,126.0,88.0,156.0,151.0,122.0,55.0,123.0,1594.0
Belgaum,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1760.0,3191.0,1580.0,5504.0,1458.0,2838.0,2955.0,2424.0,3086.0,3479.0,2888.0,2436.0,33599.0
Belgaum,14.14.a,Number of patients given AYUSH treatment,TOTAL,12980.0,15380.0,16536.0,16328.0,16223.0,18906.0,17618.0,15477.0,15621.0,15567.0,16080.0,15423.0,192139.0
Belgaum,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2497.0,2458.0,2155.0,2745.0,2527.0,2740.0,2492.0,2756.0,2850.0,2211.0,2447.0,2327.0,30205.0
Belgaum,14.14.c,Number of Adolescents counselled,TOTAL,309.0,393.0,374.0,667.0,454.0,633.0,559.0,412.0,1483.0,486.0,524.0,460.0,6754.0
Belgaum,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,26774.0,29886.0,37218.0,34339.0,26964.0,37343.0,30393.0,37710.0,33604.0,30488.0,32596.0,33756.0,391071.0
Belgaum,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1920.0,2060.0,2664.0,2700.0,3230.0,8113.0,2962.0,2723.0,2285.0,2091.0,2279.0,2321.0,35348.0
Belgaum,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,3448.0,5986.0,7046.0,6208.0,4770.0,7854.0,6082.0,9666.0,7236.0,6836.0,7940.0,8499.0,81571.0
Belgaum,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,245.0,124.0,175.0,186.0,220.0,246.0,166.0,151.0,95.0,211.0,123.0,215.0,2157.0
Belgaum,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,5083.0,5488.0,7116.0,7683.0,6721.0,7371.0,7130.0,6888.0,6769.0,7057.0,7907.0,7456.0,82669.0
Belgaum,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,151.0,114.0,189.0,186.0,231.0,370.0,216.0,147.0,109.0,88.0,121.0,325.0,2247.0
Belgaum,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,8021.0,8610.0,10624.0,11161.0,7999.0,9987.0,7611.0,10779.0,10345.0,10190.0,10697.0,9601.0,115625.0
Belgaum,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,28.0,41.0,342.0,65.0,168.0,200.0,420.0,22.0,20.0,20.0,147.0,307.0,1780.0
Belgaum,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,16552.0,20084.0,24786.0,25052.0,19490.0,25212.0,20823.0,27333.0,24350.0,24083.0,26544.0,25556.0,279865.0
Belgaum,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,424.0,279.0,706.0,437.0,619.0,816.0,802.0,320.0,224.0,319.0,391.0,847.0,6184.0
Belgaum,15.2,Number of Widal tests conducted,Number tested,1668.0,1596.0,2530.0,2327.0,2419.0,3074.0,1980.0,2035.0,1921.0,1983.0,2091.0,2232.0,25856.0
Belgaum,15.3.a,Number of VDRL tests conducted on males,Number tested,127.0,736.0,700.0,967.0,205.0,738.0,733.0,804.0,423.0,775.0,844.0,946.0,7998.0
Belgaum,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,316.0,582.0,660.0,786.0,398.0,1440.0,560.0,571.0,349.0,507.0,433.0,696.0,7298.0
Belgaum,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,4053.0,3854.0,4775.0,3640.0,3855.0,4089.0,2717.0,3609.0,3663.0,3208.0,3689.0,3994.0,45146.0
Belgaum,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4496.0,5172.0,6135.0,5393.0,4458.0,6267.0,4010.0,4984.0,4435.0,4490.0,4966.0,5636.0,60442.0
Belgaum,15.4.1,Number of blood smears examined for Malaria,TOTAL,43952.0,47738.0,51140.0,51609.0,47356.0,53771.0,45373.0,49700.0,50543.0,47796.0,48221.0,47898.0,585097.0
Belgaum,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,4.0,3.0,110.0,7.0,3.0,493.0,258.0,7.0,7.0,6.0,5.0,10.0,913.0
Belgaum,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,12.0,0.0,0.0,6.0,0.0,3.0,1.0,3.0,0.0,0.0,25.0
Belgaum,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,15840.0,10320.0,5520.0,29710.0,22710.0,26000.0,21000.0,19650.0,8150.0,50000.0,23270.0,3270.0,235440.0
Belgaum,16.1.1,Stock position of DPT vaccines,2. Stocks Received,19500.0,23000.0,27000.0,24000.0,36000.0,33000.0,32000.0,0.0,69500.0,15000.0,0.0,19000.0,298000.0
Belgaum,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,32710.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32710.0
Belgaum,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,25020.0,27800.0,2810.0,31000.0,0.0,38000.0,33350.0,11500.0,27650.0,41730.0,20000.0,17000.0,275860.0
Belgaum,16.1.1,Stock position of DPT vaccines,5. Total Stock,10320.0,5520.0,29710.0,22710.0,26000.0,21000.0,19650.0,8150.0,50000.0,23270.0,3270.0,5270.0,224870.0
Belgaum,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,31640.0,15640.0,9090.0,38890.0,27790.0,30590.0,28640.0,26140.0,13140.0,42640.0,37640.0,8140.0,309980.0
Belgaum,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,31000.0,32000.0,34000.0,32000.0,32000.0,35000.0,35000.0,0.0,60000.0,30000.0,0.0,28000.0,349000.0
Belgaum,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,47000.0,38550.0,4200.0,43100.0,29200.0,36950.0,37500.0,13000.0,30500.0,35000.0,29500.0,27500.0,372000.0
Belgaum,16.1.1A,Stock Position of Pentavalent,5. Total Stock,15640.0,9090.0,38890.0,27790.0,30590.0,28640.0,26140.0,13140.0,42640.0,37640.0,8140.0,8640.0,286980.0
Belgaum,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,51200.0,27900.0,11400.0,65000.0,44140.0,48340.0,44540.0,13440.0,640.0,17440.0,8360.0,4280.0,336680.0
Belgaum,16.1.2,Stock position of OPV vaccines,2. Stocks Received,56300.0,48000.0,67000.0,56000.0,60000.0,60000.0,16000.0,0.0,66800.0,810580.0,805580.0,52000.0,2098260.0
Belgaum,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,79600.0,64500.0,13400.0,76860.0,55800.0,63800.0,47100.0,12800.0,50000.0,819660.0,809660.0,50500.0,2143680.0
Belgaum,16.1.2,Stock position of OPV vaccines,5. Total Stock,27900.0,11400.0,65000.0,44140.0,48340.0,44540.0,13440.0,640.0,17440.0,8360.0,4280.0,5780.0,291260.0
Belgaum,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,36850.0,19750.0,11050.0,58050.0,44850.0,40050.0,38500.0,8650.0,0.0,55000.0,45350.0,7850.0,365950.0
Belgaum,16.1.3,Stock position of TT vaccines,2. Stocks Received,36000.0,42000.0,52000.0,40000.0,42000.0,58000.0,7500.0,0.0,92000.0,40000.0,0.0,36000.0,445500.0
Belgaum,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.3,Stock position of TT vaccines,4. Stock Distributed,53100.0,50700.0,5000.0,53200.0,46800.0,59550.0,37350.0,8650.0,37000.0,49650.0,37500.0,32500.0,471000.0
Belgaum,16.1.3,Stock position of TT vaccines,5. Total Stock,19750.0,11050.0,58050.0,44850.0,40050.0,38500.0,8650.0,0.0,55000.0,45350.0,7850.0,11350.0,340450.0
Belgaum,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Belgaum,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Belgaum,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Belgaum,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0
Belgaum,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,24070.0,5500.0,4430.0,28930.0,21730.0,22530.0,19780.0,20880.0,9880.0,28380.0,32380.0,5880.0,224370.0
Belgaum,16.1.5,Stock position of BCG vaccines,2. Stocks Received,15000.0,23500.0,29000.0,24000.0,23000.0,27000.0,27000.0,0.0,41000.0,22500.0,0.0,22000.0,254000.0
Belgaum,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,33570.0,24570.0,4500.0,31200.0,22200.0,29750.0,25900.0,11000.0,22500.0,18500.0,26500.0,20590.0,270780.0
Belgaum,16.1.5,Stock position of BCG vaccines,5. Total Stock,5500.0,4430.0,28930.0,21730.0,22530.0,19780.0,20880.0,9880.0,28380.0,32380.0,5880.0,7290.0,207590.0
Belgaum,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,19035.0,14035.0,3495.0,23995.0,12495.0,13945.0,7445.0,13345.0,3845.0,25845.0,19095.0,3845.0,160420.0
Belgaum,16.1.6,Stock position of Measles vaccines,2. Stocks Received,20500.0,14000.0,23000.0,14000.0,19000.0,10000.0,25000.0,0.0,42000.0,14000.0,0.0,20000.0,201500.0
Belgaum,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,25500.0,24540.0,2500.0,25500.0,17550.0,16500.0,19100.0,9500.0,20000.0,20750.0,15250.0,18500.0,215190.0
Belgaum,16.1.6,Stock position of Measles vaccines,5. Total Stock,14035.0,3495.0,23995.0,12495.0,13945.0,7445.0,13345.0,3845.0,25845.0,19095.0,3845.0,5345.0,146730.0
Belgaum,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Belgaum,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Belgaum,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Belgaum,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,0.0,0.0,0.0
Belgaum,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9220.0,6340.0,1300.0,10100.0,8530.0,7260.0,14010.0,13310.0,11210.0,11810.0,8310.0,2010.0,103410.0
Belgaum,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,8000.0,7000.0,9500.0,8000.0,6000.0,14100.0,6000.0,0.0,6000.0,4000.0,0.0,6000.0,74600.0
Belgaum,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,10880.0,12040.0,700.0,9570.0,7270.0,7350.0,6700.0,2100.0,5400.0,7500.0,6300.0,4900.0,80710.0
Belgaum,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,6340.0,1300.0,10100.0,8530.0,7260.0,14010.0,13310.0,11210.0,11810.0,8310.0,2010.0,3110.0,97300.0
Belgaum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5000.0,5000.0,5000.0,8800.0,2950.0,0.0,0.0,0.0,0.0,0.0,12000.0,4200.0,42950.0
Belgaum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,5000.0,1800.0,0.0,0.0,0.0,0.0,0.0,12000.0,0.0,0.0,18800.0
Belgaum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1200.0,7650.0,2950.0,0.0,0.0,0.0,0.0,0.0,7800.0,1700.0,21300.0
Belgaum,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,5000.0,5000.0,8800.0,2950.0,0.0,0.0,0.0,0.0,0.0,12000.0,4200.0,2500.0,40450.0
Belgaum,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,0.0,25200.0,226800.0,15120.0,15120.0,15120.0,166320.0,10080.0,161280.0,45360.0,680400.0
Belgaum,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,25200.0,252000.0,0.0,0.0,0.0,151200.0,0.0,151200.0,0.0,0.0,579600.0
Belgaum,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,0.0,50400.0,211680.0,,0.0,0.0,156240.0,0.0,115920.0,25200.0,559440.0
Belgaum,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,25200.0,226800.0,15120.0,15120.0,15120.0,166320.0,10080.0,161280.0,45360.0,20160.0,700560.0
Belgaum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,0.0,0.0,40400.0,,0.0,90000.0,0.0,76000.0,20800.0,227200.0
Belgaum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,0.0,16000.0,0.0,,90000.0,0.0,76000.0,0.0,0.0,182000.0
Belgaum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,0.0,5600.0,10400.0,,0.0,90000.0,0.0,55200.0,11950.0,173150.0
Belgaum,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,10400.0,30000.0,0.0,90000.0,0.0,76000.0,20800.0,8850.0,236050.0
Belgaum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,19348.0,11598.0,0.0,,,,0.0,40000.0,10500.0,81446.0
Belgaum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,0.0,0.0,0.0,,,,40000.0,0.0,0.0,40000.0
Belgaum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Belgaum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,7750.0,11598.0,0.0,,,,0.0,29500.0,6950.0,55798.0
Belgaum,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,11598.0,0.0,0.0,0.0,0.0,0.0,40000.0,10500.0,3550.0,65648.0
Belgaum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3400.0,3100.0,800.0,20854.0,20854.0,19354.0,19154.0,19154.0,18654.0,18654.0,18654.0,16654.0,179286.0
Belgaum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,21354.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21354.0
Belgaum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,300.0,2300.0,1300.0,0.0,1500.0,200.0,0.0,500.0,,0.0,2000.0,0.0,8100.0
Belgaum,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3100.0,800.0,20854.0,20854.0,19354.0,19154.0,19154.0,18654.0,18654.0,18654.0,16654.0,16654.0,192540.0
Belgaum,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,0.0,,0.0
Belgaum,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,0.0,,0.0
Belgaum,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,0.0,,0.0
Belgaum,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,0.0,,0.0
Belgaum,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,0.0,143288.0,33288.0,176576.0
Belgaum,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,263288.0,0.0,0.0,263288.0
Belgaum,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,0.0,0.0,0.0,0.0
Belgaum,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,120000.0,110000.0,0.0,230000.0
Belgaum,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,143288.0,33288.0,33288.0,209864.0
Belgaum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Belgaum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Belgaum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Belgaum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Belgaum,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,10250.0,10250.0,10250.0,10250.0,,,,0.0,,,,,41000.0
Belgaum,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,,,,0.0,,,,,0.0
Belgaum,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,,,,,0.0
Belgaum,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,10250.0,,,,0.0,,,,,10250.0
Belgaum,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,10250.0,10250.0,10250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30750.0
Belgaum,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,28750.0,16770.0,10070.0,2370.0,8366.0,6366.0,5266.0,64661.0,64161.0,63261.0,62961.0,44461.0,377463.0
Belgaum,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,67256.0,0.0,0.0,67196.0,0.0,0.0,0.0,0.0,0.0,134452.0
Belgaum,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,11980.0,6700.0,7700.0,61260.0,2000.0,1100.0,7801.0,500.0,900.0,300.0,18500.0,12600.0,131341.0
Belgaum,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,16770.0,10070.0,2370.0,8366.0,6366.0,5266.0,64661.0,64161.0,63261.0,62961.0,44461.0,31861.0,380574.0
Belgaum,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7000.0,3800.0,200.0,7900.0,4600.0,5000.0,25800.0,13100.0,8800.0,15400.0,0.0,0.0,91600.0
Belgaum,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9600.0,1800.0,7900.0,7000.0,7000.0,31000.0,0.0,0.0,6600.0,0.0,6600.0,8300.0,85800.0
Belgaum,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,12800.0,5400.0,200.0,10300.0,6600.0,10200.0,12700.0,4300.0,0.0,15400.0,6600.0,8100.0,92600.0
Belgaum,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3800.0,200.0,7900.0,4600.0,5000.0,25800.0,13100.0,8800.0,15400.0,0.0,0.0,200.0,84800.0
Belgaum,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,45800.0,4200.0,11200.0,76800.0,58000.0,27000.0,182200.0,54200.0,0.0,75000.0,0.0,0.0,534400.0
Belgaum,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,15000.0,61600.0,76800.0,96000.0,36000.0,240200.0,0.0,0.0,77000.0,0.0,36000.0,80000.0,718600.0
Belgaum,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,56600.0,54600.0,11200.0,114800.0,67000.0,85000.0,128000.0,54200.0,2000.0,75000.0,36000.0,80000.0,764400.0
Belgaum,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,4200.0,11200.0,76800.0,58000.0,27000.0,182200.0,54200.0,0.0,75000.0,0.0,0.0,0.0,488600.0
Belgaum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7200.0,2800.0,2000.0,5600.0,5200.0,2400.0,6800.0,1600.0,0.0,7200.0,1500.0,3100.0,45400.0
Belgaum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4800.0,7000.0,4800.0,7200.0,4800.0,9600.0,0.0,0.0,7200.0,0.0,7200.0,4800.0,57400.0
Belgaum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Belgaum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,9200.0,7800.0,1200.0,7600.0,7600.0,5200.0,5200.0,1600.0,,5700.0,5600.0,6200.0,62900.0
Belgaum,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2800.0,2000.0,5600.0,5200.0,2400.0,6800.0,1600.0,0.0,7200.0,1500.0,3100.0,1700.0,39900.0
Belgaum,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,4.0,,,,4.0
Belgaum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,12.0,3.0,2.0,2.0,7.0,7.0,7.0,4.0,3.0,7.0,6.0,6.0,66.0
Belgaum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Belgaum,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,12.0,3.0,2.0,2.0,7.0,7.0,7.0,4.0,3.0,7.0,6.0,6.0,66.0
Belgaum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,7.0,2.0,3.0,5.0,,,2.0,4.0,1.0,1.0,3.0,29.0
Belgaum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Belgaum,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,7.0,2.0,3.0,5.0,,,2.0,4.0,1.0,1.0,3.0,29.0
Belgaum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,15.0,9.0,5.0,8.0,14.0,5.0,4.0,12.0,17.0,7.0,14.0,10.0,120.0
Belgaum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Belgaum,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,15.0,9.0,5.0,8.0,14.0,5.0,4.0,12.0,17.0,7.0,14.0,10.0,120.0
Belgaum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,5.0,2.0,1.0,2.0,10.0,10.0,12.0,9.0,6.0,11.0,4.0,8.0,80.0
Belgaum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,1.0,2.0
Belgaum,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,2.0,1.0,2.0,10.0,11.0,12.0,9.0,6.0,11.0,4.0,9.0,82.0
Belgaum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,1.0,,,3.0,1.0,,,1.0,1.0,9.0
Belgaum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,1.0,,,,1.0,,3.0
Belgaum,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,1.0,1.0,1.0,,,4.0,1.0,,,2.0,1.0,12.0
Belgaum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Belgaum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Belgaum,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,,,,,,,1.0
Belgaum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,1.0,,,,,,,,,2.0
Belgaum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,1.0,,,,,1.0,,,,3.0
Belgaum,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,,2.0,,,,,1.0,,,,5.0
Belgaum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Belgaum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Belgaum,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Belgaum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,3.0,,,,1.0,3.0,1.0,1.0,6.0,2.0,1.0,4.0,22.0
Belgaum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,1.0,3.0,,1.0,1.0,2.0,,1.0,10.0
Belgaum,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,,1.0,,2.0,6.0,1.0,2.0,7.0,4.0,1.0,5.0,32.0
Belgaum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,1.0,,,1.0,,3.0
Belgaum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,1.0,,1.0,2.0
Belgaum,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,1.0,,1.0,1.0,1.0,5.0
Belgaum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Belgaum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,6.0,2.0,1.0,5.0,6.0,5.0,2.0,6.0,6.0,3.0,6.0,9.0,57.0
Belgaum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,3.0,1.0,1.0,3.0,6.0,2.0,1.0,2.0,4.0,2.0,1.0,27.0
Belgaum,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,5.0,3.0,6.0,9.0,11.0,4.0,7.0,8.0,7.0,8.0,10.0,85.0
Belgaum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,1.0,1.0,,,1.0,,,,,4.0
Belgaum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,26.0,13.0,29.0,25.0,19.0,17.0,14.0,14.0,14.0,19.0,22.0,23.0,235.0
Belgaum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,51.0,43.0,50.0,39.0,56.0,69.0,44.0,49.0,40.0,66.0,53.0,44.0,604.0
Belgaum,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,77.0,56.0,80.0,65.0,76.0,86.0,58.0,64.0,54.0,85.0,75.0,67.0,843.0
Belgaum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,1.0,1.0,,,,,,1.0,,,4.0
Belgaum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,,,1.0,2.0
Belgaum,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,1.0,1.0,1.0,,,,,,1.0,,1.0,6.0
Belgaum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,3.0,,,,2.0,,2.0,8.0
Belgaum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,23.0,18.0,14.0,16.0,27.0,12.0,20.0,17.0,12.0,21.0,15.0,23.0,218.0
Belgaum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,13.0,15.0,11.0,9.0,10.0,14.0,11.0,19.0,13.0,21.0,10.0,16.0,162.0
Belgaum,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,37.0,33.0,25.0,25.0,37.0,29.0,31.0,36.0,25.0,44.0,25.0,41.0,388.0
Belgaum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,2.0,1.0,2.0,1.0,,,1.0,1.0,2.0,,,,10.0
Belgaum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,29.0,16.0,27.0,26.0,21.0,30.0,32.0,17.0,23.0,31.0,23.0,21.0,296.0
Belgaum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,4.0,4.0,1.0,4.0,3.0,2.0,3.0,2.0,3.0,4.0,5.0,36.0
Belgaum,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,32.0,21.0,33.0,28.0,25.0,33.0,35.0,21.0,27.0,34.0,27.0,26.0,342.0
Belgaum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,2.0,4.0,2.0,2.0,4.0,1.0,2.0,1.0,5.0,2.0,1.0,27.0
Belgaum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,78.0,87.0,71.0,64.0,94.0,92.0,98.0,132.0,112.0,110.0,119.0,103.0,1160.0
Belgaum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,131.0,128.0,105.0,93.0,165.0,169.0,153.0,160.0,151.0,199.0,175.0,158.0,1787.0
Belgaum,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,210.0,217.0,180.0,159.0,261.0,265.0,252.0,294.0,264.0,314.0,296.0,262.0,2974.0
Belgaum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,1.0,3.0,,,2.0,2.0,1.0,4.0,2.0,,3.0,19.0
Belgaum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,17.0,21.0,17.0,23.0,40.0,32.0,20.0,21.0,35.0,24.0,33.0,18.0,301.0
Belgaum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,70.0,71.0,71.0,92.0,109.0,101.0,94.0,112.0,122.0,129.0,101.0,96.0,1168.0
Belgaum,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,88.0,93.0,91.0,115.0,149.0,135.0,116.0,134.0,161.0,155.0,134.0,117.0,1488.0
Belgaum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Belgaum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Belgaum,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,1.0,,,,1.0
Belgaum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,2.0,,,,,,,,,,,2.0
Belgaum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Belgaum,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,2.0,,,,,,,,,,,2.0
Belgaum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,3.0,,,4.0,,2.0,,,,2.0,,,11.0
Belgaum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Belgaum,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,3.0,,,4.0,,2.0,,,,2.0,,,11.0
Belgaum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,2.0,,1.0,,,1.0,1.0,,,,,,5.0
Belgaum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Belgaum,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,2.0,,1.0,,,1.0,1.0,,,,,,5.0
Belgaum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,2.0,,,,,,,,,,,,2.0
Belgaum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Belgaum,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,2.0,,,,,,,,,,,,2.0
Belgaum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Belgaum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,1.0,,2.0,1.0,3.0,3.0,2.0,1.0,2.0,2.0,,21.0
Belgaum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Belgaum,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,1.0,,2.0,1.0,3.0,3.0,2.0,1.0,2.0,2.0,,21.0
Belgaum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,3.0,2.0,1.0,4.0,2.0,1.0,2.0,,2.0,6.0,4.0,28.0
Belgaum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,38.0,51.0,42.0,48.0,37.0,33.0,47.0,43.0,55.0,56.0,50.0,44.0,544.0
Belgaum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,12.0,13.0,16.0,14.0,5.0,6.0,10.0,8.0,15.0,15.0,13.0,10.0,137.0
Belgaum,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,51.0,67.0,60.0,63.0,46.0,41.0,58.0,53.0,70.0,73.0,69.0,58.0,709.0
Belgaum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,1.0,1.0,1.0,2.0,1.0,2.0,1.0,,3.0,1.0,2.0,16.0
Belgaum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,30.0,41.0,40.0,21.0,23.0,24.0,34.0,23.0,27.0,25.0,28.0,25.0,341.0
Belgaum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,4.0,6.0,6.0,2.0,9.0,1.0,7.0,6.0,3.0,2.0,6.0,2.0,54.0
Belgaum,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,35.0,48.0,47.0,24.0,34.0,26.0,43.0,30.0,30.0,30.0,35.0,29.0,411.0
Belgaum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,1.0,,,,,,1.0,,,,3.0
Belgaum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,2.0,6.0,3.0,,1.0,1.0,3.0,5.0,2.0,3.0,2.0,29.0
Belgaum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,2.0,3.0,6.0,3.0,3.0,5.0,2.0,3.0,3.0,,,2.0,32.0
Belgaum,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,5.0,13.0,6.0,3.0,6.0,3.0,6.0,9.0,2.0,3.0,4.0,64.0
Belgaum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,,2.0,4.0,,2.0,2.0,3.0,,1.0,,16.0
Belgaum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,25.0,18.0,24.0,11.0,34.0,27.0,27.0,31.0,20.0,34.0,23.0,23.0,297.0
Belgaum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,46.0,42.0,32.0,41.0,61.0,65.0,52.0,57.0,45.0,54.0,47.0,37.0,579.0
Belgaum,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,72.0,61.0,56.0,54.0,99.0,92.0,81.0,90.0,68.0,88.0,71.0,60.0,892.0
Belgaum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,1.0,1.0,3.0,2.0,,2.0,,,1.0,3.0,,15.0
Belgaum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,28.0,32.0,44.0,29.0,32.0,27.0,28.0,37.0,25.0,49.0,32.0,24.0,387.0
Belgaum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,55.0,57.0,39.0,69.0,71.0,79.0,68.0,56.0,64.0,72.0,82.0,61.0,773.0
Belgaum,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,85.0,90.0,84.0,101.0,105.0,106.0,98.0,93.0,89.0,122.0,117.0,85.0,1175.0
Belgaum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,5.0,9.0,8.0,8.0,10.0,4.0,3.0,,3.0,6.0,2.0,62.0
Belgaum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,102.0,83.0,87.0,92.0,110.0,104.0,96.0,99.0,102.0,99.0,103.0,85.0,1162.0
Belgaum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,325.0,340.0,355.0,347.0,466.0,488.0,395.0,459.0,481.0,512.0,417.0,403.0,4988.0
Belgaum,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,431.0,428.0,451.0,447.0,584.0,602.0,495.0,561.0,583.0,614.0,526.0,490.0,6212.0
Bellary,1.1,Total number of pregnant women Registered for ANC,TOTAL,5275.0,5128.0,5823.0,5064.0,5069.0,5081.0,4991.0,5248.0,5691.0,5896.0,5811.0,5480.0,64557.0
Bellary,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,4408.0,4312.0,4846.0,4279.0,4305.0,4306.0,4292.0,4428.0,4479.0,4787.0,4528.0,4293.0,53263.0
Bellary,1.2,Number of Pregnant women registered under JSY,TOTAL,3949.0,3732.0,4007.0,3640.0,3643.0,3572.0,3635.0,3879.0,3722.0,3710.0,3810.0,3954.0,45253.0
Bellary,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3881.0,4772.0,5276.0,5035.0,4821.0,5218.0,4640.0,3801.0,5210.0,5529.0,5110.0,5227.0,58520.0
Bellary,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,5973.0,5355.0,6126.0,5112.0,4961.0,5238.0,5016.0,5308.0,5060.0,5020.0,5030.0,5429.0,63628.0
Bellary,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5858.0,6016.0,6789.0,5757.0,5723.0,5842.0,5856.0,5848.0,5941.0,5956.0,5828.0,6036.0,71450.0
Bellary,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3598.0,3322.0,3214.0,3990.0,3562.0,4154.0,4018.0,1961.0,3555.0,3432.0,3487.0,3690.0,41983.0
Bellary,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,96.0,99.0,68.0,132.0,87.0,99.0,99.0,59.0,56.0,69.0,53.0,134.0,1051.0
Bellary,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,14.0,12.0,11.0,12.0,16.0,20.0,15.0,0.0,13.0,15.0,11.0,9.0,148.0
Bellary,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,6139.0,5316.0,5625.0,5133.0,5068.0,7117.0,5144.0,5420.0,5011.0,5052.0,5478.0,5768.0,66271.0
Bellary,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,286.0,336.0,268.0,337.0,242.0,368.0,340.0,319.0,357.0,267.0,365.0,368.0,3853.0
Bellary,1.8,Number of pregnancy test kits used at SC level,TOTAL,1348.0,1317.0,1182.0,1260.0,1140.0,1080.0,1282.0,1231.0,1133.0,1195.0,1203.0,1265.0,14636.0
Bellary,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,18.0,18.0,24.0,24.0,27.0,22.0,22.0,14.0,23.0,21.0,22.0,11.0,246.0
Bellary,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,42.0,29.0,44.0,40.0,22.0,32.0,31.0,50.0,38.0,21.0,21.0,23.0,393.0
Bellary,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,60.0,47.0,68.0,64.0,49.0,54.0,53.0,64.0,61.0,42.0,43.0,34.0,639.0
Bellary,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,56.0,45.0,67.0,57.0,40.0,49.0,48.0,58.0,60.0,36.0,43.0,34.0,593.0
Bellary,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,6.0,3.0,2.0,1.0,0.0,1.0,5.0,4.0,0.0,0.0,1.0,24.0
Bellary,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2818.0,2589.0,2770.0,2695.0,2956.0,3082.0,3146.0,3115.0,2854.0,2811.0,2735.0,2542.0,34113.0
Bellary,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,499.0,301.0,490.0,282.0,373.0,713.0,860.0,378.0,689.0,663.0,260.0,593.0,6101.0
Bellary,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,795.0,750.0,1591.0,1425.0,642.0,594.0,1509.0,1505.0,1173.0,1535.0,1187.0,1200.0,13906.0
Bellary,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,397.0,202.0,231.0,198.0,370.0,122.0,230.0,729.0,119.0,88.0,382.0,445.0,3513.0
Bellary,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,933.0,886.0,881.0,790.0,840.0,979.0,973.0,960.0,886.0,845.0,889.0,773.0,10635.0
Bellary,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,17.0,14.0,22.0,11.0,9.0,4.0,0.0,0.0,0.0,3.0,0.0,0.0,80.0
Bellary,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,73.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,73.0
Bellary,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,305.0,321.0,370.0,301.0,384.0,391.0,382.0,312.0,275.0,282.0,325.0,354.0,4002.0
Bellary,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,305.0,321.0,370.0,301.0,384.0,391.0,382.0,312.0,275.0,282.0,325.0,354.0,4002.0
Bellary,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,516.0,558.0,449.0,384.0,445.0,564.0,546.0,538.0,543.0,389.0,462.0,444.0,5838.0
Bellary,4.1.1.a,Number of male live births,TOTAL,2023.0,1802.0,1884.0,1778.0,1962.0,2143.0,2088.0,2077.0,1911.0,1914.0,1762.0,1711.0,23055.0
Bellary,4.1.1.b,Number of female live births,TOTAL,1765.0,1673.0,1793.0,1724.0,1824.0,1932.0,2061.0,1996.0,1806.0,1731.0,1852.0,1623.0,21780.0
Bellary,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3788.0,3475.0,3677.0,3502.0,3786.0,4075.0,4149.0,4073.0,3717.0,3645.0,3614.0,3334.0,44835.0
Bellary,4.1.2,Number of still births,TOTAL,48.0,59.0,72.0,57.0,74.0,75.0,93.0,88.0,99.0,73.0,79.0,65.0,882.0
Bellary,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,140.0,143.0,144.0,133.0,123.0,86.0,111.0,85.0,88.0,101.0,86.0,111.0,1351.0
Bellary,4.2.1,Number of Newborns weighed at birth,TOTAL,3513.0,3435.0,3652.0,3490.0,3777.0,3992.0,4056.0,4070.0,3675.0,3585.0,3591.0,3345.0,44181.0
Bellary,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,432.0,283.0,237.0,219.0,249.0,270.0,283.0,362.0,314.0,272.0,322.0,262.0,3505.0
Bellary,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3483.0,3450.0,3628.0,3490.0,3709.0,3748.0,3766.0,3848.0,3425.0,3353.0,3108.0,3093.0,42101.0
Bellary,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,37.0,34.0,42.0,15.0,18.0,14.0,16.0,26.0,20.0,77.0,38.0,17.0,354.0
Bellary,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,4.0,10.0,3.0,5.0,5.0,5.0,5.0,4.0,3.0,44.0
Bellary,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,254.0,147.0,194.0,138.0,213.0,302.0,218.0,120.0,162.0,142.0,158.0,188.0,2236.0
Bellary,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,291.0,181.0,236.0,157.0,241.0,319.0,239.0,151.0,187.0,224.0,200.0,208.0,2634.0
Bellary,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,1.0,1.0,1.0,0.0,1.0,104.0,0.0,3.0,88.0,22.0,4.0,225.0
Bellary,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,993.0,853.0,776.0,755.0,884.0,951.0,941.0,843.0,824.0,691.0,746.0,678.0,9935.0
Bellary,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,26.0,18.0,35.0,37.0,27.0,35.0,36.0,16.0,12.0,27.0,25.0,24.0,318.0
Bellary,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,944.0,702.0,768.0,834.0,879.0,905.0,947.0,900.0,762.0,823.0,778.0,646.0,9888.0
Bellary,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,129.0,65.0,56.0,51.0,53.0,127.0,121.0,100.0,137.0,91.0,138.0,107.0,1175.0
Bellary,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3386.0,3151.0,3319.0,3490.0,3516.0,3756.0,3645.0,3110.0,3538.0,3350.0,3433.0,3004.0,40698.0
Bellary,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,4785.0,3838.0,4356.0,4145.0,4459.0,23018.0,5021.0,5145.0,4598.0,4467.0,4496.0,6706.0,75034.0
Bellary,6.3,PNC maternal complications attended,TOTAL,12.0,23.0,12.0,15.0,16.0,14.0,34.0,12.0,19.0,59.0,16.0,36.0,268.0
Bellary,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,10.0,25.0,28.0,32.0,34.0,33.0,37.0,33.0,24.0,36.0,31.0,21.0,344.0
Bellary,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,30.0,4.0,3.0,6.0,2.0,0.0,2.0,0.0,0.0,1.0,2.0,0.0,50.0
Bellary,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,40.0,29.0,31.0,38.0,36.0,33.0,39.0,33.0,24.0,37.0,33.0,21.0,394.0
Bellary,7.2,Number of MTPs conducted at Private Facilities,TOTAL,40.0,47.0,57.0,41.0,26.0,49.0,31.0,39.0,41.0,35.0,33.0,40.0,479.0
Bellary,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,637.0,629.0,721.0,609.0,675.0,659.0,661.0,613.0,609.0,660.0,580.0,672.0,7725.0
Bellary,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1131.0,1277.0,1356.0,1263.0,1332.0,1274.0,1174.0,1214.0,1254.0,1107.0,1251.0,1416.0,15049.0
Bellary,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1768.0,1906.0,2077.0,1872.0,2007.0,1933.0,1835.0,1827.0,1863.0,1767.0,1831.0,2088.0,22774.0
Bellary,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,32.0,26.0,259.0,10.0,10.0,30.0,0.0,5.0,3.0,5.0,28.0,0.0,408.0
Bellary,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0
Bellary,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,3.0,3.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,9.0
Bellary,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,3.0,3.0,2.0,0.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,12.0
Bellary,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,5.0
Bellary,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,194.0,140.0,147.0,121.0,169.0,160.0,125.0,152.0,141.0,167.0,155.0,121.0,1792.0
Bellary,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,17.0,15.0,35.0,18.0,37.0,54.0,94.0,70.0,83.0,87.0,106.0,616.0
Bellary,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,299.0,483.0,396.0,390.0,342.0,331.0,392.0,423.0,463.0,380.0,398.0,332.0,4629.0
Bellary,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,493.0,640.0,558.0,546.0,529.0,528.0,571.0,669.0,674.0,630.0,640.0,559.0,7037.0
Bellary,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,24.0,11.0,135.0,13.0,11.0,12.0,23.0,10.0,7.0,21.0,11.0,11.0,289.0
Bellary,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,110.0,119.0,149.0,96.0,95.0,40.0,58.0,49.0,37.0,161.0,179.0,156.0,1249.0
Bellary,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,150.0,137.0,164.0,176.0,188.0,173.0,190.0,269.0,187.0,147.0,193.0,111.0,2085.0
Bellary,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,243.0,174.0,105.0,180.0,296.0,301.0,330.0,293.0,309.0,89.0,132.0,74.0,2526.0
Bellary,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,503.0,430.0,418.0,452.0,579.0,514.0,578.0,611.0,533.0,397.0,504.0,341.0,5860.0
Bellary,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,84.0,100.0,63.0,50.0,110.0,55.0,77.0,76.0,75.0,85.0,125.0,105.0,1005.0
Bellary,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,5.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0,3.0,0.0,16.0
Bellary,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,29.0,44.0,29.0,36.0,8.0,36.0,0.0,0.0,0.0,0.0,0.0,0.0,182.0
Bellary,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,102.0,114.0,138.0,100.0,40.0,31.0,42.0,21.0,17.0,93.0,75.0,30.0,803.0
Bellary,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,131.0,163.0,167.0,140.0,48.0,67.0,42.0,21.0,17.0,97.0,78.0,30.0,1001.0
Bellary,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,131.0,138.0,98.0,122.0,73.0,140.0,192.0,142.0,164.0,140.0,99.0,66.0,1505.0
Bellary,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,277.0,311.0,246.0,294.0,235.0,240.0,293.0,282.0,240.0,256.0,252.0,246.0,3172.0
Bellary,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,265.0,264.0,277.0,256.0,260.0,280.0,244.0,267.0,261.0,312.0,319.0,306.0,3311.0
Bellary,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,42.0,28.0,32.0,74.0,56.0,79.0,83.0,87.0,76.0,60.0,72.0,91.0,780.0
Bellary,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,236.0,240.0,218.0,256.0,292.0,278.0,129.0,233.0,120.0,187.0,87.0,101.0,2377.0
Bellary,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bellary,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,820.0,843.0,773.0,880.0,843.0,877.0,749.0,869.0,697.0,815.0,730.0,744.0,9640.0
Bellary,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,159.0,146.0,211.0,143.0,111.0,70.0,60.0,16.0,75.0,219.0,41.0,59.0,1310.0
Bellary,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,74.0,52.0,69.0,75.0,56.0,87.0,332.0,254.0,116.0,66.0,111.0,70.0,1362.0
Bellary,9.06,Number of IUCD removals,TOTAL,182.0,150.0,342.0,151.0,136.0,220.0,127.0,202.0,171.0,447.0,149.0,248.0,2525.0
Bellary,9.07,Number of Oral Pills cycles distributed,TOTAL,6172.0,6192.0,5784.0,5196.0,5625.0,5957.0,6219.0,6630.0,7179.0,7442.0,6928.0,6790.0,76114.0
Bellary,9.08,Number of Condom pieces distributed,TOTAL,48080.0,52708.0,51578.0,48229.0,48301.0,49135.0,52527.0,51076.0,51630.0,51838.0,58188.0,50552.0,613842.0
Bellary,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,47.0,16.0,0.0,0.0,0.0,0.0,63.0
Bellary,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,25.0,4.0,14.0,27.0,7.0,13.0,11.0,50.0,8.0,15.0,2.0,27.0,203.0
Bellary,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Bellary,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,5.0
Bellary,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,9.11.3.b,Number of deaths following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Bellary,9.12,Number of Institutions having NSV trained doctors,TOTAL,24.0,25.0,27.0,30.0,20.0,25.0,25.0,25.0,26.0,28.0,26.0,32.0,-1.0
Bellary,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5105.0,4517.0,5561.0,5786.0,5656.0,5853.0,5525.0,5904.0,5481.0,5442.0,5944.0,5168.0,65942.0
Bellary,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,39.0,45.0,0.0,43.0,46.0,77.0,25.0,41.0,21.0,13.0,59.0,64.0,473.0
Bellary,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,25.0,21.0,2.0,57.0,54.0,75.0,25.0,30.0,22.0,22.0,61.0,67.0,461.0
Bellary,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,34.0,13.0,39.0,57.0,44.0,80.0,34.0,28.0,10.0,18.0,73.0,72.0,502.0
Bellary,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4905.0,4918.0,5528.0,5095.0,4983.0,4872.0,4734.0,5558.0,5179.0,5425.0,5245.0,5069.0,61511.0
Bellary,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4914.0,4647.0,5326.0,5133.0,4838.0,4902.0,4646.0,5111.0,5375.0,5193.0,5160.0,5159.0,60404.0
Bellary,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5238.0,4983.0,5550.0,5078.0,5036.0,4986.0,5002.0,5362.0,5211.0,5445.0,5265.0,5396.0,62552.0
Bellary,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2676.0,2377.0,2599.0,2891.0,3154.0,3362.0,3409.0,3330.0,2998.0,3028.0,2857.0,2782.0,35463.0
Bellary,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4846.0,4979.0,5513.0,5105.0,4946.0,4953.0,4811.0,5510.0,5179.0,5404.0,5304.0,5041.0,61591.0
Bellary,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4831.0,4678.0,5299.0,5119.0,4835.0,4974.0,4702.0,5112.0,5379.0,5209.0,5247.0,5146.0,60531.0
Bellary,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5164.0,5039.0,5497.0,5105.0,5113.0,5078.0,5048.0,5339.0,5216.0,5432.0,5338.0,5388.0,62757.0
Bellary,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2160.0,1826.0,1990.0,2402.0,2727.0,2939.0,2906.0,2903.0,2611.0,2630.0,2366.0,2260.0,29720.0
Bellary,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,125.0,92.0,29.0,30.0,7.0,0.0,33.0,2.0,21.0,0.0,1.0,12.0,352.0
Bellary,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,142.0,42.0,5.0,7.0,1.0,1.0,7.0,1.0,24.0,0.0,0.0,12.0,242.0
Bellary,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,61.0,48.0,8.0,10.0,0.0,0.0,12.0,2.0,29.0,1.0,312.0,6.0,489.0
Bellary,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4554.0,4720.0,5219.0,5139.0,5035.0,5156.0,4894.0,4935.0,4805.0,5082.0,5210.0,5267.0,60016.0
Bellary,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,4062.0,4242.0,4722.0,6411.0,4268.0,4268.0,4129.0,4437.0,4349.0,4348.0,4935.0,5010.0,55181.0
Bellary,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,4045.0,2808.0,3657.0,4136.0,4376.0,4443.0,4019.0,4427.0,4597.0,4943.0,4633.0,5168.0,51252.0
Bellary,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2279.0,2361.0,2516.0,2506.0,2419.0,2501.0,2371.0,2386.0,2354.0,2495.0,2564.0,2587.0,29339.0
Bellary,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2150.0,2173.0,2397.0,2304.0,2271.0,2330.0,2177.0,2266.0,2254.0,2333.0,2359.0,2356.0,27370.0
Bellary,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4429.0,4534.0,4913.0,4810.0,4690.0,4831.0,4548.0,4652.0,4608.0,4828.0,4923.0,4943.0,56709.0
Bellary,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,4233.0,4374.0,4585.0,6866.0,4457.0,4333.0,4178.0,4560.0,4299.0,4510.0,4942.0,5072.0,56409.0
Bellary,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,4236.0,4348.0,4561.0,6847.0,4465.0,4302.0,4155.0,4558.0,4301.0,4504.0,4944.0,5069.0,56290.0
Bellary,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,244.0,3.0,12.0,98.0,106.0,0.0,28.0,44.0,75.0,57.0,30.0,37.0,734.0
Bellary,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,476.0,599.0,599.0,730.0,525.0,813.0,467.0,456.0,452.0,482.0,574.0,602.0,6775.0
Bellary,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,466.0,525.0,550.0,700.0,466.0,792.0,417.0,451.0,421.0,489.0,522.0,587.0,6386.0
Bellary,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,942.0,1124.0,1149.0,1430.0,991.0,1605.0,884.0,907.0,873.0,971.0,1096.0,1189.0,13161.0
Bellary,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,455.0,524.0,673.0,4551.0,4470.0,6067.0,1136.0,3778.0,1794.0,1408.0,1112.0,949.0,26917.0
Bellary,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,669.0,670.0,859.0,4016.0,4409.0,5713.0,1407.0,3981.0,2186.0,1369.0,1361.0,1014.0,27654.0
Bellary,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,731.0,617.0,936.0,2633.0,2644.0,4490.0,1329.0,2851.0,1859.0,1261.0,1702.0,1009.0,22062.0
Bellary,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,15.0,3.0,2.0,1.0,1.0,0.0,0.0,1.0,1.0,3.0,3.0,2.0,32.0
Bellary,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,3.0,3.0,3.0,3.0,6.0,1.0,5.0,4.0,2.0,5.0,36.0
Bellary,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1655.0,1670.0,1728.0,1654.0,1665.0,1637.0,1599.0,1666.0,1658.0,1640.0,1646.0,1657.0,19875.0
Bellary,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1628.0,1639.0,1721.0,1637.0,1639.0,1622.0,1583.0,1659.0,1651.0,1628.0,1638.0,1651.0,19696.0
Bellary,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1090.0,1046.0,1062.0,1035.0,1006.0,1043.0,1027.0,1038.0,994.0,1039.0,1034.0,1016.0,12430.0
Bellary,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,3514.0,2817.0,3701.0,6105.0,3813.0,3671.0,3436.0,3868.0,4226.0,4301.0,4621.0,4707.0,48780.0
Bellary,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3155.0,2812.0,3105.0,3802.0,6616.0,4097.0,3850.0,3962.0,3863.0,3909.0,4958.0,3508.0,47637.0
Bellary,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,159.0,172.0,141.0,2332.0,33582.0,231.0,271.0,223.0,239.0,308.0,17382.0,9454.0,64494.0
Bellary,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,5.0,5.0,12.0,1743.0,37210.0,8.0,3.0,9.0,13.0,5.0,10715.0,6692.0,56420.0
Bellary,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,28.0,18.0,20.0,27.0,4.0,7.0,3.0,2.0,2.0,7.0,7.0,9.0,134.0
Bellary,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1393.0,1304.0,1473.0,1517.0,1584.0,1568.0,1495.0,1373.0,1399.0,1332.0,1422.0,1489.0,17349.0
Bellary,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,27.0,32.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,60.0
Bellary,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,61.0,53.0,109.0,69.0,68.0,119.0,85.0,87.0,129.0,91.0,104.0,130.0,1105.0
Bellary,13.1,Number of Patients operated for cataract,TOTAL,685.0,743.0,1020.0,740.0,461.0,423.0,300.0,926.0,598.0,574.0,764.0,421.0,7655.0
Bellary,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,684.0,702.0,1020.0,740.0,460.0,336.0,87.0,934.0,601.0,572.0,802.0,432.0,7370.0
Bellary,13.3,Number of School children detected with Refractive errors,TOTAL,28.0,0.0,19.0,307.0,96.0,320.0,35.0,96.0,151.0,81.0,120.0,47.0,1300.0
Bellary,13.4,Number of children provided free glasses,TOTAL,6.0,0.0,3.0,33.0,38.0,134.0,30.0,87.0,110.0,103.0,81.0,35.0,660.0
Bellary,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,8.0,10.0,13.0,9.0,11.0,12.0,10.0,13.0,14.0,14.0,11.0,-1.0
Bellary,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,53.0,52.0,51.0,44.0,49.0,48.0,46.0,44.0,48.0,49.0,49.0,61.0,-1.0
Bellary,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,304.0,321.0,310.0,308.0,309.0,296.0,298.0,309.0,311.0,295.0,316.0,318.0,-1.0
Bellary,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,9.0,9.0,11.0,12.0,9.0,11.0,8.0,12.0,13.0,14.0,13.0,-1.0
Bellary,14.05,Number of RKS meetings held during the month,TOTAL,23.0,20.0,20.0,19.0,17.0,16.0,19.0,20.0,15.0,17.0,20.0,21.0,227.0
Bellary,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,36.0,33.0,35.0,34.0,23.0,27.0,30.0,29.0,34.0,32.0,32.0,43.0,-1.0
Bellary,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,472.0,2426.0,331.0,340.0,352.0,360.0,364.0,533.0,411.0,401.0,506.0,312.0,6808.0
Bellary,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,11.0,10.0,10.0,11.0,7.0,10.0,9.0,9.0,10.0,11.0,13.0,11.0,-1.0
Bellary,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,2.0,24.0,30.0,2.0,3.0,2.0,2.0,2.0,2.0,1.0,1.0,-1.0
Bellary,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,553.0,470.0,510.0,647.0,736.0,837.0,716.0,611.0,609.0,609.0,658.0,676.0,7632.0
Bellary,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2649.0,2641.0,2901.0,2538.0,2887.0,2921.0,2665.0,2407.0,2071.0,2383.0,2263.0,2609.0,30935.0
Bellary,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,795.0,581.0,547.0,651.0,657.0,1494.0,720.0,648.0,456.0,740.0,523.0,547.0,8359.0
Bellary,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6108.0,6524.0,6690.0,6652.0,7411.0,6204.0,6909.0,6665.0,6421.0,6175.0,6069.0,5991.0,77819.0
Bellary,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1348.0,1051.0,1057.0,1298.0,1393.0,2331.0,1436.0,1259.0,1065.0,1349.0,1181.0,1223.0,15991.0
Bellary,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8757.0,9165.0,9591.0,9190.0,10298.0,9125.0,9574.0,9072.0,8492.0,8558.0,8332.0,8600.0,108754.0
Bellary,14.10.2.a,Number of death cases of Inpatient males,TOTAL,40.0,39.0,30.0,57.0,49.0,39.0,46.0,37.0,35.0,36.0,46.0,46.0,500.0
Bellary,14.10.2.b,Number of death cases of Inpatient females,TOTAL,26.0,38.0,23.0,30.0,17.0,21.0,26.0,28.0,22.0,31.0,27.0,19.0,308.0
Bellary,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,66.0,77.0,53.0,87.0,66.0,60.0,72.0,65.0,57.0,67.0,73.0,65.0,808.0
Bellary,14.11,In-Patient Head Count at midnight,TOTAL,13416.0,14243.0,15481.0,16005.0,17323.0,14669.0,14612.0,13639.0,13053.0,13176.0,12816.0,11433.0,169866.0
Bellary,14.12.1,OPD attendance (All),TOTAL,136815.0,128060.0,142199.0,135279.0,141604.0,144681.0,137054.0,151433.0,150348.0,148028.0,152807.0,153997.0,1722305.0
Bellary,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,357.0,275.0,529.0,405.0,702.0,605.0,1497.0,313.0,501.0,406.0,258.0,314.0,6162.0
Bellary,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,71.0,106.0,94.0,39.0,62.0,107.0,38.0,92.0,67.0,56.0,109.0,146.0,987.0
Bellary,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,502.0,596.0,399.0,318.0,337.0,455.0,436.0,456.0,435.0,351.0,634.0,473.0,5392.0
Bellary,14.14.a,Number of patients given AYUSH treatment,TOTAL,2596.0,2769.0,3059.0,2932.0,2950.0,2649.0,2485.0,2617.0,2494.0,2684.0,2735.0,2708.0,32678.0
Bellary,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,736.0,496.0,451.0,819.0,836.0,815.0,777.0,693.0,758.0,637.0,777.0,766.0,8561.0
Bellary,14.14.c,Number of Adolescents counselled,TOTAL,319.0,240.0,194.0,269.0,514.0,324.0,286.0,317.0,331.0,243.0,325.0,333.0,3695.0
Bellary,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,13990.0,12019.0,14098.0,15207.0,14101.0,15016.0,14399.0,14130.0,12895.0,12376.0,12761.0,13891.0,164883.0
Bellary,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,677.0,600.0,732.0,573.0,510.0,589.0,607.0,591.0,602.0,481.0,714.0,596.0,7272.0
Bellary,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2457.0,3004.0,2794.0,2718.0,2638.0,3240.0,2498.0,2785.0,3141.0,2685.0,3049.0,2834.0,33843.0
Bellary,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,43.0,42.0,43.0,33.0,25.0,27.0,33.0,37.0,31.0,8.0,29.0,28.0,379.0
Bellary,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2597.0,3299.0,3209.0,4225.0,2849.0,3597.0,3042.0,3077.0,3224.0,2816.0,3091.0,3104.0,38130.0
Bellary,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,38.0,36.0,34.0,25.0,15.0,33.0,22.0,29.0,31.0,10.0,33.0,23.0,329.0
Bellary,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,6210.0,6038.0,7078.0,6761.0,6279.0,7014.0,5332.0,6230.0,6114.0,5729.0,5614.0,5704.0,74103.0
Bellary,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,68.0,39.0,4.0,30.0,8.0,6.0,7.0,4.0,3.0,4.0,2.0,4.0,179.0
Bellary,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,11264.0,12341.0,13081.0,13704.0,11766.0,13851.0,10872.0,12092.0,12479.0,11230.0,11754.0,11642.0,146076.0
Bellary,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,149.0,117.0,81.0,88.0,48.0,66.0,62.0,70.0,65.0,22.0,64.0,55.0,887.0
Bellary,15.2,Number of Widal tests conducted,Number tested,989.0,773.0,994.0,1657.0,1389.0,1711.0,1754.0,1412.0,1097.0,1132.0,1264.0,1452.0,15624.0
Bellary,15.3.a,Number of VDRL tests conducted on males,Number tested,550.0,105.0,111.0,160.0,333.0,211.0,120.0,234.0,125.0,96.0,65.0,51.0,2161.0
Bellary,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,282.0,401.0,435.0,403.0,305.0,312.0,323.0,172.0,342.0,427.0,364.0,327.0,4093.0
Bellary,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2748.0,3954.0,3268.0,2841.0,2265.0,2759.0,2407.0,2658.0,2425.0,2414.0,2797.0,2880.0,33416.0
Bellary,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3580.0,4460.0,3814.0,3404.0,2903.0,3282.0,2850.0,3064.0,2892.0,2937.0,3226.0,3258.0,39670.0
Bellary,15.4.1,Number of blood smears examined for Malaria,TOTAL,21720.0,24487.0,27576.0,28057.0,29870.0,31847.0,28613.0,33309.0,28605.0,23279.0,26067.0,26708.0,330138.0
Bellary,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,11.0,17.0,31.0,37.0,12.0,11.0,488.0,32.0,2.0,6.0,2.0,7.0,656.0
Bellary,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,8.0,13.0,2.0,22.0,1.0,3.0,28.0,10.0,2.0,0.0,0.0,0.0,89.0
Bellary,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,8000.0,3000.0,1500.0,9500.0,6500.0,10250.0,2000.0,2000.0,2000.0,5000.0,15500.0,5750.0,71000.0
Bellary,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,10000.0,20000.0,15000.0,15000.0,10000.0,10000.0,12000.0,20000.0,15000.0,0.0,15000.0,142000.0
Bellary,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,5000.0,11500.0,12000.0,18000.0,11250.0,18250.0,10000.0,12000.0,17000.0,4500.0,9750.0,16000.0,145250.0
Bellary,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,1500.0,9500.0,6500.0,10250.0,2000.0,2000.0,2000.0,5000.0,15500.0,5750.0,4750.0,67750.0
Bellary,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,17500.0,10500.0,17500.0,22500.0,28500.0,32000.0,15000.0,21000.0,26000.0,14000.0,25500.0,13000.0,243000.0
Bellary,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,27000.0,27000.0,27000.0,24000.0,6000.0,25000.0,20000.0,15000.0,20000.0,0.0,25000.0,216000.0
Bellary,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,7000.0,20000.0,22000.0,21500.0,20500.0,23000.0,19000.0,15000.0,27000.0,8500.0,12500.0,27000.0,223000.0
Bellary,16.1.1A,Stock Position of Pentavalent,5. Total Stock,10500.0,17500.0,22500.0,28000.0,32000.0,15000.0,21000.0,26000.0,14000.0,25500.0,13000.0,11000.0,236000.0
Bellary,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,30000.0,18500.0,15000.0,15500.0,11500.0,7000.0,4000.0,13500.0,10000.0,3500.0,500.0,8000.0,137000.0
Bellary,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,33000.0,40000.0,40000.0,25000.0,33000.0,40000.0,32000.0,30000.0,15000.0,40000.0,40000.0,368000.0
Bellary,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11500.0,36500.0,39500.0,44000.0,29500.0,36000.0,30500.0,35500.0,36500.0,18000.0,32500.0,36000.0,386000.0
Bellary,16.1.2,Stock position of OPV vaccines,5. Total Stock,18500.0,15000.0,15500.0,11500.0,7000.0,4000.0,13500.0,10000.0,3500.0,500.0,8000.0,12000.0,119000.0
Bellary,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,15000.0,7500.0,14500.0,18500.0,28000.0,18000.0,9000.0,12500.0,16000.0,9000.0,20500.0,4500.0,173000.0
Bellary,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,27000.0,27000.0,27000.0,15000.0,20000.0,25000.0,25000.0,20000.0,20000.0,0.0,30000.0,236000.0
Bellary,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.3,Stock position of TT vaccines,4. Stock Distributed,7500.0,20000.0,23000.0,17500.0,25000.0,29000.0,21500.0,21500.0,27000.0,8500.0,16000.0,26500.0,243000.0
Bellary,16.1.3,Stock position of TT vaccines,5. Total Stock,7500.0,14500.0,18500.0,28000.0,18000.0,9000.0,12500.0,16000.0,9000.0,20500.0,4500.0,8000.0,166000.0
Bellary,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4500.0,0.0,1500.0,3500.0,3500.0,15500.0,14000.0,9000.0,8000.0,6000.0,16000.0,5500.0,87000.0
Bellary,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,14000.0,18000.0,20000.0,25000.0,14000.0,10000.0,15000.0,15000.0,15000.0,0.0,15000.0,161000.0
Bellary,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4500.0,12500.0,16000.0,20000.0,13000.0,15500.0,15000.0,16000.0,17000.0,5000.0,10500.0,18000.0,163000.0
Bellary,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,1500.0,3500.0,3500.0,15500.0,14000.0,9000.0,8000.0,6000.0,16000.0,5500.0,2500.0,85000.0
Bellary,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3750.0,0.0,3500.0,6500.0,6000.0,6500.0,500.0,500.0,5750.0,1000.0,6750.0,250.0,41000.0
Bellary,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,15000.0,15000.0,15000.0,10000.0,5000.0,0.0,15000.0,10000.0,10000.0,0.0,15000.0,110000.0
Bellary,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3750.0,11500.0,12000.0,15500.0,9500.0,11000.0,0.0,9750.0,14750.0,4250.0,6500.0,14750.0,113250.0
Bellary,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,3500.0,6500.0,6000.0,6500.0,500.0,500.0,5750.0,1000.0,6750.0,250.0,500.0,37750.0
Bellary,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,3250.0,0.0,6000.0,500.0,0.0,0.0,500.0,3500.0,9500.0,7500.0,15500.0,5000.0,51250.0
Bellary,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,15000.0,0.0,12000.0,10000.0,15000.0,10000.0,20000.0,15000.0,15000.0,0.0,10000.0,122000.0
Bellary,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3250.0,9000.0,5500.0,12500.0,10000.0,14500.0,7000.0,14000.0,17000.0,7000.0,10500.0,15000.0,125250.0
Bellary,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,6000.0,500.0,0.0,0.0,500.0,3500.0,9500.0,7500.0,15500.0,5000.0,0.0,48000.0
Bellary,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,500.0,0.0,2400.0,5100.0,7200.0,10800.0,11400.0,5700.0,2100.0,500.0,11000.0,6000.0,62700.0
Bellary,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,9000.0,9000.0,9000.0,9000.0,6600.0,0.0,0.0,5000.0,13000.0,0.0,5000.0,65600.0
Bellary,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,500.0,6600.0,6300.0,6900.0,5400.0,6000.0,5700.0,3600.0,6600.0,2500.0,5000.0,8000.0,63100.0
Bellary,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,2400.0,5100.0,7200.0,10800.0,11400.0,5700.0,2100.0,500.0,11000.0,6000.0,3000.0,65200.0
Bellary,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,9744.0,9144.0,8269.0,7869.0,6919.0,5919.0,4469.0,3669.0,2169.0,969.0,769.0,769.0,60678.0
Bellary,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,875.0,400.0,950.0,1000.0,1450.0,800.0,1500.0,1200.0,200.0,0.0,200.0,9175.0
Bellary,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9144.0,8269.0,7869.0,6919.0,5919.0,4469.0,3669.0,2169.0,969.0,769.0,769.0,569.0,51503.0
Bellary,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,146660.0,131540.0,76360.0,68800.0,200560.0,182920.0,122440.0,87160.0,51880.0,16600.0,11560.0,6940.0,1103420.0
Bellary,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,151500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,151500.0
Bellary,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,15120.0,54180.0,7560.0,19740.0,17640.0,60480.0,35280.0,35280.0,35280.0,5040.0,4620.0,2500.0,292720.0
Bellary,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,131540.0,77360.0,68800.0,200560.0,182920.0,122440.0,87160.0,51880.0,16600.0,11560.0,6940.0,4440.0,962200.0
Bellary,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,140.0,140.0,0.0,0.0,6000.0,4250.0,50.0,0.0,30800.0,26600.0,25400.0,24200.0,117580.0
Bellary,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,6000.0,0.0,0.0,0.0,36000.0,0.0,0.0,0.0,0.0,42000.0
Bellary,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,140.0,0.0,0.0,1750.0,4200.0,50.0,5200.0,4200.0,1200.0,1200.0,0.0,17940.0
Bellary,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,140.0,0.0,0.0,6000.0,4250.0,50.0,0.0,30800.0,26600.0,25400.0,24200.0,24200.0,141640.0
Bellary,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,850.0,700.0,700.0,550.0,250.0,250.0,100.0,100.0,100.0,100.0,0.0,0.0,3700.0
Bellary,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,150.0,0.0,150.0,300.0,0.0,150.0,0.0,0.0,0.0,100.0,0.0,0.0,850.0
Bellary,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,700.0,700.0,550.0,250.0,250.0,100.0,100.0,100.0,100.0,0.0,0.0,0.0,2850.0
Bellary,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5675.0,4975.0,4175.0,3675.0,7825.0,7325.0,6625.0,6125.0,5625.0,4525.0,4325.0,3525.0,64400.0
Bellary,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,4550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4550.0
Bellary,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,700.0,800.0,500.0,400.0,500.0,700.0,500.0,500.0,1100.0,200.0,800.0,600.0,7300.0
Bellary,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4975.0,4175.0,3675.0,7825.0,7325.0,6625.0,6125.0,5625.0,4525.0,4325.0,3525.0,2925.0,61650.0
Bellary,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15950.0,15950.0
Bellary,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4600.0,4600.0
Bellary,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11350.0,11350.0
Bellary,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,5018.0,5018.0,5018.0,5018.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20072.0
Bellary,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,5018.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5018.0
Bellary,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,5018.0,5018.0,5018.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15054.0
Bellary,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,770.0,570.0,365.0,315.0,5605.0,28017.0,27202.0,26702.0,26702.0,25807.0,22607.0,15187.0,179849.0
Bellary,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,111900.0,22612.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,134512.0
Bellary,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,200.0,205.0,0.0,106610.0,200.0,815.0,500.0,0.0,895.0,3200.0,7420.0,2800.0,122845.0
Bellary,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,570.0,365.0,365.0,5605.0,28017.0,27202.0,26702.0,26702.0,25807.0,22607.0,15187.0,12387.0,191516.0
Bellary,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,0.0,700.0,0.0,0.0,2300.0,0.0,0.0,0.0,0.0,0.0,3000.0
Bellary,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,6600.0,6600.0,0.0,6600.0,0.0,3300.0,6600.0,0.0,3300.0,6600.0,39600.0
Bellary,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,0.0,5900.0,7300.0,0.0,4300.0,2300.0,3300.0,6600.0,0.0,3300.0,5800.0,38800.0
Bellary,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,700.0,0.0,0.0,2300.0,0.0,0.0,0.0,0.0,0.0,800.0,3800.0
Bellary,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,0.0,64800.0,48000.0,48000.0,48000.0,78400.0,14400.0,14400.0,14400.0,8400.0,0.0,338800.0
Bellary,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,120000.0,0.0,0.0,0.0,100000.0,0.0,0.0,0.0,0.0,0.0,0.0,220000.0
Bellary,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,55200.0,16800.0,0.0,0.0,69600.0,64000.0,0.0,0.0,6000.0,8400.0,0.0,220000.0
Bellary,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,64800.0,48000.0,48000.0,48000.0,78400.0,14400.0,14400.0,14400.0,8400.0,0.0,0.0,338800.0
Bellary,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,6400.0,4800.0,4800.0,4800.0,6200.0,1400.0,1400.0,1400.0,1400.0,0.0,32600.0
Bellary,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,12000.0,0.0,0.0,0.0,7200.0,0.0,0.0,0.0,0.0,0.0,0.0,19200.0
Bellary,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bellary,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,5600.0,1600.0,0.0,0.0,5800.0,4800.0,0.0,0.0,0.0,1400.0,0.0,19200.0
Bellary,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,6400.0,4800.0,4800.0,4800.0,6200.0,1400.0,1400.0,1400.0,1400.0,0.0,0.0,32600.0
Bellary,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,3.0,1.0,1.0,1.0,,2.0,,,,1.0,10.0
Bellary,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,2.0,,1.0,3.0,4.0,2.0,2.0,4.0,1.0,,19.0
Bellary,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,1.0,2.0,,2.0,1.0,7.0
Bellary,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,3.0,,1.0,3.0,4.0,3.0,4.0,4.0,3.0,1.0,26.0
Bellary,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,2.0,4.0,13.0,10.0,9.0,18.0,31.0,24.0,21.0,21.0,26.0,182.0
Bellary,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,,,,1.0,,1.0,,4.0
Bellary,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,2.0,4.0,14.0,11.0,9.0,18.0,31.0,25.0,21.0,22.0,26.0,186.0
Bellary,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,4.0,1.0,9.0,17.0,10.0,3.0,19.0,19.0,20.0,15.0,28.0,146.0
Bellary,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,3.0,1.0,,1.0,,,1.0,7.0
Bellary,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,4.0,1.0,9.0,17.0,13.0,4.0,19.0,20.0,20.0,15.0,29.0,153.0
Bellary,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,9.0,1.0,15.0,11.0,7.0,5.0,8.0,4.0,5.0,3.0,11.0,4.0,83.0
Bellary,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,1.0,2.0,1.0,1.0,,,,1.0,3.0,10.0
Bellary,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,9.0,1.0,16.0,12.0,9.0,6.0,9.0,4.0,5.0,3.0,12.0,7.0,93.0
Bellary,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,2.0,2.0,3.0,5.0,1.0,1.0,,,,3.0,,17.0
Bellary,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,1.0,1.0,,2.0
Bellary,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,2.0,2.0,3.0,5.0,1.0,1.0,,,1.0,4.0,,19.0
Bellary,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bellary,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,1.0,,,,1.0,,2.0
Bellary,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,1.0,,,,1.0,,2.0
Bellary,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,3.0,2.0,1.0,1.0,1.0,1.0,,,,,,,9.0
Bellary,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,1.0,,1.0,,1.0,,3.0
Bellary,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,3.0,2.0,1.0,1.0,1.0,1.0,1.0,,1.0,,1.0,,12.0
Bellary,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bellary,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bellary,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bellary,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,2.0,7.0,9.0,10.0,12.0,3.0,3.0,4.0,1.0,5.0,5.0,66.0
Bellary,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,,,1.0,5.0,2.0,3.0,,2.0,1.0,1.0,17.0
Bellary,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,3.0,7.0,9.0,11.0,17.0,5.0,6.0,4.0,3.0,6.0,6.0,83.0
Bellary,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Bellary,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,2.0,,1.0,,,,,,,1.0,,1.0,5.0
Bellary,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,1.0,,,,,,,1.0,,1.0,5.0
Bellary,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,4.0,4.0,2.0,3.0,4.0,2.0,6.0,5.0,2.0,7.0,2.0,42.0
Bellary,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,,3.0,1.0,1.0,2.0,2.0,3.0,2.0,2.0,2.0,20.0
Bellary,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,6.0,4.0,5.0,4.0,5.0,4.0,8.0,8.0,4.0,9.0,4.0,62.0
Bellary,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Bellary,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,10.0,5.0,11.0,13.0,4.0,6.0,9.0,10.0,4.0,8.0,7.0,6.0,93.0
Bellary,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,18.0,8.0,16.0,14.0,25.0,20.0,11.0,25.0,17.0,29.0,21.0,19.0,223.0
Bellary,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,28.0,13.0,27.0,27.0,29.0,27.0,20.0,35.0,21.0,37.0,28.0,25.0,317.0
Bellary,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bellary,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Bellary,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Bellary,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,,,1.0,,4.0,2.0,,1.0,,,2.0,13.0
Bellary,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,2.0,3.0,2.0,,5.0,1.0,1.0,3.0,,3.0,1.0,23.0
Bellary,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,5.0,2.0,3.0,3.0,,9.0,3.0,1.0,4.0,,3.0,3.0,36.0
Bellary,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,1.0,,,,,,,,,1.0,2.0
Bellary,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,5.0,6.0,3.0,7.0,4.0,4.0,7.0,4.0,5.0,3.0,6.0,6.0,60.0
Bellary,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,2.0,2.0,,3.0,1.0,,,,,,1.0,,9.0
Bellary,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,7.0,8.0,4.0,10.0,5.0,4.0,7.0,4.0,5.0,3.0,7.0,7.0,71.0
Bellary,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,2.0,,,,,2.0,,,2.0,2.0,8.0
Bellary,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,30.0,27.0,29.0,32.0,44.0,37.0,46.0,38.0,39.0,36.0,34.0,35.0,427.0
Bellary,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,28.0,25.0,14.0,24.0,24.0,33.0,34.0,32.0,24.0,30.0,35.0,29.0,332.0
Bellary,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,58.0,52.0,45.0,56.0,68.0,70.0,80.0,72.0,63.0,66.0,71.0,66.0,767.0
Bellary,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,2.0,,1.0,1.0,,,1.0,1.0,2.0,8.0
Bellary,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,12.0,5.0,8.0,11.0,10.0,7.0,10.0,8.0,14.0,8.0,6.0,10.0,109.0
Bellary,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,9.0,5.0,5.0,8.0,11.0,16.0,15.0,8.0,12.0,16.0,17.0,13.0,135.0
Bellary,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,21.0,10.0,13.0,21.0,21.0,24.0,26.0,16.0,26.0,25.0,24.0,25.0,252.0
Bellary,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bellary,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bellary,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bellary,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,1.0,,2.0
Bellary,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bellary,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,1.0,,2.0
Bellary,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,1.0,,,1.0,,1.0,,1.0,,1.0,6.0
Bellary,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bellary,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,1.0,,,1.0,,1.0,,1.0,,1.0,6.0
Bellary,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,5.0,,1.0,3.0,,1.0,1.0,2.0,,14.0
Bellary,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bellary,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,5.0,,1.0,3.0,,1.0,1.0,2.0,,14.0
Bellary,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Bellary,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bellary,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,1.0,,,,,,,,1.0
Bellary,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bellary,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,2.0,2.0,4.0,1.0,1.0,,1.0,2.0,,1.0,15.0
Bellary,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bellary,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,2.0,2.0,4.0,1.0,1.0,,1.0,2.0,,1.0,15.0
Bellary,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,1.0,1.0,2.0,,2.0,1.0,2.0,1.0,2.0,5.0,19.0
Bellary,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,17.0,10.0,19.0,14.0,16.0,14.0,18.0,18.0,18.0,17.0,18.0,19.0,198.0
Bellary,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,6.0,2.0,4.0,2.0,3.0,6.0,2.0,3.0,3.0,4.0,,3.0,38.0
Bellary,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,23.0,14.0,24.0,17.0,21.0,20.0,22.0,22.0,23.0,22.0,20.0,27.0,255.0
Bellary,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,1.0,,,1.0,,,3.0
Bellary,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,18.0,20.0,11.0,11.0,19.0,14.0,18.0,20.0,15.0,13.0,10.0,8.0,177.0
Bellary,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,3.0,,2.0,3.0,,1.0,1.0,2.0,2.0,1.0,2.0,20.0
Bellary,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,21.0,23.0,11.0,13.0,23.0,14.0,20.0,21.0,17.0,16.0,11.0,10.0,200.0
Bellary,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,2.0,1.0,1.0,1.0,,1.0,1.0,1.0,1.0,1.0,,,10.0
Bellary,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,3.0,3.0,4.0,2.0,5.0,4.0,4.0,2.0,2.0,5.0,,34.0
Bellary,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,1.0,2.0,2.0,5.0,1.0,1.0,,1.0,,2.0,16.0
Bellary,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,5.0,5.0,7.0,4.0,11.0,6.0,6.0,3.0,4.0,5.0,2.0,60.0
Bellary,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,2.0,,1.0,,2.0,,,1.0,7.0
Bellary,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,11.0,6.0,8.0,9.0,3.0,8.0,8.0,1.0,10.0,15.0,5.0,10.0,94.0
Bellary,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,10.0,3.0,8.0,12.0,10.0,9.0,15.0,9.0,14.0,8.0,11.0,11.0,120.0
Bellary,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,22.0,9.0,16.0,21.0,15.0,17.0,24.0,10.0,26.0,23.0,16.0,22.0,221.0
Bellary,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,,1.0,,,2.0,,1.0,1.0,7.0
Bellary,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,7.0,12.0,9.0,13.0,11.0,13.0,9.0,14.0,8.0,11.0,9.0,125.0
Bellary,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,16.0,15.0,16.0,18.0,15.0,32.0,12.0,12.0,11.0,17.0,15.0,15.0,194.0
Bellary,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,25.0,23.0,29.0,27.0,28.0,44.0,25.0,21.0,27.0,25.0,27.0,25.0,326.0
Bellary,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,6.0,2.0,5.0,2.0,5.0,8.0,6.0,2.0,,8.0,5.0,5.0,54.0
Bellary,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,58.0,60.0,74.0,48.0,86.0,77.0,56.0,75.0,70.0,82.0,89.0,69.0,844.0
Bellary,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,209.0,205.0,213.0,272.0,281.0,294.0,242.0,294.0,310.0,296.0,293.0,218.0,3127.0
Bellary,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,273.0,267.0,292.0,322.0,372.0,379.0,304.0,371.0,380.0,386.0,387.0,292.0,4025.0
Bidar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2809.0,2683.0,3044.0,2956.0,2989.0,3014.0,2731.0,3006.0,2520.0,2846.0,2802.0,2641.0,34041.0
Bidar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2019.0,1847.0,2047.0,2064.0,2102.0,2191.0,1913.0,2169.0,1834.0,2072.0,2051.0,2008.0,24317.0
Bidar,1.2,Number of Pregnant women registered under JSY,TOTAL,2238.0,2053.0,2384.0,2204.0,2266.0,2398.0,2071.0,2276.0,1864.0,2139.0,2194.0,2186.0,26273.0
Bidar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3511.0,3212.0,3470.0,2825.0,3380.0,3022.0,2760.0,2746.0,2848.0,2747.0,2424.0,2362.0,35307.0
Bidar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3624.0,3205.0,3341.0,3183.0,3295.0,3512.0,2995.0,3411.0,3124.0,3130.0,3106.0,3008.0,38934.0
Bidar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3661.0,3432.0,3407.0,3468.0,3475.0,3715.0,3165.0,3561.0,3314.0,3203.0,3358.0,3201.0,40960.0
Bidar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,7498.0,1479.0,1815.0,1755.0,1690.0,1833.0,1664.0,1745.0,1495.0,1210.0,934.0,1184.0,24302.0
Bidar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,128.0,136.0,150.0,165.0,198.0,108.0,103.0,124.0,111.0,128.0,198.0,149.0,1698.0
Bidar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,10.0,10.0,17.0,28.0,19.0,10.0,12.0,12.0,5.0,7.0,22.0,9.0,161.0
Bidar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3658.0,3383.0,4032.0,4621.0,4366.0,4710.0,3963.0,4298.0,3328.0,3985.0,3685.0,3836.0,47865.0
Bidar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,183.0,184.0,186.0,257.0,270.0,205.0,269.0,173.0,123.0,137.0,165.0,127.0,2279.0
Bidar,1.8,Number of pregnancy test kits used at SC level,TOTAL,420.0,315.0,378.0,366.0,365.0,357.0,262.0,326.0,306.0,309.0,340.0,294.0,4038.0
Bidar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,22.0,13.0,9.0,22.0,26.0,21.0,16.0,9.0,10.0,8.0,10.0,171.0
Bidar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,10.0,2.0,4.0,5.0,13.0,12.0,12.0,7.0,9.0,7.0,3.0,6.0,90.0
Bidar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,15.0,24.0,17.0,14.0,35.0,38.0,33.0,23.0,18.0,17.0,11.0,16.0,261.0
Bidar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,12.0,18.0,15.0,7.0,32.0,27.0,23.0,19.0,13.0,13.0,9.0,12.0,200.0
Bidar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,2.0,3.0,0.0,0.0,2.0,0.0,3.0,2.0,2.0,0.0,0.0,14.0
Bidar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2153.0,2105.0,2189.0,2349.0,2744.0,2832.0,2602.0,2461.0,2126.0,1976.0,2226.0,2194.0,27957.0
Bidar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,654.0,557.0,556.0,550.0,641.0,673.0,685.0,533.0,618.0,523.0,614.0,651.0,7255.0
Bidar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,974.0,1240.0,1372.0,1044.0,1031.0,1862.0,1617.0,1347.0,1329.0,1328.0,1347.0,1069.0,15560.0
Bidar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,16.0,4.0,91.0,48.0,40.0,23.0,29.0,141.0,86.0,72.0,40.0,59.0,649.0
Bidar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,385.0,384.0,458.0,334.0,625.0,665.0,616.0,537.0,433.0,475.0,524.0,388.0,5824.0
Bidar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,221.0,240.0,250.0,271.0,290.0,341.0,230.0,271.0,208.0,222.0,262.0,170.0,2976.0
Bidar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,221.0,240.0,250.0,271.0,290.0,341.0,230.0,271.0,208.0,222.0,262.0,170.0,2976.0
Bidar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,111.0,138.0,164.0,120.0,176.0,192.0,160.0,129.0,125.0,123.0,140.0,80.0,1658.0
Bidar,4.1.1.a,Number of male live births,TOTAL,1314.0,1334.0,1364.0,1400.0,1855.0,1805.0,1667.0,1491.0,1322.0,1342.0,1377.0,1307.0,17578.0
Bidar,4.1.1.b,Number of female live births,TOTAL,1265.0,1156.0,1337.0,1306.0,1647.0,1711.0,1618.0,1503.0,1226.0,1120.0,1348.0,1262.0,16499.0
Bidar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2579.0,2490.0,2701.0,2706.0,3502.0,3516.0,3285.0,2994.0,2548.0,2462.0,2725.0,2569.0,34077.0
Bidar,4.1.2,Number of still births,TOTAL,41.0,49.0,36.0,50.0,47.0,49.0,31.0,32.0,23.0,32.0,39.0,38.0,467.0
Bidar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,101.0,56.0,57.0,59.0,104.0,68.0,45.0,77.0,36.0,80.0,83.0,54.0,820.0
Bidar,4.2.1,Number of Newborns weighed at birth,TOTAL,2525.0,2470.0,2751.0,2693.0,3502.0,3467.0,3274.0,2994.0,2523.0,2460.0,2670.0,2545.0,33874.0
Bidar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,179.0,158.0,161.0,157.0,222.0,255.0,154.0,163.0,143.0,183.0,129.0,135.0,2039.0
Bidar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2486.0,2436.0,2708.0,2655.0,3437.0,3461.0,3255.0,2966.0,2555.0,2426.0,2743.0,2507.0,33635.0
Bidar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,15.0,8.0,7.0,8.0,27.0,11.0,16.0,6.0,14.0,17.0,2.0,8.0,139.0
Bidar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,1.0,6.0,1.0,0.0,0.0,0.0,15.0,2.0,0.0,0.0,25.0
Bidar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,55.0,54.0,267.0,303.0,321.0,393.0,275.0,313.0,266.0,282.0,316.0,222.0,3067.0
Bidar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,70.0,62.0,275.0,317.0,349.0,404.0,291.0,319.0,295.0,301.0,318.0,230.0,3231.0
Bidar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,20.0,35.0,25.0,25.0,35.0,35.0,31.0,21.0,24.0,35.0,38.0,25.0,349.0
Bidar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,376.0,368.0,752.0,400.0,504.0,594.0,457.0,411.0,351.0,411.0,408.0,342.0,5374.0
Bidar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,226.0,241.0,49.0,302.0,300.0,344.0,241.0,283.0,208.0,242.0,293.0,192.0,2921.0
Bidar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,446.0,352.0,843.0,493.0,590.0,618.0,545.0,451.0,340.0,478.0,481.0,398.0,6035.0
Bidar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,122.0,88.0,115.0,122.0,155.0,149.0,111.0,88.0,99.0,77.0,94.0,107.0,1327.0
Bidar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1815.0,1827.0,1890.0,2059.0,2299.0,2404.0,2242.0,2348.0,1917.0,1921.0,2033.0,1636.0,24391.0
Bidar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1719.0,1778.0,1830.0,1754.0,2193.0,2593.0,2393.0,2029.0,1795.0,1850.0,2102.0,1878.0,23914.0
Bidar,6.3,PNC maternal complications attended,TOTAL,32.0,46.0,22.0,37.0,307.0,36.0,40.0,31.0,27.0,27.0,46.0,68.0,719.0
Bidar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,6.0,7.0,9.0,10.0,10.0,4.0,8.0,10.0,9.0,10.0,6.0,101.0
Bidar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,16.0,5.0,7.0,4.0,5.0,4.0,3.0,9.0,6.0,5.0,5.0,4.0,73.0
Bidar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,28.0,11.0,14.0,13.0,15.0,14.0,7.0,17.0,16.0,14.0,15.0,10.0,174.0
Bidar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,40.0,34.0,34.0,34.0,80.0,42.0,23.0,51.0,33.0,52.0,47.0,35.0,505.0
Bidar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,205.0,192.0,191.0,196.0,196.0,176.0,160.0,209.0,205.0,191.0,184.0,188.0,2293.0
Bidar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,345.0,310.0,295.0,343.0,340.0,317.0,281.0,327.0,350.0,284.0,294.0,323.0,3809.0
Bidar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,550.0,502.0,486.0,539.0,536.0,493.0,441.0,536.0,555.0,475.0,478.0,511.0,6102.0
Bidar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,9.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,0.0,10.0,31.0,0.0,56.0
Bidar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Bidar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Bidar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,3.0,1.0,24.0,0.0,0.0,0.0,0.0,28.0,25.0,81.0
Bidar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,13.0,2.0,24.0,0.0,0.0,0.0,0.0,28.0,25.0,92.0
Bidar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,17.0,0.0,0.0,0.0,22.0
Bidar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,10.0,17.0,0.0,0.0,0.0,12.0,30.0,43.0,10.0,20.0,20.0,29.0,191.0
Bidar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,10.0,17.0,0.0,0.0,0.0,12.0,30.0,43.0,10.0,20.0,20.0,29.0,191.0
Bidar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,76.0,0.0,66.0,75.0,65.0,0.0,1.0,43.0,6.0,40.0,0.0,54.0,426.0
Bidar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,11.0,15.0,16.0,29.0,39.0,30.0,9.0,33.0,8.0,0.0,9.0,7.0,206.0
Bidar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,61.0,94.0,102.0,148.0,113.0,133.0,62.0,160.0,96.0,78.0,63.0,103.0,1213.0
Bidar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,182.0,229.0,233.0,260.0,201.0,256.0,186.0,286.0,193.0,188.0,209.0,206.0,2629.0
Bidar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,254.0,338.0,351.0,437.0,353.0,419.0,257.0,479.0,297.0,266.0,281.0,316.0,4048.0
Bidar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,113.0,19.0,196.0,216.0,158.0,64.0,74.0,246.0,70.0,200.0,66.0,201.0,1623.0
Bidar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,2.0,2.0,1.0,0.0,5.0,3.0,6.0,0.0,0.0,2.0,7.0,30.0
Bidar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,19.0,3.0,9.0,7.0,8.0,6.0,12.0,4.0,68.0
Bidar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,2.0,2.0,2.0,1.0,19.0,8.0,12.0,13.0,8.0,6.0,14.0,11.0,98.0
Bidar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,5.0,3.0,14.0,7.0,7.0,5.0,7.0,6.0,8.0,19.0,23.0,17.0,121.0
Bidar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,85.0,70.0,57.0,72.0,99.0,65.0,66.0,71.0,59.0,64.0,58.0,51.0,817.0
Bidar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,37.0,25.0,26.0,55.0,33.0,18.0,23.0,17.0,20.0,11.0,26.0,21.0,312.0
Bidar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,2.0,12.0,13.0,18.0,18.0,19.0,24.0,24.0,19.0,18.0,3.0,171.0
Bidar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,18.0,8.0,12.0,14.0,17.0,16.0,21.0,22.0,16.0,21.0,13.0,18.0,196.0
Bidar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bidar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,141.0,105.0,107.0,154.0,167.0,117.0,129.0,134.0,119.0,115.0,115.0,93.0,1496.0
Bidar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,13.0,31.0,9.0,7.0,10.0,7.0,5.0,8.0,6.0,7.0,5.0,2.0,110.0
Bidar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,27.0,15.0,21.0,28.0,29.0,23.0,16.0,39.0,17.0,37.0,19.0,32.0,303.0
Bidar,9.06,Number of IUCD removals,TOTAL,98.0,571.0,103.0,113.0,74.0,64.0,74.0,69.0,50.0,58.0,134.0,187.0,1595.0
Bidar,9.07,Number of Oral Pills cycles distributed,TOTAL,3661.0,6864.0,2165.0,2096.0,8229.0,1815.0,2862.0,3936.0,1903.0,2205.0,4429.0,3767.0,43932.0
Bidar,9.08,Number of Condom pieces distributed,TOTAL,24818.0,19822.0,26350.0,23925.0,21640.0,18837.0,25645.0,21774.0,21210.0,25729.0,22436.0,22377.0,274563.0
Bidar,9.09,Number of Centchroman (weekly) pills given,TOTAL,8.0,540.0,0.0,0.0,58.0,62.0,220.0,469.0,440.0,0.0,0.0,0.0,1797.0
Bidar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,3.0,3.0,4.0,14.0,4.0,20.0,5.0,1.0,2.0,2.0,13.0,81.0
Bidar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,3.0
Bidar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,9.12,Number of Institutions having NSV trained doctors,TOTAL,17.0,24.0,20.0,14.0,21.0,16.0,13.0,12.0,20.0,14.0,18.0,17.0,-1.0
Bidar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3355.0,3220.0,3803.0,3611.0,3757.0,4096.0,3933.0,4001.0,3189.0,2721.0,3022.0,2917.0,41625.0
Bidar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,29.0,33.0,20.0,0.0,0.0,5.0,0.0,49.0,51.0,56.0,0.0,0.0,243.0
Bidar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,37.0,29.0,14.0,2.0,0.0,3.0,1.0,49.0,53.0,43.0,0.0,0.0,231.0
Bidar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,33.0,38.0,22.0,1.0,0.0,13.0,0.0,47.0,47.0,48.0,5.0,0.0,254.0
Bidar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3001.0,2916.0,3101.0,3121.0,3038.0,3147.0,3264.0,3731.0,3233.0,3307.0,3047.0,2949.0,37855.0
Bidar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2752.0,2735.0,2738.0,2910.0,2861.0,2971.0,2886.0,3248.0,3261.0,3253.0,2953.0,2978.0,35546.0
Bidar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2898.0,2761.0,2864.0,2878.0,2961.0,2899.0,3031.0,3005.0,3050.0,3165.0,2991.0,3113.0,35616.0
Bidar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2427.0,2345.0,2395.0,2476.0,2795.0,3066.0,2911.0,2889.0,2447.0,2270.0,2511.0,2101.0,30633.0
Bidar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2929.0,2878.0,3046.0,3204.0,2964.0,3129.0,3270.0,3794.0,3261.0,3195.0,3012.0,3530.0,38212.0
Bidar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2763.0,2714.0,2718.0,2877.0,2836.0,2929.0,2860.0,3271.0,3198.0,3203.0,2918.0,3003.0,35290.0
Bidar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2906.0,2734.0,2773.0,2865.0,2926.0,2844.0,3025.0,3057.0,3018.0,3076.0,2977.0,3090.0,35291.0
Bidar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1241.0,1141.0,1388.0,1444.0,1967.0,2340.0,2005.0,1547.0,1948.0,1597.0,1922.0,1664.0,20204.0
Bidar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,40.0,55.0,57.0,13.0,12.0,5.0,30.0,20.0,131.0,1.0,4.0,0.0,368.0
Bidar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,14.0,58.0,51.0,17.0,10.0,3.0,24.0,13.0,111.0,13.0,10.0,0.0,324.0
Bidar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3.0,59.0,73.0,22.0,15.0,22.0,11.0,13.0,48.0,8.0,12.0,0.0,286.0
Bidar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2434.0,2392.0,2797.0,3205.0,2780.0,2665.0,2695.0,2786.0,2489.0,2476.0,2442.0,2504.0,31665.0
Bidar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1828.0,1747.0,1905.0,2193.0,1953.0,2077.0,2011.0,2531.0,1977.0,1938.0,2176.0,2337.0,24673.0
Bidar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Bidar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1422.0,1435.0,1317.0,1850.0,1663.0,1374.0,1341.0,1629.0,1257.0,1146.0,1198.0,1247.0,16879.0
Bidar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1289.0,1255.0,1260.0,1755.0,1639.0,1239.0,1267.0,1489.0,1168.0,1058.0,1096.0,1179.0,15694.0
Bidar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2711.0,2690.0,2577.0,3605.0,3302.0,2613.0,2608.0,3118.0,2425.0,2204.0,2294.0,2426.0,32573.0
Bidar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2015.0,1971.0,2091.0,2387.0,2225.0,2226.0,2245.0,2396.0,2171.0,2188.0,2224.0,2408.0,26547.0
Bidar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2005.0,1970.0,2068.0,2374.0,2208.0,2216.0,2210.0,2387.0,2174.0,2146.0,2247.0,2392.0,26397.0
Bidar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,23.0,66.0,43.0,112.0,82.0,64.0,54.0,14.0,34.0,101.0,58.0,84.0,735.0
Bidar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,155.0,155.0,426.0,403.0,186.0,607.0,523.0,326.0,245.0,255.0,321.0,376.0,3978.0
Bidar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,141.0,149.0,399.0,357.0,170.0,553.0,489.0,279.0,206.0,224.0,309.0,346.0,3622.0
Bidar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,296.0,304.0,825.0,760.0,356.0,1160.0,1012.0,605.0,451.0,479.0,630.0,722.0,7600.0
Bidar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,38.0,65.0,67.0,444.0,1413.0,4730.0,303.0,2076.0,2078.0,1226.0,2126.0,826.0,15392.0
Bidar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,323.0,311.0,357.0,754.0,1786.0,5324.0,511.0,2943.0,2257.0,1521.0,2643.0,1054.0,19784.0
Bidar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,437.0,338.0,412.0,579.0,1520.0,4264.0,657.0,1733.0,1698.0,1503.0,2711.0,1513.0,17365.0
Bidar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,9.0,3.0,0.0,2.0,0.0,2.0,4.0,0.0,0.0,1.0,0.0,0.0,21.0
Bidar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Bidar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,4.0,6.0,3.0,2.0,3.0,7.0,5.0,3.0,0.0,1.0,1.0,2.0,37.0
Bidar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1299.0,1354.0,1387.0,1393.0,1391.0,1399.0,1424.0,1411.0,1376.0,1285.0,1297.0,1320.0,16336.0
Bidar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1263.0,1290.0,1286.0,1427.0,1321.0,1361.0,1370.0,1330.0,1292.0,1248.0,1225.0,1243.0,15656.0
Bidar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,884.0,867.0,848.0,919.0,867.0,873.0,857.0,875.0,869.0,885.0,846.0,849.0,10439.0
Bidar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2352.0,2392.0,2576.0,2944.0,2647.0,2493.0,2438.0,2579.0,2346.0,2261.0,2625.0,2582.0,30235.0
Bidar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,194.0,168.0,172.0,883.0,10438.0,196.0,187.0,258.0,214.0,199.0,17682.0,3946.0,34537.0
Bidar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,35.0,13.0,17.0,720.0,10316.0,13.0,49.0,29.0,10.0,15.0,13675.0,3847.0,28739.0
Bidar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Bidar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,28.0,18.0,0.0,9.0,3.0,4.0,10.0,27.0,6.0,14.0,22.0,7.0,148.0
Bidar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,821.0,760.0,758.0,828.0,921.0,832.0,907.0,873.0,760.0,685.0,767.0,754.0,9666.0
Bidar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,0.0,0.0,1.0,7.0,6.0,0.0,5.0,0.0,0.0,0.0,22.0
Bidar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,95.0,64.0,91.0,82.0,111.0,161.0,253.0,220.0,73.0,95.0,119.0,98.0,1462.0
Bidar,13.1,Number of Patients operated for cataract,TOTAL,103.0,103.0,113.0,121.0,95.0,106.0,59.0,105.0,74.0,71.0,87.0,110.0,1147.0
Bidar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,103.0,103.0,113.0,121.0,95.0,106.0,59.0,105.0,74.0,71.0,87.0,109.0,1146.0
Bidar,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,0.0,7.0,3.0,0.0,0.0,2.0,26.0,19.0,18.0,12.0,0.0,89.0
Bidar,13.4,Number of children provided free glasses,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,2.0,19.0,15.0,14.0,10.0,0.0,62.0
Bidar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,11.0,7.0,9.0,8.0,9.0,12.0,8.0,11.0,11.0,11.0,-1.0
Bidar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,30.0,33.0,32.0,35.0,35.0,33.0,31.0,36.0,32.0,29.0,31.0,31.0,-1.0
Bidar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,467.0,497.0,438.0,583.0,416.0,568.0,409.0,399.0,426.0,459.0,471.0,532.0,-1.0
Bidar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,12.0,14.0,12.0,12.0,13.0,13.0,13.0,13.0,15.0,15.0,14.0,-1.0
Bidar,14.05,Number of RKS meetings held during the month,TOTAL,15.0,20.0,15.0,16.0,15.0,18.0,17.0,16.0,15.0,34.0,25.0,27.0,233.0
Bidar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,28.0,30.0,29.0,28.0,32.0,27.0,28.0,32.0,28.0,27.0,35.0,30.0,-1.0
Bidar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,185.0,236.0,171.0,208.0,240.0,270.0,261.0,236.0,245.0,241.0,253.0,269.0,2815.0
Bidar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,10.0,8.0,12.0,7.0,7.0,9.0,10.0,11.0,8.0,11.0,10.0,13.0,-1.0
Bidar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,0.0,0.0,2.0,2.0,2.0,2.0,3.0,2.0,2.0,3.0,3.0,1.0,-1.0
Bidar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,466.0,567.0,579.0,556.0,590.0,636.0,729.0,646.0,533.0,422.0,1228.0,471.0,7423.0
Bidar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2250.0,2595.0,2788.0,2467.0,2583.0,2775.0,3005.0,2824.0,2336.0,1953.0,1659.0,2474.0,29709.0
Bidar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,386.0,572.0,546.0,747.0,527.0,510.0,619.0,1795.0,476.0,326.0,1795.0,433.0,8732.0
Bidar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4678.0,4815.0,5206.0,5349.0,5602.0,6327.0,5363.0,4295.0,4479.0,4160.0,3515.0,5039.0,58828.0
Bidar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,852.0,1139.0,1125.0,1303.0,1117.0,1146.0,1348.0,2441.0,1009.0,748.0,3023.0,904.0,16155.0
Bidar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6928.0,7410.0,7994.0,7816.0,8185.0,9102.0,8368.0,7119.0,6815.0,6113.0,5174.0,7513.0,88537.0
Bidar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,61.0,68.0,58.0,61.0,58.0,58.0,50.0,66.0,59.0,56.0,50.0,62.0,707.0
Bidar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,39.0,75.0,27.0,52.0,26.0,44.0,26.0,35.0,31.0,38.0,37.0,33.0,463.0
Bidar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,100.0,143.0,85.0,113.0,84.0,102.0,76.0,101.0,90.0,94.0,87.0,95.0,1170.0
Bidar,14.11,In-Patient Head Count at midnight,TOTAL,4442.0,4623.0,3696.0,5003.0,5819.0,6132.0,5283.0,6567.0,3710.0,4641.0,5412.0,5470.0,60798.0
Bidar,14.12.1,OPD attendance (All),TOTAL,131570.0,141168.0,135764.0,133571.0,145576.0,164261.0,168510.0,208555.0,136950.0,139914.0,197979.0,153044.0,1856862.0
Bidar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,459.0,494.0,460.0,617.0,572.0,648.0,510.0,536.0,486.0,460.0,401.0,419.0,6062.0
Bidar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,20.0,13.0,103.0,9.0,15.0,0.0,0.0,1.0,3.0,5.0,3.0,172.0
Bidar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,290.0,562.0,325.0,136.0,376.0,497.0,390.0,556.0,540.0,385.0,480.0,449.0,4986.0
Bidar,14.14.a,Number of patients given AYUSH treatment,TOTAL,941.0,726.0,1570.0,1314.0,2423.0,2415.0,1660.0,1701.0,1716.0,1682.0,1584.0,1867.0,19599.0
Bidar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,834.0,554.0,881.0,970.0,917.0,918.0,1036.0,878.0,1038.0,924.0,964.0,944.0,10858.0
Bidar,14.14.c,Number of Adolescents counselled,TOTAL,75.0,282.0,417.0,414.0,412.0,428.0,367.0,509.0,472.0,473.0,426.0,373.0,4648.0
Bidar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8423.0,7719.0,8119.0,7297.0,7575.0,7749.0,6714.0,7394.0,7482.0,6748.0,8926.0,8466.0,92612.0
Bidar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,393.0,407.0,492.0,421.0,516.0,451.0,322.0,400.0,315.0,325.0,364.0,315.0,4721.0
Bidar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1388.0,1725.0,1901.0,1584.0,1829.0,1908.0,1525.0,1617.0,1813.0,1787.0,1806.0,1585.0,20468.0
Bidar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,22.0,27.0,24.0,20.0,19.0,17.0,29.0,30.0,24.0,18.0,26.0,19.0,275.0
Bidar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1601.0,1582.0,1988.0,2005.0,1697.0,1966.0,1442.0,1927.0,1729.0,1462.0,1805.0,1756.0,20960.0
Bidar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,23.0,30.0,30.0,15.0,13.0,19.0,20.0,23.0,20.0,12.0,15.0,10.0,230.0
Bidar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3747.0,4144.0,4526.0,4202.0,3755.0,3161.0,3380.0,4089.0,3177.0,3703.0,4090.0,3183.0,45157.0
Bidar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,6.0,3.0,3.0,2.0,13.0,1.0,3.0,15.0,4.0,5.0,4.0,62.0
Bidar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6736.0,7451.0,8415.0,7791.0,7281.0,7035.0,6347.0,7633.0,6719.0,6952.0,7701.0,6524.0,86585.0
Bidar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,48.0,63.0,57.0,38.0,34.0,49.0,50.0,56.0,59.0,34.0,46.0,33.0,567.0
Bidar,15.2,Number of Widal tests conducted,Number tested,815.0,966.0,1041.0,1311.0,1715.0,1254.0,912.0,1108.0,1023.0,760.0,1197.0,1443.0,13545.0
Bidar,15.3.a,Number of VDRL tests conducted on males,Number tested,102.0,178.0,234.0,157.0,222.0,85.0,60.0,191.0,61.0,219.0,184.0,232.0,1925.0
Bidar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,216.0,196.0,323.0,164.0,685.0,350.0,119.0,147.0,175.0,108.0,446.0,534.0,3463.0
Bidar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2554.0,2451.0,2634.0,2103.0,2166.0,1989.0,1089.0,1803.0,1187.0,1240.0,2393.0,2264.0,23873.0
Bidar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2872.0,2825.0,3191.0,2424.0,3073.0,2424.0,1268.0,2141.0,1423.0,1567.0,3023.0,3030.0,29261.0
Bidar,15.4.1,Number of blood smears examined for Malaria,TOTAL,12861.0,12609.0,17966.0,14130.0,13961.0,14367.0,12778.0,11902.0,11938.0,11275.0,14726.0,14385.0,162898.0
Bidar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,334.0,8.0,6.0,39.0,5.0,12.0,7.0,5.0,2.0,2.0,1.0,2.0,423.0
Bidar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,2.0,0.0,0.0,1.0,5.0
Bidar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4810.0,12560.0,8210.0,9560.0,11260.0,8760.0,560.0,3360.0,4460.0,4910.0,11060.0,10360.0,89870.0
Bidar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,14000.0,,10000.0,9000.0,8000.0,6000.0,9000.0,5000.0,9000.0,8000.0,5000.0,8000.0,91000.0
Bidar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6250.0,4350.0,8650.0,7300.0,10500.0,9800.0,6200.0,3900.0,8550.0,1850.0,5700.0,10300.0,83350.0
Bidar,16.1.1,Stock position of DPT vaccines,5. Total Stock,12560.0,8210.0,9560.0,11260.0,8760.0,4960.0,3360.0,4460.0,4910.0,11060.0,10360.0,8060.0,97520.0
Bidar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3500.0,12400.0,7750.0,9200.0,14600.0,15150.0,1600.0,5350.0,1850.0,2585.0,4650.0,6850.0,85485.0
Bidar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,18000.0,,13000.0,14000.0,15000.0,13000.0,14000.0,8000.0,8000.0,10000.0,10000.0,10000.0,133000.0
Bidar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,9100.0,4650.0,11550.0,8600.0,14450.0,12600.0,10250.0,11500.0,7265.0,7935.0,7800.0,11450.0,117150.0
Bidar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,12400.0,7750.0,9200.0,14600.0,15150.0,15550.0,5350.0,1850.0,2585.0,4650.0,6850.0,5400.0,101335.0
Bidar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6000.0,22700.0,5700.0,25200.0,28000.0,20200.0,400.0,3000.0,0.0,11700.0,8900.0,3380.0,135180.0
Bidar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,34000.0,,40000.0,25000.0,18000.0,14000.0,21000.0,8000.0,24000.0,315380.0,314380.0,24000.0,837760.0
Bidar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,17300.0,17000.0,20500.0,22200.0,25800.0,18000.0,18400.0,11000.0,21200.0,318180.0,319900.0,15300.0,824780.0
Bidar,16.1.2,Stock position of OPV vaccines,5. Total Stock,22700.0,5700.0,25200.0,28000.0,20200.0,16200.0,3000.0,0.0,2800.0,8900.0,3380.0,12080.0,148160.0
Bidar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,6500.0,16700.0,8100.0,22400.0,18950.0,16800.0,2450.0,6550.0,9950.0,10650.0,15350.0,20100.0,154500.0
Bidar,16.1.3,Stock position of TT vaccines,2. Stocks Received,22000.0,,28000.0,16000.0,14000.0,8000.0,15000.0,16000.0,16000.0,16000.0,15000.0,16000.0,182000.0
Bidar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11800.0,8600.0,13700.0,19450.0,16150.0,18500.0,10900.0,12600.0,15300.0,11300.0,10250.0,15950.0,164500.0
Bidar,16.1.3,Stock position of TT vaccines,5. Total Stock,16700.0,8100.0,22400.0,18950.0,16800.0,6300.0,6550.0,9950.0,10650.0,15350.0,20100.0,20150.0,172000.0
Bidar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2030.0,9530.0,1880.0,8180.0,9730.0,7430.0,1600.0,1050.0,350.0,1850.0,4650.0,6000.0,54280.0
Bidar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,15000.0,,14000.0,9000.0,7000.0,6000.0,9000.0,8000.0,9000.0,9000.0,8000.0,10000.0,104000.0
Bidar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7500.0,7120.0,7700.0,7450.0,9300.0,9000.0,9550.0,8700.0,7500.0,6200.0,6650.0,9650.0,96320.0
Bidar,16.1.5,Stock position of BCG vaccines,5. Total Stock,9530.0,2410.0,8180.0,9730.0,7430.0,4430.0,1050.0,350.0,1850.0,4650.0,6000.0,6350.0,61960.0
Bidar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2250.0,7150.0,5525.0,7325.0,15950.0,16255.0,7575.0,5725.0,6000.0,5725.0,6175.0,9000.0,94655.0
Bidar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,9500.0,,7000.0,14000.0,10000.0,10000.0,4000.0,6000.0,6000.0,8000.0,7000.0,8000.0,89500.0
Bidar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4600.0,1625.0,5200.0,5375.0,9725.0,10500.0,5850.0,5575.0,6275.0,7550.0,4175.0,6275.0,72725.0
Bidar,16.1.6,Stock position of Measles vaccines,5. Total Stock,7150.0,5525.0,7325.0,15950.0,16225.0,15755.0,5725.0,6150.0,5725.0,6175.0,9000.0,10725.0,111430.0
Bidar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,0.0,,,0.0
Bidar,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,0.0,,,0.0
Bidar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bidar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Bidar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,3960.0,2160.0,6630.0,6630.0,5660.0,1060.0,2310.0,3710.0,2660.0,4610.0,4860.0,44250.0
Bidar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,4500.0,,9300.0,4500.0,5000.0,5000.0,5000.0,4000.0,4000.0,4000.0,3000.0,4000.0,52300.0
Bidar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,0.0,,,0.0,,,0.0
Bidar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,540.0,1800.0,4830.0,5400.0,5970.0,6900.0,3750.0,2600.0,5050.0,2050.0,2750.0,4550.0,46190.0
Bidar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3960.0,2160.0,6630.0,5730.0,5660.0,3760.0,2310.0,3710.0,2660.0,4610.0,4860.0,4310.0,50360.0
Bidar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,3350.0,3350.0,,,,,,,,6700.0
Bidar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bidar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,100.0,,,,,,,,100.0
Bidar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,3350.0,3250.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6600.0
Bidar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,100800.0,,,,,,,,100800.0
Bidar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,100800.0,,,,,,,,,100800.0
Bidar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,45360.0,,,,,,,,45360.0
Bidar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,100800.0,55440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,156240.0
Bidar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,3400.0,,3400.0
Bidar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Bidar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,1200.0,,1200.0
Bidar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2200.0,0.0,2200.0
Bidar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,500.0,,500.0
Bidar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,1500.0,,,,,,,,,1500.0
Bidar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,50.0,,50.0
Bidar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,0.0,0.0,0.0,450.0,0.0,1950.0
Bidar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1300.0,1300.0,1300.0,3350.0,1300.0,,,,,13000.0,1300.0,,22850.0
Bidar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,0.0,,,0.0
Bidar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,0.0,,,0.0
Bidar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,0.0,,,0.0
Bidar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1300.0,1300.0,1300.0,3350.0,1300.0,0.0,0.0,0.0,0.0,13000.0,1300.0,0.0,22850.0
Bidar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Bidar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Bidar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Bidar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bidar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,5055.0,,2155.0,11355.0,,,,,,,,,18565.0
Bidar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,28800.0,,,,,,,,,28800.0
Bidar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,2400.0,,1300.0,11200.0,,,,,,,,,14900.0
Bidar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,2655.0,0.0,855.0,28955.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32465.0
Bidar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3400.0,2200.0,1600.0,4900.0,5100.0,,,,,,4200.0,,21400.0
Bidar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,3300.0,3300.0,6800.0,,,,,,,3300.0,,16700.0
Bidar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1200.0,600.0,,2900.0,1700.0,,,,,,1700.0,,8100.0
Bidar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2200.0,4900.0,4900.0,8800.0,3400.0,0.0,0.0,0.0,0.0,0.0,5800.0,0.0,30000.0
Bidar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,29000.0,20600.0,15400.0,8600.0,56200.0,,,,,,53150.0,,182950.0
Bidar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,,,84000.0,,,,,,,7200.0,,91200.0
Bidar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8400.0,7200.0,9600.0,36400.0,4400.0,,,,,,8300.0,,74300.0
Bidar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,20600.0,13400.0,5800.0,56200.0,51800.0,0.0,0.0,0.0,0.0,0.0,52050.0,0.0,199850.0
Bidar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1800.0,600.0,,,4600.0,,,,,,7500.0,,14500.0
Bidar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,7200.0,,,,,,,,,7200.0
Bidar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Bidar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1200.0,,,2600.0,2000.0,,,,,,2500.0,,8300.0
Bidar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,600.0,600.0,0.0,4600.0,2600.0,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,13400.0
Bidar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,2.0,,,,,,2.0,,2.0,6.0
Bidar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,3.0,1.0,,1.0,,3.0,2.0,2.0,2.0,,15.0
Bidar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bidar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,1.0,3.0,1.0,,1.0,,3.0,2.0,2.0,2.0,,15.0
Bidar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,13.0,10.0,9.0,12.0,12.0,5.0,6.0,10.0,3.0,4.0,7.0,91.0
Bidar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Bidar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,13.0,10.0,9.0,12.0,12.0,5.0,6.0,10.0,3.0,4.0,7.0,91.0
Bidar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,4.0,2.0,11.0,5.0,7.0,7.0,6.0,4.0,10.0,3.0,6.0,65.0
Bidar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Bidar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,4.0,2.0,11.0,5.0,7.0,7.0,6.0,5.0,10.0,3.0,6.0,66.0
Bidar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,10.0,11.0,11.0,17.0,10.0,4.0,13.0,8.0,12.0,17.0,10.0,125.0
Bidar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,,,1.0
Bidar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,10.0,12.0,11.0,17.0,10.0,4.0,13.0,8.0,12.0,17.0,10.0,126.0
Bidar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,,1.0,,,,2.0
Bidar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bidar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,,1.0,,,,2.0
Bidar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Bidar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bidar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,1.0,1.0
Bidar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Bidar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,1.0,,,2.0,,,,,,,1.0,4.0
Bidar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,2.0,1.0,,,,,,1.0,5.0
Bidar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bidar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bidar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bidar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,3.0,,2.0,1.0,1.0,2.0,2.0,,2.0,2.0,2.0,17.0
Bidar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,2.0,1.0,,,,2.0,,1.0,,2.0,1.0,9.0
Bidar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,5.0,1.0,2.0,1.0,1.0,4.0,2.0,1.0,2.0,4.0,3.0,26.0
Bidar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Bidar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Bidar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,,1.0,,,,,,,,,2.0
Bidar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,5.0,11.0,3.0,4.0,6.0,5.0,3.0,5.0,7.0,4.0,4.0,60.0
Bidar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,1.0,,4.0,4.0,3.0,,3.0,2.0,3.0,3.0,26.0
Bidar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,6.0,12.0,3.0,8.0,10.0,8.0,3.0,8.0,9.0,7.0,7.0,86.0
Bidar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,2.0,2.0,,,,,,5.0
Bidar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,3.0,2.0,3.0,4.0,3.0,3.0,1.0,1.0,3.0,2.0,5.0,35.0
Bidar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,3.0,6.0,,3.0,2.0,5.0,,,2.0,4.0,4.0,3.0,32.0
Bidar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,8.0,9.0,2.0,6.0,7.0,10.0,5.0,1.0,3.0,7.0,6.0,8.0,72.0
Bidar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Bidar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,1.0,,,,1.0,,,2.0
Bidar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,1.0,,,,1.0,,,2.0
Bidar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Bidar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,1.0,,,,1.0,,1.0,1.0,,,5.0
Bidar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,,1.0,,3.0,1.0,,1.0,,7.0
Bidar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,1.0,,,1.0,1.0,3.0,2.0,1.0,2.0,,13.0
Bidar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,3.0,10.0,1.0,3.0,1.0,4.0,5.0,4.0,3.0,4.0,3.0,44.0
Bidar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,1.0,1.0,,,,,,1.0,,,3.0
Bidar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,3.0,11.0,2.0,3.0,1.0,4.0,5.0,4.0,4.0,4.0,3.0,47.0
Bidar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,1.0,,,,,1.0,,1.0,4.0
Bidar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,14.0,20.0,30.0,27.0,30.0,26.0,22.0,30.0,28.0,26.0,21.0,25.0,299.0
Bidar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,19.0,22.0,23.0,19.0,20.0,25.0,19.0,24.0,14.0,20.0,24.0,17.0,246.0
Bidar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,33.0,42.0,54.0,46.0,51.0,51.0,41.0,54.0,42.0,47.0,45.0,43.0,549.0
Bidar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Bidar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,3.0,7.0,7.0,3.0,8.0,4.0,10.0,4.0,9.0,4.0,5.0,69.0
Bidar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,6.0,6.0,5.0,8.0,9.0,6.0,13.0,9.0,11.0,14.0,14.0,12.0,113.0
Bidar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,11.0,10.0,12.0,15.0,12.0,14.0,17.0,19.0,15.0,23.0,18.0,17.0,183.0
Bidar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bidar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bidar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bidar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,1.0,,,,1.0,,,,3.0
Bidar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bidar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,1.0,,,,1.0,,,,3.0
Bidar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Bidar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bidar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Bidar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Bidar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bidar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Bidar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Bidar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bidar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,,,,,,1.0
Bidar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bidar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,1.0,1.0,1.0,,,,3.0,,7.0
Bidar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bidar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,1.0,1.0,1.0,,,,3.0,,7.0
Bidar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,1.0,1.0,1.0,1.0,,,,,,,6.0
Bidar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,19.0,22.0,21.0,7.0,8.0,12.0,12.0,13.0,17.0,11.0,9.0,25.0,176.0
Bidar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,2.0,8.0,2.0,,,2.0,2.0,2.0,3.0,,2.0,25.0
Bidar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,21.0,26.0,30.0,10.0,9.0,13.0,14.0,15.0,19.0,14.0,9.0,27.0,207.0
Bidar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,1.0,,,1.0,,,,,3.0
Bidar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,10.0,13.0,13.0,10.0,7.0,11.0,11.0,18.0,9.0,11.0,10.0,13.0,136.0
Bidar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,1.0,1.0,2.0,2.0,1.0,3.0,,1.0,2.0,2.0,3.0,18.0
Bidar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,10.0,15.0,14.0,12.0,10.0,12.0,14.0,19.0,10.0,13.0,12.0,16.0,157.0
Bidar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,2.0,2.0,,1.0,1.0,,,,,,7.0
Bidar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,4.0,3.0,2.0,6.0,8.0,4.0,,3.0,,1.0,2.0,34.0
Bidar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,3.0,4.0,2.0,1.0,1.0,1.0,5.0,,,,2.0,,19.0
Bidar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,9.0,7.0,5.0,7.0,10.0,10.0,,3.0,,3.0,2.0,60.0
Bidar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,1.0,,1.0,1.0,,,,,4.0
Bidar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,,4.0,6.0,8.0,8.0,9.0,6.0,3.0,8.0,5.0,,61.0
Bidar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,1.0,5.0,1.0,2.0,7.0,3.0,11.0,5.0,7.0,4.0,3.0,52.0
Bidar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,1.0,9.0,7.0,11.0,15.0,13.0,18.0,8.0,15.0,9.0,3.0,117.0
Bidar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,2.0,,1.0,,,,,,,1.0,5.0
Bidar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,9.0,11.0,5.0,9.0,14.0,10.0,5.0,8.0,12.0,12.0,15.0,118.0
Bidar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,7.0,12.0,8.0,7.0,7.0,12.0,16.0,11.0,4.0,13.0,8.0,19.0,124.0
Bidar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,15.0,22.0,21.0,12.0,17.0,26.0,26.0,16.0,12.0,25.0,20.0,35.0,247.0
Bidar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,5.0,1.0,9.0,4.0,2.0,2.0,5.0,4.0,2.0,3.0,8.0,45.0
Bidar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,58.0,86.0,76.0,79.0,66.0,74.0,83.0,77.0,65.0,85.0,72.0,75.0,896.0
Bidar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,202.0,184.0,163.0,158.0,168.0,265.0,206.0,244.0,219.0,256.0,193.0,184.0,2442.0
Bidar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,260.0,275.0,240.0,246.0,238.0,341.0,291.0,326.0,288.0,343.0,268.0,267.0,3383.0
Bijapur,1.1,Total number of pregnant women Registered for ANC,TOTAL,4792.0,4604.0,5522.0,4925.0,4576.0,4864.0,4580.0,4606.0,4346.0,4611.0,4443.0,4376.0,56245.0
Bijapur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3009.0,2895.0,3346.0,2836.0,2906.0,3177.0,2890.0,2991.0,2883.0,3182.0,3018.0,2859.0,35992.0
Bijapur,1.2,Number of Pregnant women registered under JSY,TOTAL,3383.0,3195.0,4074.0,3654.0,3485.0,3512.0,3211.0,3272.0,3127.0,3512.0,3292.0,3255.0,40972.0
Bijapur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,4083.0,4078.0,4644.0,4485.0,4497.0,4601.0,4476.0,4698.0,4603.0,4240.0,4183.0,4286.0,52874.0
Bijapur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4550.0,4879.0,5298.0,5377.0,4994.0,4933.0,5266.0,4784.0,4953.0,4541.0,5556.0,4887.0,60018.0
Bijapur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4749.0,5188.0,5039.0,5626.0,5114.0,5428.0,5006.0,4997.0,5258.0,4926.0,5055.0,4568.0,60954.0
Bijapur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2076.0,2479.0,2271.0,2406.0,2204.0,2074.0,2720.0,1670.0,2329.0,2623.0,2377.0,2056.0,27285.0
Bijapur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,73.0,91.0,106.0,223.0,90.0,90.0,130.0,85.0,123.0,130.0,73.0,80.0,1294.0
Bijapur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,6.0,18.0,33.0,10.0,12.0,15.0,21.0,8.0,14.0,21.0,2.0,166.0
Bijapur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2416.0,2957.0,2902.0,2928.0,2065.0,2855.0,2262.0,2740.0,2152.0,2422.0,2337.0,2542.0,30578.0
Bijapur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,37.0,107.0,66.0,125.0,55.0,68.0,122.0,80.0,83.0,73.0,90.0,78.0,984.0
Bijapur,1.8,Number of pregnancy test kits used at SC level,TOTAL,200.0,128.0,107.0,86.0,94.0,91.0,142.0,180.0,181.0,167.0,173.0,211.0,1760.0
Bijapur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,70.0,41.0,44.0,50.0,34.0,18.0,19.0,14.0,11.0,12.0,11.0,9.0,333.0
Bijapur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,41.0,18.0,25.0,23.0,30.0,22.0,17.0,15.0,17.0,13.0,13.0,6.0,240.0
Bijapur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,111.0,59.0,69.0,73.0,64.0,40.0,36.0,29.0,28.0,25.0,24.0,15.0,573.0
Bijapur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,100.0,67.0,70.0,62.0,48.0,34.0,29.0,22.0,20.0,21.0,18.0,10.0,501.0
Bijapur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,1.0,3.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,7.0
Bijapur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1926.0,1851.0,1929.0,2001.0,2259.0,2431.0,2262.0,2280.0,2009.0,1920.0,1905.0,1799.0,24572.0
Bijapur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,332.0,309.0,375.0,398.0,370.0,459.0,397.0,416.0,517.0,316.0,296.0,248.0,4433.0
Bijapur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,630.0,546.0,425.0,505.0,505.0,1195.0,748.0,609.0,543.0,658.0,535.0,554.0,7453.0
Bijapur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,16.0,0.0,41.0,0.0,0.0,84.0,0.0,0.0,36.0,54.0,0.0,5.0,236.0
Bijapur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,321.0,650.0,584.0,1109.0,1275.0,894.0,1546.0,728.0,1146.0,597.0,1729.0,908.0,11487.0
Bijapur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,3.0,5.0,5.0,8.0,8.0,9.0,23.0,10.0,16.0,20.0,9.0,15.0,131.0
Bijapur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,63.0,71.0,62.0,53.0,48.0,71.0,47.0,66.0,67.0,75.0,63.0,75.0,761.0
Bijapur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,66.0,76.0,67.0,61.0,56.0,80.0,70.0,76.0,83.0,95.0,72.0,90.0,892.0
Bijapur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,39.0,187.0,104.0,271.0,103.0,286.0,490.0,179.0,166.0,181.0,464.0,155.0,2625.0
Bijapur,4.1.1.a,Number of male live births,TOTAL,1231.0,1320.0,1296.0,1648.0,1741.0,1726.0,1947.0,1635.0,1564.0,1363.0,1886.0,1414.0,18771.0
Bijapur,4.1.1.b,Number of female live births,TOTAL,1147.0,1238.0,1246.0,1500.0,1854.0,1630.0,1861.0,1394.0,1620.0,1244.0,1761.0,1305.0,17800.0
Bijapur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2378.0,2558.0,2542.0,3148.0,3595.0,3356.0,3808.0,3029.0,3184.0,2607.0,3647.0,2719.0,36571.0
Bijapur,4.1.2,Number of still births,TOTAL,19.0,23.0,48.0,30.0,19.0,40.0,39.0,28.0,41.0,26.0,20.0,15.0,348.0
Bijapur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,50.0,57.0,19.0,28.0,35.0,40.0,51.0,43.0,46.0,23.0,155.0,33.0,580.0
Bijapur,4.2.1,Number of Newborns weighed at birth,TOTAL,2360.0,2563.0,2496.0,3125.0,3500.0,3323.0,3804.0,2943.0,3121.0,2591.0,3637.0,2710.0,36173.0
Bijapur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,171.0,340.0,166.0,236.0,366.0,360.0,448.0,239.0,278.0,220.0,349.0,281.0,3454.0
Bijapur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2334.0,2526.0,2489.0,3097.0,3436.0,3186.0,3737.0,2928.0,2963.0,2480.0,3553.0,2643.0,35372.0
Bijapur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,5.0,60.0,59.0,91.0,77.0,71.0,81.0,36.0,74.0,84.0,67.0,711.0
Bijapur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,10.0,0.0,2.0,10.0,4.0,15.0,2.0,14.0,15.0,72.0
Bijapur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,52.0,28.0,55.0,102.0,130.0,169.0,52.0,25.0,13.0,132.0,68.0,13.0,839.0
Bijapur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,58.0,33.0,115.0,171.0,221.0,248.0,133.0,110.0,64.0,208.0,166.0,95.0,1622.0
Bijapur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,51.0,14.0,62.0,21.0,58.0,35.0,50.0,7.0,33.0,52.0,34.0,104.0,521.0
Bijapur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,88.0,107.0,149.0,121.0,156.0,123.0,337.0,289.0,114.0,168.0,195.0,455.0,2302.0
Bijapur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,57.0,3.0,13.0,19.0,11.0,12.0,26.0,27.0,9.0,24.0,22.0,20.0,243.0
Bijapur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,121.0,157.0,176.0,187.0,305.0,405.0,348.0,299.0,231.0,174.0,199.0,710.0,3312.0
Bijapur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,25.0,12.0,17.0,26.0,16.0,37.0,26.0,19.0,16.0,19.0,16.0,41.0,270.0
Bijapur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1928.0,1881.0,2087.0,2000.0,2164.0,2229.0,2499.0,2239.0,1968.0,2164.0,1941.0,1544.0,24644.0
Bijapur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2475.0,2653.0,2636.0,3039.0,3080.0,2626.0,3049.0,3081.0,2706.0,2444.0,2728.0,2293.0,32810.0
Bijapur,6.3,PNC maternal complications attended,TOTAL,25.0,23.0,26.0,80.0,20.0,10.0,4.0,2.0,4.0,6.0,33.0,154.0,387.0
Bijapur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,7.0,5.0,9.0,10.0,11.0,11.0,8.0,3.0,6.0,4.0,6.0,92.0
Bijapur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,4.0,0.0,5.0,3.0,4.0,2.0,9.0,3.0,5.0,3.0,2.0,44.0
Bijapur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,16.0,11.0,5.0,14.0,13.0,15.0,13.0,17.0,6.0,11.0,7.0,8.0,136.0
Bijapur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,7.0,31.0,36.0,37.0,40.0,8.0,13.0,8.0,63.0,36.0,112.0,61.0,452.0
Bijapur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,318.0,331.0,345.0,375.0,376.0,480.0,419.0,432.0,465.0,428.0,351.0,379.0,4699.0
Bijapur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,628.0,712.0,722.0,786.0,791.0,886.0,750.0,811.0,840.0,933.0,743.0,765.0,9367.0
Bijapur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,946.0,1043.0,1067.0,1161.0,1167.0,1366.0,1169.0,1243.0,1305.0,1361.0,1094.0,1144.0,14066.0
Bijapur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,22.0,80.0,99.0,126.0,26.0,26.0,118.0,101.0,17.0,120.0,108.0,132.0,975.0
Bijapur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,21.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Bijapur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
Bijapur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,21.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,50.0
Bijapur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,201.0,231.0,655.0,511.0,349.0,86.0,117.0,472.0,121.0,449.0,505.0,529.0,4226.0
Bijapur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,48.0,48.0,73.0,179.0,145.0,138.0,96.0,259.0,140.0,206.0,182.0,138.0,1652.0
Bijapur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,298.0,261.0,316.0,346.0,237.0,301.0,343.0,411.0,423.0,383.0,329.0,361.0,4009.0
Bijapur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,547.0,540.0,1044.0,1036.0,731.0,525.0,556.0,1142.0,684.0,1038.0,1016.0,1028.0,9887.0
Bijapur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,1.0,2.0,2.0,21.0,0.0,0.0,55.0,6.0,2.0,1.0,0.0,3.0,93.0
Bijapur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,71.0,61.0,70.0,39.0,58.0,112.0,119.0,92.0,90.0,135.0,62.0,83.0,992.0
Bijapur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,25.0,16.0,0.0,14.0,18.0,27.0,29.0,23.0,12.0,26.0,34.0,12.0,236.0
Bijapur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,35.0,42.0,63.0,19.0,38.0,57.0,46.0,75.0,64.0,43.0,51.0,57.0,590.0
Bijapur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,131.0,119.0,133.0,72.0,114.0,196.0,194.0,190.0,166.0,204.0,147.0,152.0,1818.0
Bijapur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,17.0,0.0,165.0,121.0,1.0,118.0,149.0,160.0,128.0,153.0,140.0,1152.0
Bijapur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,3.0,6.0,2.0,6.0,0.0,4.0,2.0,3.0,23.0,3.0,3.0,55.0
Bijapur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0
Bijapur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,20.0,26.0,8.0,0.0,15.0,23.0,12.0,23.0,0.0,0.0,0.0,127.0
Bijapur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,23.0,32.0,10.0,6.0,15.0,29.0,14.0,26.0,23.0,3.0,3.0,184.0
Bijapur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,2.0,142.0,14.0,21.0,14.0,17.0,27.0,14.0,16.0,14.0,25.0,7.0,313.0
Bijapur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,532.0,541.0,539.0,531.0,545.0,590.0,528.0,500.0,544.0,518.0,406.0,444.0,6218.0
Bijapur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,104.0,97.0,105.0,97.0,80.0,86.0,96.0,81.0,68.0,67.0,60.0,65.0,1006.0
Bijapur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,0.0,0.0,19.0,12.0,11.0,9.0,10.0,17.0,15.0,19.0,11.0,123.0
Bijapur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,19.0,36.0,20.0,32.0,33.0,36.0,35.0,33.0,30.0,29.0,19.0,21.0,343.0
Bijapur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Bijapur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,655.0,674.0,664.0,679.0,670.0,723.0,668.0,624.0,659.0,629.0,504.0,541.0,7690.0
Bijapur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,22.0,20.0,26.0,59.0,40.0,32.0,22.0,29.0,28.0,47.0,46.0,56.0,427.0
Bijapur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,2.0,27.0,12.0,52.0,28.0,8.0,29.0,30.0,30.0,25.0,124.0,32.0,399.0
Bijapur,9.06,Number of IUCD removals,TOTAL,258.0,265.0,287.0,310.0,284.0,317.0,236.0,299.0,255.0,263.0,167.0,566.0,3507.0
Bijapur,9.07,Number of Oral Pills cycles distributed,TOTAL,4138.0,4017.0,4013.0,5224.0,4434.0,4897.0,4668.0,5396.0,5243.0,5283.0,4329.0,6308.0,57950.0
Bijapur,9.08,Number of Condom pieces distributed,TOTAL,37466.0,35660.0,41934.0,40909.0,46362.0,38660.0,43412.0,47025.0,48948.0,50256.0,45959.0,51902.0,528493.0
Bijapur,9.09,Number of Centchroman (weekly) pills given,TOTAL,231.0,510.0,109.0,468.0,994.0,200.0,271.0,371.0,0.0,0.0,0.0,0.0,3154.0
Bijapur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,45.0,5.0,24.0,8.0,28.0,42.0,25.0,15.0,28.0,4.0,6.0,230.0
Bijapur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,9.12,Number of Institutions having NSV trained doctors,TOTAL,6.0,6.0,9.0,10.0,10.0,8.0,5.0,9.0,6.0,9.0,9.0,12.0,-1.0
Bijapur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4849.0,5535.0,5545.0,6344.0,6040.0,6833.0,6602.0,6784.0,5943.0,4886.0,5706.0,5149.0,70216.0
Bijapur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,197.0,62.0,34.0,68.0,101.0,97.0,132.0,127.0,164.0,121.0,119.0,35.0,1257.0
Bijapur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,53.0,46.0,131.0,62.0,35.0,79.0,119.0,153.0,188.0,121.0,102.0,32.0,1121.0
Bijapur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,82.0,52.0,89.0,228.0,31.0,90.0,131.0,121.0,155.0,128.0,99.0,31.0,1237.0
Bijapur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4007.0,4460.0,4544.0,4647.0,4911.0,4594.0,4994.0,5518.0,4909.0,4650.0,4190.0,4206.0,55630.0
Bijapur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4074.0,4101.0,4338.0,4627.0,4499.0,4490.0,4391.0,4774.0,4978.0,4556.0,4297.0,4294.0,53419.0
Bijapur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,4297.0,4520.0,4234.0,4445.0,4614.0,4695.0,4755.0,4625.0,4751.0,4694.0,4441.0,4468.0,54539.0
Bijapur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2491.0,2763.0,2750.0,3620.0,2750.0,3678.0,4174.0,3696.0,2661.0,2852.0,3109.0,2423.0,36967.0
Bijapur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4104.0,4505.0,4561.0,4704.0,4550.0,4591.0,6943.0,5058.0,4886.0,4499.0,4178.0,4244.0,56823.0
Bijapur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4068.0,4231.0,4431.0,4667.0,4528.0,4505.0,4556.0,4637.0,4979.0,4579.0,4309.0,4256.0,53746.0
Bijapur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,4276.0,4400.0,4286.0,4568.0,4514.0,4712.0,4660.0,4430.0,4650.0,4642.0,4461.0,4614.0,54213.0
Bijapur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1529.0,1554.0,1455.0,1646.0,1883.0,1901.0,2847.0,2463.0,1572.0,1851.0,1791.0,1664.0,22156.0
Bijapur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,214.0,157.0,18.0,1.0,0.0,29.0,99.0,62.0,155.0,95.0,31.0,50.0,911.0
Bijapur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,232.0,161.0,17.0,4.0,2.0,47.0,50.0,16.0,132.0,76.0,1.0,14.0,752.0
Bijapur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,241.0,63.0,24.0,2.0,7.0,20.0,49.0,64.0,152.0,58.0,1.0,16.0,697.0
Bijapur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3701.0,4121.0,4311.0,4523.0,4167.0,4423.0,4167.0,4403.0,4072.0,3936.0,3727.0,3901.0,49452.0
Bijapur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3298.0,3080.0,3260.0,3077.0,3345.0,3469.0,3181.0,3630.0,3648.0,3461.0,3183.0,3412.0,40044.0
Bijapur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2832.0,1696.0,2656.0,2914.0,2750.0,2597.0,1090.0,411.0,2214.0,2952.0,2699.0,3398.0,28209.0
Bijapur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1970.0,2097.0,2167.0,2161.0,2063.0,2173.0,2101.0,2311.0,1919.0,1872.0,1963.0,2039.0,24836.0
Bijapur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1685.0,1843.0,2082.0,2072.0,1903.0,2032.0,1989.0,2017.0,1804.0,1634.0,1780.0,1844.0,22685.0
Bijapur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3655.0,3940.0,4249.0,4233.0,3966.0,4205.0,4090.0,4328.0,3723.0,3506.0,3743.0,3883.0,47521.0
Bijapur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3528.0,3339.0,3483.0,3495.0,3456.0,3764.0,3637.0,4123.0,3716.0,3507.0,3425.0,3470.0,42943.0
Bijapur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3448.0,3289.0,3400.0,3557.0,3406.0,3740.0,3626.0,4097.0,3702.0,3474.0,3406.0,3474.0,42619.0
Bijapur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,19.0,195.0,139.0,251.0,111.0,154.0,8.0,217.0,114.0,235.0,75.0,94.0,1612.0
Bijapur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1086.0,857.0,938.0,975.0,930.0,916.0,1149.0,968.0,957.0,899.0,1049.0,1314.0,12038.0
Bijapur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1046.0,796.0,914.0,859.0,887.0,842.0,1242.0,815.0,866.0,803.0,891.0,1167.0,11128.0
Bijapur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2132.0,1653.0,1852.0,1834.0,1817.0,1758.0,2391.0,1783.0,1823.0,1702.0,1940.0,2481.0,23166.0
Bijapur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,926.0,332.0,261.0,2011.0,6094.0,11961.0,5545.0,2444.0,2317.0,745.0,1137.0,668.0,34441.0
Bijapur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,420.0,363.0,365.0,1841.0,6444.0,12112.0,541.0,2567.0,2683.0,789.0,1451.0,956.0,30532.0
Bijapur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,446.0,377.0,388.0,1313.0,3494.0,8808.0,559.0,2465.0,1539.0,1254.0,1401.0,612.0,22656.0
Bijapur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,0.0,0.0,43.0,0.0,0.0,0.0,0.0,0.0,0.0,44.0
Bijapur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,7.0
Bijapur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1479.0,1481.0,1501.0,1476.0,1472.0,1467.0,1502.0,1475.0,1551.0,1442.0,1462.0,1465.0,17773.0
Bijapur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1408.0,1392.0,1416.0,1409.0,1412.0,1422.0,1429.0,1432.0,1502.0,1408.0,1406.0,1382.0,17018.0
Bijapur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,961.0,1007.0,980.0,970.0,989.0,1000.0,994.0,1033.0,1079.0,1019.0,989.0,980.0,12001.0
Bijapur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2477.0,1174.0,1885.0,2105.0,2072.0,2014.0,882.0,90.0,1710.0,2425.0,2297.0,2153.0,21284.0
Bijapur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3450.0,3447.0,3605.0,3722.0,5680.0,3775.0,3451.0,3524.0,3341.0,3144.0,3169.0,4728.0,45036.0
Bijapur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,583.0,652.0,566.0,856.0,591.0,636.0,530.0,559.0,596.0,517.0,10250.0,5695.0,22031.0
Bijapur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,164.0,157.0,157.0,631.0,204.0,236.0,138.0,99.0,149.0,107.0,11347.0,7247.0,20636.0
Bijapur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Bijapur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,14.0,11.0,0.0,3.0,11.0,0.0,1.0,28.0,15.0,6.0,12.0,6.0,107.0
Bijapur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,318.0,422.0,537.0,277.0,281.0,344.0,332.0,443.0,418.0,269.0,277.0,208.0,4126.0
Bijapur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,77.0,223.0,1.0,4.0,5.0,68.0,66.0,66.0,0.0,2.0,17.0,3.0,532.0
Bijapur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,71.0,44.0,23.0,34.0,53.0,73.0,51.0,164.0,79.0,49.0,107.0,44.0,792.0
Bijapur,13.1,Number of Patients operated for cataract,TOTAL,84.0,92.0,94.0,119.0,49.0,23.0,21.0,21.0,16.0,30.0,63.0,63.0,675.0
Bijapur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,84.0,123.0,93.0,136.0,49.0,72.0,19.0,19.0,29.0,34.0,63.0,63.0,784.0
Bijapur,13.3,Number of School children detected with Refractive errors,TOTAL,18.0,1.0,0.0,20.0,10.0,7.0,2.0,6.0,11.0,34.0,60.0,88.0,257.0
Bijapur,13.4,Number of children provided free glasses,TOTAL,18.0,1.0,5.0,2.0,152.0,9.0,1.0,5.0,11.0,7.0,29.0,123.0,363.0
Bijapur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,6.0,6.0,10.0,8.0,10.0,9.0,9.0,9.0,10.0,9.0,9.0,-1.0
Bijapur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,38.0,36.0,41.0,35.0,32.0,29.0,32.0,32.0,32.0,31.0,32.0,27.0,-1.0
Bijapur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,506.0,472.0,559.0,470.0,628.0,476.0,466.0,499.0,490.0,469.0,390.0,419.0,-1.0
Bijapur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,4.0,4.0,10.0,9.0,9.0,9.0,8.0,9.0,10.0,10.0,9.0,-1.0
Bijapur,14.05,Number of RKS meetings held during the month,TOTAL,18.0,20.0,23.0,25.0,22.0,16.0,9.0,13.0,21.0,25.0,22.0,23.0,237.0
Bijapur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,26.0,29.0,26.0,30.0,26.0,30.0,23.0,33.0,24.0,30.0,31.0,35.0,-1.0
Bijapur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,374.0,326.0,310.0,247.0,281.0,290.0,309.0,309.0,301.0,251.0,249.0,266.0,3513.0
Bijapur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,3.0,4.0,4.0,4.0,4.0,4.0,3.0,5.0,5.0,5.0,6.0,-1.0
Bijapur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,3.0,3.0,4.0,4.0,3.0,2.0,3.0,5.0,2.0,2.0,2.0,-1.0
Bijapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,708.0,603.0,786.0,659.0,644.0,727.0,2395.0,733.0,752.0,426.0,681.0,479.0,9593.0
Bijapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2991.0,6619.0,6335.0,6646.0,4544.0,4013.0,30943.0,4984.0,3892.0,2327.0,6661.0,2970.0,82925.0
Bijapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,665.0,583.0,641.0,538.0,599.0,969.0,2125.0,690.0,659.0,448.0,684.0,414.0,9015.0
Bijapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5418.0,8284.0,7733.0,8475.0,7938.0,6598.0,25566.0,6806.0,5819.0,4819.0,8487.0,4984.0,100927.0
Bijapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1373.0,1186.0,1427.0,1197.0,1243.0,1696.0,4520.0,1423.0,1411.0,874.0,1365.0,893.0,18608.0
Bijapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8409.0,14903.0,14068.0,15121.0,12482.0,10611.0,56509.0,11790.0,9711.0,7146.0,15148.0,7954.0,183852.0
Bijapur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,22.0,77.0,91.0,88.0,40.0,26.0,80.0,45.0,40.0,36.0,77.0,30.0,652.0
Bijapur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,11.0,46.0,29.0,44.0,28.0,16.0,32.0,36.0,23.0,19.0,41.0,9.0,334.0
Bijapur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,33.0,123.0,120.0,132.0,68.0,42.0,112.0,81.0,63.0,55.0,118.0,39.0,986.0
Bijapur,14.11,In-Patient Head Count at midnight,TOTAL,10828.0,15305.0,11768.0,20393.0,11643.0,12201.0,15594.0,10000.0,10623.0,9263.0,14554.0,13854.0,156026.0
Bijapur,14.12.1,OPD attendance (All),TOTAL,95716.0,200068.0,171244.0,225651.0,183847.0,162880.0,202135.0,166593.0,150419.0,125565.0,225991.0,121202.0,2031311.0
Bijapur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,250.0,2153.0,518.0,2402.0,6554.0,392.0,2032.0,2084.0,1170.0,560.0,1355.0,294.0,19764.0
Bijapur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,0.0,0.0,6.0,19.0,16.0,11.0,55.0,178.0,11.0,13.0,6.0,315.0
Bijapur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,280.0,5084.0,1243.0,5225.0,1557.0,518.0,5309.0,2746.0,2611.0,417.0,2872.0,370.0,28232.0
Bijapur,14.14.a,Number of patients given AYUSH treatment,TOTAL,9944.0,9792.0,9810.0,12211.0,12892.0,13252.0,13250.0,12898.0,12462.0,10996.0,11151.0,11440.0,140098.0
Bijapur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,169.0,213.0,224.0,249.0,262.0,301.0,298.0,269.0,318.0,347.0,321.0,340.0,3311.0
Bijapur,14.14.c,Number of Adolescents counselled,TOTAL,815.0,691.0,619.0,788.0,677.0,723.0,687.0,705.0,690.0,829.0,977.0,1053.0,9254.0
Bijapur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4710.0,21032.0,5109.0,27339.0,7908.0,8525.0,25353.0,17193.0,16511.0,7094.0,26249.0,8460.0,175483.0
Bijapur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,98.0,4700.0,133.0,4717.0,159.0,501.0,3924.0,2547.0,1523.0,909.0,3317.0,159.0,22687.0
Bijapur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1536.0,3012.0,1613.0,2771.0,1603.0,1741.0,2415.0,2251.0,1736.0,1448.0,2473.0,1353.0,23952.0
Bijapur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,66.0,81.0,67.0,89.0,45.0,76.0,60.0,75.0,46.0,43.0,70.0,42.0,760.0
Bijapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1566.0,2094.0,1662.0,2488.0,2275.0,2419.0,2394.0,2379.0,2284.0,2115.0,4315.0,2688.0,28679.0
Bijapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,59.0,72.0,58.0,47.0,27.0,108.0,51.0,66.0,51.0,32.0,224.0,137.0,932.0
Bijapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3346.0,4158.0,4104.0,4929.0,4082.0,4145.0,3807.0,4607.0,4308.0,4071.0,5224.0,5056.0,51837.0
Bijapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,7.0,103.0,2.0,35.0,37.0,139.0,3.0,57.0,5.0,5.0,48.0,100.0,541.0
Bijapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6448.0,9264.0,7379.0,10188.0,7960.0,8305.0,8616.0,9237.0,8328.0,7634.0,12012.0,9097.0,104468.0
Bijapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,132.0,256.0,127.0,171.0,109.0,323.0,114.0,198.0,102.0,80.0,342.0,279.0,2233.0
Bijapur,15.2,Number of Widal tests conducted,Number tested,409.0,467.0,457.0,1130.0,612.0,800.0,909.0,884.0,491.0,535.0,888.0,694.0,8276.0
Bijapur,15.3.a,Number of VDRL tests conducted on males,Number tested,9.0,202.0,2.0,47.0,70.0,58.0,58.0,29.0,49.0,687.0,24.0,7.0,1242.0
Bijapur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,23.0,590.0,22.0,329.0,430.0,158.0,481.0,136.0,145.0,326.0,772.0,466.0,3878.0
Bijapur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1133.0,1778.0,1080.0,1225.0,844.0,1724.0,1103.0,1686.0,1060.0,1673.0,2135.0,2292.0,17733.0
Bijapur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1165.0,2570.0,1104.0,1601.0,1344.0,1940.0,1642.0,1851.0,1254.0,2686.0,2931.0,2765.0,22853.0
Bijapur,15.4.1,Number of blood smears examined for Malaria,TOTAL,21666.0,24290.0,22445.0,26511.0,24795.0,26957.0,19947.0,25512.0,22809.0,21992.0,24104.0,22121.0,283149.0
Bijapur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,32.0,463.0,39.0,23.0,11.0,20.0,7.0,11.0,8.0,10.0,8.0,468.0,1100.0
Bijapur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,2.0,2.0,1.0,1.0,11.0
Bijapur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10400.0,12310.0,3750.0,25690.0,17100.0,32010.0,14370.0,16760.0,10140.0,2090.0,2470.0,2910.0,150000.0
Bijapur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,0.0,22000.0,30000.0,15000.0,6000.0,5000.0,,,5000.0,5000.0,4500.0,97500.0
Bijapur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3090.0,8560.0,60.0,38590.0,90.0,23640.0,2610.0,6620.0,8050.0,4620.0,4560.0,4540.0,105030.0
Bijapur,16.1.1,Stock position of DPT vaccines,5. Total Stock,12310.0,3750.0,25690.0,17100.0,32010.0,14370.0,16760.0,10140.0,2090.0,2470.0,2910.0,2870.0,142470.0
Bijapur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,26840.0,18580.0,8320.0,18080.0,840.0,25540.0,16710.0,19810.0,9550.0,820.0,4560.0,3770.0,153420.0
Bijapur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,10000.0,15000.0,10000.0,10000.0,25000.0,20000.0,10000.0,,10000.0,15000.0,15000.0,15000.0,155000.0
Bijapur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,18260.0,25260.0,240.0,27240.0,300.0,28830.0,6900.0,10260.0,18730.0,11260.0,15790.0,7240.0,170310.0
Bijapur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,18580.0,8320.0,18080.0,840.0,25540.0,16710.0,19810.0,9550.0,820.0,4560.0,3770.0,11530.0,138110.0
Bijapur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,34180.0,41780.0,23560.0,42600.0,7960.0,27060.0,6580.0,34800.0,17260.0,12700.0,10340.0,22040.0,280860.0
Bijapur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,20000.0,20000.0,20000.0,20000.0,30000.0,40000.0,,30000.0,440840.0,445140.0,30000.0,1135980.0
Bijapur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,20280.0,20280.0
Bijapur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,32400.0,38220.0,960.0,54640.0,900.0,50480.0,11780.0,17540.0,34560.0,430500.0,433440.0,24320.0,1129740.0
Bijapur,16.1.2,Stock position of OPV vaccines,5. Total Stock,41780.0,23560.0,42600.0,7960.0,27060.0,6580.0,34800.0,17260.0,12700.0,23040.0,22040.0,7440.0,266820.0
Bijapur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,19960.0,19950.0,9340.0,59330.0,23590.0,53580.0,20470.0,25450.0,15420.0,14290.0,7280.0,5170.0,273830.0
Bijapur,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,50000.0,41790.0,30000.0,15000.0,10000.0,0.0,5000.0,0.0,10000.0,10000.0,191790.0
Bijapur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10010.0,20610.0,10.0,77530.0,10.0,48110.0,5020.0,10030.0,6130.0,7010.0,12110.0,11000.0,207580.0
Bijapur,16.1.3,Stock position of TT vaccines,5. Total Stock,19950.0,9340.0,59330.0,23590.0,53580.0,20470.0,25450.0,15420.0,14290.0,7280.0,5170.0,4170.0,258040.0
Bijapur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,18410.0,9230.0,6290.0,15760.0,3510.0,16910.0,3650.0,12500.0,4310.0,1610.0,7600.0,6780.0,106560.0
Bijapur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,15000.0,10000.0,10000.0,15000.0,10000.0,15000.0,,12000.0,15000.0,10000.0,10000.0,124000.0
Bijapur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,11180.0,17940.0,530.0,22250.0,1600.0,23260.0,6150.0,8190.0,14700.0,9010.0,10820.0,10600.0,136230.0
Bijapur,16.1.5,Stock position of BCG vaccines,5. Total Stock,9230.0,6290.0,15760.0,3510.0,16910.0,3650.0,12500.0,4310.0,1610.0,7600.0,6780.0,6180.0,94330.0
Bijapur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,21465.0,18375.0,10765.0,15665.0,4295.0,14155.0,5990.0,12400.0,6740.0,5320.0,4220.0,4100.0,123490.0
Bijapur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,5000.0,5000.0,10000.0,10000.0,10000.0,,10000.0,5000.0,10000.0,4000.0,74000.0
Bijapur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8090.0,7610.0,100.0,16370.0,140.0,18165.0,3590.0,5660.0,11420.0,6100.0,10120.0,7600.0,94965.0
Bijapur,16.1.6,Stock position of Measles vaccines,5. Total Stock,18375.0,10765.0,15665.0,4295.0,14155.0,5990.0,12400.0,6740.0,5320.0,4220.0,4100.0,500.0,102525.0
Bijapur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,5500.0,0.0,5000.0,14500.0,0.0,0.0,,,,5000.0,25000.0,13900.0,68900.0
Bijapur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,15000.0,10000.0,5000.0,0.0,0.0,,,20000.0,25000.0,0.0,0.0,75000.0
Bijapur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,5500.0,10000.0,500.0,19500.0,0.0,0.0,,,15000.0,5000.0,11100.0,13600.0,80200.0
Bijapur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,5000.0,14500.0,0.0,0.0,0.0,0.0,0.0,5000.0,25000.0,13900.0,300.0,63700.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5620.0,6120.0,3110.0,5590.0,5090.0,4990.0,2410.0,3910.0,2870.0,4330.0,2800.0,2750.0,49590.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2000.0,0.0,2500.0,2500.0,0.0,2500.0,2500.0,,2500.0,0.0,2500.0,2500.0,19500.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1500.0,3010.0,20.0,3000.0,100.0,5080.0,1000.0,1040.0,1040.0,1530.0,2550.0,1890.0,21760.0
Bijapur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,6120.0,3110.0,5590.0,5090.0,4990.0,2410.0,3910.0,2870.0,4330.0,2800.0,2750.0,3360.0,47330.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,10800.0,9900.0,9500.0,9200.0,5500.0,2500.0,,,,0.0,317520.0,0.0,364920.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,900.0,400.0,300.0,3700.0,3000.0,2500.0,,,,0.0,10080.0,0.0,20880.0
Bijapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9900.0,9500.0,9200.0,5500.0,2500.0,0.0,0.0,0.0,0.0,0.0,307440.0,0.0,344040.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,238560.0,365760.0,347760.0,337680.0,216720.0,151200.0,95760.0,372960.0,317520.0,317520.0,62900.0,307440.0,3131780.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,151200.0,0.0,0.0,0.0,0.0,0.0,277200.0,151200.0,,0.0,0.0,0.0,579600.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,24000.0,18000.0,10080.0,120960.0,65520.0,55440.0,,206640.0,,0.0,700.0,5040.0,506380.0
Bijapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,365760.0,347760.0,337680.0,216720.0,151200.0,95760.0,372960.0,317520.0,317520.0,317520.0,62200.0,302400.0,3205000.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,7000.0,7000.0,6300.0,5500.0,500.0,0.0,,16000.0,63200.0,63200.0,0.0,62200.0,230900.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,60000.0,,0.0,0.0,0.0,76000.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,700.0,800.0,5000.0,500.0,0.0,,12800.0,,300.0,0.0,1000.0,21100.0
Bijapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,7000.0,6300.0,5500.0,500.0,0.0,0.0,16000.0,63200.0,63200.0,62900.0,0.0,61200.0,285800.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Bijapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,15930.0,15930.0,9380.0,9380.0,9380.0,9380.0,9380.0,9380.0,9380.0,0.0,0.0,,97520.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,,0.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,6550.0,0.0,0.0,0.0,0.0,,,9380.0,0.0,0.0,,15930.0
Bijapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,15930.0,9380.0,9380.0,9380.0,9380.0,9380.0,9380.0,9380.0,0.0,0.0,0.0,0.0,81590.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1760.0,1720.0,1720.0,1270.0,125.0,125.0,0.0,,,0.0,0.0,,6720.0
Bijapur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.02,Stock Position of Gloves,4. Stock Distributed,40.0,0.0,450.0,1145.0,0.0,125.0,0.0,,,0.0,0.0,,1760.0
Bijapur,16.3.02,Stock Position of Gloves,5. Total Stock,1720.0,1720.0,1270.0,125.0,125.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4960.0
Bijapur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,51460.0,,51460.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,,0.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,51460.0,,51460.0
Bijapur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,46404.0,46404.0,46404.0,46404.0,46404.0,46404.0,46404.0,7329.0,7329.0,7150.0,7150.0,353786.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,46404.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,46404.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,39075.0,,179.0,600.0,2400.0,42254.0
Bijapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,46404.0,46404.0,46404.0,46404.0,46404.0,46404.0,46404.0,7329.0,7329.0,7150.0,6550.0,4750.0,357936.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,4000.0,4000.0,4000.0,3800.0,3500.0,3500.0,3500.0,3500.0,3500.0,3500.0,3500.0,0.0,40300.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,2250.0,0.0,2250.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,200.0,300.0,0.0,0.0,0.0,,,0.0,5750.0,0.0,6250.0
Bijapur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,4000.0,4000.0,3800.0,3500.0,3500.0,3500.0,3500.0,3500.0,3500.0,3500.0,0.0,0.0,36300.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,55200.0,123712.0,123712.0,13412.0,13412.0,13412.0,11812.0,354672.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,12500.0,55200.0,68012.0,,,,0.0,0.0,0.0,135712.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,12500.0,0.0,300.0,,110300.0,,0.0,1600.0,3200.0,127900.0
Bijapur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,55200.0,122912.0,123712.0,13412.0,13412.0,13412.0,11812.0,8612.0,362484.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,7400.0,3400.0,0.0,6600.0,1900.0,7300.0,10300.0,8200.0,5000.0,0.0,1400.0,0.0,51500.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,6600.0,6600.0,5400.0,13200.0,0.0,,,6600.0,3300.0,6600.0,51300.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,7000.0,3400.0,0.0,11300.0,0.0,10200.0,2100.0,3200.0,5000.0,5200.0,4700.0,4900.0,57000.0
Bijapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3400.0,0.0,6600.0,1900.0,7300.0,10300.0,8200.0,5000.0,0.0,1400.0,0.0,1700.0,45800.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,98400.0,35400.0,2400.0,98400.0,2400.0,50400.0,2400.0,2400.0,2400.0,122400.0,122400.0,122400.0,661800.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,45000.0,50400.0,96000.0,76800.0,48000.0,200000.0,0.0,,120000.0,0.0,0.0,48000.0,684200.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,108000.0,83400.0,0.0,172800.0,0.0,248000.0,0.0,,,,0.0,0.0,612200.0
Bijapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,35400.0,2400.0,98400.0,2400.0,50400.0,2400.0,2400.0,2400.0,122400.0,122400.0,122400.0,170400.0,733800.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7400.0,2600.0,2400.0,9600.0,2400.0,9600.0,2400.0,2400.0,2400.0,16800.0,16800.0,14400.0,89200.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,9600.0,7200.0,7200.0,7200.0,7200.0,0.0,,14400.0,0.0,0.0,12000.0,67200.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,7200.0,9800.0,0.0,14400.0,0.0,14400.0,0.0,,,0.0,2400.0,2400.0,50600.0
Bijapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,2600.0,2400.0,9600.0,2400.0,9600.0,2400.0,2400.0,2400.0,16800.0,16800.0,14400.0,24000.0,105800.0
Bijapur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,2.0,2.0,6.0,,,2.0,,,,2.0,2.0,16.0
Bijapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,1.0,,1.0,,3.0,,1.0,1.0,4.0,4.0,,15.0
Bijapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,2.0,,,3.0
Bijapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,2.0,,1.0,,3.0,,1.0,1.0,6.0,4.0,,18.0
Bijapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,6.0,6.0,9.0,9.0,12.0,10.0,13.0,3.0,10.0,4.0,1.0,85.0
Bijapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,,,,,,1.0,,3.0
Bijapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,6.0,6.0,10.0,9.0,12.0,10.0,13.0,3.0,10.0,5.0,1.0,88.0
Bijapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,9.0,7.0,11.0,6.0,13.0,9.0,19.0,4.0,8.0,4.0,4.0,98.0
Bijapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,1.0,2.0,,1.0,,,5.0
Bijapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,9.0,7.0,11.0,6.0,14.0,10.0,21.0,4.0,9.0,4.0,4.0,103.0
Bijapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,6.0,8.0,6.0,15.0,13.0,33.0,14.0,22.0,5.0,8.0,12.0,6.0,148.0
Bijapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,,,,,,2.0,2.0,2.0,1.0,,8.0
Bijapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,9.0,6.0,15.0,13.0,33.0,14.0,24.0,7.0,10.0,13.0,6.0,156.0
Bijapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,2.0,2.0,,,5.0,,1.0,1.0,2.0,1.0,,15.0
Bijapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,4.0,1.0,1.0,2.0,1.0,2.0,2.0,,,,14.0
Bijapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,2.0,6.0,1.0,1.0,7.0,1.0,3.0,3.0,2.0,1.0,,29.0
Bijapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Bijapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,1.0,,2.0
Bijapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Bijapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,1.0,,,,,,1.0,,3.0
Bijapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Bijapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Bijapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Bijapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,7.0,2.0,7.0,8.0,4.0,20.0,8.0,15.0,5.0,7.0,9.0,1.0,93.0
Bijapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,4.0,2.0,3.0,4.0,7.0,7.0,5.0,6.0,2.0,5.0,6.0,3.0,54.0
Bijapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,11.0,4.0,10.0,12.0,11.0,27.0,13.0,21.0,7.0,12.0,15.0,4.0,147.0
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,1.0,,,,,,,,,,,,1.0
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,,,,,,,,,,,1.0
Bijapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,,,,,,1.0,,,,,,3.0
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,4.0,3.0,2.0,6.0,1.0,2.0,3.0,3.0,3.0,3.0,2.0,35.0
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,4.0,1.0,1.0,2.0,1.0,3.0,3.0,1.0,1.0,2.0,,,19.0
Bijapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,5.0,4.0,4.0,7.0,4.0,5.0,4.0,4.0,5.0,3.0,2.0,54.0
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,6.0,4.0,5.0,1.0,3.0,5.0,1.0,5.0,6.0,7.0,10.0,56.0
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,8.0,12.0,4.0,14.0,15.0,17.0,15.0,14.0,10.0,14.0,15.0,23.0,161.0
Bijapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,11.0,18.0,8.0,19.0,16.0,20.0,20.0,15.0,15.0,20.0,23.0,33.0,218.0
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,1.0,1.0,,,,,2.0
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,5.0,,,,,,5.0
Bijapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,6.0,1.0,,,,,7.0
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,2.0,1.0,,,2.0,1.0,1.0,,,,1.0,8.0
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,1.0,2.0,4.0,2.0,1.0,2.0,3.0,2.0,1.0,4.0,25.0
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,7.0,4.0,6.0,6.0,3.0,5.0,4.0,5.0,10.0,8.0,1.0,4.0,63.0
Bijapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,8.0,8.0,8.0,8.0,7.0,9.0,6.0,8.0,13.0,10.0,2.0,9.0,96.0
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,1.0,,,,1.0,3.0,,,,1.0,,,6.0
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,5.0,8.0,10.0,14.0,2.0,7.0,9.0,7.0,8.0,8.0,10.0,11.0,99.0
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,3.0,1.0,2.0,,,3.0,,,1.0,,,11.0
Bijapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,7.0,11.0,11.0,16.0,3.0,10.0,12.0,7.0,8.0,10.0,10.0,11.0,116.0
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,5.0,1.0,1.0,1.0,1.0,,,1.0,1.0,,12.0
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,29.0,41.0,24.0,28.0,31.0,36.0,33.0,27.0,37.0,49.0,40.0,39.0,414.0
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,34.0,32.0,34.0,26.0,22.0,31.0,34.0,38.0,40.0,43.0,39.0,29.0,402.0
Bijapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,64.0,73.0,63.0,55.0,54.0,68.0,68.0,65.0,77.0,93.0,80.0,68.0,828.0
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,2.0,,,1.0,,,,,,,4.0
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,10.0,9.0,4.0,1.0,6.0,13.0,14.0,6.0,14.0,8.0,3.0,12.0,100.0
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,20.0,24.0,20.0,19.0,18.0,38.0,14.0,30.0,43.0,39.0,26.0,16.0,307.0
Bijapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,31.0,33.0,26.0,20.0,24.0,52.0,28.0,36.0,57.0,47.0,29.0,28.0,411.0
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,1.0,,,,,,,,,1.0,2.0
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,1.0,,,,,,,,,1.0,2.0
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,,,,,,1.0,,2.0
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,,,,,,1.0,,2.0
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,1.0,1.0,,,,1.0,,,,,4.0
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,1.0,1.0,,,,1.0,,,,,4.0
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,1.0,2.0
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,1.0,2.0
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,,,3.0,1.0,,1.0,1.0,2.0,,,10.0
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Bijapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,,,3.0,1.0,,1.0,1.0,2.0,,,10.0
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,3.0,1.0,,,2.0,3.0,2.0,,4.0,,4.0,21.0
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,25.0,28.0,24.0,17.0,20.0,14.0,21.0,23.0,21.0,21.0,22.0,24.0,260.0
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,5.0,5.0,1.0,7.0,3.0,2.0,1.0,1.0,3.0,2.0,8.0,5.0,43.0
Bijapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,32.0,36.0,26.0,24.0,23.0,18.0,25.0,26.0,24.0,27.0,30.0,33.0,324.0
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,3.0,,1.0,1.0,1.0,,1.0,,,1.0,,9.0
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,14.0,19.0,7.0,15.0,10.0,9.0,12.0,10.0,15.0,10.0,9.0,4.0,134.0
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,4.0,1.0,5.0,1.0,,2.0,,3.0,2.0,1.0,,20.0
Bijapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,16.0,26.0,8.0,21.0,12.0,10.0,14.0,11.0,18.0,12.0,11.0,4.0,163.0
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,2.0,,1.0,3.0,,1.0,,,,1.0,,8.0
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,4.0,,1.0,1.0,2.0,4.0,1.0,2.0,1.0,2.0,1.0,2.0,21.0
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,2.0,4.0,4.0,,1.0,2.0,1.0,1.0,15.0
Bijapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,2.0,1.0,2.0,7.0,8.0,6.0,2.0,2.0,4.0,3.0,3.0,44.0
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,2.0,,,1.0,,,,,,,3.0
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,9.0,7.0,12.0,7.0,13.0,8.0,10.0,15.0,16.0,18.0,16.0,13.0,144.0
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,11.0,15.0,8.0,16.0,8.0,13.0,9.0,10.0,13.0,14.0,13.0,8.0,138.0
Bijapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,20.0,22.0,22.0,23.0,21.0,22.0,19.0,25.0,29.0,32.0,29.0,21.0,285.0
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,2.0,,,2.0,,,,2.0,1.0,1.0,,9.0
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,11.0,15.0,16.0,17.0,14.0,9.0,12.0,13.0,18.0,13.0,10.0,156.0
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,17.0,12.0,17.0,11.0,21.0,16.0,25.0,23.0,22.0,30.0,22.0,16.0,232.0
Bijapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,26.0,25.0,32.0,27.0,40.0,30.0,34.0,35.0,37.0,49.0,36.0,26.0,397.0
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,4.0,2.0,2.0,3.0,5.0,8.0,5.0,4.0,3.0,3.0,5.0,47.0
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,59.0,56.0,68.0,70.0,61.0,70.0,45.0,77.0,77.0,73.0,76.0,60.0,792.0
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,174.0,206.0,202.0,197.0,178.0,258.0,179.0,231.0,252.0,274.0,234.0,167.0,2552.0
Bijapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,236.0,266.0,272.0,269.0,242.0,333.0,232.0,313.0,333.0,350.0,313.0,232.0,3391.0
Chamrajnagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1359.0,1159.0,1292.0,1168.0,1083.0,1146.0,1169.0,1311.0,1110.0,1098.0,1073.0,960.0,13928.0
Chamrajnagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1181.0,1015.0,1125.0,1006.0,966.0,1005.0,1032.0,1127.0,987.0,954.0,945.0,861.0,12204.0
Chamrajnagar,1.2,Number of Pregnant women registered under JSY,TOTAL,1280.0,1048.0,1200.0,1073.0,1000.0,1073.0,1112.0,1233.0,1027.0,1054.0,1017.0,903.0,13020.0
Chamrajnagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1277.0,1481.0,1080.0,1149.0,1140.0,1197.0,1272.0,935.0,846.0,828.0,856.0,752.0,12813.0
Chamrajnagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1452.0,1241.0,1267.0,1167.0,1260.0,1304.0,1382.0,1437.0,1305.0,1204.0,1270.0,1260.0,15549.0
Chamrajnagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1188.0,1196.0,1159.0,1225.0,1201.0,1277.0,1226.0,1257.0,1270.0,1067.0,1124.0,1146.0,14336.0
Chamrajnagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,900.0,863.0,725.0,674.0,1006.0,836.0,937.0,754.0,608.0,612.0,660.0,702.0,9277.0
Chamrajnagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,50.0,34.0,49.0,26.0,46.0,33.0,49.0,36.0,30.0,49.0,49.0,22.0,473.0
Chamrajnagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,2.0,2.0,2.0,1.0,3.0,4.0,0.0,1.0,1.0,0.0,1.0,8.0,25.0
Chamrajnagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,885.0,1030.0,827.0,1147.0,711.0,933.0,838.0,934.0,1046.0,801.0,799.0,739.0,10690.0
Chamrajnagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,11.0,26.0,6.0,25.0,10.0,72.0,19.0,9.0,12.0,47.0,13.0,17.0,267.0
Chamrajnagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,128.0,86.0,81.0,150.0,275.0,355.0,200.0,237.0,173.0,169.0,247.0,222.0,2323.0
Chamrajnagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,1.0,5.0,3.0,6.0,4.0,5.0,4.0,2.0,0.0,0.0,0.0,30.0
Chamrajnagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,2.0,1.0,1.0,4.0,2.0,3.0,3.0,6.0,1.0,3.0,2.0,28.0
Chamrajnagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,3.0,6.0,4.0,10.0,6.0,8.0,7.0,8.0,1.0,3.0,2.0,58.0
Chamrajnagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,3.0,5.0,2.0,10.0,6.0,6.0,5.0,7.0,1.0,3.0,0.0,48.0
Chamrajnagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,10.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,0.0,0.0,0.0,13.0
Chamrajnagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,812.0,843.0,866.0,789.0,814.0,846.0,865.0,874.0,759.0,774.0,748.0,726.0,9716.0
Chamrajnagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,1.0,1.0,6.0,5.0,22.0
Chamrajnagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,47.0,8.0,1.0,15.0,82.0,292.0,398.0,587.0,350.0,154.0,544.0,391.0,2869.0
Chamrajnagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,184.0,201.0,184.0,195.0,153.0,184.0,182.0,184.0,140.0,174.0,176.0,170.0,2127.0
Chamrajnagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,41.0,26.0,26.0,26.0,32.0,39.0,43.0,30.0,14.0,18.0,35.0,10.0,340.0
Chamrajnagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,109.0,122.0,74.0,84.0,65.0,76.0,64.0,143.0,95.0,85.0,167.0,130.0,1214.0
Chamrajnagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,150.0,148.0,100.0,110.0,97.0,115.0,107.0,173.0,109.0,103.0,202.0,140.0,1554.0
Chamrajnagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,91.0,98.0,49.0,49.0,41.0,46.0,52.0,104.0,34.0,53.0,93.0,88.0,798.0
Chamrajnagar,4.1.1.a,Number of male live births,TOTAL,459.0,480.0,503.0,430.0,471.0,474.0,499.0,507.0,430.0,431.0,435.0,421.0,5540.0
Chamrajnagar,4.1.1.b,Number of female live births,TOTAL,429.0,470.0,456.0,454.0,416.0,460.0,461.0,463.0,408.0,425.0,393.0,392.0,5227.0
Chamrajnagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,888.0,950.0,959.0,884.0,887.0,934.0,960.0,970.0,838.0,856.0,828.0,813.0,10767.0
Chamrajnagar,4.1.2,Number of still births,TOTAL,10.0,6.0,19.0,11.0,14.0,7.0,16.0,8.0,10.0,17.0,8.0,11.0,137.0
Chamrajnagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,35.0,26.0,34.0,35.0,38.0,25.0,31.0,33.0,31.0,37.0,45.0,26.0,396.0
Chamrajnagar,4.2.1,Number of Newborns weighed at birth,TOTAL,877.0,945.0,948.0,881.0,885.0,933.0,957.0,970.0,833.0,856.0,825.0,799.0,10709.0
Chamrajnagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,124.0,99.0,139.0,102.0,133.0,92.0,127.0,100.0,103.0,74.0,110.0,64.0,1267.0
Chamrajnagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,874.0,916.0,933.0,882.0,880.0,926.0,939.0,936.0,809.0,831.0,783.0,766.0,10475.0
Chamrajnagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,2.0,5.0,2.0,6.0,0.0,1.0,1.0,0.0,0.0,0.0,6.0,23.0
Chamrajnagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,41.0,26.0,26.0,28.0,29.0,38.0,37.0,36.0,12.0,6.0,18.0,2.0,299.0
Chamrajnagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,20.0,30.0,70.0,66.0,54.0,37.0,51.0,4.0,55.0,50.0,65.0,49.0,551.0
Chamrajnagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,61.0,58.0,101.0,96.0,89.0,75.0,89.0,41.0,67.0,56.0,83.0,57.0,873.0
Chamrajnagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,8.0,2.0,0.0,2.0,10.0,42.0,37.0,4.0,0.0,0.0,1.0,1.0,107.0
Chamrajnagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,239.0,162.0,204.0,219.0,189.0,252.0,164.0,183.0,221.0,227.0,127.0,207.0,2394.0
Chamrajnagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,32.0,6.0,3.0,3.0,37.0,9.0,0.0,0.0,0.0,1.0,0.0,0.0,91.0
Chamrajnagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,223.0,261.0,354.0,374.0,205.0,369.0,360.0,428.0,376.0,425.0,414.0,369.0,4158.0
Chamrajnagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,7.0,2.0,22.0,13.0,8.0,6.0,2.0,1.0,0.0,0.0,5.0,2.0,68.0
Chamrajnagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,852.0,923.0,967.0,823.0,858.0,925.0,947.0,978.0,794.0,752.0,701.0,751.0,10271.0
Chamrajnagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,787.0,808.0,870.0,803.0,759.0,914.0,972.0,970.0,912.0,871.0,932.0,839.0,10437.0
Chamrajnagar,6.3,PNC maternal complications attended,TOTAL,0.0,1.0,0.0,2.0,7.0,0.0,0.0,3.0,1.0,0.0,0.0,0.0,14.0
Chamrajnagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,13.0,13.0,14.0,10.0,5.0,7.0,1.0,8.0,1.0,4.0,4.0,89.0
Chamrajnagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,11.0,1.0,4.0,2.0,7.0,1.0,5.0,0.0,0.0,0.0,6.0,5.0,42.0
Chamrajnagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,20.0,14.0,17.0,16.0,17.0,6.0,12.0,1.0,8.0,1.0,10.0,9.0,131.0
Chamrajnagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,3.0,0.0,2.0,2.0,1.0,7.0,3.0,3.0,6.0,0.0,27.0
Chamrajnagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,248.0,288.0,250.0,255.0,174.0,277.0,194.0,200.0,119.0,137.0,120.0,110.0,2372.0
Chamrajnagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,458.0,469.0,571.0,454.0,471.0,319.0,406.0,437.0,383.0,362.0,322.0,333.0,4985.0
Chamrajnagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,706.0,757.0,821.0,709.0,645.0,596.0,600.0,637.0,502.0,499.0,442.0,443.0,7357.0
Chamrajnagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,2.0,12.0,0.0,43.0,2.0,0.0,10.0,2.0,3.0,29.0,0.0,103.0
Chamrajnagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chamrajnagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chamrajnagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,89.0,47.0,74.0,57.0,0.0,70.0,53.0,56.0,66.0,0.0,57.0,57.0,626.0
Chamrajnagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,29.0,78.0,34.0,102.0,18.0,37.0,0.0,75.0,47.0,30.0,30.0,54.0,534.0
Chamrajnagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,167.0,229.0,188.0,243.0,158.0,207.0,78.0,226.0,321.0,99.0,182.0,200.0,2298.0
Chamrajnagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,285.0,354.0,296.0,402.0,176.0,314.0,131.0,357.0,434.0,129.0,269.0,311.0,3458.0
Chamrajnagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Chamrajnagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,47.0,18.0,15.0,18.0,15.0,10.0,28.0,10.0,16.0,3.0,12.0,16.0,208.0
Chamrajnagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,54.0,69.0,43.0,58.0,38.0,72.0,34.0,67.0,26.0,31.0,19.0,50.0,561.0
Chamrajnagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,101.0,87.0,58.0,76.0,53.0,82.0,62.0,77.0,42.0,34.0,31.0,66.0,769.0
Chamrajnagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,0.0,0.0,2.0,8.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Chamrajnagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chamrajnagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,3.0,1.0,0.0,2.0,3.0,2.0,6.0,1.0,6.0,1.0,2.0,3.0,30.0
Chamrajnagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,29.0,28.0,28.0,11.0,9.0,18.0,19.0,27.0,18.0,32.0,45.0,16.0,280.0
Chamrajnagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,32.0,29.0,28.0,13.0,12.0,22.0,25.0,28.0,24.0,33.0,47.0,19.0,312.0
Chamrajnagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,14.0,14.0,9.0,1.0,8.0,13.0,18.0,11.0,9.0,15.0,20.0,10.0,142.0
Chamrajnagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,61.0,66.0,72.0,72.0,73.0,63.0,56.0,47.0,32.0,32.0,27.0,34.0,635.0
Chamrajnagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,80.0,84.0,79.0,132.0,87.0,82.0,77.0,76.0,53.0,57.0,34.0,65.0,906.0
Chamrajnagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,4.0,4.0,8.0,4.0,5.0,6.0,4.0,8.0,13.0,2.0,2.0,63.0
Chamrajnagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,41.0,31.0,30.0,57.0,34.0,23.0,12.0,19.0,19.0,24.0,4.0,28.0,322.0
Chamrajnagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chamrajnagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,185.0,185.0,185.0,269.0,198.0,173.0,151.0,146.0,112.0,126.0,67.0,129.0,1926.0
Chamrajnagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,26.0,28.0,19.0,39.0,9.0,6.0,4.0,5.0,5.0,24.0,4.0,11.0,180.0
Chamrajnagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,15.0,5.0,11.0,29.0,11.0,5.0,8.0,13.0,10.0,17.0,8.0,11.0,143.0
Chamrajnagar,9.06,Number of IUCD removals,TOTAL,52.0,38.0,68.0,44.0,53.0,46.0,49.0,47.0,54.0,48.0,43.0,55.0,597.0
Chamrajnagar,9.07,Number of Oral Pills cycles distributed,TOTAL,2774.0,2172.0,2293.0,2389.0,2792.0,2283.0,2121.0,1996.0,2110.0,2106.0,2361.0,3723.0,29120.0
Chamrajnagar,9.08,Number of Condom pieces distributed,TOTAL,27878.0,28238.0,30760.0,30021.0,29143.0,32609.0,30149.0,30300.0,34016.0,31300.0,34964.0,33540.0,372918.0
Chamrajnagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Chamrajnagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chamrajnagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,30.0,26.0,16.0,23.0,20.0,10.0,15.0,10.0,11.0,11.0,13.0,14.0,-1.0
Chamrajnagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,916.0,935.0,988.0,907.0,952.0,903.0,1005.0,1013.0,910.0,900.0,861.0,830.0,11120.0
Chamrajnagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,21.0,11.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35.0
Chamrajnagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,25.0,9.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0
Chamrajnagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,30.0,9.0,14.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,56.0
Chamrajnagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1169.0,1149.0,1158.0,1310.0,1206.0,1244.0,1258.0,1320.0,1258.0,1209.0,1115.0,1138.0,14534.0
Chamrajnagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1100.0,1107.0,1116.0,1185.0,1192.0,1245.0,1209.0,1220.0,1193.0,1202.0,1154.0,1162.0,14085.0
Chamrajnagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1171.0,1081.0,1094.0,1178.0,1108.0,1222.0,1321.0,1289.0,1201.0,1139.0,1034.0,1238.0,14076.0
Chamrajnagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,900.0,884.0,741.0,904.0,914.0,880.0,899.0,946.0,860.0,880.0,846.0,773.0,10427.0
Chamrajnagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1163.0,1140.0,1137.0,1276.0,1180.0,1093.0,1215.0,1258.0,1249.0,1181.0,1118.0,1156.0,14166.0
Chamrajnagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1106.0,1101.0,1098.0,1165.0,1085.0,1137.0,1189.0,1207.0,1187.0,1179.0,1155.0,1161.0,13770.0
Chamrajnagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1172.0,1056.0,1075.0,1159.0,987.0,1106.0,1288.0,1264.0,1202.0,1122.0,1034.0,1235.0,13700.0
Chamrajnagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,766.0,780.0,877.0,704.0,751.0,682.0,772.0,740.0,654.0,650.0,807.0,761.0,8944.0
Chamrajnagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,17.0,10.0,5.0,0.0,113.0,20.0,0.0,0.0,8.0,0.0,0.0,0.0,173.0
Chamrajnagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,21.0,15.0,3.0,0.0,105.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,169.0
Chamrajnagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,26.0,15.0,2.0,1.0,18.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,72.0
Chamrajnagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1183.0,1120.0,1153.0,1256.0,1089.0,1164.0,1151.0,1139.0,1090.0,1049.0,1070.0,1093.0,13557.0
Chamrajnagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1027.0,1048.0,1007.0,1031.0,894.0,1003.0,973.0,1098.0,971.0,920.0,973.0,1027.0,11972.0
Chamrajnagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,595.0,568.0,582.0,693.0,555.0,583.0,547.0,520.0,562.0,526.0,585.0,539.0,6855.0
Chamrajnagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,565.0,548.0,567.0,575.0,523.0,511.0,479.0,479.0,516.0,473.0,479.0,526.0,6241.0
Chamrajnagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1160.0,1116.0,1149.0,1268.0,1078.0,1094.0,1026.0,999.0,1078.0,999.0,1064.0,1065.0,13096.0
Chamrajnagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1067.0,1056.0,1053.0,1168.0,971.0,1128.0,1056.0,1120.0,984.0,925.0,975.0,1049.0,12552.0
Chamrajnagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1068.0,1051.0,1053.0,1166.0,979.0,1116.0,1055.0,1112.0,981.0,922.0,970.0,1025.0,12498.0
Chamrajnagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,28.0,8.0,27.0,58.0,16.0,9.0,6.0,7.0,9.0,9.0,8.0,11.0,196.0
Chamrajnagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,17.0,11.0,5.0,7.0,24.0,15.0,3.0,21.0,14.0,19.0,19.0,32.0,187.0
Chamrajnagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,20.0,4.0,5.0,8.0,15.0,11.0,3.0,15.0,13.0,13.0,13.0,36.0,156.0
Chamrajnagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,37.0,15.0,10.0,15.0,39.0,26.0,6.0,36.0,27.0,32.0,32.0,68.0,343.0
Chamrajnagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,9.0,5.0,5.0,1657.0,4033.0,3411.0,153.0,486.0,606.0,144.0,216.0,149.0,10874.0
Chamrajnagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,9.0,1.0,4.0,1899.0,4238.0,3721.0,204.0,457.0,707.0,127.0,293.0,129.0,11789.0
Chamrajnagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,18.0,21.0,35.0,1441.0,3324.0,4323.0,115.0,298.0,713.0,386.0,187.0,268.0,11129.0
Chamrajnagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,0.0,4.0
Chamrajnagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,12.0,11.0,5.0,6.0,13.0,9.0,16.0,13.0,4.0,9.0,6.0,6.0,110.0
Chamrajnagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,546.0,529.0,523.0,522.0,537.0,531.0,559.0,557.0,546.0,569.0,547.0,559.0,6525.0
Chamrajnagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,521.0,503.0,501.0,496.0,522.0,506.0,543.0,542.0,531.0,539.0,521.0,531.0,6256.0
Chamrajnagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,426.0,407.0,404.0,388.0,390.0,412.0,429.0,425.0,433.0,407.0,391.0,406.0,4918.0
Chamrajnagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1037.0,1069.0,905.0,1226.0,1106.0,990.0,951.0,1004.0,869.0,916.0,1016.0,1299.0,12388.0
Chamrajnagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,1.0,0.0,9.0,403.0,6338.0,68.0,12.0,17.0,2.0,2.0,3356.0,5311.0,15519.0
Chamrajnagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,1.0,0.0,0.0,347.0,5665.0,53.0,7.0,7.0,5.0,1.0,3536.0,3943.0,13565.0
Chamrajnagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,3.0,0.0,0.0,1.0,1.0,1.0,2.0,0.0,5.0,3.0,2.0,16.0,34.0
Chamrajnagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,194.0,254.0,175.0,152.0,204.0,186.0,121.0,124.0,108.0,127.0,141.0,162.0,1948.0
Chamrajnagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,7.0,57.0,66.0,3.0,22.0,45.0,202.0,27.0,25.0,113.0,14.0,22.0,603.0
Chamrajnagar,13.1,Number of Patients operated for cataract,TOTAL,7.0,0.0,3.0,31.0,3.0,18.0,81.0,4.0,13.0,12.0,15.0,3.0,190.0
Chamrajnagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,7.0,0.0,3.0,31.0,3.0,18.0,81.0,4.0,13.0,12.0,15.0,3.0,190.0
Chamrajnagar,13.3,Number of School children detected with Refractive errors,TOTAL,8.0,15.0,12.0,65.0,76.0,67.0,34.0,7.0,67.0,39.0,220.0,427.0,1037.0
Chamrajnagar,13.4,Number of children provided free glasses,TOTAL,8.0,9.0,9.0,0.0,7.0,13.0,0.0,65.0,21.0,37.0,128.0,349.0,646.0
Chamrajnagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,8.0,8.0,7.0,7.0,8.0,8.0,7.0,6.0,8.0,8.0,8.0,-1.0
Chamrajnagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,31.0,33.0,31.0,35.0,32.0,29.0,31.0,27.0,30.0,29.0,28.0,28.0,-1.0
Chamrajnagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,166.0,168.0,178.0,207.0,225.0,324.0,276.0,271.0,284.0,252.0,284.0,258.0,-1.0
Chamrajnagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,5.0,7.0,7.0,6.0,6.0,5.0,7.0,6.0,6.0,7.0,7.0,-1.0
Chamrajnagar,14.05,Number of RKS meetings held during the month,TOTAL,11.0,15.0,10.0,7.0,10.0,16.0,12.0,18.0,24.0,22.0,27.0,29.0,201.0
Chamrajnagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,32.0,28.0,20.0,27.0,23.0,21.0,24.0,22.0,27.0,27.0,25.0,26.0,-1.0
Chamrajnagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,111.0,133.0,166.0,174.0,172.0,156.0,167.0,180.0,63.0,72.0,108.0,97.0,1599.0
Chamrajnagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,7.0,6.0,5.0,6.0,6.0,6.0,5.0,5.0,5.0,5.0,5.0,-1.0
Chamrajnagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,16.0,0.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,1.0,32.0,-1.0
Chamrajnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,480.0,418.0,379.0,370.0,377.0,395.0,383.0,499.0,309.0,297.0,441.0,400.0,4748.0
Chamrajnagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2130.0,1849.0,2051.0,1799.0,1948.0,2031.0,1759.0,1774.0,1569.0,2240.0,2871.0,1856.0,23877.0
Chamrajnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,484.0,370.0,560.0,382.0,386.0,477.0,423.0,503.0,372.0,341.0,423.0,471.0,5192.0
Chamrajnagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3209.0,3552.0,3248.0,2730.0,2829.0,3165.0,2560.0,2721.0,2339.0,2956.0,3655.0,2806.0,35770.0
Chamrajnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,964.0,788.0,939.0,752.0,763.0,872.0,806.0,1002.0,681.0,638.0,864.0,871.0,9940.0
Chamrajnagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5339.0,5401.0,5299.0,4529.0,4777.0,5196.0,4319.0,4495.0,3908.0,5196.0,6526.0,4662.0,59647.0
Chamrajnagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,16.0,25.0,21.0,18.0,16.0,26.0,23.0,24.0,26.0,18.0,31.0,22.0,266.0
Chamrajnagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,10.0,10.0,8.0,10.0,14.0,9.0,9.0,9.0,10.0,10.0,10.0,15.0,124.0
Chamrajnagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,26.0,35.0,29.0,28.0,30.0,35.0,32.0,33.0,36.0,28.0,41.0,37.0,390.0
Chamrajnagar,14.11,In-Patient Head Count at midnight,TOTAL,9654.0,12005.0,17765.0,16961.0,17321.0,15838.0,13576.0,13170.0,10828.0,7932.0,7112.0,6952.0,149114.0
Chamrajnagar,14.12.1,OPD attendance (All),TOTAL,107301.0,111216.0,131151.0,135889.0,134226.0,142083.0,109033.0,126237.0,115747.0,115624.0,127006.0,125269.0,1480782.0
Chamrajnagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,363.0,528.0,257.0,514.0,415.0,441.0,434.0,465.0,403.0,360.0,446.0,368.0,4994.0
Chamrajnagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,56.0,47.0,64.0,50.0,71.0,51.0,62.0,102.0,54.0,64.0,56.0,77.0,754.0
Chamrajnagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,406.0,425.0,323.0,367.0,361.0,424.0,319.0,400.0,480.0,462.0,449.0,424.0,4840.0
Chamrajnagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,966.0,919.0,949.0,911.0,773.0,613.0,905.0,565.0,547.0,773.0,943.0,859.0,9723.0
Chamrajnagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,169.0,155.0,204.0,152.0,197.0,178.0,151.0,59.0,199.0,168.0,258.0,229.0,2119.0
Chamrajnagar,14.14.c,Number of Adolescents counselled,TOTAL,154.0,161.0,181.0,155.0,121.0,136.0,121.0,91.0,106.0,128.0,178.0,208.0,1740.0
Chamrajnagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5510.0,5295.0,5556.0,5262.0,5015.0,5870.0,4539.0,5240.0,4928.0,4756.0,5528.0,6135.0,63634.0
Chamrajnagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,129.0,242.0,247.0,249.0,235.0,272.0,198.0,211.0,253.0,197.0,250.0,261.0,2744.0
Chamrajnagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1363.0,1288.0,1443.0,1566.0,1279.0,1609.0,945.0,1680.0,1349.0,1340.0,1489.0,1370.0,16721.0
Chamrajnagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,15.0,22.0,17.0,21.0,17.0,20.0,10.0,23.0,14.0,15.0,15.0,12.0,201.0
Chamrajnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1333.0,1206.0,1545.0,1493.0,1234.0,1512.0,822.0,1372.0,1225.0,1301.0,1540.0,1266.0,15849.0
Chamrajnagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,8.0,16.0,15.0,13.0,16.0,13.0,9.0,18.0,9.0,9.0,9.0,14.0,149.0
Chamrajnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1504.0,1243.0,1384.0,1211.0,1168.0,1366.0,877.0,1465.0,1384.0,1276.0,1393.0,1184.0,15455.0
Chamrajnagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,0.0,2.0,0.0,2.0,5.0,2.0,1.0,1.0,8.0,4.0,0.0,25.0
Chamrajnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4200.0,3737.0,4372.0,4270.0,3681.0,4487.0,2644.0,4517.0,3958.0,3917.0,4422.0,3820.0,48025.0
Chamrajnagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,23.0,38.0,34.0,34.0,35.0,38.0,21.0,42.0,24.0,32.0,28.0,26.0,375.0
Chamrajnagar,15.2,Number of Widal tests conducted,Number tested,990.0,921.0,985.0,1223.0,1056.0,994.0,720.0,1067.0,868.0,823.0,830.0,1068.0,11545.0
Chamrajnagar,15.3.a,Number of VDRL tests conducted on males,Number tested,153.0,220.0,118.0,160.0,96.0,116.0,62.0,148.0,86.0,168.0,125.0,134.0,1586.0
Chamrajnagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,174.0,290.0,205.0,202.0,194.0,171.0,167.0,294.0,143.0,133.0,143.0,129.0,2245.0
Chamrajnagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1005.0,842.0,1055.0,903.0,878.0,975.0,767.0,1154.0,969.0,895.0,904.0,821.0,11168.0
Chamrajnagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1332.0,1352.0,1378.0,1265.0,1168.0,1262.0,996.0,1596.0,1198.0,1196.0,1172.0,1084.0,14999.0
Chamrajnagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,8083.0,7898.0,9835.0,10656.0,9067.0,9966.0,7459.0,8555.0,9314.0,7755.0,8146.0,10622.0,107356.0
Chamrajnagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,0.0,5.0,7.0,4.0,6.0,4.0,6.0,2.0,0.0,1.0,0.0,36.0
Chamrajnagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,1.0,4.0,1.0,2.0,3.0,1.0,2.0,0.0,0.0,1.0,16.0
Chamrajnagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2500.0,0.0,4500.0,3000.0,8500.0,4500.0,4500.0,2500.0,4000.0,5500.0,5500.0,8000.0,53000.0
Chamrajnagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,6000.0,3000.0,20000.0,0.0,4000.0,0.0,2500.0,2000.0,0.0,5000.0,0.0,42500.0
Chamrajnagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2500.0,1500.0,4500.0,14500.0,4000.0,4000.0,2000.0,1000.0,500.0,0.0,2500.0,2500.0,39500.0
Chamrajnagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,4500.0,3000.0,8500.0,4500.0,4500.0,2500.0,4000.0,5500.0,5500.0,8000.0,5500.0,56000.0
Chamrajnagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,13000.0,13500.0,13000.0,11500.0,8500.0,6500.0,13500.0,10500.0,13000.0,9000.0,9000.0,6000.0,127000.0
Chamrajnagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,9000.0,2000.0,3000.0,0.0,0.0,10000.0,0.0,6000.0,0.0,0.0,2000.0,8000.0,40000.0
Chamrajnagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,8500.0,2500.0,4500.0,3000.0,2000.0,3000.0,3000.0,3500.0,4000.0,0.0,5000.0,4000.0,43000.0
Chamrajnagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,13500.0,13000.0,11500.0,8500.0,6500.0,13500.0,10500.0,13000.0,9000.0,9000.0,6000.0,10000.0,124000.0
Chamrajnagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,13000.0,13000.0,12000.0,8500.0,11000.0,6500.0,15500.0,6500.0,4500.0,11500.0,11000.0,14700.0,127700.0
Chamrajnagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,5000.0,4000.0,5000.0,15000.0,0.0,15000.0,0.0,9000.0,15000.0,125000.0,135000.0,8000.0,336000.0
Chamrajnagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,5000.0,5000.0,8500.0,12500.0,4500.0,6000.0,9000.0,11000.0,8000.0,125500.0,131300.0,5000.0,331300.0
Chamrajnagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,13000.0,12000.0,8500.0,11000.0,6500.0,15500.0,6500.0,4500.0,11500.0,11000.0,14700.0,17700.0,132400.0
Chamrajnagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13000.0,12000.0,14000.0,13000.0,13000.0,6000.0,15000.0,9500.0,11500.0,11000.0,11000.0,8500.0,137500.0
Chamrajnagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,5000.0,4000.0,20000.0,0.0,15000.0,0.0,5000.0,4000.0,0.0,0.0,7000.0,70000.0
Chamrajnagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11000.0,3000.0,5000.0,20000.0,7000.0,6000.0,5500.0,3000.0,4500.0,0.0,2500.0,5000.0,72500.0
Chamrajnagar,16.1.3,Stock position of TT vaccines,5. Total Stock,12000.0,14000.0,13000.0,13000.0,6000.0,15000.0,9500.0,11500.0,11000.0,11000.0,8500.0,10500.0,135000.0
Chamrajnagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,4500.0,5500.0,5500.0,5000.0,5000.0,2500.0,5000.0,500.0,3000.0,3500.0,3500.0,2000.0,45500.0
Chamrajnagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,6000.0,2000.0,2000.0,2000.0,0.0,4000.0,0.0,5000.0,3000.0,0.0,2000.0,5000.0,31000.0
Chamrajnagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,5000.0,2000.0,2500.0,2000.0,2500.0,1500.0,4500.0,2500.0,2500.0,0.0,3500.0,2000.0,30500.0
Chamrajnagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,5500.0,5500.0,5000.0,5000.0,2500.0,5000.0,500.0,3000.0,3500.0,3500.0,2000.0,5000.0,46000.0
Chamrajnagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3500.0,1500.0,5750.0,2750.0,3500.0,2500.0,5500.0,1000.0,2250.0,3500.0,3500.0,1750.0,37000.0
Chamrajnagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,6000.0,1000.0,6000.0,0.0,5000.0,0.0,4000.0,3000.0,0.0,2000.0,5000.0,34000.0
Chamrajnagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4000.0,1750.0,4000.0,5250.0,1000.0,2000.0,4500.0,2750.0,1750.0,0.0,3750.0,1750.0,32500.0
Chamrajnagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,1500.0,5750.0,2750.0,3500.0,2500.0,5500.0,1000.0,2250.0,3500.0,3500.0,1750.0,5000.0,38500.0
Chamrajnagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5000.0,4000.0,4000.0,2000.0,2000.0,1500.0,2200.0,1200.0,1200.0,2700.0,2700.0,2700.0,31200.0
Chamrajnagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1000.0,0.0,1000.0,0.0,1200.0,0.0,1200.0,1500.0,0.0,0.0,2000.0,7900.0
Chamrajnagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1000.0,1000.0,2000.0,1000.0,500.0,500.0,1000.0,1200.0,0.0,0.0,0.0,1200.0,9400.0
Chamrajnagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,4000.0,4000.0,2000.0,2000.0,1500.0,2200.0,1200.0,1200.0,2700.0,2700.0,2700.0,3500.0,29700.0
Chamrajnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1200.0,1200.0,800.0,800.0,800.0,0.0,0.0,0.0,0.0,440.0,440.0,440.0,6120.0
Chamrajnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,440.0,0.0,0.0,0.0,440.0
Chamrajnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,400.0,0.0,0.0,800.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,1400.0
Chamrajnagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1200.0,800.0,800.0,800.0,0.0,0.0,0.0,0.0,440.0,440.0,440.0,240.0,5160.0
Chamrajnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48000.0,48000.0,48000.0,144000.0
Chamrajnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,151200.0,0.0,0.0,0.0,0.0,206160.0,0.0,0.0,0.0,357360.0
Chamrajnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,151200.0,0.0,0.0,0.0,0.0,158160.0,0.0,0.0,0.0,309360.0
Chamrajnagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,48000.0,48000.0,48000.0,48000.0,192000.0
Chamrajnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0,5400.0,5400.0,16200.0
Chamrajnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,65400.0,0.0,0.0,0.0,65400.0
Chamrajnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,60000.0
Chamrajnagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0,5400.0,5400.0,5400.0,21600.0
Chamrajnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,15000.0
Chamrajnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,0.0,15000.0
Chamrajnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,15000.0
Chamrajnagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15000.0,0.0,0.0,0.0,15000.0
Chamrajnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,1000.0,1000.0,1000.0,1000.0,10015.0,8015.0,8015.0,8015.0,8015.0,8015.0,8015.0,6015.0,68120.0
Chamrajnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,9015.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9015.0
Chamrajnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,4000.0
Chamrajnagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1000.0,1000.0,1000.0,10015.0,8015.0,8015.0,8015.0,8015.0,8015.0,8015.0,6015.0,6015.0,73135.0
Chamrajnagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,148000.0,50000.0,38000.0,0.0,0.0,0.0,0.0,0.0,236000.0
Chamrajnagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,250000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,250000.0
Chamrajnagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,102000.0,98000.0,12000.0,38000.0,0.0,0.0,0.0,0.0,0.0,250000.0
Chamrajnagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,148000.0,50000.0,38000.0,0.0,0.0,0.0,0.0,0.0,0.0,236000.0
Chamrajnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1850.0,1440.0,1440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4730.0
Chamrajnagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,410.0,0.0,1440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1850.0
Chamrajnagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1440.0,1440.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2880.0
Chamrajnagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,20476.0,18676.0,18676.0,18376.0,15743.0,15743.0,15743.0,94688.0,91488.0,81088.0,68788.0,67988.0,527473.0
Chamrajnagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,49967.0,0.0,0.0,84545.0,0.0,0.0,0.0,0.0,0.0,134512.0
Chamrajnagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1800.0,0.0,300.0,52600.0,0.0,0.0,5600.0,3200.0,10400.0,12300.0,800.0,0.0,87000.0
Chamrajnagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,18676.0,18676.0,18376.0,15743.0,15743.0,15743.0,94688.0,91488.0,81088.0,68788.0,67988.0,67988.0,574985.0
Chamrajnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8400.0,11400.0,11400.0,11400.0,3900.0,3900.0,3900.0,900.0,900.0,7500.0,7500.0,7500.0,78600.0
Chamrajnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000.0,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,6600.0,0.0,0.0,2000.0,19400.0
Chamrajnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3000.0,0.0,0.0,12300.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,3300.0,21600.0
Chamrajnagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,11400.0,11400.0,11400.0,3900.0,3900.0,3900.0,900.0,900.0,7500.0,7500.0,7500.0,6200.0,76400.0
Chamrajnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,12800.0,19800.0,15000.0,12000.0,6000.0,6000.0,6000.0,1000.0,0.0,60600.0,36600.0,36600.0,212400.0
Chamrajnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,15000.0,0.0,6000.0,48000.0,0.0,5000.0,0.0,0.0,75000.0,0.0,0.0,60000.0,209000.0
Chamrajnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,8000.0,4800.0,9000.0,54000.0,0.0,5000.0,5000.0,1000.0,14400.0,24000.0,0.0,14400.0,139600.0
Chamrajnagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19800.0,15000.0,12000.0,6000.0,6000.0,6000.0,1000.0,0.0,60600.0,36600.0,36600.0,82200.0,281800.0
Chamrajnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7600.0,9400.0,8200.0,8200.0,5200.0,5200.0,7600.0,7600.0,7600.0,15200.0,15200.0,15200.0,112200.0
Chamrajnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,0.0,7200.0,0.0,2400.0,0.0,0.0,9600.0,0.0,0.0,2400.0,24000.0
Chamrajnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chamrajnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,600.0,1200.0,0.0,10200.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,14000.0
Chamrajnagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,9400.0,8200.0,8200.0,5200.0,5200.0,7600.0,7600.0,7600.0,15200.0,15200.0,15200.0,17600.0,122200.0
Chamrajnagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,,,,1.0,2.0,1.0,5.0
Chamrajnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Chamrajnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chamrajnagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Chamrajnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,1.0,1.0,,1.0,1.0,,,,4.0
Chamrajnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chamrajnagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,1.0,1.0,,1.0,1.0,,,,4.0
Chamrajnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,1.0,,1.0,,1.0,1.0,,,,,,8.0
Chamrajnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,1.0,1.0,1.0,,1.0,,,,,4.0
Chamrajnagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,1.0,,2.0,1.0,2.0,1.0,1.0,,,,,12.0
Chamrajnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,,,1.0,2.0,,1.0,5.0,2.0,2.0,,16.0
Chamrajnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Chamrajnagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,,,1.0,3.0,,1.0,5.0,2.0,2.0,,17.0
Chamrajnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,,1.0,,3.0,2.0,1.0,1.0,,,2.0,1.0,13.0
Chamrajnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chamrajnagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,,1.0,,3.0,2.0,1.0,1.0,,,2.0,1.0,13.0
Chamrajnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chamrajnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chamrajnagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Chamrajnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,2.0,,,,,,,,,,,,2.0
Chamrajnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,1.0,,,,,,,1.0
Chamrajnagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,2.0,,,,,1.0,,,,,,,3.0
Chamrajnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chamrajnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chamrajnagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chamrajnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,1.0,4.0,2.0,4.0,1.0,3.0,,2.0,,3.0,1.0,26.0
Chamrajnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,2.0,,,,,,1.0,,1.0,4.0
Chamrajnagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,1.0,4.0,4.0,4.0,1.0,3.0,,2.0,1.0,3.0,2.0,30.0
Chamrajnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,,,,,,,,,1.0
Chamrajnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,,,,1.0
Chamrajnagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,,,,1.0,,,,,2.0
Chamrajnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,3.0,3.0,2.0,3.0,6.0,2.0,2.0,1.0,1.0,1.0,3.0,29.0
Chamrajnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,4.0,2.0,3.0,1.0,1.0,1.0,2.0,1.0,3.0,2.0,1.0,21.0
Chamrajnagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,7.0,5.0,5.0,4.0,7.0,3.0,4.0,2.0,4.0,3.0,4.0,50.0
Chamrajnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Chamrajnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,1.0,,4.0,5.0,4.0,3.0,3.0,7.0,4.0,2.0,3.0,2.0,38.0
Chamrajnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,16.0,14.0,9.0,12.0,14.0,17.0,4.0,11.0,13.0,6.0,9.0,9.0,134.0
Chamrajnagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,17.0,15.0,13.0,17.0,18.0,20.0,7.0,18.0,17.0,8.0,12.0,11.0,173.0
Chamrajnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,1.0,,,,,1.0,,,,,2.0
Chamrajnagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,1.0,,,,,1.0,,,,,2.0
Chamrajnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,,1.0,1.0,1.0,1.0,,,,,5.0
Chamrajnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,3.0,,,,,,,,2.0,,,7.0
Chamrajnagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,3.0,,,1.0,1.0,1.0,1.0,,2.0,,,12.0
Chamrajnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Chamrajnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,2.0,1.0,1.0,2.0,,2.0,2.0,3.0,1.0,1.0,1.0,17.0
Chamrajnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,,,,,1.0,,2.0
Chamrajnagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,3.0,1.0,1.0,2.0,1.0,2.0,2.0,3.0,1.0,2.0,1.0,20.0
Chamrajnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,1.0,,,1.0,1.0,,4.0
Chamrajnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,16.0,22.0,10.0,18.0,23.0,26.0,22.0,28.0,25.0,24.0,20.0,20.0,254.0
Chamrajnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,25.0,23.0,25.0,32.0,22.0,28.0,22.0,45.0,35.0,27.0,33.0,34.0,351.0
Chamrajnagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,41.0,45.0,35.0,51.0,45.0,54.0,45.0,73.0,60.0,52.0,54.0,54.0,609.0
Chamrajnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Chamrajnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,7.0,4.0,2.0,5.0,3.0,4.0,2.0,4.0,4.0,2.0,3.0,5.0,45.0
Chamrajnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,12.0,12.0,14.0,13.0,13.0,20.0,14.0,12.0,12.0,14.0,20.0,10.0,166.0
Chamrajnagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,19.0,16.0,16.0,18.0,16.0,25.0,16.0,16.0,16.0,16.0,23.0,15.0,212.0
Chamrajnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chamrajnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Chamrajnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Chamrajnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Chamrajnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,,1.0
Chamrajnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chamrajnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,1.0,,,,,,,1.0,,,4.0
Chamrajnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chamrajnagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,1.0,,,,,,,1.0,,,4.0
Chamrajnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,1.0,,,1.0,,1.0,,3.0
Chamrajnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,14.0,6.0,6.0,5.0,11.0,5.0,10.0,7.0,9.0,4.0,7.0,92.0
Chamrajnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,2.0,4.0,3.0,2.0,2.0,1.0,5.0,4.0,2.0,3.0,2.0,33.0
Chamrajnagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,16.0,10.0,9.0,7.0,14.0,6.0,15.0,12.0,11.0,8.0,9.0,128.0
Chamrajnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,,,,1.0,,1.0,3.0
Chamrajnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,11.0,14.0,19.0,15.0,12.0,12.0,18.0,10.0,13.0,14.0,21.0,11.0,170.0
Chamrajnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,2.0,3.0,1.0,3.0,,2.0,3.0,1.0,2.0,3.0,1.0,22.0
Chamrajnagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,12.0,16.0,22.0,16.0,16.0,12.0,20.0,13.0,14.0,17.0,24.0,13.0,195.0
Chamrajnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chamrajnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,,,1.0,,1.0,,1.0,1.0,,1.0,,7.0
Chamrajnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,,3.0,3.0,,1.0,2.0,,,11.0
Chamrajnagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,,1.0,2.0,,4.0,3.0,1.0,2.0,2.0,1.0,,18.0
Chamrajnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,,,,,,,,,2.0
Chamrajnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,9.0,8.0,8.0,8.0,9.0,11.0,21.0,13.0,13.0,14.0,11.0,129.0
Chamrajnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,7.0,10.0,17.0,17.0,22.0,23.0,17.0,26.0,20.0,18.0,13.0,16.0,206.0
Chamrajnagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,11.0,19.0,26.0,26.0,30.0,32.0,28.0,47.0,33.0,31.0,27.0,27.0,337.0
Chamrajnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,1.0,,,,,1.0,3.0
Chamrajnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,10.0,10.0,14.0,8.0,6.0,22.0,11.0,20.0,16.0,13.0,18.0,14.0,162.0
Chamrajnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,16.0,15.0,26.0,38.0,24.0,41.0,28.0,32.0,35.0,43.0,39.0,34.0,371.0
Chamrajnagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,26.0,26.0,40.0,46.0,30.0,63.0,40.0,52.0,51.0,56.0,57.0,49.0,536.0
Chamrajnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,2.0,4.0,3.0,1.0,2.0,4.0,2.0,4.0,2.0,1.0,,26.0
Chamrajnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,58.0,56.0,72.0,51.0,58.0,56.0,41.0,56.0,56.0,43.0,46.0,48.0,641.0
Chamrajnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,200.0,176.0,201.0,234.0,187.0,271.0,199.0,238.0,242.0,217.0,213.0,177.0,2555.0
Chamrajnagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,259.0,234.0,277.0,288.0,246.0,329.0,244.0,296.0,302.0,262.0,260.0,225.0,3222.0
Chikkaballapur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1866.0,1679.0,2023.0,1906.0,1826.0,1743.0,1479.0,1820.0,1664.0,1658.0,1583.0,1619.0,20866.0
Chikkaballapur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1499.0,1366.0,1580.0,1485.0,1487.0,1517.0,1311.0,1530.0,1429.0,1397.0,1372.0,1313.0,17286.0
Chikkaballapur,1.2,Number of Pregnant women registered under JSY,TOTAL,1502.0,1430.0,1646.0,1518.0,1441.0,1548.0,1357.0,1639.0,1502.0,1508.0,1447.0,1544.0,18082.0
Chikkaballapur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2234.0,1895.0,2267.0,1867.0,1837.0,1794.0,1550.0,1728.0,1517.0,1615.0,1551.0,1386.0,21241.0
Chikkaballapur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1839.0,1754.0,1967.0,1799.0,1723.0,1919.0,1747.0,1885.0,1865.0,2030.0,1823.0,1850.0,22201.0
Chikkaballapur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1880.0,1995.0,2097.0,2095.0,2066.0,2067.0,1879.0,1789.0,1936.0,1972.0,1750.0,1786.0,23312.0
Chikkaballapur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1585.0,1595.0,1970.0,1284.0,1209.0,1285.0,1106.0,1098.0,1092.0,1395.0,1197.0,1254.0,16070.0
Chikkaballapur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,32.0,35.0,33.0,36.0,28.0,18.0,21.0,16.0,96.0,17.0,27.0,39.0,398.0
Chikkaballapur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,1.0,0.0,4.0,6.0,0.0,0.0,1.0,110.0,2.0,124.0
Chikkaballapur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1199.0,1205.0,1232.0,1302.0,1211.0,1456.0,1128.0,1450.0,1733.0,1680.0,1600.0,1507.0,16703.0
Chikkaballapur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,67.0,66.0,89.0,72.0,68.0,64.0,56.0,67.0,69.0,167.0,61.0,91.0,937.0
Chikkaballapur,1.8,Number of pregnancy test kits used at SC level,TOTAL,305.0,243.0,286.0,278.0,227.0,324.0,340.0,385.0,333.0,352.0,245.0,217.0,3535.0
Chikkaballapur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,6.0,6.0,2.0,4.0,5.0,9.0,5.0,1.0,1.0,1.0,5.0,48.0
Chikkaballapur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,14.0,6.0,9.0,9.0,10.0,6.0,6.0,14.0,12.0,13.0,11.0,11.0,121.0
Chikkaballapur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,17.0,12.0,15.0,11.0,14.0,11.0,15.0,19.0,13.0,14.0,12.0,16.0,169.0
Chikkaballapur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,12.0,9.0,9.0,8.0,13.0,10.0,10.0,18.0,7.0,13.0,12.0,12.0,133.0
Chikkaballapur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0,1.0,2.0,9.0
Chikkaballapur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1042.0,1052.0,1091.0,1095.0,1046.0,1104.0,1007.0,1077.0,1035.0,916.0,1049.0,1052.0,12566.0
Chikkaballapur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,424.0,462.0,394.0,415.0,236.0,300.0,316.0,340.0,433.0,305.0,477.0,352.0,4454.0
Chikkaballapur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,274.0,172.0,160.0,271.0,170.0,210.0,141.0,174.0,727.0,206.0,324.0,348.0,3177.0
Chikkaballapur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,32.0,23.0,15.0,26.0,10.0,24.0,25.0,25.0,31.0,27.0,53.0,16.0,307.0
Chikkaballapur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,4.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Chikkaballapur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,39.0,39.0,36.0,116.0,28.0,44.0,3.0,0.0,26.0,44.0,8.0,123.0,506.0
Chikkaballapur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Chikkaballapur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,190.0,185.0,203.0,240.0,196.0,238.0,194.0,227.0,223.0,206.0,242.0,208.0,2552.0
Chikkaballapur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,190.0,185.0,203.0,240.0,196.0,238.0,194.0,227.0,223.0,206.0,242.0,208.0,2552.0
Chikkaballapur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,29.0,23.0,39.0,65.0,23.0,29.0,2.0,0.0,20.0,25.0,10.0,9.0,274.0
Chikkaballapur,4.1.1.a,Number of male live births,TOTAL,571.0,552.0,608.0,645.0,542.0,638.0,544.0,538.0,546.0,571.0,611.0,555.0,6921.0
Chikkaballapur,4.1.1.b,Number of female live births,TOTAL,539.0,556.0,590.0,582.0,556.0,583.0,468.0,557.0,536.0,468.0,542.0,529.0,6506.0
Chikkaballapur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1110.0,1108.0,1198.0,1227.0,1098.0,1221.0,1012.0,1095.0,1082.0,1039.0,1153.0,1084.0,13427.0
Chikkaballapur,4.1.2,Number of still births,TOTAL,11.0,16.0,55.0,9.0,23.0,11.0,13.0,11.0,13.0,8.0,7.0,11.0,188.0
Chikkaballapur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,22.0,48.0,40.0,25.0,31.0,44.0,36.0,42.0,40.0,25.0,35.0,53.0,441.0
Chikkaballapur,4.2.1,Number of Newborns weighed at birth,TOTAL,1102.0,1047.0,1160.0,1233.0,1096.0,1092.0,908.0,1091.0,1090.0,994.0,1102.0,1071.0,12986.0
Chikkaballapur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,175.0,165.0,140.0,199.0,165.0,186.0,152.0,192.0,183.0,135.0,110.0,191.0,1993.0
Chikkaballapur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1113.0,959.0,920.0,1115.0,1023.0,987.0,889.0,1046.0,1076.0,1037.0,1064.0,1089.0,12318.0
Chikkaballapur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,0.0,0.0,0.0,0.0,10.0
Chikkaballapur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,3.0,6.0,6.0,10.0,5.0,8.0,9.0,23.0,18.0,30.0,73.0,100.0,291.0
Chikkaballapur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,3.0,6.0,6.0,10.0,5.0,8.0,19.0,23.0,18.0,30.0,73.0,100.0,301.0
Chikkaballapur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chikkaballapur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,154.0,152.0,165.0,209.0,193.0,155.0,152.0,212.0,190.0,208.0,305.0,509.0,2604.0
Chikkaballapur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,0.0,2.0,14.0,6.0,32.0
Chikkaballapur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,205.0,196.0,189.0,263.0,232.0,206.0,177.0,232.0,221.0,366.0,378.0,661.0,3326.0
Chikkaballapur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,20.0,22.0,12.0,11.0,10.0,7.0,18.0,6.0,43.0,128.0,108.0,114.0,499.0
Chikkaballapur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,937.0,917.0,943.0,1064.0,876.0,961.0,1017.0,849.0,902.0,871.0,797.0,791.0,10925.0
Chikkaballapur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,901.0,793.0,881.0,938.0,930.0,946.0,748.0,959.0,1094.0,965.0,842.0,861.0,10858.0
Chikkaballapur,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,2.0,2.0,2.0,2.0,9.0,6.0,8.0,5.0,7.0,8.0,52.0
Chikkaballapur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,14.0,23.0,8.0,14.0,12.0,9.0,9.0,18.0,11.0,7.0,11.0,21.0,157.0
Chikkaballapur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,9.0,8.0,6.0,12.0,2.0,21.0,1.0,1.0,2.0,0.0,4.0,15.0,81.0
Chikkaballapur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,23.0,31.0,14.0,26.0,14.0,30.0,10.0,19.0,13.0,7.0,15.0,36.0,238.0
Chikkaballapur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,3.0,2.0,0.0,2.0,5.0,3.0,1.0,3.0,0.0,3.0,1.0,24.0
Chikkaballapur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,281.0,325.0,300.0,499.0,248.0,294.0,230.0,121.0,201.0,220.0,227.0,342.0,3288.0
Chikkaballapur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,520.0,584.0,605.0,407.0,638.0,607.0,527.0,276.0,607.0,637.0,625.0,701.0,6734.0
Chikkaballapur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,801.0,909.0,905.0,906.0,886.0,901.0,757.0,397.0,808.0,857.0,852.0,1043.0,10022.0
Chikkaballapur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,27.0,62.0,3.0,4.0,53.0,15.0,0.0,0.0,0.0,0.0,0.0,167.0
Chikkaballapur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Chikkaballapur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Chikkaballapur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,5.0,8.0
Chikkaballapur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,9.0,12.0,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,36.0
Chikkaballapur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,73.0,70.0,63.0,31.0,42.0,83.0,65.0,148.0,114.0,170.0,193.0,121.0,1173.0
Chikkaballapur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,82.0,82.0,78.0,31.0,42.0,83.0,65.0,148.0,114.0,170.0,193.0,121.0,1209.0
Chikkaballapur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chikkaballapur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,108.0,164.0,136.0,38.0,114.0,70.0,121.0,187.0,245.0,166.0,136.0,156.0,1641.0
Chikkaballapur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,108.0,164.0,138.0,38.0,114.0,70.0,121.0,187.0,245.0,166.0,136.0,156.0,1643.0
Chikkaballapur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,2.0,0.0,0.0,1.0,3.0,0.0,0.0,0.0,0.0,3.0,2.0,11.0
Chikkaballapur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Chikkaballapur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chikkaballapur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,96.0,151.0,31.0,96.0,70.0,99.0,84.0,25.0,111.0,156.0,116.0,90.0,1125.0
Chikkaballapur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,96.0,151.0,33.0,96.0,74.0,99.0,84.0,25.0,111.0,156.0,116.0,90.0,1131.0
Chikkaballapur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,5.0,9.0,10.0,7.0,7.0,6.0,0.0,0.0,3.0,0.0,0.0,4.0,51.0
Chikkaballapur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,185.0,180.0,162.0,178.0,162.0,179.0,144.0,162.0,111.0,123.0,104.0,91.0,1781.0
Chikkaballapur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,89.0,87.0,88.0,85.0,55.0,79.0,78.0,69.0,72.0,84.0,74.0,79.0,939.0
Chikkaballapur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,0.0,1.0,3.0,8.0,7.0,6.0,5.0,6.0,5.0,5.0,5.0,10.0,61.0
Chikkaballapur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,34.0,85.0,71.0,74.0,86.0,107.0,48.0,43.0,87.0,65.0,83.0,61.0,844.0
Chikkaballapur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikkaballapur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,308.0,353.0,324.0,345.0,310.0,371.0,275.0,280.0,275.0,277.0,266.0,241.0,3625.0
Chikkaballapur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,17.0,27.0,14.0,28.0,25.0,44.0,24.0,19.0,40.0,41.0,50.0,40.0,369.0
Chikkaballapur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,2.0,0.0,1.0,2.0,1.0,1.0,0.0,1.0,3.0,2.0,0.0,13.0
Chikkaballapur,9.06,Number of IUCD removals,TOTAL,100.0,75.0,77.0,94.0,52.0,49.0,66.0,42.0,73.0,53.0,59.0,65.0,805.0
Chikkaballapur,9.07,Number of Oral Pills cycles distributed,TOTAL,1088.0,1084.0,1121.0,977.0,1205.0,1129.0,1014.0,776.0,655.0,563.0,609.0,1064.0,11285.0
Chikkaballapur,9.08,Number of Condom pieces distributed,TOTAL,11876.0,12417.0,12509.0,11667.0,12900.0,11313.0,12301.0,10945.0,9986.0,10563.0,8365.0,11053.0,135895.0
Chikkaballapur,9.09,Number of Centchroman (weekly) pills given,TOTAL,51.0,120.0,0.0,0.0,0.0,40.0,50.0,3.0,0.0,0.0,0.0,0.0,264.0
Chikkaballapur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,30.0,5.0,2.0,1.0,2.0,3.0,5.0,0.0,160.0,1.0,0.0,6.0,215.0
Chikkaballapur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Chikkaballapur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Chikkaballapur,9.12,Number of Institutions having NSV trained doctors,TOTAL,12.0,12.0,9.0,11.0,14.0,11.0,13.0,11.0,14.0,15.0,13.0,16.0,-1.0
Chikkaballapur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1461.0,1490.0,1513.0,1694.0,1419.0,1744.0,1541.0,1609.0,1547.0,1373.0,1444.0,1375.0,18210.0
Chikkaballapur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,340.0,116.0,109.0,38.0,54.0,163.0,0.0,181.0,175.0,4.0,13.0,0.0,1193.0
Chikkaballapur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,222.0,108.0,115.0,36.0,54.0,167.0,0.0,180.0,179.0,3.0,16.0,0.0,1080.0
Chikkaballapur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,227.0,118.0,119.0,48.0,65.0,171.0,0.0,180.0,184.0,5.0,356.0,4.0,1477.0
Chikkaballapur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1961.0,1973.0,2169.0,1982.0,1955.0,2094.0,1946.0,2163.0,1921.0,1899.0,1797.0,1699.0,23559.0
Chikkaballapur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1886.0,1878.0,2177.0,2033.0,1963.0,1777.0,1949.0,2004.0,1848.0,1964.0,1804.0,1798.0,23081.0
Chikkaballapur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2030.0,1930.0,2246.0,2095.0,2062.0,1897.0,1971.0,1959.0,1778.0,1956.0,1627.0,1681.0,23232.0
Chikkaballapur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1192.0,1346.0,1321.0,1394.0,1247.0,1319.0,1418.0,1472.0,1456.0,1261.0,1306.0,1277.0,16009.0
Chikkaballapur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1981.0,1967.0,2154.0,1971.0,1942.0,2015.0,1939.0,2029.0,1926.0,1908.0,1813.0,1692.0,23337.0
Chikkaballapur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1911.0,1864.0,2200.0,2016.0,1904.0,1875.0,1929.0,1971.0,1867.0,1951.0,1825.0,1787.0,23100.0
Chikkaballapur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2042.0,1949.0,2273.0,2201.0,1995.0,1994.0,1943.0,1756.0,1779.0,1940.0,1987.0,1673.0,23532.0
Chikkaballapur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,628.0,903.0,1115.0,879.0,752.0,1165.0,1183.0,1116.0,1193.0,1075.0,943.0,712.0,11664.0
Chikkaballapur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,138.0,80.0,86.0,54.0,22.0,37.0,10.0,327.0,170.0,19.0,353.0,2.0,1298.0
Chikkaballapur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,119.0,72.0,97.0,59.0,6.0,24.0,12.0,175.0,172.0,19.0,170.0,2.0,927.0
Chikkaballapur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,172.0,90.0,121.0,76.0,47.0,50.0,34.0,198.0,228.0,138.0,203.0,2.0,1359.0
Chikkaballapur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1736.0,1889.0,2131.0,1890.0,1831.0,1930.0,1618.0,1847.0,1718.0,1939.0,1679.0,1557.0,21765.0
Chikkaballapur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1174.0,1400.0,1633.0,1409.0,1384.0,1578.0,1443.0,1404.0,1303.0,1521.0,1251.0,1403.0,16903.0
Chikkaballapur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,906.0,806.0,1052.0,999.0,1070.0,1289.0,1059.0,1221.0,1094.0,1321.0,1339.0,1356.0,13512.0
Chikkaballapur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,753.0,800.0,1479.0,1149.0,1117.0,1507.0,1244.0,1030.0,718.0,1368.0,720.0,882.0,12767.0
Chikkaballapur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,697.0,788.0,1417.0,1192.0,1068.0,1462.0,1172.0,935.0,708.0,1333.0,678.0,863.0,12313.0
Chikkaballapur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1450.0,1588.0,2896.0,2341.0,2185.0,2969.0,2416.0,1965.0,1426.0,2701.0,1398.0,1745.0,25080.0
Chikkaballapur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1587.0,1854.0,2088.0,1783.0,1678.0,1723.0,1713.0,1623.0,1586.0,1694.0,1474.0,1463.0,20266.0
Chikkaballapur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1583.0,1856.0,2069.0,1773.0,1667.0,1727.0,1737.0,1628.0,1558.0,1693.0,1472.0,1469.0,20232.0
Chikkaballapur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,198.0,341.0,481.0,239.0,332.0,306.0,157.0,94.0,133.0,322.0,80.0,70.0,2753.0
Chikkaballapur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,725.0,1039.0,721.0,422.0,606.0,647.0,1041.0,736.0,389.0,585.0,972.0,435.0,8318.0
Chikkaballapur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,737.0,1011.0,629.0,488.0,534.0,668.0,1021.0,650.0,383.0,644.0,916.0,389.0,8070.0
Chikkaballapur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1462.0,2050.0,1350.0,910.0,1140.0,1315.0,2062.0,1386.0,772.0,1229.0,1888.0,824.0,16388.0
Chikkaballapur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,307.0,185.0,383.0,2573.0,2441.0,3135.0,763.0,2271.0,1300.0,500.0,567.0,472.0,14897.0
Chikkaballapur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,230.0,159.0,363.0,2557.0,2412.0,3052.0,842.0,2290.0,1342.0,746.0,660.0,430.0,15083.0
Chikkaballapur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,187.0,166.0,258.0,2398.0,2214.0,4093.0,687.0,2304.0,807.0,641.0,748.0,398.0,14901.0
Chikkaballapur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,0.0,3.0,1.0,4.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,13.0
Chikkaballapur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,149.0,137.0,115.0,115.0,66.0,57.0,40.0,76.0,97.0,45.0,39.0,57.0,993.0
Chikkaballapur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,891.0,864.0,904.0,888.0,876.0,847.0,821.0,827.0,890.0,862.0,798.0,831.0,10299.0
Chikkaballapur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,705.0,681.0,720.0,741.0,704.0,732.0,666.0,703.0,727.0,699.0,653.0,672.0,8403.0
Chikkaballapur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,574.0,555.0,584.0,602.0,561.0,592.0,532.0,593.0,584.0,544.0,542.0,520.0,6783.0
Chikkaballapur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,885.0,1186.0,1014.0,1026.0,1079.0,1157.0,963.0,930.0,851.0,1204.0,1009.0,979.0,12283.0
Chikkaballapur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1838.0,1815.0,2030.0,2880.0,1907.0,1791.0,1710.0,1811.0,1557.0,1865.0,3670.0,1577.0,24451.0
Chikkaballapur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,198.0,493.0,872.0,2599.0,7428.0,1572.0,488.0,388.0,132.0,390.0,4508.0,2738.0,21806.0
Chikkaballapur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,176.0,367.0,195.0,2405.0,11965.0,1454.0,466.0,458.0,485.0,332.0,5352.0,2413.0,26068.0
Chikkaballapur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,3.0,4.0,4.0,20.0,1.0,2.0,8.0,1.0,1.0,30.0,38.0,121.0
Chikkaballapur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,672.0,709.0,755.0,717.0,819.0,620.0,698.0,763.0,690.0,614.0,652.0,611.0,8320.0
Chikkaballapur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,8.0,0.0,10.0,0.0,22.0
Chikkaballapur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,52.0,76.0,134.0,87.0,56.0,166.0,64.0,185.0,38.0,45.0,92.0,98.0,1093.0
Chikkaballapur,13.1,Number of Patients operated for cataract,TOTAL,244.0,235.0,112.0,79.0,256.0,214.0,222.0,203.0,112.0,324.0,299.0,752.0,3052.0
Chikkaballapur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,221.0,207.0,226.0,141.0,252.0,214.0,200.0,182.0,111.0,248.0,286.0,249.0,2537.0
Chikkaballapur,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,9.0,18.0,37.0,36.0,87.0,8.0,502.0,65.0,111.0,101.0,215.0,1191.0
Chikkaballapur,13.4,Number of children provided free glasses,TOTAL,0.0,9.0,8.0,27.0,0.0,0.0,0.0,6.0,0.0,1.0,403.0,279.0,733.0
Chikkaballapur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,4.0,0.0,0.0,8.0
Chikkaballapur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,4.0
Chikkaballapur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,6.0,6.0,7.0,7.0,8.0,6.0,7.0,7.0,7.0,6.0,-1.0
Chikkaballapur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,20.0,21.0,18.0,18.0,22.0,19.0,17.0,16.0,21.0,19.0,17.0,20.0,-1.0
Chikkaballapur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,307.0,198.0,254.0,275.0,249.0,239.0,206.0,229.0,244.0,248.0,263.0,299.0,-1.0
Chikkaballapur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,3.0,5.0,3.0,6.0,7.0,6.0,7.0,6.0,6.0,7.0,3.0,5.0,-1.0
Chikkaballapur,14.05,Number of RKS meetings held during the month,TOTAL,13.0,16.0,15.0,15.0,15.0,14.0,15.0,12.0,12.0,25.0,17.0,24.0,193.0
Chikkaballapur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,26.0,26.0,26.0,27.0,31.0,30.0,34.0,30.0,34.0,34.0,28.0,31.0,-1.0
Chikkaballapur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,146.0,136.0,119.0,159.0,64.0,114.0,117.0,127.0,103.0,167.0,162.0,92.0,1506.0
Chikkaballapur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,7.0,5.0,7.0,7.0,8.0,7.0,6.0,5.0,9.0,8.0,6.0,-1.0
Chikkaballapur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,2.0,3.0,4.0,265.0,2.0,5.0,3.0,3.0,4.0,-1.0
Chikkaballapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,372.0,293.0,392.0,461.0,273.0,361.0,220.0,361.0,231.0,186.0,287.0,269.0,3706.0
Chikkaballapur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1670.0,1175.0,1462.0,1259.0,1277.0,1472.0,1298.0,1084.0,1135.0,1108.0,1385.0,1294.0,15619.0
Chikkaballapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,522.0,260.0,460.0,534.0,353.0,560.0,275.0,646.0,229.0,257.0,260.0,203.0,4559.0
Chikkaballapur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2748.0,2458.0,2775.0,2689.0,2204.0,2554.0,2259.0,1827.0,1676.0,1926.0,2431.0,2525.0,28072.0
Chikkaballapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,894.0,553.0,852.0,995.0,626.0,921.0,495.0,1007.0,460.0,443.0,547.0,472.0,8265.0
Chikkaballapur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4418.0,3633.0,4237.0,3948.0,3481.0,4026.0,3557.0,2911.0,2811.0,3034.0,3816.0,3819.0,43691.0
Chikkaballapur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,25.0,23.0,19.0,16.0,18.0,14.0,16.0,25.0,17.0,18.0,32.0,16.0,239.0
Chikkaballapur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,15.0,14.0,6.0,10.0,11.0,7.0,12.0,11.0,11.0,11.0,13.0,20.0,141.0
Chikkaballapur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,40.0,37.0,25.0,26.0,29.0,21.0,28.0,36.0,28.0,29.0,45.0,36.0,380.0
Chikkaballapur,14.11,In-Patient Head Count at midnight,TOTAL,9878.0,7049.0,10229.0,8073.0,11630.0,9892.0,7825.0,6269.0,12435.0,11081.0,8601.0,8235.0,111197.0
Chikkaballapur,14.12.1,OPD attendance (All),TOTAL,91299.0,100409.0,110150.0,105900.0,109623.0,105432.0,94547.0,93614.0,104216.0,100010.0,104994.0,102366.0,1222560.0
Chikkaballapur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,212.0,93.0,162.0,188.0,180.0,239.0,145.0,203.0,254.0,959.0,213.0,205.0,3053.0
Chikkaballapur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,13.0,5.0,3.0,21.0,5.0,2.0,12.0,6.0,12.0,26.0,28.0,41.0,174.0
Chikkaballapur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,194.0,200.0,168.0,157.0,184.0,181.0,151.0,237.0,185.0,174.0,178.0,205.0,2214.0
Chikkaballapur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1463.0,722.0,765.0,1869.0,1662.0,1941.0,1709.0,1747.0,1520.0,3096.0,3421.0,3267.0,23182.0
Chikkaballapur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,576.0,494.0,491.0,662.0,419.0,562.0,496.0,593.0,414.0,523.0,504.0,485.0,6219.0
Chikkaballapur,14.14.c,Number of Adolescents counselled,TOTAL,325.0,331.0,620.0,340.0,266.0,277.0,291.0,392.0,278.0,241.0,491.0,353.0,4205.0
Chikkaballapur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4331.0,4574.0,5043.0,4675.0,4159.0,4862.0,4277.0,4740.0,5625.0,4803.0,5358.0,4867.0,57314.0
Chikkaballapur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,366.0,463.0,444.0,438.0,431.0,386.0,388.0,372.0,442.0,374.0,475.0,374.0,4953.0
Chikkaballapur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1239.0,1246.0,1334.0,1169.0,1139.0,1236.0,1118.0,1337.0,1227.0,1001.0,1275.0,1272.0,14593.0
Chikkaballapur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,15.0,19.0,16.0,18.0,10.0,15.0,17.0,25.0,10.0,13.0,21.0,186.0
Chikkaballapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,902.0,1029.0,978.0,954.0,1079.0,1143.0,879.0,1040.0,957.0,853.0,1109.0,965.0,11888.0
Chikkaballapur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,5.0,9.0,7.0,15.0,16.0,12.0,9.0,15.0,9.0,7.0,10.0,28.0,142.0
Chikkaballapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1982.0,1803.0,1948.0,1892.0,1724.0,1835.0,1577.0,1846.0,1608.0,1380.0,1648.0,1532.0,20775.0
Chikkaballapur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,2.0,3.0,1.0,21.0,2.0,5.0,9.0,5.0,2.0,6.0,4.0,63.0
Chikkaballapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4123.0,4078.0,4260.0,4015.0,3942.0,4214.0,3574.0,4223.0,3792.0,3234.0,4032.0,3769.0,47256.0
Chikkaballapur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,15.0,26.0,29.0,32.0,55.0,24.0,29.0,41.0,39.0,19.0,29.0,53.0,391.0
Chikkaballapur,15.2,Number of Widal tests conducted,Number tested,351.0,335.0,592.0,851.0,666.0,558.0,547.0,663.0,504.0,641.0,1018.0,1014.0,7740.0
Chikkaballapur,15.3.a,Number of VDRL tests conducted on males,Number tested,55.0,63.0,49.0,116.0,226.0,51.0,139.0,128.0,21.0,140.0,128.0,138.0,1254.0
Chikkaballapur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,169.0,192.0,123.0,95.0,306.0,125.0,147.0,282.0,46.0,151.0,293.0,172.0,2101.0
Chikkaballapur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,858.0,702.0,866.0,858.0,877.0,847.0,772.0,945.0,839.0,1109.0,1080.0,1168.0,10921.0
Chikkaballapur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1082.0,957.0,1038.0,1069.0,1409.0,1023.0,1058.0,1355.0,906.0,1400.0,1501.0,1478.0,14276.0
Chikkaballapur,15.4.1,Number of blood smears examined for Malaria,TOTAL,15074.0,14743.0,17222.0,17380.0,17275.0,18653.0,14581.0,17108.0,16808.0,14100.0,17049.0,16669.0,196662.0
Chikkaballapur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,1.0,1.0,111.0,11.0,11.0,20.0,2.0,597.0,1.0,0.0,0.0,756.0
Chikkaballapur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,2.0,7.0,10.0,9.0,0.0,0.0,0.0,0.0,0.0,28.0
Chikkaballapur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,0.0,1000.0,3000.0,3500.0,500.0,7000.0,8000.0,500.0,,,10500.0,8500.0,42500.0
Chikkaballapur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,7500.0,7500.0,3000.0,10000.0,5000.0,0.0,8000.0,,,0.0,0.0,46000.0
Chikkaballapur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4000.0,5500.0,7000.0,6000.0,3500.0,4000.0,7500.0,1500.0,,,2000.0,6000.0,47000.0
Chikkaballapur,16.1.1,Stock position of DPT vaccines,5. Total Stock,1000.0,3000.0,3500.0,500.0,7000.0,8000.0,500.0,7000.0,0.0,0.0,8500.0,2500.0,41500.0
Chikkaballapur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,0.0,4000.0,6000.0,8000.0,10000.0,11500.0,17500.0,9000.0,,,13000.0,9000.0,88000.0
Chikkaballapur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,9000.0,9000.0,9000.0,6000.0,6000.0,9000.0,0.0,6000.0,,,0.0,0.0,54000.0
Chikkaballapur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5000.0,7000.0,7000.0,4000.0,4500.0,3000.0,8500.0,5000.0,,,4000.0,7500.0,55500.0
Chikkaballapur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,4000.0,6000.0,8000.0,10000.0,11500.0,17500.0,9000.0,10000.0,0.0,0.0,9000.0,1500.0,86500.0
Chikkaballapur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,1130.0,3630.0,12030.0,2530.0,15530.0,10030.0,11000.0,1500.0,,,13355.0,9855.0,80590.0
Chikkaballapur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,20000.0,10000.0,20000.0,0.0,10000.0,0.0,12000.0,,,190000.0,20000.0,292000.0
Chikkaballapur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7500.0,11600.0,19500.0,7000.0,5500.0,9030.0,9500.0,6000.0,,,193500.0,15000.0,284130.0
Chikkaballapur,16.1.2,Stock position of OPV vaccines,5. Total Stock,3630.0,12030.0,2530.0,15530.0,10030.0,11000.0,1500.0,7500.0,0.0,0.0,9855.0,14855.0,88460.0
Chikkaballapur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,10.0,2510.0,5510.0,4010.0,13010.0,15000.0,20000.0,6000.0,,,20500.0,17000.0,103550.0
Chikkaballapur,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,10000.0,12000.0,15000.0,10000.0,16000.0,0.0,15000.0,,,0.0,0.0,86000.0
Chikkaballapur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5500.0,7000.0,13500.0,6000.0,8010.0,11000.0,14000.0,4000.0,,,3500.0,5000.0,77510.0
Chikkaballapur,16.1.3,Stock position of TT vaccines,5. Total Stock,2510.0,5510.0,4010.0,13010.0,15000.0,20000.0,6000.0,17000.0,0.0,0.0,17000.0,12000.0,112040.0
Chikkaballapur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2600.0,3100.0,500.0,0.0,5000.0,4500.0,5000.0,500.0,,,3500.0,1000.0,25700.0
Chikkaballapur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,2000.0,4000.0,6000.0,2000.0,4000.0,0.0,6000.0,,,0.0,5000.0,32000.0
Chikkaballapur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2500.0,4600.0,4500.0,1000.0,2500.0,3500.0,4500.0,1500.0,,,2500.0,5000.0,32100.0
Chikkaballapur,16.1.5,Stock position of BCG vaccines,5. Total Stock,3100.0,500.0,0.0,5000.0,4500.0,5000.0,500.0,5000.0,0.0,0.0,1000.0,1000.0,25600.0
Chikkaballapur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,500.0,4000.0,500.0,0.0,4000.0,3500.0,5750.0,2250.0,,,2750.0,250.0,23500.0
Chikkaballapur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,5000.0,5000.0,5000.0,5000.0,0.0,5000.0,,,0.0,5000.0,35000.0
Chikkaballapur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1500.0,3500.0,5500.0,1000.0,5500.0,2750.0,3500.0,1500.0,,,2500.0,4000.0,31250.0
Chikkaballapur,16.1.6,Stock position of Measles vaccines,5. Total Stock,4000.0,500.0,0.0,4000.0,3500.0,5750.0,2250.0,5750.0,0.0,0.0,250.0,1250.0,27250.0
Chikkaballapur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,4500.0,1000.0,0.0,3500.0,5500.0,2500.0,,,8500.0,6500.0,32000.0
Chikkaballapur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,10000.0,5000.0,0.0,5000.0,5000.0,0.0,10000.0,,,0.0,0.0,35000.0
Chikkaballapur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,5500.0,8500.0,1000.0,1500.0,3000.0,3000.0,5000.0,,,2000.0,3500.0,33000.0
Chikkaballapur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,4500.0,1000.0,0.0,3500.0,5500.0,2500.0,7500.0,0.0,0.0,6500.0,3000.0,34000.0
Chikkaballapur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,1500.0,600.0,2100.0,1500.0,2400.0,3400.0,2000.0,,,7500.0,4000.0,25000.0
Chikkaballapur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,2100.0,900.0,3000.0,0.0,2100.0,2500.0,0.0,2500.0,,,0.0,0.0,13100.0
Chikkaballapur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,600.0,1800.0,1500.0,600.0,1200.0,1500.0,1400.0,0.0,,,3500.0,2000.0,14100.0
Chikkaballapur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1500.0,600.0,2100.0,1500.0,2400.0,3400.0,2000.0,4500.0,0.0,0.0,4000.0,2000.0,24000.0
Chikkaballapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,400.0,0.0,0.0,0.0,0.0,0.0,,,6000.0,0.0,7200.0
Chikkaballapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,,,0.0,0.0,6000.0
Chikkaballapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,400.0,0.0,0.0,0.0,0.0,3600.0,,,6000.0,0.0,10000.0
Chikkaballapur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,400.0,400.0,0.0,0.0,0.0,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,3200.0
Chikkaballapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,2270.0,2270.0,2270.0,270.0,270.0,270.0,270.0,270.0,,,110400.0,0.0,118560.0
Chikkaballapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50400.0,,,0.0,0.0,50400.0
Chikkaballapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,20160.0,,,110400.0,0.0,132560.0
Chikkaballapur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,2270.0,2270.0,270.0,270.0,270.0,270.0,270.0,30510.0,0.0,0.0,0.0,0.0,36400.0
Chikkaballapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,360.0,360.0,360.0,60.0,60.0,60.0,60.0,60.0,,,7000.0,0.0,8380.0
Chikkaballapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11000.0,,,0.0,0.0,11000.0
Chikkaballapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,300.0,0.0,0.0,0.0,0.0,5000.0,,,7000.0,0.0,12300.0
Chikkaballapur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,360.0,360.0,60.0,60.0,60.0,60.0,60.0,6060.0,0.0,0.0,0.0,0.0,7080.0
Chikkaballapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,400.0,400.0,400.0,0.0,0.0,0.0,5865.0,5865.0,,,3000.0,0.0,15930.0
Chikkaballapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,400.0,0.0,0.0,0.0,0.0,1000.0,,,3000.0,0.0,4400.0
Chikkaballapur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,400.0,400.0,0.0,0.0,0.0,0.0,5865.0,4865.0,0.0,0.0,0.0,0.0,11530.0
Chikkaballapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,8365.0,8365.0,6865.0,6865.0,5865.0,5865.0,0.0,0.0,,,4865.0,4865.0,51920.0
Chikkaballapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,1500.0,0.0,1000.0,0.0,0.0,0.0,0.0,,,0.0,0.0,2500.0
Chikkaballapur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,8365.0,6865.0,6865.0,5865.0,5865.0,5865.0,0.0,0.0,0.0,0.0,4865.0,4865.0,49420.0
Chikkaballapur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikkaballapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,0.0,2600.0,600.0,0.0,2200.0,800.0,3300.0,1600.0,,,3600.0,2600.0,17300.0
Chikkaballapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,4600.0,0.0,0.0,3300.0,0.0,3300.0,0.0,3300.0,,,0.0,6600.0,21100.0
Chikkaballapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,2000.0,600.0,1100.0,1400.0,800.0,1700.0,300.0,,,1000.0,2000.0,12900.0
Chikkaballapur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2600.0,600.0,0.0,2200.0,800.0,3300.0,1600.0,4600.0,0.0,0.0,2600.0,7200.0,25500.0
Chikkaballapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,13500.0,49500.0,42900.0,35700.0,41700.0,29300.0,52500.0,36500.0,,,33300.0,16500.0,351400.0
Chikkaballapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,45000.0,12000.0,26400.0,12000.0,0.0,40000.0,0.0,0.0,,,0.0,28800.0,164200.0
Chikkaballapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,9000.0,18600.0,33600.0,6000.0,12400.0,16800.0,16000.0,12400.0,,,16800.0,20400.0,162000.0
Chikkaballapur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,49500.0,42900.0,35700.0,41700.0,29300.0,52500.0,36500.0,24100.0,0.0,0.0,16500.0,24900.0,353600.0
Chikkaballapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,2600.0,2200.0,3500.0,1700.0,3900.0,3500.0,,,3900.0,3100.0,24400.0
Chikkaballapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,3000.0,0.0,2400.0,0.0,2400.0,0.0,0.0,,,0.0,2400.0,10200.0
Chikkaballapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0
Chikkaballapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,400.0,400.0,1100.0,1800.0,200.0,400.0,400.0,,,800.0,4500.0,10000.0
Chikkaballapur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,2600.0,2200.0,3500.0,1700.0,3900.0,3500.0,3100.0,0.0,0.0,3100.0,1000.0,24600.0
Chikkaballapur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,,,,,,1.0,,2.0
Chikkaballapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,1.0,,2.0
Chikkaballapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chikkaballapur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,,,,,1.0,,2.0
Chikkaballapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,2.0,2.0,2.0,1.0,,3.0,2.0,1.0,1.0,,3.0,17.0
Chikkaballapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Chikkaballapur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,2.0,2.0,2.0,1.0,1.0,3.0,2.0,1.0,1.0,,3.0,18.0
Chikkaballapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,2.0,,1.0,2.0,2.0,2.0,2.0,,3.0,15.0
Chikkaballapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,1.0,,,,,,1.0,,3.0
Chikkaballapur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,2.0,1.0,1.0,2.0,2.0,2.0,2.0,1.0,3.0,18.0
Chikkaballapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,,,1.0,,1.0,2.0,2.0,1.0,2.0,11.0
Chikkaballapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chikkaballapur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,,,1.0,,1.0,2.0,2.0,1.0,2.0,11.0
Chikkaballapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,2.0,,2.0,,,1.0,3.0,9.0
Chikkaballapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,1.0,,1.0
Chikkaballapur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,2.0,,2.0,,,2.0,3.0,10.0
Chikkaballapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Chikkaballapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Chikkaballapur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,1.0,,1.0,2.0
Chikkaballapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,1.0,,,,,,,,,1.0
Chikkaballapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chikkaballapur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,1.0,,,,,,,,,1.0
Chikkaballapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chikkaballapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chikkaballapur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chikkaballapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,2.0,,1.0,2.0,2.0,1.0,4.0,,3.0,2.0,18.0
Chikkaballapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,1.0,1.0,,,,2.0,1.0,,6.0
Chikkaballapur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,2.0,1.0,2.0,3.0,2.0,1.0,4.0,2.0,4.0,2.0,24.0
Chikkaballapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,,1.0,2.0
Chikkaballapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,2.0,,,,3.0
Chikkaballapur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,1.0,1.0,,,2.0,,,1.0,5.0
Chikkaballapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Chikkaballapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,3.0,4.0,2.0,1.0,4.0,,3.0,3.0,3.0,2.0,2.0,,27.0
Chikkaballapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,3.0,,2.0,3.0,2.0,2.0,,2.0,2.0,1.0,19.0
Chikkaballapur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,5.0,5.0,1.0,6.0,3.0,5.0,5.0,3.0,4.0,4.0,2.0,47.0
Chikkaballapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Chikkaballapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,6.0,4.0,3.0,1.0,1.0,1.0,1.0,2.0,3.0,2.0,7.0,6.0,37.0
Chikkaballapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,8.0,7.0,3.0,8.0,6.0,3.0,5.0,3.0,8.0,10.0,7.0,14.0,82.0
Chikkaballapur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,14.0,11.0,6.0,9.0,7.0,5.0,6.0,5.0,11.0,12.0,14.0,20.0,120.0
Chikkaballapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Chikkaballapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,1.0,,,1.0
Chikkaballapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Chikkaballapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Chikkaballapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,,,,1.0,2.0,,1.0,,5.0
Chikkaballapur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,,,,,1.0,4.0,,1.0,,7.0
Chikkaballapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Chikkaballapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,2.0,1.0,4.0,1.0,2.0,3.0,4.0,4.0,,,4.0,27.0
Chikkaballapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,2.0,1.0,4.0,1.0,2.0,4.0,4.0,4.0,,,4.0,28.0
Chikkaballapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,1.0,,1.0,,,,,,3.0
Chikkaballapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,19.0,14.0,8.0,15.0,3.0,9.0,7.0,9.0,9.0,7.0,12.0,14.0,126.0
Chikkaballapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,8.0,7.0,3.0,12.0,12.0,6.0,6.0,9.0,9.0,11.0,10.0,13.0,106.0
Chikkaballapur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,27.0,21.0,12.0,27.0,16.0,15.0,14.0,18.0,18.0,18.0,22.0,27.0,235.0
Chikkaballapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,,,,,1.0,1.0,1.0,,,4.0
Chikkaballapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,1.0,3.0,2.0,1.0,2.0,1.0,2.0,2.0,2.0,4.0,1.0,,21.0
Chikkaballapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,4.0,2.0,2.0,1.0,5.0,3.0,,3.0,3.0,3.0,4.0,2.0,32.0
Chikkaballapur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,5.0,6.0,4.0,2.0,7.0,4.0,2.0,6.0,6.0,8.0,5.0,2.0,57.0
Chikkaballapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chikkaballapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,1.0,,,,1.0,1.0,,,,,4.0
Chikkaballapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,1.0,,,,1.0,1.0,,,,,4.0
Chikkaballapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Chikkaballapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,1.0,,,,1.0
Chikkaballapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,1.0,1.0,,1.0,,,3.0
Chikkaballapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,1.0,1.0,,1.0,,,3.0
Chikkaballapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Chikkaballapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,,,,,,,,,,1.0
Chikkaballapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,,,3.0,,2.0,,2.0,8.0
Chikkaballapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chikkaballapur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,,,3.0,,2.0,,2.0,8.0
Chikkaballapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,2.0,1.0,,,,,2.0,1.0,,7.0
Chikkaballapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,17.0,8.0,14.0,12.0,5.0,4.0,4.0,8.0,7.0,12.0,13.0,116.0
Chikkaballapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,4.0,3.0,,1.0,,1.0,,5.0,2.0,4.0,2.0,24.0
Chikkaballapur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,15.0,21.0,11.0,16.0,14.0,5.0,5.0,4.0,13.0,11.0,17.0,15.0,147.0
Chikkaballapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2.0,1.0,1.0,1.0,,,,1.0,1.0,,1.0,,8.0
Chikkaballapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,11.0,11.0,5.0,11.0,9.0,11.0,8.0,10.0,9.0,3.0,5.0,7.0,100.0
Chikkaballapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,,,,1.0,1.0,,1.0,1.0,,1.0,2.0,8.0
Chikkaballapur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,14.0,12.0,6.0,12.0,10.0,12.0,8.0,12.0,11.0,3.0,7.0,9.0,116.0
Chikkaballapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Chikkaballapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,5.0,2.0,1.0,,1.0,1.0,,1.0,,,11.0
Chikkaballapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,1.0,,,1.0,,,,,4.0
Chikkaballapur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,6.0,3.0,2.0,,1.0,2.0,,1.0,,,15.0
Chikkaballapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,,,1.0,,,,1.0,3.0
Chikkaballapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,1.0,4.0,9.0,5.0,2.0,4.0,2.0,3.0,6.0,6.0,3.0,4.0,49.0
Chikkaballapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,3.0,3.0,4.0,5.0,3.0,6.0,5.0,7.0,6.0,3.0,8.0,56.0
Chikkaballapur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,4.0,7.0,12.0,9.0,8.0,7.0,8.0,9.0,13.0,12.0,6.0,13.0,108.0
Chikkaballapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,,1.0,,,,,2.0
Chikkaballapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,4.0,11.0,12.0,12.0,7.0,13.0,9.0,11.0,11.0,6.0,13.0,120.0
Chikkaballapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,24.0,12.0,13.0,16.0,16.0,15.0,10.0,6.0,27.0,15.0,18.0,21.0,193.0
Chikkaballapur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,35.0,17.0,24.0,28.0,28.0,22.0,23.0,16.0,38.0,26.0,24.0,34.0,315.0
Chikkaballapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,2.0,1.0,1.0,4.0,2.0,2.0,2.0,1.0,2.0,2.0,,2.0,21.0
Chikkaballapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,39.0,47.0,58.0,54.0,47.0,55.0,48.0,44.0,37.0,34.0,44.0,43.0,550.0
Chikkaballapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,167.0,129.0,139.0,167.0,171.0,192.0,174.0,195.0,189.0,202.0,181.0,142.0,2048.0
Chikkaballapur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,208.0,177.0,198.0,225.0,220.0,249.0,224.0,240.0,228.0,238.0,225.0,187.0,2619.0
Chikmagalur,1.1,Total number of pregnant women Registered for ANC,TOTAL,1299.0,1152.0,1363.0,1267.0,1371.0,1395.0,1172.0,1397.0,1257.0,1244.0,1224.0,1134.0,15275.0
Chikmagalur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1030.0,897.0,1073.0,1035.0,1119.0,1128.0,1012.0,1097.0,993.0,1013.0,967.0,846.0,12210.0
Chikmagalur,1.2,Number of Pregnant women registered under JSY,TOTAL,1070.0,942.0,1015.0,1045.0,1111.0,1118.0,917.0,1098.0,1009.0,1010.0,992.0,951.0,12278.0
Chikmagalur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1357.0,1226.0,1320.0,1232.0,1297.0,1241.0,1229.0,1309.0,1319.0,1254.0,1347.0,1265.0,15396.0
Chikmagalur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1156.0,1071.0,1241.0,1209.0,1298.0,1270.0,1128.0,1309.0,1172.0,1153.0,1137.0,1051.0,14195.0
Chikmagalur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1196.0,1178.0,1204.0,1315.0,1253.0,1319.0,1250.0,1294.0,1336.0,1279.0,1233.0,1207.0,15064.0
Chikmagalur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,820.0,685.0,751.0,641.0,546.0,462.0,441.0,422.0,526.0,468.0,589.0,519.0,6870.0
Chikmagalur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,42.0,38.0,25.0,24.0,19.0,9.0,13.0,16.0,14.0,17.0,16.0,17.0,250.0
Chikmagalur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,1.0,1.0,1.0,1.0,0.0,1.0,1.0,4.0,4.0,1.0,1.0,19.0
Chikmagalur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1238.0,1116.0,1221.0,1257.0,1354.0,1533.0,1180.0,1514.0,1453.0,1139.0,1381.0,1319.0,15705.0
Chikmagalur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,20.0,16.0,4.0,13.0,24.0,29.0,30.0,23.0,16.0,8.0,19.0,36.0,238.0
Chikmagalur,1.8,Number of pregnancy test kits used at SC level,TOTAL,409.0,447.0,433.0,404.0,465.0,552.0,441.0,529.0,530.0,610.0,519.0,359.0,5698.0
Chikmagalur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,2.0,1.0,1.0,5.0,1.0,1.0,1.0,1.0,0.0,0.0,0.0,14.0
Chikmagalur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,1.0,5.0,3.0,5.0,3.0,1.0,6.0,3.0,3.0,4.0,1.0,35.0
Chikmagalur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,3.0,6.0,4.0,10.0,4.0,2.0,7.0,4.0,3.0,4.0,1.0,49.0
Chikmagalur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,3.0,6.0,4.0,8.0,3.0,2.0,6.0,4.0,3.0,4.0,1.0,45.0
Chikmagalur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,2.0,2.0,0.0,3.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,10.0
Chikmagalur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,864.0,848.0,773.0,717.0,718.0,691.0,696.0,774.0,694.0,656.0,713.0,755.0,8899.0
Chikmagalur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,404.0,484.0,434.0,372.0,424.0,294.0,373.0,423.0,439.0,433.0,434.0,172.0,4686.0
Chikmagalur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,344.0,334.0,233.0,301.0,281.0,281.0,291.0,309.0,244.0,215.0,185.0,295.0,3313.0
Chikmagalur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,15.0,11.0,4.0,0.0,1.0,0.0,0.0,0.0,2.0,0.0,0.0,10.0,43.0
Chikmagalur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,412.0,366.0,382.0,378.0,380.0,404.0,450.0,394.0,396.0,427.0,498.0,437.0,4924.0
Chikmagalur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,15.0,13.0,12.0,15.0,11.0,12.0,12.0,10.0,13.0,23.0,20.0,156.0
Chikmagalur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,111.0,104.0,113.0,92.0,94.0,125.0,101.0,89.0,42.0,2.0,20.0,35.0,928.0
Chikmagalur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,220.0,221.0,190.0,144.0,148.0,157.0,175.0,184.0,156.0,156.0,143.0,189.0,2083.0
Chikmagalur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,331.0,325.0,303.0,236.0,242.0,282.0,276.0,273.0,198.0,158.0,163.0,224.0,3011.0
Chikmagalur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,247.0,267.0,268.0,275.0,283.0,301.0,321.0,305.0,293.0,306.0,346.0,304.0,3516.0
Chikmagalur,4.1.1.a,Number of male live births,TOTAL,639.0,599.0,594.0,551.0,566.0,574.0,578.0,589.0,568.0,582.0,667.0,623.0,7130.0
Chikmagalur,4.1.1.b,Number of female live births,TOTAL,620.0,619.0,567.0,545.0,533.0,526.0,580.0,584.0,523.0,504.0,554.0,579.0,6734.0
Chikmagalur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1259.0,1218.0,1161.0,1096.0,1099.0,1100.0,1158.0,1173.0,1091.0,1086.0,1221.0,1202.0,13864.0
Chikmagalur,4.1.2,Number of still births,TOTAL,12.0,7.0,8.0,7.0,14.0,8.0,5.0,8.0,12.0,9.0,15.0,3.0,108.0
Chikmagalur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,97.0,106.0,124.0,119.0,135.0,56.0,57.0,64.0,41.0,44.0,86.0,55.0,984.0
Chikmagalur,4.2.1,Number of Newborns weighed at birth,TOTAL,1271.0,1218.0,1155.0,1087.0,1096.0,1090.0,1144.0,1174.0,1089.0,1059.0,1223.0,1180.0,13786.0
Chikmagalur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,114.0,116.0,88.0,97.0,105.0,93.0,87.0,94.0,82.0,104.0,143.0,107.0,1230.0
Chikmagalur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1260.0,1217.0,1152.0,1092.0,1100.0,1096.0,1142.0,1159.0,1085.0,1069.0,987.0,1184.0,13543.0
Chikmagalur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,3.0
Chikmagalur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,8.0,4.0,13.0,9.0,10.0,11.0,6.0,5.0,0.0,2.0,1.0,0.0,69.0
Chikmagalur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,60.0,71.0,47.0,67.0,54.0,57.0,57.0,51.0,47.0,42.0,23.0,17.0,593.0
Chikmagalur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,68.0,75.0,61.0,76.0,64.0,68.0,63.0,56.0,48.0,44.0,24.0,18.0,665.0
Chikmagalur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,6.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,4.0,16.0,1.0,0.0,29.0
Chikmagalur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,93.0,229.0,220.0,82.0,73.0,91.0,150.0,67.0,137.0,80.0,59.0,32.0,1313.0
Chikmagalur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,1.0,43.0,47.0,5.0,60.0,8.0,5.0,45.0,41.0,1.0,0.0,258.0
Chikmagalur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,76.0,341.0,247.0,150.0,267.0,161.0,168.0,124.0,135.0,99.0,57.0,30.0,1855.0
Chikmagalur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,11.0,11.0,27.0,3.0,4.0,0.0,0.0,12.0,17.0,23.0,7.0,0.0,115.0
Chikmagalur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,576.0,564.0,535.0,432.0,460.0,393.0,557.0,488.0,463.0,503.0,483.0,526.0,5980.0
Chikmagalur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1221.0,1179.0,1066.0,988.0,1168.0,1209.0,1282.0,1270.0,934.0,952.0,978.0,1047.0,13294.0
Chikmagalur,6.3,PNC maternal complications attended,TOTAL,67.0,4.0,2.0,2.0,3.0,3.0,4.0,6.0,1.0,0.0,6.0,4.0,102.0
Chikmagalur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,12.0,4.0,6.0,4.0,9.0,4.0,7.0,6.0,3.0,4.0,7.0,74.0
Chikmagalur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,2.0,3.0,0.0,0.0,2.0,1.0,1.0,0.0,3.0,0.0,0.0,14.0
Chikmagalur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,10.0,14.0,7.0,6.0,4.0,11.0,5.0,8.0,6.0,6.0,4.0,7.0,88.0
Chikmagalur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,74.0,74.0,78.0,89.0,110.0,76.0,62.0,43.0,53.0,64.0,51.0,50.0,824.0
Chikmagalur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,225.0,280.0,264.0,193.0,176.0,182.0,147.0,150.0,159.0,132.0,166.0,200.0,2274.0
Chikmagalur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,579.0,621.0,675.0,562.0,501.0,623.0,465.0,589.0,600.0,509.0,504.0,536.0,6764.0
Chikmagalur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,804.0,901.0,939.0,755.0,677.0,805.0,612.0,739.0,759.0,641.0,670.0,736.0,9038.0
Chikmagalur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,4.0,4.0,2.0,4.0,0.0,3.0,0.0,8.0,0.0,0.0,0.0,0.0,25.0
Chikmagalur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Chikmagalur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Chikmagalur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,12.0,7.0,0.0,0.0,0.0,0.0,14.0,0.0,0.0,0.0,0.0,33.0
Chikmagalur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,95.0,88.0,138.0,67.0,41.0,72.0,39.0,50.0,66.0,15.0,47.0,74.0,792.0
Chikmagalur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,156.0,166.0,87.0,112.0,137.0,147.0,72.0,97.0,143.0,97.0,118.0,115.0,1447.0
Chikmagalur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,251.0,266.0,232.0,179.0,178.0,219.0,111.0,161.0,209.0,112.0,165.0,189.0,2272.0
Chikmagalur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,5.0,7.0,2.0,2.0,1.0,2.0,0.0,0.0,0.0,0.0,1.0,2.0,22.0
Chikmagalur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,47.0,33.0,46.0,27.0,40.0,33.0,29.0,41.0,15.0,3.0,2.0,3.0,319.0
Chikmagalur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,47.0,33.0,46.0,27.0,40.0,33.0,29.0,41.0,15.0,3.0,2.0,3.0,319.0
Chikmagalur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,16.0,13.0,1.0,15.0,11.0,11.0,15.0,24.0,10.0,1.0,6.0,35.0,158.0
Chikmagalur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Chikmagalur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,43.0,43.0,37.0,35.0,37.0,40.0,37.0,35.0,16.0,0.0,6.0,8.0,337.0
Chikmagalur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,39.0,35.0,34.0,32.0,32.0,37.0,43.0,40.0,80.0,71.0,55.0,54.0,552.0
Chikmagalur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,82.0,78.0,71.0,67.0,69.0,77.0,80.0,75.0,96.0,71.0,61.0,63.0,890.0
Chikmagalur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,30.0,33.0,37.0,47.0,34.0,47.0,59.0,44.0,46.0,61.0,83.0,29.0,550.0
Chikmagalur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,70.0,91.0,92.0,84.0,104.0,74.0,79.0,104.0,56.0,74.0,71.0,63.0,962.0
Chikmagalur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,48.0,56.0,60.0,70.0,55.0,47.0,53.0,49.0,54.0,54.0,48.0,31.0,625.0
Chikmagalur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,13.0,14.0,13.0,16.0,25.0,12.0,12.0,14.0,11.0,17.0,15.0,20.0,182.0
Chikmagalur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,51.0,66.0,59.0,50.0,61.0,45.0,51.0,52.0,44.0,41.0,38.0,49.0,607.0
Chikmagalur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chikmagalur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,182.0,227.0,224.0,220.0,245.0,178.0,195.0,219.0,165.0,186.0,172.0,163.0,2376.0
Chikmagalur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,17.0,31.0,10.0,9.0,9.0,16.0,7.0,22.0,17.0,12.0,21.0,13.0,184.0
Chikmagalur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,78.0,63.0,42.0,76.0,59.0,58.0,50.0,68.0,71.0,38.0,54.0,50.0,707.0
Chikmagalur,9.06,Number of IUCD removals,TOTAL,100.0,97.0,106.0,75.0,87.0,77.0,76.0,95.0,93.0,85.0,83.0,71.0,1045.0
Chikmagalur,9.07,Number of Oral Pills cycles distributed,TOTAL,2424.0,2426.0,2456.0,2616.0,2428.0,2556.0,2445.0,2543.0,2541.0,2765.0,2650.0,2462.0,30312.0
Chikmagalur,9.08,Number of Condom pieces distributed,TOTAL,40828.0,40458.0,36670.0,35906.0,38029.0,40845.0,37378.0,39510.0,39636.0,36628.0,41048.0,41639.0,468575.0
Chikmagalur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,38.0,0.0,20.0,56.0,5.0,216.0,134.0,0.0,0.0,0.0,469.0
Chikmagalur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,1.0,0.0,1.0,4.0,7.0,2.0,4.0,2.0,17.0,14.0,11.0,63.0
Chikmagalur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Chikmagalur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Chikmagalur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,9.12,Number of Institutions having NSV trained doctors,TOTAL,13.0,11.0,14.0,9.0,14.0,14.0,16.0,11.0,10.0,11.0,7.0,16.0,-1.0
Chikmagalur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1224.0,1176.0,1102.0,1171.0,1127.0,1110.0,1151.0,1140.0,1056.0,1110.0,1234.0,1168.0,13769.0
Chikmagalur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,6.0,51.0,78.0,50.0,52.0,16.0,35.0,41.0,28.0,34.0,24.0,1.0,416.0
Chikmagalur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4.0,6.0,5.0,4.0,7.0,1.0,4.0,6.0,6.0,0.0,25.0,0.0,68.0
Chikmagalur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,11.0,3.0,11.0,7.0,8.0,2.0,8.0,10.0,6.0,0.0,18.0,10.0,94.0
Chikmagalur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1324.0,1376.0,1359.0,1302.0,1164.0,1331.0,1170.0,1307.0,1312.0,1328.0,1305.0,1278.0,15556.0
Chikmagalur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1201.0,1262.0,1363.0,1432.0,1230.0,1255.0,1246.0,1304.0,1335.0,1283.0,1277.0,1356.0,15544.0
Chikmagalur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1341.0,1225.0,1378.0,1441.0,1387.0,1370.0,1252.0,1336.0,1293.0,1342.0,1238.0,1282.0,15885.0
Chikmagalur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1214.0,1074.0,1108.0,915.0,1077.0,1041.0,1121.0,1079.0,1046.0,1032.0,1101.0,1133.0,12941.0
Chikmagalur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1321.0,1360.0,1363.0,1318.0,1148.0,1325.0,1168.0,1300.0,1309.0,1333.0,1304.0,1272.0,15521.0
Chikmagalur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1198.0,1248.0,1361.0,1415.0,1227.0,1246.0,1243.0,1308.0,1328.0,1288.0,1283.0,1356.0,15501.0
Chikmagalur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1343.0,1207.0,1358.0,1443.0,1391.0,1380.0,1268.0,1321.0,1289.0,1332.0,1235.0,1291.0,15858.0
Chikmagalur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,861.0,774.0,742.0,931.0,738.0,744.0,828.0,992.0,745.0,719.0,1059.0,1052.0,10185.0
Chikmagalur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,9.0,14.0,27.0,10.0,8.0,3.0,4.0,0.0,7.0,1.0,0.0,0.0,83.0
Chikmagalur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,7.0,9.0,25.0,10.0,1.0,0.0,1.0,3.0,5.0,1.0,9.0,0.0,71.0
Chikmagalur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,14.0,18.0,33.0,9.0,4.0,1.0,4.0,6.0,5.0,2.0,0.0,9.0,105.0
Chikmagalur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1246.0,1207.0,1311.0,1332.0,1209.0,1383.0,1185.0,1273.0,1366.0,1332.0,1282.0,1253.0,15379.0
Chikmagalur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,863.0,997.0,1047.0,1036.0,915.0,1144.0,1060.0,1179.0,1004.0,1046.0,1071.0,992.0,12354.0
Chikmagalur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,3.0,3.0,6.0,16.0,0.0,0.0,3.0,31.0
Chikmagalur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,556.0,529.0,654.0,619.0,554.0,588.0,750.0,574.0,629.0,577.0,1016.0,656.0,7702.0
Chikmagalur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,452.0,479.0,542.0,543.0,460.0,543.0,622.0,529.0,530.0,579.0,972.0,567.0,6818.0
Chikmagalur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1008.0,1008.0,1196.0,1162.0,1014.0,1131.0,1372.0,1103.0,1159.0,1156.0,1988.0,1223.0,14520.0
Chikmagalur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1157.0,1145.0,1308.0,1297.0,1149.0,1335.0,1199.0,1296.0,1163.0,1172.0,1166.0,1074.0,14461.0
Chikmagalur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1156.0,1143.0,1306.0,1295.0,1147.0,1332.0,1200.0,1288.0,1157.0,1170.0,1161.0,1072.0,14427.0
Chikmagalur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,97.0,99.0,117.0,130.0,113.0,121.0,100.0,176.0,103.0,54.0,55.0,66.0,1231.0
Chikmagalur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,270.0,253.0,295.0,250.0,253.0,222.0,271.0,290.0,245.0,233.0,393.0,194.0,3169.0
Chikmagalur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,244.0,211.0,247.0,228.0,210.0,239.0,250.0,257.0,209.0,228.0,395.0,161.0,2879.0
Chikmagalur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,514.0,464.0,542.0,478.0,463.0,461.0,521.0,547.0,454.0,461.0,788.0,355.0,6048.0
Chikmagalur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,9.0,7.0,26.0,2147.0,1999.0,4496.0,215.0,1984.0,644.0,214.0,62.0,85.0,11888.0
Chikmagalur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,2.0,6.0,23.0,2224.0,2670.0,4217.0,222.0,2011.0,680.0,156.0,52.0,100.0,12363.0
Chikmagalur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,5.0,33.0,16.0,2374.0,2513.0,4774.0,242.0,2655.0,1203.0,174.0,49.0,106.0,14144.0
Chikmagalur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,2.0,0.0,2.0,0.0,0.0,0.0,3.0,0.0,0.0,1.0,11.0
Chikmagalur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Chikmagalur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,10.0,0.0,1.0,0.0,0.0,0.0,0.0,8.0,21.0
Chikmagalur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,618.0,602.0,611.0,610.0,616.0,602.0,591.0,617.0,608.0,587.0,581.0,603.0,7246.0
Chikmagalur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,574.0,575.0,591.0,581.0,695.0,585.0,567.0,592.0,582.0,563.0,557.0,580.0,7042.0
Chikmagalur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,462.0,460.0,469.0,473.0,566.0,489.0,446.0,498.0,483.0,466.0,452.0,473.0,5737.0
Chikmagalur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chikmagalur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1126.0,1206.0,1175.0,1228.0,1156.0,1236.0,1171.0,1227.0,1279.0,1280.0,1275.0,1346.0,14705.0
Chikmagalur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,4.0,5.0,4.0,180.0,9418.0,12.0,10.0,8.0,13.0,6.0,9610.0,771.0,20041.0
Chikmagalur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,1.0,0.0,171.0,8384.0,3.0,0.0,0.0,4.0,0.0,10017.0,845.0,19425.0
Chikmagalur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,1.0,0.0,16.0,0.0,2.0,2.0,5.0,21.0,5.0,4.0,4.0,67.0
Chikmagalur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,440.0,491.0,478.0,467.0,580.0,517.0,515.0,515.0,439.0,542.0,496.0,546.0,6026.0
Chikmagalur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,6.0,9.0,0.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,19.0
Chikmagalur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,259.0,191.0,230.0,228.0,360.0,266.0,239.0,215.0,161.0,249.0,218.0,154.0,2770.0
Chikmagalur,13.1,Number of Patients operated for cataract,TOTAL,81.0,101.0,97.0,86.0,66.0,37.0,56.0,97.0,60.0,62.0,89.0,82.0,914.0
Chikmagalur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,81.0,100.0,97.0,83.0,66.0,39.0,56.0,96.0,58.0,63.0,89.0,84.0,912.0
Chikmagalur,13.3,Number of School children detected with Refractive errors,TOTAL,5.0,13.0,14.0,33.0,76.0,42.0,11.0,33.0,67.0,47.0,43.0,66.0,450.0
Chikmagalur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,3.0,2.0,5.0,0.0,5.0,85.0,48.0,71.0,81.0,300.0
Chikmagalur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,12.0,11.0,11.0,11.0,9.0,11.0,11.0,10.0,10.0,11.0,11.0,11.0,-1.0
Chikmagalur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,22.0,16.0,19.0,19.0,15.0,16.0,19.0,13.0,13.0,15.0,12.0,13.0,-1.0
Chikmagalur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,613.0,553.0,638.0,711.0,680.0,718.0,619.0,662.0,710.0,657.0,645.0,812.0,-1.0
Chikmagalur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,7.0,7.0,8.0,7.0,7.0,7.0,8.0,8.0,7.0,6.0,-1.0
Chikmagalur,14.05,Number of RKS meetings held during the month,TOTAL,19.0,23.0,27.0,28.0,34.0,29.0,23.0,23.0,20.0,24.0,22.0,28.0,300.0
Chikmagalur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,18.0,18.0,20.0,20.0,20.0,20.0,24.0,22.0,22.0,23.0,20.0,21.0,-1.0
Chikmagalur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,171.0,216.0,193.0,169.0,197.0,162.0,186.0,184.0,281.0,213.0,244.0,243.0,2459.0
Chikmagalur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,11.0,11.0,10.0,9.0,7.0,9.0,9.0,9.0,11.0,10.0,9.0,9.0,-1.0
Chikmagalur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,2.0,3.0,1.0,0.0,2.0,3.0,2.0,2.0,0.0,14.0,6.0,-1.0
Chikmagalur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,470.0,396.0,345.0,413.0,614.0,812.0,296.0,420.0,418.0,277.0,428.0,317.0,5206.0
Chikmagalur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3188.0,2905.0,3097.0,2130.0,2109.0,2261.0,2017.0,2188.0,1952.0,1778.0,1621.0,2375.0,27621.0
Chikmagalur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,310.0,345.0,315.0,325.0,409.0,670.0,230.0,333.0,300.0,261.0,401.0,207.0,4106.0
Chikmagalur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3774.0,3336.0,3777.0,2467.0,2264.0,2359.0,2026.0,2399.0,2119.0,1821.0,1723.0,2527.0,30592.0
Chikmagalur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,780.0,741.0,660.0,738.0,1023.0,1482.0,526.0,753.0,718.0,538.0,829.0,524.0,9312.0
Chikmagalur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6962.0,6241.0,6874.0,4597.0,4373.0,4620.0,4043.0,4587.0,4071.0,3599.0,3344.0,4902.0,58213.0
Chikmagalur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,33.0,34.0,75.0,17.0,28.0,26.0,24.0,29.0,32.0,34.0,36.0,34.0,402.0
Chikmagalur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,27.0,27.0,15.0,13.0,25.0,18.0,11.0,16.0,16.0,23.0,11.0,15.0,217.0
Chikmagalur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,60.0,61.0,90.0,30.0,53.0,44.0,35.0,45.0,48.0,57.0,47.0,49.0,619.0
Chikmagalur,14.11,In-Patient Head Count at midnight,TOTAL,8337.0,8789.0,13404.0,8564.0,7477.0,6984.0,6936.0,6028.0,6720.0,5180.0,7281.0,7047.0,92747.0
Chikmagalur,14.12.1,OPD attendance (All),TOTAL,116570.0,114819.0,131133.0,121119.0,130292.0,138740.0,115167.0,127836.0,123122.0,116440.0,131400.0,130533.0,1497171.0
Chikmagalur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,389.0,339.0,353.0,245.0,191.0,290.0,251.0,286.0,180.0,180.0,166.0,207.0,3077.0
Chikmagalur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,91.0,35.0,136.0,67.0,57.0,71.0,56.0,79.0,21.0,26.0,71.0,50.0,760.0
Chikmagalur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,274.0,254.0,204.0,133.0,103.0,146.0,117.0,219.0,166.0,158.0,173.0,214.0,2161.0
Chikmagalur,14.14.a,Number of patients given AYUSH treatment,TOTAL,1437.0,1487.0,1481.0,1192.0,1061.0,1526.0,1478.0,1664.0,1490.0,931.0,1819.0,2024.0,17590.0
Chikmagalur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1729.0,2093.0,2070.0,2073.0,2474.0,2172.0,1978.0,2116.0,1860.0,2535.0,2525.0,2384.0,26009.0
Chikmagalur,14.14.c,Number of Adolescents counselled,TOTAL,278.0,257.0,328.0,222.0,235.0,218.0,212.0,182.0,170.0,231.0,152.0,205.0,2690.0
Chikmagalur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4189.0,4055.0,4243.0,4524.0,3927.0,4820.0,3289.0,4471.0,4082.0,3317.0,4150.0,4050.0,49117.0
Chikmagalur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,104.0,104.0,103.0,115.0,85.0,284.0,138.0,114.0,132.0,82.0,120.0,116.0,1497.0
Chikmagalur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1189.0,1093.0,1246.0,1228.0,957.0,1320.0,915.0,1119.0,1190.0,1091.0,1318.0,1160.0,13826.0
Chikmagalur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,16.0,12.0,25.0,22.0,6.0,23.0,13.0,17.0,24.0,13.0,19.0,14.0,204.0
Chikmagalur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1257.0,1198.0,1347.0,1220.0,862.0,1195.0,875.0,1085.0,1076.0,1196.0,1490.0,1598.0,14399.0
Chikmagalur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,13.0,17.0,13.0,21.0,6.0,31.0,10.0,14.0,11.0,14.0,17.0,16.0,183.0
Chikmagalur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1077.0,824.0,1358.0,1267.0,1113.0,1393.0,1003.0,1257.0,1222.0,888.0,983.0,1130.0,13515.0
Chikmagalur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,3.0,2.0,14.0,3.0,28.0,2.0,2.0,13.0,1.0,6.0,2.0,78.0
Chikmagalur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3523.0,3115.0,3951.0,3715.0,2932.0,3908.0,2793.0,3461.0,3488.0,3175.0,3791.0,3888.0,41740.0
Chikmagalur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,31.0,32.0,40.0,57.0,15.0,82.0,25.0,33.0,48.0,28.0,42.0,32.0,465.0
Chikmagalur,15.2,Number of Widal tests conducted,Number tested,729.0,751.0,983.0,1191.0,1126.0,1520.0,745.0,913.0,754.0,729.0,1062.0,963.0,11466.0
Chikmagalur,15.3.a,Number of VDRL tests conducted on males,Number tested,33.0,85.0,80.0,41.0,31.0,75.0,43.0,38.0,51.0,98.0,187.0,70.0,832.0
Chikmagalur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,103.0,148.0,138.0,90.0,61.0,150.0,97.0,58.0,82.0,73.0,38.0,101.0,1139.0
Chikmagalur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,713.0,595.0,793.0,797.0,880.0,1145.0,834.0,711.0,995.0,826.0,918.0,939.0,10146.0
Chikmagalur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,849.0,828.0,1011.0,928.0,972.0,1370.0,974.0,807.0,1128.0,997.0,1143.0,1110.0,12117.0
Chikmagalur,15.4.1,Number of blood smears examined for Malaria,TOTAL,16121.0,17519.0,20588.0,20071.0,21133.0,22246.0,16428.0,20048.0,16532.0,14920.0,16375.0,19783.0,221764.0
Chikmagalur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,25.0,15.0,109.0,7.0,15.0,9.0,14.0,21.0,281.0,5.0,5.0,511.0
Chikmagalur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,1.0,0.0,0.0,0.0,3.0,1.0,2.0,4.0,1.0,1.0,1.0,14.0
Chikmagalur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,610.0,6000.0,910.0,2870.0,120.0,4650.0,7420.0,6220.0,9500.0,8440.0,7440.0,6710.0,60890.0
Chikmagalur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,60000.0,,4500.0,7500.0,10000.0,10000.0,0.0,5000.0,,,,,97000.0
Chikmagalur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,610.0,5090.0,2540.0,10250.0,5470.0,7230.0,1200.0,1720.0,1060.0,1000.0,730.0,2020.0,38920.0
Chikmagalur,16.1.1,Stock position of DPT vaccines,5. Total Stock,60000.0,910.0,2870.0,120.0,4650.0,7420.0,6220.0,9500.0,8440.0,7440.0,6710.0,4690.0,118970.0
Chikmagalur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,7350.0,6300.0,1430.0,12630.0,8160.0,8930.0,6400.0,9200.0,13500.0,9850.0,6380.0,7070.0,97200.0
Chikmagalur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2080.0,,15000.0,2000.0,3000.0,5000.0,3000.0,6000.0,,,3000.0,3000.0,42080.0
Chikmagalur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3130.0,4870.0,3800.0,6470.0,2230.0,7530.0,200.0,1700.0,3650.0,3470.0,2310.0,4220.0,43580.0
Chikmagalur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,6300.0,1430.0,12630.0,8160.0,8930.0,6400.0,9200.0,13500.0,9850.0,6380.0,7070.0,5850.0,95700.0
Chikmagalur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6060.0,21620.0,11100.0,10760.0,12320.0,3460.0,6530.0,12530.0,16470.0,4870.0,2500.0,17680.0,125900.0
Chikmagalur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,23800.0,,6200.0,14000.0,,18000.0,10000.0,12000.0,,9000.0,27000.0,,120000.0
Chikmagalur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8240.0,10520.0,6540.0,12440.0,8860.0,14930.0,4000.0,8060.0,11600.0,11370.0,11820.0,4940.0,113320.0
Chikmagalur,16.1.2,Stock position of OPV vaccines,5. Total Stock,21620.0,11100.0,10760.0,12320.0,3460.0,6530.0,12530.0,16470.0,4870.0,2500.0,17680.0,12740.0,132580.0
Chikmagalur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4010.0,15910.0,11200.0,7210.0,4780.0,10080.0,6410.0,11890.0,12850.0,9410.0,9780.0,8830.0,112360.0
Chikmagalur,16.1.3,Stock position of TT vaccines,2. Stocks Received,16500.0,,,12500.0,17500.0,10000.0,6000.0,6000.0,,5000.0,2000.0,8000.0,83500.0
Chikmagalur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4600.0,4710.0,3990.0,14930.0,12200.0,13670.0,520.0,5040.0,3440.0,4630.0,2950.0,1900.0,72580.0
Chikmagalur,16.1.3,Stock position of TT vaccines,5. Total Stock,15910.0,11200.0,7210.0,4780.0,10080.0,6410.0,11890.0,12850.0,9410.0,9780.0,8830.0,14930.0,123280.0
Chikmagalur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1100.0,8680.0,6090.0,8880.0,7350.0,6950.0,4350.0,6820.0,8400.0,5450.0,4560.0,3730.0,72360.0
Chikmagalur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,12000.0,,4000.0,2000.0,2000.0,2000.0,3000.0,3000.0,,2000.0,2000.0,10000.0,42000.0
Chikmagalur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4420.0,2590.0,1210.0,3530.0,2400.0,4600.0,530.0,1420.0,2950.0,2890.0,2830.0,2140.0,31510.0
Chikmagalur,16.1.5,Stock position of BCG vaccines,5. Total Stock,8680.0,6090.0,8880.0,7350.0,6950.0,4350.0,6820.0,8400.0,5450.0,4560.0,3730.0,11590.0,82850.0
Chikmagalur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,4570.0,7325.0,2795.0,685.0,5985.0,6220.0,4410.0,5710.0,8505.0,5500.0,4970.0,4695.0,61370.0
Chikmagalur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,,,8000.0,3000.0,4000.0,3000.0,5000.0,,3000.0,2000.0,5000.0,38000.0
Chikmagalur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2245.0,4530.0,2110.0,2700.0,2765.0,5810.0,1700.0,2205.0,3005.0,3530.0,2275.0,2905.0,35780.0
Chikmagalur,16.1.6,Stock position of Measles vaccines,5. Total Stock,7325.0,2795.0,685.0,5985.0,6220.0,4410.0,5710.0,8505.0,5500.0,4970.0,4695.0,6790.0,63590.0
Chikmagalur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,7460.0,5590.0,4440.0,3140.0,1920.0,2640.0,1750.0,2150.0,4460.0,3540.0,3080.0,1820.0,41990.0
Chikmagalur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,900.0,900.0,,600.0,3000.0,,,,2500.0,7900.0
Chikmagalur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1870.0,1150.0,1300.0,2120.0,180.0,890.0,200.0,690.0,920.0,460.0,1260.0,830.0,11870.0
Chikmagalur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5590.0,4440.0,3140.0,1920.0,2640.0,1750.0,2150.0,4460.0,3540.0,3080.0,1820.0,3490.0,38020.0
Chikmagalur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3000.0,,2350.0,6527.0,6477.0,6427.0,5437.0,5387.0,5337.0,5337.0,5237.0,4417.0,55933.0
Chikmagalur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,2350.0,4177.0,0.0,,,,,,,,,6527.0
Chikmagalur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,3000.0,,,6527.0,50.0,990.0,50.0,50.0,,100.0,820.0,,11587.0
Chikmagalur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,2350.0,6527.0,0.0,6427.0,5437.0,5387.0,5337.0,5337.0,5237.0,4417.0,4417.0,50873.0
Chikmagalur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,82680.0,56480.0,131040.0,110880.0,75600.0,40320.0,497000.0
Chikmagalur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,82680.0,,151200.0,,,,,233880.0
Chikmagalur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,26200.0,76640.0,20160.0,35280.0,35280.0,15960.0,209520.0
Chikmagalur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,82680.0,56480.0,131040.0,110880.0,75600.0,40320.0,24360.0,521360.0
Chikmagalur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,11100.0,7800.0,5900.0,4700.0,900.0,,30400.0
Chikmagalur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,11100.0,,,,,,,11100.0
Chikmagalur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,3300.0,1900.0,1200.0,3800.0,900.0,,11100.0
Chikmagalur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,11100.0,7800.0,5900.0,4700.0,900.0,0.0,0.0,30400.0
Chikmagalur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,3000.0,,,,,10000.0,10000.0,7700.0,5500.0,36200.0
Chikmagalur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,3000.0,,,,,10000.0,,,,,13000.0
Chikmagalur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,3000.0,,,,,,2300.0,2200.0,50.0,7550.0
Chikmagalur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,10000.0,10000.0,7700.0,5500.0,5450.0,41650.0
Chikmagalur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4350.0,4350.0,3850.0,7155.0,6655.0,6655.0,6655.0,6155.0,6155.0,6155.0,6155.0,5655.0,69945.0
Chikmagalur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,3305.0,3305.0,,,,,,,,,6610.0
Chikmagalur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,500.0,,3805.0,,,500.0,,,,500.0,,5305.0
Chikmagalur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4350.0,3850.0,7155.0,6655.0,6655.0,6655.0,6155.0,6155.0,6155.0,6155.0,5655.0,5655.0,71250.0
Chikmagalur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,207.0,,,,,,207.0
Chikmagalur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,207.0,,,,,,,207.0
Chikmagalur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,50.0,,,,,,50.0
Chikmagalur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,207.0,157.0,0.0,0.0,0.0,0.0,0.0,364.0
Chikmagalur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,97722.0,,,,,,97722.0
Chikmagalur,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,97722.0,,,,,,,97722.0
Chikmagalur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,21600.0,,,,,,21600.0
Chikmagalur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,97722.0,76122.0,0.0,0.0,0.0,0.0,0.0,173844.0
Chikmagalur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,27356.0,,,,27356.0
Chikmagalur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,34356.0,,,,,34356.0
Chikmagalur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,7000.0,27356.0,,,,34356.0
Chikmagalur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,27356.0,0.0,0.0,0.0,0.0,27356.0
Chikmagalur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Chikmagalur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Chikmagalur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Chikmagalur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chikmagalur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2447.0,2447.0,1782.0,1782.0,407.0,357.0,,157.0,157.0,,,,9536.0
Chikmagalur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,750.0,,750.0
Chikmagalur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,665.0,,1375.0,50.0,,,,157.0,,750.0,,2997.0
Chikmagalur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2447.0,1782.0,1782.0,407.0,357.0,357.0,0.0,157.0,0.0,0.0,0.0,0.0,7289.0
Chikmagalur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,65704.0,,76122.0,53522.0,,,,195348.0
Chikmagalur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,65704.0,,,,,,,,65704.0
Chikmagalur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,65704.0,,22600.0,53522.0,,,,141826.0
Chikmagalur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,65704.0,0.0,0.0,53522.0,0.0,0.0,0.0,0.0,119226.0
Chikmagalur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,15825.0,13825.0,11425.0,10225.0,7825.0,6625.0,4925.0,7625.0,10725.0,9925.0,9525.0,15125.0,123600.0
Chikmagalur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,,,,,3000.0,3300.0,,,6600.0,,12900.0
Chikmagalur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2000.0,2400.0,1200.0,2400.0,1200.0,1700.0,300.0,200.0,800.0,400.0,1000.0,900.0,14500.0
Chikmagalur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,13825.0,11425.0,10225.0,7825.0,6625.0,4925.0,7625.0,10725.0,9925.0,9525.0,15125.0,14225.0,122000.0
Chikmagalur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,24100.0,19100.0,5300.0,9100.0,11100.0,16700.0,1600.0,15400.0,15000.0,5700.0,12600.0,36700.0,172400.0
Chikmagalur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,7200.0,,7200.0,24000.0,24000.0,,20000.0,14000.0,,14400.0,36000.0,10800.0,157600.0
Chikmagalur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,12200.0,13800.0,3400.0,22000.0,18400.0,15100.0,6200.0,14400.0,9300.0,7500.0,11900.0,11000.0,145200.0
Chikmagalur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19100.0,5300.0,9100.0,11100.0,16700.0,1600.0,15400.0,15000.0,5700.0,12600.0,36700.0,36500.0,184800.0
Chikmagalur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4770.0,7070.0,6070.0,6570.0,4670.0,4270.0,,,2970.0,2770.0,4870.0,4870.0,48900.0
Chikmagalur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,,600.0,600.0,,,,3070.0,,2400.0,,,9070.0
Chikmagalur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chikmagalur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,100.0,1000.0,100.0,2500.0,400.0,4270.0,,100.0,200.0,300.0,,600.0,9570.0
Chikmagalur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7070.0,6070.0,6570.0,4670.0,4270.0,0.0,0.0,2970.0,2770.0,4870.0,4870.0,4270.0,48400.0
Chikmagalur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,1.0,,,,,,,,,,,1.0
Chikmagalur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,1.0,,,,,,,,1.0
Chikmagalur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Chikmagalur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,1.0,,1.0,,,,,,2.0
Chikmagalur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,,,,,1.0,,,1.0
Chikmagalur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Chikmagalur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,,,,,,,1.0,,,2.0
Chikmagalur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,,,,,,,,,,2.0,2.0
Chikmagalur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chikmagalur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,,,,,,,,,,,2.0,2.0
Chikmagalur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,2.0,,,1.0,,,,,,,4.0
Chikmagalur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Chikmagalur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,2.0,,,2.0,,,,,,,5.0
Chikmagalur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,1.0,1.0,,,1.0,3.0
Chikmagalur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,,1.0,,,,,2.0
Chikmagalur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,2.0,1.0,,,1.0,5.0
Chikmagalur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chikmagalur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chikmagalur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Chikmagalur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chikmagalur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chikmagalur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Chikmagalur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chikmagalur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chikmagalur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chikmagalur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,,1.0,1.0,,2.0,3.0,,2.0,1.0,11.0
Chikmagalur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,1.0,,,,,,,1.0,3.0
Chikmagalur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,1.0,2.0,1.0,,2.0,3.0,,2.0,2.0,14.0
Chikmagalur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Chikmagalur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,,,1.0
Chikmagalur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,,1.0,2.0,4.0,1.0,4.0,,,,2.0,2.0,2.0,18.0
Chikmagalur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,2.0,,,,,1.0,1.0,1.0,1.0,,7.0
Chikmagalur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,1.0,4.0,4.0,1.0,4.0,,1.0,1.0,3.0,3.0,2.0,25.0
Chikmagalur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Chikmagalur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,10.0,8.0,13.0,2.0,6.0,6.0,8.0,7.0,9.0,6.0,2.0,4.0,81.0
Chikmagalur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,20.0,17.0,35.0,17.0,21.0,38.0,23.0,28.0,20.0,24.0,29.0,17.0,289.0
Chikmagalur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,30.0,25.0,48.0,19.0,27.0,44.0,31.0,35.0,29.0,30.0,32.0,21.0,371.0
Chikmagalur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Chikmagalur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,1.0,,1.0
Chikmagalur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Chikmagalur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,1.0,,,,1.0,,,1.0,,4.0
Chikmagalur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,1.0,2.0,,,,1.0,,2.0,,7.0
Chikmagalur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,,2.0,2.0,,,1.0,1.0,,4.0,,12.0
Chikmagalur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,,1.0,1.0,3.0,1.0,,2.0,,2.0,1.0,2.0,16.0
Chikmagalur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,,,,,2.0,,,,,2.0,5.0
Chikmagalur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,1.0,1.0,1.0,3.0,1.0,2.0,2.0,,2.0,1.0,4.0,21.0
Chikmagalur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,,,,,,,1.0,,,1.0,,3.0
Chikmagalur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,20.0,26.0,30.0,30.0,25.0,31.0,31.0,32.0,31.0,26.0,30.0,26.0,338.0
Chikmagalur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,47.0,34.0,52.0,48.0,59.0,48.0,30.0,48.0,51.0,53.0,48.0,43.0,561.0
Chikmagalur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,68.0,60.0,82.0,78.0,84.0,79.0,61.0,81.0,82.0,79.0,79.0,69.0,902.0
Chikmagalur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Chikmagalur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,6.0,2.0,3.0,6.0,3.0,9.0,8.0,3.0,8.0,8.0,4.0,4.0,64.0
Chikmagalur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,23.0,10.0,15.0,21.0,32.0,28.0,25.0,18.0,29.0,23.0,28.0,25.0,277.0
Chikmagalur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,29.0,12.0,18.0,27.0,35.0,37.0,33.0,21.0,38.0,31.0,32.0,29.0,342.0
Chikmagalur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chikmagalur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Chikmagalur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,1.0,,,,,1.0,,,,,2.0
Chikmagalur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,1.0,,,,,1.0,,,,,2.0
Chikmagalur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Chikmagalur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Chikmagalur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chikmagalur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,,,1.0,,,1.0,,,1.0,,5.0
Chikmagalur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chikmagalur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,,,1.0,,,1.0,,,1.0,,5.0
Chikmagalur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,4.0,1.0,,,,,,,,,,6.0
Chikmagalur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,15.0,12.0,3.0,2.0,3.0,5.0,7.0,1.0,2.0,4.0,8.0,3.0,65.0
Chikmagalur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,5.0,4.0,1.0,2.0,,2.0,3.0,,3.0,5.0,4.0,2.0,31.0
Chikmagalur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,21.0,20.0,5.0,4.0,3.0,7.0,10.0,1.0,5.0,9.0,12.0,5.0,102.0
Chikmagalur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,1.0,,,1.0,,,3.0
Chikmagalur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,20.0,16.0,11.0,8.0,10.0,16.0,10.0,17.0,9.0,14.0,7.0,11.0,149.0
Chikmagalur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,1.0,6.0,3.0,,3.0,4.0,4.0,3.0,2.0,1.0,3.0,33.0
Chikmagalur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,23.0,17.0,17.0,11.0,10.0,20.0,15.0,21.0,12.0,17.0,8.0,14.0,185.0
Chikmagalur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Chikmagalur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,4.0,,1.0,,1.0,2.0,,,2.0,1.0,12.0
Chikmagalur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,,2.0,,,,,,,,3.0
Chikmagalur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,5.0,,3.0,,1.0,2.0,,1.0,2.0,1.0,16.0
Chikmagalur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Chikmagalur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,15.0,7.0,10.0,12.0,13.0,7.0,13.0,8.0,9.0,6.0,9.0,13.0,122.0
Chikmagalur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,15.0,5.0,18.0,13.0,17.0,16.0,11.0,11.0,13.0,17.0,22.0,15.0,173.0
Chikmagalur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,30.0,12.0,29.0,25.0,30.0,23.0,24.0,19.0,22.0,23.0,31.0,28.0,296.0
Chikmagalur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,,,,,,,1.0,1.0,,4.0
Chikmagalur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,12.0,8.0,13.0,14.0,16.0,6.0,7.0,12.0,17.0,10.0,4.0,128.0
Chikmagalur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,23.0,26.0,15.0,22.0,36.0,33.0,12.0,31.0,20.0,36.0,27.0,18.0,299.0
Chikmagalur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,32.0,39.0,24.0,35.0,50.0,49.0,18.0,38.0,32.0,54.0,38.0,22.0,431.0
Chikmagalur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,1.0,1.0,1.0,,,,,1.0,1.0,1.0,2.0,9.0
Chikmagalur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,27.0,30.0,37.0,33.0,25.0,29.0,21.0,22.0,24.0,31.0,27.0,21.0,327.0
Chikmagalur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,86.0,81.0,109.0,108.0,127.0,132.0,120.0,109.0,94.0,102.0,103.0,72.0,1243.0
Chikmagalur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,114.0,112.0,147.0,142.0,152.0,161.0,141.0,131.0,119.0,134.0,131.0,95.0,1579.0
Chitradurga,1.1,Total number of pregnant women Registered for ANC,TOTAL,2586.0,2293.0,2763.0,2501.0,2394.0,2436.0,2396.0,2629.0,2545.0,2431.0,2187.0,2352.0,29513.0
Chitradurga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2064.0,1799.0,2136.0,1941.0,1898.0,1977.0,1881.0,2054.0,2018.0,1936.0,1764.0,1832.0,23300.0
Chitradurga,1.2,Number of Pregnant women registered under JSY,TOTAL,2242.0,2033.0,2463.0,2293.0,2219.0,2267.0,2267.0,2445.0,2389.0,2254.0,2046.0,2188.0,27106.0
Chitradurga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3179.0,3112.0,3228.0,2748.0,3195.0,2523.0,2706.0,2793.0,2674.0,2356.0,2268.0,2380.0,33162.0
Chitradurga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2076.0,2156.0,2321.0,2128.0,2043.0,2097.0,2133.0,2377.0,2342.0,2054.0,2142.0,2069.0,25938.0
Chitradurga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2482.0,2571.0,2719.0,2505.0,2364.0,2558.0,2535.0,2818.0,3040.0,2612.0,2332.0,2553.0,31089.0
Chitradurga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2433.0,2674.0,2920.0,2297.0,2916.0,2354.0,2314.0,1602.0,2031.0,1359.0,1331.0,1862.0,26093.0
Chitradurga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,26.0,56.0,63.0,52.0,57.0,30.0,35.0,46.0,39.0,38.0,61.0,61.0,564.0
Chitradurga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,5.0,3.0,1.0,14.0,3.0,0.0,1.0,0.0,2.0,1.0,6.0,36.0
Chitradurga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3228.0,3275.0,3644.0,3647.0,3064.0,3482.0,2954.0,3404.0,3368.0,2904.0,3226.0,3497.0,39693.0
Chitradurga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,109.0,109.0,127.0,118.0,131.0,131.0,137.0,137.0,149.0,108.0,94.0,107.0,1457.0
Chitradurga,1.8,Number of pregnancy test kits used at SC level,TOTAL,959.0,751.0,737.0,769.0,727.0,791.0,691.0,843.0,744.0,757.0,819.0,812.0,9400.0
Chitradurga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,3.0,2.0,4.0,10.0,5.0,1.0,3.0,3.0,3.0,14.0,4.0,0.0,52.0
Chitradurga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,15.0,5.0,15.0,9.0,9.0,6.0,8.0,6.0,9.0,6.0,10.0,5.0,103.0
Chitradurga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,18.0,7.0,19.0,19.0,14.0,7.0,11.0,9.0,12.0,20.0,14.0,5.0,155.0
Chitradurga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,18.0,6.0,14.0,16.0,9.0,6.0,10.0,9.0,9.0,9.0,13.0,4.0,123.0
Chitradurga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,0.0,1.0,0.0,10.0,2.0,0.0,1.0,0.0,1.0,1.0,2.0,20.0
Chitradurga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1477.0,1326.0,1515.0,1438.0,1426.0,1478.0,1361.0,1420.0,1383.0,1334.0,1362.0,1232.0,16752.0
Chitradurga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,605.0,465.0,476.0,516.0,518.0,497.0,563.0,538.0,390.0,391.0,431.0,365.0,5755.0
Chitradurga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,541.0,562.0,665.0,827.0,690.0,1387.0,584.0,1655.0,1504.0,1229.0,1134.0,1477.0,12255.0
Chitradurga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,10.0,1.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,18.0
Chitradurga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chitradurga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,530.0,546.0,555.0,569.0,574.0,658.0,570.0,619.0,543.0,507.0,501.0,554.0,6726.0
Chitradurga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,3.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,12.0
Chitradurga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,319.0,323.0,326.0,332.0,314.0,397.0,330.0,357.0,366.0,356.0,324.0,356.0,4100.0
Chitradurga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,319.0,323.0,326.0,332.0,314.0,397.0,330.0,357.0,366.0,356.0,324.0,356.0,4100.0
Chitradurga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,333.0,325.0,334.0,275.0,278.0,401.0,286.0,325.0,335.0,325.0,330.0,331.0,3878.0
Chitradurga,4.1.1.a,Number of male live births,TOTAL,1053.0,966.0,1095.0,1023.0,1073.0,1084.0,1044.0,988.0,1016.0,969.0,966.0,924.0,12201.0
Chitradurga,4.1.1.b,Number of female live births,TOTAL,958.0,901.0,983.0,986.0,973.0,1037.0,960.0,1065.0,962.0,907.0,894.0,853.0,11479.0
Chitradurga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2011.0,1867.0,2078.0,2009.0,2046.0,2121.0,2004.0,2053.0,1978.0,1876.0,1860.0,1777.0,23680.0
Chitradurga,4.1.2,Number of still births,TOTAL,16.0,17.0,18.0,25.0,24.0,30.0,34.0,29.0,25.0,24.0,23.0,28.0,293.0
Chitradurga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,46.0,59.0,50.0,85.0,65.0,62.0,33.0,59.0,81.0,40.0,74.0,61.0,715.0
Chitradurga,4.2.1,Number of Newborns weighed at birth,TOTAL,1931.0,1867.0,2025.0,1956.0,2035.0,2117.0,1683.0,1996.0,1922.0,1866.0,1848.0,1772.0,23018.0
Chitradurga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,214.0,189.0,218.0,210.0,225.0,255.0,181.0,246.0,204.0,217.0,271.0,175.0,2605.0
Chitradurga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1953.0,1858.0,2051.0,1975.0,2008.0,2119.0,1988.0,2022.0,1934.0,1862.0,1491.0,1755.0,23016.0
Chitradurga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,8.0,0.0,5.0,7.0,0.0,0.0,1.0,3.0,13.0,1.0,1.0,39.0
Chitradurga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chitradurga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,48.0,51.0,58.0,56.0,52.0,53.0,38.0,41.0,54.0,32.0,16.0,23.0,522.0
Chitradurga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,49.0,59.0,58.0,61.0,59.0,53.0,38.0,42.0,57.0,45.0,17.0,24.0,562.0
Chitradurga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,165.0,181.0,170.0,169.0,186.0,206.0,175.0,220.0,159.0,0.0,0.0,0.0,1631.0
Chitradurga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,543.0,556.0,634.0,500.0,532.0,617.0,570.0,679.0,670.0,497.0,479.0,555.0,6832.0
Chitradurga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,58.0,67.0,161.0,175.0,168.0,234.0,165.0,140.0,182.0,32.0,20.0,40.0,1442.0
Chitradurga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,409.0,455.0,136.0,104.0,139.0,255.0,234.0,235.0,246.0,443.0,81.0,132.0,2869.0
Chitradurga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,30.0,33.0,39.0,36.0,39.0,37.0,15.0,41.0,39.0,33.0,46.0,28.0,416.0
Chitradurga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1581.0,1465.0,1680.0,1677.0,1634.0,1716.0,1649.0,1594.0,1464.0,1672.0,1418.0,1643.0,19193.0
Chitradurga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2063.0,1900.0,2087.0,2050.0,2043.0,2239.0,2190.0,2299.0,2237.0,1827.0,1854.0,1834.0,24623.0
Chitradurga,6.3,PNC maternal complications attended,TOTAL,12.0,13.0,5.0,4.0,27.0,20.0,16.0,39.0,24.0,14.0,33.0,13.0,220.0
Chitradurga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,5.0,3.0,4.0,1.0,3.0,3.0,7.0,2.0,2.0,8.0,4.0,51.0
Chitradurga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,1.0,2.0,1.0,1.0,0.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,8.0
Chitradurga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,10.0,7.0,4.0,5.0,1.0,4.0,3.0,8.0,3.0,2.0,8.0,4.0,59.0
Chitradurga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,17.0,23.0,27.0,26.0,29.0,27.0,27.0,34.0,59.0,21.0,27.0,31.0,348.0
Chitradurga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,318.0,379.0,277.0,231.0,274.0,369.0,303.0,232.0,335.0,148.0,196.0,155.0,3217.0
Chitradurga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,754.0,1002.0,771.0,672.0,643.0,735.0,704.0,665.0,692.0,530.0,561.0,511.0,8240.0
Chitradurga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1072.0,1381.0,1048.0,903.0,917.0,1104.0,1007.0,897.0,1027.0,678.0,757.0,666.0,11457.0
Chitradurga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,2.0,2.0,5.0,1.0,12.0,12.0,3.0,3.0,40.0
Chitradurga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,5.0
Chitradurga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,5.0
Chitradurga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,14.0,87.0,0.0,80.0,33.0,58.0,0.0,43.0,0.0,50.0,46.0,24.0,435.0
Chitradurga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,33.0,68.0,33.0,55.0,25.0,48.0,90.0,46.0,33.0,87.0,75.0,53.0,646.0
Chitradurga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,349.0,447.0,394.0,434.0,303.0,333.0,396.0,376.0,396.0,226.0,407.0,316.0,4377.0
Chitradurga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,396.0,602.0,427.0,569.0,361.0,439.0,486.0,465.0,429.0,363.0,528.0,393.0,5458.0
Chitradurga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,7.0,10.0,2.0,0.0,1.0,2.0,5.0,0.0,2.0,0.0,0.0,29.0
Chitradurga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,7.0,0.0,0.0,27.0,2.0,0.0,0.0,0.0,36.0
Chitradurga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,19.0,16.0,14.0,22.0,0.0,20.0,20.0,27.0,16.0,24.0,20.0,9.0,207.0
Chitradurga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,30.0,36.0,21.0,16.0,11.0,9.0,9.0,20.0,32.0,10.0,15.0,11.0,220.0
Chitradurga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,49.0,52.0,35.0,38.0,18.0,29.0,29.0,74.0,50.0,34.0,35.0,20.0,463.0
Chitradurga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,45.0,37.0,16.0,23.0,10.0,29.0,37.0,38.0,30.0,83.0,50.0,44.0,442.0
Chitradurga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0,0.0,0.0,0.0,4.0
Chitradurga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,1.0,0.0,0.0,5.0
Chitradurga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,39.0,54.0,23.0,78.0,88.0,81.0,59.0,64.0,57.0,55.0,51.0,49.0,698.0
Chitradurga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,39.0,54.0,23.0,78.0,89.0,82.0,61.0,64.0,61.0,56.0,51.0,49.0,707.0
Chitradurga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,41.0,42.0,78.0,63.0,42.0,63.0,48.0,83.0,58.0,22.0,28.0,38.0,606.0
Chitradurga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,214.0,223.0,216.0,283.0,264.0,245.0,231.0,257.0,241.0,240.0,230.0,226.0,2870.0
Chitradurga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,78.0,47.0,68.0,74.0,65.0,75.0,65.0,77.0,77.0,81.0,72.0,87.0,866.0
Chitradurga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,9.0,14.0,20.0,15.0,15.0,21.0,17.0,17.0,18.0,13.0,15.0,15.0,189.0
Chitradurga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,20.0,35.0,27.0,47.0,26.0,29.0,36.0,33.0,27.0,49.0,38.0,19.0,386.0
Chitradurga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Chitradurga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,321.0,319.0,331.0,419.0,370.0,370.0,349.0,384.0,363.0,383.0,355.0,347.0,4311.0
Chitradurga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,37.0,26.0,39.0,68.0,54.0,16.0,52.0,17.0,34.0,29.0,37.0,39.0,448.0
Chitradurga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,31.0,44.0,52.0,43.0,53.0,52.0,39.0,56.0,39.0,47.0,18.0,33.0,507.0
Chitradurga,9.06,Number of IUCD removals,TOTAL,181.0,87.0,82.0,191.0,114.0,163.0,87.0,124.0,122.0,83.0,99.0,132.0,1465.0
Chitradurga,9.07,Number of Oral Pills cycles distributed,TOTAL,5979.0,6069.0,5819.0,6712.0,6405.0,6733.0,7867.0,6894.0,6855.0,7244.0,7336.0,7106.0,81019.0
Chitradurga,9.08,Number of Condom pieces distributed,TOTAL,44593.0,44678.0,47049.0,47172.0,50853.0,50685.0,49469.0,52000.0,55144.0,54956.0,59480.0,62944.0,619023.0
Chitradurga,9.09,Number of Centchroman (weekly) pills given,TOTAL,146.0,96.0,347.0,278.0,148.0,34.0,158.0,180.0,0.0,0.0,0.0,0.0,1387.0
Chitradurga,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,3.0,0.0,17.0,62.0,41.0,0.0,34.0,1.0,0.0,0.0,218.0,376.0
Chitradurga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Chitradurga,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chitradurga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,9.12,Number of Institutions having NSV trained doctors,TOTAL,29.0,23.0,28.0,30.0,30.0,23.0,27.0,24.0,25.0,21.0,25.0,27.0,-1.0
Chitradurga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2019.0,2442.0,2506.0,2456.0,2416.0,2500.0,2402.0,2436.0,2362.0,1860.0,2077.0,1877.0,27353.0
Chitradurga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,5.0,59.0,14.0,0.0,5.0,9.0,44.0,3.0,15.0,3.0,6.0,9.0,172.0
Chitradurga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,4.0,37.0,1.0,1.0,4.0,4.0,46.0,2.0,9.0,0.0,0.0,7.0,115.0
Chitradurga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3.0,30.0,18.0,9.0,9.0,8.0,35.0,0.0,11.0,8.0,0.0,1.0,132.0
Chitradurga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2343.0,2378.0,2509.0,2633.0,2639.0,2484.0,2627.0,2795.0,2615.0,2504.0,2503.0,2393.0,30423.0
Chitradurga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2311.0,2247.0,2512.0,2652.0,2351.0,2623.0,2529.0,2721.0,2755.0,2487.0,2410.0,2627.0,30225.0
Chitradurga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2494.0,2188.0,2483.0,2630.0,2494.0,2533.0,2660.0,2606.0,2704.0,2609.0,2388.0,2651.0,30440.0
Chitradurga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1345.0,1720.0,1912.0,1776.0,1905.0,1877.0,1878.0,2023.0,1972.0,1603.0,1604.0,1575.0,21190.0
Chitradurga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2308.0,2358.0,2366.0,2495.0,2683.0,2498.0,2624.0,2793.0,2624.0,2490.0,2501.0,2375.0,30115.0
Chitradurga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2300.0,2082.0,2373.0,2497.0,2351.0,2625.0,2532.0,2714.0,2765.0,2485.0,2407.0,2623.0,29754.0
Chitradurga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2436.0,2021.0,2301.0,2448.0,2480.0,2528.0,2750.0,2599.0,2706.0,2598.0,2393.0,2636.0,29896.0
Chitradurga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,825.0,1231.0,1389.0,1587.0,1356.0,1411.0,1630.0,1704.0,1631.0,1415.0,1425.0,1396.0,17000.0
Chitradurga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,70.0,65.0,178.0,236.0,99.0,60.0,0.0,173.0,0.0,0.0,0.0,881.0
Chitradurga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,52.0,71.0,187.0,218.0,106.0,61.0,0.0,152.0,0.0,0.0,0.0,847.0
Chitradurga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,50.0,67.0,216.0,219.0,105.0,44.0,0.0,143.0,0.0,0.0,3.0,847.0
Chitradurga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2394.0,2250.0,2403.0,2489.0,2293.0,2325.0,2427.0,2292.0,2319.0,2332.0,2306.0,2535.0,28365.0
Chitradurga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1806.0,1875.0,2019.0,1955.0,1584.0,1882.0,1874.0,2104.0,2173.0,1931.0,1987.0,2223.0,23413.0
Chitradurga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,331.0,342.0,983.0,1521.0,1662.0,2117.0,2188.0,2078.0,2107.0,2197.0,2235.0,2470.0,20231.0
Chitradurga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1065.0,1014.0,1190.0,1175.0,1071.0,1130.0,1137.0,1089.0,1131.0,1147.0,1108.0,1199.0,13456.0
Chitradurga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,920.0,913.0,1309.0,1074.0,944.0,1032.0,1100.0,976.0,1039.0,1028.0,962.0,1122.0,12419.0
Chitradurga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1985.0,1927.0,2499.0,2249.0,2015.0,2162.0,2237.0,2065.0,2170.0,2175.0,2070.0,2321.0,25875.0
Chitradurga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1827.0,1882.0,2099.0,2074.0,1792.0,1900.0,2028.0,2159.0,2133.0,1924.0,1934.0,2156.0,23908.0
Chitradurga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1801.0,1871.0,2068.0,2059.0,1781.0,2332.0,2017.0,2158.0,2131.0,1921.0,1921.0,2149.0,24209.0
Chitradurga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,123.0,85.0,103.0,111.0,82.0,76.0,46.0,0.0,4.0,11.0,3.0,11.0,655.0
Chitradurga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,223.0,216.0,278.0,374.0,840.0,178.0,219.0,207.0,233.0,233.0,216.0,323.0,3540.0
Chitradurga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,195.0,195.0,219.0,313.0,787.0,151.0,210.0,209.0,202.0,214.0,183.0,313.0,3191.0
Chitradurga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,418.0,411.0,497.0,687.0,1627.0,329.0,429.0,416.0,435.0,447.0,399.0,636.0,6731.0
Chitradurga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,75.0,12.0,32.0,1029.0,5183.0,7927.0,211.0,1853.0,365.0,105.0,163.0,44.0,16999.0
Chitradurga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,52.0,4.0,9.0,992.0,5482.0,7962.0,234.0,1934.0,421.0,86.0,188.0,40.0,17404.0
Chitradurga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,51.0,0.0,9.0,830.0,4164.0,7806.0,198.0,2180.0,715.0,377.0,308.0,0.0,16638.0
Chitradurga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,23.0,0.0,0.0,1.0,0.0,4.0,2.0,0.0,2.0,33.0
Chitradurga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,8.0,29.0,15.0,31.0,8.0,17.0,31.0,17.0,20.0,21.0,11.0,214.0
Chitradurga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1419.0,1497.0,1535.0,1561.0,1490.0,1532.0,1549.0,1581.0,1618.0,1598.0,1551.0,1560.0,18491.0
Chitradurga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1288.0,1329.0,1402.0,1414.0,1398.0,1404.0,1410.0,1455.0,1516.0,1465.0,1404.0,1469.0,16954.0
Chitradurga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,933.0,949.0,995.0,963.0,1015.0,992.0,1017.0,1024.0,1045.0,1028.0,949.0,1007.0,11917.0
Chitradurga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,131.0,186.0,714.0,1057.0,1105.0,1567.0,1588.0,1827.0,1911.0,1687.0,1647.0,1755.0,15175.0
Chitradurga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2083.0,2226.0,2392.0,2360.0,2646.0,2347.0,2395.0,2272.0,2215.0,2246.0,2104.0,2594.0,27880.0
Chitradurga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,40.0,217.0,171.0,3656.0,15146.0,147.0,46.0,79.0,46.0,82.0,17.0,7918.0,27565.0
Chitradurga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,78.0,3270.0,19086.0,28.0,0.0,5.0,6.0,48.0,11.0,7581.0,30113.0
Chitradurga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,31.0,12.0,9.0,2.0,9.0,18.0,12.0,2.0,13.0,8.0,13.0,25.0,154.0
Chitradurga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,336.0,413.0,362.0,279.0,289.0,345.0,271.0,280.0,408.0,318.0,370.0,435.0,4106.0
Chitradurga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,3.0,0.0,0.0,0.0,42.0,0.0,10.0,0.0,0.0,0.0,6.0,61.0
Chitradurga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,128.0,126.0,112.0,174.0,182.0,105.0,99.0,8.0,82.0,72.0,121.0,125.0,1334.0
Chitradurga,13.1,Number of Patients operated for cataract,TOTAL,98.0,105.0,149.0,170.0,46.0,48.0,98.0,102.0,125.0,27.0,212.0,299.0,1479.0
Chitradurga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,98.0,105.0,149.0,169.0,43.0,48.0,98.0,102.0,125.0,55.0,212.0,169.0,1373.0
Chitradurga,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,19.0,7.0,0.0,0.0,18.0,0.0,0.0,14.0,5.0,63.0
Chitradurga,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,17.0,12.0,2.0,32.0
Chitradurga,13.5,Number of eyes collected through eye donation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chitradurga,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Chitradurga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,5.0,6.0,6.0,7.0,7.0,7.0,6.0,9.0,6.0,8.0,7.0,-1.0
Chitradurga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,40.0,42.0,35.0,38.0,34.0,29.0,33.0,35.0,30.0,34.0,28.0,36.0,-1.0
Chitradurga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,320.0,314.0,318.0,327.0,365.0,408.0,386.0,400.0,352.0,360.0,350.0,386.0,-1.0
Chitradurga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,9.0,9.0,10.0,8.0,8.0,11.0,9.0,12.0,10.0,14.0,12.0,-1.0
Chitradurga,14.05,Number of RKS meetings held during the month,TOTAL,13.0,9.0,16.0,18.0,10.0,11.0,9.0,14.0,26.0,28.0,36.0,33.0,223.0
Chitradurga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,39.0,47.0,40.0,42.0,40.0,36.0,38.0,34.0,40.0,33.0,33.0,35.0,-1.0
Chitradurga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,378.0,375.0,265.0,312.0,410.0,470.0,416.0,394.0,455.0,352.0,434.0,476.0,4737.0
Chitradurga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,7.0,7.0,7.0,8.0,6.0,6.0,6.0,8.0,5.0,6.0,9.0,-1.0
Chitradurga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,20.0,44.0,38.0,55.0,38.0,3.0,3.0,3.0,4.0,4.0,5.0,12.0,-1.0
Chitradurga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1090.0,1055.0,1063.0,969.0,929.0,2538.0,1141.0,754.0,1093.0,752.0,855.0,856.0,13095.0
Chitradurga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4625.0,5431.0,5292.0,4806.0,4690.0,5848.0,4121.0,4316.0,3907.0,3881.0,2788.0,2899.0,52604.0
Chitradurga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,857.0,1013.0,1061.0,807.0,861.0,2642.0,1047.0,831.0,1014.0,689.0,719.0,876.0,12417.0
Chitradurga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6387.0,7127.0,7338.0,6539.0,6287.0,8341.0,5431.0,6128.0,6739.0,5836.0,4707.0,5216.0,76076.0
Chitradurga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1947.0,2068.0,2124.0,1776.0,1790.0,5180.0,2188.0,1585.0,2107.0,1441.0,1574.0,1732.0,25512.0
Chitradurga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,11012.0,12558.0,12630.0,11345.0,10977.0,14189.0,9552.0,10444.0,10646.0,9717.0,7495.0,8115.0,128680.0
Chitradurga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,71.0,51.0,59.0,64.0,86.0,65.0,50.0,67.0,70.0,57.0,47.0,27.0,714.0
Chitradurga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,34.0,30.0,42.0,35.0,38.0,45.0,31.0,33.0,38.0,24.0,45.0,19.0,414.0
Chitradurga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,105.0,81.0,101.0,99.0,124.0,110.0,81.0,100.0,108.0,81.0,92.0,46.0,1128.0
Chitradurga,14.11,In-Patient Head Count at midnight,TOTAL,13971.0,13298.0,16029.0,15670.0,14763.0,15961.0,13917.0,17391.0,14328.0,14313.0,16263.0,14891.0,180795.0
Chitradurga,14.12.1,OPD attendance (All),TOTAL,171060.0,177005.0,206455.0,192875.0,200934.0,212895.0,177673.0,185222.0,183933.0,177298.0,185386.0,218309.0,2289045.0
Chitradurga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,350.0,496.0,542.0,444.0,396.0,541.0,431.0,495.0,501.0,503.0,475.0,481.0,5655.0
Chitradurga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,28.0,154.0,93.0,67.0,103.0,93.0,20.0,43.0,28.0,62.0,56.0,69.0,816.0
Chitradurga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,46.0,41.0,29.0,26.0,24.0,23.0,233.0,154.0,42.0,48.0,51.0,31.0,748.0
Chitradurga,14.14.a,Number of patients given AYUSH treatment,TOTAL,3225.0,3333.0,3116.0,3316.0,3657.0,3424.0,3073.0,2347.0,2511.0,2505.0,2599.0,2172.0,35278.0
Chitradurga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,489.0,462.0,587.0,539.0,527.0,502.0,398.0,526.0,528.0,514.0,753.0,520.0,6345.0
Chitradurga,14.14.c,Number of Adolescents counselled,TOTAL,15.0,39.0,13.0,1.0,15.0,44.0,11.0,20.0,32.0,28.0,69.0,37.0,324.0
Chitradurga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,5202.0,5873.0,6650.0,6543.0,6232.0,6825.0,6302.0,7570.0,7229.0,5318.0,6209.0,5868.0,75821.0
Chitradurga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,159.0,254.0,304.0,283.0,230.0,233.0,270.0,267.0,285.0,229.0,248.0,239.0,3001.0
Chitradurga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1280.0,1443.0,1855.0,1660.0,1728.0,2157.0,1480.0,1627.0,1756.0,1685.0,1446.0,1325.0,19442.0
Chitradurga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,19.0,23.0,35.0,30.0,24.0,29.0,22.0,27.0,31.0,26.0,30.0,19.0,315.0
Chitradurga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1212.0,1706.0,1760.0,1642.0,1336.0,1601.0,1441.0,1538.0,1449.0,1333.0,1301.0,1341.0,17660.0
Chitradurga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,17.0,25.0,26.0,22.0,31.0,25.0,19.0,27.0,17.0,15.0,29.0,21.0,274.0
Chitradurga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2333.0,2823.0,2942.0,2810.0,2820.0,2388.0,2038.0,2665.0,2392.0,2187.0,2271.0,2097.0,29766.0
Chitradurga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,9.0,16.0,6.0,3.0,6.0,29.0,32.0,29.0,2.0,4.0,1.0,137.0
Chitradurga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4825.0,5972.0,6557.0,6112.0,5884.0,6146.0,4959.0,5830.0,5597.0,5205.0,5018.0,4763.0,66868.0
Chitradurga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,36.0,57.0,77.0,58.0,58.0,60.0,70.0,86.0,77.0,43.0,63.0,41.0,726.0
Chitradurga,15.2,Number of Widal tests conducted,Number tested,1264.0,1578.0,2440.0,2861.0,3243.0,2856.0,1539.0,1496.0,1264.0,1725.0,2156.0,2576.0,24998.0
Chitradurga,15.3.a,Number of VDRL tests conducted on males,Number tested,184.0,267.0,197.0,217.0,231.0,122.0,249.0,170.0,142.0,22.0,34.0,43.0,1878.0
Chitradurga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,274.0,366.0,492.0,346.0,645.0,302.0,441.0,250.0,221.0,124.0,185.0,92.0,3738.0
Chitradurga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1069.0,1165.0,1578.0,1481.0,1018.0,1147.0,1239.0,1176.0,1279.0,1189.0,1573.0,1616.0,15530.0
Chitradurga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1527.0,1798.0,2267.0,2044.0,1894.0,1571.0,1929.0,1596.0,1642.0,1335.0,1792.0,1751.0,21146.0
Chitradurga,15.4.1,Number of blood smears examined for Malaria,TOTAL,25830.0,26957.0,31772.0,31833.0,30635.0,31401.0,24773.0,26686.0,27304.0,23054.0,26695.0,27655.0,334595.0
Chitradurga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,0.0,0.0,1.0,17.0,11.0,2.0,0.0,2.0,5.0,15.0,0.0,1.0,54.0
Chitradurga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0,0.0,0.0,26.0
Chitradurga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,,8500.0,2500.0,3000.0,1500.0,1500.0,0.0,1500.0,4500.0,5500.0,3500.0,4500.0,36500.0
Chitradurga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,13000.0,,6000.0,5000.0,17000.0,11500.0,10000.0,5000.0,5000.0,,5000.0,500.0,78000.0
Chitradurga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4500.0,6000.0,5500.0,6500.0,17000.0,13000.0,8500.0,2000.0,4000.0,2000.0,4000.0,4000.0,77000.0
Chitradurga,16.1.1,Stock position of DPT vaccines,5. Total Stock,8500.0,2500.0,3000.0,1500.0,1500.0,0.0,1500.0,4500.0,5500.0,3500.0,4500.0,1000.0,37500.0
Chitradurga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,4000.0,12000.0,4000.0,,4000.0,2000.0,3000.0,4500.0,500.0,4000.0,3000.0,5000.0,46000.0
Chitradurga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,18000.0,,6500.0,10000.0,7000.0,10000.0,8000.0,1500.0,13000.0,4000.0,11000.0,5000.0,94000.0
Chitradurga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,10000.0,8000.0,10500.0,6000.0,9000.0,9000.0,6500.0,5500.0,9500.0,5000.0,9000.0,8500.0,96500.0
Chitradurga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,12000.0,4000.0,0.0,4000.0,2000.0,3000.0,4500.0,500.0,4000.0,3000.0,5000.0,1500.0,43500.0
Chitradurga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8500.0,16000.0,2500.0,,4000.0,1000.0,1000.0,,4000.0,3500.0,500.0,1000.0,42000.0
Chitradurga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,22000.0,,18000.0,20000.0,16000.0,16500.0,20000.0,15000.0,15000.0,8000.0,20000.0,20000.0,190500.0
Chitradurga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14500.0,13500.0,20500.0,16000.0,19000.0,16500.0,21000.0,11000.0,15500.0,11000.0,19500.0,11000.0,189000.0
Chitradurga,16.1.2,Stock position of OPV vaccines,5. Total Stock,16000.0,2500.0,0.0,4000.0,1000.0,1000.0,0.0,4000.0,3500.0,500.0,1000.0,10000.0,43500.0
Chitradurga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,2000.0,11500.0,2000.0,,2000.0,1500.0,1000.0,3500.0,7500.0,5000.0,3000.0,3000.0,42000.0
Chitradurga,16.1.3,Stock position of TT vaccines,2. Stocks Received,20000.0,,10000.0,11000.0,20000.0,24000.0,15000.0,8000.0,8000.0,5000.0,12000.0,9000.0,142000.0
Chitradurga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,10500.0,9500.0,12000.0,9000.0,20500.0,24500.0,12500.0,4000.0,10500.0,7000.0,12000.0,6000.0,138000.0
Chitradurga,16.1.3,Stock position of TT vaccines,5. Total Stock,11500.0,2000.0,0.0,2000.0,1500.0,1000.0,3500.0,7500.0,5000.0,3000.0,3000.0,6000.0,46000.0
Chitradurga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3000.0,8500.0,1500.0,500.0,2500.0,3000.0,2000.0,4500.0,4500.0,3000.0,4000.0,5000.0,42000.0
Chitradurga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,,10000.0,8000.0,7000.0,7000.0,10000.0,6000.0,8000.0,5000.0,10000.0,5000.0,86000.0
Chitradurga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4500.0,7000.0,11000.0,6000.0,6500.0,8000.0,7500.0,6000.0,9500.0,4000.0,9000.0,7500.0,86500.0
Chitradurga,16.1.5,Stock position of BCG vaccines,5. Total Stock,8500.0,1500.0,500.0,2500.0,3000.0,2000.0,4500.0,4500.0,3000.0,4000.0,5000.0,2500.0,41500.0
Chitradurga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,,7500.0,1250.0,,4000.0,3500.0,500.0,6250.0,500.0,,4000.0,4750.0,32250.0
Chitradurga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,,7000.0,9000.0,6000.0,3000.0,12000.0,,7000.0,8000.0,7000.0,5000.0,74000.0
Chitradurga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2500.0,6250.0,8250.0,5000.0,6500.0,6000.0,6250.0,5750.0,7500.0,4000.0,6250.0,7750.0,72000.0
Chitradurga,16.1.6,Stock position of Measles vaccines,5. Total Stock,7500.0,1250.0,0.0,4000.0,3500.0,500.0,6250.0,500.0,0.0,4000.0,4750.0,2000.0,34250.0
Chitradurga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,0.0,,4000.0,2000.0,1500.0,0.0,7500.0
Chitradurga,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,3000.0,7000.0,8000.0,7000.0,8000.0,5000.0,4000.0,10000.0,7500.0,59500.0
Chitradurga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,3000.0,7000.0,8000.0,7000.0,4000.0,7000.0,4500.0,11500.0,7500.0,59500.0
Chitradurga,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4000.0,2000.0,1500.0,0.0,0.0,7500.0
Chitradurga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,,3000.0,3000.0,2400.0,900.0,600.0,0.0,500.0,3000.0,1500.0,500.0,2000.0,17400.0
Chitradurga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3600.0,,,,,300.0,3000.0,3000.0,,,2000.0,2500.0,14400.0
Chitradurga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,600.0,,600.0,1500.0,300.0,900.0,2500.0,500.0,1500.0,1000.0,500.0,2500.0,12400.0
Chitradurga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3000.0,3000.0,2400.0,900.0,600.0,0.0,500.0,3000.0,1500.0,500.0,2000.0,2000.0,19400.0
Chitradurga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1600.0,1000.0,400.0,350.0,1350.0,150.0,0.0,,,,,,4850.0
Chitradurga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,1200.0,,,,,,,,6000.0,7200.0
Chitradurga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,600.0,50.0,200.0,1200.0,150.0,,,,,,250.0,3050.0
Chitradurga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1000.0,400.0,350.0,1350.0,150.0,0.0,0.0,0.0,0.0,0.0,0.0,5750.0,9000.0
Chitradurga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,12120.0,,,,131040.0,100800.0,35280.0,,,,44160.0,,323400.0
Chitradurga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,151200.0,,,0.0,,,85200.0,,60480.0,296880.0
Chitradurga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,12120.0,,,20160.0,30240.0,65520.0,35280.0,,,41040.0,44160.0,25220.0,273740.0
Chitradurga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,131040.0,100800.0,35280.0,0.0,0.0,0.0,44160.0,0.0,35260.0,346540.0
Chitradurga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,11600.0,1200.0,,,,13200.0,4300.0,30300.0
Chitradurga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,16000.0,,0.0,,,18000.0,,,34000.0
Chitradurga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,4400.0,10400.0,1200.0,,,4800.0,8900.0,1500.0,31200.0
Chitradurga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,11600.0,1200.0,0.0,0.0,0.0,13200.0,4300.0,2800.0,33100.0
Chitradurga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,5000.0,4850.0,9850.0
Chitradurga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,5000.0,,,5000.0
Chitradurga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,150.0,300.0,450.0
Chitradurga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,4850.0,4550.0,14400.0
Chitradurga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5195.0,5195.0,5195.0,5195.0,4195.0,4195.0,,,,,7815.0,7815.0,44800.0
Chitradurga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,7815.0,,,7815.0
Chitradurga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,1000.0,,4195.0,,,,,,,5195.0
Chitradurga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,5195.0,5195.0,5195.0,4195.0,4195.0,0.0,0.0,0.0,0.0,7815.0,7815.0,7815.0,47420.0
Chitradurga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,1500.0,1500.0,550.0,,3550.0
Chitradurga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,950.0,550.0,,1500.0
Chitradurga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1500.0,550.0,0.0,0.0,2050.0
Chitradurga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Chitradurga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Chitradurga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Chitradurga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,14501.0,11401.0,6001.0,4400.0,2700.0,2700.0,,,41703.0
Chitradurga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,14501.0,,,,,,,,,14501.0
Chitradurga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,3100.0,5400.0,1601.0,1700.0,,2700.0,,,14501.0
Chitradurga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,14501.0,11401.0,6001.0,4400.0,2700.0,2700.0,0.0,0.0,0.0,41703.0
Chitradurga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,650.0,650.0,70.0,30.0,,,,,,,1400.0
Chitradurga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,650.0,,,,,,,,,1300.0,,1950.0
Chitradurga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,580.0,40.0,30.0,,,,,1300.0,,1950.0
Chitradurga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,650.0,650.0,70.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1400.0
Chitradurga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,134512.0,112112.0,68900.0,59800.0,50200.0,47000.0,38000.0,32200.0,542724.0
Chitradurga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Chitradurga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,22400.0,43212.0,9100.0,9600.0,3200.0,9000.0,5800.0,6900.0,109212.0
Chitradurga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,112112.0,68900.0,59800.0,50200.0,47000.0,38000.0,32200.0,25300.0,433512.0
Chitradurga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5200.0,3800.0,800.0,4200.0,3100.0,2400.0,1200.0,3000.0,0.0,5400.0,4400.0,3000.0,36500.0
Chitradurga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,,,6600.0,,3300.0,,6600.0,3300.0,6600.0,,3300.0,6600.0,36300.0
Chitradurga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1400.0,3000.0,3200.0,1100.0,4000.0,1200.0,4800.0,6300.0,1200.0,1000.0,4700.0,6700.0,38600.0
Chitradurga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3800.0,800.0,4200.0,3100.0,2400.0,1200.0,3000.0,0.0,5400.0,4400.0,3000.0,2900.0,34200.0
Chitradurga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,10900.0,8500.0,56100.0,34100.0,29300.0,2100.0,,14000.0,0.0,8000.0,3600.0,7600.0,174200.0
Chitradurga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,,50000.0,,,,,35000.0,,10000.0,,19600.0,14400.0,129000.0
Chitradurga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2400.0,2400.0,22000.0,4800.0,27200.0,2100.0,21000.0,14000.0,2000.0,4400.0,15600.0,14800.0,132700.0
Chitradurga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,8500.0,56100.0,34100.0,29300.0,2100.0,0.0,14000.0,0.0,8000.0,3600.0,7600.0,7200.0,170500.0
Chitradurga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,800.0,800.0,800.0,800.0,800.0,300.0,300.0,200.0,200.0,200.0,200.0,2000.0,7400.0
Chitradurga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,,,,,,,2400.0,2400.0,,,2800.0,2400.0,10000.0
Chitradurga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Chitradurga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,,,,,500.0,,2500.0,2400.0,,,1000.0,2400.0,8800.0
Chitradurga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,800.0,800.0,800.0,800.0,300.0,300.0,200.0,200.0,200.0,200.0,2000.0,2000.0,8600.0
Chitradurga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Chitradurga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,2.0,,2.0,2.0,1.0,3.0,1.0,1.0,,2.0,1.0,15.0
Chitradurga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,,1.0
Chitradurga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,,2.0,2.0,1.0,3.0,1.0,1.0,,2.0,1.0,16.0
Chitradurga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,2.0,8.0,3.0,1.0,7.0,,5.0,5.0,7.0,5.0,3.0,49.0
Chitradurga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,,,1.0,2.0
Chitradurga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,4.0,2.0,8.0,3.0,1.0,7.0,,5.0,5.0,7.0,5.0,4.0,51.0
Chitradurga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,1.0,,1.0,,2.0,,1.0,2.0,3.0,,,11.0
Chitradurga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Chitradurga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,,1.0,,2.0,,1.0,2.0,3.0,,,11.0
Chitradurga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,5.0,4.0,1.0,1.0,3.0,2.0,,1.0,1.0,2.0,3.0,24.0
Chitradurga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Chitradurga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,5.0,4.0,1.0,1.0,3.0,2.0,,1.0,1.0,2.0,4.0,25.0
Chitradurga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,1.0,,,,2.0,2.0,,6.0
Chitradurga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,1.0,,2.0
Chitradurga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,1.0,,1.0,,,,2.0,3.0,,8.0
Chitradurga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,1.0,,1.0
Chitradurga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chitradurga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,1.0,,1.0
Chitradurga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,1.0,,,,1.0
Chitradurga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,1.0,1.0
Chitradurga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,1.0,,,1.0,2.0
Chitradurga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Chitradurga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Chitradurga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Chitradurga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,2.0,,1.0,2.0,1.0,,2.0,2.0,4.0,4.0,19.0
Chitradurga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,1.0,1.0,1.0,,1.0,2.0,,2.0,1.0,10.0
Chitradurga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,3.0,1.0,2.0,3.0,1.0,1.0,4.0,2.0,6.0,5.0,29.0
Chitradurga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Chitradurga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,,,,,,,1.0
Chitradurga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,1.0,,1.0,2.0,1.0,,,,1.0,,7.0
Chitradurga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,1.0,,1.0,3.0,1.0,1.0,,,1.0,,9.0
Chitradurga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,8.0,2.0,4.0,3.0,2.0,7.0,3.0,8.0,3.0,2.0,1.0,5.0,48.0
Chitradurga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,4.0,,,1.0,,6.0,,4.0,3.0,2.0,1.0,4.0,25.0
Chitradurga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,12.0,2.0,4.0,4.0,2.0,13.0,3.0,12.0,6.0,4.0,2.0,9.0,73.0
Chitradurga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Chitradurga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,7.0,10.0,7.0,10.0,6.0,4.0,8.0,9.0,7.0,9.0,9.0,7.0,93.0
Chitradurga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,18.0,14.0,8.0,18.0,22.0,21.0,15.0,18.0,22.0,17.0,13.0,17.0,203.0
Chitradurga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,26.0,24.0,15.0,28.0,28.0,25.0,23.0,27.0,29.0,26.0,22.0,24.0,297.0
Chitradurga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Chitradurga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,1.0,,1.0,3.0
Chitradurga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,1.0,,,,,,1.0,,1.0,4.0
Chitradurga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,1.0,,,,,,1.0,3.0
Chitradurga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,8.0,2.0,3.0,3.0,1.0,2.0,5.0,7.0,10.0,8.0,3.0,2.0,54.0
Chitradurga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,9.0,2.0,1.0,7.0,3.0,7.0,3.0,4.0,9.0,8.0,11.0,5.0,69.0
Chitradurga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,18.0,4.0,4.0,10.0,4.0,10.0,8.0,11.0,19.0,16.0,14.0,8.0,126.0
Chitradurga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,,4.0,4.0,3.0,1.0,5.0,,3.0,1.0,4.0,4.0,,29.0
Chitradurga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,1.0,2.0,,,,,,,,,1.0,5.0
Chitradurga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,5.0,6.0,3.0,1.0,5.0,,3.0,1.0,4.0,4.0,1.0,34.0
Chitradurga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,3.0,2.0,,,1.0,1.0,,1.0,1.0,9.0
Chitradurga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,19.0,16.0,17.0,18.0,25.0,38.0,14.0,25.0,35.0,39.0,27.0,21.0,294.0
Chitradurga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,28.0,28.0,30.0,30.0,33.0,45.0,32.0,34.0,35.0,43.0,37.0,22.0,397.0
Chitradurga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,47.0,44.0,47.0,51.0,60.0,83.0,46.0,60.0,71.0,82.0,65.0,44.0,700.0
Chitradurga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,1.0,,,,1.0,1.0,,1.0,4.0
Chitradurga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,8.0,6.0,10.0,7.0,5.0,13.0,9.0,11.0,9.0,8.0,9.0,7.0,102.0
Chitradurga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,15.0,11.0,22.0,25.0,23.0,25.0,14.0,33.0,23.0,11.0,23.0,23.0,248.0
Chitradurga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,23.0,17.0,32.0,32.0,29.0,38.0,23.0,44.0,33.0,20.0,32.0,31.0,354.0
Chitradurga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Chitradurga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Chitradurga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Chitradurga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Chitradurga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Chitradurga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,1.0,1.0,,,,3.0,,,5.0
Chitradurga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Chitradurga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,1.0,1.0,,,,3.0,,,5.0
Chitradurga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Chitradurga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Chitradurga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,1.0,,,1.0
Chitradurga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,,,1.0,,,,,,1.0,3.0
Chitradurga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Chitradurga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,,,1.0,,,,,,1.0,3.0
Chitradurga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Chitradurga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,2.0,,,,,,1.0,1.0,1.0,5.0
Chitradurga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Chitradurga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,2.0,,,,,,1.0,1.0,1.0,5.0
Chitradurga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,6.0,1.0,2.0,2.0,1.0,,4.0,,,,,18.0
Chitradurga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,13.0,12.0,13.0,20.0,17.0,10.0,12.0,10.0,9.0,10.0,7.0,18.0,151.0
Chitradurga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,2.0,2.0,4.0,4.0,3.0,2.0,5.0,3.0,5.0,3.0,8.0,44.0
Chitradurga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,18.0,20.0,16.0,26.0,23.0,14.0,14.0,19.0,12.0,15.0,10.0,26.0,213.0
Chitradurga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,2.0,,,,,,1.0,,,,,3.0
Chitradurga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,16.0,19.0,13.0,10.0,13.0,22.0,14.0,16.0,17.0,20.0,12.0,14.0,186.0
Chitradurga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,4.0,4.0,9.0,2.0,2.0,4.0,3.0,7.0,1.0,,3.0,3.0,42.0
Chitradurga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,20.0,25.0,22.0,12.0,15.0,26.0,17.0,24.0,18.0,20.0,15.0,17.0,231.0
Chitradurga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,1.0,,,1.0,,1.0,4.0
Chitradurga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,2.0,3.0,2.0,3.0,1.0,2.0,2.0,2.0,,2.0,,20.0
Chitradurga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,1.0,3.0,,3.0,,1.0,1.0,5.0,2.0,16.0
Chitradurga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,3.0,3.0,6.0,2.0,6.0,2.0,3.0,2.0,7.0,3.0,40.0
Chitradurga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,2.0,,1.0,1.0,,3.0,1.0,,,,1.0,,9.0
Chitradurga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,7.0,9.0,12.0,8.0,4.0,16.0,9.0,11.0,11.0,13.0,13.0,7.0,120.0
Chitradurga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,12.0,12.0,11.0,11.0,10.0,17.0,25.0,16.0,22.0,19.0,18.0,15.0,188.0
Chitradurga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,21.0,21.0,24.0,20.0,14.0,36.0,35.0,27.0,33.0,32.0,32.0,22.0,317.0
Chitradurga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,1.0,1.0,,,,,2.0
Chitradurga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,11.0,13.0,3.0,9.0,13.0,8.0,18.0,14.0,14.0,14.0,16.0,144.0
Chitradurga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,17.0,25.0,22.0,27.0,30.0,44.0,35.0,46.0,22.0,35.0,28.0,39.0,370.0
Chitradurga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,28.0,36.0,35.0,30.0,39.0,57.0,44.0,65.0,36.0,49.0,42.0,55.0,516.0
Chitradurga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,7.0,2.0,4.0,1.0,2.0,1.0,2.0,3.0,1.0,3.0,,3.0,29.0
Chitradurga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,53.0,54.0,54.0,52.0,67.0,50.0,44.0,55.0,63.0,63.0,61.0,51.0,667.0
Chitradurga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,173.0,171.0,216.0,242.0,230.0,316.0,233.0,257.0,238.0,253.0,218.0,198.0,2745.0
Chitradurga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,233.0,227.0,274.0,295.0,299.0,367.0,279.0,315.0,302.0,319.0,279.0,252.0,3441.0
Dakshina Kannada,1.1,Total number of pregnant women Registered for ANC,TOTAL,2281.0,2208.0,2681.0,2510.0,2371.0,2418.0,2190.0,2566.0,2259.0,2377.0,2154.0,2247.0,28262.0
Dakshina Kannada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1702.0,1623.0,1914.0,1776.0,1776.0,1848.0,1712.0,1988.0,1693.0,1749.0,1597.0,1658.0,21036.0
Dakshina Kannada,1.2,Number of Pregnant women registered under JSY,TOTAL,911.0,894.0,1061.0,953.0,912.0,958.0,879.0,1040.0,895.0,940.0,864.0,910.0,11217.0
Dakshina Kannada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3180.0,3056.0,3025.0,2234.0,2248.0,2318.0,2137.0,2265.0,2288.0,2241.0,2046.0,2087.0,29125.0
Dakshina Kannada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2299.0,2177.0,2303.0,2203.0,2006.0,2033.0,1984.0,2082.0,2177.0,2253.0,2032.0,1843.0,25392.0
Dakshina Kannada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2169.0,2008.0,2108.0,2047.0,2040.0,1976.0,1935.0,1965.0,2104.0,2332.0,1885.0,1855.0,24424.0
Dakshina Kannada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2660.0,2770.0,2916.0,2751.0,3832.0,3446.0,2626.0,2220.0,2436.0,2355.0,2928.0,2744.0,33684.0
Dakshina Kannada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,73.0,52.0,55.0,40.0,50.0,63.0,68.0,55.0,71.0,61.0,64.0,57.0,709.0
Dakshina Kannada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,9.0,8.0,5.0,3.0,1.0,0.0,7.0,8.0,9.0,3.0,7.0,13.0,73.0
Dakshina Kannada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1356.0,1068.0,1224.0,1205.0,1404.0,1342.0,1200.0,1270.0,1116.0,1114.0,1292.0,1193.0,14784.0
Dakshina Kannada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,19.0,12.0,9.0,6.0,7.0,6.0,5.0,6.0,13.0,11.0,9.0,8.0,111.0
Dakshina Kannada,1.8,Number of pregnancy test kits used at SC level,TOTAL,343.0,318.0,359.0,322.0,299.0,315.0,279.0,325.0,302.0,350.0,343.0,298.0,3853.0
Dakshina Kannada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,4.0,1.0,0.0,1.0,2.0,1.0,0.0,0.0,2.0,0.0,0.0,2.0,13.0
Dakshina Kannada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,2.0,2.0,2.0,1.0,0.0,1.0,0.0,1.0,0.0,9.0
Dakshina Kannada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,4.0,1.0,0.0,3.0,4.0,3.0,1.0,0.0,3.0,0.0,1.0,2.0,22.0
Dakshina Kannada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,4.0,1.0,0.0,3.0,3.0,3.0,1.0,0.0,2.0,0.0,1.0,1.0,19.0
Dakshina Kannada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,4.0
Dakshina Kannada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,905.0,865.0,812.0,711.0,714.0,822.0,857.0,883.0,766.0,653.0,704.0,729.0,9421.0
Dakshina Kannada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,28.0,40.0,6.0,2.0,0.0,2.0,5.0,1.0,11.0,2.0,4.0,4.0,105.0
Dakshina Kannada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,509.0,831.0,700.0,818.0,1117.0,955.0,813.0,999.0,791.0,396.0,769.0,734.0,9432.0
Dakshina Kannada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,337.0,273.0,117.0,507.0,497.0,364.0,250.0,975.0,463.0,162.0,301.0,805.0,5051.0
Dakshina Kannada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1814.0,1746.0,1384.0,1411.0,1579.0,1309.0,1704.0,1672.0,1557.0,1586.0,1251.0,1239.0,18252.0
Dakshina Kannada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,1.0,3.0,2.0,2.0,1.0,0.0,1.0,2.0,4.0,16.0
Dakshina Kannada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,257.0,243.0,239.0,230.0,229.0,272.0,248.0,273.0,229.0,190.0,204.0,204.0,2818.0
Dakshina Kannada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,257.0,243.0,239.0,231.0,232.0,274.0,250.0,274.0,229.0,191.0,206.0,208.0,2834.0
Dakshina Kannada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,429.0,578.0,372.0,451.0,359.0,312.0,368.0,355.0,357.0,380.0,333.0,265.0,4559.0
Dakshina Kannada,4.1.1.a,Number of male live births,TOTAL,1437.0,1323.0,1120.0,1021.0,1159.0,1088.0,1253.0,1260.0,1168.0,1151.0,1038.0,1034.0,14052.0
Dakshina Kannada,4.1.1.b,Number of female live births,TOTAL,1277.0,1286.0,1082.0,1100.0,1118.0,1042.0,1307.0,1293.0,1144.0,1080.0,907.0,923.0,13559.0
Dakshina Kannada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2714.0,2609.0,2202.0,2121.0,2277.0,2130.0,2560.0,2553.0,2312.0,2231.0,1945.0,1957.0,27611.0
Dakshina Kannada,4.1.2,Number of still births,TOTAL,26.0,17.0,15.0,16.0,28.0,25.0,22.0,21.0,23.0,10.0,17.0,21.0,241.0
Dakshina Kannada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,165.0,134.0,143.0,122.0,159.0,142.0,153.0,160.0,134.0,121.0,146.0,114.0,1693.0
Dakshina Kannada,4.2.1,Number of Newborns weighed at birth,TOTAL,2600.0,2599.0,2204.0,2101.0,2277.0,2131.0,2556.0,2553.0,2312.0,2230.0,1945.0,1957.0,27465.0
Dakshina Kannada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,423.0,314.0,222.0,249.0,486.0,299.0,285.0,287.0,231.0,227.0,208.0,288.0,3519.0
Dakshina Kannada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2310.0,2244.0,2022.0,1668.0,2099.0,1799.0,2352.0,2276.0,2047.0,2083.0,1707.0,1793.0,24400.0
Dakshina Kannada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dakshina Kannada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,1.0,1.0,3.0,2.0,2.0,2.0,1.0,1.0,3.0,4.0,20.0
Dakshina Kannada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,240.0,242.0,232.0,216.0,171.0,175.0,227.0,324.0,272.0,168.0,202.0,180.0,2649.0
Dakshina Kannada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,240.0,243.0,233.0,217.0,174.0,177.0,229.0,326.0,273.0,169.0,205.0,184.0,2670.0
Dakshina Kannada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,72.0,59.0,71.0,48.0,71.0,85.0,120.0,140.0,142.0,117.0,113.0,160.0,1198.0
Dakshina Kannada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,348.0,344.0,354.0,297.0,287.0,405.0,420.0,399.0,392.0,277.0,278.0,277.0,4078.0
Dakshina Kannada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,52.0,25.0,23.0,21.0,21.0,48.0,59.0,35.0,43.0,28.0,38.0,39.0,432.0
Dakshina Kannada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,654.0,561.0,609.0,477.0,512.0,599.0,715.0,558.0,557.0,469.0,499.0,582.0,6792.0
Dakshina Kannada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,61.0,71.0,53.0,39.0,68.0,42.0,67.0,79.0,47.0,79.0,80.0,73.0,759.0
Dakshina Kannada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2330.0,2219.0,1858.0,1728.0,2286.0,2043.0,2487.0,2454.0,2267.0,2161.0,1911.0,1925.0,25669.0
Dakshina Kannada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2851.0,2738.0,2284.0,2181.0,2526.0,2210.0,2668.0,2677.0,2492.0,2489.0,1537.0,1627.0,28280.0
Dakshina Kannada,6.3,PNC maternal complications attended,TOTAL,16.0,15.0,15.0,2.0,3.0,2.0,0.0,5.0,0.0,3.0,0.0,1.0,62.0
Dakshina Kannada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,30.0,23.0,22.0,33.0,33.0,26.0,25.0,36.0,29.0,43.0,42.0,39.0,381.0
Dakshina Kannada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,6.0,2.0,7.0,5.0,9.0,8.0,16.0,9.0,16.0,14.0,5.0,101.0
Dakshina Kannada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,34.0,29.0,24.0,40.0,38.0,35.0,33.0,52.0,38.0,59.0,56.0,44.0,482.0
Dakshina Kannada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,103.0,100.0,96.0,82.0,105.0,91.0,106.0,91.0,93.0,75.0,73.0,71.0,1086.0
Dakshina Kannada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,189.0,184.0,189.0,216.0,142.0,159.0,229.0,229.0,177.0,150.0,127.0,90.0,2081.0
Dakshina Kannada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,438.0,470.0,452.0,388.0,415.0,435.0,536.0,492.0,401.0,349.0,337.0,354.0,5067.0
Dakshina Kannada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,627.0,654.0,641.0,604.0,557.0,594.0,765.0,721.0,578.0,499.0,464.0,444.0,7148.0
Dakshina Kannada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,18.0,18.0,18.0,11.0,16.0,43.0,19.0,19.0,13.0,13.0,13.0,14.0,215.0
Dakshina Kannada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,2.0,4.0,5.0,4.0,7.0,1.0,3.0,4.0,1.0,1.0,1.0,35.0
Dakshina Kannada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,2.0,4.0,5.0,4.0,7.0,1.0,3.0,4.0,1.0,1.0,1.0,35.0
Dakshina Kannada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,103.0,108.0,61.0,47.0,45.0,36.0,36.0,11.0,20.0,21.0,13.0,10.0,511.0
Dakshina Kannada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,56.0,34.0,39.0,89.0,26.0,32.0,25.0,40.0,23.0,4.0,42.0,20.0,430.0
Dakshina Kannada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,54.0,56.0,49.0,67.0,57.0,45.0,45.0,34.0,135.0,26.0,38.0,30.0,636.0
Dakshina Kannada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,213.0,198.0,149.0,203.0,128.0,113.0,106.0,85.0,178.0,51.0,93.0,60.0,1577.0
Dakshina Kannada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,16.0,21.0,15.0,16.0,16.0,6.0,30.0,18.0,13.0,21.0,5.0,2.0,179.0
Dakshina Kannada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,2.0,1.0,1.0,0.0,0.0,1.0,0.0,3.0,0.0,1.0,0.0,9.0
Dakshina Kannada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,2.0,1.0,1.0,0.0,0.0,1.0,0.0,3.0,0.0,1.0,0.0,9.0
Dakshina Kannada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,5.0,26.0,17.0,23.0,43.0,40.0,28.0,35.0,24.0,19.0,11.0,27.0,298.0
Dakshina Kannada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,3.0,1.0,1.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0,1.0,0.0,10.0
Dakshina Kannada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,94.0,96.0,115.0,114.0,87.0,112.0,116.0,139.0,101.0,75.0,73.0,80.0,1202.0
Dakshina Kannada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,97.0,97.0,116.0,114.0,88.0,113.0,116.0,139.0,101.0,77.0,74.0,80.0,1212.0
Dakshina Kannada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,99.0,73.0,56.0,57.0,83.0,71.0,40.0,53.0,30.0,46.0,47.0,32.0,687.0
Dakshina Kannada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,3.0,8.0,7.0,10.0,5.0,5.0,6.0,1.0,1.0,3.0,3.0,3.0,55.0
Dakshina Kannada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,132.0,118.0,159.0,146.0,126.0,133.0,113.0,120.0,96.0,96.0,110.0,87.0,1436.0
Dakshina Kannada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,26.0,30.0,39.0,52.0,33.0,28.0,32.0,36.0,41.0,31.0,29.0,35.0,412.0
Dakshina Kannada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,76.0,59.0,71.0,66.0,45.0,86.0,68.0,57.0,49.0,45.0,72.0,46.0,740.0
Dakshina Kannada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dakshina Kannada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,237.0,215.0,276.0,274.0,209.0,252.0,219.0,214.0,187.0,175.0,214.0,171.0,2643.0
Dakshina Kannada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,40.0,29.0,26.0,19.0,9.0,34.0,21.0,26.0,20.0,17.0,26.0,15.0,282.0
Dakshina Kannada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,186.0,118.0,113.0,67.0,60.0,49.0,39.0,51.0,49.0,64.0,31.0,36.0,863.0
Dakshina Kannada,9.06,Number of IUCD removals,TOTAL,128.0,83.0,91.0,108.0,108.0,94.0,93.0,93.0,73.0,118.0,72.0,92.0,1153.0
Dakshina Kannada,9.07,Number of Oral Pills cycles distributed,TOTAL,2828.0,2699.0,2484.0,2600.0,2670.0,2960.0,2773.0,2419.0,3119.0,3103.0,3051.0,3098.0,33804.0
Dakshina Kannada,9.08,Number of Condom pieces distributed,TOTAL,34918.0,35922.0,35806.0,36599.0,38480.0,37364.0,38403.0,38738.0,39439.0,39859.0,39740.0,39685.0,454953.0
Dakshina Kannada,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,10.0,0.0,0.0,0.0,24.0,0.0,35.0
Dakshina Kannada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,3.0
Dakshina Kannada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Dakshina Kannada,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,2.0,5.0,3.0,2.0,2.0,2.0,2.0,3.0,3.0,3.0,3.0,-1.0
Dakshina Kannada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2560.0,2441.0,2458.0,2529.0,2137.0,2042.0,2515.0,2657.0,2296.0,2268.0,2037.0,2069.0,28009.0
Dakshina Kannada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,15.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,17.0
Dakshina Kannada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Dakshina Kannada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,16.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0
Dakshina Kannada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2509.0,2790.0,2644.0,2722.0,2525.0,2525.0,2594.0,2913.0,2692.0,3136.0,2467.0,2264.0,31781.0
Dakshina Kannada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2308.0,2365.0,2709.0,2646.0,2524.0,2722.0,2668.0,2664.0,2610.0,3050.0,2706.0,2520.0,31492.0
Dakshina Kannada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2545.0,2308.0,2736.0,2531.0,2625.0,2708.0,2704.0,2769.0,2427.0,2892.0,2568.0,2640.0,31453.0
Dakshina Kannada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2194.0,2240.0,2155.0,2266.0,1888.0,1822.0,2296.0,2368.0,2054.0,2113.0,1826.0,1844.0,25066.0
Dakshina Kannada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2506.0,2786.0,2648.0,2721.0,2525.0,2517.0,2543.0,2916.0,2695.0,3134.0,2464.0,2262.0,31717.0
Dakshina Kannada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2316.0,2365.0,2716.0,2643.0,2524.0,2698.0,2615.0,2658.0,2618.0,3053.0,2705.0,2518.0,31429.0
Dakshina Kannada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2557.0,2309.0,2732.0,2534.0,2625.0,2689.0,2659.0,2769.0,2429.0,2890.0,2569.0,2643.0,31405.0
Dakshina Kannada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1291.0,1850.0,1796.0,1982.0,1677.0,1641.0,1959.0,1712.0,1723.0,1893.0,1598.0,1509.0,20631.0
Dakshina Kannada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,14.0
Dakshina Kannada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,0.0,0.0,0.0,14.0
Dakshina Kannada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,4.0,0.0,0.0,0.0,0.0,3.0,11.0,0.0,2.0,0.0,0.0,0.0,20.0
Dakshina Kannada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2505.0,2362.0,2608.0,2512.0,2553.0,2745.0,2512.0,2756.0,2529.0,2989.0,2768.0,2599.0,31438.0
Dakshina Kannada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1863.0,1819.0,2090.0,1871.0,1834.0,2097.0,1845.0,2147.0,1902.0,1869.0,2069.0,1908.0,23314.0
Dakshina Kannada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1289.0,1239.0,1321.0,1228.0,1296.0,1363.0,1226.0,1353.0,1293.0,1537.0,1400.0,1301.0,15846.0
Dakshina Kannada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1157.0,1099.0,1241.0,1241.0,1227.0,1329.0,1226.0,1334.0,1160.0,1397.0,1289.0,1239.0,14939.0
Dakshina Kannada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2446.0,2338.0,2562.0,2469.0,2523.0,2692.0,2452.0,2687.0,2453.0,2934.0,2689.0,2540.0,30785.0
Dakshina Kannada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2080.0,1971.0,2307.0,2133.0,2091.0,2336.0,2392.0,2709.0,2223.0,2161.0,2318.0,2153.0,26874.0
Dakshina Kannada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2082.0,1940.0,2307.0,2133.0,2091.0,2300.0,2314.0,2709.0,2222.0,2159.0,2317.0,2154.0,26728.0
Dakshina Kannada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,139.0,98.0,42.0,125.0,82.0,49.0,127.0,77.0,94.0,151.0,121.0,81.0,1186.0
Dakshina Kannada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,250.0,230.0,238.0,290.0,207.0,164.0,203.0,127.0,151.0,85.0,177.0,94.0,2216.0
Dakshina Kannada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,279.0,223.0,223.0,249.0,169.0,139.0,195.0,123.0,149.0,93.0,137.0,86.0,2065.0
Dakshina Kannada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,529.0,453.0,461.0,539.0,376.0,303.0,398.0,250.0,300.0,178.0,314.0,180.0,4281.0
Dakshina Kannada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,291.0,103.0,636.0,1874.0,3495.0,4577.0,346.0,3083.0,2408.0,2057.0,1187.0,388.0,20445.0
Dakshina Kannada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,285.0,78.0,586.0,2014.0,3626.0,4519.0,223.0,3171.0,2658.0,2167.0,1410.0,371.0,21108.0
Dakshina Kannada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,223.0,49.0,535.0,2835.0,3904.0,4594.0,357.0,3853.0,2714.0,2903.0,1468.0,746.0,24181.0
Dakshina Kannada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,3.0,1.0,2.0,2.0,0.0,2.0,1.0,0.0,2.0,1.0,2.0,16.0
Dakshina Kannada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,4.0,1.0,1.0,1.0,1.0,2.0,1.0,1.0,1.0,1.0,5.0,21.0
Dakshina Kannada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,714.0,701.0,729.0,693.0,730.0,720.0,736.0,735.0,725.0,763.0,755.0,722.0,8723.0
Dakshina Kannada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,741.0,699.0,728.0,708.0,728.0,718.0,734.0,733.0,723.0,758.0,748.0,720.0,8738.0
Dakshina Kannada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,509.0,494.0,510.0,508.0,540.0,505.0,511.0,513.0,517.0,536.0,519.0,500.0,6162.0
Dakshina Kannada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2484.0,2344.0,2581.0,2494.0,2764.0,2724.0,2501.0,2753.0,2603.0,3056.0,2857.0,2901.0,32062.0
Dakshina Kannada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,0.0,31.0,25046.0,140.0,0.0,2.0,2.0,0.0,9054.0,13524.0,47799.0
Dakshina Kannada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,35.0,25490.0,188.0,0.0,0.0,0.0,0.0,9267.0,14431.0,49411.0
Dakshina Kannada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,3.0,1.0,8.0,14.0,2.0,4.0,3.0,1.0,5.0,13.0,1.0,59.0
Dakshina Kannada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,455.0,489.0,563.0,535.0,659.0,481.0,431.0,464.0,449.0,502.0,577.0,483.0,6088.0
Dakshina Kannada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,18.0,10.0,15.0,6.0,27.0,28.0,47.0,28.0,9.0,18.0,47.0,5.0,258.0
Dakshina Kannada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,76.0,78.0,154.0,123.0,185.0,200.0,146.0,58.0,71.0,67.0,100.0,113.0,1371.0
Dakshina Kannada,13.1,Number of Patients operated for cataract,TOTAL,252.0,258.0,300.0,193.0,242.0,249.0,247.0,248.0,200.0,195.0,143.0,159.0,2686.0
Dakshina Kannada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,252.0,258.0,270.0,193.0,242.0,219.0,247.0,248.0,200.0,195.0,143.0,159.0,2626.0
Dakshina Kannada,13.3,Number of School children detected with Refractive errors,TOTAL,83.0,25.0,20.0,316.0,131.0,134.0,31.0,106.0,130.0,189.0,73.0,43.0,1281.0
Dakshina Kannada,13.4,Number of children provided free glasses,TOTAL,57.0,6.0,6.0,9.0,23.0,31.0,9.0,84.0,94.0,86.0,39.0,45.0,489.0
Dakshina Kannada,13.5,Number of eyes collected through eye donation,TOTAL,4.0,2.0,0.0,0.0,2.0,4.0,8.0,4.0,2.0,10.0,0.0,0.0,36.0
Dakshina Kannada,13.6,Number of eyes utilised for corneal transplant,TOTAL,4.0,2.0,0.0,0.0,2.0,4.0,8.0,4.0,2.0,10.0,0.0,0.0,36.0
Dakshina Kannada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,4.0,4.0,4.0,5.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,-1.0
Dakshina Kannada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,10.0,10.0,9.0,8.0,9.0,8.0,9.0,9.0,9.0,8.0,9.0,9.0,-1.0
Dakshina Kannada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,386.0,391.0,407.0,395.0,410.0,397.0,397.0,402.0,395.0,394.0,403.0,415.0,-1.0
Dakshina Kannada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,7.0,6.0,9.0,8.0,9.0,9.0,8.0,8.0,7.0,7.0,9.0,-1.0
Dakshina Kannada,14.05,Number of RKS meetings held during the month,TOTAL,15.0,15.0,15.0,14.0,12.0,15.0,16.0,14.0,12.0,26.0,26.0,22.0,202.0
Dakshina Kannada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,20.0,21.0,19.0,17.0,18.0,19.0,19.0,20.0,21.0,18.0,18.0,20.0,-1.0
Dakshina Kannada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,435.0,358.0,333.0,238.0,359.0,298.0,255.0,250.0,235.0,258.0,277.0,297.0,3593.0
Dakshina Kannada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,7.0,7.0,6.0,6.0,7.0,6.0,6.0,6.0,7.0,7.0,8.0,6.0,-1.0
Dakshina Kannada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,15.0,15.0,16.0,16.0,17.0,18.0,17.0,16.0,16.0,16.0,16.0,17.0,-1.0
Dakshina Kannada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,2302.0,1818.0,2010.0,2121.0,2098.0,1958.0,2501.0,2149.0,2725.0,2044.0,1959.0,1776.0,25461.0
Dakshina Kannada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,9452.0,8651.0,8705.0,8153.0,8806.0,9629.0,10771.0,10613.0,8369.0,7863.0,8192.0,7962.0,107166.0
Dakshina Kannada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1962.0,1409.0,1530.0,1741.0,1564.0,1389.0,1646.0,1257.0,1283.0,1243.0,1463.0,1505.0,17992.0
Dakshina Kannada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,9713.0,8878.0,9023.0,8010.0,11154.0,11741.0,8795.0,8504.0,8093.0,10395.0,7816.0,8871.0,110993.0
Dakshina Kannada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,4264.0,3227.0,3540.0,3862.0,3662.0,3347.0,4147.0,3406.0,4008.0,3287.0,3422.0,3281.0,43453.0
Dakshina Kannada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,19165.0,17529.0,17728.0,16163.0,19960.0,21370.0,19566.0,19117.0,16462.0,18258.0,16008.0,16833.0,218159.0
Dakshina Kannada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,173.0,175.0,172.0,121.0,211.0,190.0,172.0,198.0,166.0,192.0,186.0,122.0,2078.0
Dakshina Kannada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,84.0,70.0,81.0,79.0,102.0,77.0,94.0,98.0,95.0,83.0,84.0,114.0,1061.0
Dakshina Kannada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,257.0,245.0,253.0,200.0,313.0,267.0,266.0,296.0,261.0,275.0,270.0,236.0,3139.0
Dakshina Kannada,14.11,In-Patient Head Count at midnight,TOTAL,42953.0,49463.0,39019.0,40435.0,47381.0,47116.0,49455.0,53214.0,98538.0,40951.0,34240.0,30564.0,573329.0
Dakshina Kannada,14.12.1,OPD attendance (All),TOTAL,325208.0,275588.0,316650.0,308319.0,363056.0,363471.0,314098.0,336961.0,319741.0,331755.0,298458.0,258055.0,3811360.0
Dakshina Kannada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,5103.0,4069.0,4215.0,3140.0,5074.0,4268.0,4883.0,4285.0,4799.0,4516.0,3462.0,3429.0,51243.0
Dakshina Kannada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,38.0,32.0,40.0,50.0,22.0,39.0,29.0,57.0,89.0,38.0,40.0,32.0,506.0
Dakshina Kannada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,5388.0,3921.0,3784.0,3795.0,5660.0,4759.0,5744.0,5282.0,5774.0,5558.0,4110.0,3322.0,57097.0
Dakshina Kannada,14.14.a,Number of patients given AYUSH treatment,TOTAL,3324.0,3587.0,3714.0,3072.0,3306.0,3655.0,3820.0,2988.0,2389.0,2887.0,4887.0,4246.0,41875.0
Dakshina Kannada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1627.0,2077.0,2125.0,2105.0,2593.0,2805.0,2410.0,2018.0,2192.0,2580.0,2547.0,1817.0,26896.0
Dakshina Kannada,14.14.c,Number of Adolescents counselled,TOTAL,504.0,534.0,559.0,544.0,924.0,679.0,523.0,514.0,457.0,478.0,429.0,498.0,6643.0
Dakshina Kannada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,18857.0,16532.0,17615.0,12712.0,21434.0,20777.0,19540.0,18527.0,17660.0,23929.0,17867.0,16579.0,222029.0
Dakshina Kannada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,364.0,305.0,404.0,330.0,498.0,416.0,353.0,279.0,265.0,288.0,346.0,387.0,4235.0
Dakshina Kannada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2360.0,1790.0,2191.0,1729.0,2941.0,2105.0,2472.0,2923.0,1742.0,2250.0,2032.0,1596.0,26131.0
Dakshina Kannada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,36.0,26.0,28.0,18.0,33.0,20.0,23.0,22.0,15.0,17.0,17.0,22.0,277.0
Dakshina Kannada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1840.0,1226.0,1289.0,1041.0,1725.0,1293.0,1577.0,1707.0,1090.0,1604.0,1030.0,948.0,16370.0
Dakshina Kannada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,14.0,14.0,20.0,13.0,22.0,11.0,13.0,12.0,12.0,8.0,9.0,10.0,158.0
Dakshina Kannada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2165.0,1890.0,2458.0,2107.0,2258.0,2350.0,2025.0,2398.0,2029.0,2049.0,2316.0,1888.0,25933.0
Dakshina Kannada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,1.0,1.0,5.0,2.0,5.0,0.0,1.0,0.0,1.0,2.0,1.0,25.0
Dakshina Kannada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6365.0,4906.0,5938.0,4877.0,6924.0,5748.0,6074.0,7028.0,4861.0,5903.0,5378.0,4432.0,68434.0
Dakshina Kannada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,56.0,41.0,49.0,36.0,57.0,36.0,36.0,35.0,27.0,26.0,28.0,33.0,460.0
Dakshina Kannada,15.2,Number of Widal tests conducted,Number tested,1392.0,1372.0,1793.0,2141.0,2182.0,2401.0,1616.0,1148.0,1247.0,930.0,1365.0,1261.0,18848.0
Dakshina Kannada,15.3.a,Number of VDRL tests conducted on males,Number tested,244.0,146.0,164.0,136.0,101.0,144.0,72.0,191.0,126.0,94.0,53.0,75.0,1546.0
Dakshina Kannada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,263.0,321.0,443.0,169.0,328.0,331.0,280.0,317.0,178.0,360.0,267.0,193.0,3450.0
Dakshina Kannada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1929.0,1597.0,1871.0,1743.0,1619.0,1965.0,1521.0,1810.0,1625.0,1764.0,1665.0,1548.0,20657.0
Dakshina Kannada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2436.0,2064.0,2478.0,2048.0,2048.0,2440.0,1873.0,2318.0,1929.0,2218.0,1985.0,1816.0,25653.0
Dakshina Kannada,15.4.1,Number of blood smears examined for Malaria,TOTAL,19365.0,25136.0,35133.0,37466.0,37783.0,41543.0,23955.0,23393.0,21425.0,20804.0,20733.0,19342.0,326078.0
Dakshina Kannada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,625.0,796.0,1157.0,1268.0,1373.0,1331.0,970.0,917.0,726.0,1120.0,403.0,319.0,11005.0
Dakshina Kannada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,75.0,108.0,146.0,238.0,254.0,181.0,149.0,144.0,96.0,128.0,49.0,39.0,1607.0
Dakshina Kannada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,230.0,0.0,360.0,220.0,20.0,140.0,60.0,760.0,1010.0,210.0,230.0,660.0,3900.0
Dakshina Kannada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4730.0,4000.0,7500.0,17500.0,4500.0,5000.0,3000.0,8000.0,5000.0,3500.0,2500.0,4000.0,69230.0
Dakshina Kannada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4960.0,3640.0,7640.0,17700.0,4380.0,5080.0,2300.0,7750.0,5800.0,3480.0,2070.0,2680.0,67480.0
Dakshina Kannada,16.1.1,Stock position of DPT vaccines,5. Total Stock,0.0,360.0,220.0,20.0,140.0,60.0,760.0,1010.0,210.0,230.0,660.0,1980.0,5650.0
Dakshina Kannada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,31460.0,0.0,90.0,940.0,1010.0,710.0,0.0,130.0,0.0,720.0,500.0,1430.0,36990.0
Dakshina Kannada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,8920.0,3000.0,10000.0,7000.0,3000.0,5000.0,5000.0,10000.0,11000.0,8000.0,8000.0,7000.0,85920.0
Dakshina Kannada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,40380.0,2910.0,9150.0,6930.0,3300.0,5710.0,4870.0,10130.0,10280.0,8220.0,7070.0,5580.0,114530.0
Dakshina Kannada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,0.0,90.0,940.0,1010.0,710.0,0.0,130.0,0.0,720.0,500.0,1430.0,2850.0,8380.0
Dakshina Kannada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,25880.0,0.0,60.0,820.0,480.0,0.0,1940.0,1420.0,140.0,180.0,680.0,4380.0,35980.0
Dakshina Kannada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15400.0,9000.0,16000.0,20000.0,0.0,15340.0,12000.0,12500.0,21000.0,12000.0,15000.0,9000.0,157240.0
Dakshina Kannada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,41280.0,8940.0,15240.0,20340.0,480.0,13400.0,12520.0,13780.0,20960.0,11500.0,11300.0,10320.0,180060.0
Dakshina Kannada,16.1.2,Stock position of OPV vaccines,5. Total Stock,0.0,60.0,820.0,480.0,0.0,1940.0,1420.0,140.0,180.0,680.0,4380.0,3060.0,13160.0
Dakshina Kannada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,20400.0,0.0,150.0,350.0,2200.0,1500.0,810.0,870.0,380.0,940.0,440.0,1940.0,29980.0
Dakshina Kannada,16.1.3,Stock position of TT vaccines,2. Stocks Received,13070.0,6500.0,9500.0,23000.0,10000.0,11000.0,7000.0,13000.0,18000.0,7300.0,8000.0,7000.0,133370.0
Dakshina Kannada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,33470.0,6350.0,9300.0,21150.0,10700.0,11690.0,6940.0,13490.0,17440.0,7800.0,6500.0,7310.0,152140.0
Dakshina Kannada,16.1.3,Stock position of TT vaccines,5. Total Stock,0.0,150.0,350.0,2200.0,1500.0,810.0,870.0,380.0,940.0,440.0,1940.0,1630.0,11210.0
Dakshina Kannada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,7890.0,0.0,0.0,320.0,0.0,660.0,460.0,240.0,30.0,610.0,420.0,1070.0,11700.0
Dakshina Kannada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5160.0,1000.0,7000.0,4000.0,3000.0,3000.0,3000.0,5000.0,5000.0,2500.0,4000.0,3000.0,45660.0
Dakshina Kannada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,13050.0,1000.0,6680.0,4320.0,2340.0,3200.0,3220.0,5210.0,4420.0,2690.0,3350.0,3800.0,53280.0
Dakshina Kannada,16.1.5,Stock position of BCG vaccines,5. Total Stock,0.0,0.0,320.0,0.0,660.0,460.0,240.0,30.0,610.0,420.0,1070.0,270.0,4080.0
Dakshina Kannada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,18715.0,0.0,120.0,410.0,525.0,475.0,1050.0,1135.0,645.0,155.0,675.0,1060.0,24965.0
Dakshina Kannada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,7935.0,3750.0,4000.0,7000.0,1500.0,5000.0,3000.0,6000.0,5500.0,6030.0,4000.0,4000.0,57715.0
Dakshina Kannada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,26650.0,3630.0,3710.0,6885.0,1550.0,4425.0,2915.0,6490.0,5990.0,5510.0,3615.0,3325.0,74695.0
Dakshina Kannada,16.1.6,Stock position of Measles vaccines,5. Total Stock,0.0,120.0,410.0,525.0,475.0,1050.0,1135.0,645.0,155.0,675.0,1060.0,1735.0,7985.0
Dakshina Kannada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3270.0,0.0,200.0,0.0,0.0,370.0,0.0,170.0,170.0,70.0,70.0,120.0,4440.0
Dakshina Kannada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,800.0,500.0,0.0,300.0,1200.0,530.0,1970.0,1300.0,600.0,1500.0,500.0,2000.0,11200.0
Dakshina Kannada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,1500.0,0.0,0.0,1500.0
Dakshina Kannada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,4070.0,300.0,200.0,300.0,830.0,900.0,1800.0,1300.0,700.0,,450.0,750.0,11600.0
Dakshina Kannada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,200.0,0.0,0.0,370.0,0.0,170.0,170.0,70.0,70.0,120.0,1370.0,2540.0
Dakshina Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3850.0,3250.0,1800.0,1800.0,1750.0,1750.0,50.0,50.0,0.0,0.0,300.0,290.0,14890.0
Dakshina Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,600.0
Dakshina Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,1450.0,0.0,50.0,0.0,1700.0,0.0,50.0,0.0,300.0,10.0,100.0,4260.0
Dakshina Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3250.0,1800.0,1800.0,1750.0,1750.0,50.0,50.0,0.0,0.0,300.0,290.0,190.0,11230.0
Dakshina Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,60480.0,60480.0,24384.0,0.0,0.0,0.0,0.0,0.0,145344.0
Dakshina Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,151200.0,60480.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,211680.0
Dakshina Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,151200.0,0.0,0.0,36096.0,24384.0,0.0,0.0,0.0,0.0,0.0,211680.0
Dakshina Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,60480.0,60480.0,24384.0,0.0,0.0,0.0,0.0,0.0,0.0,145344.0
Dakshina Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,1600.0,1500.0,1270.0,6370.0
Dakshina Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,0.0,0.0,0.0,16000.0
Dakshina Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14000.0,400.0,100.0,230.0,0.0,14730.0
Dakshina Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,1600.0,1500.0,1270.0,1270.0,7640.0
Dakshina Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Dakshina Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,600.0,15000.0
Dakshina Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,1600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1600.0
Dakshina Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,1000.0,0.0,1000.0
Dakshina Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,1600.0,600.0,600.0,15600.0
Dakshina Kannada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0
Dakshina Kannada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,,0.0,0.0
Dakshina Kannada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,,,0.0,0.0
Dakshina Kannada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,35047.0,35047.0,,0.0,0.0,70094.0
Dakshina Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,,,0.0,0.0,0.0
Dakshina Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,35047.0,35047.0,0.0,0.0,0.0,70094.0
Dakshina Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,,0.0,0.0,,1500.0,800.0,2300.0
Dakshina Kannada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,,,0.0,,0.0,0.0,,1494.0,0.0,1494.0
Dakshina Kannada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,,,0.0,,0.0,0.0,,2194.0,28.0,2222.0
Dakshina Kannada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,800.0,772.0,1572.0
Dakshina Kannada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,,,0.0,,0.0,0.0,,6198.0,5798.0,11996.0
Dakshina Kannada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,,,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,,0.0,,0.0,0.0,,0.0,0.0,0.0
Dakshina Kannada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,,,0.0,,0.0,0.0,,400.0,300.0,700.0
Dakshina Kannada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5798.0,5498.0,11296.0
Dakshina Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,13400.0,,400.0,400.0,0.0,3000.0,100.0,2000.0,200.0,800.0,1000.0,1600.0,22900.0
Dakshina Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,2400.0,1000.0,1000.0,37400.0,3000.0,0.0,3300.0,2000.0,1500.0,2000.0,1400.0,2000.0,57000.0
Dakshina Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,15800.0,600.0,1000.0,37800.0,0.0,2900.0,1400.0,3800.0,900.0,1800.0,800.0,2200.0,69000.0
Dakshina Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,400.0,400.0,0.0,3000.0,100.0,2000.0,200.0,800.0,1000.0,1600.0,1400.0,10900.0
Dakshina Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,18600.0,0.0,1200.0,1800.0,0.0,17000.0,0.0,3800.0,1600.0,5400.0,4800.0,3200.0,57400.0
Dakshina Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,6200.0,2400.0,24000.0,1800.0,24000.0,0.0,30000.0,6800.0,24000.0,14400.0,24000.0,19200.0,176800.0
Dakshina Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,24800.0,1200.0,23400.0,3600.0,7000.0,17000.0,26200.0,9000.0,20200.0,15000.0,25600.0,18200.0,191200.0
Dakshina Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,1200.0,1800.0,0.0,17000.0,0.0,3800.0,1600.0,5400.0,4800.0,3200.0,4200.0,43000.0
Dakshina Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10900.0,0.0,400.0,300.0,0.0,0.0,700.0,500.0,200.0,100.0,0.0,1200.0,14300.0
Dakshina Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,100.0,500.0,0.0,300.0,0.0,2100.0,0.0,0.0,0.0,5250.0,2200.0,0.0,10450.0
Dakshina Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dakshina Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,11000.0,100.0,100.0,600.0,0.0,1400.0,200.0,300.0,100.0,5350.0,1000.0,0.0,20150.0
Dakshina Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,400.0,300.0,0.0,0.0,700.0,500.0,200.0,100.0,0.0,1200.0,1200.0,4600.0
Dakshina Kannada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,1.0,1.0,,2.0,3.0,,,2.0,,2.0,1.0,15.0
Dakshina Kannada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,3.0,1.0,1.0,2.0,,2.0,3.0,1.0,,5.0,5.0,2.0,25.0
Dakshina Kannada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,,,2.0,,,,1.0,1.0,1.0,6.0
Dakshina Kannada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,3.0,1.0,2.0,2.0,,4.0,3.0,1.0,,6.0,6.0,3.0,31.0
Dakshina Kannada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,3.0,2.0,1.0,1.0,,,,2.0,1.0,10.0
Dakshina Kannada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,1.0,,1.0,,,1.0,,,,3.0
Dakshina Kannada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,4.0,2.0,2.0,1.0,,1.0,,2.0,1.0,13.0
Dakshina Kannada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,1.0,2.0,3.0,1.0,,2.0,1.0,4.0,2.0,17.0
Dakshina Kannada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Dakshina Kannada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,,1.0,2.0,3.0,1.0,,2.0,1.0,4.0,2.0,18.0
Dakshina Kannada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,,2.0,3.0,5.0,5.0,7.0,5.0,7.0,3.0,8.0,6.0,54.0
Dakshina Kannada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,2.0,,,,1.0,3.0,,2.0,3.0,12.0
Dakshina Kannada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,,2.0,5.0,5.0,5.0,7.0,6.0,10.0,3.0,10.0,9.0,66.0
Dakshina Kannada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,2.0,1.0,,1.0,1.0,,,,,7.0
Dakshina Kannada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dakshina Kannada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,2.0,1.0,,1.0,1.0,,,,,7.0
Dakshina Kannada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dakshina Kannada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dakshina Kannada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dakshina Kannada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Dakshina Kannada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dakshina Kannada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,1.0,1.0
Dakshina Kannada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dakshina Kannada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dakshina Kannada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dakshina Kannada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,10.0,,2.0,3.0,11.0,2.0,3.0,7.0,9.0,7.0,4.0,6.0,64.0
Dakshina Kannada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,,2.0,1.0,4.0,3.0,2.0,,,,13.0
Dakshina Kannada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,10.0,1.0,2.0,3.0,13.0,3.0,7.0,10.0,11.0,7.0,4.0,6.0,77.0
Dakshina Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Dakshina Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,1.0,,,,,,,,,,,1.0
Dakshina Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,3.0,1.0,,2.0,1.0,,2.0,1.0,,,,11.0
Dakshina Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,1.0,2.0,,,,5.0,1.0,,2.0,2.0,15.0
Dakshina Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,5.0,2.0,2.0,2.0,1.0,,7.0,2.0,,2.0,2.0,26.0
Dakshina Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,2.0,1.0,1.0,,,,4.0
Dakshina Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,23.0,8.0,16.0,27.0,26.0,21.0,14.0,29.0,21.0,42.0,20.0,19.0,266.0
Dakshina Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,18.0,20.0,37.0,28.0,39.0,29.0,26.0,31.0,36.0,24.0,20.0,25.0,333.0
Dakshina Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,41.0,28.0,53.0,55.0,65.0,50.0,42.0,61.0,58.0,66.0,40.0,44.0,603.0
Dakshina Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,1.0,2.0,1.0,,2.0,1.0,2.0,2.0,,,,11.0
Dakshina Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,,,,1.0,1.0,1.0,1.0,,,,,5.0
Dakshina Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,1.0,2.0,1.0,1.0,3.0,2.0,3.0,2.0,,,,16.0
Dakshina Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,3.0,1.0,,,1.0,1.0,3.0,1.0,1.0,,4.0,16.0
Dakshina Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,43.0,73.0,54.0,32.0,50.0,37.0,46.0,44.0,46.0,60.0,62.0,53.0,600.0
Dakshina Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,31.0,37.0,38.0,26.0,31.0,25.0,25.0,26.0,17.0,29.0,44.0,22.0,351.0
Dakshina Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,75.0,113.0,93.0,58.0,81.0,63.0,72.0,73.0,64.0,90.0,106.0,79.0,967.0
Dakshina Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Dakshina Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,11.0,2.0,1.0,1.0,8.0,4.0,2.0,3.0,4.0,,,3.0,39.0
Dakshina Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,2.0,,3.0,,,,,1.0,,,7.0
Dakshina Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,13.0,2.0,3.0,1.0,11.0,4.0,2.0,3.0,4.0,1.0,,3.0,47.0
Dakshina Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Dakshina Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,21.0,23.0,36.0,26.0,30.0,32.0,37.0,45.0,30.0,41.0,35.0,30.0,386.0
Dakshina Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,69.0,49.0,89.0,53.0,112.0,90.0,69.0,67.0,96.0,86.0,78.0,48.0,906.0
Dakshina Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,90.0,72.0,125.0,79.0,142.0,122.0,106.0,113.0,126.0,127.0,113.0,78.0,1293.0
Dakshina Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,,1.0,,,,,,,,,2.0
Dakshina Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,9.0,10.0,4.0,12.0,6.0,10.0,8.0,8.0,7.0,9.0,10.0,95.0
Dakshina Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,36.0,31.0,38.0,51.0,69.0,66.0,46.0,38.0,54.0,47.0,46.0,40.0,562.0
Dakshina Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,38.0,41.0,48.0,56.0,81.0,72.0,56.0,46.0,62.0,54.0,55.0,50.0,659.0
Dakshina Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Dakshina Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,1.0,1.0
Dakshina Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,1.0,,,2.0,,,,,,,2.0,7.0
Dakshina Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dakshina Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,1.0,,,2.0,,,,,,,2.0,7.0
Dakshina Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,,,,,1.0,,,,,1.0,4.0
Dakshina Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,9.0,10.0,13.0,10.0,12.0,10.0,12.0,8.0,8.0,17.0,10.0,9.0,128.0
Dakshina Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,3.0,7.0,6.0,3.0,14.0,9.0,6.0,5.0,9.0,5.0,8.0,77.0
Dakshina Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,12.0,14.0,20.0,16.0,15.0,24.0,22.0,14.0,13.0,26.0,15.0,18.0,209.0
Dakshina Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,,,1.0,,,,2.0
Dakshina Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,9.0,13.0,10.0,8.0,21.0,17.0,17.0,18.0,15.0,13.0,14.0,162.0
Dakshina Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,5.0,8.0,6.0,5.0,5.0,7.0,8.0,4.0,5.0,8.0,10.0,4.0,75.0
Dakshina Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,12.0,18.0,19.0,15.0,13.0,28.0,25.0,21.0,24.0,23.0,23.0,18.0,239.0
Dakshina Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Dakshina Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,,1.0,,,,,,,1.0,,3.0
Dakshina Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,,,,,,,,,2.0
Dakshina Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,1.0,2.0,,,,,,,1.0,,5.0
Dakshina Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,,,2.0,,,,,,3.0
Dakshina Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,11.0,24.0,19.0,21.0,30.0,36.0,35.0,33.0,25.0,22.0,17.0,19.0,292.0
Dakshina Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,50.0,18.0,35.0,43.0,55.0,47.0,30.0,38.0,35.0,36.0,43.0,32.0,462.0
Dakshina Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,62.0,42.0,54.0,64.0,85.0,83.0,67.0,71.0,60.0,58.0,60.0,51.0,757.0
Dakshina Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,,1.0,,,,2.0
Dakshina Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,18.0,9.0,22.0,13.0,15.0,13.0,4.0,14.0,5.0,17.0,13.0,14.0,157.0
Dakshina Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,42.0,29.0,38.0,38.0,38.0,44.0,42.0,39.0,28.0,28.0,36.0,32.0,434.0
Dakshina Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,60.0,38.0,60.0,51.0,53.0,58.0,46.0,53.0,34.0,45.0,49.0,46.0,593.0
Dakshina Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,1.0,2.0,,,,,,,,4.0
Dakshina Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,16.0,14.0,13.0,9.0,23.0,26.0,14.0,17.0,12.0,11.0,12.0,5.0,172.0
Dakshina Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,34.0,36.0,46.0,75.0,87.0,81.0,88.0,73.0,62.0,72.0,62.0,45.0,761.0
Dakshina Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,50.0,51.0,59.0,85.0,112.0,107.0,102.0,90.0,74.0,83.0,74.0,50.0,937.0
Davanagere,1.1,Total number of pregnant women Registered for ANC,TOTAL,3066.0,3310.0,3270.0,3138.0,3091.0,3068.0,2843.0,3219.0,3146.0,2819.0,2826.0,2743.0,36539.0
Davanagere,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2039.0,2255.0,2386.0,2328.0,2308.0,2153.0,1980.0,2447.0,2092.0,2004.0,2096.0,2148.0,26236.0
Davanagere,1.2,Number of Pregnant women registered under JSY,TOTAL,2365.0,2375.0,2700.0,2372.0,2503.0,2516.0,2259.0,2744.0,2432.0,2270.0,2219.0,2311.0,29066.0
Davanagere,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3555.0,3402.0,5114.0,3664.0,4332.0,4524.0,3702.0,3962.0,3737.0,4028.0,3837.0,3446.0,47303.0
Davanagere,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2553.0,2548.0,2820.0,2608.0,2639.0,2597.0,2158.0,2578.0,2389.0,2372.0,2389.0,2762.0,30413.0
Davanagere,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3225.0,3312.0,3554.0,3545.0,3371.0,3007.0,2738.0,3259.0,3158.0,3046.0,2868.0,3209.0,38292.0
Davanagere,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2154.0,3224.0,6527.0,2225.0,2113.0,2654.0,2099.0,2111.0,2022.0,2807.0,10023.0,5620.0,43579.0
Davanagere,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,57.0,134.0,72.0,91.0,170.0,159.0,73.0,123.0,111.0,127.0,137.0,91.0,1345.0
Davanagere,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,64.0,108.0,55.0,71.0,107.0,97.0,69.0,39.0,29.0,12.0,22.0,22.0,695.0
Davanagere,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2156.0,3065.0,2644.0,3682.0,2449.0,2842.0,2743.0,2520.0,2663.0,2596.0,2916.0,2986.0,33262.0
Davanagere,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,163.0,141.0,236.0,184.0,160.0,112.0,75.0,97.0,147.0,91.0,136.0,160.0,1702.0
Davanagere,1.8,Number of pregnancy test kits used at SC level,TOTAL,278.0,309.0,238.0,180.0,228.0,165.0,196.0,206.0,193.0,218.0,219.0,268.0,2698.0
Davanagere,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,7.0,14.0,6.0,10.0,6.0,4.0,9.0,7.0,3.0,11.0,2.0,0.0,79.0
Davanagere,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2.0,5.0,3.0,16.0,2.0,1.0,6.0,4.0,2.0,1.0,1.0,0.0,43.0
Davanagere,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,9.0,19.0,9.0,26.0,8.0,5.0,15.0,11.0,5.0,12.0,3.0,0.0,122.0
Davanagere,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,6.0,10.0,7.0,8.0,5.0,2.0,7.0,9.0,4.0,11.0,2.0,0.0,71.0
Davanagere,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,1.0,0.0,1.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,6.0
Davanagere,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1967.0,1862.0,1923.0,1784.0,1949.0,1987.0,1822.0,1974.0,1858.0,1895.0,1940.0,1760.0,22721.0
Davanagere,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,670.0,558.0,756.0,599.0,774.0,816.0,1132.0,1261.0,1055.0,1242.0,1034.0,1021.0,10918.0
Davanagere,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,309.0,727.0,643.0,294.0,471.0,826.0,391.0,414.0,918.0,705.0,459.0,680.0,6837.0
Davanagere,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,18.0,17.0,0.0,0.0,0.0,0.0,3.0,5.0,0.0,0.0,3.0,46.0
Davanagere,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,124.0,114.0,105.0,114.0,130.0,131.0,114.0,139.0,332.0,319.0,709.0,832.0,3163.0
Davanagere,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,267.0,358.0,433.0,402.0,417.0,451.0,743.0,448.0,441.0,449.0,469.0,421.0,5299.0
Davanagere,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,267.0,358.0,433.0,402.0,417.0,451.0,743.0,448.0,441.0,449.0,469.0,421.0,5299.0
Davanagere,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,36.0,69.0,45.0,74.0,80.0,85.0,67.0,61.0,149.0,171.0,173.0,197.0,1207.0
Davanagere,4.1.1.a,Number of male live births,TOTAL,1058.0,1049.0,1058.0,1026.0,1099.0,1118.0,1048.0,1062.0,1153.0,1211.0,1409.0,1455.0,13746.0
Davanagere,4.1.1.b,Number of female live births,TOTAL,1075.0,951.0,1055.0,928.0,1035.0,1066.0,966.0,1072.0,1086.0,1100.0,1278.0,1306.0,12918.0
Davanagere,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2133.0,2000.0,2113.0,1954.0,2134.0,2184.0,2014.0,2134.0,2239.0,2311.0,2687.0,2761.0,26664.0
Davanagere,4.1.2,Number of still births,TOTAL,47.0,49.0,52.0,92.0,62.0,55.0,41.0,41.0,44.0,56.0,50.0,49.0,638.0
Davanagere,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,148.0,93.0,139.0,145.0,91.0,99.0,93.0,128.0,149.0,124.0,116.0,117.0,1442.0
Davanagere,4.2.1,Number of Newborns weighed at birth,TOTAL,1556.0,1868.0,2159.0,2001.0,2169.0,2203.0,2035.0,2176.0,2217.0,2311.0,2735.0,2728.0,26158.0
Davanagere,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,596.0,579.0,684.0,558.0,434.0,510.0,592.0,457.0,563.0,500.0,485.0,434.0,6392.0
Davanagere,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2072.0,1823.0,2104.0,1996.0,2000.0,2198.0,2036.0,2118.0,2191.0,2206.0,2694.0,2557.0,25995.0
Davanagere,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,6.0,4.0,6.0,13.0,6.0,16.0,12.0,11.0,10.0,7.0,11.0,108.0
Davanagere,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,1.0,0.0,0.0,5.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,15.0
Davanagere,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,16.0,27.0,12.0,16.0,30.0,2.0,31.0,10.0,22.0,39.0,27.0,25.0,257.0
Davanagere,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,26.0,34.0,16.0,22.0,48.0,8.0,47.0,22.0,38.0,49.0,34.0,36.0,380.0
Davanagere,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,2.0,2.0,1.0,2.0,2.0,0.0,0.0,0.0,15.0,8.0,0.0,1.0,33.0
Davanagere,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1219.0,920.0,1045.0,1157.0,1366.0,1004.0,963.0,799.0,799.0,964.0,1019.0,910.0,12165.0
Davanagere,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,83.0,106.0,71.0,144.0,101.0,99.0,91.0,64.0,48.0,101.0,94.0,59.0,1061.0
Davanagere,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,885.0,856.0,954.0,883.0,1113.0,1523.0,1243.0,959.0,1054.0,845.0,1135.0,1026.0,12476.0
Davanagere,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,201.0,117.0,95.0,197.0,162.0,208.0,208.0,192.0,113.0,180.0,136.0,144.0,1953.0
Davanagere,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1889.0,1673.0,1885.0,1773.0,1167.0,1833.0,1853.0,1301.0,1292.0,1021.0,926.0,903.0,17516.0
Davanagere,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2264.0,1761.0,2107.0,1971.0,1999.0,1963.0,1947.0,2003.0,1649.0,1912.0,1645.0,2065.0,23286.0
Davanagere,6.3,PNC maternal complications attended,TOTAL,5.0,5.0,1.0,3.0,12.0,87.0,10.0,2.0,4.0,4.0,12.0,33.0,178.0
Davanagere,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,37.0,39.0,54.0,66.0,45.0,59.0,43.0,38.0,56.0,74.0,50.0,46.0,607.0
Davanagere,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,55.0,38.0,58.0,42.0,37.0,36.0,58.0,61.0,72.0,43.0,41.0,41.0,582.0
Davanagere,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,92.0,77.0,112.0,108.0,82.0,95.0,101.0,99.0,128.0,117.0,91.0,87.0,1189.0
Davanagere,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,3.0,5.0,4.0,3.0,2.0,4.0,13.0,9.0,10.0,3.0,5.0,61.0
Davanagere,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,292.0,327.0,348.0,264.0,265.0,310.0,261.0,242.0,277.0,266.0,237.0,250.0,3339.0
Davanagere,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,834.0,749.0,1045.0,845.0,899.0,902.0,565.0,764.0,867.0,857.0,815.0,882.0,10024.0
Davanagere,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1126.0,1076.0,1393.0,1109.0,1164.0,1212.0,826.0,1006.0,1144.0,1123.0,1052.0,1132.0,13363.0
Davanagere,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,7.0,0.0,4.0,2.0,3.0,48.0,6.0,0.0,0.0,7.0,6.0,83.0
Davanagere,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Davanagere,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Davanagere,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,3.0,1.0,1.0,0.0,1.0,0.0,0.0,1.0,0.0,8.0
Davanagere,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,2.0,4.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,12.0
Davanagere,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,2.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Davanagere,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,30.0,22.0,27.0,9.0,7.0,5.0,0.0,13.0,5.0,14.0,0.0,9.0,141.0
Davanagere,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,30.0,24.0,27.0,14.0,7.0,5.0,0.0,13.0,5.0,14.0,0.0,9.0,148.0
Davanagere,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,186.0,165.0,168.0,203.0,206.0,196.0,189.0,192.0,173.0,189.0,192.0,189.0,2248.0
Davanagere,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,156.0,110.0,102.0,162.0,90.0,121.0,136.0,157.0,107.0,108.0,145.0,158.0,1552.0
Davanagere,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,61.0,66.0,55.0,40.0,52.0,66.0,93.0,108.0,105.0,79.0,66.0,58.0,849.0
Davanagere,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,200.0,267.0,238.0,266.0,210.0,297.0,198.0,334.0,356.0,296.0,351.0,221.0,3234.0
Davanagere,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,417.0,443.0,395.0,468.0,352.0,484.0,427.0,599.0,568.0,483.0,562.0,437.0,5635.0
Davanagere,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,150.0,151.0,152.0,162.0,162.0,148.0,134.0,149.0,150.0,155.0,158.0,172.0,1843.0
Davanagere,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,4.0,10.0,1.0,0.0,0.0,0.0,1.0,6.0,0.0,0.0,0.0,0.0,22.0
Davanagere,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,13.0,11.0,2.0,10.0,0.0,4.0,0.0,5.0,0.0,5.0,0.0,0.0,50.0
Davanagere,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,252.0,294.0,281.0,345.0,216.0,222.0,264.0,253.0,234.0,250.0,196.0,195.0,3002.0
Davanagere,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,269.0,315.0,284.0,355.0,216.0,226.0,265.0,264.0,234.0,255.0,196.0,195.0,3074.0
Davanagere,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,136.0,111.0,107.0,118.0,120.0,110.0,117.0,111.0,125.0,125.0,144.0,146.0,1470.0
Davanagere,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,134.0,107.0,133.0,110.0,99.0,138.0,131.0,126.0,105.0,131.0,115.0,99.0,1428.0
Davanagere,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,110.0,130.0,117.0,103.0,97.0,101.0,88.0,87.0,94.0,106.0,96.0,88.0,1217.0
Davanagere,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,8.0,25.0,26.0,34.0,34.0,26.0,21.0,24.0,20.0,20.0,18.0,17.0,273.0
Davanagere,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,133.0,133.0,100.0,92.0,93.0,91.0,75.0,74.0,45.0,74.0,64.0,69.0,1043.0
Davanagere,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Davanagere,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,385.0,395.0,376.0,339.0,323.0,356.0,315.0,311.0,264.0,331.0,293.0,273.0,3961.0
Davanagere,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,18.0,9.0,13.0,8.0,13.0,53.0,25.0,13.0,15.0,33.0,4.0,5.0,209.0
Davanagere,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,164.0,154.0,142.0,168.0,162.0,152.0,163.0,178.0,135.0,130.0,132.0,138.0,1818.0
Davanagere,9.06,Number of IUCD removals,TOTAL,217.0,206.0,207.0,238.0,189.0,197.0,183.0,145.0,186.0,114.0,141.0,136.0,2159.0
Davanagere,9.07,Number of Oral Pills cycles distributed,TOTAL,5417.0,5386.0,5284.0,7556.0,5424.0,4505.0,4423.0,5302.0,7112.0,5529.0,6560.0,6408.0,68906.0
Davanagere,9.08,Number of Condom pieces distributed,TOTAL,29506.0,26875.0,28600.0,29257.0,28379.0,30712.0,28251.0,28115.0,31189.0,34827.0,35132.0,39148.0,369991.0
Davanagere,9.09,Number of Centchroman (weekly) pills given,TOTAL,66.0,58.0,36.0,138.0,33.0,254.0,538.0,55.0,50.0,22.0,5.0,2.0,1257.0
Davanagere,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,35.0,42.0,98.0,90.0,33.0,31.0,32.0,8.0,80.0,68.0,15.0,53.0,585.0
Davanagere,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Davanagere,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0
Davanagere,9.12,Number of Institutions having NSV trained doctors,TOTAL,25.0,25.0,29.0,24.0,25.0,23.0,28.0,28.0,32.0,21.0,19.0,17.0,-1.0
Davanagere,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4126.0,3867.0,4145.0,3644.0,3600.0,4033.0,3686.0,4000.0,3632.0,3850.0,3597.0,3391.0,45571.0
Davanagere,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,375.0,302.0,312.0,434.0,388.0,312.0,156.0,42.0,56.0,51.0,24.0,39.0,2491.0
Davanagere,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,326.0,210.0,314.0,424.0,298.0,304.0,114.0,39.0,65.0,45.0,23.0,27.0,2189.0
Davanagere,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,282.0,177.0,241.0,373.0,320.0,290.0,137.0,52.0,58.0,58.0,14.0,29.0,2031.0
Davanagere,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2899.0,3090.0,3863.0,3206.0,2827.0,3039.0,2980.0,3180.0,3215.0,3302.0,3073.0,3355.0,38029.0
Davanagere,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2911.0,2830.0,3121.0,3236.0,2705.0,2830.0,2710.0,3065.0,3117.0,3150.0,3071.0,3255.0,36001.0
Davanagere,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3030.0,2910.0,2941.0,3161.0,3053.0,2814.0,2723.0,2918.0,3050.0,3157.0,2975.0,3205.0,35937.0
Davanagere,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3525.0,3404.0,3733.0,3160.0,3485.0,3329.0,3234.0,3420.0,3156.0,2660.0,2491.0,2291.0,37888.0
Davanagere,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3258.0,3286.0,4057.0,3231.0,3152.0,3228.0,3027.0,3300.0,3184.0,3323.0,3079.0,3351.0,39476.0
Davanagere,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3193.0,2944.0,3321.0,3331.0,2837.0,3037.0,2816.0,3146.0,3133.0,3144.0,3049.0,3249.0,37200.0
Davanagere,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3254.0,3007.0,3103.0,3286.0,3109.0,3032.0,2835.0,2959.0,3043.0,3172.0,2971.0,3182.0,36953.0
Davanagere,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2533.0,1648.0,2456.0,2421.0,2387.0,2107.0,2042.0,2117.0,2000.0,2807.0,2804.0,2737.0,28059.0
Davanagere,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,299.0,641.0,676.0,601.0,727.0,700.0,702.0,740.0,697.0,145.0,85.0,42.0,6055.0
Davanagere,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,362.0,165.0,154.0,266.0,134.0,172.0,129.0,64.0,159.0,109.0,80.0,27.0,1821.0
Davanagere,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,331.0,161.0,151.0,252.0,118.0,181.0,134.0,72.0,151.0,87.0,73.0,20.0,1731.0
Davanagere,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2933.0,3017.0,3139.0,3161.0,2932.0,2947.0,2450.0,2750.0,2654.0,2957.0,2760.0,2948.0,34648.0
Davanagere,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2498.0,1687.0,1690.0,1749.0,1903.0,1572.0,1630.0,1708.0,1910.0,1866.0,2097.0,2336.0,22646.0
Davanagere,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,50.0,126.0,104.0,411.0,633.0,912.0,917.0,1198.0,1654.0,1926.0,2274.0,2472.0,12677.0
Davanagere,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2030.0,1874.0,1863.0,1797.0,1621.0,1591.0,1533.0,1737.0,1691.0,1831.0,1943.0,1961.0,21472.0
Davanagere,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1756.0,1562.0,1678.0,1551.0,1446.0,1439.0,1389.0,1623.0,1454.0,1680.0,1758.0,1762.0,19098.0
Davanagere,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3786.0,3436.0,3541.0,3348.0,3067.0,3030.0,2922.0,3360.0,3145.0,3511.0,3701.0,3723.0,40570.0
Davanagere,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2358.0,2332.0,2529.0,2572.0,2498.0,2417.0,2220.0,2501.0,2389.0,2410.0,2363.0,2465.0,29054.0
Davanagere,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2348.0,2315.0,2501.0,2540.0,2451.0,2382.0,2198.0,2486.0,2396.0,2397.0,2351.0,2466.0,28831.0
Davanagere,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,209.0,209.0,478.0,225.0,176.0,234.0,162.0,280.0,197.0,279.0,104.0,172.0,2725.0
Davanagere,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,615.0,589.0,611.0,545.0,528.0,569.0,489.0,617.0,551.0,650.0,596.0,635.0,6995.0
Davanagere,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,533.0,453.0,449.0,463.0,446.0,432.0,414.0,510.0,447.0,513.0,495.0,541.0,5696.0
Davanagere,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1148.0,1042.0,1060.0,1008.0,974.0,1001.0,903.0,1127.0,998.0,1163.0,1091.0,1176.0,12691.0
Davanagere,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,27.0,10.0,152.0,1131.0,3634.0,7335.0,464.0,1988.0,861.0,900.0,707.0,252.0,17461.0
Davanagere,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,44.0,15.0,172.0,1348.0,3685.0,7324.0,484.0,2084.0,806.0,912.0,734.0,221.0,17829.0
Davanagere,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,109.0,15.0,50.0,985.0,2968.0,6561.0,286.0,2323.0,573.0,1036.0,1067.0,97.0,16070.0
Davanagere,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,1.0,2.0,1.0,3.0,0.0,1.0,12.0
Davanagere,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,14.0,8.0,16.0,20.0,37.0,25.0,30.0,23.0,41.0,57.0,39.0,311.0
Davanagere,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1454.0,1459.0,1451.0,1408.0,1437.0,1420.0,1435.0,1411.0,1460.0,1505.0,1451.0,1459.0,17350.0
Davanagere,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1425.0,1431.0,1439.0,1385.0,1396.0,1417.0,1415.0,1393.0,1445.0,1457.0,1425.0,1429.0,17057.0
Davanagere,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,980.0,987.0,990.0,953.0,983.0,993.0,980.0,972.0,978.0,995.0,974.0,965.0,11750.0
Davanagere,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,28.0,56.0,32.0,355.0,393.0,750.0,704.0,989.0,1353.0,1454.0,1703.0,1555.0,9372.0
Davanagere,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2418.0,2451.0,2518.0,3209.0,2856.0,2549.0,2093.0,3289.0,2258.0,2420.0,3010.0,2602.0,31673.0
Davanagere,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,113.0,102.0,143.0,9316.0,11517.0,320.0,124.0,96.0,93.0,127.0,16292.0,964.0,39207.0
Davanagere,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,49.0,65.0,34.0,7881.0,11224.0,436.0,45.0,124.0,62.0,35.0,14583.0,634.0,35172.0
Davanagere,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,1.0,5.0,5.0,24.0,3.0,3.0,1.0,14.0,2.0,12.0,7.0,82.0
Davanagere,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,376.0,434.0,402.0,310.0,408.0,339.0,353.0,390.0,391.0,432.0,508.0,408.0,4751.0
Davanagere,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Davanagere,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,123.0,90.0,102.0,100.0,138.0,108.0,176.0,193.0,158.0,144.0,165.0,115.0,1612.0
Davanagere,13.1,Number of Patients operated for cataract,TOTAL,5.0,5.0,39.0,32.0,162.0,42.0,5.0,92.0,22.0,101.0,33.0,4.0,542.0
Davanagere,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,5.0,5.0,79.0,26.0,26.0,42.0,24.0,175.0,22.0,101.0,54.0,4.0,563.0
Davanagere,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,0.0,30.0,8.0,6.0,37.0,6.0,16.0,79.0,124.0,2489.0,35.0,2833.0
Davanagere,13.4,Number of children provided free glasses,TOTAL,21.0,0.0,30.0,3.0,0.0,0.0,0.0,0.0,99.0,24.0,189.0,145.0,511.0
Davanagere,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,9.0,7.0,6.0,6.0,8.0,8.0,10.0,10.0,11.0,10.0,7.0,-1.0
Davanagere,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,41.0,40.0,41.0,41.0,42.0,44.0,42.0,43.0,40.0,43.0,42.0,42.0,-1.0
Davanagere,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,310.0,312.0,318.0,315.0,308.0,333.0,320.0,322.0,307.0,306.0,325.0,332.0,-1.0
Davanagere,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,10.0,10.0,10.0,7.0,8.0,9.0,9.0,11.0,10.0,12.0,11.0,9.0,-1.0
Davanagere,14.05,Number of RKS meetings held during the month,TOTAL,46.0,57.0,48.0,61.0,62.0,60.0,62.0,66.0,56.0,58.0,56.0,56.0,688.0
Davanagere,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,27.0,28.0,29.0,28.0,29.0,24.0,26.0,24.0,41.0,31.0,29.0,25.0,-1.0
Davanagere,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,243.0,244.0,269.0,234.0,239.0,119.0,127.0,169.0,202.0,240.0,372.0,306.0,2764.0
Davanagere,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,9.0,6.0,6.0,4.0,6.0,6.0,6.0,7.0,8.0,9.0,9.0,-1.0
Davanagere,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,3.0,3.0,3.0,-1.0
Davanagere,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,428.0,469.0,491.0,389.0,425.0,503.0,443.0,391.0,348.0,354.0,376.0,488.0,5105.0
Davanagere,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3468.0,3468.0,4451.0,3435.0,3444.0,3867.0,3733.0,3532.0,2983.0,3154.0,3376.0,3339.0,42250.0
Davanagere,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,420.0,387.0,451.0,433.0,416.0,429.0,355.0,392.0,335.0,389.0,393.0,428.0,4828.0
Davanagere,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5905.0,6110.0,6661.0,6287.0,5823.0,6406.0,5967.0,6334.0,6157.0,5764.0,5971.0,6679.0,74064.0
Davanagere,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,848.0,856.0,942.0,822.0,841.0,932.0,798.0,783.0,683.0,743.0,769.0,916.0,9933.0
Davanagere,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9373.0,9578.0,11112.0,9722.0,9267.0,10273.0,9700.0,9866.0,9140.0,8918.0,9347.0,10018.0,116314.0
Davanagere,14.10.2.a,Number of death cases of Inpatient males,TOTAL,85.0,81.0,94.0,66.0,148.0,94.0,136.0,63.0,110.0,94.0,79.0,80.0,1130.0
Davanagere,14.10.2.b,Number of death cases of Inpatient females,TOTAL,49.0,53.0,55.0,60.0,53.0,60.0,60.0,41.0,66.0,61.0,72.0,70.0,700.0
Davanagere,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,134.0,134.0,149.0,126.0,201.0,154.0,196.0,104.0,176.0,155.0,151.0,150.0,1830.0
Davanagere,14.11,In-Patient Head Count at midnight,TOTAL,6631.0,6425.0,6579.0,6502.0,6606.0,6954.0,6426.0,6715.0,8015.0,5993.0,5630.0,5170.0,77646.0
Davanagere,14.12.1,OPD attendance (All),TOTAL,149277.0,160199.0,178104.0,165293.0,167347.0,182857.0,160724.0,166110.0,154307.0,154072.0,168881.0,161902.0,1969073.0
Davanagere,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1175.0,940.0,917.0,822.0,1749.0,1018.0,946.0,1111.0,1048.0,1124.0,1033.0,902.0,12785.0
Davanagere,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,38.0,0.0,44.0,0.0,25.0,1.0,8.0,0.0,22.0,15.0,9.0,9.0,171.0
Davanagere,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,481.0,553.0,495.0,557.0,463.0,529.0,484.0,396.0,479.0,412.0,466.0,418.0,5733.0
Davanagere,14.14.a,Number of patients given AYUSH treatment,TOTAL,2796.0,3096.0,3144.0,2712.0,2438.0,2681.0,1765.0,2317.0,910.0,2224.0,2302.0,2095.0,28480.0
Davanagere,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,761.0,1008.0,1062.0,676.0,894.0,797.0,838.0,790.0,798.0,816.0,1006.0,938.0,10384.0
Davanagere,14.14.c,Number of Adolescents counselled,TOTAL,132.0,163.0,211.0,481.0,150.0,172.0,134.0,186.0,219.0,220.0,233.0,452.0,2753.0
Davanagere,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8453.0,7594.0,10817.0,10078.0,8659.0,9867.0,8066.0,8908.0,9426.0,8560.0,8366.0,8208.0,107002.0
Davanagere,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1267.0,958.0,1691.0,1636.0,1567.0,1037.0,839.0,1354.0,1184.0,1121.0,1227.0,1131.0,15012.0
Davanagere,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1547.0,1774.0,1970.0,1669.0,1632.0,1908.0,1454.0,1764.0,1629.0,1606.0,1592.0,1639.0,20184.0
Davanagere,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,39.0,42.0,46.0,36.0,117.0,34.0,75.0,46.0,42.0,29.0,24.0,32.0,562.0
Davanagere,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1329.0,1565.0,1814.0,1592.0,1449.0,1690.0,1374.0,1888.0,1742.0,1591.0,1989.0,1701.0,19724.0
Davanagere,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,40.0,44.0,40.0,23.0,111.0,36.0,94.0,32.0,85.0,25.0,37.0,45.0,612.0
Davanagere,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3212.0,3223.0,3555.0,3145.0,2970.0,3301.0,2185.0,3198.0,3049.0,2559.0,3019.0,2897.0,36313.0
Davanagere,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,49.0,85.0,41.0,208.0,37.0,109.0,26.0,34.0,16.0,46.0,28.0,683.0
Davanagere,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6088.0,6562.0,7339.0,6406.0,6051.0,6899.0,5013.0,6850.0,6420.0,5756.0,6600.0,6237.0,76221.0
Davanagere,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,83.0,135.0,171.0,100.0,436.0,107.0,278.0,104.0,161.0,70.0,107.0,105.0,1857.0
Davanagere,15.2,Number of Widal tests conducted,Number tested,376.0,519.0,689.0,734.0,715.0,979.0,750.0,797.0,619.0,572.0,447.0,420.0,7617.0
Davanagere,15.3.a,Number of VDRL tests conducted on males,Number tested,74.0,76.0,93.0,72.0,53.0,111.0,68.0,112.0,111.0,82.0,61.0,51.0,964.0
Davanagere,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,22.0,40.0,48.0,86.0,51.0,42.0,25.0,110.0,116.0,131.0,35.0,59.0,765.0
Davanagere,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,776.0,771.0,719.0,603.0,720.0,704.0,490.0,600.0,502.0,530.0,1137.0,681.0,8233.0
Davanagere,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,872.0,887.0,860.0,761.0,824.0,857.0,583.0,822.0,729.0,743.0,1233.0,791.0,9962.0
Davanagere,15.4.1,Number of blood smears examined for Malaria,TOTAL,19355.0,20246.0,22337.0,20969.0,22386.0,26915.0,21625.0,24026.0,21411.0,18048.0,21330.0,20976.0,259624.0
Davanagere,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,289.0,5.0,337.0,7.0,7.0,11.0,7.0,584.0,3.0,1.0,1.0,1.0,1253.0
Davanagere,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,12.0,1.0,1.0,0.0,2.0,1.0,0.0,0.0,0.0,17.0
Davanagere,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1000.0,500.0,2000.0,1000.0,0.0,,4500.0,5500.0,500.0,500.0,500.0,3000.0,19000.0
Davanagere,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,5000.0,5000.0,10000.0,15000.0,15000.0,5000.0,4000.0,3000.0,5000.0,5000.0,2000.0,76000.0
Davanagere,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2500.0,3500.0,6000.0,11000.0,15000.0,10500.0,4000.0,9000.0,3000.0,5000.0,2500.0,2500.0,74500.0
Davanagere,16.1.1,Stock position of DPT vaccines,5. Total Stock,500.0,2000.0,1000.0,0.0,0.0,4500.0,5500.0,500.0,500.0,500.0,3000.0,2500.0,20500.0
Davanagere,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,7000.0,3500.0,7000.0,500.0,0.0,2000.0,2000.0,6000.0,4000.0,2500.0,,500.0,35000.0
Davanagere,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,5000.0,10000.0,5000.0,10000.0,15000.0,10000.0,10000.0,10000.0,5000.0,6000.0,9000.0,10000.0,105000.0
Davanagere,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,8500.0,6500.0,11500.0,10500.0,13000.0,10000.0,6000.0,12000.0,6500.0,8500.0,8500.0,8500.0,110000.0
Davanagere,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3500.0,7000.0,500.0,0.0,2000.0,2000.0,6000.0,4000.0,2500.0,0.0,500.0,2000.0,30000.0
Davanagere,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,20600.0,7100.0,5000.0,,,1500.0,2500.0,11500.0,500.0,6500.0,500.0,14500.0,70200.0
Davanagere,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,10000.0,10000.0,20000.0,20000.0,25000.0,20000.0,16000.0,20000.0,310000.0,335000.0,15000.0,811000.0
Davanagere,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,23500.0,12100.0,15000.0,20000.0,18500.0,24000.0,11000.0,27000.0,14000.0,316000.0,321000.0,20500.0,822600.0
Davanagere,16.1.2,Stock position of OPV vaccines,5. Total Stock,7100.0,5000.0,0.0,0.0,1500.0,2500.0,11500.0,500.0,6500.0,500.0,14500.0,9000.0,58600.0
Davanagere,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,12000.0,9000.0,8500.0,9000.0,10500.0,6000.0,5000.0,9000.0,4000.0,5500.0,9000.0,12500.0,100000.0
Davanagere,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,30000.0,15000.0,15000.0,10000.0,10000.0,10000.0,10000.0,10000.0,5000.0,145000.0
Davanagere,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.3,Stock position of TT vaccines,4. Stock Distributed,13000.0,10500.0,9500.0,28500.0,19500.0,16000.0,6000.0,15000.0,8500.0,6500.0,6500.0,14500.0,154000.0
Davanagere,16.1.3,Stock position of TT vaccines,5. Total Stock,9000.0,8500.0,9000.0,10500.0,6000.0,5000.0,9000.0,4000.0,5500.0,9000.0,12500.0,3000.0,91000.0
Davanagere,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,0.0,,,,,0.0
Davanagere,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,10000.0,,,,,0.0,,,,,10000.0
Davanagere,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,1000.0,,,,,0.0,,,,,1000.0
Davanagere,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,9000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9000.0
Davanagere,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,7500.0,5500.0,4000.0,3000.0,2000.0,1000.0,1000.0,2500.0,1000.0,4000.0,3000.0,2500.0,37000.0
Davanagere,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,5000.0,10000.0,5000.0,5000.0,5000.0,5000.0,6000.0,10000.0,4000.0,4000.0,6000.0,70000.0
Davanagere,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7000.0,6500.0,11000.0,6000.0,6000.0,5000.0,3500.0,7500.0,7000.0,5000.0,4500.0,6000.0,75000.0
Davanagere,16.1.5,Stock position of BCG vaccines,5. Total Stock,5500.0,4000.0,3000.0,2000.0,1000.0,1000.0,2500.0,1000.0,4000.0,3000.0,2500.0,2500.0,32000.0
Davanagere,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2750.0,500.0,500.0,5250.0,2000.0,5750.0,6250.0,5500.0,4500.0,4000.0,4000.0,3750.0,44750.0
Davanagere,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5000.0,15000.0,5000.0,10000.0,5000.0,3000.0,5000.0,5000.0,6000.0,5000.0,5000.0,74000.0
Davanagere,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,7250.0,5250.0,10250.0,8250.0,6250.0,4500.0,3750.0,6000.0,5500.0,6000.0,5250.0,8000.0,76250.0
Davanagere,16.1.6,Stock position of Measles vaccines,5. Total Stock,500.0,250.0,5250.0,2000.0,5750.0,6250.0,5500.0,4500.0,4000.0,4000.0,3750.0,750.0,42500.0
Davanagere,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,2000.0,1000.0,3500.0,,1000.0,7500.0
Davanagere,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,3000.0,,,,5000.0,5000.0,8000.0,2000.0,8000.0,4500.0,35500.0
Davanagere,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,0.0,,,,3000.0,6000.0,5500.0,5500.0,7000.0,5500.0,32500.0
Davanagere,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,3000.0,0.0,0.0,0.0,2000.0,1000.0,3500.0,0.0,1000.0,0.0,10500.0
Davanagere,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5000.0,11500.0,14100.0,11100.0,8100.0,5600.0,6600.0,7600.0,6000.0,3600.0,5200.0,6000.0,90400.0
Davanagere,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,10000.0,5100.0,,,,3000.0,3000.0,2000.0,,4000.0,2500.0,2500.0,32100.0
Davanagere,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3500.0,2500.0,3000.0,3000.0,2500.0,2000.0,2000.0,3600.0,2400.0,2400.0,1700.0,4000.0,32600.0
Davanagere,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,11500.0,14100.0,11100.0,8100.0,5600.0,6600.0,7600.0,6000.0,3600.0,5200.0,6000.0,4500.0,89900.0
Davanagere,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,7285.0,6685.0,5885.0,5885.0,135.0,135.0,85.0,85.0,85.0,85.0,85.0,85.0,26520.0
Davanagere,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,800.0,50.0,5750.0,,50.0,,,,,,,7250.0
Davanagere,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,6685.0,5885.0,5835.0,135.0,135.0,85.0,85.0,85.0,85.0,85.0,85.0,85.0,19270.0
Davanagere,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,0.0,1000.0,22280.0,200.0,161480.0,186680.0,116120.0,101000.0,15320.0,15320.0,15320.0,634720.0
Davanagere,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,2000.0,21280.0,,161280.0,151200.0,,,,,,,335760.0
Davanagere,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,1000.0,,22080.0,,126000.0,70560.0,15120.0,85680.0,,,10080.0,330520.0
Davanagere,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,1000.0,22280.0,200.0,161480.0,186680.0,116120.0,101000.0,15320.0,15320.0,15320.0,5240.0,639960.0
Davanagere,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,16000.0,19000.0,12000.0,1000.0,1000.0,1000.0,1000.0,51000.0
Davanagere,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,16000.0,16000.0,,,,,,,32000.0
Davanagere,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,13000.0,7000.0,11000.0,,,,1000.0,32000.0
Davanagere,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,16000.0,19000.0,12000.0,1000.0,1000.0,1000.0,1000.0,0.0,51000.0
Davanagere,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,1120.0,1720.0,,,720.0,720.0,720.0,720.0,720.0,720.0,7160.0
Davanagere,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,1120.0,600.0,,,1720.0,,,,,,,3440.0
Davanagere,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,,,1000.0,,,,,,,1000.0
Davanagere,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,1120.0,1720.0,1720.0,0.0,720.0,720.0,720.0,720.0,720.0,720.0,720.0,9600.0
Davanagere,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,6090.0,6090.0,,,6090.0,6090.0,6090.0,6090.0,6090.0,6090.0,48720.0
Davanagere,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,6090.0,,,,6090.0,,,,,,,12180.0
Davanagere,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,0.0,,,,,,,,,,,0.0
Davanagere,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,6090.0,6090.0,6090.0,0.0,6090.0,6090.0,6090.0,6090.0,6090.0,6090.0,6090.0,60900.0
Davanagere,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,2700.0,,2700.0,,,,,,,,5400.0
Davanagere,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,2700.0,0.0,2700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5400.0
Davanagere,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Davanagere,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Davanagere,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Davanagere,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Davanagere,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3600.0,1200.0,,2800.0,4800.0,2600.0,6400.0,2800.0,200.0,2400.0,2400.0,500.0,29700.0
Davanagere,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,,6600.0,6600.0,,6600.0,,3300.0,6600.0,,3300.0,6600.0,42600.0
Davanagere,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5400.0,1200.0,3800.0,4600.0,2200.0,2800.0,3600.0,5900.0,4400.0,,5200.0,4000.0,43100.0
Davanagere,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1200.0,0.0,2800.0,4800.0,2600.0,6400.0,2800.0,200.0,2400.0,2400.0,500.0,3100.0,29200.0
Davanagere,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,49000.0,37000.0,25000.0,8600.0,,,67600.0,32900.0,14900.0,6900.0,900.0,4900.0,247700.0
Davanagere,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,12000.0,,10000.0,28800.0,19200.0,80000.0,,6000.0,14400.0,18400.0,18000.0,18000.0,224800.0
Davanagere,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,24000.0,12000.0,26400.0,37400.0,16800.0,12400.0,34700.0,24000.0,22400.0,24400.0,14000.0,22900.0,271400.0
Davanagere,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,37000.0,25000.0,8600.0,0.0,2400.0,67600.0,32900.0,14900.0,6900.0,900.0,4900.0,0.0,201100.0
Davanagere,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,12700.0,12700.0,11700.0,10700.0,11100.0,9100.0,13900.0,6100.0,2100.0,3100.0,3100.0,3100.0,99400.0
Davanagere,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,,,2400.0,,4800.0,,2400.0,1000.0,,,,13000.0
Davanagere,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Davanagere,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2400.0,1000.0,1000.0,2000.0,2000.0,,7800.0,6400.0,0.0,,,,22600.0
Davanagere,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,12700.0,11700.0,10700.0,11100.0,9100.0,13900.0,6100.0,2100.0,3100.0,3100.0,3100.0,3100.0,89800.0
Davanagere,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,1.0,,1.0,2.0,,,,1.0,,,,8.0
Davanagere,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,3.0,1.0,1.0,1.0,1.0,,6.0,2.0,2.0,1.0,1.0,1.0,20.0
Davanagere,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,2.0,,1.0,2.0,1.0,,,,6.0
Davanagere,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,3.0,1.0,1.0,1.0,3.0,,7.0,4.0,3.0,1.0,1.0,1.0,26.0
Davanagere,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,1.0,1.0,5.0,6.0,,3.0,4.0,,2.0,3.0,2.0,28.0
Davanagere,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Davanagere,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,1.0,1.0,5.0,6.0,,3.0,4.0,,2.0,3.0,2.0,28.0
Davanagere,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,1.0,2.0,2.0,1.0,4.0,1.0,,3.0,3.0,1.0,19.0
Davanagere,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,1.0,,2.0
Davanagere,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,2.0,2.0,2.0,4.0,1.0,,3.0,4.0,1.0,21.0
Davanagere,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,1.0,4.0,1.0,3.0,,,4.0,5.0,5.0,3.0,9.0,36.0
Davanagere,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,1.0,1.0,,,,,,,,1.0,,3.0
Davanagere,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,5.0,1.0,3.0,,,4.0,5.0,5.0,4.0,9.0,39.0
Davanagere,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,1.0,,,,,2.0
Davanagere,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Davanagere,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,1.0,,,,,2.0
Davanagere,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Davanagere,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,2.0,,,,,,,,,,2.0
Davanagere,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,2.0,,,,,,,,,,2.0
Davanagere,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,2.0,2.0
Davanagere,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Davanagere,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,2.0,2.0
Davanagere,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Davanagere,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Davanagere,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Davanagere,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,,2.0,1.0,,,,,,2.0,6.0
Davanagere,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,,2.0,,,,,,2.0,5.0
Davanagere,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,1.0,,2.0,3.0,,,,,,4.0,11.0
Davanagere,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Davanagere,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Davanagere,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,,
Davanagere,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,2.0,4.0,,1.0,7.0,4.0,3.0,3.0,1.0,1.0,2.0,30.0
Davanagere,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,1.0,,1.0,1.0,2.0,3.0,3.0,2.0,3.0,,1.0,19.0
Davanagere,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,3.0,4.0,1.0,2.0,9.0,7.0,6.0,5.0,4.0,1.0,3.0,49.0
Davanagere,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,10.0,6.0,7.0,3.0,9.0,6.0,7.0,5.0,6.0,6.0,10.0,7.0,82.0
Davanagere,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,26.0,29.0,33.0,28.0,33.0,36.0,45.0,38.0,29.0,48.0,40.0,30.0,415.0
Davanagere,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,36.0,35.0,40.0,31.0,42.0,42.0,52.0,43.0,35.0,54.0,50.0,37.0,497.0
Davanagere,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Davanagere,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Davanagere,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,1.0,,1.0
Davanagere,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,,,,,,1.0
Davanagere,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,1.0,,1.0,1.0,,2.0,,,1.0,,9.0
Davanagere,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,2.0,1.0,,,3.0,,,,,,7.0,13.0
Davanagere,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,4.0,2.0,1.0,1.0,4.0,,2.0,,,1.0,7.0,23.0
Davanagere,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Davanagere,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,2.0,1.0,,2.0,3.0,1.0,2.0,2.0,3.0,1.0,2.0,22.0
Davanagere,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,1.0,,,1.0,,,3.0
Davanagere,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,2.0,2.0,,2.0,4.0,2.0,2.0,2.0,4.0,1.0,2.0,26.0
Davanagere,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,1.0,1.0,1.0,,,,,2.0,6.0
Davanagere,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,51.0,27.0,35.0,34.0,29.0,43.0,34.0,46.0,33.0,41.0,34.0,21.0,428.0
Davanagere,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,36.0,51.0,41.0,36.0,52.0,45.0,37.0,48.0,39.0,57.0,43.0,48.0,533.0
Davanagere,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,87.0,78.0,76.0,71.0,82.0,89.0,72.0,94.0,72.0,98.0,77.0,71.0,967.0
Davanagere,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,,,1.0,1.0,,1.0,,1.0,5.0
Davanagere,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,10.0,9.0,9.0,9.0,20.0,9.0,3.0,10.0,10.0,5.0,15.0,4.0,113.0
Davanagere,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,31.0,33.0,45.0,50.0,50.0,36.0,41.0,52.0,42.0,29.0,41.0,35.0,485.0
Davanagere,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,41.0,42.0,54.0,60.0,70.0,45.0,45.0,63.0,52.0,35.0,56.0,40.0,603.0
Davanagere,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Davanagere,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Davanagere,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,1.0,1.0,1.0,,,,3.0
Davanagere,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Davanagere,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,1.0,1.0,1.0,,,,3.0
Davanagere,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,2.0,,,1.0,3.0
Davanagere,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Davanagere,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,2.0,,,1.0,3.0
Davanagere,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,1.0,,,1.0,,,,,2.0
Davanagere,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Davanagere,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,1.0,,,1.0,,,,,2.0
Davanagere,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,1.0,,1.0
Davanagere,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Davanagere,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,1.0,,1.0
Davanagere,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Davanagere,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,1.0,1.0,,1.0,,,1.0,,,5.0
Davanagere,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Davanagere,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,1.0,1.0,,1.0,,,1.0,,,5.0
Davanagere,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,5.0,2.0,,,1.0,1.0,,,4.0,1.0,1.0,16.0
Davanagere,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,11.0,5.0,18.0,10.0,14.0,13.0,10.0,7.0,11.0,14.0,15.0,10.0,138.0
Davanagere,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,4.0,3.0,2.0,4.0,4.0,,4.0,2.0,3.0,3.0,2.0,32.0
Davanagere,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,13.0,14.0,23.0,12.0,18.0,18.0,11.0,11.0,13.0,21.0,19.0,13.0,186.0
Davanagere,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,1.0,,,,,2.0,,3.0
Davanagere,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,17.0,13.0,14.0,14.0,11.0,13.0,21.0,15.0,9.0,18.0,11.0,164.0
Davanagere,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,3.0,3.0,6.0,2.0,3.0,2.0,2.0,2.0,3.0,2.0,1.0,30.0
Davanagere,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,9.0,20.0,16.0,20.0,16.0,15.0,15.0,23.0,17.0,12.0,22.0,12.0,197.0
Davanagere,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,1.0,,1.0,1.0,,,,3.0
Davanagere,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,,2.0,1.0,4.0,2.0,5.0,4.0,2.0,1.0,1.0,2.0,26.0
Davanagere,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,1.0,,,,1.0,2.0,2.0,1.0,3.0,1.0,,12.0
Davanagere,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,3.0,1.0,2.0,1.0,4.0,4.0,7.0,7.0,4.0,4.0,2.0,2.0,41.0
Davanagere,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,1.0,,,,1.0,1.0,2.0,,,,7.0
Davanagere,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,21.0,15.0,20.0,21.0,14.0,15.0,18.0,15.0,17.0,11.0,17.0,9.0,193.0
Davanagere,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,29.0,29.0,33.0,21.0,30.0,29.0,37.0,31.0,23.0,34.0,23.0,31.0,350.0
Davanagere,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,51.0,45.0,54.0,42.0,44.0,44.0,56.0,47.0,42.0,45.0,40.0,40.0,550.0
Davanagere,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,1.0,,2.0,1.0,,2.0,,,,7.0
Davanagere,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,10.0,15.0,19.0,15.0,19.0,9.0,7.0,19.0,14.0,16.0,16.0,21.0,180.0
Davanagere,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,24.0,23.0,28.0,30.0,30.0,25.0,39.0,22.0,20.0,34.0,18.0,41.0,334.0
Davanagere,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,34.0,38.0,48.0,46.0,49.0,36.0,47.0,41.0,36.0,50.0,34.0,62.0,521.0
Davanagere,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,2.0,1.0,2.0,2.0,1.0,4.0,2.0,3.0,,2.0,3.0,25.0
Davanagere,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,98.0,106.0,113.0,100.0,101.0,68.0,98.0,105.0,131.0,98.0,110.0,122.0,1250.0
Davanagere,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,179.0,195.0,193.0,177.0,273.0,237.0,245.0,246.0,246.0,231.0,232.0,188.0,2642.0
Davanagere,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,280.0,303.0,307.0,279.0,376.0,306.0,347.0,353.0,380.0,329.0,344.0,313.0,3917.0
Dharwad,1.1,Total number of pregnant women Registered for ANC,TOTAL,3170.0,2671.0,3308.0,2974.0,3046.0,3104.0,2871.0,3247.0,3034.0,2876.0,3080.0,3324.0,36705.0
Dharwad,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2473.0,2121.0,2579.0,2321.0,2404.0,2397.0,2227.0,2519.0,2335.0,2286.0,2730.0,2318.0,28710.0
Dharwad,1.2,Number of Pregnant women registered under JSY,TOTAL,2381.0,1987.0,2484.0,2242.0,2707.0,2255.0,2182.0,2384.0,2291.0,2183.0,2354.0,2238.0,27688.0
Dharwad,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3626.0,2927.0,3050.0,2763.0,2916.0,3251.0,2897.0,3267.0,3050.0,3115.0,2886.0,3228.0,36976.0
Dharwad,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2959.0,2781.0,3385.0,2806.0,2895.0,2784.0,2559.0,3160.0,2709.0,2688.0,2901.0,2739.0,34366.0
Dharwad,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3140.0,3093.0,3548.0,3797.0,3275.0,3445.0,3038.0,3388.0,3207.0,3022.0,3039.0,3371.0,39363.0
Dharwad,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2594.0,1894.0,3133.0,2974.0,1922.0,1853.0,1431.0,1795.0,1576.0,1801.0,1895.0,1669.0,24537.0
Dharwad,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,282.0,325.0,433.0,341.0,266.0,545.0,323.0,383.0,290.0,264.0,295.0,386.0,4133.0
Dharwad,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,46.0,103.0,65.0,31.0,31.0,39.0,28.0,36.0,19.0,36.0,37.0,28.0,499.0
Dharwad,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3942.0,4292.0,4530.0,3812.0,3640.0,3825.0,3531.0,3937.0,3784.0,3458.0,3468.0,3297.0,45516.0
Dharwad,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,181.0,236.0,228.0,389.0,127.0,202.0,213.0,214.0,197.0,263.0,296.0,197.0,2743.0
Dharwad,1.8,Number of pregnancy test kits used at SC level,TOTAL,367.0,330.0,468.0,417.0,517.0,615.0,561.0,661.0,698.0,720.0,846.0,777.0,6977.0
Dharwad,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,0.0,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,4.0
Dharwad,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,1.0,0.0,0.0,2.0,2.0,0.0,1.0,1.0,1.0,1.0,1.0,10.0
Dharwad,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,1.0,1.0,0.0,2.0,3.0,1.0,1.0,1.0,1.0,1.0,1.0,14.0
Dharwad,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,1.0,3.0,0.0,1.0,1.0,1.0,1.0,1.0,9.0
Dharwad,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Dharwad,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1655.0,1752.0,1853.0,1939.0,2025.0,2095.0,1933.0,2017.0,1825.0,1800.0,1917.0,1699.0,22510.0
Dharwad,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,68.0,47.0,28.0,73.0,156.0,222.0,208.0,153.0,91.0,112.0,106.0,142.0,1406.0
Dharwad,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,542.0,672.0,963.0,1036.0,908.0,939.0,902.0,995.0,1087.0,751.0,653.0,677.0,10125.0
Dharwad,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,50.0,80.0,50.0,76.0,46.0,43.0,49.0,79.0,46.0,76.0,83.0,79.0,757.0
Dharwad,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1048.0,1171.0,1325.0,1254.0,1208.0,1236.0,1398.0,1393.0,1179.0,1128.0,1236.0,1271.0,14847.0
Dharwad,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,,,,,,,,,,,,,
Dharwad,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,318.0,324.0,250.0,338.0,374.0,376.0,319.0,342.0,418.0,384.0,320.0,257.0,4020.0
Dharwad,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,318.0,324.0,250.0,338.0,374.0,376.0,319.0,342.0,418.0,384.0,320.0,257.0,4020.0
Dharwad,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,492.0,452.0,533.0,525.0,477.0,559.0,512.0,547.0,463.0,509.0,460.0,541.0,6070.0
Dharwad,4.1.1.a,Number of male live births,TOTAL,1325.0,1500.0,1615.0,1613.0,1654.0,1628.0,1697.0,1674.0,1495.0,1479.0,1586.0,1570.0,18836.0
Dharwad,4.1.1.b,Number of female live births,TOTAL,1323.0,1394.0,1510.0,1520.0,1493.0,1632.0,1541.0,1621.0,1436.0,1383.0,1497.0,1343.0,17693.0
Dharwad,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2648.0,2894.0,3125.0,3133.0,3147.0,3260.0,3238.0,3295.0,2931.0,2862.0,3083.0,2913.0,36529.0
Dharwad,4.1.2,Number of still births,TOTAL,57.0,47.0,72.0,67.0,89.0,94.0,117.0,125.0,84.0,69.0,75.0,63.0,959.0
Dharwad,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,93.0,165.0,163.0,133.0,128.0,130.0,84.0,97.0,94.0,88.0,112.0,99.0,1386.0
Dharwad,4.2.1,Number of Newborns weighed at birth,TOTAL,2502.0,2922.0,3126.0,3151.0,3146.0,3034.0,3038.0,3089.0,2511.0,2861.0,3084.0,2813.0,35277.0
Dharwad,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,370.0,473.0,553.0,503.0,526.0,525.0,428.0,524.0,588.0,492.0,490.0,818.0,6290.0
Dharwad,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2518.0,2848.0,2946.0,2734.0,2845.0,2815.0,3051.0,2990.0,2509.0,2631.0,2980.0,2165.0,33032.0
Dharwad,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,5.0,1.0,3.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,15.0
Dharwad,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,,,,,,,,,,,,,
Dharwad,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,468.0,462.0,142.0,768.0,523.0,728.0,745.0,829.0,260.0,722.0,630.0,594.0,6871.0
Dharwad,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,473.0,463.0,145.0,768.0,525.0,728.0,745.0,829.0,260.0,723.0,633.0,594.0,6886.0
Dharwad,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,209.0,37.0,43.0,206.0,28.0,43.0,25.0,58.0,30.0,55.0,31.0,93.0,858.0
Dharwad,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1003.0,1058.0,1044.0,566.0,459.0,1001.0,926.0,783.0,711.0,716.0,710.0,847.0,9824.0
Dharwad,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,94.0,108.0,154.0,78.0,89.0,63.0,59.0,50.0,92.0,50.0,202.0,187.0,1226.0
Dharwad,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1050.0,1292.0,1220.0,1297.0,1260.0,1397.0,1314.0,1192.0,928.0,1148.0,1280.0,1245.0,14623.0
Dharwad,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,9.0,20.0,56.0,17.0,22.0,19.0,41.0,26.0,35.0,39.0,47.0,18.0,349.0
Dharwad,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1913.0,2329.0,2616.0,2016.0,2256.0,2358.0,2000.0,2070.0,1798.0,1808.0,2026.0,1892.0,25082.0
Dharwad,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1920.0,2104.0,2864.0,2595.0,2855.0,3149.0,2745.0,2744.0,2537.0,2470.0,2949.0,2682.0,31614.0
Dharwad,6.3,PNC maternal complications attended,TOTAL,28.0,55.0,71.0,126.0,52.0,106.0,113.0,100.0,104.0,87.0,94.0,100.0,1036.0
Dharwad,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,7.0,7.0,9.0,15.0,8.0,10.0,6.0,5.0,6.0,8.0,16.0,16.0,113.0
Dharwad,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,8.0,3.0,0.0,12.0,3.0,8.0,6.0,11.0,8.0,13.0,18.0,8.0,98.0
Dharwad,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,15.0,10.0,9.0,27.0,11.0,18.0,12.0,16.0,14.0,21.0,34.0,24.0,211.0
Dharwad,7.2,Number of MTPs conducted at Private Facilities,TOTAL,123.0,135.0,98.0,47.0,71.0,73.0,39.0,48.0,40.0,97.0,55.0,41.0,867.0
Dharwad,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,316.0,358.0,576.0,577.0,530.0,617.0,545.0,257.0,508.0,309.0,401.0,502.0,5496.0
Dharwad,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,527.0,701.0,847.0,764.0,817.0,812.0,763.0,587.0,663.0,613.0,772.0,870.0,8736.0
Dharwad,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,843.0,1059.0,1423.0,1341.0,1347.0,1429.0,1308.0,844.0,1171.0,922.0,1173.0,1372.0,14232.0
Dharwad,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,0.0,7.0,0.0,0.0,16.0
Dharwad,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,4.0,24.0,28.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,58.0
Dharwad,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dharwad,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,23.0,22.0,43.0,2.0,21.0,2.0,3.0,0.0,1.0,0.0,0.0,117.0
Dharwad,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,4.0,47.0,50.0,43.0,4.0,21.0,2.0,3.0,0.0,1.0,0.0,0.0,175.0
Dharwad,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,0.0,0.0,1.0,3.0,1.0,0.0,0.0,0.0,4.0,0.0,0.0,10.0
Dharwad,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,9.0,39.0,26.0,7.0,0.0,19.0,0.0,16.0,0.0,0.0,0.0,0.0,116.0
Dharwad,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dharwad,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,104.0,146.0,106.0,93.0,75.0,94.0,74.0,76.0,147.0,82.0,105.0,87.0,1189.0
Dharwad,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,113.0,185.0,132.0,100.0,75.0,113.0,74.0,92.0,147.0,82.0,105.0,87.0,1305.0
Dharwad,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,188.0,207.0,82.0,81.0,89.0,164.0,153.0,103.0,109.0,94.0,142.0,128.0,1540.0
Dharwad,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,39.0,24.0,30.0,14.0,0.0,35.0,8.0,14.0,20.0,6.0,3.0,20.0,213.0
Dharwad,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dharwad,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,145.0,104.0,170.0,217.0,129.0,267.0,134.0,282.0,190.0,138.0,226.0,228.0,2230.0
Dharwad,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,184.0,128.0,200.0,231.0,129.0,302.0,142.0,296.0,210.0,144.0,229.0,248.0,2443.0
Dharwad,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,164.0,206.0,206.0,195.0,148.0,61.0,83.0,224.0,132.0,89.0,97.0,92.0,1697.0
Dharwad,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,3.0,0.0,0.0,0.0,0.0,0.0,13.0,0.0,0.0,1.0,0.0,17.0
Dharwad,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dharwad,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,206.0,201.0,225.0,154.0,202.0,131.0,162.0,201.0,188.0,219.0,86.0,69.0,2044.0
Dharwad,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,206.0,204.0,225.0,154.0,202.0,131.0,162.0,214.0,188.0,219.0,87.0,69.0,2061.0
Dharwad,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,42.0,40.0,68.0,52.0,64.0,74.0,80.0,51.0,116.0,94.0,36.0,108.0,825.0
Dharwad,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,275.0,278.0,253.0,268.0,267.0,263.0,253.0,262.0,242.0,236.0,218.0,208.0,3023.0
Dharwad,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,64.0,40.0,75.0,34.0,75.0,37.0,47.0,37.0,37.0,31.0,32.0,32.0,541.0
Dharwad,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,,,,,,,,,,,,,
Dharwad,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,285.0,424.0,495.0,448.0,296.0,418.0,483.0,440.0,356.0,386.0,385.0,360.0,4776.0
Dharwad,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Dharwad,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,624.0,742.0,823.0,750.0,638.0,718.0,783.0,739.0,635.0,653.0,635.0,600.0,8340.0
Dharwad,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,15.0,14.0,34.0,26.0,701.0,137.0,215.0,98.0,141.0,205.0,237.0,179.0,2002.0
Dharwad,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,80.0,71.0,81.0,83.0,56.0,66.0,76.0,67.0,53.0,71.0,46.0,52.0,802.0
Dharwad,9.06,Number of IUCD removals,TOTAL,160.0,176.0,175.0,141.0,175.0,178.0,182.0,171.0,161.0,262.0,164.0,133.0,2078.0
Dharwad,9.07,Number of Oral Pills cycles distributed,TOTAL,2850.0,3073.0,2971.0,2624.0,2270.0,2538.0,2352.0,2300.0,2025.0,2346.0,2272.0,2563.0,30184.0
Dharwad,9.08,Number of Condom pieces distributed,TOTAL,20520.0,21927.0,23669.0,25339.0,31652.0,21301.0,22597.0,21603.0,18941.0,24288.0,25035.0,21937.0,278809.0
Dharwad,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,131.0,119.0,126.0,116.0,144.0,98.0,112.0,132.0,111.0,101.0,100.0,121.0,1411.0
Dharwad,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Dharwad,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,9.12,Number of Institutions having NSV trained doctors,TOTAL,16.0,13.0,13.0,11.0,9.0,10.0,10.0,11.0,8.0,12.0,9.0,9.0,-1.0
Dharwad,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3806.0,3744.0,3703.0,3546.0,3693.0,3887.0,1905.0,2027.0,1827.0,3389.0,3074.0,3106.0,37707.0
Dharwad,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,63.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0,73.0
Dharwad,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,67.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67.0
Dharwad,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1.0,63.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,64.0
Dharwad,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3151.0,3031.0,3360.0,3121.0,3179.0,3132.0,3311.0,3384.0,3226.0,3141.0,2939.0,2954.0,37929.0
Dharwad,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3005.0,2942.0,3217.0,3136.0,2956.0,3258.0,3139.0,3230.0,3196.0,3069.0,2935.0,2957.0,37040.0
Dharwad,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3083.0,2880.0,3301.0,3257.0,3033.0,3291.0,3308.0,3182.0,3218.0,3178.0,3029.0,3020.0,37780.0
Dharwad,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2456.0,2387.0,2317.0,2392.0,2601.0,2615.0,2661.0,2882.0,2149.0,2251.0,2687.0,2899.0,30297.0
Dharwad,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3135.0,3026.0,3362.0,3121.0,3177.0,3137.0,3310.0,3370.0,3364.0,2797.0,2999.0,3039.0,37837.0
Dharwad,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3005.0,2934.0,3219.0,3136.0,2958.0,3260.0,3135.0,3209.0,3278.0,2725.0,3003.0,3018.0,36880.0
Dharwad,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3091.0,2881.0,3299.0,3260.0,3034.0,3291.0,3299.0,3169.0,3273.0,2819.0,3078.0,3069.0,37563.0
Dharwad,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,893.0,926.0,995.0,904.0,982.0,1068.0,1149.0,1257.0,775.0,1044.0,1524.0,1417.0,12934.0
Dharwad,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,45.0,47.0,18.0,19.0,4.0,0.0,6.0,0.0,3.0,0.0,0.0,0.0,142.0
Dharwad,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,63.0,52.0,20.0,19.0,7.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,173.0
Dharwad,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,53.0,54.0,18.0,21.0,6.0,0.0,13.0,0.0,0.0,0.0,0.0,0.0,165.0
Dharwad,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3104.0,2753.0,3326.0,3213.0,3096.0,3280.0,3135.0,3267.0,3052.0,2722.0,2736.0,2953.0,36637.0
Dharwad,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2518.0,2193.0,3084.0,2828.0,2733.0,2882.0,2659.0,2694.0,2644.0,2550.0,2442.0,2718.0,31945.0
Dharwad,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2851.0,2102.0,2793.0,2978.0,2936.0,2872.0,2861.0,2549.0,2250.0,2488.0,2506.0,2721.0,31907.0
Dharwad,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1607.0,1424.0,1697.0,1642.0,1500.0,1587.0,1594.0,1629.0,1443.0,1481.0,1430.0,1524.0,18558.0
Dharwad,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1426.0,1327.0,1685.0,1586.0,1458.0,1496.0,1414.0,1490.0,1338.0,1316.0,1341.0,1372.0,17249.0
Dharwad,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3033.0,2751.0,3382.0,3228.0,2958.0,3083.0,3008.0,3119.0,2781.0,2797.0,2771.0,2896.0,35807.0
Dharwad,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2641.0,2435.0,3056.0,2897.0,2845.0,3067.0,2737.0,2894.0,2742.0,2570.0,2600.0,2870.0,33354.0
Dharwad,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2627.0,2440.0,3057.0,2892.0,2846.0,3050.0,2769.0,2882.0,2741.0,2370.0,2596.0,2870.0,33140.0
Dharwad,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,472.0,320.0,152.0,107.0,138.0,157.0,361.0,352.0,314.0,333.0,233.0,290.0,3229.0
Dharwad,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,882.0,742.0,899.0,819.0,813.0,969.0,948.0,1010.0,936.0,880.0,861.0,994.0,10753.0
Dharwad,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,861.0,691.0,791.0,743.0,752.0,922.0,877.0,881.0,822.0,778.0,753.0,929.0,9800.0
Dharwad,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1743.0,1433.0,1690.0,1562.0,1565.0,1891.0,1825.0,1891.0,1758.0,1658.0,1614.0,1923.0,20553.0
Dharwad,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,579.0,466.0,757.0,1499.0,4556.0,6274.0,1084.0,3163.0,2617.0,1507.0,1753.0,1471.0,25726.0
Dharwad,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,640.0,628.0,840.0,1603.0,4940.0,6147.0,1194.0,3540.0,2676.0,1697.0,2230.0,1581.0,27716.0
Dharwad,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,601.0,656.0,714.0,1300.0,3922.0,5340.0,1215.0,3892.0,2629.0,1790.0,2059.0,1629.0,25747.0
Dharwad,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Dharwad,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,7.0,0.0,1.0,4.0,2.0,3.0,0.0,0.0,0.0,0.0,17.0
Dharwad,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1118.0,1121.0,1192.0,1170.0,1179.0,1168.0,1184.0,1251.0,1254.0,1190.0,1202.0,1222.0,14251.0
Dharwad,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1104.0,1059.0,1190.0,1129.0,1104.0,1131.0,1139.0,1224.0,1201.0,1136.0,1097.0,1167.0,13681.0
Dharwad,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,541.0,491.0,505.0,497.0,505.0,500.0,501.0,507.0,504.0,496.0,487.0,506.0,6040.0
Dharwad,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2588.0,1872.0,2367.0,2545.0,2383.0,2597.0,2392.0,2441.0,2326.0,2202.0,2102.0,2063.0,27878.0
Dharwad,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2696.0,2383.0,2782.0,3085.0,3714.0,2981.0,2772.0,2942.0,2416.0,2429.0,2412.0,2766.0,33378.0
Dharwad,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,83.0,96.0,133.0,1506.0,19555.0,313.0,153.0,130.0,160.0,174.0,11023.0,4456.0,37782.0
Dharwad,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,1735.0,16209.0,112.0,10.0,11.0,13.0,2.0,9233.0,4532.0,31857.0
Dharwad,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,18.0,2.0,4.0,0.0,1.0,0.0,0.0,9.0,1.0,28.0,9.0,8.0,80.0
Dharwad,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,610.0,585.0,495.0,489.0,510.0,459.0,485.0,452.0,447.0,382.0,394.0,516.0,5824.0
Dharwad,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,0.0,5.0
Dharwad,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,62.0,57.0,61.0,25.0,87.0,53.0,316.0,170.0,61.0,115.0,15.0,44.0,1066.0
Dharwad,13.1,Number of Patients operated for cataract,TOTAL,131.0,176.0,2149.0,2252.0,1999.0,1253.0,1169.0,363.0,433.0,512.0,296.0,344.0,11077.0
Dharwad,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,104.0,176.0,2149.0,2251.0,1999.0,1253.0,1169.0,363.0,433.0,512.0,296.0,295.0,11000.0
Dharwad,13.3,Number of School children detected with Refractive errors,TOTAL,91.0,85.0,146.0,257.0,196.0,240.0,104.0,146.0,182.0,137.0,94.0,108.0,1786.0
Dharwad,13.4,Number of children provided free glasses,TOTAL,6.0,0.0,50.0,152.0,121.0,221.0,27.0,65.0,122.0,62.0,44.0,108.0,978.0
Dharwad,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,59.0,21.0,34.0,37.0,29.0,0.0,0.0,1.0,0.0,0.0,181.0
Dharwad,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,43.0,17.0,23.0,18.0,21.0,0.0,0.0,0.0,0.0,0.0,122.0
Dharwad,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,7.0,7.0,7.0,7.0,6.0,7.0,9.0,5.0,7.0,7.0,8.0,-1.0
Dharwad,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,19.0,19.0,19.0,20.0,18.0,19.0,18.0,19.0,18.0,19.0,19.0,19.0,-1.0
Dharwad,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,283.0,263.0,289.0,296.0,289.0,279.0,303.0,325.0,314.0,310.0,327.0,354.0,-1.0
Dharwad,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,7.0,7.0,7.0,7.0,7.0,7.0,8.0,5.0,8.0,6.0,7.0,-1.0
Dharwad,14.05,Number of RKS meetings held during the month,TOTAL,8.0,7.0,6.0,9.0,15.0,8.0,7.0,6.0,7.0,16.0,12.0,18.0,119.0
Dharwad,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,20.0,21.0,23.0,19.0,17.0,19.0,22.0,18.0,22.0,22.0,18.0,-1.0
Dharwad,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,357.0,340.0,346.0,320.0,301.0,275.0,314.0,283.0,268.0,280.0,281.0,258.0,3623.0
Dharwad,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,7.0,6.0,7.0,7.0,7.0,7.0,8.0,5.0,7.0,7.0,7.0,-1.0
Dharwad,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,161.0,0.0,0.0,-1.0
Dharwad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1166.0,1276.0,1313.0,1198.0,2206.0,1571.0,1475.0,1585.0,1987.0,955.0,1603.0,1348.0,17683.0
Dharwad,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4795.0,4619.0,5162.0,5627.0,4510.0,4623.0,4778.0,4764.0,4057.0,4625.0,4078.0,3962.0,55600.0
Dharwad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1416.0,1380.0,1693.0,1639.0,1606.0,1396.0,1423.0,1339.0,1839.0,753.0,1586.0,1312.0,17382.0
Dharwad,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6876.0,7776.0,8417.0,7778.0,6546.0,6889.0,6630.0,6984.0,6027.0,6910.0,6500.0,5926.0,83259.0
Dharwad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2582.0,2656.0,3006.0,2837.0,3812.0,2967.0,2898.0,2924.0,3826.0,1708.0,3189.0,2660.0,35065.0
Dharwad,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,11671.0,12395.0,13579.0,13405.0,11056.0,11512.0,11408.0,11748.0,10084.0,11535.0,10578.0,9888.0,138859.0
Dharwad,14.10.2.a,Number of death cases of Inpatient males,TOTAL,226.0,216.0,204.0,254.0,269.0,264.0,313.0,259.0,246.0,232.0,227.0,237.0,2947.0
Dharwad,14.10.2.b,Number of death cases of Inpatient females,TOTAL,150.0,147.0,162.0,149.0,167.0,164.0,162.0,146.0,146.0,160.0,123.0,146.0,1822.0
Dharwad,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,376.0,363.0,366.0,403.0,436.0,428.0,475.0,405.0,392.0,392.0,350.0,383.0,4769.0
Dharwad,14.11,In-Patient Head Count at midnight,TOTAL,36694.0,39245.0,41595.0,39067.0,40398.0,40626.0,37692.0,41251.0,35564.0,35674.0,34027.0,33516.0,455349.0
Dharwad,14.12.1,OPD attendance (All),TOTAL,209907.0,213709.0,241398.0,242376.0,218011.0,238593.0,193579.0,201775.0,204535.0,207642.0,205419.0,189814.0,2566758.0
Dharwad,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1224.0,1249.0,1402.0,1432.0,1969.0,1883.0,2011.0,1929.0,2020.0,1847.0,2119.0,1047.0,20132.0
Dharwad,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,85.0,348.0,64.0,69.0,78.0,120.0,102.0,145.0,126.0,38.0,267.0,282.0,1724.0
Dharwad,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1209.0,3185.0,1265.0,3184.0,1187.0,2253.0,988.0,1239.0,3394.0,3034.0,3077.0,2790.0,26805.0
Dharwad,14.14.a,Number of patients given AYUSH treatment,TOTAL,2760.0,4091.0,4306.0,3155.0,2892.0,3111.0,2870.0,3266.0,3061.0,3119.0,2891.0,2988.0,38510.0
Dharwad,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,626.0,590.0,558.0,931.0,584.0,573.0,599.0,564.0,509.0,714.0,418.0,410.0,7076.0
Dharwad,14.14.c,Number of Adolescents counselled,TOTAL,112.0,134.0,194.0,192.0,219.0,218.0,172.0,181.0,197.0,117.0,145.0,114.0,1995.0
Dharwad,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,20740.0,11579.0,23789.0,20175.0,30737.0,22502.0,20218.0,24364.0,23293.0,21645.0,29259.0,23993.0,272294.0
Dharwad,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1024.0,465.0,1105.0,2614.0,1052.0,1019.0,2725.0,1046.0,1023.0,897.0,822.0,931.0,14723.0
Dharwad,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,3365.0,3352.0,3664.0,3875.0,3168.0,3819.0,3297.0,3812.0,4524.0,3720.0,3517.0,3420.0,43533.0
Dharwad,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,81.0,83.0,64.0,50.0,53.0,68.0,44.0,79.0,49.0,56.0,42.0,80.0,749.0
Dharwad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2777.0,2871.0,3267.0,3088.0,2786.0,2290.0,1871.0,2361.0,2688.0,2807.0,2820.0,2750.0,32376.0
Dharwad,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,48.0,59.0,49.0,33.0,48.0,39.0,28.0,141.0,21.0,35.0,38.0,48.0,587.0
Dharwad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2980.0,2967.0,3788.0,3008.0,3019.0,4058.0,2909.0,3632.0,3686.0,3157.0,3235.0,5350.0,41789.0
Dharwad,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,20.0,15.0,6.0,22.0,15.0,2.0,17.0,9.0,3.0,24.0,31.0,169.0
Dharwad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,9122.0,9190.0,10719.0,9971.0,8973.0,10167.0,8077.0,9805.0,10898.0,9684.0,9572.0,11520.0,117698.0
Dharwad,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,134.0,162.0,128.0,89.0,123.0,122.0,74.0,237.0,79.0,94.0,104.0,159.0,1505.0
Dharwad,15.2,Number of Widal tests conducted,Number tested,984.0,1569.0,1692.0,2168.0,2976.0,1444.0,2481.0,2075.0,1768.0,1532.0,1449.0,1616.0,21754.0
Dharwad,15.3.a,Number of VDRL tests conducted on males,Number tested,290.0,264.0,564.0,224.0,251.0,235.0,145.0,199.0,208.0,263.0,155.0,197.0,2995.0
Dharwad,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,591.0,587.0,728.0,759.0,2830.0,2264.0,2770.0,329.0,1630.0,456.0,597.0,539.0,14080.0
Dharwad,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,3155.0,3562.0,4069.0,2798.0,3140.0,3751.0,5078.0,6009.0,4688.0,2135.0,2590.0,2731.0,43706.0
Dharwad,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,4036.0,4413.0,5361.0,3781.0,6221.0,6250.0,7993.0,6537.0,6526.0,2854.0,3342.0,3467.0,60781.0
Dharwad,15.4.1,Number of blood smears examined for Malaria,TOTAL,19777.0,19471.0,34656.0,22537.0,23133.0,21301.0,20237.0,21413.0,19901.0,17535.0,19019.0,19504.0,258484.0
Dharwad,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,243.0,222.0,39.0,48.0,9.0,30.0,27.0,21.0,18.0,14.0,5.0,6.0,682.0
Dharwad,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,1.0,2.0,0.0,1.0,3.0,2.0,3.0,2.0,1.0,0.0,17.0
Dharwad,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3000.0,7000.0,1500.0,3000.0,3700.0,7700.0,12500.0,5500.0,5500.0,12000.0,9000.0,10000.0,80400.0
Dharwad,16.1.1,Stock position of DPT vaccines,2. Stocks Received,8000.0,0.0,8000.0,10000.0,15000.0,16800.0,0.0,5000.0,15000.0,0.0,8000.0,8000.0,93800.0
Dharwad,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Dharwad,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4000.0,5500.0,6500.0,9300.0,11000.0,12000.0,7000.0,5000.0,8500.0,3000.0,7000.0,5500.0,84300.0
Dharwad,16.1.1,Stock position of DPT vaccines,5. Total Stock,7000.0,1500.0,3000.0,3700.0,7700.0,12500.0,5500.0,5500.0,12000.0,9000.0,10000.0,12500.0,89900.0
Dharwad,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,9500.0,19500.0,9000.0,12000.0,22000.0,33000.0,22000.0,7000.0,8500.0,8500.0,2500.0,4500.0,158000.0
Dharwad,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,0.0,14000.0,20000.0,15000.0,,0.0,8000.0,10500.0,0.0,12000.0,12000.0,103500.0
Dharwad,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,10000.0,,,0.0,,0.0,0.0,0.0,,10000.0
Dharwad,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2000.0,10500.0,11000.0,0.0,4000.0,11000.0,15000.0,6500.0,10500.0,6000.0,10000.0,6000.0,92500.0
Dharwad,16.1.1A,Stock Position of Pentavalent,5. Total Stock,19500.0,9000.0,12000.0,22000.0,33000.0,22000.0,7000.0,8500.0,8500.0,2500.0,4500.0,10500.0,159000.0
Dharwad,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,12000.0,28000.0,4000.0,10000.0,11500.0,23500.0,26500.0,100.0,900.0,200.0,0.0,,116700.0
Dharwad,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25000.0,0.0,25000.0,25000.0,25000.0,26000.0,0.0,10000.0,18300.0,10000.0,22000.0,,186300.0
Dharwad,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9000.0,24000.0,19000.0,23500.0,13000.0,23000.0,26400.0,9200.0,19000.0,10200.0,22000.0,,198300.0
Dharwad,16.1.2,Stock position of OPV vaccines,5. Total Stock,28000.0,4000.0,10000.0,11500.0,23500.0,26500.0,100.0,900.0,200.0,0.0,0.0,0.0,104700.0
Dharwad,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8000.0,10500.0,2000.0,3000.0,10700.0,8700.0,25200.0,13200.0,8200.0,16700.0,13700.0,14700.0,134600.0
Dharwad,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,0.0,15000.0,20000.0,12000.0,36000.0,0.0,8000.0,21000.0,0.0,8000.0,10000.0,138000.0
Dharwad,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5500.0,8500.0,14000.0,12300.0,14000.0,19500.0,12000.0,13000.0,12500.0,3000.0,7000.0,4500.0,125800.0
Dharwad,16.1.3,Stock position of TT vaccines,5. Total Stock,10500.0,2000.0,3000.0,10700.0,8700.0,25200.0,13200.0,8200.0,16700.0,13700.0,14700.0,20200.0,146800.0
Dharwad,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,,0.0
Dharwad,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,,0.0
Dharwad,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,,0.0
Dharwad,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,,0.0
Dharwad,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6000.0,9000.0,3000.0,6500.0,9000.0,15500.0,10000.0,2500.0,4000.0,8500.0,3500.0,3500.0,81000.0
Dharwad,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,0.0,10000.0,10000.0,10000.0,1500.0,0.0,7500.0,13000.0,0.0,8000.0,8000.0,78000.0
Dharwad,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7000.0,6000.0,6500.0,7500.0,3500.0,7000.0,7500.0,6000.0,8500.0,5000.0,8000.0,2500.0,75000.0
Dharwad,16.1.5,Stock position of BCG vaccines,5. Total Stock,9000.0,3000.0,6500.0,9000.0,15500.0,10000.0,2500.0,4000.0,8500.0,3500.0,3500.0,9000.0,84000.0
Dharwad,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6900.0,7900.0,1500.0,5000.0,9000.0,16500.0,10000.0,1000.0,4500.0,7250.0,2000.0,3500.0,75050.0
Dharwad,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,0.0,8000.0,10000.0,10000.0,2500.0,0.0,9000.0,10000.0,0.0,8000.0,8000.0,69500.0
Dharwad,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3000.0,6400.0,4500.0,6000.0,2500.0,9000.0,9000.0,5500.0,7250.0,5250.0,6500.0,3000.0,67900.0
Dharwad,16.1.6,Stock position of Measles vaccines,5. Total Stock,7900.0,1500.0,5000.0,9000.0,16500.0,10000.0,1000.0,4500.0,7250.0,2000.0,3500.0,8500.0,76650.0
Dharwad,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,6150.0,1550.0,13500.0,1350.0,9850.0,5350.0,10000.0,0.0,20000.0,9300.0,28300.0,19300.0,124650.0
Dharwad,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,15000.0,0.0,15000.0,0.0,10000.0,0.0,25000.0,0.0,25000.0,0.0,0.0,90000.0
Dharwad,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.1.7,Stock position of JE vaccines,4. Stock Distributed,4600.0,3050.0,12150.0,6500.0,4500.0,5350.0,10000.0,5000.0,10700.0,6000.0,9000.0,6000.0,82850.0
Dharwad,16.1.7,Stock position of JE vaccines,5. Total Stock,1550.0,13500.0,1350.0,9850.0,5350.0,10000.0,0.0,20000.0,9300.0,28300.0,19300.0,13300.0,131800.0
Dharwad,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9560.0,9500.0,8000.0,5500.0,4000.0,8500.0,8000.0,5000.0,4000.0,5500.0,5000.0,3300.0,75860.0
Dharwad,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,,0.0,,3000.0,0.0,0.0,,8000.0
Dharwad,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,60.0,1500.0,2500.0,1500.0,500.0,500.0,3000.0,1000.0,1500.0,500.0,1700.0,,14260.0
Dharwad,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9500.0,8000.0,5500.0,4000.0,8500.0,8000.0,5000.0,4000.0,5500.0,5000.0,3300.0,3300.0,69600.0
Dharwad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2000.0,2000.0,0.0,0.0,0.0,,,,,0.0,1200.0,1200.0,6400.0
Dharwad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,,,,1200.0,0.0,0.0,1200.0
Dharwad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,,,,,0.0,0.0,,0.0
Dharwad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,2000.0,0.0,0.0,0.0,,,,,0.0,0.0,0.0,2000.0
Dharwad,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,1200.0,1200.0,5600.0
Dharwad,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,160000.0,70000.0,0.0,151200.0,145200.0,87560.0,85680.0,12000.0,10000.0,8000.0,19700.0,19700.0,769040.0
Dharwad,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,151200.0,0.0,,151200.0,0.0,,,19700.0,0.0,,322100.0
Dharwad,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,,0.0
Dharwad,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,90000.0,70000.0,0.0,6000.0,57640.0,153080.0,73680.0,2000.0,2000.0,8000.0,0.0,700.0,463100.0
Dharwad,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,70000.0,0.0,151200.0,145200.0,87560.0,85680.0,12000.0,10000.0,8000.0,19700.0,19700.0,19000.0,628040.0
Dharwad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,6000.0,6000.0,1000.0,1700.0,1000.0,600.0,8000.0,2000.0,1500.0,1000.0,10000.0,10000.0,48800.0
Dharwad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,900.0,0.0,,16000.0,0.0,,,10000.0,0.0,,26900.0
Dharwad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,,0.0
Dharwad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,5000.0,200.0,700.0,400.0,8600.0,6000.0,500.0,500.0,1000.0,0.0,,22900.0
Dharwad,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,6000.0,1000.0,1700.0,1000.0,600.0,8000.0,2000.0,1500.0,1000.0,10000.0,10000.0,10000.0,52800.0
Dharwad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,0.0,0.0,,0.0,10000.0,10000.0,27200.0
Dharwad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,10000.0,0.0,,10000.0
Dharwad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,0.0,0.0,,0.0
Dharwad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,1200.0,,,,0.0,0.0,,1200.0
Dharwad,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1200.0,1200.0,1200.0,1200.0,1200.0,0.0,0.0,0.0,0.0,10000.0,10000.0,10000.0,36000.0
Dharwad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3394.0,3394.0,3394.0,3394.0,3394.0,3394.0,3394.0,,,,,,23758.0
Dharwad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dharwad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dharwad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,,0.0,0.0,,,,,,0.0
Dharwad,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3394.0,3394.0,3394.0,3394.0,3394.0,3394.0,3394.0,0.0,0.0,0.0,0.0,0.0,23758.0
Dharwad,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,,,0.0,40000.0,30000.0,30000.0,30000.0,30000.0,160000.0
Dharwad,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,,,250000.0,,,,,,250000.0
Dharwad,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,,,0.0,,,,,,0.0
Dharwad,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,,,,210000.0,10000.0,,,,,220000.0
Dharwad,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,40000.0,30000.0,30000.0,30000.0,30000.0,30000.0,190000.0
Dharwad,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,0.0,50.0,50.0
Dharwad,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,,,,,,,,14250.0,,14250.0
Dharwad,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,14200.0,,14200.0
Dharwad,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0,50.0,100.0
Dharwad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,,,,,,,,127.0,,127.0
Dharwad,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,,,,,,,,1500.0,,1500.0
Dharwad,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,,,,,,,,,0.0
Dharwad,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,,,,,,,,1627.0,,1627.0
Dharwad,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Dharwad,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,,0.0,12656.0,12656.0,2656.0,1000.0,1000.0,29968.0
Dharwad,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,52256.0,24768.0,,67056.0,,,,,,144080.0
Dharwad,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,,,,,0.0
Dharwad,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,52256.0,24768.0,,54400.0,,10000.0,1656.0,0.0,,143080.0
Dharwad,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,12656.0,12656.0,2656.0,1000.0,1000.0,1000.0,30968.0
Dharwad,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11200.0,12600.0,9000.0,5000.0,4300.0,5700.0,13300.0,8800.0,5800.0,8000.0,5600.0,6600.0,95900.0
Dharwad,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,0.0,2900.0,3300.0,12200.0,0.0,,6600.0,0.0,5400.0,0.0,33400.0
Dharwad,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1600.0,3600.0,4000.0,3600.0,1900.0,4600.0,4500.0,3000.0,4400.0,2400.0,4400.0,2400.0,40400.0
Dharwad,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,12600.0,9000.0,5000.0,4300.0,5700.0,13300.0,8800.0,5800.0,8000.0,5600.0,6600.0,4200.0,88900.0
Dharwad,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,46800.0,51000.0,37200.0,48800.0,41200.0,53200.0,111300.0,65300.0,39300.0,24700.0,5500.0,6400.0,530700.0
Dharwad,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,30000.0,19200.0,36000.0,28800.0,26400.0,86600.0,0.0,,27400.0,0.0,23700.0,73500.0,351600.0
Dharwad,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,0.0
Dharwad,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,25800.0,33000.0,24400.0,36400.0,14400.0,28500.0,46000.0,26000.0,42000.0,19200.0,22800.0,14200.0,332700.0
Dharwad,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,51000.0,37200.0,48800.0,41200.0,53200.0,111300.0,65300.0,39300.0,24700.0,5500.0,6400.0,65700.0,549600.0
Dharwad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3600.0,6000.0,3000.0,5400.0,5900.0,7200.0,10100.0,7700.0,4200.0,5900.0,3300.0,5700.0,68000.0
Dharwad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,4800.0,2400.0,2400.0,4800.0,0.0,,4800.0,0.0,4800.0,2400.0,28800.0
Dharwad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,,,0.0,,0.0,0.0,0.0,,0.0
Dharwad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,3000.0,2400.0,1900.0,1100.0,1900.0,2400.0,3500.0,3100.0,2600.0,2400.0,1500.0,25800.0
Dharwad,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6000.0,3000.0,5400.0,5900.0,7200.0,10100.0,7700.0,4200.0,5900.0,3300.0,5700.0,6600.0,71000.0
Dharwad,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,3.0,,,1.0,,2.0,1.0,5.0,12.0
Dharwad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,3.0,,1.0,1.0,3.0,3.0,,4.0,5.0,9.0,12.0,42.0
Dharwad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,1.0,1.0,1.0,1.0,,,,4.0,2.0,,11.0
Dharwad,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,4.0,1.0,2.0,2.0,4.0,3.0,,4.0,9.0,11.0,12.0,53.0
Dharwad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,4.0,3.0,1.0,2.0,3.0,,7.0,,4.0,5.0,9.0,7.0,45.0
Dharwad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,1.0,,1.0,,,,1.0,1.0,1.0,1.0,7.0
Dharwad,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,3.0,2.0,2.0,4.0,,7.0,,5.0,6.0,10.0,8.0,52.0
Dharwad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,4.0,3.0,1.0,2.0,4.0,7.0,1.0,2.0,3.0,12.0,18.0,9.0,66.0
Dharwad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,1.0,2.0,4.0
Dharwad,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,4.0,3.0,1.0,2.0,4.0,7.0,1.0,2.0,3.0,13.0,19.0,11.0,70.0
Dharwad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,6.0,1.0,7.0,1.0,1.0,4.0,,4.0,10.0,7.0,12.0,57.0
Dharwad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,2.0,1.0,,1.0,,,,1.0,,,7.0
Dharwad,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,6.0,3.0,8.0,1.0,2.0,4.0,,4.0,11.0,7.0,12.0,64.0
Dharwad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,1.0,1.0,1.0,1.0,,,4.0
Dharwad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dharwad,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,1.0,1.0,1.0,1.0,,,4.0
Dharwad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dharwad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dharwad,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Dharwad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,,2.0,,,,,,,3.0
Dharwad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dharwad,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,,2.0,,,,,,,3.0
Dharwad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Dharwad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Dharwad,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Dharwad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,,,2.0,1.0,1.0,,,1.0,3.0,4.0,13.0
Dharwad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,1.0,,2.0,,,,,,4.0
Dharwad,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,1.0,,3.0,1.0,3.0,,,1.0,3.0,4.0,17.0
Dharwad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Dharwad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,1.0,,,,,,1.0,2.0
Dharwad,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,,,,,,2.0,3.0
Dharwad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,1.0,,,,,,,,2.0
Dharwad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,5.0,5.0,4.0,3.0,3.0,6.0,2.0,3.0,,,4.0,37.0
Dharwad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,3.0,1.0,1.0,1.0,1.0,,,3.0,2.0,,14.0
Dharwad,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,6.0,8.0,5.0,5.0,4.0,7.0,2.0,3.0,3.0,2.0,4.0,53.0
Dharwad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,1.0,,1.0,,,,2.0
Dharwad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,6.0,8.0,7.0,5.0,7.0,13.0,3.0,3.0,7.0,5.0,6.0,74.0
Dharwad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,17.0,13.0,19.0,17.0,22.0,20.0,23.0,7.0,6.0,28.0,17.0,22.0,211.0
Dharwad,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,21.0,19.0,27.0,24.0,27.0,27.0,37.0,10.0,10.0,35.0,22.0,28.0,287.0
Dharwad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,,,,,,,1.0,,,2.0
Dharwad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,1.0,,2.0,3.0
Dharwad,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,,,,,,,2.0,,2.0,5.0
Dharwad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,3.0,,4.0,5.0,7.0,8.0,9.0,,3.0,14.0,4.0,4.0,61.0
Dharwad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,5.0,,5.0,6.0,7.0,6.0,4.0,1.0,1.0,16.0,3.0,9.0,63.0
Dharwad,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,8.0,,9.0,11.0,14.0,14.0,13.0,1.0,4.0,30.0,7.0,13.0,124.0
Dharwad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Dharwad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,4.0,1.0,3.0,3.0,1.0,4.0,1.0,,4.0,2.0,4.0,30.0
Dharwad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,1.0,1.0,,,1.0,2.0,1.0,,,2.0,9.0
Dharwad,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,4.0,4.0,2.0,4.0,3.0,1.0,5.0,3.0,1.0,5.0,2.0,6.0,40.0
Dharwad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,3.0,,,,,,,2.0,3.0,,8.0
Dharwad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,18.0,20.0,25.0,12.0,23.0,26.0,18.0,12.0,21.0,28.0,16.0,19.0,238.0
Dharwad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,37.0,31.0,45.0,29.0,47.0,50.0,35.0,31.0,65.0,54.0,32.0,30.0,486.0
Dharwad,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,55.0,51.0,73.0,41.0,70.0,76.0,53.0,43.0,86.0,84.0,51.0,49.0,732.0
Dharwad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Dharwad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,11.0,,6.0,2.0,4.0,6.0,5.0,4.0,4.0,3.0,3.0,2.0,50.0
Dharwad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,16.0,16.0,16.0,26.0,17.0,17.0,19.0,14.0,22.0,19.0,24.0,17.0,223.0
Dharwad,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,27.0,16.0,22.0,28.0,21.0,23.0,25.0,18.0,26.0,23.0,27.0,19.0,275.0
Dharwad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Dharwad,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Dharwad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Dharwad,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Dharwad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Dharwad,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Dharwad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Dharwad,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Dharwad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Dharwad,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Dharwad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,2.0,,,,,2.0,,,5.0
Dharwad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Dharwad,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,2.0,,,,,2.0,,,5.0
Dharwad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Dharwad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,1.0,2.0,5.0,3.0,10.0,3.0,3.0,2.0,7.0,6.0,2.0,4.0,48.0
Dharwad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,4.0,,1.0,4.0,3.0,6.0,,,2.0,1.0,3.0,25.0
Dharwad,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,3.0,6.0,5.0,4.0,14.0,6.0,9.0,2.0,7.0,8.0,3.0,7.0,74.0
Dharwad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,,,,,,
Dharwad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,2.0,7.0,2.0,2.0,,,3.0,4.0,2.0,4.0,3.0,2.0,31.0
Dharwad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,1.0,,,1.0,,1.0,,,1.0,2.0,1.0,9.0
Dharwad,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,4.0,8.0,2.0,2.0,1.0,,4.0,4.0,2.0,5.0,5.0,3.0,40.0
Dharwad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,,,,1.0,,2.0
Dharwad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,3.0,,1.0,,,,,2.0,7.0
Dharwad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,1.0,,1.0,1.0,,2.0,,3.0,8.0
Dharwad,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,1.0,,4.0,,2.0,1.0,,2.0,1.0,5.0,17.0
Dharwad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,2.0,,,,1.0,,,1.0,,1.0,,1.0,6.0
Dharwad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,17.0,11.0,6.0,8.0,8.0,19.0,9.0,10.0,20.0,15.0,19.0,17.0,159.0
Dharwad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,20.0,19.0,5.0,18.0,24.0,23.0,15.0,16.0,20.0,14.0,18.0,28.0,220.0
Dharwad,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,39.0,30.0,11.0,26.0,33.0,42.0,24.0,27.0,40.0,30.0,37.0,46.0,385.0
Dharwad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,1.0,,,,,1.0,,,1.0,,1.0,5.0
Dharwad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,29.0,13.0,11.0,17.0,11.0,18.0,22.0,7.0,24.0,10.0,17.0,10.0,189.0
Dharwad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,21.0,32.0,23.0,20.0,40.0,36.0,24.0,18.0,25.0,23.0,26.0,12.0,300.0
Dharwad,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,51.0,46.0,34.0,37.0,51.0,54.0,47.0,25.0,49.0,34.0,43.0,23.0,494.0
Dharwad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,,3.0,,,,1.0,1.0,1.0,3.0,1.0,11.0
Dharwad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,33.0,47.0,29.0,48.0,30.0,32.0,36.0,27.0,27.0,31.0,31.0,25.0,396.0
Dharwad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,72.0,111.0,110.0,101.0,129.0,129.0,110.0,106.0,109.0,86.0,109.0,76.0,1248.0
Dharwad,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,106.0,158.0,139.0,152.0,159.0,161.0,146.0,134.0,137.0,118.0,143.0,102.0,1655.0
Gadag,1.1,Total number of pregnant women Registered for ANC,TOTAL,1839.0,1813.0,1960.0,1758.0,1642.0,1913.0,1687.0,1858.0,1701.0,1716.0,1721.0,1808.0,21416.0
Gadag,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1525.0,1444.0,1475.0,1391.0,1271.0,1540.0,1360.0,1453.0,1366.0,1363.0,1325.0,1364.0,16877.0
Gadag,1.2,Number of Pregnant women registered under JSY,TOTAL,1635.0,1581.0,1715.0,1528.0,1433.0,1689.0,1442.0,1614.0,1467.0,1506.0,1510.0,1582.0,18702.0
Gadag,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1756.0,1752.0,1410.0,1621.0,1565.0,1831.0,1656.0,1695.0,1636.0,1672.0,1795.0,1564.0,19953.0
Gadag,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1324.0,1285.0,1441.0,1320.0,1224.0,1417.0,1223.0,1382.0,1218.0,1168.0,1241.0,1312.0,15555.0
Gadag,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1842.0,1800.0,1857.0,1831.0,1691.0,1805.0,1674.0,1938.0,1818.0,1770.0,1775.0,1816.0,21617.0
Gadag,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,621.0,419.0,409.0,1225.0,207.0,256.0,93.0,84.0,73.0,23.0,42.0,87.0,3539.0
Gadag,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,21.0,10.0,63.0,129.0,141.0,147.0,145.0,37.0,7.0,11.0,18.0,25.0,754.0
Gadag,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,1.0,0.0,15.0,18.0,20.0,21.0,0.0,0.0,1.0,0.0,0.0,76.0
Gadag,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,978.0,1344.0,1530.0,2552.0,2618.0,2792.0,1799.0,2445.0,2010.0,2299.0,2015.0,2393.0,24775.0
Gadag,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,26.0,37.0,49.0,105.0,100.0,113.0,92.0,79.0,78.0,119.0,103.0,81.0,982.0
Gadag,1.8,Number of pregnancy test kits used at SC level,TOTAL,352.0,289.0,301.0,278.0,260.0,266.0,249.0,288.0,294.0,178.0,203.0,208.0,3166.0
Gadag,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,10.0,9.0,25.0,28.0,8.0,25.0,30.0,32.0,11.0,14.0,11.0,13.0,216.0
Gadag,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,1.0,2.0,0.0,0.0,1.0,0.0,0.0,8.0,3.0,0.0,0.0,15.0
Gadag,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,10.0,10.0,27.0,28.0,8.0,26.0,30.0,32.0,19.0,17.0,11.0,13.0,231.0
Gadag,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,10.0,10.0,27.0,28.0,8.0,26.0,30.0,32.0,19.0,17.0,11.0,13.0,231.0
Gadag,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0,0.0,1.0,0.0,7.0
Gadag,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1109.0,1026.0,1053.0,1020.0,1091.0,1110.0,1070.0,1143.0,1065.0,957.0,987.0,884.0,12515.0
Gadag,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,63.0,60.0,88.0,301.0,335.0,225.0,302.0,35.0,89.0,124.0,40.0,37.0,1699.0
Gadag,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,310.0,819.0,632.0,1011.0,601.0,923.0,1893.0,1041.0,596.0,1031.0,707.0,292.0,9856.0
Gadag,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,857.0,838.0,921.0,829.0,666.0,918.0,930.0,972.0,864.0,776.0,782.0,504.0,9857.0
Gadag,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,342.0,344.0,390.0,369.0,350.0,393.0,360.0,397.0,397.0,337.0,319.0,321.0,4319.0
Gadag,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,2.0
Gadag,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,91.0,25.0,56.0,57.0,54.0,69.0,39.0,59.0,47.0,92.0,54.0,61.0,704.0
Gadag,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,91.0,25.0,56.0,57.0,54.0,69.0,39.0,59.0,47.0,92.0,54.0,61.0,704.0
Gadag,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,101.0,82.0,115.0,92.0,96.0,55.0,91.0,96.0,133.0,122.0,119.0,199.0,1301.0
Gadag,4.1.1.a,Number of male live births,TOTAL,776.0,722.0,797.0,699.0,715.0,728.0,761.0,804.0,747.0,681.0,660.0,627.0,8717.0
Gadag,4.1.1.b,Number of female live births,TOTAL,663.0,657.0,660.0,701.0,715.0,774.0,678.0,754.0,709.0,611.0,640.0,575.0,8137.0
Gadag,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1439.0,1379.0,1457.0,1400.0,1430.0,1502.0,1439.0,1558.0,1456.0,1292.0,1300.0,1202.0,16854.0
Gadag,4.1.2,Number of still births,TOTAL,25.0,17.0,13.0,20.0,20.0,28.0,28.0,18.0,26.0,21.0,20.0,16.0,252.0
Gadag,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,24.0,13.0,12.0,18.0,19.0,21.0,23.0,23.0,18.0,21.0,16.0,25.0,233.0
Gadag,4.2.1,Number of Newborns weighed at birth,TOTAL,1426.0,1334.0,1454.0,1394.0,1427.0,1501.0,1430.0,1557.0,1450.0,1290.0,1300.0,1201.0,16764.0
Gadag,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,100.0,86.0,107.0,102.0,115.0,143.0,94.0,105.0,107.0,108.0,75.0,83.0,1225.0
Gadag,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1410.0,1315.0,1441.0,1383.0,1405.0,1482.0,1420.0,1546.0,1444.0,1284.0,1289.0,1184.0,16603.0
Gadag,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,2.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0,1.0,2.0,0.0,0.0,9.0
Gadag,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,45.0,0.0,0.0,0.0,0.0,0.0,0.0,45.0
Gadag,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,13.0,0.0,73.0,26.0,0.0,45.0,19.0,0.0,19.0,14.0,25.0,29.0,263.0
Gadag,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,15.0,0.0,74.0,27.0,0.0,90.0,19.0,2.0,20.0,16.0,25.0,29.0,317.0
Gadag,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,9.0,7.0,10.0,6.0,9.0,10.0,0.0,8.0,9.0,10.0,11.0,10.0,99.0
Gadag,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,47.0,43.0,38.0,98.0,119.0,121.0,106.0,92.0,93.0,104.0,167.0,204.0,1232.0
Gadag,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,19.0,10.0,17.0,44.0,38.0,46.0,53.0,48.0,58.0,55.0,166.0,165.0,719.0
Gadag,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,37.0,39.0,26.0,324.0,474.0,473.0,377.0,249.0,249.0,215.0,415.0,439.0,3317.0
Gadag,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,0.0,65.0,50.0,61.0,63.0,0.0,0.0,0.0,0.0,4.0,243.0
Gadag,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1271.0,1230.0,1300.0,1272.0,1358.0,1331.0,1368.0,1351.0,1428.0,1180.0,1289.0,1142.0,15520.0
Gadag,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1410.0,1211.0,1395.0,1354.0,1353.0,1530.0,1347.0,1449.0,1419.0,1455.0,1343.0,1403.0,16669.0
Gadag,6.3,PNC maternal complications attended,TOTAL,0.0,2.0,1.0,5.0,0.0,1.0,2.0,0.0,1.0,3.0,0.0,4.0,19.0
Gadag,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,1.0,0.0,0.0,1.0,5.0,5.0,5.0,1.0,6.0,4.0,0.0,1.0,29.0
Gadag,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,0.0,1.0,0.0,4.0,2.0,0.0,0.0,0.0,0.0,1.0,1.0,11.0
Gadag,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,3.0,0.0,1.0,1.0,9.0,7.0,5.0,1.0,6.0,4.0,1.0,2.0,40.0
Gadag,7.2,Number of MTPs conducted at Private Facilities,TOTAL,1.0,0.0,1.0,0.0,3.0,0.0,1.0,0.0,1.0,0.0,0.0,2.0,9.0
Gadag,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,285.0,285.0,263.0,141.0,312.0,146.0,214.0,152.0,210.0,290.0,195.0,249.0,2742.0
Gadag,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,388.0,358.0,494.0,574.0,484.0,601.0,343.0,327.0,425.0,515.0,401.0,488.0,5398.0
Gadag,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,673.0,643.0,757.0,715.0,796.0,747.0,557.0,479.0,635.0,805.0,596.0,737.0,8140.0
Gadag,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Gadag,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gadag,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gadag,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,99.0,83.0,83.0,62.0,27.0,89.0,68.0,52.0,57.0,86.0,50.0,112.0,868.0
Gadag,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,104.0,74.0,92.0,84.0,32.0,107.0,81.0,74.0,39.0,49.0,71.0,68.0,875.0
Gadag,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,203.0,157.0,175.0,146.0,59.0,196.0,149.0,126.0,96.0,135.0,121.0,180.0,1743.0
Gadag,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,148.0,162.0,138.0,136.0,102.0,160.0,104.0,183.0,193.0,153.0,119.0,164.0,1762.0
Gadag,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gadag,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,7.0,5.0,16.0,16.0,4.0,33.0,20.0,46.0,36.0,36.0,37.0,42.0,298.0
Gadag,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,7.0,6.0,16.0,16.0,4.0,33.0,20.0,46.0,36.0,36.0,37.0,42.0,299.0
Gadag,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,72.0,96.0,53.0,61.0,18.0,73.0,36.0,122.0,80.0,57.0,66.0,62.0,796.0
Gadag,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,65.0,13.0,25.0,37.0,44.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,192.0
Gadag,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,65.0,13.0,25.0,37.0,44.0,0.0,8.0,0.0,0.0,0.0,0.0,0.0,192.0
Gadag,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,1.0,0.0,0.0,74.0,39.0,26.0,2.0,0.0,1.0,1.0,21.0,165.0
Gadag,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,4.0,7.0,7.0,7.0,4.0,2.0,1.0,3.0,2.0,2.0,0.0,4.0,43.0
Gadag,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,243.0,256.0,225.0,230.0,236.0,215.0,238.0,212.0,227.0,236.0,228.0,200.0,2746.0
Gadag,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,20.0,16.0,20.0,13.0,20.0,16.0,16.0,13.0,15.0,15.0,11.0,14.0,189.0
Gadag,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,28.0,26.0,25.0,11.0,18.0,19.0,35.0,26.0,20.0,13.0,31.0,41.0,293.0
Gadag,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gadag,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,295.0,305.0,277.0,261.0,278.0,252.0,290.0,254.0,264.0,266.0,270.0,259.0,3271.0
Gadag,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,5.0,4.0,9.0,9.0,11.0,18.0,11.0,7.0,7.0,4.0,11.0,8.0,104.0
Gadag,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,53.0,67.0,77.0,90.0,88.0,113.0,70.0,84.0,61.0,59.0,39.0,41.0,842.0
Gadag,9.06,Number of IUCD removals,TOTAL,29.0,15.0,9.0,11.0,15.0,10.0,42.0,19.0,10.0,15.0,10.0,7.0,192.0
Gadag,9.07,Number of Oral Pills cycles distributed,TOTAL,2416.0,2367.0,2528.0,2630.0,2746.0,2749.0,2885.0,2829.0,2836.0,3019.0,3086.0,3126.0,33217.0
Gadag,9.08,Number of Condom pieces distributed,TOTAL,19628.0,19476.0,19168.0,21364.0,20346.0,20678.0,20834.0,19123.0,19648.0,21122.0,21153.0,21310.0,243850.0
Gadag,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,0.0,1.0,0.0,6.0
Gadag,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Gadag,9.12,Number of Institutions having NSV trained doctors,TOTAL,21.0,19.0,19.0,24.0,19.0,17.0,18.0,3.0,3.0,3.0,3.0,3.0,-1.0
Gadag,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1707.0,1505.0,1666.0,1813.0,1727.0,1790.0,1740.0,2001.0,1815.0,1653.0,1478.0,1486.0,20381.0
Gadag,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1641.0,1735.0,1797.0,1690.0,1695.0,1654.0,1676.0,1946.0,1810.0,1851.0,1648.0,1652.0,20795.0
Gadag,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1606.0,1557.0,1767.0,1795.0,1695.0,1677.0,1583.0,1823.0,1832.0,1814.0,1692.0,1853.0,20694.0
Gadag,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1769.0,1598.0,1674.0,1770.0,1711.0,1687.0,1723.0,1847.0,1742.0,1816.0,1632.0,1752.0,20721.0
Gadag,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1041.0,1039.0,1056.0,1073.0,1139.0,1220.0,1133.0,1219.0,1084.0,1021.0,890.0,895.0,12810.0
Gadag,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1641.0,1735.0,1797.0,1690.0,1695.0,1654.0,1676.0,1946.0,1810.0,1851.0,1648.0,1652.0,20795.0
Gadag,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1606.0,1557.0,1767.0,1795.0,1695.0,1677.0,1583.0,1823.0,1832.0,1814.0,1692.0,1850.0,20691.0
Gadag,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1769.0,1598.0,1674.0,1770.0,1711.0,1687.0,1723.0,1847.0,1742.0,1812.0,1632.0,1752.0,20717.0
Gadag,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,964.0,984.0,863.0,973.0,1029.0,1095.0,1019.0,1087.0,890.0,891.0,776.0,783.0,11354.0
Gadag,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,8.0
Gadag,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1639.0,1490.0,1767.0,1762.0,1766.0,1784.0,1618.0,1803.0,1627.0,1595.0,1513.0,1720.0,20084.0
Gadag,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1444.0,1415.0,1843.0,1504.0,1341.0,1526.0,1485.0,1667.0,1535.0,1471.0,1457.0,1532.0,18220.0
Gadag,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,823.0,812.0,904.0,893.0,921.0,928.0,832.0,919.0,855.0,825.0,800.0,876.0,10388.0
Gadag,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,814.0,693.0,851.0,860.0,844.0,853.0,791.0,873.0,762.0,756.0,717.0,816.0,9630.0
Gadag,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1637.0,1505.0,1755.0,1753.0,1765.0,1781.0,1623.0,1792.0,1617.0,1581.0,1517.0,1692.0,20018.0
Gadag,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1444.0,1415.0,1843.0,1504.0,1341.0,1526.0,1485.0,1667.0,1535.0,1471.0,1457.0,1532.0,18220.0
Gadag,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1444.0,1415.0,1843.0,1504.0,1341.0,1526.0,1485.0,1667.0,1535.0,1471.0,1457.0,1532.0,18220.0
Gadag,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Gadag,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,15.0,0.0,11.0,4.0,56.0,49.0,11.0,4.0,17.0,8.0,1.0,17.0,193.0
Gadag,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,13.0,0.0,6.0,4.0,48.0,54.0,9.0,13.0,14.0,7.0,2.0,19.0,189.0
Gadag,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,28.0,0.0,17.0,8.0,104.0,103.0,20.0,17.0,31.0,15.0,3.0,36.0,382.0
Gadag,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,6.0,9.0,1032.0,4947.0,5711.0,2.0,1742.0,1171.0,1085.0,220.0,467.0,16392.0
Gadag,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,32.0,12.0,0.0,1147.0,4824.0,5544.0,35.0,2029.0,1310.0,846.0,266.0,466.0,16511.0
Gadag,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,27.0,16.0,0.0,1089.0,3796.0,4776.0,40.0,2298.0,2030.0,684.0,422.0,537.0,15715.0
Gadag,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gadag,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,674.0,674.0,680.0,691.0,693.0,691.0,693.0,695.0,692.0,692.0,692.0,692.0,8259.0
Gadag,10.4.2,Number of Immunisation sessions held during the month,TOTAL,663.0,654.0,665.0,672.0,673.0,665.0,675.0,679.0,666.0,675.0,653.0,658.0,7998.0
Gadag,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,463.0,453.0,457.0,464.0,485.0,476.0,466.0,460.0,437.0,442.0,440.0,434.0,5477.0
Gadag,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1639.0,1490.0,1767.0,1762.0,1766.0,1784.0,1618.0,1803.0,1627.0,1595.0,1513.0,1720.0,20084.0
Gadag,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,2.0,5.0,1856.0,19835.0,49.0,0.0,0.0,0.0,0.0,2381.0,10203.0,34331.0
Gadag,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,0.0,1774.0,19300.0,3.0,0.0,0.0,0.0,1.0,2158.0,7491.0,30727.0
Gadag,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,2.0,3.0,11.0,0.0,1.0,0.0,2.0,3.0,8.0,4.0,9.0,53.0
Gadag,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,593.0,534.0,548.0,653.0,584.0,575.0,537.0,549.0,527.0,677.0,635.0,595.0,7007.0
Gadag,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,3.0,0.0,3.0,3.0,0.0,0.0,0.0,4.0,13.0
Gadag,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,0.0,3.0,3.0,27.0,3.0,3.0,4.0,0.0,7.0,60.0,78.0,75.0,263.0
Gadag,13.1,Number of Patients operated for cataract,TOTAL,35.0,25.0,67.0,39.0,91.0,66.0,75.0,58.0,7.0,93.0,55.0,70.0,681.0
Gadag,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,35.0,25.0,67.0,39.0,91.0,66.0,75.0,58.0,7.0,93.0,55.0,70.0,681.0
Gadag,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,4.0,58.0,54.0,10.0,13.0,18.0,28.0,22.0,10.0,217.0
Gadag,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,7.0
Gadag,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,10.0,10.0,10.0,10.0,10.0,10.0,9.0,10.0,10.0,9.0,10.0,-1.0
Gadag,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,24.0,25.0,25.0,26.0,27.0,25.0,26.0,25.0,28.0,26.0,24.0,27.0,-1.0
Gadag,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,308.0,287.0,301.0,317.0,312.0,300.0,326.0,324.0,315.0,323.0,328.0,401.0,-1.0
Gadag,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,6.0,7.0,8.0,7.0,7.0,7.0,5.0,5.0,7.0,7.0,7.0,8.0,-1.0
Gadag,14.05,Number of RKS meetings held during the month,TOTAL,7.0,6.0,11.0,8.0,12.0,11.0,8.0,8.0,5.0,13.0,8.0,16.0,113.0
Gadag,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,26.0,27.0,25.0,29.0,26.0,28.0,27.0,26.0,27.0,26.0,23.0,27.0,-1.0
Gadag,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,172.0,155.0,240.0,227.0,274.0,275.0,306.0,74.0,120.0,158.0,113.0,188.0,2302.0
Gadag,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,9.0,8.0,7.0,8.0,7.0,6.0,7.0,7.0,8.0,8.0,8.0,-1.0
Gadag,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,2.0,1.0,2.0,3.0,3.0,2.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Gadag,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,529.0,457.0,337.0,567.0,679.0,304.0,963.0,807.0,625.0,640.0,938.0,545.0,7391.0
Gadag,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1819.0,1723.0,2069.0,2587.0,1593.0,1748.0,1945.0,2810.0,1504.0,1875.0,3186.0,2868.0,25727.0
Gadag,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,484.0,461.0,313.0,850.0,612.0,356.0,738.0,707.0,481.0,520.0,694.0,506.0,6722.0
Gadag,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3065.0,2918.0,3456.0,3562.0,3361.0,3262.0,3524.0,4123.0,2893.0,3068.0,4441.0,4070.0,41743.0
Gadag,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1013.0,918.0,650.0,1417.0,1291.0,660.0,1701.0,1514.0,1106.0,1160.0,1632.0,1051.0,14113.0
Gadag,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4884.0,4641.0,5525.0,6149.0,4954.0,5010.0,5469.0,6933.0,4397.0,4943.0,7627.0,6938.0,67470.0
Gadag,14.10.2.a,Number of death cases of Inpatient males,TOTAL,3.0,1.0,16.0,12.0,15.0,17.0,12.0,7.0,11.0,5.0,4.0,9.0,112.0
Gadag,14.10.2.b,Number of death cases of Inpatient females,TOTAL,1.0,1.0,14.0,6.0,5.0,11.0,10.0,3.0,3.0,7.0,1.0,7.0,69.0
Gadag,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,4.0,2.0,30.0,18.0,20.0,28.0,22.0,10.0,14.0,12.0,5.0,16.0,181.0
Gadag,14.11,In-Patient Head Count at midnight,TOTAL,4430.0,4845.0,4264.0,4676.0,4467.0,4869.0,4680.0,4402.0,4668.0,4356.0,4146.0,5424.0,55227.0
Gadag,14.12.1,OPD attendance (All),TOTAL,64112.0,66633.0,78305.0,104877.0,105867.0,109530.0,93756.0,131744.0,83091.0,82473.0,84269.0,89762.0,1094419.0
Gadag,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,30.0,29.0,29.0,217.0,226.0,25.0,29.0,48.0,103.0,97.0,57.0,67.0,957.0
Gadag,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,2.0,2.0,0.0,35.0,38.0,0.0,0.0,42.0,35.0,51.0,57.0,50.0,312.0
Gadag,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,200.0,150.0,83.0,171.0,254.0,387.0,72.0,175.0,171.0,195.0,185.0,238.0,2281.0
Gadag,14.14.a,Number of patients given AYUSH treatment,TOTAL,2245.0,2361.0,2110.0,2776.0,3317.0,2994.0,2707.0,3095.0,2431.0,2287.0,2927.0,3120.0,32370.0
Gadag,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,100.0,119.0,462.0,733.0,1208.0,1048.0,1117.0,1035.0,493.0,1073.0,1023.0,954.0,9365.0
Gadag,14.14.c,Number of Adolescents counselled,TOTAL,61.0,43.0,48.0,276.0,633.0,701.0,329.0,398.0,96.0,405.0,429.0,589.0,4008.0
Gadag,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3411.0,3765.0,5111.0,5670.0,4820.0,3866.0,11271.0,5091.0,4859.0,3980.0,4052.0,4524.0,60420.0
Gadag,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,179.0,158.0,178.0,298.0,262.0,141.0,152.0,326.0,273.0,191.0,344.0,219.0,2721.0
Gadag,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1072.0,1143.0,1284.0,1245.0,764.0,1154.0,943.0,1250.0,1260.0,1162.0,1281.0,1368.0,13926.0
Gadag,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,22.0,30.0,29.0,19.0,20.0,20.0,30.0,17.0,26.0,18.0,16.0,39.0,286.0
Gadag,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,952.0,1183.0,1322.0,1284.0,835.0,954.0,729.0,1181.0,1415.0,1369.0,1299.0,1454.0,13977.0
Gadag,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,16.0,25.0,30.0,13.0,20.0,11.0,41.0,16.0,22.0,19.0,14.0,15.0,242.0
Gadag,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1658.0,1800.0,2268.0,1805.0,1592.0,1824.0,1345.0,2003.0,1911.0,1797.0,1690.0,1968.0,21661.0
Gadag,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,3.0,1.0,7.0,3.0,12.0,52.0,6.0,3.0,5.0,1.0,1.0,95.0
Gadag,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3682.0,4126.0,4874.0,4334.0,3191.0,3932.0,3017.0,4434.0,4586.0,4328.0,4270.0,4790.0,49564.0
Gadag,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,39.0,58.0,60.0,39.0,43.0,43.0,123.0,39.0,51.0,42.0,31.0,55.0,623.0
Gadag,15.2,Number of Widal tests conducted,Number tested,409.0,646.0,764.0,4734.0,1072.0,1031.0,615.0,733.0,772.0,860.0,730.0,644.0,13010.0
Gadag,15.3.a,Number of VDRL tests conducted on males,Number tested,60.0,56.0,39.0,62.0,71.0,56.0,74.0,191.0,89.0,50.0,47.0,339.0,1134.0
Gadag,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,86.0,101.0,294.0,214.0,200.0,139.0,212.0,319.0,331.0,107.0,51.0,247.0,2301.0
Gadag,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1281.0,1472.0,1663.0,1764.0,1478.0,2049.0,1456.0,2012.0,1505.0,1628.0,1577.0,1571.0,19456.0
Gadag,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1427.0,1629.0,1996.0,2040.0,1749.0,2244.0,1742.0,2522.0,1925.0,1785.0,1675.0,2157.0,22891.0
Gadag,15.4.1,Number of blood smears examined for Malaria,TOTAL,23760.0,22087.0,23453.0,25120.0,21634.0,23438.0,20830.0,21816.0,22668.0,21604.0,19886.0,20431.0,266727.0
Gadag,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,52.0,62.0,88.0,65.0,46.0,32.0,34.0,35.0,48.0,31.0,27.0,16.0,536.0
Gadag,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,5.0,1.0,0.0,1.0,0.0,1.0,0.0,2.0,3.0,1.0,2.0,1.0,17.0
Gadag,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,5700.0,9420.0,7180.0,5400.0,8190.0,7950.0,18270.0,14920.0,10190.0,6300.0,7700.0,9920.0,111140.0
Gadag,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,,,10000.0,12000.0,15000.0,,,,5000.0,5000.0,,52000.0
Gadag,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1280.0,2240.0,1780.0,7210.0,12240.0,4680.0,3350.0,4730.0,3890.0,3600.0,2780.0,2180.0,49960.0
Gadag,16.1.1,Stock position of DPT vaccines,5. Total Stock,9420.0,7180.0,5400.0,8190.0,7950.0,18270.0,14920.0,10190.0,6300.0,7700.0,9920.0,7740.0,113180.0
Gadag,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,8550.0,8650.0,8340.0,8850.0,7770.0,8510.0,17980.0,12100.0,5580.0,10110.0,11210.0,16430.0,124080.0
Gadag,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,5000.0,5000.0,5000.0,5000.0,7000.0,14000.0,,,10000.0,6500.0,10000.0,,67500.0
Gadag,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,4900.0,5310.0,4490.0,6080.0,6260.0,4530.0,5880.0,6520.0,5470.0,5400.0,4780.0,5220.0,64840.0
Gadag,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8650.0,8340.0,8850.0,7770.0,8510.0,17980.0,12100.0,5580.0,10110.0,11210.0,16430.0,11210.0,126740.0
Gadag,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,6080.0,8800.0,15040.0,15760.0,15360.0,16460.0,25700.0,15700.0,4940.0,6320.0,9740.0,12400.0,152300.0
Gadag,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,15000.0,10000.0,10000.0,12000.0,20000.0,,,11000.0,6000.0,10000.0,5600.0,109600.0
Gadag,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,7280.0,8760.0,9280.0,10400.0,10900.0,10760.0,10000.0,10760.0,9620.0,8680.0,7340.0,6300.0,110080.0
Gadag,16.1.2,Stock position of OPV vaccines,5. Total Stock,8800.0,15040.0,15760.0,15360.0,16460.0,25700.0,15700.0,4940.0,6320.0,3640.0,12400.0,11700.0,151820.0
Gadag,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,13830.0,13540.0,13310.0,13180.0,11820.0,5590.0,18660.0,12130.0,4360.0,13360.0,16770.0,21290.0,157840.0
Gadag,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,5000.0,5000.0,10000.0,10000.0,20000.0,,,15000.0,10000.0,10000.0,,90000.0
Gadag,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5290.0,5230.0,5130.0,11360.0,16230.0,6930.0,6530.0,7770.0,6000.0,6590.0,5480.0,5800.0,88340.0
Gadag,16.1.3,Stock position of TT vaccines,5. Total Stock,13540.0,13310.0,13180.0,11820.0,5590.0,18660.0,12130.0,4360.0,13360.0,16770.0,21290.0,15490.0,159500.0
Gadag,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3060.0,4620.0,1990.0,5670.0,5650.0,6650.0,12840.0,10400.0,7450.0,6450.0,5720.0,7620.0,78120.0
Gadag,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4000.0,,6000.0,3000.0,4000.0,9000.0,,,2000.0,2000.0,4000.0,,34000.0
Gadag,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2440.0,2630.0,2320.0,3020.0,3000.0,2810.0,2440.0,2950.0,3000.0,2730.0,2100.0,2610.0,32050.0
Gadag,16.1.5,Stock position of BCG vaccines,5. Total Stock,4620.0,1990.0,5670.0,5650.0,6650.0,12840.0,10400.0,7450.0,6450.0,5720.0,7620.0,5010.0,80070.0
Gadag,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,12945.0,12995.0,9805.0,6640.0,4685.0,4445.0,11220.0,7350.0,3470.0,4780.0,6565.0,5815.0,90715.0
Gadag,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,,,2000.0,4000.0,9000.0,,,5000.0,5000.0,2500.0,,31500.0
Gadag,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3950.0,3190.0,3165.0,3955.0,4240.0,2225.0,3870.0,3880.0,3690.0,3215.0,3250.0,3490.0,42120.0
Gadag,16.1.6,Stock position of Measles vaccines,5. Total Stock,12995.0,9805.0,6640.0,4685.0,4445.0,11220.0,7350.0,3470.0,4780.0,6565.0,5815.0,2325.0,80095.0
Gadag,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,10320.0,8940.0,7790.0,5520.0,4310.0,2930.0,3940.0,2950.0,1480.0,2200.0,4320.0,5860.0,60560.0
Gadag,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,,,,,,2000.0,,,2000.0,3000.0,2000.0,,9000.0
Gadag,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1380.0,1150.0,2270.0,1210.0,1380.0,990.0,990.0,1470.0,1280.0,880.0,460.0,1490.0,14950.0
Gadag,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,8940.0,7790.0,5520.0,4310.0,2930.0,3940.0,2950.0,1480.0,2200.0,4320.0,5860.0,4370.0,54610.0
Gadag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,250.0,250.0,250.0,250.0,200.0,200.0,150.0,,,,,,1550.0
Gadag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gadag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,50.0,,50.0,150.0,,,,,,250.0
Gadag,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,250.0,250.0,250.0,200.0,200.0,150.0,0.0,0.0,0.0,0.0,0.0,0.0,1300.0
Gadag,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,185960.0,177960.0,170960.0,158960.0,139360.0,121160.0,277060.0,251060.0,230560.0,204560.0,192060.0,169060.0,2278720.0
Gadag,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,176400.0,,,,,,,176400.0
Gadag,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,8000.0,7000.0,12000.0,19600.0,18200.0,20500.0,26000.0,20500.0,26000.0,12500.0,23000.0,18200.0,211500.0
Gadag,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,177960.0,170960.0,158960.0,139360.0,121160.0,277060.0,251060.0,230560.0,204560.0,192060.0,169060.0,150860.0,2243620.0
Gadag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,14200.0,12200.0,10100.0,7600.0,5100.0,2000.0,16000.0,13600.0,13600.0,11800.0,8600.0,5400.0,120200.0
Gadag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,16000.0,,,,,,,16000.0
Gadag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,2000.0,2100.0,2500.0,2500.0,3100.0,2000.0,2400.0,2100.0,1800.0,3200.0,3200.0,2300.0,29200.0
Gadag,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,12200.0,10100.0,7600.0,5100.0,2000.0,16000.0,13600.0,11500.0,11800.0,8600.0,5400.0,3100.0,107000.0
Gadag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gadag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,6365.0,5365.0,5365.0,4365.0,4365.0,4363.0,4916.0,4416.0,4416.0,3916.0,3916.0,3400.0,55168.0
Gadag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,2153.0,,,,,,,2153.0
Gadag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1000.0,,1000.0,,,,500.0,1000.0,500.0,,516.0,,4516.0
Gadag,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,5365.0,5365.0,4365.0,4365.0,4365.0,6516.0,4416.0,3416.0,3916.0,3916.0,3400.0,3400.0,52805.0
Gadag,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Gadag,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Gadag,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Gadag,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gadag,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3590.0,4330.0,4895.0,6065.0,5565.0,6325.0,11035.0,8920.0,6320.0,3845.0,5505.0,4635.0,71030.0
Gadag,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,3000.0,3300.0,2000.0,3300.0,7240.0,,,,3300.0,1000.0,,26140.0
Gadag,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2260.0,2435.0,2130.0,2500.0,2540.0,2530.0,2115.0,2600.0,2475.0,1640.0,1870.0,1840.0,26935.0
Gadag,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,4330.0,4895.0,6065.0,5565.0,6325.0,11035.0,8920.0,6320.0,3845.0,5505.0,4635.0,2795.0,70235.0
Gadag,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,69050.0,75250.0,63250.0,79650.0,74650.0,73850.0,117250.0,96850.0,79050.0,63050.0,49050.0,54850.0,895800.0
Gadag,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,20000.0,,30000.0,15600.0,31200.0,60000.0,,,,,20000.0,,176800.0
Gadag,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,13800.0,12000.0,13600.0,20600.0,32000.0,16600.0,20400.0,17800.0,16000.0,14000.0,4200.0,14000.0,195000.0
Gadag,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,75250.0,63250.0,79650.0,74650.0,73850.0,117250.0,96850.0,79050.0,63050.0,49050.0,64850.0,40850.0,877600.0
Gadag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,10730.0,11230.0,10100.0,10970.0,9550.0,10240.0,13920.0,12705.0,11270.0,9925.0,8785.0,7505.0,126930.0
Gadag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,,2400.0,,2400.0,2400.0,,,,,,,9600.0
Gadag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Gadag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1900.0,1130.0,1530.0,1420.0,1710.0,1120.0,1215.0,1435.0,1345.0,1140.0,1280.0,1600.0,16825.0
Gadag,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,11230.0,10100.0,10970.0,9550.0,10240.0,11520.0,12705.0,11270.0,9925.0,8785.0,7505.0,5905.0,119705.0
Gadag,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,1.0,1.0
Gadag,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Gadag,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Gadag,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Gadag,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,,1.0,,3.0,,2.0,1.0,,7.0
Gadag,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,1.0,,,1.0
Gadag,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,,1.0,,3.0,,3.0,1.0,,8.0
Gadag,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,1.0,1.0,,3.0,1.0,1.0,4.0,,1.0,13.0
Gadag,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,,,,1.0,,1.0,,,3.0
Gadag,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,1.0,1.0,,3.0,2.0,1.0,5.0,,1.0,16.0
Gadag,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,3.0,2.0,1.0,2.0,1.0,,1.0,2.0,3.0,1.0,,16.0
Gadag,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,1.0,2.0,,,,3.0
Gadag,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,3.0,2.0,1.0,2.0,1.0,,2.0,4.0,3.0,1.0,,19.0
Gadag,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,1.0,,,2.0,,,,,,1.0,4.0
Gadag,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gadag,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,1.0,,,2.0,,,,,,1.0,4.0
Gadag,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Gadag,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gadag,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,1.0,,,,,,,1.0
Gadag,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Gadag,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,1.0,,,,1.0
Gadag,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,1.0,,,1.0,2.0
Gadag,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gadag,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gadag,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gadag,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,1.0,2.0,1.0,1.0,,2.0,,1.0,,2.0,10.0
Gadag,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,,,1.0,1.0,,,1.0,4.0
Gadag,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,1.0,3.0,1.0,1.0,,3.0,1.0,1.0,,3.0,14.0
Gadag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,,,,,,,,1.0,2.0
Gadag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,1.0,,1.0,,,2.0
Gadag,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,,,,1.0,,1.0,,1.0,4.0
Gadag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,1.0,2.0,4.0,4.0,3.0,1.0,,2.0,,2.0,2.0,23.0
Gadag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,3.0,,2.0,,,3.0,,2.0,2.0,1.0,1.0,14.0
Gadag,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,4.0,2.0,6.0,4.0,3.0,4.0,,4.0,2.0,3.0,3.0,37.0
Gadag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,1.0,1.0,,,,1.0,,,,3.0
Gadag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,6.0,1.0,6.0,9.0,1.0,4.0,11.0,5.0,2.0,2.0,6.0,58.0
Gadag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,30.0,22.0,17.0,20.0,21.0,20.0,24.0,27.0,17.0,19.0,23.0,19.0,259.0
Gadag,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,35.0,28.0,18.0,27.0,31.0,21.0,28.0,38.0,23.0,21.0,25.0,25.0,320.0
Gadag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,1.0,,,,,,1.0
Gadag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gadag,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,,,,,,1.0
Gadag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Gadag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,1.0,1.0,1.0,,,,,,4.0
Gadag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,2.0,,1.0,1.0,,,,3.0,2.0,10.0
Gadag,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,,,3.0,1.0,2.0,3.0,,,,3.0,2.0,15.0
Gadag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Gadag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,2.0,2.0,2.0,9.0,2.0,2.0,6.0,5.0,6.0,2.0,6.0,47.0
Gadag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,1.0,,1.0,2.0,2.0,,1.0,,,,8.0
Gadag,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,3.0,3.0,2.0,10.0,4.0,4.0,6.0,6.0,6.0,2.0,7.0,56.0
Gadag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,1.0,1.0,1.0,,1.0,,,,,1.0,1.0,,6.0
Gadag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,10.0,21.0,19.0,12.0,21.0,16.0,18.0,27.0,21.0,32.0,21.0,15.0,233.0
Gadag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,19.0,23.0,19.0,34.0,34.0,43.0,25.0,38.0,38.0,31.0,30.0,34.0,368.0
Gadag,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,30.0,45.0,39.0,46.0,56.0,59.0,43.0,65.0,59.0,64.0,52.0,49.0,607.0
Gadag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,,2.0,,1.0,,4.0
Gadag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,2.0,3.0,9.0,6.0,4.0,10.0,5.0,2.0,4.0,9.0,3.0,6.0,63.0
Gadag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,15.0,12.0,25.0,18.0,24.0,29.0,35.0,35.0,25.0,21.0,18.0,31.0,288.0
Gadag,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,17.0,15.0,34.0,24.0,28.0,40.0,40.0,37.0,31.0,30.0,22.0,37.0,355.0
Gadag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,1.0,,,,,,,,1.0
Gadag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gadag,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,1.0,,,,,,,,1.0
Gadag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Gadag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gadag,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,1.0,,,,,,,,,1.0
Gadag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Gadag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gadag,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,1.0,,,,,1.0
Gadag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,1.0,1.0,,,,1.0,,3.0
Gadag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gadag,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,1.0,1.0,,,,1.0,,3.0
Gadag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Gadag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gadag,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,1.0,,,1.0
Gadag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,2.0,2.0,,1.0,1.0,,,2.0,,1.0,2.0,12.0
Gadag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gadag,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,2.0,2.0,,1.0,1.0,,,2.0,,1.0,2.0,12.0
Gadag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,2.0,1.0,,,,,,1.0,,,,4.0
Gadag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,6.0,4.0,4.0,10.0,5.0,3.0,5.0,5.0,6.0,3.0,5.0,5.0,61.0
Gadag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,1.0,2.0,,2.0,1.0,1.0,1.0,1.0,3.0,1.0,2.0,15.0
Gadag,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,6.0,7.0,7.0,10.0,7.0,4.0,6.0,6.0,8.0,6.0,6.0,7.0,80.0
Gadag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,,,,,1.0,1.0,,3.0
Gadag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,6.0,3.0,8.0,4.0,3.0,4.0,3.0,4.0,7.0,5.0,4.0,6.0,57.0
Gadag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,,1.0,1.0,1.0,1.0,1.0,,,1.0,1.0,7.0
Gadag,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,3.0,8.0,6.0,4.0,5.0,4.0,5.0,7.0,6.0,6.0,7.0,67.0
Gadag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Gadag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,,,,,,,1.0,2.0
Gadag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,1.0,,1.0,,1.0,3.0,1.0,1.0,1.0,,10.0
Gadag,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,1.0,2.0,,1.0,,1.0,3.0,1.0,1.0,1.0,1.0,12.0
Gadag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Gadag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,6.0,3.0,4.0,5.0,4.0,3.0,3.0,2.0,6.0,6.0,2.0,3.0,47.0
Gadag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,8.0,13.0,11.0,20.0,13.0,11.0,8.0,8.0,16.0,21.0,14.0,11.0,154.0
Gadag,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,14.0,16.0,15.0,25.0,17.0,14.0,11.0,10.0,23.0,27.0,16.0,14.0,202.0
Gadag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,1.0,,1.0,,,,,2.0
Gadag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,2.0,5.0,5.0,9.0,9.0,5.0,13.0,4.0,5.0,14.0,1.0,78.0
Gadag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,17.0,9.0,9.0,9.0,15.0,23.0,15.0,15.0,18.0,30.0,20.0,5.0,185.0
Gadag,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,23.0,11.0,14.0,14.0,24.0,33.0,20.0,29.0,22.0,35.0,34.0,6.0,265.0
Gadag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,2.0,2.0,1.0,,1.0,1.0,,3.0,2.0,,1.0,16.0
Gadag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,28.0,24.0,26.0,26.0,27.0,46.0,45.0,40.0,41.0,45.0,25.0,36.0,409.0
Gadag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,113.0,89.0,131.0,132.0,161.0,172.0,118.0,138.0,146.0,175.0,132.0,118.0,1625.0
Gadag,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,144.0,115.0,159.0,159.0,188.0,219.0,164.0,178.0,190.0,222.0,157.0,155.0,2050.0
Gulbarga,1.1,Total number of pregnant women Registered for ANC,TOTAL,5519.0,5035.0,5789.0,5958.0,5262.0,5541.0,5031.0,5469.0,5161.0,5303.0,5430.0,5372.0,64870.0
Gulbarga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3507.0,3240.0,3589.0,3592.0,3256.0,3689.0,3377.0,3677.0,3353.0,3500.0,3496.0,3509.0,41785.0
Gulbarga,1.2,Number of Pregnant women registered under JSY,TOTAL,4515.0,3528.0,4276.0,4026.0,4071.0,4270.0,3504.0,4932.0,3830.0,3911.0,4027.0,3967.0,48857.0
Gulbarga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3112.0,3530.0,3656.0,3630.0,3887.0,3776.0,4051.0,3975.0,3766.0,3470.0,4450.0,4775.0,46078.0
Gulbarga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,4898.0,4872.0,5420.0,6099.0,4616.0,5270.0,5312.0,5077.0,5871.0,5546.0,5751.0,5502.0,64234.0
Gulbarga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,5743.0,6066.0,6021.0,7232.0,5471.0,6642.0,6316.0,6555.0,6971.0,6405.0,6060.0,6457.0,75939.0
Gulbarga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,5193.0,5508.0,4630.0,5658.0,3378.0,3533.0,3854.0,5434.0,4289.0,2269.0,4184.0,2816.0,50746.0
Gulbarga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,158.0,140.0,123.0,124.0,139.0,145.0,143.0,132.0,151.0,117.0,224.0,148.0,1744.0
Gulbarga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,21.0,8.0,13.0,15.0,14.0,10.0,2.0,12.0,8.0,9.0,8.0,125.0
Gulbarga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2956.0,2656.0,3108.0,3040.0,2621.0,3380.0,3077.0,2613.0,3107.0,3161.0,3691.0,3212.0,36622.0
Gulbarga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,225.0,257.0,238.0,174.0,134.0,550.0,124.0,266.0,362.0,398.0,141.0,190.0,3059.0
Gulbarga,1.8,Number of pregnancy test kits used at SC level,TOTAL,128.0,140.0,197.0,176.0,147.0,114.0,98.0,64.0,83.0,86.0,106.0,101.0,1440.0
Gulbarga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,66.0,34.0,45.0,62.0,52.0,60.0,52.0,57.0,42.0,26.0,30.0,40.0,566.0
Gulbarga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,28.0,28.0,41.0,56.0,55.0,76.0,48.0,64.0,51.0,53.0,43.0,48.0,591.0
Gulbarga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,94.0,62.0,86.0,118.0,107.0,136.0,100.0,121.0,93.0,79.0,73.0,88.0,1157.0
Gulbarga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,103.0,61.0,84.0,101.0,107.0,125.0,90.0,120.0,85.0,77.0,68.0,63.0,1084.0
Gulbarga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,15.0,1.0,0.0,15.0,3.0,3.0,6.0,4.0,4.0,1.0,3.0,4.0,59.0
Gulbarga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2704.0,2520.0,2909.0,2824.0,3495.0,3529.0,3241.0,2821.0,2805.0,2600.0,2719.0,2618.0,34785.0
Gulbarga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1536.0,1269.0,1523.0,1483.0,1680.0,1493.0,1520.0,1410.0,1264.0,1192.0,1288.0,1258.0,16916.0
Gulbarga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,650.0,1625.0,1676.0,1334.0,965.0,1411.0,1533.0,1175.0,1052.0,961.0,621.0,1315.0,14318.0
Gulbarga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,3.0,2.0,5.0,19.0,11.0,8.0,2.0,20.0,87.0,0.0,0.0,0.0,157.0
Gulbarga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,999.0,1070.0,1100.0,1127.0,1155.0,1043.0,1067.0,1074.0,1116.0,1090.0,1039.0,1163.0,13043.0
Gulbarga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,159.0,160.0,177.0,194.0,197.0,192.0,192.0,186.0,166.0,182.0,224.0,202.0,2231.0
Gulbarga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,159.0,160.0,177.0,194.0,197.0,192.0,192.0,186.0,166.0,182.0,224.0,202.0,2231.0
Gulbarga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,308.0,335.0,339.0,400.0,339.0,155.0,173.0,265.0,244.0,401.0,354.0,357.0,3670.0
Gulbarga,4.1.1.a,Number of male live births,TOTAL,1940.0,1871.0,2086.0,2065.0,2451.0,2415.0,2265.0,2035.0,1999.0,1914.0,1996.0,1983.0,25020.0
Gulbarga,4.1.1.b,Number of female live births,TOTAL,1837.0,1754.0,2004.0,1983.0,2283.0,2246.0,2110.0,1940.0,1980.0,1817.0,1803.0,1913.0,23670.0
Gulbarga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3777.0,3625.0,4090.0,4048.0,4734.0,4661.0,4375.0,3975.0,3979.0,3731.0,3799.0,3896.0,48690.0
Gulbarga,4.1.2,Number of still births,TOTAL,61.0,44.0,66.0,64.0,59.0,67.0,82.0,47.0,45.0,51.0,40.0,39.0,665.0
Gulbarga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,100.0,28.0,107.0,131.0,48.0,241.0,91.0,55.0,73.0,62.0,113.0,37.0,1086.0
Gulbarga,4.2.1,Number of Newborns weighed at birth,TOTAL,3635.0,3598.0,3926.0,3993.0,4577.0,4499.0,4231.0,3917.0,3959.0,3602.0,3782.0,3758.0,47477.0
Gulbarga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,514.0,464.0,490.0,382.0,623.0,514.0,601.0,331.0,302.0,276.0,279.0,274.0,5050.0
Gulbarga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3652.0,3579.0,3781.0,3906.0,4546.0,4422.0,4189.0,3872.0,3894.0,3568.0,3772.0,3444.0,46625.0
Gulbarga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,19.0,48.0,69.0,49.0,130.0,81.0,133.0,44.0,97.0,111.0,171.0,42.0,994.0
Gulbarga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,13.0,21.0,16.0,10.0,9.0,6.0,5.0,9.0,12.0,4.0,11.0,120.0
Gulbarga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,205.0,63.0,81.0,252.0,121.0,80.0,85.0,63.0,68.0,86.0,86.0,134.0,1324.0
Gulbarga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,228.0,124.0,171.0,317.0,261.0,170.0,224.0,112.0,174.0,209.0,261.0,187.0,2438.0
Gulbarga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,1008.0,682.0,632.0,1112.0,810.0,1018.0,15.0,151.0,621.0,723.0,736.0,7508.0
Gulbarga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1039.0,1190.0,732.0,867.0,1581.0,702.0,1094.0,299.0,357.0,874.0,866.0,776.0,10377.0
Gulbarga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,162.0,187.0,147.0,445.0,466.0,144.0,193.0,92.0,186.0,196.0,371.0,674.0,3263.0
Gulbarga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,835.0,1200.0,912.0,521.0,974.0,1176.0,938.0,592.0,670.0,1144.0,961.0,1077.0,11000.0
Gulbarga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,80.0,128.0,118.0,133.0,141.0,143.0,78.0,71.0,99.0,90.0,90.0,86.0,1257.0
Gulbarga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,2946.0,3079.0,3500.0,3271.0,4203.0,3944.0,3767.0,2771.0,2555.0,3222.0,2726.0,3229.0,39213.0
Gulbarga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2250.0,2287.0,2465.0,2517.0,2773.0,3520.0,2467.0,2305.0,1746.0,2774.0,2455.0,2628.0,30187.0
Gulbarga,6.3,PNC maternal complications attended,TOTAL,5.0,7.0,8.0,16.0,49.0,22.0,6.0,5.0,3.0,7.0,6.0,4.0,138.0
Gulbarga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,22.0,20.0,18.0,10.0,33.0,21.0,10.0,9.0,18.0,12.0,28.0,35.0,236.0
Gulbarga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,9.0,3.0,5.0,13.0,4.0,16.0,16.0,0.0,11.0,9.0,25.0,22.0,133.0
Gulbarga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,31.0,23.0,23.0,23.0,37.0,37.0,26.0,9.0,29.0,21.0,53.0,57.0,369.0
Gulbarga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,2.0,2.0,1.0,0.0,0.0,0.0,38.0,46.0,0.0,0.0,0.0,89.0
Gulbarga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,725.0,328.0,428.0,429.0,455.0,644.0,628.0,490.0,393.0,881.0,504.0,399.0,6304.0
Gulbarga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,948.0,580.0,654.0,773.0,1093.0,1256.0,1340.0,1578.0,1394.0,1627.0,1438.0,1208.0,13889.0
Gulbarga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1673.0,908.0,1082.0,1202.0,1548.0,1900.0,1968.0,2068.0,1787.0,2508.0,1942.0,1607.0,20193.0
Gulbarga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,14.0,15.0
Gulbarga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Gulbarga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,20.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Gulbarga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,22.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,23.0
Gulbarga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,305.0,332.0,261.0,290.0,256.0,284.0,348.0,383.0,315.0,368.0,311.0,259.0,3712.0
Gulbarga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,106.0,119.0,154.0,130.0,161.0,120.0,133.0,169.0,134.0,85.0,114.0,60.0,1485.0
Gulbarga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,255.0,237.0,319.0,288.0,272.0,345.0,306.0,483.0,294.0,211.0,326.0,314.0,3650.0
Gulbarga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,666.0,688.0,734.0,708.0,689.0,749.0,787.0,1035.0,743.0,664.0,751.0,633.0,8847.0
Gulbarga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,5.0,17.0,18.0,23.0,15.0,17.0,22.0,12.0,21.0,15.0,11.0,12.0,188.0
Gulbarga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,45.0,35.0,89.0,47.0,64.0,26.0,52.0,113.0,65.0,51.0,29.0,65.0,681.0
Gulbarga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,66.0,91.0,105.0,91.0,70.0,30.0,66.0,76.0,28.0,19.0,39.0,33.0,714.0
Gulbarga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,159.0,194.0,211.0,224.0,190.0,163.0,90.0,104.0,127.0,29.0,101.0,112.0,1704.0
Gulbarga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,270.0,320.0,405.0,362.0,324.0,219.0,208.0,293.0,220.0,99.0,169.0,210.0,3099.0
Gulbarga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,342.0,359.0,336.0,391.0,386.0,389.0,327.0,454.0,343.0,353.0,357.0,346.0,4383.0
Gulbarga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,1.0,5.0,6.0,6.0,0.0,6.0,0.0,4.0,4.0,6.0,38.0
Gulbarga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,13.0,14.0,12.0,23.0,15.0,78.0
Gulbarga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,25.0,32.0,38.0,33.0,48.0,37.0,40.0,27.0,44.0,73.0,71.0,32.0,500.0
Gulbarga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,25.0,32.0,39.0,38.0,55.0,43.0,40.0,46.0,58.0,89.0,98.0,53.0,616.0
Gulbarga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,231.0,215.0,239.0,250.0,230.0,233.0,233.0,267.0,273.0,281.0,281.0,264.0,2997.0
Gulbarga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,23.0,45.0,50.0,56.0,50.0,47.0,79.0,56.0,54.0,56.0,63.0,52.0,631.0
Gulbarga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,4.0,6.0,8.0,0.0,16.0,13.0,13.0,12.0,10.0,13.0,13.0,13.0,121.0
Gulbarga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,41.0,75.0,89.0,23.0,37.0,83.0,45.0,47.0,62.0,53.0,67.0,83.0,705.0
Gulbarga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Gulbarga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,299.0,341.0,386.0,329.0,333.0,376.0,370.0,382.0,399.0,403.0,424.0,412.0,4454.0
Gulbarga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,22.0,21.0,23.0,20.0,16.0,17.0,13.0,25.0,17.0,17.0,32.0,41.0,264.0
Gulbarga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,189.0,0.0,24.0,232.0,204.0,11.0,210.0,195.0,183.0,183.0,128.0,184.0,1743.0
Gulbarga,9.06,Number of IUCD removals,TOTAL,140.0,81.0,124.0,78.0,77.0,95.0,151.0,132.0,138.0,104.0,168.0,276.0,1564.0
Gulbarga,9.07,Number of Oral Pills cycles distributed,TOTAL,1918.0,1712.0,1164.0,1088.0,1174.0,1420.0,1564.0,1563.0,1720.0,1749.0,2237.0,2117.0,19426.0
Gulbarga,9.08,Number of Condom pieces distributed,TOTAL,20151.0,23456.0,31179.0,18146.0,16382.0,26804.0,22930.0,18376.0,18273.0,18643.0,19855.0,19658.0,253853.0
Gulbarga,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,72.0,99.0,74.0,47.0,60.0,69.0,43.0,67.0,70.0,58.0,66.0,62.0,787.0
Gulbarga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Gulbarga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,0.0,5.0,16.0
Gulbarga,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,1.0,6.0
Gulbarga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,9.12,Number of Institutions having NSV trained doctors,TOTAL,21.0,25.0,23.0,26.0,25.0,25.0,25.0,25.0,24.0,21.0,33.0,24.0,-1.0
Gulbarga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,5754.0,5247.0,6532.0,6204.0,6442.0,6946.0,6694.0,6556.0,6436.0,5617.0,5702.0,6181.0,74311.0
Gulbarga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,72.0,200.0,99.0,157.0,73.0,218.0,60.0,33.0,63.0,102.0,99.0,114.0,1290.0
Gulbarga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,86.0,178.0,79.0,149.0,83.0,168.0,54.0,23.0,49.0,121.0,100.0,71.0,1161.0
Gulbarga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,88.0,209.0,74.0,169.0,84.0,190.0,65.0,21.0,55.0,129.0,119.0,44.0,1247.0
Gulbarga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,4888.0,4953.0,5194.0,5850.0,5422.0,5897.0,5652.0,5901.0,5812.0,5410.0,4962.0,4946.0,64887.0
Gulbarga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,4695.0,4701.0,4768.0,5677.0,5057.0,5594.0,5336.0,5294.0,6015.0,5598.0,4883.0,5098.0,62716.0
Gulbarga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,5107.0,4910.0,5043.0,5480.0,5189.0,5675.0,5653.0,5289.0,5958.0,5964.0,5307.0,5418.0,64993.0
Gulbarga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3735.0,3525.0,4302.0,3929.0,4852.0,4492.0,4551.0,4236.0,4086.0,3721.0,3633.0,3927.0,48989.0
Gulbarga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,4870.0,4895.0,5236.0,5939.0,5424.0,5718.0,5617.0,5845.0,5760.0,5453.0,4988.0,4908.0,64653.0
Gulbarga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,4663.0,4638.0,4785.0,5679.0,5028.0,5472.0,5299.0,5192.0,5950.0,5663.0,4925.0,5060.0,62354.0
Gulbarga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,5049.0,4858.0,5052.0,5487.0,5143.0,5563.0,5578.0,5263.0,5869.0,6049.0,5373.0,5245.0,64529.0
Gulbarga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2667.0,2681.0,3127.0,2867.0,3455.0,3210.0,3466.0,2664.0,3087.0,2838.0,2384.0,3029.0,35475.0
Gulbarga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,305.0,306.0,462.0,221.0,928.0,223.0,186.0,199.0,189.0,13.0,79.0,14.0,3125.0
Gulbarga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,285.0,311.0,378.0,223.0,804.0,244.0,174.0,185.0,153.0,22.0,82.0,17.0,2878.0
Gulbarga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,263.0,296.0,411.0,219.0,759.0,255.0,177.0,220.0,148.0,12.0,94.0,32.0,2886.0
Gulbarga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,4545.0,4719.0,5007.0,5437.0,4724.0,5147.0,4715.0,4543.0,4928.0,4759.0,4887.0,4871.0,58282.0
Gulbarga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,3072.0,3014.0,3751.0,3417.0,3229.0,3593.0,3269.0,3119.0,3335.0,3377.0,3674.0,3562.0,40412.0
Gulbarga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17.0,17.0
Gulbarga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2221.0,2182.0,2422.0,2666.0,2440.0,2724.0,2549.0,2470.0,2495.0,2390.0,2532.0,2533.0,29624.0
Gulbarga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,2210.0,2261.0,2412.0,2599.0,2294.0,2518.0,2401.0,2349.0,2334.0,2217.0,2355.0,2303.0,28253.0
Gulbarga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,4431.0,4443.0,4834.0,5265.0,4734.0,5242.0,4950.0,4819.0,4829.0,4607.0,4887.0,4836.0,57877.0
Gulbarga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3582.0,3341.0,4045.0,3954.0,3639.0,4076.0,3550.0,3638.0,3861.0,3799.0,4087.0,3910.0,45482.0
Gulbarga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3461.0,3239.0,3937.0,3849.0,3527.0,4083.0,3572.0,3680.0,3906.0,3888.0,4139.0,3943.0,45224.0
Gulbarga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,328.0,388.0,365.0,352.0,385.0,477.0,268.0,486.0,398.0,341.0,397.0,460.0,4645.0
Gulbarga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,970.0,926.0,1049.0,1135.0,1192.0,1717.0,1333.0,1440.0,1491.0,1596.0,1630.0,1490.0,15969.0
Gulbarga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,902.0,830.0,978.0,1034.0,1125.0,1550.0,1160.0,1369.0,1377.0,1448.0,1518.0,1456.0,14747.0
Gulbarga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1872.0,1756.0,2027.0,2169.0,2317.0,3267.0,2493.0,2809.0,2868.0,3044.0,3148.0,2946.0,30716.0
Gulbarga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,461.0,551.0,741.0,2624.0,3225.0,4601.0,848.0,2577.0,2483.0,1738.0,2041.0,2120.0,24010.0
Gulbarga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1182.0,1371.0,1595.0,3130.0,4375.0,5675.0,1610.0,3253.0,3222.0,2531.0,2965.0,2541.0,33450.0
Gulbarga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1356.0,1415.0,1826.0,2254.0,3574.0,4253.0,1759.0,2724.0,2696.0,2413.0,2899.0,2754.0,29923.0
Gulbarga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0
Gulbarga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,5.0
Gulbarga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1832.0,1951.0,1842.0,1975.0,1824.0,2047.0,1987.0,1890.0,2066.0,1979.0,1959.0,1894.0,23246.0
Gulbarga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1791.0,1843.0,1677.0,1930.0,1653.0,2019.0,1890.0,1721.0,2018.0,1894.0,1744.0,1815.0,21995.0
Gulbarga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1217.0,1162.0,1071.0,1251.0,1058.0,1262.0,1191.0,1135.0,1314.0,1226.0,1244.0,1209.0,14340.0
Gulbarga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3470.0,3687.0,3466.0,4143.0,4861.0,4057.0,3457.0,3195.0,2847.0,2091.0,3943.0,1986.0,41203.0
Gulbarga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,527.0,562.0,697.0,1666.0,6822.0,532.0,504.0,688.0,526.0,342.0,5770.0,1301.0,19937.0
Gulbarga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,237.0,152.0,237.0,1273.0,6039.0,189.0,187.0,264.0,182.0,110.0,5134.0,2248.0,16252.0
Gulbarga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Gulbarga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,30.0,31.0,0.0,5.0,37.0,34.0,9.0,47.0,41.0,29.0,12.0,34.0,309.0
Gulbarga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,379.0,414.0,462.0,425.0,513.0,407.0,451.0,402.0,480.0,646.0,562.0,426.0,5567.0
Gulbarga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,39.0,9.0,10.0,1.0,4.0,26.0,20.0,0.0,0.0,0.0,0.0,109.0
Gulbarga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,44.0,40.0,15.0,23.0,35.0,50.0,22.0,31.0,20.0,41.0,75.0,40.0,436.0
Gulbarga,13.1,Number of Patients operated for cataract,TOTAL,127.0,76.0,115.0,150.0,68.0,95.0,29.0,102.0,104.0,46.0,65.0,158.0,1135.0
Gulbarga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,127.0,76.0,115.0,150.0,68.0,80.0,29.0,102.0,104.0,46.0,65.0,58.0,1020.0
Gulbarga,13.3,Number of School children detected with Refractive errors,TOTAL,13.0,5.0,33.0,23.0,27.0,42.0,2.0,48.0,30.0,35.0,69.0,55.0,382.0
Gulbarga,13.4,Number of children provided free glasses,TOTAL,13.0,0.0,15.0,0.0,0.0,6.0,0.0,18.0,10.0,9.0,87.0,21.0,179.0
Gulbarga,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,11.0,11.0,13.0,13.0,11.0,11.0,11.0,13.0,12.0,10.0,11.0,-1.0
Gulbarga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,58.0,55.0,58.0,54.0,61.0,51.0,54.0,49.0,50.0,56.0,51.0,55.0,-1.0
Gulbarga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,541.0,352.0,339.0,471.0,389.0,381.0,369.0,355.0,369.0,373.0,352.0,375.0,-1.0
Gulbarga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,18.0,16.0,16.0,16.0,16.0,14.0,13.0,17.0,16.0,16.0,16.0,15.0,-1.0
Gulbarga,14.05,Number of RKS meetings held during the month,TOTAL,11.0,27.0,14.0,16.0,20.0,10.0,11.0,8.0,14.0,11.0,22.0,14.0,178.0
Gulbarga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,24.0,23.0,22.0,23.0,22.0,27.0,24.0,25.0,24.0,28.0,29.0,-1.0
Gulbarga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,116.0,116.0,100.0,80.0,79.0,87.0,106.0,90.0,74.0,58.0,125.0,80.0,1111.0
Gulbarga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,9.0,7.0,8.0,8.0,8.0,10.0,9.0,10.0,9.0,9.0,10.0,-1.0
Gulbarga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,4.0,7.0,6.0,6.0,5.0,4.0,5.0,7.0,5.0,5.0,4.0,-1.0
Gulbarga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,583.0,569.0,824.0,636.0,612.0,583.0,635.0,612.0,460.0,496.0,616.0,816.0,7442.0
Gulbarga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2643.0,2749.0,4646.0,3056.0,3288.0,2971.0,3311.0,2891.0,2463.0,2451.0,2875.0,3406.0,36750.0
Gulbarga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,502.0,507.0,760.0,675.0,626.0,569.0,701.0,665.0,471.0,492.0,520.0,717.0,7205.0
Gulbarga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6762.0,7057.0,8137.0,6526.0,6505.0,6853.0,6540.0,7293.0,5181.0,6338.0,6940.0,7316.0,81448.0
Gulbarga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1085.0,1076.0,1584.0,1311.0,1238.0,1152.0,1336.0,1277.0,931.0,988.0,1136.0,1533.0,14647.0
Gulbarga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9405.0,9806.0,12783.0,9582.0,9793.0,9824.0,9851.0,10184.0,7644.0,8789.0,9815.0,10722.0,118198.0
Gulbarga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,38.0,54.0,60.0,49.0,63.0,49.0,55.0,56.0,40.0,63.0,53.0,55.0,635.0
Gulbarga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,40.0,45.0,35.0,30.0,51.0,26.0,41.0,43.0,27.0,34.0,27.0,82.0,481.0
Gulbarga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,78.0,99.0,95.0,79.0,114.0,75.0,96.0,99.0,67.0,97.0,80.0,137.0,1116.0
Gulbarga,14.11,In-Patient Head Count at midnight,TOTAL,15059.0,13850.0,14504.0,14071.0,14124.0,16167.0,14874.0,14190.0,14582.0,18593.0,15547.0,14288.0,179849.0
Gulbarga,14.12.1,OPD attendance (All),TOTAL,138576.0,130969.0,145653.0,149046.0,150948.0,174362.0,148563.0,149584.0,134902.0,142984.0,164200.0,159629.0,1789416.0
Gulbarga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,481.0,438.0,484.0,499.0,419.0,448.0,364.0,367.0,403.0,388.0,466.0,404.0,5161.0
Gulbarga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,15.0,10.0,28.0,17.0,13.0,9.0,8.0,9.0,13.0,0.0,0.0,6.0,128.0
Gulbarga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,144.0,177.0,141.0,181.0,160.0,145.0,158.0,142.0,133.0,98.0,256.0,160.0,1895.0
Gulbarga,14.14.a,Number of patients given AYUSH treatment,TOTAL,6742.0,6869.0,7306.0,7787.0,6326.0,8977.0,9071.0,10372.0,8672.0,8885.0,8335.0,8710.0,98052.0
Gulbarga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1083.0,768.0,1315.0,1281.0,1420.0,1306.0,1558.0,1479.0,1407.0,1333.0,1628.0,1665.0,16243.0
Gulbarga,14.14.c,Number of Adolescents counselled,TOTAL,164.0,128.0,195.0,252.0,169.0,179.0,160.0,188.0,405.0,309.0,241.0,338.0,2728.0
Gulbarga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,8828.0,8633.0,9572.0,8708.0,7692.0,10449.0,8102.0,9799.0,8923.0,7891.0,9468.0,8834.0,106899.0
Gulbarga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,455.0,641.0,365.0,787.0,494.0,879.0,366.0,607.0,494.0,772.0,423.0,444.0,6727.0
Gulbarga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1727.0,1521.0,1704.0,1827.0,1875.0,2209.0,1579.0,1896.0,1995.0,2131.0,1567.0,1787.0,21818.0
Gulbarga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,48.0,20.0,35.0,38.0,33.0,39.0,30.0,33.0,37.0,20.0,133.0,43.0,509.0
Gulbarga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2217.0,2120.0,2445.0,2122.0,2246.0,2992.0,2188.0,2903.0,2330.0,2243.0,2259.0,2552.0,28617.0
Gulbarga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,33.0,30.0,33.0,29.0,29.0,25.0,159.0,38.0,38.0,13.0,278.0,48.0,753.0
Gulbarga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3955.0,3602.0,4528.0,4585.0,3458.0,4487.0,3290.0,4401.0,3852.0,3759.0,3269.0,4117.0,47303.0
Gulbarga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,8.0,1.0,4.0,21.0,23.0,32.0,83.0,3.0,3.0,3.0,114.0,73.0,368.0
Gulbarga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,7899.0,7243.0,8677.0,8534.0,7579.0,9688.0,7057.0,9200.0,8177.0,8133.0,7095.0,8456.0,97738.0
Gulbarga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,89.0,51.0,72.0,88.0,85.0,96.0,272.0,74.0,78.0,36.0,525.0,164.0,1630.0
Gulbarga,15.2,Number of Widal tests conducted,Number tested,823.0,874.0,1029.0,1252.0,1302.0,1532.0,1333.0,1077.0,992.0,819.0,1007.0,1226.0,13266.0
Gulbarga,15.3.a,Number of VDRL tests conducted on males,Number tested,101.0,51.0,286.0,120.0,101.0,30.0,30.0,22.0,68.0,41.0,98.0,31.0,979.0
Gulbarga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,169.0,212.0,85.0,253.0,454.0,434.0,408.0,334.0,517.0,579.0,837.0,577.0,4859.0
Gulbarga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2015.0,1763.0,2337.0,2199.0,1623.0,2581.0,2093.0,2152.0,2108.0,2083.0,1726.0,2103.0,24783.0
Gulbarga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2285.0,2026.0,2708.0,2572.0,2178.0,3045.0,2531.0,2508.0,2693.0,2703.0,2661.0,2711.0,30621.0
Gulbarga,15.4.1,Number of blood smears examined for Malaria,TOTAL,19490.0,18771.0,23410.0,23852.0,24442.0,25997.0,19556.0,20386.0,21259.0,21643.0,18978.0,19914.0,257698.0
Gulbarga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,5.0,13.0,19.0,258.0,15.0,31.0,8.0,13.0,14.0,20.0,525.0,5.0,926.0
Gulbarga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,5.0,6.0,7.0,3.0,3.0,1.0,2.0,5.0,9.0,0.0,0.0,42.0
Gulbarga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,9500.0,8000.0,24000.0,19500.0,34000.0,17000.0,15000.0,31000.0,29500.0,29000.0,19500.0,2000.0,238000.0
Gulbarga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,40000.0,30000.0,30000.0,30000.0,30000.0,28000.0,32000.0,20000.0,35000.0,5000.0,0.0,35000.0,315000.0
Gulbarga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,41500.0,14000.0,34500.0,15500.0,47000.0,30000.0,16000.0,21500.0,35500.0,14500.0,17500.0,25000.0,312500.0
Gulbarga,16.1.1,Stock position of DPT vaccines,5. Total Stock,8000.0,24000.0,19500.0,34000.0,17000.0,15000.0,31000.0,29500.0,29000.0,19500.0,2000.0,12000.0,240500.0
Gulbarga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,28500.0,13000.0,50000.0,34500.0,57000.0,16500.0,31500.0,38500.0,48000.0,48000.0,49500.0,17500.0,432500.0
Gulbarga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,51000.0,54000.0,45000.0,45000.0,30000.0,45000.0,33000.0,36000.0,57000.0,30000.0,0.0,45000.0,471000.0
Gulbarga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,66500.0,17000.0,60500.0,22500.0,70500.0,30000.0,26000.0,26500.0,57000.0,28500.0,32000.0,42500.0,479500.0
Gulbarga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,13000.0,50000.0,34500.0,57000.0,16500.0,31500.0,38500.0,48000.0,48000.0,49500.0,17500.0,20000.0,424000.0
Gulbarga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,22000.0,13500.0,53000.0,28500.0,82500.0,31000.0,63500.0,43500.0,99000.0,50000.0,24000.0,0.0,510500.0
Gulbarga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,100000.0,80000.0,100000.0,100000.0,75000.0,100000.0,45000.0,99000.0,80000.0,20000.0,0.0,108000.0,907000.0
Gulbarga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,108500.0,40500.0,124500.0,46000.0,126500.0,67500.0,65000.0,43500.0,129000.0,46000.0,24000.0,103000.0,924000.0
Gulbarga,16.1.2,Stock position of OPV vaccines,5. Total Stock,13500.0,53000.0,28500.0,82500.0,31000.0,63500.0,43500.0,99000.0,50000.0,24000.0,0.0,5000.0,493500.0
Gulbarga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,28000.0,2000.0,53000.0,22000.0,61000.0,34500.0,49500.0,76500.0,76000.0,51000.0,71000.0,10000.0,534500.0
Gulbarga,16.1.3,Stock position of TT vaccines,2. Stocks Received,40000.0,80000.0,68000.0,70000.0,60000.0,64500.0,65000.0,55000.0,55000.0,60000.0,0.0,60000.0,677500.0
Gulbarga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,66000.0,29000.0,99000.0,31000.0,86500.0,49500.0,38000.0,55500.0,80000.0,40000.0,61000.0,56500.0,692000.0
Gulbarga,16.1.3,Stock position of TT vaccines,5. Total Stock,2000.0,53000.0,22000.0,61000.0,34500.0,49500.0,76500.0,76000.0,51000.0,71000.0,10000.0,13500.0,520000.0
Gulbarga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,0.0,,,,,0.0,,0.0,0.0,0.0
Gulbarga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12000.0,9000.0,28500.0,9000.0,31500.0,16500.0,25500.0,44500.0,46000.0,31000.0,47500.0,15000.0,316000.0
Gulbarga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,50000.0,40000.0,30000.0,40000.0,40000.0,44000.0,50000.0,40000.0,45000.0,40000.0,0.0,40000.0,459000.0
Gulbarga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,53000.0,20500.0,49500.0,17500.0,55000.0,35000.0,31000.0,38500.0,60000.0,23500.0,32500.0,43000.0,459000.0
Gulbarga,16.1.5,Stock position of BCG vaccines,5. Total Stock,9000.0,28500.0,9000.0,31500.0,16500.0,25500.0,44500.0,46000.0,31000.0,47500.0,15000.0,12000.0,316000.0
Gulbarga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,26500.0,23750.0,27800.0,17500.0,23500.0,27200.0,23700.0,40200.0,36700.0,37950.0,32450.0,7450.0,324700.0
Gulbarga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,25000.0,15000.0,20000.0,20000.0,40000.0,20000.0,30000.0,20000.0,40000.0,15000.0,0.0,35000.0,280000.0
Gulbarga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,27750.0,10950.0,30300.0,14000.0,36300.0,23500.0,13500.0,23500.0,38750.0,20500.0,25000.0,27500.0,291550.0
Gulbarga,16.1.6,Stock position of Measles vaccines,5. Total Stock,23750.0,27800.0,17500.0,23500.0,27200.0,23700.0,40200.0,36700.0,37950.0,32450.0,7450.0,14950.0,313150.0
Gulbarga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,0.0,,,,,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,6900.0,22900.0,13800.0,24000.0,14600.0,13500.0,14900.0,15400.0,19900.0,9900.0,0.0,155800.0
Gulbarga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,24000.0,21000.0,15000.0,15000.0,15000.0,10000.0,12500.0,5000.0,17500.0,0.0,0.0,15000.0,150000.0
Gulbarga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,17100.0,5000.0,24100.0,4800.0,24400.0,11100.0,11100.0,4500.0,13000.0,10000.0,9900.0,15000.0,150000.0
Gulbarga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,6900.0,22900.0,13800.0,24000.0,14600.0,13500.0,14900.0,15400.0,19900.0,9900.0,0.0,0.0,155800.0
Gulbarga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.02,Stock Position of Gloves,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,,,,,,,,,,,,
Gulbarga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,,,,,,,,,,
Gulbarga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,,,,,,,,,,,,
Gulbarga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Gulbarga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6000.0,9000.0,25800.0,6600.0,19800.0,11500.0,19400.0,400.0,23500.0,400.0,13600.0,600.0,136600.0
Gulbarga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,9000.0,19800.0,0.0,16500.0,0.0,26400.0,0.0,23100.0,0.0,13200.0,0.0,26400.0,134400.0
Gulbarga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,6000.0,3000.0,19200.0,3300.0,8300.0,18500.0,19000.0,0.0,23100.0,0.0,13000.0,23700.0,137100.0
Gulbarga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,9000.0,25800.0,6600.0,19800.0,11500.0,19400.0,400.0,23500.0,400.0,13600.0,600.0,3300.0,133900.0
Gulbarga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,0.0,,41300.0,26400.0,24000.0,16800.0,25400.0,59400.0,31200.0,12800.0,75200.0,14000.0,326500.0
Gulbarga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,46800.0,86400.0,50000.0,24000.0,0.0,40000.0,60000.0,0.0,24000.0,72000.0,0.0,36000.0,439200.0
Gulbarga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,46800.0,45100.0,64900.0,26400.0,7200.0,31400.0,26000.0,28200.0,42400.0,9600.0,61200.0,18000.0,407200.0
Gulbarga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,0.0,41300.0,26400.0,24000.0,16800.0,25400.0,59400.0,31200.0,12800.0,75200.0,14000.0,32000.0,358500.0
Gulbarga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1600.0,,7200.0,3400.0,14400.0,9600.0,11800.0,400.0,5200.0,17200.0,17200.0,17200.0,105200.0
Gulbarga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,7200.0,0.0,12000.0,0.0,12000.0,0.0,4800.0,12000.0,0.0,0.0,0.0,48000.0
Gulbarga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Gulbarga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1600.0,,3800.0,1000.0,4800.0,9800.0,11400.0,0.0,0.0,0.0,0.0,2400.0,34800.0
Gulbarga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,7200.0,3400.0,14400.0,9600.0,11800.0,400.0,5200.0,17200.0,17200.0,17200.0,14800.0,118400.0
Gulbarga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,7.0,1.0,,1.0,,3.0,,,1.0,1.0,,,14.0
Gulbarga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,12.0,1.0,12.0,9.0,5.0,6.0,5.0,15.0,10.0,5.0,6.0,,86.0
Gulbarga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,4.0,4.0,6.0,2.0,3.0,3.0,2.0,1.0,4.0,1.0,31.0
Gulbarga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,12.0,2.0,16.0,13.0,11.0,8.0,8.0,18.0,12.0,6.0,10.0,1.0,117.0
Gulbarga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,24.0,9.0,23.0,21.0,38.0,19.0,11.0,12.0,7.0,9.0,27.0,13.0,213.0
Gulbarga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,1.0,4.0,2.0,2.0,1.0,1.0,,1.0,3.0,,16.0
Gulbarga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,25.0,9.0,24.0,25.0,40.0,21.0,12.0,13.0,7.0,10.0,30.0,13.0,229.0
Gulbarga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,11.0,12.0,9.0,7.0,18.0,5.0,5.0,12.0,10.0,17.0,7.0,9.0,122.0
Gulbarga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,1.0,1.0,1.0,,1.0,,1.0,1.0,,,7.0
Gulbarga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,12.0,12.0,10.0,8.0,19.0,5.0,6.0,12.0,11.0,18.0,7.0,9.0,129.0
Gulbarga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,,,3.0,1.0,2.0,2.0,1.0,7.0,1.0,3.0,21.0
Gulbarga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,7.0,,1.0,9.0
Gulbarga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,,,4.0,1.0,2.0,2.0,1.0,14.0,1.0,4.0,30.0
Gulbarga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,1.0,,1.0,,,,1.0,1.0,1.0,,6.0
Gulbarga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gulbarga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,1.0,,1.0,,,,1.0,1.0,1.0,,6.0
Gulbarga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,1.0,,1.0,,,2.0
Gulbarga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gulbarga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,1.0,,,2.0
Gulbarga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,1.0,,,1.0,1.0,,1.0,,1.0,,,5.0
Gulbarga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gulbarga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,1.0,,,1.0,1.0,,1.0,,1.0,,,5.0
Gulbarga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Gulbarga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Gulbarga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Gulbarga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,,2.0,,6.0,2.0,1.0,3.0,,5.0,3.0,2.0,25.0
Gulbarga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,2.0,1.0,,1.0,2.0,,,3.0,,,1.0,11.0
Gulbarga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,2.0,3.0,,7.0,4.0,1.0,3.0,3.0,5.0,3.0,3.0,36.0
Gulbarga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Gulbarga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,,,,,1.0
Gulbarga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,5.0,5.0,12.0,8.0,3.0,5.0,5.0,3.0,6.0,8.0,8.0,6.0,74.0
Gulbarga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,6.0,6.0,1.0,2.0,,,1.0,1.0,2.0,3.0,4.0,28.0
Gulbarga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,11.0,18.0,9.0,5.0,5.0,5.0,4.0,7.0,10.0,11.0,10.0,102.0
Gulbarga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Gulbarga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,6.0,16.0,9.0,5.0,9.0,8.0,3.0,11.0,8.0,12.0,5.0,5.0,97.0
Gulbarga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,6.0,11.0,11.0,3.0,11.0,9.0,7.0,9.0,6.0,11.0,8.0,14.0,106.0
Gulbarga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,12.0,28.0,20.0,8.0,20.0,17.0,10.0,20.0,14.0,23.0,13.0,19.0,204.0
Gulbarga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Gulbarga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,2.0,,,1.0,,4.0
Gulbarga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,2.0,1.0,3.0,3.0,3.0,3.0,1.0,2.0,2.0,1.0,2.0,23.0
Gulbarga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,7.0,5.0,7.0,1.0,5.0,2.0,4.0,8.0,3.0,,1.0,5.0,48.0
Gulbarga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,7.0,7.0,8.0,4.0,8.0,6.0,7.0,11.0,5.0,2.0,3.0,7.0,75.0
Gulbarga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,1.0,,,,1.0
Gulbarga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,7.0,8.0,4.0,7.0,4.0,2.0,10.0,4.0,6.0,3.0,4.0,61.0
Gulbarga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,1.0,1.0,,,1.0,,,3.0
Gulbarga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,7.0,8.0,4.0,7.0,5.0,3.0,10.0,5.0,7.0,3.0,4.0,65.0
Gulbarga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,1.0,,,,1.0,,,1.0,,3.0
Gulbarga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,14.0,17.0,19.0,15.0,13.0,11.0,20.0,16.0,19.0,7.0,12.0,170.0
Gulbarga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,13.0,13.0,8.0,16.0,13.0,26.0,15.0,11.0,19.0,32.0,13.0,17.0,196.0
Gulbarga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,20.0,27.0,25.0,36.0,28.0,39.0,26.0,32.0,35.0,51.0,21.0,29.0,369.0
Gulbarga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Gulbarga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,6.0,6.0,5.0,5.0,9.0,3.0,5.0,6.0,10.0,5.0,3.0,1.0,64.0
Gulbarga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,8.0,5.0,7.0,7.0,8.0,5.0,7.0,3.0,6.0,7.0,9.0,4.0,76.0
Gulbarga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,14.0,11.0,12.0,12.0,17.0,8.0,13.0,9.0,16.0,12.0,12.0,5.0,141.0
Gulbarga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Gulbarga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,3.0,,1.0,,1.0,2.0,,2.0,,1.0,3.0,3.0,16.0
Gulbarga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,3.0,,1.0,,1.0,2.0,,2.0,,1.0,3.0,3.0,16.0
Gulbarga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,1.0,1.0,,1.0,,,,1.0,,,5.0
Gulbarga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,1.0,1.0,,1.0,,,,1.0,,,5.0
Gulbarga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,,,,,,1.0,,1.0,,,4.0
Gulbarga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,,,,,,1.0,,1.0,,,4.0
Gulbarga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Gulbarga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,,,,,,,1.0
Gulbarga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Gulbarga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,,,,1.0,1.0,5.0,4.0,2.0,2.0,2.0,3.0,21.0
Gulbarga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Gulbarga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,,,,1.0,1.0,5.0,4.0,2.0,2.0,2.0,3.0,21.0
Gulbarga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,1.0,1.0,,1.0,1.0,,1.0,2.0,3.0,12.0
Gulbarga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,23.0,26.0,40.0,37.0,7.0,12.0,15.0,19.0,20.0,26.0,29.0,30.0,284.0
Gulbarga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,6.0,9.0,4.0,11.0,2.0,3.0,3.0,4.0,5.0,4.0,4.0,4.0,59.0
Gulbarga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,29.0,36.0,45.0,49.0,10.0,15.0,19.0,24.0,25.0,31.0,35.0,37.0,355.0
Gulbarga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,2.0,,2.0,1.0,3.0,,,9.0
Gulbarga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,19.0,11.0,15.0,15.0,16.0,16.0,14.0,24.0,16.0,19.0,16.0,15.0,196.0
Gulbarga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,4.0,2.0,3.0,1.0,1.0,,1.0,1.0,1.0,1.0,4.0,21.0
Gulbarga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,21.0,16.0,17.0,18.0,17.0,19.0,14.0,27.0,18.0,23.0,17.0,19.0,226.0
Gulbarga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,2.0,1.0,,,,1.0,2.0,,1.0,,1.0,,8.0
Gulbarga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,5.0,4.0,2.0,4.0,10.0,4.0,4.0,4.0,2.0,,,41.0
Gulbarga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,2.0,2.0,2.0,2.0,,,2.0,1.0,,,11.0
Gulbarga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,6.0,6.0,4.0,6.0,13.0,6.0,4.0,7.0,3.0,1.0,,60.0
Gulbarga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,1.0,1.0,1.0,1.0,1.0,,,,7.0
Gulbarga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,8.0,7.0,4.0,5.0,5.0,1.0,,4.0,7.0,2.0,6.0,51.0
Gulbarga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,9.0,10.0,10.0,5.0,5.0,5.0,4.0,6.0,7.0,2.0,8.0,75.0
Gulbarga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,6.0,17.0,18.0,15.0,11.0,11.0,7.0,5.0,11.0,14.0,4.0,14.0,133.0
Gulbarga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,1.0,1.0,,1.0,1.0,,,1.0,6.0
Gulbarga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,3.0,1.0,3.0,4.0,5.0,9.0,1.0,4.0,4.0,5.0,9.0,6.0,54.0
Gulbarga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,12.0,2.0,7.0,6.0,9.0,10.0,5.0,3.0,5.0,3.0,5.0,6.0,73.0
Gulbarga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,15.0,4.0,10.0,10.0,15.0,20.0,6.0,8.0,10.0,8.0,14.0,13.0,133.0
Gulbarga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,6.0,4.0,4.0,,6.0,3.0,6.0,2.0,4.0,7.0,4.0,5.0,51.0
Gulbarga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,71.0,66.0,75.0,68.0,94.0,91.0,102.0,98.0,95.0,66.0,74.0,77.0,977.0
Gulbarga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,184.0,152.0,189.0,160.0,204.0,265.0,231.0,263.0,218.0,255.0,210.0,173.0,2504.0
Gulbarga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,261.0,222.0,268.0,228.0,304.0,359.0,339.0,363.0,317.0,328.0,288.0,255.0,3532.0
Hassan,1.1,Total number of pregnant women Registered for ANC,TOTAL,1947.0,1966.0,2160.0,2181.0,2153.0,2197.0,1967.0,2276.0,1929.0,1830.0,1862.0,1753.0,24221.0
Hassan,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1597.0,1611.0,1761.0,1766.0,1796.0,1811.0,1612.0,1867.0,1572.0,1523.0,1532.0,1399.0,19847.0
Hassan,1.2,Number of Pregnant women registered under JSY,TOTAL,1734.0,1833.0,1949.0,1985.0,1934.0,2027.0,1798.0,2073.0,1775.0,1668.0,1720.0,1586.0,22082.0
Hassan,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2408.0,2479.0,2406.0,2289.0,2480.0,2368.0,2274.0,2526.0,3272.0,2581.0,2096.0,2225.0,29404.0
Hassan,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1528.0,1432.0,1604.0,1662.0,1713.0,1734.0,1612.0,1682.0,1531.0,1422.0,1412.0,1457.0,18789.0
Hassan,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1789.0,1920.0,1941.0,2050.0,2046.0,2115.0,2065.0,2062.0,2103.0,1845.0,1736.0,1962.0,23634.0
Hassan,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1462.0,1492.0,1754.0,1678.0,1568.0,1454.0,1581.0,1358.0,1091.0,1157.0,936.0,933.0,16464.0
Hassan,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,49.0,31.0,13.0,23.0,38.0,26.0,23.0,33.0,34.0,26.0,26.0,38.0,360.0
Hassan,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,3.0,0.0,1.0,0.0,6.0
Hassan,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1864.0,1750.0,1993.0,1598.0,1710.0,1739.0,1540.0,1781.0,1711.0,1592.0,1584.0,1564.0,20426.0
Hassan,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,48.0,53.0,54.0,61.0,64.0,6.0,11.0,16.0,14.0,9.0,23.0,10.0,369.0
Hassan,1.8,Number of pregnancy test kits used at SC level,TOTAL,628.0,688.0,731.0,683.0,717.0,641.0,650.0,712.0,585.0,510.0,364.0,403.0,7312.0
Hassan,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0,0.0,0.0,8.0
Hassan,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,6.0,3.0,7.0,4.0,8.0,4.0,8.0,3.0,5.0,3.0,7.0,2.0,60.0
Hassan,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,8.0,4.0,8.0,4.0,8.0,4.0,8.0,3.0,6.0,6.0,7.0,2.0,68.0
Hassan,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,5.0,4.0,7.0,3.0,8.0,4.0,7.0,1.0,6.0,5.0,7.0,2.0,59.0
Hassan,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,4.0,1.0,0.0,0.0,0.0,2.0,0.0,1.0,0.0,2.0,1.0,11.0
Hassan,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1662.0,1460.0,1411.0,1414.0,1294.0,1416.0,1376.0,1437.0,1515.0,1465.0,1591.0,1484.0,17525.0
Hassan,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,582.0,819.0,543.0,506.0,431.0,721.0,441.0,485.0,524.0,501.0,543.0,463.0,6559.0
Hassan,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,292.0,532.0,1373.0,749.0,633.0,642.0,309.0,268.0,820.0,826.0,661.0,768.0,7873.0
Hassan,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,167.0,143.0,168.0,103.0,156.0,268.0,200.0,237.0,212.0,164.0,213.0,189.0,2220.0
Hassan,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,554.0,579.0,581.0,558.0,532.0,602.0,552.0,541.0,570.0,587.0,600.0,629.0,6885.0
Hassan,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,72.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,72.0
Hassan,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,1.0,0.0,6.0,10.0,4.0,2.0,1.0,5.0,3.0,6.0,3.0,0.0,41.0
Hassan,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,354.0,374.0,278.0,313.0,273.0,381.0,305.0,360.0,397.0,386.0,374.0,77.0,3872.0
Hassan,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,355.0,374.0,284.0,323.0,277.0,383.0,306.0,365.0,400.0,392.0,377.0,77.0,3913.0
Hassan,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,337.0,372.0,340.0,338.0,331.0,393.0,354.0,352.0,361.0,377.0,381.0,354.0,4290.0
Hassan,4.1.1.a,Number of male live births,TOTAL,1177.0,1073.0,1041.0,1016.0,957.0,1133.0,990.0,1007.0,1086.0,1085.0,1122.0,1114.0,12801.0
Hassan,4.1.1.b,Number of female live births,TOTAL,1049.0,969.0,949.0,959.0,877.0,946.0,941.0,980.0,1005.0,973.0,1076.0,997.0,11721.0
Hassan,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2226.0,2042.0,1990.0,1975.0,1834.0,2079.0,1931.0,1987.0,2091.0,2058.0,2198.0,2111.0,24522.0
Hassan,4.1.2,Number of still births,TOTAL,4.0,1.0,6.0,4.0,5.0,6.0,9.0,2.0,8.0,2.0,7.0,7.0,61.0
Hassan,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,40.0,75.0,87.0,103.0,92.0,88.0,72.0,74.0,78.0,99.0,110.0,108.0,1026.0
Hassan,4.2.1,Number of Newborns weighed at birth,TOTAL,2130.0,2007.0,1992.0,1975.0,1816.0,2078.0,1914.0,1982.0,2018.0,2037.0,2201.0,1995.0,24145.0
Hassan,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,176.0,94.0,112.0,105.0,83.0,154.0,209.0,193.0,154.0,95.0,169.0,218.0,1762.0
Hassan,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1229.0,1629.0,1843.0,1840.0,1790.0,1223.0,1698.0,1796.0,1177.0,1970.0,2150.0,1981.0,20326.0
Hassan,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,7.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,12.0
Hassan,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,0.0,7.0,10.0,4.0,2.0,1.0,5.0,3.0,6.0,3.0,4.0,47.0
Hassan,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,46.0,16.0,32.0,43.0,35.0,21.0,22.0,28.0,32.0,52.0,28.0,34.0,389.0
Hassan,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,55.0,16.0,39.0,53.0,39.0,23.0,23.0,38.0,35.0,58.0,31.0,38.0,448.0
Hassan,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,5.0,5.0,4.0,2.0,3.0,4.0,2.0,10.0,2.0,4.0,6.0,0.0,47.0
Hassan,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,79.0,125.0,108.0,143.0,116.0,51.0,76.0,89.0,204.0,229.0,139.0,150.0,1509.0
Hassan,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,9.0,0.0,9.0,10.0,1.0,7.0,11.0,24.0,53.0,34.0,31.0,62.0,251.0
Hassan,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,89.0,157.0,210.0,230.0,236.0,233.0,188.0,211.0,223.0,201.0,204.0,302.0,2484.0
Hassan,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,11.0,13.0,10.0,8.0,14.0,11.0,12.0,13.0,11.0,17.0,13.0,143.0
Hassan,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1084.0,962.0,970.0,907.0,944.0,1018.0,981.0,900.0,965.0,1421.0,1320.0,1078.0,12550.0
Hassan,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1885.0,1775.0,1803.0,1851.0,1780.0,1992.0,1895.0,2027.0,1928.0,2031.0,2048.0,2213.0,23228.0
Hassan,6.3,PNC maternal complications attended,TOTAL,1.0,2.0,0.0,13.0,1.0,12.0,2.0,3.0,1.0,0.0,4.0,2.0,41.0
Hassan,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,15.0,13.0,26.0,23.0,25.0,28.0,21.0,23.0,23.0,21.0,33.0,34.0,285.0
Hassan,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,7.0,9.0,18.0,6.0,11.0,1.0,10.0,11.0,13.0,9.0,10.0,109.0
Hassan,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,19.0,20.0,35.0,41.0,31.0,39.0,22.0,33.0,34.0,34.0,42.0,44.0,394.0
Hassan,7.2,Number of MTPs conducted at Private Facilities,TOTAL,10.0,40.0,15.0,36.0,26.0,36.0,25.0,27.0,25.0,37.0,45.0,64.0,386.0
Hassan,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,384.0,406.0,399.0,426.0,395.0,402.0,419.0,399.0,436.0,371.0,356.0,406.0,4799.0
Hassan,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,636.0,692.0,681.0,653.0,649.0,672.0,636.0,641.0,688.0,623.0,575.0,709.0,7855.0
Hassan,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1020.0,1098.0,1080.0,1079.0,1044.0,1074.0,1055.0,1040.0,1124.0,994.0,931.0,1115.0,12654.0
Hassan,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,40.0,0.0,0.0,0.0,0.0,6.0,4.0,2.0,5.0,0.0,0.0,15.0,72.0
Hassan,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,1.0,4.0
Hassan,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,3.0,1.0,1.0,2.0,0.0,0.0,0.0,1.0,0.0,4.0,0.0,14.0
Hassan,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,3.0,2.0,1.0,2.0,0.0,1.0,0.0,1.0,1.0,4.0,1.0,18.0
Hassan,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,41.0,49.0,38.0,28.0,13.0,48.0,21.0,49.0,25.0,0.0,55.0,27.0,394.0
Hassan,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,129.0,56.0,154.0,52.0,69.0,96.0,95.0,128.0,58.0,94.0,87.0,88.0,1106.0
Hassan,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,384.0,388.0,210.0,288.0,200.0,227.0,247.0,418.0,273.0,281.0,370.0,317.0,3603.0
Hassan,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,554.0,493.0,402.0,368.0,282.0,371.0,363.0,595.0,356.0,375.0,512.0,432.0,5103.0
Hassan,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,17.0,14.0,11.0,8.0,4.0,6.0,11.0,11.0,18.0,10.0,15.0,15.0,140.0
Hassan,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,11.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,1.0,14.0
Hassan,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,4.0,32.0,55.0,16.0,6.0,7.0,9.0,33.0,20.0,17.0,19.0,19.0,237.0
Hassan,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,15.0,32.0,55.0,16.0,6.0,7.0,9.0,33.0,20.0,19.0,19.0,20.0,251.0
Hassan,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,15.0,17.0,28.0,21.0,16.0,24.0,20.0,24.0,35.0,18.0,19.0,36.0,273.0
Hassan,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,1.0,0.0,1.0,3.0,0.0,0.0,1.0,1.0,0.0,2.0,0.0,0.0,9.0
Hassan,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,81.0,107.0,78.0,88.0,95.0,133.0,91.0,134.0,100.0,105.0,89.0,87.0,1188.0
Hassan,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,82.0,107.0,79.0,91.0,95.0,133.0,92.0,135.0,100.0,107.0,89.0,87.0,1197.0
Hassan,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,29.0,37.0,17.0,29.0,32.0,32.0,33.0,30.0,41.0,30.0,26.0,18.0,354.0
Hassan,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,45.0,47.0,42.0,34.0,41.0,49.0,43.0,55.0,51.0,43.0,40.0,41.0,531.0
Hassan,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,112.0,119.0,152.0,125.0,120.0,110.0,99.0,103.0,107.0,88.0,76.0,126.0,1337.0
Hassan,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,46.0,48.0,50.0,38.0,29.0,38.0,31.0,33.0,46.0,43.0,31.0,26.0,459.0
Hassan,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,90.0,92.0,136.0,113.0,136.0,154.0,133.0,148.0,117.0,140.0,177.0,142.0,1578.0
Hassan,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Hassan,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,293.0,306.0,380.0,310.0,326.0,351.0,306.0,339.0,321.0,314.0,324.0,335.0,3905.0
Hassan,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,14.0,5.0,5.0,3.0,5.0,5.0,11.0,2.0,9.0,85.0,14.0,120.0,278.0
Hassan,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,59.0,65.0,52.0,73.0,69.0,79.0,68.0,58.0,80.0,86.0,114.0,79.0,882.0
Hassan,9.06,Number of IUCD removals,TOTAL,106.0,138.0,119.0,111.0,121.0,128.0,123.0,126.0,77.0,98.0,99.0,114.0,1360.0
Hassan,9.07,Number of Oral Pills cycles distributed,TOTAL,3567.0,3590.0,3394.0,3205.0,3136.0,3502.0,3580.0,3614.0,3601.0,3984.0,3944.0,4100.0,43217.0
Hassan,9.08,Number of Condom pieces distributed,TOTAL,32769.0,33447.0,35778.0,35837.0,35491.0,37335.0,37448.0,37158.0,38799.0,38893.0,37299.0,38273.0,438527.0
Hassan,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,3.0,7.0,0.0,0.0,4.0,7.0,12.0,8.0,6.0,2.0,2.0,8.0,59.0
Hassan,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Hassan,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Hassan,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,9.12,Number of Institutions having NSV trained doctors,TOTAL,15.0,16.0,22.0,20.0,20.0,21.0,16.0,6.0,21.0,14.0,18.0,19.0,-1.0
Hassan,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2215.0,1967.0,1845.0,2052.0,1853.0,2039.0,1908.0,1274.0,2133.0,2133.0,2135.0,2171.0,23725.0
Hassan,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0
Hassan,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Hassan,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,2.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,12.0
Hassan,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2197.0,2429.0,2278.0,2223.0,2125.0,2071.0,2108.0,2093.0,2119.0,2130.0,2117.0,2238.0,26128.0
Hassan,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2186.0,2171.0,2321.0,2395.0,2070.0,2151.0,2073.0,2043.0,2189.0,2098.0,2033.0,2232.0,25962.0
Hassan,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2196.0,2150.0,2263.0,2495.0,2180.0,2116.0,2117.0,2023.0,2117.0,2214.0,1980.0,2187.0,26038.0
Hassan,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2075.0,1842.0,1747.0,1930.0,1766.0,1962.0,1832.0,1202.0,2042.0,2032.0,2087.0,2036.0,22553.0
Hassan,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2201.0,2458.0,2286.0,2227.0,2123.0,2058.0,2103.0,2097.0,2117.0,2135.0,2119.0,2237.0,26161.0
Hassan,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2187.0,2186.0,2340.0,2395.0,2069.0,2159.0,2070.0,2044.0,2185.0,2105.0,2030.0,2223.0,25993.0
Hassan,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2197.0,2162.0,2332.0,2518.0,2180.0,2119.0,2118.0,2013.0,2119.0,2223.0,1955.0,2178.0,26114.0
Hassan,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2028.0,1815.0,1722.0,1905.0,1745.0,1929.0,1824.0,1182.0,1992.0,1990.0,2071.0,2012.0,22215.0
Hassan,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,68.0,0.0,0.0,0.0,0.0,0.0,68.0
Hassan,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,42.0,0.0,0.0,0.0,0.0,0.0,45.0
Hassan,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,9.0,0.0,0.0,0.0,45.0,0.0,0.0,0.0,0.0,5.0,59.0
Hassan,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1990.0,2095.0,2038.0,2175.0,1965.0,2005.0,2059.0,2133.0,2113.0,2168.0,2074.0,1953.0,24768.0
Hassan,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1711.0,1782.0,1934.0,2056.0,1964.0,1980.0,1932.0,2010.0,1893.0,1761.0,1931.0,1843.0,22797.0
Hassan,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1024.0,1041.0,1030.0,1109.0,1016.0,1041.0,1033.0,1102.0,1102.0,1100.0,1111.0,1007.0,12716.0
Hassan,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,951.0,974.0,947.0,1058.0,935.0,950.0,987.0,1013.0,994.0,1052.0,958.0,888.0,11707.0
Hassan,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1975.0,2015.0,1977.0,2167.0,1951.0,1991.0,2020.0,2115.0,2096.0,2152.0,2069.0,1895.0,24423.0
Hassan,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1745.0,1877.0,1975.0,2154.0,1965.0,2016.0,1932.0,2041.0,1901.0,1773.0,1951.0,1863.0,23193.0
Hassan,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1739.0,1876.0,1979.0,2151.0,1965.0,2013.0,1926.0,2040.0,1911.0,1773.0,1952.0,1863.0,23188.0
Hassan,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,16.0,8.0,3.0,0.0,0.0,0.0,46.0,0.0,0.0,0.0,73.0
Hassan,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,38.0,43.0,58.0,38.0,61.0,37.0,31.0,26.0,51.0,49.0,63.0,27.0,522.0
Hassan,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,29.0,40.0,51.0,40.0,36.0,39.0,28.0,27.0,50.0,32.0,49.0,28.0,449.0
Hassan,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,67.0,83.0,109.0,78.0,97.0,76.0,59.0,53.0,101.0,81.0,112.0,55.0,971.0
Hassan,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,175.0,219.0,411.0,2087.0,4900.0,5645.0,518.0,2371.0,1426.0,538.0,496.0,1014.0,19800.0
Hassan,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,92.0,110.0,423.0,2281.0,4867.0,5621.0,407.0,2491.0,1543.0,437.0,496.0,971.0,19739.0
Hassan,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,35.0,69.0,382.0,1868.0,5733.0,7095.0,473.0,2915.0,1946.0,544.0,516.0,937.0,22513.0
Hassan,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Hassan,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,2.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,11.0
Hassan,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1397.0,1547.0,1605.0,1613.0,1601.0,1615.0,1597.0,1541.0,1604.0,1592.0,1592.0,1594.0,18898.0
Hassan,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1303.0,1479.0,1531.0,1566.0,1526.0,1534.0,1515.0,1490.0,1533.0,1548.0,1535.0,1535.0,18095.0
Hassan,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,987.0,1094.0,1112.0,1185.0,1110.0,1153.0,1124.0,1112.0,1131.0,1121.0,1137.0,1133.0,13399.0
Hassan,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1800.0,1811.0,1726.0,2029.0,2334.0,1885.0,1905.0,1983.0,1892.0,1643.0,2057.0,1951.0,23016.0
Hassan,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,28.0,28.0,1755.0,17622.0,96.0,54.0,0.0,12.0,16.0,8225.0,2321.0,30157.0
Hassan,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,6.0,0.0,1834.0,17292.0,78.0,14.0,0.0,0.0,0.0,7925.0,2219.0,29368.0
Hassan,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,16.0,4.0,0.0,0.0,0.0,0.0,0.0,2.0,9.0,9.0,0.0,5.0,45.0
Hassan,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1230.0,1247.0,1113.0,1003.0,996.0,960.0,962.0,998.0,994.0,1031.0,1018.0,1112.0,12664.0
Hassan,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,30.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30.0
Hassan,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,47.0,44.0,77.0,59.0,63.0,51.0,50.0,32.0,43.0,49.0,44.0,64.0,623.0
Hassan,13.1,Number of Patients operated for cataract,TOTAL,275.0,382.0,428.0,464.0,311.0,258.0,278.0,262.0,226.0,147.0,301.0,274.0,3606.0
Hassan,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,275.0,382.0,427.0,464.0,311.0,257.0,278.0,261.0,226.0,147.0,304.0,263.0,3595.0
Hassan,13.3,Number of School children detected with Refractive errors,TOTAL,44.0,5.0,52.0,125.0,157.0,160.0,76.0,96.0,57.0,95.0,59.0,50.0,976.0
Hassan,13.4,Number of children provided free glasses,TOTAL,39.0,0.0,21.0,119.0,125.0,49.0,5.0,47.0,28.0,80.0,117.0,72.0,702.0
Hassan,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Hassan,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,9.0,8.0,8.0,10.0,9.0,10.0,7.0,7.0,10.0,8.0,11.0,-1.0
Hassan,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,28.0,33.0,29.0,30.0,31.0,28.0,33.0,32.0,29.0,26.0,30.0,25.0,-1.0
Hassan,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,898.0,897.0,911.0,905.0,937.0,920.0,932.0,989.0,979.0,997.0,964.0,1031.0,-1.0
Hassan,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,22.0,18.0,17.0,18.0,19.0,19.0,19.0,17.0,18.0,18.0,18.0,19.0,-1.0
Hassan,14.05,Number of RKS meetings held during the month,TOTAL,11.0,14.0,17.0,19.0,27.0,14.0,12.0,13.0,12.0,13.0,23.0,28.0,203.0
Hassan,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,21.0,32.0,26.0,30.0,30.0,23.0,28.0,30.0,30.0,26.0,28.0,26.0,-1.0
Hassan,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,350.0,374.0,325.0,299.0,343.0,229.0,269.0,287.0,340.0,419.0,418.0,390.0,4043.0
Hassan,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,10.0,12.0,11.0,9.0,9.0,9.0,10.0,8.0,7.0,8.0,7.0,9.0,-1.0
Hassan,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,5.0,8.0,8.0,8.0,15.0,12.0,8.0,4.0,4.0,4.0,10.0,-1.0
Hassan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,482.0,507.0,548.0,500.0,500.0,761.0,380.0,600.0,629.0,415.0,489.0,593.0,6404.0
Hassan,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4237.0,3833.0,4012.0,3219.0,3824.0,3521.0,3502.0,3456.0,3802.0,3372.0,3207.0,3973.0,43958.0
Hassan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,416.0,432.0,481.0,372.0,445.0,468.0,423.0,537.0,785.0,455.0,427.0,545.0,5786.0
Hassan,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5519.0,4890.0,5181.0,4393.0,4440.0,4481.0,4481.0,4675.0,4810.0,4494.0,4611.0,4898.0,56873.0
Hassan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,898.0,939.0,1029.0,872.0,945.0,1229.0,803.0,1137.0,1414.0,870.0,916.0,1138.0,12190.0
Hassan,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9756.0,8723.0,9193.0,7612.0,8264.0,8002.0,7983.0,8131.0,8612.0,7866.0,7818.0,8871.0,100831.0
Hassan,14.10.2.a,Number of death cases of Inpatient males,TOTAL,70.0,81.0,55.0,69.0,81.0,63.0,85.0,89.0,91.0,91.0,83.0,97.0,955.0
Hassan,14.10.2.b,Number of death cases of Inpatient females,TOTAL,41.0,48.0,67.0,46.0,47.0,44.0,30.0,37.0,40.0,46.0,39.0,54.0,539.0
Hassan,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,111.0,129.0,122.0,115.0,128.0,107.0,115.0,126.0,131.0,137.0,122.0,151.0,1494.0
Hassan,14.11,In-Patient Head Count at midnight,TOTAL,20955.0,19725.0,19499.0,18164.0,17207.0,6956.0,18720.0,45061.0,18669.0,18840.0,19288.0,21638.0,244722.0
Hassan,14.12.1,OPD attendance (All),TOTAL,187869.0,186895.0,196507.0,193639.0,202322.0,207524.0,178170.0,186146.0,187829.0,184604.0,192381.0,194794.0,2298680.0
Hassan,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1145.0,1159.0,1071.0,1104.0,870.0,1034.0,909.0,1019.0,1107.0,1283.0,1185.0,1071.0,12957.0
Hassan,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,439.0,0.0,459.0,3.0,3.0,2.0,0.0,8.0,0.0,2.0,6.0,177.0,1099.0
Hassan,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1116.0,1653.0,897.0,1616.0,1587.0,1034.0,1135.0,1060.0,1054.0,1302.0,1537.0,1772.0,15763.0
Hassan,14.14.a,Number of patients given AYUSH treatment,TOTAL,6078.0,6480.0,6540.0,6209.0,6710.0,6662.0,6723.0,7056.0,8024.0,8124.0,7600.0,6534.0,82740.0
Hassan,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2022.0,2074.0,1841.0,1400.0,1145.0,1599.0,1509.0,1203.0,1708.0,1728.0,1582.0,1763.0,19574.0
Hassan,14.14.c,Number of Adolescents counselled,TOTAL,417.0,354.0,432.0,359.0,384.0,433.0,387.0,398.0,435.0,385.0,370.0,919.0,5273.0
Hassan,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,9730.0,9567.0,10351.0,9674.0,9222.0,10158.0,9479.0,10305.0,9435.0,8726.0,9985.0,8859.0,115491.0
Hassan,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,449.0,626.0,718.0,560.0,572.0,421.0,321.0,469.0,511.0,464.0,535.0,380.0,6026.0
Hassan,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2236.0,1987.0,2557.0,2632.0,2453.0,2703.0,2288.0,2782.0,2633.0,1992.0,2745.0,2589.0,29597.0
Hassan,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,29.0,13.0,32.0,131.0,21.0,144.0,38.0,28.0,32.0,12.0,27.0,26.0,533.0
Hassan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2092.0,1665.0,2038.0,2097.0,1835.0,1968.0,1901.0,2467.0,2315.0,1585.0,2341.0,2130.0,24434.0
Hassan,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,22.0,15.0,31.0,125.0,23.0,249.0,23.0,25.0,23.0,19.0,9.0,12.0,576.0
Hassan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2275.0,2156.0,2788.0,2242.0,1915.0,2368.0,2054.0,2511.0,2255.0,2207.0,2180.0,2443.0,27394.0
Hassan,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,3.0,3.0,55.0,2.0,148.0,51.0,0.0,1.0,7.0,10.0,3.0,285.0
Hassan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6603.0,5808.0,7383.0,6971.0,6203.0,7039.0,6243.0,7760.0,7203.0,5784.0,7266.0,7162.0,81425.0
Hassan,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,53.0,31.0,66.0,311.0,46.0,541.0,112.0,53.0,56.0,38.0,46.0,41.0,1394.0
Hassan,15.2,Number of Widal tests conducted,Number tested,1069.0,1169.0,1446.0,1755.0,1658.0,2195.0,1527.0,1752.0,1575.0,1422.0,1631.0,1702.0,18901.0
Hassan,15.3.a,Number of VDRL tests conducted on males,Number tested,868.0,583.0,567.0,564.0,477.0,512.0,570.0,538.0,527.0,339.0,613.0,401.0,6559.0
Hassan,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,616.0,482.0,573.0,644.0,575.0,500.0,660.0,612.0,569.0,464.0,625.0,529.0,6849.0
Hassan,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1954.0,1910.0,2255.0,2004.0,1824.0,2248.0,1444.0,2120.0,2192.0,2433.0,2079.0,2011.0,24474.0
Hassan,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3438.0,2975.0,3395.0,3212.0,2876.0,3260.0,2674.0,3270.0,3288.0,3236.0,3317.0,2941.0,37882.0
Hassan,15.4.1,Number of blood smears examined for Malaria,TOTAL,21074.0,23868.0,27792.0,28044.0,29133.0,29624.0,22133.0,26538.0,24229.0,22722.0,24670.0,24216.0,304043.0
Hassan,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,30.0,50.0,13.0,515.0,14.0,198.0,8.0,222.0,11.0,9.0,3.0,1076.0
Hassan,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,1.0,2.0,2.0,0.0,1.0,2.0,4.0,0.0,0.0,0.0,12.0
Hassan,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,2900.0,410.0,5960.0,5890.0,13050.0,18580.0,11100.0,9640.0,9870.0,7420.0,8800.0,4870.0,98490.0
Hassan,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,6000.0,6000.0,20000.0,15000.0,12000.0,0.0,7000.0,4000.0,4000.0,0.0,4000.0,80000.0
Hassan,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,4490.0,450.0,6070.0,12840.0,9470.0,19480.0,1460.0,6770.0,6450.0,2620.0,3930.0,8580.0,82610.0
Hassan,16.1.1,Stock position of DPT vaccines,5. Total Stock,410.0,5960.0,5890.0,13050.0,18580.0,11100.0,9640.0,9870.0,7420.0,8800.0,4870.0,290.0,95880.0
Hassan,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,12660.0,10310.0,12460.0,11970.0,9840.0,14050.0,8200.0,6260.0,9840.0,10560.0,13560.0,7540.0,127250.0
Hassan,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,8000.0,9000.0,9000.0,10000.0,10000.0,7000.0,0.0,12000.0,10000.0,7000.0,0.0,9000.0,91000.0
Hassan,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,10350.0,6850.0,9490.0,12130.0,5790.0,12850.0,1940.0,8420.0,9280.0,4000.0,6020.0,15460.0,102580.0
Hassan,16.1.1A,Stock Position of Pentavalent,5. Total Stock,10310.0,12460.0,11970.0,9840.0,14050.0,8200.0,6260.0,9840.0,10560.0,13560.0,7540.0,1080.0,115670.0
Hassan,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18600.0,11660.0,16740.0,15580.0,12840.0,16080.0,8900.0,1980.0,9340.0,10120.0,15520.0,16660.0,154020.0
Hassan,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,13000.0,18000.0,20000.0,15000.0,22000.0,0.0,15000.0,16000.0,246000.0,240000.0,5000.0,620000.0
Hassan,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,16940.0,7920.0,19160.0,22740.0,11760.0,29180.0,6920.0,7640.0,15220.0,240600.0,238860.0,19540.0,636480.0
Hassan,16.1.2,Stock position of OPV vaccines,5. Total Stock,11660.0,16740.0,15580.0,12840.0,16080.0,8900.0,1980.0,9340.0,10120.0,15520.0,16660.0,2120.0,137540.0
Hassan,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,11020.0,7530.0,10230.0,9070.0,16330.0,19700.0,5170.0,2130.0,9000.0,9130.0,12920.0,5460.0,117690.0
Hassan,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,6000.0,10000.0,24000.0,15000.0,15000.0,0.0,10000.0,10000.0,7500.0,0.0,8000.0,113500.0
Hassan,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.3,Stock position of TT vaccines,4. Stock Distributed,11490.0,3300.0,11160.0,16740.0,11630.0,29530.0,3040.0,3130.0,9870.0,3710.0,7460.0,13040.0,124100.0
Hassan,16.1.3,Stock position of TT vaccines,5. Total Stock,7530.0,10230.0,9070.0,16330.0,19700.0,5170.0,2130.0,9000.0,9130.0,12920.0,5460.0,420.0,107090.0
Hassan,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,10840.0,9240.0,8560.0,7630.0,7790.0,6770.0,4520.0,2480.0,6000.0,6740.0,7660.0,3510.0,81740.0
Hassan,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,2000.0,6000.0,6000.0,3000.0,5000.0,0.0,6000.0,7000.0,4000.0,0.0,6000.0,50000.0
Hassan,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6600.0,2680.0,6930.0,5840.0,4020.0,7250.0,2040.0,2480.0,6260.0,3080.0,4150.0,8060.0,59390.0
Hassan,16.1.5,Stock position of BCG vaccines,5. Total Stock,9240.0,8560.0,7630.0,7790.0,6770.0,4520.0,2480.0,6000.0,6740.0,7660.0,3510.0,1450.0,72350.0
Hassan,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,10900.0,8845.0,9100.0,8040.0,6215.0,8355.0,5490.0,3600.0,9945.0,8265.0,9275.0,3770.0,91800.0
Hassan,16.1.6,Stock position of Measles vaccines,2. Stocks Received,6000.0,3000.0,6000.0,6000.0,6000.0,7000.0,0.0,10000.0,6000.0,4000.0,0.0,7000.0,61000.0
Hassan,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,8055.0,2745.0,7060.0,7825.0,3860.0,9865.0,1890.0,3655.0,7680.0,2990.0,5505.0,10180.0,71310.0
Hassan,16.1.6,Stock position of Measles vaccines,5. Total Stock,8845.0,9100.0,8040.0,6215.0,8355.0,5490.0,3600.0,9945.0,8265.0,9275.0,3770.0,590.0,81490.0
Hassan,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5330.0,3600.0,4080.0,3270.0,2890.0,3680.0,4330.0,2600.0,3650.0,4580.0,5860.0,3800.0,47670.0
Hassan,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1500.0,1500.0,3000.0,3000.0,4200.0,0.0,3000.0,3000.0,2500.0,0.0,0.0,21700.0
Hassan,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1730.0,1020.0,2310.0,3380.0,2210.0,3550.0,1730.0,1950.0,2070.0,1220.0,2060.0,3530.0,26760.0
Hassan,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3600.0,4080.0,3270.0,2890.0,3680.0,4330.0,2600.0,3650.0,4580.0,5860.0,3800.0,270.0,42610.0
Hassan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3300.0,2700.0,2550.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,14650.0
Hassan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,6000.0
Hassan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,150.0,2450.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,350.0,3650.0
Hassan,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2700.0,2550.0,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0,5650.0,17000.0
Hassan,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,213400.0,179400.0,170900.0,154400.0,87400.0,255800.0,86800.0,79800.0,65300.0,233460.0,76220.0,76220.0,1679100.0
Hassan,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,176400.0,0.0,0.0,0.0,206160.0,0.0,0.0,0.0,382560.0
Hassan,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,34000.0,8500.0,16500.0,67000.0,8000.0,169000.0,7000.0,14500.0,38000.0,157240.0,0.0,0.0,519740.0
Hassan,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,179400.0,170900.0,154400.0,87400.0,255800.0,86800.0,79800.0,65300.0,233460.0,76220.0,76220.0,76220.0,1541920.0
Hassan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,2000.0,2000.0,2000.0,2000.0,0.0,16000.0,0.0,0.0,0.0,60000.0,0.0,0.0,84000.0
Hassan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,16000.0,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,76000.0
Hassan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,2000.0,0.0,16000.0,0.0,0.0,0.0,60000.0,0.0,0.0,78000.0
Hassan,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,2000.0,2000.0,2000.0,0.0,16000.0,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,82000.0
Hassan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,15630.0,14130.0,13630.0,13630.0,13130.0,13130.0,12630.0,10930.0,10930.0,10415.0,9915.0,9915.0,148015.0
Hassan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1500.0,500.0,0.0,500.0,0.0,500.0,1700.0,0.0,515.0,500.0,0.0,2000.0,7715.0
Hassan,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,14130.0,13630.0,13630.0,13130.0,13130.0,12630.0,10930.0,10930.0,10415.0,9915.0,9915.0,7915.0,140300.0
Hassan,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,60000.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,67500.0
Hassan,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,60000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0
Hassan,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,52500.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0
Hassan,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,60000.0,7500.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,67500.0
Hassan,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16726.0,16726.0,16726.0,91.0,50269.0
Hassan,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16726.0,0.0,0.0,0.0,0.0,16726.0
Hassan,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16635.0,0.0,16635.0
Hassan,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16726.0,16726.0,16726.0,91.0,91.0,50360.0
Hassan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0
Hassan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2654.0,2654.0,2631.0,2551.0,151.0,0.0,0.0,131.0,85.0,4.0,4.0,4.0,10869.0
Hassan,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,23.0,80.0,2400.0,0.0,0.0,0.0,46.0,81.0,0.0,0.0,0.0,2630.0
Hassan,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2654.0,2631.0,2551.0,151.0,151.0,0.0,0.0,85.0,4.0,4.0,4.0,4.0,8239.0
Hassan,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,126250.0,121250.0,121250.0,121250.0,64150.0,74100.0,29100.0,90896.0,88396.0,88396.0,88396.0,88396.0,1101830.0
Hassan,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,25700.0,41950.0,0.0,66796.0,0.0,0.0,0.0,0.0,0.0,134446.0
Hassan,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,5000.0,0.0,0.0,82800.0,32000.0,45000.0,5000.0,2500.0,0.0,0.0,0.0,0.0,172300.0
Hassan,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,121250.0,121250.0,121250.0,64150.0,74100.0,29100.0,90896.0,88396.0,88396.0,88396.0,88396.0,88396.0,1063976.0
Hassan,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,12000.0,14400.0,14400.0,17700.0,3700.0,7000.0,10300.0,10300.0,7300.0,6600.0,6600.0,3600.0,113900.0
Hassan,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000.0,0.0,3300.0,0.0,3300.0,3300.0,0.0,3300.0,6600.0,0.0,0.0,0.0,25800.0
Hassan,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3600.0,0.0,0.0,14000.0,0.0,0.0,0.0,6300.0,7300.0,0.0,3000.0,0.0,34200.0
Hassan,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,14400.0,14400.0,17700.0,3700.0,7000.0,10300.0,10300.0,7300.0,6600.0,6600.0,3600.0,3600.0,105500.0
Hassan,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,192000.0,153600.0,153600.0,153600.0,36000.0,46000.0,106000.0,106000.0,61600.0,149600.0,149600.0,146600.0,1454200.0
Hassan,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,10000.0,70000.0,0.0,0.0,136000.0,0.0,2.0,0.0,216002.0
Hassan,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Hassan,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,38400.0,0.0,0.0,117600.0,0.0,10000.0,0.0,44400.0,48000.0,0.0,3000.0,0.0,261400.0
Hassan,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,153600.0,153600.0,153600.0,36000.0,46000.0,106000.0,106000.0,61600.0,149600.0,149600.0,146600.0,146600.0,1408800.0
Hassan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,9600.0,8600.0,8600.0,11000.0,0.0,2400.0,9600.0,9600.0,7100.0,25100.0,25100.0,25100.0,141800.0
Hassan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,0.0,2400.0,0.0,2400.0,7200.0,0.0,2400.0,21600.0,0.0,0.0,0.0,38400.0
Hassan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Hassan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,3400.0,0.0,0.0,11000.0,0.0,0.0,0.0,4900.0,3600.0,0.0,0.0,0.0,22900.0
Hassan,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,8600.0,8600.0,11000.0,0.0,2400.0,9600.0,9600.0,7100.0,25100.0,25100.0,25100.0,25100.0,157300.0
Hassan,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,,,,,1.0,1.0,,3.0
Hassan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,1.0,,,1.0,,2.0
Hassan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Hassan,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,1.0,,,1.0,,2.0
Hassan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,,1.0,,,,1.0,,,,,1.0,4.0
Hassan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Hassan,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,,1.0,,,,2.0,,,,,1.0,5.0
Hassan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,2.0,1.0,,,1.0,,,,2.0,7.0
Hassan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,3.0,2.0,1.0,,,,,,1.0,,,7.0
Hassan,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,4.0,2.0,3.0,1.0,,,1.0,,1.0,,2.0,14.0
Hassan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,2.0,,4.0,2.0,2.0,2.0,,1.0,2.0,1.0,1.0,,17.0
Hassan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,2.0,1.0,,1.0,1.0,5.0
Hassan,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,2.0,,4.0,2.0,2.0,2.0,,3.0,3.0,1.0,2.0,1.0,22.0
Hassan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,3.0,,2.0,,2.0,,2.0,1.0,1.0,,2.0,13.0
Hassan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,2.0,,,,,,,,,,,2.0
Hassan,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,5.0,,2.0,,2.0,,2.0,1.0,1.0,,2.0,15.0
Hassan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hassan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hassan,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Hassan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Hassan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,,,,,,,,1.0
Hassan,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,1.0,,,,,,,,,,2.0
Hassan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Hassan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Hassan,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Hassan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,5.0,5.0,4.0,4.0,3.0,2.0,2.0,3.0,,2.0,3.0,35.0
Hassan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,,,,,,,
Hassan,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,5.0,5.0,4.0,4.0,3.0,2.0,2.0,3.0,,2.0,3.0,35.0
Hassan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,,
Hassan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,1.0,,1.0
Hassan,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,1.0,,1.0
Hassan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Hassan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,,2.0,,1.0,2.0,,1.0,2.0,2.0,1.0,14.0
Hassan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,1.0,2.0,1.0,2.0,2.0,1.0,2.0,1.0,1.0,,,13.0
Hassan,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,3.0,2.0,3.0,2.0,4.0,3.0,2.0,2.0,3.0,2.0,1.0,28.0
Hassan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,7.0,1.0,3.0,3.0,6.0,2.0,5.0,5.0,5.0,2.0,,42.0
Hassan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,15.0,20.0,17.0,12.0,20.0,23.0,13.0,21.0,14.0,29.0,19.0,25.0,228.0
Hassan,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,18.0,27.0,18.0,15.0,23.0,29.0,15.0,26.0,19.0,34.0,21.0,25.0,270.0
Hassan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Hassan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Hassan,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Hassan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Hassan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,,,1.0,,,,2.0,1.0,,1.0,6.0
Hassan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,2.0,,,,,,,2.0
Hassan,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,,,1.0,2.0,1.0,,2.0,1.0,,1.0,9.0
Hassan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,2.0,1.0,1.0,2.0,1.0,,2.0,2.0,3.0,,1.0,16.0
Hassan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,,
Hassan,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,2.0,1.0,1.0,2.0,1.0,,2.0,2.0,3.0,,1.0,16.0
Hassan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,23.0,29.0,22.0,27.0,34.0,22.0,12.0,16.0,15.0,26.0,35.0,18.0,279.0
Hassan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,36.0,35.0,42.0,35.0,46.0,28.0,35.0,33.0,34.0,44.0,39.0,40.0,447.0
Hassan,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,59.0,64.0,64.0,62.0,80.0,50.0,47.0,49.0,49.0,70.0,74.0,58.0,726.0
Hassan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,1.0,1.0,,,,,,,,2.0
Hassan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,5.0,4.0,6.0,3.0,6.0,7.0,8.0,10.0,5.0,3.0,6.0,7.0,70.0
Hassan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,10.0,18.0,10.0,14.0,17.0,12.0,8.0,16.0,21.0,16.0,21.0,17.0,180.0
Hassan,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,15.0,22.0,16.0,18.0,24.0,19.0,16.0,26.0,26.0,19.0,27.0,24.0,252.0
Hassan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Hassan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Hassan,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Hassan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Hassan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Hassan,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,,,,,,,,,1.0
Hassan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,2.0,1.0,,,,,,,3.0
Hassan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Hassan,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,2.0,1.0,,,,,,,3.0
Hassan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Hassan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Hassan,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,,,,,,,1.0
Hassan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Hassan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Hassan,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,,,,,,,,,,1.0
Hassan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,1.0,,1.0,,,,1.0,,3.0
Hassan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Hassan,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,1.0,,1.0,,,,1.0,,3.0
Hassan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,,,1.0,,,,1.0,1.0,1.0,,2.0,7.0
Hassan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,18.0,20.0,18.0,9.0,7.0,15.0,9.0,15.0,9.0,19.0,8.0,14.0,161.0
Hassan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,8.0,4.0,1.0,5.0,5.0,6.0,4.0,8.0,4.0,5.0,5.0,58.0
Hassan,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,22.0,28.0,22.0,11.0,12.0,20.0,15.0,20.0,18.0,24.0,13.0,21.0,226.0
Hassan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Hassan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,13.0,36.0,17.0,15.0,17.0,14.0,18.0,16.0,11.0,17.0,19.0,19.0,212.0
Hassan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,3.0,4.0,1.0,6.0,7.0,3.0,3.0,1.0,5.0,3.0,3.0,40.0
Hassan,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,14.0,39.0,21.0,16.0,23.0,21.0,21.0,20.0,12.0,22.0,22.0,22.0,253.0
Hassan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Hassan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,1.0,2.0,,,,3.0,1.0,1.0,1.0,,1.0,10.0
Hassan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,2.0,,1.0,,,,1.0,,,,,5.0
Hassan,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,3.0,2.0,1.0,,,3.0,2.0,1.0,1.0,,1.0,15.0
Hassan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,,,,,,,,2.0,3.0
Hassan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,11.0,7.0,8.0,15.0,11.0,3.0,5.0,13.0,9.0,7.0,4.0,10.0,103.0
Hassan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,9.0,8.0,12.0,9.0,14.0,9.0,8.0,14.0,13.0,15.0,14.0,12.0,137.0
Hassan,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,20.0,15.0,21.0,24.0,25.0,12.0,13.0,27.0,22.0,22.0,18.0,24.0,243.0
Hassan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,1.0,1.0,,,1.0,,,1.0,,,5.0
Hassan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,11.0,9.0,14.0,12.0,8.0,14.0,12.0,12.0,6.0,15.0,8.0,10.0,131.0
Hassan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,25.0,20.0,23.0,23.0,28.0,28.0,29.0,35.0,17.0,25.0,16.0,25.0,294.0
Hassan,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,36.0,30.0,38.0,36.0,36.0,42.0,42.0,47.0,23.0,41.0,24.0,35.0,430.0
Hassan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,4.0,,5.0,4.0,1.0,3.0,1.0,3.0,1.0,2.0,2.0,27.0
Hassan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,60.0,66.0,81.0,48.0,69.0,72.0,69.0,85.0,75.0,97.0,72.0,65.0,859.0
Hassan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,243.0,255.0,299.0,250.0,354.0,313.0,306.0,323.0,325.0,337.0,330.0,254.0,3589.0
Hassan,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,304.0,325.0,380.0,303.0,427.0,386.0,378.0,409.0,403.0,435.0,404.0,321.0,4475.0
Haveri,1.1,Total number of pregnant women Registered for ANC,TOTAL,2875.0,2840.0,3239.0,2897.0,2892.0,2938.0,2718.0,2805.0,2630.0,2684.0,2832.0,2744.0,34094.0
Haveri,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2504.0,2431.0,2774.0,2496.0,2551.0,2566.0,2418.0,2498.0,2329.0,2367.0,2469.0,2443.0,29846.0
Haveri,1.2,Number of Pregnant women registered under JSY,TOTAL,2560.0,2565.0,2945.0,2594.0,2619.0,2681.0,2450.0,2561.0,2371.0,2467.0,2567.0,2513.0,30893.0
Haveri,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3183.0,3175.0,3264.0,3210.0,3225.0,3125.0,3089.0,3075.0,3097.0,3074.0,3052.0,3025.0,37594.0
Haveri,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1711.0,1808.0,1923.0,2018.0,1880.0,1886.0,1842.0,1865.0,1673.0,1745.0,1750.0,1735.0,21836.0
Haveri,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2625.0,2666.0,2825.0,2906.0,2688.0,2796.0,2700.0,2790.0,2799.0,2595.0,2765.0,2826.0,32981.0
Haveri,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,635.0,652.0,626.0,402.0,323.0,212.0,263.0,340.0,327.0,169.0,194.0,132.0,4275.0
Haveri,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,88.0,84.0,85.0,206.0,119.0,56.0,74.0,103.0,80.0,80.0,72.0,53.0,1100.0
Haveri,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,13.0,9.0,27.0,21.0,8.0,14.0,19.0,19.0,8.0,8.0,13.0,162.0
Haveri,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2604.0,2505.0,2898.0,2445.0,2719.0,3626.0,3004.0,2030.0,2558.0,2638.0,2891.0,2633.0,32551.0
Haveri,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,23.0,18.0,40.0,37.0,33.0,63.0,61.0,91.0,41.0,35.0,51.0,45.0,538.0
Haveri,1.8,Number of pregnancy test kits used at SC level,TOTAL,387.0,325.0,440.0,289.0,253.0,355.0,303.0,249.0,273.0,333.0,316.0,286.0,3809.0
Haveri,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,5.0,1.0,3.0,2.0,3.0,4.0,5.0,2.0,2.0,1.0,1.0,29.0
Haveri,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,3.0,1.0,0.0,0.0,0.0,4.0,2.0,1.0,0.0,0.0,1.0,0.0,12.0
Haveri,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,3.0,6.0,1.0,3.0,2.0,7.0,6.0,6.0,2.0,2.0,2.0,1.0,41.0
Haveri,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,3.0,3.0,1.0,0.0,1.0,5.0,5.0,5.0,1.0,1.0,2.0,1.0,28.0
Haveri,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,3.0,0.0,0.0,0.0,1.0,0.0,9.0,0.0,0.0,0.0,0.0,13.0
Haveri,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1581.0,1562.0,1635.0,1660.0,1678.0,1745.0,1651.0,1718.0,1646.0,1724.0,1765.0,1546.0,19911.0
Haveri,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,416.0,207.0,282.0,296.0,365.0,435.0,312.0,419.0,506.0,423.0,389.0,346.0,4396.0
Haveri,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,499.0,925.0,1246.0,1010.0,726.0,1587.0,533.0,2253.0,875.0,707.0,926.0,928.0,12215.0
Haveri,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,13.0,0.0,9.0,7.0,9.0,14.0,5.0,52.0,30.0,36.0,0.0,175.0
Haveri,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,418.0,465.0,445.0,444.0,458.0,486.0,445.0,465.0,446.0,400.0,407.0,407.0,5286.0
Haveri,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,37.0,22.0,34.0,36.0,28.0,35.0,27.0,36.0,40.0,59.0,47.0,35.0,436.0
Haveri,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,181.0,207.0,176.0,254.0,212.0,230.0,197.0,195.0,201.0,193.0,217.0,195.0,2458.0
Haveri,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,218.0,229.0,210.0,290.0,240.0,265.0,224.0,231.0,241.0,252.0,264.0,230.0,2894.0
Haveri,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,198.0,233.0,215.0,209.0,207.0,224.0,207.0,207.0,165.0,166.0,199.0,193.0,2423.0
Haveri,4.1.1.a,Number of male live births,TOTAL,1055.0,1020.0,1063.0,1076.0,1073.0,1119.0,1079.0,1107.0,1102.0,1053.0,1082.0,1024.0,12853.0
Haveri,4.1.1.b,Number of female live births,TOTAL,918.0,983.0,992.0,1005.0,1046.0,1100.0,1003.0,1063.0,965.0,1055.0,1065.0,915.0,12110.0
Haveri,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1973.0,2003.0,2055.0,2081.0,2119.0,2219.0,2082.0,2170.0,2067.0,2108.0,2147.0,1939.0,24963.0
Haveri,4.1.2,Number of still births,TOTAL,36.0,36.0,36.0,41.0,31.0,36.0,33.0,25.0,28.0,32.0,38.0,25.0,397.0
Haveri,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,71.0,80.0,78.0,93.0,93.0,115.0,81.0,90.0,74.0,78.0,65.0,83.0,1001.0
Haveri,4.2.1,Number of Newborns weighed at birth,TOTAL,1986.0,2003.0,2053.0,2079.0,2119.0,2209.0,2077.0,2168.0,2066.0,2102.0,2144.0,1938.0,24944.0
Haveri,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,143.0,198.0,266.0,147.0,174.0,204.0,327.0,191.0,231.0,224.0,143.0,181.0,2429.0
Haveri,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1982.0,2003.0,2043.0,2079.0,2116.0,2196.0,1994.0,2168.0,2047.0,2102.0,2120.0,1936.0,24786.0
Haveri,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,22.0,21.0,7.0,3.0,8.0,47.0,7.0,12.0,8.0,6.0,15.0,7.0,163.0
Haveri,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,35.0,22.0,12.0,32.0,19.0,36.0,29.0,47.0,43.0,51.0,40.0,22.0,388.0
Haveri,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,182.0,229.0,201.0,270.0,243.0,258.0,194.0,216.0,94.0,235.0,78.0,208.0,2408.0
Haveri,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,239.0,272.0,220.0,305.0,270.0,341.0,230.0,275.0,145.0,292.0,133.0,237.0,2959.0
Haveri,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,63.0,88.0,58.0,52.0,82.0,249.0,219.0,94.0,49.0,64.0,7.0,55.0,1080.0
Haveri,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,196.0,249.0,188.0,331.0,274.0,452.0,429.0,339.0,314.0,318.0,256.0,280.0,3626.0
Haveri,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,9.0,15.0,8.0,50.0,6.0,201.0,238.0,52.0,80.0,129.0,31.0,26.0,845.0
Haveri,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,719.0,658.0,804.0,685.0,654.0,594.0,718.0,768.0,579.0,512.0,451.0,553.0,7695.0
Haveri,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,25.0,18.0,20.0,17.0,35.0,29.0,45.0,60.0,22.0,22.0,39.0,32.0,364.0
Haveri,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1381.0,1517.0,1580.0,1466.0,1577.0,1648.0,1605.0,1681.0,1626.0,1950.0,1791.0,1768.0,19590.0
Haveri,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2363.0,2344.0,2451.0,2491.0,2506.0,2641.0,2355.0,2760.0,2536.0,2537.0,2476.0,2271.0,29731.0
Haveri,6.3,PNC maternal complications attended,TOTAL,46.0,33.0,43.0,12.0,48.0,67.0,165.0,23.0,2.0,6.0,5.0,4.0,454.0
Haveri,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,5.0,6.0,0.0,3.0,16.0,9.0,13.0,7.0,6.0,14.0,8.0,8.0,95.0
Haveri,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,5.0,6.0,5.0,1.0,4.0,3.0,2.0,0.0,1.0,2.0,8.0,42.0
Haveri,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,10.0,11.0,6.0,8.0,17.0,13.0,16.0,9.0,6.0,15.0,10.0,16.0,137.0
Haveri,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,2.0,0.0,0.0,6.0,0.0,1.0,2.0,0.0,0.0,0.0,11.0
Haveri,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,877.0,1000.0,1096.0,999.0,929.0,1397.0,827.0,1038.0,1227.0,894.0,819.0,1066.0,12169.0
Haveri,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1399.0,1663.0,1603.0,1635.0,1461.0,1585.0,1390.0,1766.0,1876.0,1496.0,1215.0,1660.0,18749.0
Haveri,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,2276.0,2663.0,2699.0,2634.0,2390.0,2982.0,2217.0,2804.0,3103.0,2390.0,2034.0,2726.0,30918.0
Haveri,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,16.0,15.0,304.0,427.0,34.0,71.0,27.0,323.0,13.0,127.0,2.0,0.0,1359.0
Haveri,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Haveri,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Haveri,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Haveri,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,57.0,44.0,69.0,0.0,0.0,0.0,7.0,0.0,0.0,19.0,20.0,19.0,235.0
Haveri,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,44.0,47.0,44.0,25.0,37.0,52.0,29.0,47.0,44.0,51.0,52.0,0.0,472.0
Haveri,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,154.0,132.0,111.0,161.0,169.0,166.0,136.0,170.0,181.0,97.0,150.0,163.0,1790.0
Haveri,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,255.0,223.0,224.0,186.0,206.0,218.0,172.0,217.0,225.0,167.0,222.0,182.0,2497.0
Haveri,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,8.0,5.0,0.0,67.0,102.0,5.0,3.0,0.0,3.0,0.0,5.0,198.0
Haveri,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,119.0,88.0,87.0,113.0,71.0,100.0,69.0,73.0,101.0,87.0,71.0,106.0,1085.0
Haveri,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,56.0,43.0,76.0,28.0,62.0,69.0,30.0,39.0,117.0,58.0,25.0,21.0,624.0
Haveri,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,147.0,116.0,146.0,59.0,108.0,132.0,142.0,160.0,196.0,62.0,168.0,188.0,1624.0
Haveri,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,322.0,247.0,309.0,200.0,241.0,301.0,241.0,272.0,414.0,207.0,264.0,315.0,3333.0
Haveri,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,42.0,17.0,3.0,13.0,12.0,3.0,66.0,93.0,84.0,85.0,36.0,42.0,496.0
Haveri,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,36.0,34.0,50.0,22.0,18.0,23.0,29.0,39.0,22.0,19.0,20.0,17.0,329.0
Haveri,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,11.0,10.0,14.0,9.0,13.0,14.0,9.0,14.0,14.0,22.0,13.0,5.0,148.0
Haveri,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,53.0,108.0,57.0,30.0,57.0,66.0,61.0,61.0,67.0,89.0,61.0,61.0,771.0
Haveri,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,100.0,152.0,121.0,61.0,88.0,103.0,99.0,114.0,103.0,130.0,94.0,83.0,1248.0
Haveri,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,11.0,21.0,0.0,5.0,14.0,7.0,5.0,3.0,5.0,0.0,0.0,3.0,74.0
Haveri,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,128.0,124.0,158.0,131.0,133.0,132.0,131.0,107.0,114.0,131.0,139.0,162.0,1590.0
Haveri,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,82.0,122.0,108.0,74.0,90.0,86.0,117.0,73.0,59.0,52.0,49.0,64.0,976.0
Haveri,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,6.0,21.0,27.0,13.0,19.0,3.0,8.0,19.0,31.0,6.0,9.0,167.0
Haveri,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,24.0,32.0,18.0,42.0,57.0,47.0,56.0,46.0,63.0,87.0,49.0,58.0,579.0
Haveri,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Haveri,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,239.0,284.0,305.0,274.0,293.0,284.0,307.0,234.0,255.0,301.0,243.0,293.0,3312.0
Haveri,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,14.0,2.0,25.0,25.0,25.0,28.0,22.0,19.0,29.0,54.0,23.0,73.0,339.0
Haveri,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5.0,48.0,41.0,39.0,16.0,34.0,22.0,70.0,30.0,17.0,35.0,23.0,380.0
Haveri,9.06,Number of IUCD removals,TOTAL,166.0,119.0,114.0,112.0,147.0,95.0,106.0,91.0,129.0,116.0,109.0,130.0,1434.0
Haveri,9.07,Number of Oral Pills cycles distributed,TOTAL,3166.0,3364.0,3216.0,2941.0,3191.0,2799.0,2838.0,3044.0,3233.0,2843.0,3339.0,3354.0,37328.0
Haveri,9.08,Number of Condom pieces distributed,TOTAL,28636.0,30636.0,28483.0,25308.0,26059.0,27830.0,28914.0,24427.0,27624.0,27205.0,29622.0,24986.0,329730.0
Haveri,9.09,Number of Centchroman (weekly) pills given,TOTAL,12.0,10.0,24.0,2.0,14.0,16.0,15.0,2.0,20.0,0.0,2.0,10.0,127.0
Haveri,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,16.0,10.0,12.0,20.0,28.0,35.0,25.0,35.0,3.0,13.0,27.0,229.0
Haveri,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0
Haveri,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Haveri,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,9.12,Number of Institutions having NSV trained doctors,TOTAL,25.0,24.0,20.0,20.0,24.0,15.0,20.0,21.0,20.0,17.0,15.0,17.0,-1.0
Haveri,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2452.0,2468.0,2467.0,2383.0,2449.0,2484.0,2385.0,2576.0,2419.0,2541.0,2491.0,2377.0,29492.0
Haveri,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,9.0,7.0,0.0,0.0,0.0,1.0,4.0,0.0,0.0,1.0,0.0,22.0
Haveri,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1.0,4.0,7.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,14.0
Haveri,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,7.0,5.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,21.0
Haveri,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2563.0,2747.0,2584.0,2632.0,2638.0,2775.0,2641.0,2699.0,2740.0,2592.0,2586.0,2596.0,31793.0
Haveri,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2541.0,2412.0,2685.0,2636.0,2403.0,2672.0,2508.0,2681.0,2686.0,2635.0,2547.0,2602.0,31008.0
Haveri,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2634.0,2564.0,2696.0,2702.0,2493.0,2711.0,2590.0,2616.0,2732.0,2605.0,2596.0,2511.0,31450.0
Haveri,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1850.0,1926.0,2030.0,2047.0,2069.0,2126.0,1827.0,2015.0,1998.0,2001.0,2028.0,1584.0,23501.0
Haveri,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2542.0,2739.0,2591.0,2612.0,2637.0,2759.0,2624.0,2741.0,2717.0,2632.0,2584.0,2596.0,31774.0
Haveri,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2525.0,2394.0,2650.0,2613.0,2369.0,2671.0,2479.0,2681.0,2672.0,2633.0,2556.0,2602.0,30845.0
Haveri,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2621.0,2551.0,2659.0,2671.0,2478.0,2704.0,2572.0,2616.0,2706.0,2600.0,2602.0,2511.0,31291.0
Haveri,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1854.0,1791.0,1915.0,1940.0,1978.0,2001.0,1719.0,2011.0,1933.0,1662.0,2015.0,1500.0,22319.0
Haveri,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,5.0,15.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0
Haveri,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,5.0,8.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,22.0
Haveri,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,3.0,6.0,7.0,14.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,31.0
Haveri,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2391.0,2391.0,2702.0,2676.0,2466.0,2780.0,2457.0,2620.0,2488.0,2450.0,2406.0,2516.0,30343.0
Haveri,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1933.0,2144.0,2481.0,2370.0,2153.0,2520.0,2287.0,2445.0,2392.0,2392.0,2479.0,2410.0,28006.0
Haveri,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1277.0,1258.0,1407.0,1414.0,1313.0,1433.0,1275.0,1334.0,1288.0,1280.0,1255.0,1297.0,15831.0
Haveri,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1111.0,1121.0,1317.0,1297.0,1194.0,1346.0,1182.0,1285.0,1206.0,1166.0,1144.0,1225.0,14594.0
Haveri,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2388.0,2379.0,2724.0,2711.0,2507.0,2779.0,2457.0,2619.0,2494.0,2446.0,2399.0,2522.0,30425.0
Haveri,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2204.0,2271.0,2561.0,2516.0,2315.0,2607.0,2451.0,2466.0,2420.0,2403.0,2508.0,2502.0,29224.0
Haveri,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2196.0,2241.0,2561.0,2515.0,2297.0,2581.0,2455.0,2466.0,2412.0,2402.0,2508.0,2505.0,29139.0
Haveri,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,15.0,13.0,13.0,0.0,38.0,7.0,5.0,13.0,0.0,0.0,0.0,104.0
Haveri,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,494.0,514.0,625.0,580.0,645.0,642.0,580.0,732.0,653.0,652.0,603.0,620.0,7340.0
Haveri,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,422.0,485.0,545.0,525.0,565.0,572.0,560.0,706.0,617.0,577.0,570.0,551.0,6695.0
Haveri,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,916.0,999.0,1170.0,1105.0,1210.0,1214.0,1140.0,1438.0,1270.0,1229.0,1173.0,1171.0,14035.0
Haveri,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,14.0,22.0,133.0,3646.0,4750.0,6056.0,495.0,3954.0,1942.0,1899.0,977.0,418.0,24306.0
Haveri,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,16.0,43.0,134.0,3446.0,4680.0,5983.0,564.0,4737.0,1741.0,2108.0,991.0,334.0,24777.0
Haveri,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,32.0,50.0,141.0,2732.0,3844.0,6268.0,501.0,3756.0,2153.0,1858.0,883.0,434.0,22652.0
Haveri,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,2.0,2.0,0.0,4.0,0.0,0.0,0.0,1.0,0.0,9.0
Haveri,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,3.0,7.0,12.0,9.0,4.0,11.0,9.0,10.0,11.0,21.0,98.0
Haveri,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1176.0,1187.0,1193.0,1193.0,1184.0,1193.0,1216.0,1195.0,1205.0,1221.0,1223.0,1204.0,14390.0
Haveri,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1152.0,1175.0,1184.0,1184.0,1170.0,1181.0,1198.0,1187.0,1184.0,1195.0,1195.0,1177.0,14182.0
Haveri,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1009.0,1015.0,1013.0,991.0,1016.0,1001.0,1015.0,1012.0,1011.0,1025.0,1023.0,1024.0,12155.0
Haveri,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2162.0,2232.0,2453.0,2490.0,2430.0,2415.0,2167.0,2150.0,2172.0,2188.0,2086.0,2219.0,27164.0
Haveri,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,63.0,33.0,57.0,3620.0,17809.0,35.0,81.0,19.0,25.0,31.0,5615.0,3968.0,31356.0
Haveri,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,8.0,13.0,0.0,1781.0,14591.0,0.0,120.0,0.0,0.0,10.0,4845.0,2835.0,24203.0
Haveri,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,20.0,11.0,11.0,8.0,14.0,3.0,12.0,5.0,4.0,5.0,27.0,25.0,145.0
Haveri,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,2950.0,3088.0,2944.0,2773.0,3082.0,2623.0,2550.0,2332.0,3121.0,3004.0,2948.0,2612.0,34027.0
Haveri,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,29.0,26.0,4.0,9.0,126.0,1.0,0.0,2.0,28.0,2.0,0.0,230.0
Haveri,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,243.0,296.0,376.0,336.0,693.0,184.0,429.0,396.0,398.0,492.0,565.0,514.0,4922.0
Haveri,13.1,Number of Patients operated for cataract,TOTAL,394.0,354.0,462.0,294.0,195.0,214.0,282.0,222.0,154.0,245.0,120.0,202.0,3138.0
Haveri,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,394.0,354.0,399.0,294.0,150.0,214.0,283.0,222.0,154.0,245.0,120.0,202.0,3031.0
Haveri,13.3,Number of School children detected with Refractive errors,TOTAL,77.0,0.0,0.0,19.0,27.0,46.0,48.0,90.0,53.0,273.0,31.0,0.0,664.0
Haveri,13.4,Number of children provided free glasses,TOTAL,68.0,0.0,0.0,0.0,0.0,0.0,0.0,40.0,0.0,161.0,0.0,0.0,269.0
Haveri,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,9.0,10.0,8.0,8.0,9.0,8.0,8.0,7.0,7.0,7.0,6.0,-1.0
Haveri,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,39.0,40.0,38.0,37.0,39.0,38.0,37.0,37.0,38.0,38.0,39.0,39.0,-1.0
Haveri,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,419.0,363.0,376.0,374.0,342.0,348.0,315.0,322.0,371.0,328.0,343.0,372.0,-1.0
Haveri,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,11.0,11.0,12.0,11.0,12.0,14.0,13.0,10.0,10.0,7.0,8.0,8.0,-1.0
Haveri,14.05,Number of RKS meetings held during the month,TOTAL,10.0,10.0,12.0,7.0,17.0,15.0,11.0,11.0,15.0,11.0,17.0,19.0,155.0
Haveri,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,27.0,23.0,27.0,25.0,24.0,21.0,27.0,26.0,23.0,23.0,24.0,-1.0
Haveri,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,396.0,388.0,359.0,299.0,417.0,287.0,344.0,267.0,326.0,340.0,357.0,403.0,4183.0
Haveri,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,5.0,4.0,2.0,5.0,5.0,5.0,6.0,5.0,6.0,5.0,6.0,-1.0
Haveri,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,5.0,6.0,6.0,5.0,5.0,3.0,4.0,4.0,4.0,4.0,4.0,-1.0
Haveri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,381.0,1007.0,1259.0,1068.0,946.0,1508.0,3588.0,831.0,827.0,893.0,1023.0,864.0,14195.0
Haveri,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2584.0,3120.0,3533.0,2880.0,2896.0,5110.0,2848.0,2987.0,2695.0,2883.0,2611.0,2695.0,36842.0
Haveri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,418.0,954.0,1101.0,914.0,872.0,1323.0,1300.0,806.0,767.0,853.0,1509.0,1499.0,12316.0
Haveri,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5776.0,6157.0,6158.0,6029.0,5858.0,7421.0,5527.0,5751.0,5415.0,5247.0,5360.0,4846.0,69545.0
Haveri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,799.0,1961.0,2360.0,1982.0,1818.0,2831.0,4888.0,1637.0,1594.0,1746.0,2532.0,2363.0,26511.0
Haveri,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8360.0,9277.0,9691.0,8909.0,8754.0,12531.0,8375.0,8738.0,8110.0,8130.0,7971.0,7541.0,106387.0
Haveri,14.10.2.a,Number of death cases of Inpatient males,TOTAL,42.0,36.0,38.0,41.0,45.0,41.0,19.0,49.0,48.0,38.0,44.0,47.0,488.0
Haveri,14.10.2.b,Number of death cases of Inpatient females,TOTAL,29.0,21.0,25.0,22.0,30.0,26.0,27.0,24.0,35.0,33.0,29.0,29.0,330.0
Haveri,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,71.0,57.0,63.0,63.0,75.0,67.0,46.0,73.0,83.0,71.0,73.0,76.0,818.0
Haveri,14.11,In-Patient Head Count at midnight,TOTAL,11815.0,10526.0,12777.0,11262.0,9719.0,14675.0,9866.0,11306.0,11613.0,11929.0,11196.0,11036.0,137720.0
Haveri,14.12.1,OPD attendance (All),TOTAL,149805.0,678521.0,170721.0,157706.0,165072.0,183907.0,153761.0,166994.0,199497.0,156094.0,166824.0,164751.0,2513653.0
Haveri,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,866.0,770.0,887.0,764.0,607.0,970.0,1068.0,822.0,616.0,796.0,741.0,763.0,9670.0
Haveri,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,37.0,55.0,68.0,90.0,56.0,73.0,37.0,79.0,80.0,146.0,101.0,39.0,861.0
Haveri,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,564.0,491.0,481.0,452.0,479.0,460.0,351.0,466.0,472.0,500.0,492.0,536.0,5744.0
Haveri,14.14.a,Number of patients given AYUSH treatment,TOTAL,9098.0,10547.0,10885.0,9446.0,8995.0,7493.0,8340.0,10088.0,9969.0,9493.0,9152.0,9979.0,113485.0
Haveri,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,803.0,792.0,945.0,875.0,943.0,923.0,764.0,1008.0,900.0,915.0,992.0,866.0,10726.0
Haveri,14.14.c,Number of Adolescents counselled,TOTAL,137.0,158.0,167.0,131.0,159.0,114.0,118.0,118.0,112.0,141.0,112.0,114.0,1581.0
Haveri,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6857.0,6065.0,7805.0,7943.0,6744.0,7412.0,6540.0,7731.0,7038.0,5817.0,6081.0,37652.0,113685.0
Haveri,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,371.0,304.0,193.0,185.0,338.0,429.0,177.0,420.0,354.0,272.0,398.0,386.0,3827.0
Haveri,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1852.0,2268.0,2459.0,2535.0,2201.0,2223.0,1908.0,2427.0,2258.0,2074.0,1770.0,1745.0,25720.0
Haveri,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,13.0,24.0,39.0,21.0,15.0,27.0,18.0,32.0,21.0,24.0,21.0,16.0,271.0
Haveri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1527.0,2235.0,1997.0,1940.0,2056.0,2315.0,1836.0,2362.0,2352.0,1941.0,2081.0,1870.0,24512.0
Haveri,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,18.0,16.0,24.0,29.0,24.0,20.0,13.0,30.0,12.0,17.0,11.0,9.0,223.0
Haveri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3435.0,3376.0,3842.0,2698.0,2841.0,2882.0,2471.0,3340.0,2907.0,2721.0,2505.0,2476.0,35494.0
Haveri,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,0.0,6.0,6.0,6.0,2.0,2.0,2.0,2.0,2.0,0.0,2.0,1.0,31.0
Haveri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,6814.0,7879.0,8298.0,7173.0,7098.0,7420.0,6215.0,8129.0,7517.0,6736.0,6356.0,6091.0,85726.0
Haveri,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,31.0,46.0,69.0,56.0,41.0,49.0,33.0,64.0,35.0,41.0,34.0,26.0,525.0
Haveri,15.2,Number of Widal tests conducted,Number tested,885.0,1011.0,1443.0,1249.0,1413.0,1414.0,1018.0,1198.0,1107.0,940.0,1228.0,1290.0,14196.0
Haveri,15.3.a,Number of VDRL tests conducted on males,Number tested,98.0,237.0,299.0,204.0,274.0,322.0,259.0,276.0,625.0,183.0,341.0,265.0,3383.0
Haveri,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,156.0,246.0,442.0,532.0,396.0,417.0,506.0,467.0,399.0,197.0,361.0,343.0,4462.0
Haveri,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1481.0,1130.0,1205.0,1132.0,1749.0,1804.0,1759.0,1764.0,1034.0,1310.0,1578.0,1659.0,17605.0
Haveri,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1735.0,1613.0,1946.0,1868.0,2419.0,2543.0,2524.0,2507.0,2058.0,1690.0,2280.0,2267.0,25450.0
Haveri,15.4.1,Number of blood smears examined for Malaria,TOTAL,17807.0,18997.0,17148.0,17959.0,17899.0,19519.0,15852.0,18594.0,16765.0,15059.0,17745.0,17330.0,210674.0
Haveri,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,18.0,22.0,61.0,46.0,36.0,30.0,13.0,32.0,21.0,22.0,13.0,13.0,327.0
Haveri,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,2.0,2.0,6.0,4.0,5.0,3.0,4.0,0.0,3.0,2.0,1.0,34.0
Haveri,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4500.0,4500.0,1000.0,,1000.0,,,3500.0,1000.0,500.0,1000.0,5000.0,22000.0
Haveri,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,,5000.0,10000.0,12000.0,20000.0,10000.0,,5000.0,4000.0,5000.0,,73000.0
Haveri,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2000.0,3500.0,6000.0,9000.0,13000.0,20000.0,6500.0,2500.0,5500.0,3500.0,1000.0,2500.0,75000.0
Haveri,16.1.1,Stock position of DPT vaccines,5. Total Stock,4500.0,1000.0,0.0,1000.0,0.0,0.0,3500.0,1000.0,500.0,1000.0,5000.0,2500.0,20000.0
Haveri,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3000.0,8000.0,7000.0,6000.0,4000.0,4500.0,,4500.0,9000.0,4500.0,4000.0,3500.0,58000.0
Haveri,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,10000.0,8000.0,10000.0,6000.0,10000.0,10000.0,18000.0,10000.0,3000.0,5000.0,7000.0,8000.0,105000.0
Haveri,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5000.0,9000.0,11000.0,8000.0,9500.0,12000.0,13000.0,5500.0,7500.0,5500.0,7500.0,6000.0,99500.0
Haveri,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8000.0,7000.0,6000.0,4000.0,4500.0,2500.0,5000.0,9000.0,4500.0,4000.0,3500.0,5500.0,63500.0
Haveri,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9500.0,13500.0,9000.0,1000.0,5500.0,4000.0,2500.0,5000.0,400.0,500.0,500.0,2500.0,53900.0
Haveri,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15000.0,10000.0,8000.0,20000.0,15000.0,17500.0,10000.0,8000.0,15800.0,9000.0,20000.0,15000.0,163300.0
Haveri,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11000.0,14500.0,16000.0,15500.0,16500.0,21500.0,8000.0,12600.0,15700.0,9000.0,18000.0,12000.0,170300.0
Haveri,16.1.2,Stock position of OPV vaccines,5. Total Stock,13500.0,9000.0,1000.0,5500.0,4000.0,0.0,4500.0,400.0,500.0,500.0,2500.0,5500.0,46900.0
Haveri,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,500.0,6000.0,8500.0,1500.0,1500.0,,,500.0,,0.0,1500.0,3000.0,23000.0
Haveri,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,10000.0,4000.0,12000.0,13710.0,20000.0,12000.0,1000.0,,10000.0,12000.0,10000.0,114710.0
Haveri,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4500.0,7500.0,11000.0,12000.0,15210.0,20000.0,11500.0,1500.0,,8500.0,10500.0,5000.0,107210.0
Haveri,16.1.3,Stock position of TT vaccines,5. Total Stock,6000.0,8500.0,1500.0,1500.0,0.0,0.0,500.0,0.0,0.0,1500.0,3000.0,8000.0,30500.0
Haveri,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3000.0,5000.0,,2000.0,2500.0,3000.0,2500.0,4500.0,3500.0,2500.0,3000.0,3500.0,35000.0
Haveri,16.1.5,Stock position of BCG vaccines,2. Stocks Received,5000.0,,7000.0,6000.0,5000.0,5000.0,5000.0,4000.0,4000.0,5000.0,5000.0,4000.0,55000.0
Haveri,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3000.0,5000.0,5000.0,5500.0,4500.0,5500.0,3000.0,5000.0,5000.0,4500.0,4500.0,4000.0,54500.0
Haveri,16.1.5,Stock position of BCG vaccines,5. Total Stock,5000.0,0.0,2000.0,2500.0,3000.0,2500.0,4500.0,3500.0,2500.0,3000.0,3500.0,3500.0,35500.0
Haveri,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3000.0,4250.0,2000.0,1750.0,2500.0,2000.0,,1500.0,1750.0,,1000.0,,19750.0
Haveri,16.1.6,Stock position of Measles vaccines,2. Stocks Received,4000.0,3000.0,6000.0,6000.0,5000.0,5000.0,6000.0,6000.0,4000.0,6000.0,5000.0,6000.0,62000.0
Haveri,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2750.0,5250.0,6250.0,5250.0,5500.0,7000.0,4500.0,5750.0,5750.0,5000.0,6000.0,5000.0,64000.0
Haveri,16.1.6,Stock position of Measles vaccines,5. Total Stock,4250.0,2000.0,1750.0,2500.0,2000.0,0.0,1500.0,1750.0,0.0,1000.0,0.0,1000.0,17750.0
Haveri,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.1.7,Stock position of JE vaccines,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,3000.0,5000.0,3500.0,2000.0,2000.0,3300.0,2000.0,3000.0,4600.0,2600.0,2600.0,1300.0,34900.0
Haveri,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,,,2000.0,3000.0,,2100.0,2100.0,,,,3000.0,15200.0
Haveri,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1000.0,1500.0,1500.0,2000.0,1700.0,1300.0,1100.0,500.0,2000.0,,1300.0,2300.0,16200.0
Haveri,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,5000.0,3500.0,2000.0,2000.0,3300.0,2000.0,3000.0,4600.0,2600.0,2600.0,1300.0,2000.0,33900.0
Haveri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,,,5400.0,5400.0,5400.0,5400.0,5400.0,5400.0,1800.0,,,,34200.0
Haveri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,,5400.0,,,,,,,,,,,5400.0
Haveri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,,,,,,,,3600.0,1800.0,,,,5400.0
Haveri,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,5400.0,5400.0,5400.0,5400.0,5400.0,5400.0,1800.0,0.0,0.0,0.0,0.0,34200.0
Haveri,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,,,,,151200.0,7014.0,7014.0,7014.0,2014.0,,60000.0,,234256.0
Haveri,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,,,,151200.0,,,,,,60000.0,,,211200.0
Haveri,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,,,,,144186.0,,,5000.0,2014.0,,60000.0,,211200.0
Haveri,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,151200.0,7014.0,7014.0,7014.0,2014.0,0.0,60000.0,0.0,0.0,234256.0
Haveri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,600.0,600.0,600.0,600.0,600.0,16600.0,4850.0,,46000.0,30000.0,100450.0
Haveri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,600.0,,,,,16000.0,,,46000.0,,,62600.0
Haveri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,,,,11750.0,4850.0,,16000.0,,32600.0
Haveri,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,600.0,600.0,600.0,600.0,600.0,16600.0,4850.0,0.0,46000.0,30000.0,30000.0,130450.0
Haveri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,,900.0,900.0,3900.0,812.0,812.0,812.0,300.0,,,,8436.0
Haveri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,,900.0,,3000.0,,,,,,,,,3900.0
Haveri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,,,,,3088.0,,,512.0,300.0,,,,3900.0
Haveri,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,900.0,900.0,3900.0,812.0,812.0,812.0,300.0,0.0,0.0,0.0,0.0,8436.0
Haveri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3600.0,3400.0,3300.0,3000.0,3000.0,2700.0,2700.0,2400.0,2400.0,1900.0,1300.0,1300.0,31000.0
Haveri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,,,,,,,,,,,,,
Haveri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,200.0,100.0,300.0,,300.0,,,,500.0,600.0,,300.0,2300.0
Haveri,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3400.0,3300.0,3000.0,3000.0,2700.0,2700.0,2700.0,2400.0,1900.0,1300.0,1300.0,1000.0,28700.0
Haveri,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,1550.0,1250.0,750.0,350.0,,,,,,,,,3900.0
Haveri,16.3.02,Stock Position of Gloves,2. Stocks Received,,,,,,,,,,,,700.0,700.0
Haveri,16.3.02,Stock Position of Gloves,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.02,Stock Position of Gloves,4. Stock Distributed,300.0,500.0,400.0,350.0,,,,,,,,50.0,1600.0
Haveri,16.3.02,Stock Position of Gloves,5. Total Stock,1250.0,750.0,350.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,650.0,3000.0
Haveri,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,,,,16.0,,,,,,,,16.0
Haveri,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,,,16.0,,,,,,,,,16.0
Haveri,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,,,,16.0,,,,,,,,16.0
Haveri,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,16.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0
Haveri,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,,,,,,,,,,,,
Haveri,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,,,,,,,,,,,,
Haveri,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,,,,,,,,,,,,
Haveri,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Haveri,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,,,,,,,,,,10250.0,,10250.0
Haveri,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,,,,,,,,,10250.0,,,10250.0
Haveri,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,,,,,,,,,,10250.0,,10250.0
Haveri,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10250.0,0.0,0.0,10250.0
Haveri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,,,,15075.0,25.0,25.0,25.0,25.0,6429.0,6429.0,6429.0,34462.0
Haveri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,,,15075.0,,6804.0,,,,,,,21879.0
Haveri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,,,,15050.0,100.0,,,,,,25.0,15175.0
Haveri,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,15075.0,25.0,6729.0,25.0,25.0,25.0,6429.0,6429.0,6404.0,41166.0
Haveri,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2850.0,2850.0,2850.0,2850.0,100.0,100.0,100.0,100.0,100.0,50.0,,,11950.0
Haveri,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,,,,,,,,,,1400.0,,1400.0
Haveri,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,,,2750.0,,,,,50.0,50.0,1400.0,,4250.0
Haveri,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2850.0,2850.0,2850.0,100.0,100.0,100.0,100.0,100.0,50.0,0.0,0.0,0.0,9100.0
Haveri,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,925.0,875.0,825.0,800.0,,90572.0,90400.0,90300.0,89700.0,89200.0,88700.0,88200.0,630497.0
Haveri,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,,,42214.0,90572.0,,,,,,,,132786.0
Haveri,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,50.0,50.0,25.0,43014.0,,172.0,100.0,600.0,500.0,500.0,500.0,,45511.0
Haveri,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,875.0,825.0,800.0,0.0,90572.0,90400.0,90300.0,89700.0,89200.0,88700.0,88200.0,88200.0,717772.0
Haveri,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,200.0,800.0,1800.0,,,,350.0,5730.0,3230.0,500.0,500.0,400.0,13510.0
Haveri,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,3000.0,,2500.0,3300.0,2550.0,8680.0,,,4950.0,4600.0,,32580.0
Haveri,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2400.0,2000.0,1800.0,2500.0,3300.0,2200.0,3300.0,2500.0,2730.0,4950.0,4700.0,400.0,32780.0
Haveri,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,800.0,1800.0,0.0,0.0,0.0,350.0,5730.0,3230.0,500.0,500.0,400.0,0.0,13310.0
Haveri,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,,6000.0,12000.0,13800.0,,,2400.0,59400.0,39400.0,8200.0,5200.0,2400.0,148800.0
Haveri,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,30000.0,21000.0,28800.0,11000.0,28800.0,28800.0,85000.0,,,24000.0,20000.0,16800.0,294200.0
Haveri,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,24000.0,15000.0,27000.0,24800.0,28800.0,26400.0,28000.0,20000.0,31200.0,27000.0,22800.0,18800.0,293800.0
Haveri,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6000.0,12000.0,13800.0,0.0,0.0,2400.0,59400.0,39400.0,8200.0,5200.0,2400.0,400.0,149200.0
Haveri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,,600.0,1400.0,1000.0,400.0,200.0,500.0,2600.0,1000.0,400.0,400.0,500.0,9000.0
Haveri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2400.0,2400.0,2400.0,2400.0,2400.0,3300.0,4800.0,,,4800.0,2400.0,2400.0,29700.0
Haveri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,,,,,,,,,,
Haveri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1800.0,1600.0,2800.0,3000.0,2600.0,3000.0,2700.0,1600.0,600.0,4800.0,2300.0,2200.0,29000.0
Haveri,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,600.0,1400.0,1000.0,400.0,200.0,500.0,2600.0,1000.0,400.0,400.0,500.0,700.0,9700.0
Haveri,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,,,,
Haveri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,1.0,,1.0,1.0,1.0,,1.0,1.0,,3.0,10.0
Haveri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,,1.0,,,,1.0,,,3.0
Haveri,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,1.0,1.0,,1.0,2.0,1.0,,1.0,2.0,,3.0,13.0
Haveri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,9.0,12.0,7.0,3.0,2.0,11.0,6.0,7.0,11.0,5.0,7.0,6.0,86.0
Haveri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,1.0,,,1.0,1.0,,,,1.0,5.0
Haveri,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,9.0,13.0,7.0,4.0,2.0,11.0,7.0,8.0,11.0,5.0,7.0,7.0,91.0
Haveri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,9.0,11.0,6.0,8.0,2.0,8.0,5.0,8.0,3.0,6.0,3.0,6.0,75.0
Haveri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,3.0,,2.0,1.0,2.0,,3.0,1.0,1.0,14.0
Haveri,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,10.0,11.0,6.0,11.0,2.0,10.0,6.0,10.0,3.0,9.0,4.0,7.0,89.0
Haveri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,14.0,5.0,9.0,5.0,7.0,7.0,5.0,2.0,2.0,4.0,4.0,3.0,67.0
Haveri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,1.0,,1.0,1.0,1.0,1.0,,2.0,2.0,1.0,,11.0
Haveri,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,15.0,6.0,9.0,6.0,8.0,8.0,6.0,2.0,4.0,6.0,5.0,3.0,78.0
Haveri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,2.0,,,,,2.0,,2.0,,,6.0
Haveri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Haveri,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,2.0,,,,,2.0,,2.0,,,7.0
Haveri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Haveri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Haveri,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,1.0,,,,,1.0
Haveri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,1.0,,,,,,,1.0,3.0
Haveri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Haveri,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,1.0,,,1.0,,,,1.0,4.0
Haveri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Haveri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Haveri,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Haveri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,11.0,8.0,8.0,4.0,9.0,2.0,2.0,10.0,4.0,8.0,4.0,75.0
Haveri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,1.0,2.0,1.0,2.0,2.0,1.0,,1.0,,,12.0
Haveri,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,12.0,9.0,10.0,5.0,11.0,4.0,3.0,10.0,5.0,8.0,4.0,87.0
Haveri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,1.0,,,,,,,,,1.0
Haveri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Haveri,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,,1.0,,,2.0
Haveri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,5.0,,7.0,4.0,1.0,7.0,5.0,4.0,5.0,8.0,4.0,3.0,53.0
Haveri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,2.0,2.0,1.0,1.0,,1.0,,2.0,1.0,2.0,2.0,16.0
Haveri,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,7.0,2.0,9.0,5.0,2.0,7.0,6.0,4.0,7.0,9.0,6.0,5.0,69.0
Haveri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,,1.0,,,,1.0,,3.0
Haveri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,10.0,6.0,6.0,9.0,14.0,11.0,15.0,6.0,10.0,11.0,15.0,16.0,129.0
Haveri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,40.0,30.0,41.0,48.0,65.0,58.0,50.0,55.0,74.0,70.0,66.0,53.0,650.0
Haveri,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,50.0,36.0,47.0,57.0,80.0,69.0,66.0,61.0,84.0,81.0,82.0,69.0,782.0
Haveri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Haveri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Haveri,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Haveri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Haveri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,2.0,,3.0,1.0,2.0,3.0,,1.0,1.0,14.0
Haveri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,1.0,1.0,1.0,,,,1.0,1.0,5.0,10.0
Haveri,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,3.0,1.0,4.0,1.0,2.0,3.0,2.0,2.0,6.0,25.0
Haveri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
Haveri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,4.0,7.0,7.0,6.0,8.0,5.0,2.0,10.0,4.0,1.0,10.0,67.0
Haveri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,1.0,1.0,1.0,1.0,,,,,5.0
Haveri,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,4.0,4.0,7.0,7.0,7.0,9.0,6.0,3.0,11.0,4.0,1.0,11.0,74.0
Haveri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,1.0,,,1.0,1.0,1.0,5.0
Haveri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,36.0,31.0,30.0,45.0,40.0,37.0,35.0,39.0,50.0,36.0,30.0,44.0,453.0
Haveri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,56.0,53.0,48.0,72.0,67.0,63.0,55.0,67.0,81.0,75.0,59.0,59.0,755.0
Haveri,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,92.0,84.0,79.0,117.0,107.0,100.0,91.0,106.0,131.0,112.0,90.0,104.0,1213.0
Haveri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,1.0,1.0,1.0,,1.0,1.0,,1.0,,,6.0
Haveri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,24.0,11.0,15.0,20.0,12.0,27.0,30.0,17.0,29.0,8.0,16.0,19.0,228.0
Haveri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,42.0,56.0,56.0,64.0,73.0,69.0,64.0,70.0,73.0,65.0,52.0,44.0,728.0
Haveri,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,66.0,67.0,72.0,85.0,86.0,96.0,95.0,88.0,102.0,74.0,68.0,63.0,962.0
Haveri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Haveri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Haveri,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Haveri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Haveri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Haveri,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Haveri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Haveri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Haveri,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Haveri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,1.0,,,,,,,,,,1.0
Haveri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Haveri,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,1.0,,,,,,,,,,1.0
Haveri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Haveri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Haveri,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Haveri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Haveri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,1.0,1.0,1.0,,,2.0,,,1.0,,8.0
Haveri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Haveri,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,1.0,1.0,1.0,,,2.0,,,1.0,,8.0
Haveri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,,,1.0,,,1.0,2.0
Haveri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,9.0,7.0,8.0,11.0,4.0,6.0,10.0,10.0,16.0,11.0,11.0,11.0,114.0
Haveri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,,5.0,1.0,6.0,4.0,,4.0,,9.0,3.0,3.0,6.0,41.0
Haveri,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,9.0,12.0,9.0,17.0,8.0,6.0,14.0,10.0,26.0,14.0,14.0,18.0,157.0
Haveri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,1.0,,,,,,,,2.0,,,4.0
Haveri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,9.0,9.0,16.0,11.0,12.0,10.0,13.0,6.0,7.0,11.0,8.0,5.0,117.0
Haveri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,2.0,1.0,2.0,2.0,3.0,,1.0,2.0,1.0,3.0,3.0,21.0
Haveri,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,11.0,12.0,17.0,13.0,14.0,13.0,13.0,7.0,9.0,14.0,11.0,8.0,142.0
Haveri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,1.0,,,1.0,,,2.0
Haveri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,2.0,2.0,,1.0,1.0,3.0,1.0,,1.0,1.0,4.0,17.0
Haveri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,,,,2.0,,1.0,,,,,4.0
Haveri,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,3.0,2.0,,1.0,3.0,4.0,2.0,,2.0,1.0,4.0,23.0
Haveri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,,2.0,1.0,1.0,,,2.0,,,7.0
Haveri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,17.0,12.0,19.0,10.0,22.0,17.0,25.0,20.0,17.0,23.0,13.0,24.0,219.0
Haveri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,16.0,19.0,23.0,22.0,25.0,25.0,38.0,32.0,27.0,14.0,19.0,25.0,285.0
Haveri,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,33.0,31.0,43.0,32.0,49.0,43.0,64.0,52.0,44.0,39.0,32.0,49.0,511.0
Haveri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,2.0,1.0,1.0,1.0,1.0,1.0,,2.0,1.0,1.0,1.0,13.0
Haveri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,12.0,12.0,19.0,17.0,17.0,22.0,21.0,11.0,19.0,17.0,24.0,12.0,203.0
Haveri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,36.0,47.0,21.0,38.0,32.0,18.0,41.0,24.0,43.0,34.0,38.0,386.0
Haveri,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,27.0,50.0,67.0,39.0,56.0,55.0,40.0,52.0,45.0,61.0,59.0,51.0,602.0
Haveri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,,,2.0,,3.0,,2.0,2.0,1.0,1.0,12.0
Haveri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,41.0,39.0,49.0,56.0,46.0,51.0,46.0,60.0,48.0,45.0,47.0,35.0,563.0
Haveri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,137.0,170.0,143.0,146.0,188.0,169.0,164.0,169.0,174.0,155.0,169.0,143.0,1927.0
Haveri,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,178.0,210.0,192.0,202.0,236.0,220.0,213.0,229.0,224.0,202.0,217.0,179.0,2502.0
Kodagu,1.1,Total number of pregnant women Registered for ANC,TOTAL,646.0,610.0,755.0,770.0,718.0,801.0,611.0,748.0,605.0,668.0,633.0,497.0,8062.0
Kodagu,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,568.0,528.0,631.0,668.0,613.0,676.0,534.0,614.0,506.0,556.0,535.0,396.0,6825.0
Kodagu,1.2,Number of Pregnant women registered under JSY,TOTAL,415.0,382.0,486.0,488.0,395.0,459.0,343.0,436.0,366.0,381.0,386.0,300.0,4837.0
Kodagu,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,776.0,811.0,981.0,757.0,783.0,789.0,743.0,705.0,704.0,629.0,635.0,653.0,8966.0
Kodagu,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,618.0,612.0,686.0,716.0,678.0,723.0,550.0,684.0,642.0,635.0,575.0,514.0,7633.0
Kodagu,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,553.0,622.0,663.0,724.0,673.0,679.0,688.0,669.0,740.0,575.0,642.0,599.0,7827.0
Kodagu,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,629.0,613.0,991.0,748.0,720.0,733.0,670.0,670.0,670.0,657.0,1212.0,659.0,8972.0
Kodagu,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,19.0,40.0,8.0,4.0,12.0,12.0,7.0,8.0,19.0,8.0,10.0,2.0,149.0
Kodagu,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,7.0
Kodagu,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,572.0,614.0,753.0,646.0,827.0,896.0,775.0,1071.0,1079.0,980.0,957.0,866.0,10036.0
Kodagu,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,17.0,16.0,19.0,16.0,16.0,6.0,7.0,22.0,27.0,7.0,28.0,30.0,211.0
Kodagu,1.8,Number of pregnancy test kits used at SC level,TOTAL,191.0,232.0,290.0,324.0,357.0,408.0,339.0,430.0,383.0,424.0,399.0,302.0,4079.0
Kodagu,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,1.0,3.0,0.0,1.0,0.0,2.0,0.0,3.0,2.0,1.0,2.0,15.0
Kodagu,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,1.0,0.0,0.0,1.0,3.0,2.0,1.0,3.0,3.0,5.0,0.0,19.0
Kodagu,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,2.0,3.0,0.0,2.0,3.0,4.0,1.0,6.0,5.0,6.0,2.0,34.0
Kodagu,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,2.0,3.0,0.0,1.0,3.0,4.0,1.0,5.0,4.0,5.0,1.0,29.0
Kodagu,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,1.0,0.0,0.0,4.0
Kodagu,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,525.0,478.0,512.0,480.0,455.0,450.0,453.0,506.0,490.0,504.0,541.0,554.0,5948.0
Kodagu,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,123.0,88.0,105.0,105.0,8.0,103.0,11.0,9.0,14.0,15.0,184.0,167.0,932.0
Kodagu,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,263.0,200.0,277.0,289.0,275.0,227.0,219.0,216.0,272.0,277.0,146.0,281.0,2942.0
Kodagu,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,6.0,18.0,1.0,15.0,1.0,1.0,7.0,5.0,3.0,1.0,1.0,4.0,63.0
Kodagu,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,76.0,84.0,76.0,74.0,93.0,75.0,75.0,109.0,80.0,78.0,92.0,89.0,1001.0
Kodagu,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,4.0
Kodagu,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,22.0,15.0,22.0,19.0,14.0,17.0,20.0,13.0,17.0,19.0,13.0,18.0,209.0
Kodagu,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,160.0,109.0,145.0,115.0,120.0,125.0,117.0,114.0,116.0,122.0,107.0,154.0,1504.0
Kodagu,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,182.0,124.0,167.0,134.0,134.0,142.0,137.0,127.0,133.0,141.0,122.0,174.0,1717.0
Kodagu,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,32.0,32.0,12.0,18.0,33.0,19.0,25.0,37.0,26.0,24.0,27.0,38.0,323.0
Kodagu,4.1.1.a,Number of male live births,TOTAL,312.0,269.0,292.0,281.0,259.0,246.0,271.0,294.0,301.0,347.0,320.0,318.0,3510.0
Kodagu,4.1.1.b,Number of female live births,TOTAL,287.0,294.0,294.0,255.0,284.0,276.0,260.0,320.0,263.0,265.0,318.0,323.0,3439.0
Kodagu,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,599.0,563.0,586.0,536.0,543.0,522.0,531.0,614.0,564.0,612.0,638.0,641.0,6949.0
Kodagu,4.1.2,Number of still births,TOTAL,7.0,12.0,6.0,3.0,8.0,7.0,8.0,5.0,14.0,9.0,7.0,7.0,93.0
Kodagu,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,24.0,35.0,38.0,51.0,54.0,36.0,33.0,32.0,24.0,26.0,43.0,34.0,430.0
Kodagu,4.2.1,Number of Newborns weighed at birth,TOTAL,600.0,562.0,585.0,534.0,545.0,476.0,533.0,616.0,569.0,541.0,639.0,641.0,6841.0
Kodagu,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,68.0,31.0,45.0,53.0,30.0,44.0,37.0,48.0,51.0,64.0,85.0,59.0,615.0
Kodagu,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,594.0,557.0,581.0,534.0,534.0,520.0,527.0,565.0,560.0,537.0,634.0,640.0,6783.0
Kodagu,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,2.0,2.0,1.0,0.0,1.0,2.0,0.0,0.0,1.0,0.0,10.0
Kodagu,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,10.0,8.0,15.0,3.0,5.0,10.0,15.0,10.0,20.0,28.0,22.0,5.0,151.0
Kodagu,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,26.0,11.0,28.0,18.0,12.0,22.0,17.0,10.0,20.0,15.0,19.0,0.0,198.0
Kodagu,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,36.0,20.0,45.0,23.0,18.0,32.0,33.0,22.0,40.0,43.0,42.0,5.0,359.0
Kodagu,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,6.0,1.0,11.0,7.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,27.0
Kodagu,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,75.0,63.0,68.0,54.0,64.0,75.0,66.0,75.0,74.0,80.0,77.0,90.0,861.0
Kodagu,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,5.0,0.0,0.0,2.0,0.0,3.0,1.0,1.0,0.0,2.0,3.0,1.0,18.0
Kodagu,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,71.0,47.0,82.0,70.0,44.0,64.0,65.0,48.0,75.0,61.0,77.0,120.0,824.0
Kodagu,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,0.0,0.0,3.0,3.0,0.0,2.0,0.0,1.0,0.0,2.0,24.0,28.0,63.0
Kodagu,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,364.0,467.0,453.0,468.0,428.0,375.0,388.0,502.0,456.0,407.0,551.0,458.0,5317.0
Kodagu,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,552.0,635.0,682.0,635.0,674.0,669.0,658.0,658.0,685.0,710.0,695.0,742.0,7995.0
Kodagu,6.3,PNC maternal complications attended,TOTAL,1.0,3.0,2.0,0.0,1.0,5.0,7.0,7.0,5.0,11.0,10.0,3.0,55.0
Kodagu,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,12.0,6.0,6.0,9.0,9.0,11.0,8.0,5.0,11.0,6.0,1.0,2.0,86.0
Kodagu,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kodagu,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,12.0,6.0,7.0,9.0,9.0,11.0,8.0,5.0,11.0,6.0,1.0,2.0,87.0
Kodagu,7.2,Number of MTPs conducted at Private Facilities,TOTAL,11.0,11.0,6.0,10.0,8.0,11.0,3.0,4.0,8.0,1.0,4.0,6.0,83.0
Kodagu,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,75.0,75.0,110.0,103.0,92.0,91.0,106.0,132.0,85.0,74.0,69.0,96.0,1108.0
Kodagu,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,264.0,297.0,387.0,383.0,330.0,358.0,304.0,365.0,330.0,281.0,250.0,281.0,3830.0
Kodagu,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,339.0,372.0,497.0,486.0,422.0,449.0,410.0,497.0,415.0,355.0,319.0,377.0,4938.0
Kodagu,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,2.0,7.0,0.0,0.0,9.0,0.0,0.0,2.0,0.0,20.0
Kodagu,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0
Kodagu,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,2.0,0.0,0.0,0.0,2.0,1.0,0.0,3.0,0.0,0.0,0.0,8.0
Kodagu,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,3.0,1.0,1.0,0.0,1.0,1.0,2.0,2.0,11.0
Kodagu,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,2.0,0.0,0.0,3.0,3.0,2.0,1.0,4.0,1.0,2.0,2.0,21.0
Kodagu,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,78.0,13.0,33.0,15.0,17.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,156.0
Kodagu,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,97.0,91.0,74.0,42.0,36.0,127.0,54.0,161.0,71.0,60.0,76.0,72.0,961.0
Kodagu,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,19.0,63.0,27.0,24.0,7.0,55.0,15.0,31.0,28.0,7.0,39.0,20.0,335.0
Kodagu,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,194.0,167.0,134.0,81.0,60.0,182.0,69.0,192.0,99.0,67.0,115.0,92.0,1452.0
Kodagu,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Kodagu,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,20.0,26.0,12.0,11.0,3.0,17.0,13.0,19.0,10.0,10.0,13.0,0.0,154.0
Kodagu,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,2.0,15.0,9.0,16.0,55.0
Kodagu,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,12.0,28.0,34.0,33.0,14.0,9.0,14.0,8.0,4.0,8.0,33.0,1.0,198.0
Kodagu,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,38.0,54.0,46.0,44.0,17.0,26.0,27.0,34.0,16.0,33.0,55.0,17.0,407.0
Kodagu,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,1.0,0.0,0.0,4.0,0.0,0.0,2.0,2.0,0.0,3.0,12.0
Kodagu,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,4.0,0.0,0.0,7.0
Kodagu,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,9.0,4.0,10.0,10.0,2.0,2.0,5.0,4.0,6.0,1.0,0.0,0.0,53.0
Kodagu,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,41.0,30.0,46.0,11.0,38.0,36.0,40.0,26.0,38.0,39.0,6.0,47.0,398.0
Kodagu,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,50.0,34.0,56.0,21.0,40.0,38.0,45.0,30.0,47.0,44.0,6.0,47.0,458.0
Kodagu,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,7.0,7.0,4.0,2.0,12.0,7.0,3.0,15.0,5.0,0.0,6.0,5.0,73.0
Kodagu,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,45.0,40.0,38.0,41.0,37.0,34.0,28.0,35.0,31.0,26.0,25.0,17.0,397.0
Kodagu,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,37.0,37.0,45.0,28.0,30.0,30.0,26.0,28.0,33.0,38.0,22.0,23.0,377.0
Kodagu,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,22.0,24.0,23.0,20.0,20.0,16.0,18.0,14.0,23.0,19.0,16.0,32.0,247.0
Kodagu,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,10.0,14.0,45.0,10.0,12.0,23.0,15.0,14.0,12.0,11.0,11.0,22.0,199.0
Kodagu,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kodagu,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,114.0,115.0,151.0,99.0,99.0,103.0,87.0,91.0,99.0,94.0,74.0,94.0,1220.0
Kodagu,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,34.0,322.0,52.0,25.0,24.0,26.0,10.0,14.0,11.0,14.0,26.0,10.0,568.0
Kodagu,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,9.0,11.0,11.0,7.0,11.0,11.0,12.0,16.0,9.0,13.0,4.0,6.0,120.0
Kodagu,9.06,Number of IUCD removals,TOTAL,54.0,58.0,46.0,51.0,44.0,303.0,78.0,41.0,52.0,39.0,55.0,37.0,858.0
Kodagu,9.07,Number of Oral Pills cycles distributed,TOTAL,1506.0,1582.0,1498.0,1527.0,1496.0,1658.0,1524.0,1480.0,1380.0,1343.0,1325.0,1328.0,17647.0
Kodagu,9.08,Number of Condom pieces distributed,TOTAL,22896.0,23607.0,25960.0,29323.0,29083.0,28505.0,27293.0,28638.0,28237.0,26689.0,29425.0,27401.0,327057.0
Kodagu,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,108.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,108.0
Kodagu,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,5.0,3.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10.0
Kodagu,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kodagu,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,9.12,Number of Institutions having NSV trained doctors,TOTAL,8.0,5.0,6.0,9.0,9.0,9.0,11.0,9.0,8.0,6.0,7.0,7.0,-1.0
Kodagu,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,717.0,612.0,633.0,602.0,547.0,556.0,548.0,626.0,612.0,523.0,698.0,670.0,7344.0
Kodagu,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,17.0,0.0,20.0,0.0,2.0,0.0,13.0,2.0,8.0,1.0,10.0,0.0,73.0
Kodagu,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,17.0,0.0,0.0,0.0,0.0,0.0,1.0,2.0,11.0,1.0,14.0,0.0,46.0
Kodagu,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,12.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,12.0,1.0,12.0,0.0,39.0
Kodagu,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,723.0,737.0,734.0,723.0,659.0,691.0,594.0,642.0,678.0,682.0,683.0,662.0,8208.0
Kodagu,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,673.0,682.0,756.0,750.0,677.0,712.0,569.0,596.0,683.0,595.0,664.0,721.0,8078.0
Kodagu,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,696.0,663.0,697.0,778.0,696.0,666.0,586.0,617.0,609.0,615.0,556.0,650.0,7829.0
Kodagu,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,546.0,487.0,536.0,481.0,460.0,480.0,478.0,582.0,521.0,432.0,599.0,520.0,6122.0
Kodagu,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,723.0,737.0,731.0,719.0,660.0,691.0,596.0,641.0,665.0,685.0,690.0,662.0,8200.0
Kodagu,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,673.0,682.0,758.0,751.0,677.0,712.0,574.0,603.0,672.0,596.0,678.0,720.0,8096.0
Kodagu,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,701.0,663.0,698.0,777.0,697.0,668.0,575.0,609.0,600.0,616.0,565.0,645.0,7814.0
Kodagu,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,503.0,424.0,492.0,437.0,433.0,452.0,444.0,516.0,478.0,403.0,534.0,499.0,5615.0
Kodagu,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,1.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,28.0,33.0
Kodagu,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,1.0,0.0,12.0,16.0
Kodagu,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,2.0,1.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,12.0,19.0
Kodagu,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,593.0,626.0,669.0,666.0,657.0,695.0,578.0,694.0,644.0,663.0,626.0,608.0,7719.0
Kodagu,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,497.0,612.0,696.0,662.0,679.0,652.0,581.0,664.0,626.0,582.0,543.0,548.0,7342.0
Kodagu,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,8.0,0.0,0.0,0.0,11.0
Kodagu,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,273.0,318.0,345.0,331.0,328.0,335.0,305.0,339.0,343.0,340.0,292.0,286.0,3835.0
Kodagu,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,274.0,301.0,281.0,276.0,299.0,340.0,279.0,343.0,296.0,283.0,301.0,306.0,3579.0
Kodagu,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,547.0,619.0,626.0,607.0,627.0,675.0,584.0,682.0,639.0,623.0,593.0,592.0,7414.0
Kodagu,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,515.0,620.0,709.0,671.0,689.0,655.0,591.0,651.0,631.0,586.0,557.0,546.0,7421.0
Kodagu,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,513.0,620.0,707.0,667.0,689.0,655.0,591.0,661.0,629.0,586.0,556.0,549.0,7423.0
Kodagu,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,17.0,0.0,2.0,1.0,0.0,2.0,0.0,4.0,10.0,0.0,12.0,11.0,59.0
Kodagu,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,111.0,84.0,96.0,110.0,114.0,74.0,89.0,83.0,87.0,74.0,74.0,81.0,1077.0
Kodagu,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,88.0,87.0,67.0,108.0,99.0,74.0,80.0,103.0,84.0,62.0,67.0,77.0,996.0
Kodagu,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,199.0,171.0,163.0,218.0,213.0,148.0,169.0,186.0,171.0,136.0,141.0,158.0,2073.0
Kodagu,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,0.0,3.0,93.0,1188.0,3313.0,2300.0,83.0,537.0,12.0,1.0,5.0,3.0,7538.0
Kodagu,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,1.0,6.0,115.0,1143.0,3558.0,2435.0,79.0,406.0,12.0,5.0,9.0,5.0,7774.0
Kodagu,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,14.0,16.0,269.0,1661.0,3852.0,2826.0,35.0,469.0,55.0,4.0,47.0,6.0,9254.0
Kodagu,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Kodagu,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Kodagu,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,346.0,354.0,350.0,356.0,343.0,357.0,351.0,349.0,352.0,352.0,349.0,347.0,4206.0
Kodagu,10.4.2,Number of Immunisation sessions held during the month,TOTAL,339.0,348.0,347.0,351.0,336.0,355.0,347.0,345.0,353.0,349.0,345.0,341.0,4156.0
Kodagu,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,238.0,247.0,248.0,255.0,250.0,254.0,247.0,242.0,256.0,254.0,244.0,248.0,2983.0
Kodagu,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,567.0,590.0,628.0,665.0,638.0,678.0,579.0,684.0,628.0,650.0,605.0,581.0,7493.0
Kodagu,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,2.0,0.0,3.0,3951.0,3285.0,0.0,5.0,0.0,0.0,0.0,1837.0,2618.0,11701.0
Kodagu,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,7.0,4015.0,3191.0,0.0,0.0,0.0,0.0,0.0,1753.0,2312.0,11278.0
Kodagu,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,1.0,2.0,7.0,0.0,1.0,3.0,2.0,2.0,11.0,2.0,2.0,8.0,41.0
Kodagu,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,71.0,149.0,132.0,95.0,127.0,129.0,123.0,203.0,165.0,163.0,233.0,150.0,1740.0
Kodagu,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,3.0
Kodagu,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,41.0,32.0,21.0,41.0,66.0,87.0,123.0,40.0,24.0,35.0,69.0,19.0,598.0
Kodagu,13.1,Number of Patients operated for cataract,TOTAL,49.0,24.0,28.0,0.0,15.0,51.0,29.0,33.0,25.0,15.0,6.0,0.0,275.0
Kodagu,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,46.0,14.0,26.0,0.0,2.0,45.0,29.0,0.0,7.0,3.0,6.0,0.0,178.0
Kodagu,13.3,Number of School children detected with Refractive errors,TOTAL,2.0,12.0,39.0,32.0,41.0,77.0,35.0,34.0,41.0,48.0,36.0,120.0,517.0
Kodagu,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,32.0,27.0,28.0,62.0,30.0,25.0,10.0,50.0,28.0,105.0,397.0
Kodagu,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,7.0,5.0,4.0,6.0,6.0,7.0,9.0,7.0,8.0,8.0,7.0,7.0,-1.0
Kodagu,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,7.0,9.0,8.0,9.0,10.0,10.0,9.0,10.0,10.0,8.0,10.0,9.0,-1.0
Kodagu,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,211.0,203.0,203.0,215.0,213.0,222.0,207.0,211.0,204.0,204.0,205.0,195.0,-1.0
Kodagu,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,8.0,7.0,9.0,9.0,8.0,9.0,8.0,8.0,8.0,11.0,10.0,-1.0
Kodagu,14.05,Number of RKS meetings held during the month,TOTAL,4.0,4.0,7.0,5.0,3.0,6.0,9.0,9.0,11.0,12.0,5.0,13.0,88.0
Kodagu,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,16.0,16.0,18.0,17.0,18.0,21.0,20.0,21.0,21.0,19.0,21.0,21.0,-1.0
Kodagu,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,170.0,171.0,163.0,113.0,118.0,98.0,147.0,149.0,147.0,145.0,161.0,187.0,1769.0
Kodagu,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,8.0,5.0,5.0,6.0,7.0,7.0,7.0,8.0,7.0,8.0,7.0,6.0,-1.0
Kodagu,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,1.0,2.0,1.0,1.0,1.0,1.0,2.0,2.0,1.0,1.0,2.0,-1.0
Kodagu,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,141.0,174.0,185.0,140.0,260.0,204.0,124.0,119.0,137.0,166.0,206.0,182.0,2038.0
Kodagu,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1092.0,1064.0,982.0,900.0,954.0,865.0,845.0,975.0,806.0,913.0,983.0,942.0,11321.0
Kodagu,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,172.0,195.0,172.0,170.0,265.0,216.0,141.0,138.0,136.0,154.0,176.0,217.0,2152.0
Kodagu,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1764.0,1791.0,1757.0,1600.0,1570.0,1565.0,1525.0,1679.0,1218.0,1445.0,1331.0,2130.0,19375.0
Kodagu,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,313.0,369.0,357.0,310.0,525.0,420.0,265.0,257.0,273.0,320.0,382.0,399.0,4190.0
Kodagu,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2856.0,2855.0,2739.0,2500.0,2524.0,2430.0,2370.0,2654.0,2024.0,2358.0,2314.0,3072.0,30696.0
Kodagu,14.10.2.a,Number of death cases of Inpatient males,TOTAL,33.0,26.0,25.0,29.0,23.0,36.0,15.0,26.0,18.0,33.0,32.0,25.0,321.0
Kodagu,14.10.2.b,Number of death cases of Inpatient females,TOTAL,12.0,19.0,10.0,14.0,16.0,20.0,14.0,13.0,14.0,16.0,19.0,11.0,178.0
Kodagu,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,45.0,45.0,35.0,43.0,39.0,56.0,29.0,39.0,32.0,49.0,51.0,36.0,499.0
Kodagu,14.11,In-Patient Head Count at midnight,TOTAL,4644.0,4721.0,4812.0,4600.0,4451.0,3511.0,4229.0,4153.0,3941.0,4646.0,4059.0,3693.0,51460.0
Kodagu,14.12.1,OPD attendance (All),TOTAL,63463.0,68155.0,77088.0,73972.0,73950.0,80839.0,64147.0,74609.0,69792.0,71929.0,78512.0,70277.0,866733.0
Kodagu,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,279.0,364.0,145.0,317.0,382.0,289.0,315.0,302.0,335.0,297.0,185.0,146.0,3356.0
Kodagu,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,134.0,100.0,23.0,62.0,85.0,115.0,65.0,20.0,17.0,34.0,115.0,169.0,939.0
Kodagu,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,487.0,433.0,638.0,528.0,565.0,756.0,532.0,729.0,672.0,602.0,737.0,739.0,7418.0
Kodagu,14.14.a,Number of patients given AYUSH treatment,TOTAL,818.0,1.0,435.0,587.0,350.0,405.0,220.0,186.0,399.0,335.0,659.0,734.0,5129.0
Kodagu,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,957.0,614.0,809.0,636.0,649.0,716.0,657.0,667.0,648.0,602.0,715.0,790.0,8460.0
Kodagu,14.14.c,Number of Adolescents counselled,TOTAL,341.0,575.0,675.0,584.0,888.0,835.0,558.0,648.0,563.0,685.0,675.0,684.0,7711.0
Kodagu,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3649.0,3692.0,3070.0,4560.0,4159.0,5019.0,4240.0,4809.0,3986.0,4135.0,4638.0,3742.0,49699.0
Kodagu,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,117.0,135.0,104.0,126.0,135.0,153.0,127.0,104.0,124.0,124.0,150.0,156.0,1555.0
Kodagu,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,662.0,749.0,970.0,819.0,880.0,977.0,682.0,929.0,819.0,800.0,888.0,785.0,9960.0
Kodagu,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,5.0,13.0,5.0,13.0,27.0,7.0,3.0,5.0,59.0,26.0,5.0,179.0
Kodagu,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,565.0,500.0,615.0,674.0,579.0,582.0,630.0,632.0,650.0,627.0,653.0,615.0,7322.0
Kodagu,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,2.0,8.0,8.0,8.0,5.0,4.0,5.0,6.0,31.0,22.0,8.0,110.0
Kodagu,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,606.0,735.0,880.0,799.0,865.0,854.0,722.0,934.0,706.0,698.0,827.0,635.0,9261.0
Kodagu,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,4.0,0.0,2.0,2.0,6.0,29.0,0.0,0.0,1.0,68.0,9.0,0.0,121.0
Kodagu,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,1833.0,1984.0,2465.0,2292.0,2324.0,2413.0,2034.0,2495.0,2175.0,2125.0,2368.0,2035.0,26543.0
Kodagu,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,18.0,7.0,23.0,15.0,27.0,61.0,11.0,8.0,12.0,158.0,57.0,13.0,410.0
Kodagu,15.2,Number of Widal tests conducted,Number tested,570.0,579.0,761.0,894.0,860.0,923.0,656.0,878.0,610.0,530.0,772.0,665.0,8698.0
Kodagu,15.3.a,Number of VDRL tests conducted on males,Number tested,91.0,50.0,55.0,36.0,90.0,141.0,48.0,89.0,49.0,100.0,51.0,71.0,871.0
Kodagu,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,43.0,119.0,124.0,110.0,65.0,123.0,67.0,95.0,66.0,76.0,94.0,157.0,1139.0
Kodagu,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,592.0,642.0,739.0,693.0,805.0,756.0,662.0,755.0,628.0,616.0,657.0,547.0,8092.0
Kodagu,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,726.0,811.0,918.0,839.0,960.0,1020.0,777.0,939.0,743.0,792.0,802.0,775.0,10102.0
Kodagu,15.4.1,Number of blood smears examined for Malaria,TOTAL,6671.0,7178.0,8874.0,8465.0,7784.0,9079.0,7145.0,8501.0,8010.0,7825.0,8205.0,8029.0,95766.0
Kodagu,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,4.0,6.0,21.0,2.0,3.0,10.0,8.0,3.0,1.0,10.0,1.0,75.0
Kodagu,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,31.0,0.0,33.0
Kodagu,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,3630.0,3670.0,2990.0,2080.0,2470.0,890.0,4300.0,,,,6100.0,5040.0,31170.0
Kodagu,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,1000.0,2000.0,8000.0,2000.0,6000.0,2000.0,,,,0.0,0.0,23000.0
Kodagu,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1960.0,1680.0,2910.0,7610.0,3580.0,2590.0,1000.0,,,,1060.0,960.0,23350.0
Kodagu,16.1.1,Stock position of DPT vaccines,5. Total Stock,3670.0,2990.0,2080.0,2470.0,890.0,4300.0,5300.0,0.0,0.0,0.0,5040.0,4080.0,30820.0
Kodagu,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3460.0,2310.0,1920.0,4100.0,3310.0,2030.0,840.0,,,,3110.0,2470.0,23550.0
Kodagu,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,2000.0,2000.0,4000.0,2000.0,1000.0,2000.0,3000.0,,,,2000.0,2000.0,20000.0
Kodagu,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3150.0,2390.0,1820.0,2790.0,2280.0,3190.0,1610.0,,,,2640.0,2130.0,22000.0
Kodagu,16.1.1A,Stock Position of Pentavalent,5. Total Stock,2310.0,1920.0,4100.0,3310.0,2030.0,840.0,2230.0,0.0,0.0,0.0,2470.0,2340.0,21550.0
Kodagu,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,7000.0,2900.0,1380.0,1720.0,3740.0,5980.0,4400.0,,,,4800.0,4480.0,36400.0
Kodagu,16.1.2,Stock position of OPV vaccines,2. Stocks Received,2000.0,4000.0,6000.0,8000.0,7000.0,4000.0,3000.0,,,,71640.0,3000.0,108640.0
Kodagu,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,6100.0,5520.0,5660.0,5980.0,4760.0,5580.0,4460.0,,,,71960.0,3260.0,113280.0
Kodagu,16.1.2,Stock position of OPV vaccines,5. Total Stock,2900.0,1380.0,1720.0,3740.0,5980.0,4400.0,2940.0,0.0,0.0,0.0,4480.0,4220.0,31760.0
Kodagu,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,5540.0,4550.0,3530.0,480.0,900.0,3860.0,4900.0,,,,5910.0,4070.0,33740.0
Kodagu,16.1.3,Stock position of TT vaccines,2. Stocks Received,1000.0,1000.0,2000.0,10000.0,10000.0,6000.0,3000.0,,,,0.0,0.0,33000.0
Kodagu,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1990.0,2020.0,5050.0,9580.0,7040.0,4960.0,1830.0,,,,1840.0,1970.0,36280.0
Kodagu,16.1.3,Stock position of TT vaccines,5. Total Stock,4550.0,3530.0,480.0,900.0,3860.0,4900.0,6070.0,0.0,0.0,0.0,4070.0,2100.0,30460.0
Kodagu,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,1510.0,1660.0,2380.0,1900.0,1240.0,1280.0,650.0,,,,1740.0,2110.0,14470.0
Kodagu,16.1.5,Stock position of BCG vaccines,2. Stocks Received,2000.0,2000.0,1000.0,2000.0,2000.0,1000.0,2000.0,,,,2000.0,1500.0,15500.0
Kodagu,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,940.0,,,,0.0,0.0,940.0
Kodagu,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,1850.0,1280.0,1480.0,2660.0,1960.0,1630.0,,,,,1630.0,1720.0,14210.0
Kodagu,16.1.5,Stock position of BCG vaccines,5. Total Stock,1660.0,2380.0,1900.0,1240.0,1280.0,650.0,1710.0,0.0,0.0,0.0,2110.0,1890.0,14820.0
Kodagu,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1530.0,2000.0,2490.0,1440.0,1590.0,1720.0,1125.0,,,,2815.0,2955.0,17665.0
Kodagu,16.1.6,Stock position of Measles vaccines,2. Stocks Received,2000.0,2000.0,1000.0,2000.0,2000.0,1000.0,3000.0,,,,2000.0,1500.0,16500.0
Kodagu,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,1300.0,,,,0.0,0.0,1300.0
Kodagu,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1530.0,1510.0,2050.0,1850.0,1870.0,1595.0,,,,,1860.0,1520.0,13785.0
Kodagu,16.1.6,Stock position of Measles vaccines,5. Total Stock,2000.0,2490.0,1440.0,1590.0,1720.0,1125.0,2825.0,0.0,0.0,0.0,2955.0,2935.0,19080.0
Kodagu,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2220.0,1540.0,2050.0,1650.0,810.0,930.0,290.0,,,,370.0,710.0,10570.0
Kodagu,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,1000.0,0.0,0.0,500.0,0.0,1000.0,,,,1000.0,500.0,4000.0
Kodagu,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,680.0,490.0,400.0,840.0,380.0,640.0,150.0,,,,660.0,360.0,4600.0
Kodagu,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1540.0,2050.0,1650.0,810.0,930.0,290.0,1140.0,0.0,0.0,0.0,710.0,850.0,9970.0
Kodagu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,9350.0,9150.0,8850.0,8700.0,8650.0,7250.0,7150.0,,,,2700.0,2700.0,64500.0
Kodagu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,200.0,300.0,150.0,50.0,1400.0,100.0,800.0,,,,0.0,100.0,3100.0
Kodagu,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,9150.0,8850.0,8700.0,8650.0,7250.0,7150.0,6350.0,0.0,0.0,0.0,2700.0,2600.0,61400.0
Kodagu,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,24500.0,19500.0,8500.0,2000.0,30240.0,18060.0,16380.0,,,,66320.0,50320.0,235820.0
Kodagu,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,50400.0,0.0,0.0,0.0,,,,0.0,0.0,50400.0
Kodagu,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,5000.0,11000.0,6500.0,22160.0,12180.0,1680.0,0.0,,,,16000.0,21000.0,95520.0
Kodagu,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,19500.0,8500.0,2000.0,30240.0,18060.0,16380.0,16380.0,0.0,0.0,0.0,50320.0,29320.0,190700.0
Kodagu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,27480.0,26980.0,23680.0,21880.0,19280.0,16280.0,15880.0,,,,10480.0,9980.0,171920.0
Kodagu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,500.0,3300.0,1800.0,2600.0,3000.0,400.0,1500.0,,,,500.0,700.0,14300.0
Kodagu,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,26980.0,23680.0,21880.0,19280.0,16280.0,15880.0,14380.0,0.0,0.0,0.0,9980.0,9280.0,157620.0
Kodagu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,845.0,142.0,42.0,40.0,40.0,,,,0.0,0.0,1109.0
Kodagu,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,703.0,100.0,2.0,0.0,25.0,,,,0.0,0.0,830.0
Kodagu,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,142.0,42.0,40.0,40.0,15.0,0.0,0.0,0.0,0.0,0.0,279.0
Kodagu,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kodagu,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,4450.0,5250.0,4250.0,2400.0,4850.0,4450.0,3900.0,,,,500.0,800.0,30850.0
Kodagu,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,0.0,5300.0,0.0,0.0,600.0,,,,1000.0,600.0,10500.0
Kodagu,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2200.0,1000.0,1850.0,2850.0,400.0,550.0,200.0,,,,700.0,1400.0,11150.0
Kodagu,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,5250.0,4250.0,2400.0,4850.0,4450.0,3900.0,4300.0,0.0,0.0,0.0,800.0,0.0,30200.0
Kodagu,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,8200.0,6000.0,2400.0,0.0,19600.0,8800.0,1400.0,,,,5000.0,1000.0,52400.0
Kodagu,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,31800.0,0.0,5000.0,4000.0,,,,2000.0,5000.0,47800.0
Kodagu,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,2200.0,3600.0,2400.0,12200.0,10800.0,12400.0,1600.0,,,,6000.0,4400.0,55600.0
Kodagu,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,6000.0,2400.0,0.0,19600.0,8800.0,1400.0,3800.0,0.0,0.0,0.0,1000.0,1600.0,44600.0
Kodagu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,3350.0,4850.0,3850.0,2800.0,4900.0,4450.0,2800.0,,,,2800.0,2800.0,32600.0
Kodagu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,0.0,0.0,3400.0,0.0,0.0,0.0,,,,0.0,0.0,5400.0
Kodagu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0
Kodagu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,500.0,1000.0,1050.0,1300.0,450.0,1650.0,0.0,,,,0.0,0.0,5950.0
Kodagu,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4850.0,3850.0,2800.0,4900.0,4450.0,2800.0,2800.0,0.0,0.0,0.0,2800.0,2800.0,32050.0
Kodagu,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,,,,,,2.0,,,,,,3.0
Kodagu,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,,,1.0,,2.0,1.0,1.0,,,1.0,1.0,9.0
Kodagu,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,1.0,,1.0,,3.0
Kodagu,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,,,1.0,,3.0,1.0,1.0,1.0,,2.0,1.0,12.0
Kodagu,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,1.0,2.0,,2.0,1.0,,,1.0,,,,,7.0
Kodagu,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Kodagu,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,1.0,2.0,,2.0,1.0,1.0,,1.0,,,,,8.0
Kodagu,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,1.0,3.0,2.0,,3.0,2.0,,,1.0,1.0,,14.0
Kodagu,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,2.0,1.0,,1.0,1.0,,,,,1.0,6.0
Kodagu,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,5.0,3.0,,4.0,3.0,,,1.0,1.0,1.0,20.0
Kodagu,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,1.0,1.0,,1.0,1.0,,,,,,1.0,5.0
Kodagu,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,,1.0,,,,1.0,3.0
Kodagu,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,1.0,1.0,1.0,1.0,1.0,,1.0,,,,2.0,8.0
Kodagu,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,3.0,1.0,,1.0,,1.0,1.0,,7.0
Kodagu,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodagu,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,3.0,1.0,,1.0,,1.0,1.0,,7.0
Kodagu,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodagu,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodagu,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kodagu,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodagu,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,2.0,,,,,,2.0
Kodagu,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,2.0,,,,,,2.0
Kodagu,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kodagu,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kodagu,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Kodagu,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,,,1.0,4.0,,2.0,1.0,1.0,2.0,11.0
Kodagu,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,1.0,,,,,,,1.0,,,3.0
Kodagu,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,,1.0,,,1.0,4.0,,2.0,2.0,1.0,2.0,14.0
Kodagu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,1.0,1.0,1.0,,,,,3.0
Kodagu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Kodagu,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,1.0,1.0,1.0,,,,,3.0
Kodagu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,1.0,,3.0,,,1.0,,,2.0,,9.0
Kodagu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,,,,,,,1.0,,,1.0,,3.0
Kodagu,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,1.0,1.0,,3.0,,,2.0,,,3.0,,12.0
Kodagu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Kodagu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,3.0,,5.0,4.0,,3.0,4.0,4.0,1.0,1.0,4.0,32.0
Kodagu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,4.0,7.0,10.0,8.0,21.0,12.0,10.0,12.0,14.0,8.0,8.0,11.0,125.0
Kodagu,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,7.0,10.0,10.0,13.0,26.0,12.0,13.0,16.0,18.0,9.0,9.0,15.0,158.0
Kodagu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kodagu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kodagu,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kodagu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Kodagu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,,,,,,
Kodagu,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,1.0,,1.0,,,,,,,,2.0
Kodagu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,1.0,2.0,,1.0,2.0,1.0,,2.0,1.0,1.0,,1.0,12.0
Kodagu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,1.0,,,,,,,,1.0
Kodagu,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,1.0,2.0,,1.0,3.0,1.0,,2.0,1.0,1.0,,1.0,13.0
Kodagu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,2.0,,,,,1.0,,,,1.0,,,4.0
Kodagu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,18.0,21.0,17.0,23.0,26.0,20.0,17.0,26.0,25.0,25.0,19.0,21.0,258.0
Kodagu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,53.0,49.0,43.0,40.0,62.0,43.0,32.0,45.0,43.0,49.0,41.0,43.0,543.0
Kodagu,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,73.0,70.0,60.0,63.0,88.0,64.0,49.0,71.0,68.0,75.0,60.0,64.0,805.0
Kodagu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,2.0,1.0,1.0,,,,,,1.0,,5.0
Kodagu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,7.0,9.0,6.0,4.0,6.0,3.0,2.0,2.0,2.0,4.0,6.0,3.0,54.0
Kodagu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,16.0,18.0,9.0,17.0,34.0,28.0,26.0,23.0,29.0,35.0,21.0,23.0,279.0
Kodagu,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,23.0,27.0,17.0,22.0,41.0,31.0,28.0,25.0,31.0,39.0,28.0,26.0,338.0
Kodagu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kodagu,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kodagu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kodagu,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kodagu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,,,,,,1.0,,2.0
Kodagu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kodagu,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,,,,,,1.0,,2.0
Kodagu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,2.0,,,2.0
Kodagu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kodagu,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,2.0,,,2.0
Kodagu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kodagu,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kodagu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,1.0,,,,,,1.0,,,,1.0,3.0
Kodagu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kodagu,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,1.0,,,,,,1.0,,,,1.0,3.0
Kodagu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,1.0,,,,3.0,,1.0,,,6.0
Kodagu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,13.0,7.0,3.0,5.0,3.0,6.0,6.0,9.0,4.0,5.0,4.0,,65.0
Kodagu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,1.0,,,3.0,3.0,1.0,2.0,2.0,,4.0,1.0,19.0
Kodagu,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,15.0,9.0,3.0,6.0,6.0,9.0,7.0,14.0,6.0,6.0,8.0,1.0,90.0
Kodagu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2.0,,,,1.0,1.0,,,1.0,1.0,,,6.0
Kodagu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,8.0,13.0,11.0,11.0,12.0,6.0,5.0,13.0,6.0,13.0,10.0,13.0,121.0
Kodagu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,3.0,1.0,5.0,6.0,5.0,4.0,4.0,2.0,1.0,2.0,5.0,40.0
Kodagu,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,12.0,16.0,12.0,16.0,19.0,12.0,9.0,17.0,9.0,15.0,12.0,18.0,167.0
Kodagu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,1.0,,,1.0,,,,,,,2.0
Kodagu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,2.0,,,1.0,,2.0,5.0,,,,,11.0
Kodagu,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,2.0,1.0,,1.0,1.0,2.0,5.0,,,,,13.0
Kodagu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kodagu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,2.0,8.0,2.0,3.0,6.0,10.0,6.0,5.0,3.0,7.0,8.0,10.0,70.0
Kodagu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,6.0,7.0,11.0,15.0,15.0,14.0,16.0,12.0,8.0,15.0,16.0,12.0,147.0
Kodagu,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,8.0,15.0,13.0,18.0,21.0,24.0,22.0,17.0,11.0,22.0,24.0,22.0,217.0
Kodagu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Kodagu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,2.0,8.0,10.0,11.0,13.0,8.0,9.0,6.0,9.0,4.0,1.0,90.0
Kodagu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,22.0,19.0,14.0,24.0,30.0,30.0,15.0,17.0,20.0,17.0,28.0,23.0,259.0
Kodagu,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,31.0,21.0,22.0,34.0,41.0,43.0,23.0,26.0,26.0,26.0,33.0,24.0,350.0
Kodagu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,,,1.0,,,1.0,1.0,1.0,,4.0
Kodagu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,17.0,9.0,7.0,13.0,9.0,11.0,6.0,10.0,8.0,16.0,18.0,8.0,132.0
Kodagu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,25.0,31.0,23.0,29.0,35.0,38.0,23.0,34.0,33.0,41.0,18.0,23.0,353.0
Kodagu,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,42.0,40.0,30.0,42.0,44.0,50.0,29.0,44.0,42.0,58.0,37.0,31.0,489.0
Kolar,1.1,Total number of pregnant women Registered for ANC,TOTAL,2173.0,1986.0,2359.0,2195.0,2077.0,2229.0,1846.0,2182.0,2071.0,2093.0,2026.0,1941.0,25178.0
Kolar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1805.0,1636.0,1984.0,1787.0,1733.0,1848.0,1565.0,1789.0,1675.0,1745.0,1688.0,1597.0,20852.0
Kolar,1.2,Number of Pregnant women registered under JSY,TOTAL,1937.0,1776.0,2164.0,1943.0,1877.0,2021.0,1687.0,1963.0,1846.0,1869.0,1856.0,1763.0,22702.0
Kolar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2784.0,2784.0,2610.0,2316.0,2088.0,2088.0,1973.0,2321.0,2163.0,2075.0,2079.0,1883.0,27164.0
Kolar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2444.0,2122.0,2445.0,2468.0,2456.0,2367.0,1952.0,2359.0,2188.0,2008.0,2051.0,1962.0,26822.0
Kolar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2358.0,2379.0,2548.0,2294.0,2365.0,2196.0,2171.0,2291.0,2280.0,1974.0,2050.0,2058.0,26964.0
Kolar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3058.0,1423.0,1189.0,1433.0,1208.0,1239.0,1035.0,566.0,1276.0,1410.0,554.0,1249.0,15640.0
Kolar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,120.0,27.0,29.0,53.0,42.0,27.0,55.0,32.0,59.0,29.0,56.0,20.0,549.0
Kolar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,3.0,39.0,25.0,15.0,1.0,20.0,25.0,12.0,10.0,28.0,12.0,190.0
Kolar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1404.0,1159.0,1612.0,1286.0,1432.0,1389.0,1277.0,1765.0,1239.0,2049.0,1263.0,2396.0,18271.0
Kolar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,51.0,33.0,92.0,24.0,50.0,57.0,40.0,40.0,44.0,34.0,38.0,110.0,613.0
Kolar,1.8,Number of pregnancy test kits used at SC level,TOTAL,488.0,410.0,543.0,459.0,491.0,451.0,337.0,433.0,383.0,426.0,472.0,442.0,5335.0
Kolar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,9.0,3.0,6.0,6.0,7.0,10.0,4.0,2.0,7.0,5.0,5.0,5.0,69.0
Kolar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,9.0,6.0,9.0,10.0,4.0,2.0,0.0,5.0,9.0,4.0,5.0,3.0,66.0
Kolar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,18.0,9.0,15.0,16.0,11.0,12.0,4.0,7.0,16.0,9.0,10.0,8.0,135.0
Kolar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,17.0,7.0,9.0,16.0,11.0,16.0,3.0,5.0,15.0,11.0,8.0,8.0,126.0
Kolar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Kolar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1288.0,1222.0,1175.0,1289.0,1237.0,1327.0,1292.0,1331.0,1202.0,1226.0,1149.0,1276.0,15014.0
Kolar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,270.0,274.0,80.0,88.0,19.0,139.0,144.0,175.0,221.0,225.0,8.0,12.0,1655.0
Kolar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,401.0,652.0,1111.0,1024.0,932.0,909.0,722.0,1057.0,942.0,721.0,757.0,1260.0,10488.0
Kolar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,1.0,1.0,26.0,41.0,42.0,31.0,100.0,0.0,242.0
Kolar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0
Kolar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,501.0,684.0,578.0,582.0,485.0,650.0,635.0,709.0,589.0,634.0,645.0,533.0,7225.0
Kolar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,226.0,182.0,185.0,224.0,202.0,214.0,178.0,186.0,157.0,147.0,156.0,183.0,2240.0
Kolar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,226.0,182.0,185.0,224.0,202.0,214.0,178.0,186.0,157.0,147.0,156.0,183.0,2240.0
Kolar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,237.0,302.0,283.0,277.0,433.0,374.0,417.0,381.0,302.0,207.0,388.0,218.0,3819.0
Kolar,4.1.1.a,Number of male live births,TOTAL,910.0,1032.0,929.0,952.0,969.0,995.0,988.0,984.0,882.0,988.0,952.0,903.0,11484.0
Kolar,4.1.1.b,Number of female live births,TOTAL,918.0,886.0,870.0,939.0,891.0,993.0,933.0,1036.0,921.0,955.0,936.0,902.0,11180.0
Kolar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1828.0,1918.0,1799.0,1891.0,1860.0,1988.0,1921.0,2020.0,1803.0,1943.0,1888.0,1805.0,22664.0
Kolar,4.1.2,Number of still births,TOTAL,14.0,17.0,21.0,16.0,15.0,26.0,22.0,20.0,13.0,20.0,22.0,22.0,228.0
Kolar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,27.0,30.0,56.0,39.0,29.0,51.0,50.0,42.0,41.0,29.0,36.0,49.0,479.0
Kolar,4.2.1,Number of Newborns weighed at birth,TOTAL,1811.0,1892.0,1784.0,1886.0,1854.0,1960.0,1896.0,1953.0,1796.0,1934.0,1878.0,1812.0,22456.0
Kolar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,191.0,258.0,128.0,190.0,149.0,226.0,134.0,214.0,229.0,225.0,137.0,173.0,2254.0
Kolar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1793.0,1724.0,1768.0,1823.0,1829.0,1934.0,1878.0,1914.0,1766.0,1910.0,1848.0,1760.0,21947.0
Kolar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,3.0,6.0,1.0,4.0,6.0,1.0,0.0,1.0,15.0,1.0,0.0,38.0
Kolar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,163.0,98.0,101.0,131.0,114.0,97.0,90.0,92.0,90.0,95.0,102.0,92.0,1265.0
Kolar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,163.0,101.0,107.0,132.0,118.0,103.0,91.0,92.0,91.0,110.0,103.0,92.0,1303.0
Kolar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,225.0,43.0,166.0,9.0,2.0,7.0,118.0,5.0,24.0,106.0,0.0,54.0,759.0
Kolar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,167.0,119.0,265.0,124.0,170.0,345.0,419.0,132.0,349.0,230.0,369.0,213.0,2902.0
Kolar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,2.0,5.0,45.0,6.0,3.0,11.0,5.0,5.0,23.0,34.0,92.0,10.0,241.0
Kolar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,521.0,205.0,485.0,246.0,244.0,276.0,430.0,239.0,335.0,262.0,317.0,279.0,3839.0
Kolar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,16.0,21.0,70.0,42.0,223.0,91.0,57.0,38.0,89.0,42.0,108.0,60.0,857.0
Kolar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1271.0,1249.0,1430.0,1630.0,1816.0,1888.0,1832.0,1940.0,1571.0,1596.0,1819.0,1620.0,19662.0
Kolar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1407.0,1263.0,1645.0,1574.0,1632.0,1635.0,1550.0,1683.0,1718.0,1763.0,1738.0,1662.0,19270.0
Kolar,6.3,PNC maternal complications attended,TOTAL,2.0,3.0,1.0,7.0,4.0,8.0,5.0,2.0,2.0,5.0,11.0,8.0,58.0
Kolar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,16.0,13.0,14.0,16.0,10.0,12.0,12.0,13.0,9.0,19.0,9.0,8.0,151.0
Kolar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,3.0,2.0,5.0,2.0,3.0,4.0,6.0,11.0,6.0,4.0,4.0,5.0,55.0
Kolar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,19.0,15.0,19.0,18.0,13.0,16.0,18.0,24.0,15.0,23.0,13.0,13.0,206.0
Kolar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,26.0,54.0,31.0,52.0,29.0,28.0,35.0,41.0,21.0,19.0,22.0,39.0,397.0
Kolar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,559.0,336.0,388.0,289.0,325.0,370.0,316.0,246.0,242.0,331.0,279.0,319.0,4000.0
Kolar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,642.0,715.0,734.0,640.0,729.0,697.0,638.0,556.0,504.0,638.0,542.0,646.0,7681.0
Kolar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1201.0,1051.0,1122.0,929.0,1054.0,1067.0,954.0,802.0,746.0,969.0,821.0,965.0,11681.0
Kolar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,3.0,0.0,17.0,9.0,0.0,20.0,60.0,0.0,46.0,14.0,12.0,15.0,196.0
Kolar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,0.0,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Kolar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,2.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Kolar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,3.0,0.0,1.0,2.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Kolar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,158.0,278.0,177.0,156.0,139.0,135.0,106.0,237.0,182.0,129.0,43.0,0.0,1740.0
Kolar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,35.0,42.0,44.0,38.0,43.0,33.0,0.0,74.0,40.0,30.0,15.0,10.0,404.0
Kolar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,188.0,191.0,311.0,175.0,141.0,200.0,201.0,190.0,243.0,132.0,233.0,423.0,2628.0
Kolar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,381.0,511.0,532.0,369.0,323.0,368.0,307.0,501.0,465.0,291.0,291.0,433.0,4772.0
Kolar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,46.0,82.0,51.0,27.0,45.0,22.0,55.0,76.0,67.0,55.0,70.0,83.0,679.0
Kolar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,89.0,50.0,60.0,91.0,83.0,43.0,12.0,22.0,34.0,51.0,41.0,17.0,593.0
Kolar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,89.0,50.0,60.0,91.0,83.0,43.0,12.0,22.0,34.0,51.0,41.0,17.0,593.0
Kolar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,38.0,20.0,22.0,21.0,22.0,45.0,19.0,30.0,32.0,57.0,5.0,16.0,327.0
Kolar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,99.0,100.0,61.0,91.0,70.0,81.0,117.0,142.0,79.0,48.0,36.0,60.0,984.0
Kolar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,99.0,100.0,61.0,91.0,70.0,81.0,117.0,142.0,79.0,48.0,36.0,60.0,984.0
Kolar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,21.0,41.0,28.0,31.0,31.0,79.0,37.0,53.0,25.0,34.0,30.0,44.0,454.0
Kolar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,77.0,96.0,74.0,100.0,95.0,58.0,47.0,55.0,67.0,43.0,41.0,56.0,809.0
Kolar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,313.0,314.0,393.0,388.0,369.0,470.0,395.0,411.0,365.0,344.0,345.0,365.0,4472.0
Kolar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,36.0,24.0,30.0,43.0,26.0,37.0,43.0,29.0,15.0,31.0,30.0,21.0,365.0
Kolar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,184.0,147.0,212.0,183.0,197.0,188.0,164.0,133.0,174.0,130.0,127.0,122.0,1961.0
Kolar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Kolar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,610.0,581.0,709.0,714.0,687.0,753.0,649.0,628.0,621.0,548.0,543.0,564.0,7607.0
Kolar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,275.0,275.0,430.0,388.0,344.0,427.0,386.0,375.0,300.0,289.0,289.0,298.0,4076.0
Kolar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,29.0,35.0,16.0,30.0,27.0,24.0,20.0,35.0,31.0,25.0,26.0,18.0,316.0
Kolar,9.06,Number of IUCD removals,TOTAL,108.0,114.0,101.0,113.0,126.0,123.0,142.0,155.0,130.0,125.0,112.0,121.0,1470.0
Kolar,9.07,Number of Oral Pills cycles distributed,TOTAL,3435.0,3109.0,2711.0,2928.0,1828.0,3634.0,3604.0,3778.0,4135.0,3867.0,3794.0,3928.0,40751.0
Kolar,9.08,Number of Condom pieces distributed,TOTAL,26664.0,23339.0,26070.0,18438.0,23714.0,26925.0,24596.0,27664.0,27557.0,27544.0,29308.0,29928.0,311747.0
Kolar,9.09,Number of Centchroman (weekly) pills given,TOTAL,10.0,19.0,13.0,321.0,3.0,27.0,0.0,0.0,0.0,0.0,0.0,0.0,393.0
Kolar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,35.0,30.0,21.0,20.0,16.0,39.0,8.0,20.0,3.0,16.0,14.0,26.0,248.0
Kolar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,3.0,8.0
Kolar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,9.12,Number of Institutions having NSV trained doctors,TOTAL,4.0,6.0,7.0,4.0,3.0,3.0,2.0,3.0,3.0,5.0,5.0,3.0,-1.0
Kolar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1674.0,1683.0,1768.0,1847.0,1797.0,1860.0,1911.0,2145.0,1767.0,1935.0,1861.0,1836.0,22084.0
Kolar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,2.0,3.0,14.0,2.0,0.0,60.0,48.0,11.0,0.0,0.0,0.0,0.0,140.0
Kolar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,2.0,8.0,2.0,1.0,0.0,51.0,45.0,5.0,0.0,0.0,0.0,0.0,114.0
Kolar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,10.0,3.0,0.0,0.0,58.0,39.0,13.0,0.0,1.0,0.0,0.0,124.0
Kolar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2434.0,2368.0,2465.0,2364.0,2338.0,2423.0,2082.0,2567.0,2796.0,2392.0,2248.0,2466.0,28943.0
Kolar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2416.0,2217.0,2316.0,2460.0,2273.0,2370.0,2012.0,2337.0,2468.0,2290.0,2158.0,2363.0,27680.0
Kolar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2371.0,2195.0,2214.0,2377.0,2302.0,2201.0,2090.0,2399.0,2277.0,2285.0,2133.0,2393.0,27237.0
Kolar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1741.0,1619.0,1672.0,1783.0,1691.0,1787.0,1471.0,1693.0,1656.0,1850.0,1709.0,1723.0,20395.0
Kolar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2437.0,2367.0,2464.0,2494.0,2322.0,2446.0,2107.0,2568.0,2773.0,2361.0,2242.0,2465.0,29046.0
Kolar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2423.0,2222.0,2322.0,2500.0,2099.0,2414.0,2144.0,2309.0,2460.0,2249.0,2149.0,2340.0,27631.0
Kolar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2365.0,2196.0,2213.0,2253.0,2187.0,2228.0,2100.0,2369.0,2273.0,2257.0,2142.0,2371.0,26954.0
Kolar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1273.0,1119.0,1221.0,1370.0,1412.0,1469.0,1313.0,1379.0,1297.0,1315.0,1218.0,1190.0,15576.0
Kolar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,3.0,16.0,23.0,6.0,201.0,199.0,23.0,42.0,12.0,26.0,25.0,0.0,576.0
Kolar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1.0,12.0,17.0,4.0,0.0,33.0,27.0,29.0,20.0,16.0,16.0,1.0,176.0
Kolar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,5.0,18.0,28.0,9.0,0.0,48.0,28.0,37.0,14.0,27.0,21.0,2.0,237.0
Kolar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2140.0,2058.0,2271.0,2193.0,2101.0,2135.0,1857.0,2234.0,2193.0,1989.0,2065.0,2174.0,25410.0
Kolar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1878.0,1682.0,2081.0,1945.0,1693.0,1935.0,1703.0,1818.0,1763.0,1591.0,1754.0,1819.0,21662.0
Kolar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1808.0,1420.0,1753.0,1944.0,1750.0,1815.0,1734.0,1884.0,1818.0,1650.0,1805.0,1844.0,21225.0
Kolar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,814.0,878.0,1052.0,878.0,852.0,914.0,838.0,962.0,914.0,858.0,903.0,850.0,10713.0
Kolar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,748.0,776.0,900.0,836.0,758.0,762.0,804.0,836.0,911.0,792.0,840.0,813.0,9776.0
Kolar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1562.0,1654.0,1952.0,1714.0,1610.0,1676.0,1642.0,1798.0,1825.0,1650.0,1743.0,1663.0,20489.0
Kolar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1937.0,1798.0,2250.0,2086.0,1844.0,1982.0,1582.0,1916.0,1858.0,1732.0,1854.0,1904.0,22743.0
Kolar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1937.0,1798.0,2250.0,2083.0,1816.0,1982.0,1583.0,1908.0,1858.0,1732.0,1853.0,1906.0,22706.0
Kolar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,29.0,50.0,41.0,13.0,14.0,18.0,45.0,33.0,33.0,73.0,0.0,7.0,356.0
Kolar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,211.0,170.0,257.0,194.0,201.0,216.0,158.0,192.0,181.0,163.0,182.0,229.0,2354.0
Kolar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,182.0,151.0,242.0,197.0,140.0,178.0,113.0,156.0,169.0,149.0,151.0,215.0,2043.0
Kolar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,393.0,321.0,499.0,391.0,341.0,394.0,271.0,348.0,350.0,312.0,333.0,444.0,4397.0
Kolar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,340.0,287.0,603.0,921.0,969.0,807.0,233.0,1455.0,1717.0,1442.0,804.0,354.0,9932.0
Kolar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,224.0,147.0,411.0,699.0,835.0,824.0,108.0,1512.0,1653.0,1094.0,725.0,392.0,8624.0
Kolar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,82.0,81.0,291.0,819.0,988.0,1049.0,58.0,1527.0,956.0,1159.0,1044.0,153.0,8207.0
Kolar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,2.0
Kolar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,932.0,878.0,908.0,929.0,946.0,962.0,954.0,948.0,943.0,934.0,927.0,945.0,11206.0
Kolar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,888.0,810.0,848.0,845.0,865.0,881.0,829.0,878.0,860.0,850.0,853.0,865.0,10272.0
Kolar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,635.0,610.0,624.0,614.0,602.0,644.0,593.0,604.0,630.0,608.0,629.0,579.0,7372.0
Kolar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1645.0,1315.0,1924.0,1684.0,1646.0,1809.0,1563.0,1673.0,1586.0,1463.0,1496.0,1526.0,19330.0
Kolar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2048.0,1983.0,2202.0,2077.0,2150.0,1987.0,1944.0,1921.0,2023.0,1844.0,2043.0,2107.0,24329.0
Kolar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,20.0,4.0,532.0,1295.0,4653.0,805.0,591.0,778.0,614.0,593.0,2765.0,1616.0,14266.0
Kolar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,4.0,0.0,0.0,851.0,5828.0,0.0,0.0,0.0,1.0,0.0,2062.0,666.0,9412.0
Kolar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,23.0,10.0,6.0,5.0,5.0,8.0,7.0,16.0,27.0,16.0,13.0,9.0,145.0
Kolar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,701.0,618.0,752.0,723.0,717.0,824.0,699.0,871.0,925.0,700.0,721.0,719.0,8970.0
Kolar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,2.0,1.0,1.0,1.0,0.0,0.0,5.0
Kolar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,141.0,92.0,93.0,93.0,99.0,164.0,67.0,80.0,188.0,237.0,177.0,150.0,1581.0
Kolar,13.1,Number of Patients operated for cataract,TOTAL,128.0,50.0,387.0,13.0,198.0,563.0,78.0,224.0,275.0,149.0,37.0,18.0,2120.0
Kolar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,128.0,35.0,384.0,13.0,164.0,229.0,78.0,199.0,255.0,149.0,74.0,18.0,1726.0
Kolar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,104.0,0.0,10.0,28.0,0.0,108.0,76.0,57.0,51.0,0.0,434.0
Kolar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20.0,0.0,0.0,0.0,20.0
Kolar,13.5,Number of eyes collected through eye donation,TOTAL,2.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,2.0,0.0,6.0
Kolar,13.6,Number of eyes utilised for corneal transplant,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,2.0,0.0,5.0
Kolar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,10.0,11.0,10.0,10.0,10.0,10.0,10.0,10.0,11.0,10.0,10.0,-1.0
Kolar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,43.0,43.0,42.0,44.0,44.0,44.0,42.0,38.0,37.0,40.0,41.0,44.0,-1.0
Kolar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,357.0,358.0,365.0,324.0,365.0,404.0,357.0,413.0,398.0,375.0,384.0,404.0,-1.0
Kolar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,9.0,9.0,9.0,9.0,9.0,8.0,8.0,8.0,7.0,8.0,9.0,8.0,-1.0
Kolar,14.05,Number of RKS meetings held during the month,TOTAL,30.0,31.0,30.0,28.0,29.0,30.0,29.0,27.0,26.0,30.0,29.0,29.0,348.0
Kolar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,24.0,22.0,21.0,23.0,15.0,19.0,20.0,17.0,16.0,21.0,19.0,18.0,-1.0
Kolar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,133.0,147.0,180.0,148.0,173.0,386.0,135.0,156.0,141.0,154.0,164.0,155.0,2072.0
Kolar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,11.0,11.0,11.0,10.0,10.0,10.0,10.0,10.0,9.0,10.0,10.0,9.0,-1.0
Kolar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,6.0,5.0,4.0,3.0,5.0,2.0,2.0,2.0,1.0,1.0,1.0,-1.0
Kolar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,661.0,237.0,230.0,1977.0,399.0,587.0,341.0,254.0,214.0,218.0,4052.0,1500.0,10670.0
Kolar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1463.0,1196.0,3964.0,1371.0,1135.0,1898.0,2608.0,1121.0,1269.0,1066.0,15902.0,2496.0,35489.0
Kolar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1498.0,166.0,197.0,1798.0,329.0,668.0,255.0,1704.0,243.0,169.0,5838.0,785.0,13650.0
Kolar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,2709.0,2538.0,12626.0,2790.0,2709.0,3247.0,7895.0,5183.0,2665.0,2900.0,15592.0,11796.0,72650.0
Kolar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2159.0,403.0,427.0,3775.0,728.0,1255.0,596.0,1958.0,457.0,387.0,9890.0,2285.0,24320.0
Kolar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,4172.0,3734.0,16590.0,4161.0,3844.0,5145.0,10503.0,6304.0,3934.0,3966.0,31494.0,14292.0,108139.0
Kolar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,25.0,15.0,13.0,15.0,10.0,14.0,14.0,17.0,12.0,41.0,20.0,16.0,212.0
Kolar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,7.0,12.0,5.0,10.0,7.0,3.0,6.0,9.0,12.0,30.0,10.0,15.0,126.0
Kolar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,32.0,27.0,18.0,25.0,17.0,17.0,20.0,26.0,24.0,71.0,30.0,31.0,338.0
Kolar,14.11,In-Patient Head Count at midnight,TOTAL,10857.0,10017.0,11748.0,10989.0,10167.0,9931.0,7993.0,8793.0,13340.0,10416.0,10516.0,14322.0,129089.0
Kolar,14.12.1,OPD attendance (All),TOTAL,162558.0,177363.0,160486.0,172205.0,219839.0,179352.0,190403.0,207905.0,207972.0,214502.0,213708.0,216982.0,2323275.0
Kolar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,997.0,325.0,2208.0,3981.0,4564.0,3125.0,6028.0,380.0,1011.0,918.0,9817.0,757.0,34111.0
Kolar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,212.0,45.0,314.0,147.0,54.0,2242.0,2529.0,62.0,164.0,183.0,0.0,26.0,5978.0
Kolar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,281.0,155.0,978.0,1676.0,1780.0,196.0,2640.0,131.0,205.0,194.0,213.0,127.0,8576.0
Kolar,14.14.a,Number of patients given AYUSH treatment,TOTAL,710.0,866.0,1362.0,1346.0,1062.0,1791.0,1049.0,1978.0,1074.0,1858.0,2433.0,2181.0,17710.0
Kolar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,526.0,908.0,748.0,835.0,266.0,1363.0,712.0,813.0,864.0,370.0,663.0,557.0,8625.0
Kolar,14.14.c,Number of Adolescents counselled,TOTAL,131.0,133.0,720.0,806.0,600.0,687.0,337.0,335.0,494.0,389.0,566.0,569.0,5767.0
Kolar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6304.0,5577.0,9400.0,6998.0,6492.0,9652.0,8974.0,11461.0,9533.0,10013.0,9176.0,10229.0,103809.0
Kolar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,503.0,311.0,422.0,282.0,334.0,555.0,410.0,334.0,480.0,405.0,350.0,293.0,4679.0
Kolar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1902.0,2540.0,2056.0,1895.0,1704.0,2121.0,1934.0,1931.0,2066.0,1900.0,2311.0,1754.0,24114.0
Kolar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,40.0,41.0,39.0,23.0,34.0,54.0,33.0,38.0,35.0,134.0,45.0,49.0,565.0
Kolar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1865.0,1467.0,1856.0,1487.0,2090.0,1774.0,1652.0,1577.0,1937.0,1455.0,1932.0,1910.0,21002.0
Kolar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,26.0,28.0,33.0,19.0,15.0,100.0,13.0,15.0,23.0,149.0,29.0,24.0,474.0
Kolar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1936.0,1952.0,2695.0,2126.0,2636.0,2755.0,2002.0,3055.0,2246.0,2395.0,2472.0,2275.0,28545.0
Kolar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,9.0,13.0,6.0,0.0,55.0,6.0,40.0,5.0,107.0,6.0,4.0,253.0
Kolar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5703.0,5959.0,6607.0,5508.0,6430.0,6650.0,5588.0,6563.0,6249.0,5750.0,6715.0,5939.0,73661.0
Kolar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,68.0,78.0,85.0,48.0,49.0,209.0,52.0,93.0,63.0,390.0,80.0,77.0,1292.0
Kolar,15.2,Number of Widal tests conducted,Number tested,1269.0,822.0,1678.0,1446.0,1445.0,1728.0,1270.0,1417.0,1429.0,1905.0,1516.0,1818.0,17743.0
Kolar,15.3.a,Number of VDRL tests conducted on males,Number tested,570.0,425.0,302.0,299.0,675.0,437.0,309.0,310.0,450.0,348.0,338.0,538.0,5001.0
Kolar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,583.0,387.0,682.0,385.0,532.0,649.0,517.0,676.0,341.0,372.0,364.0,618.0,6106.0
Kolar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2016.0,2283.0,2011.0,1840.0,1437.0,1767.0,1645.0,1720.0,1616.0,1799.0,1792.0,1725.0,21651.0
Kolar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3169.0,3095.0,2995.0,2524.0,2644.0,2853.0,2471.0,2706.0,2407.0,2519.0,2494.0,2881.0,32758.0
Kolar,15.4.1,Number of blood smears examined for Malaria,TOTAL,13497.0,14992.0,18657.0,18534.0,19627.0,22065.0,16441.0,18566.0,17447.0,18894.0,19060.0,19020.0,216800.0
Kolar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,3.0,4.0,7.0,1.0,1.0,10.0,6.0,3.0,640.0,780.0,1.0,0.0,1456.0
Kolar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,0.0,6.0,0.0,4.0,3.0,9.0,6.0,13.0,4.0,0.0,7.0,54.0
Kolar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,230.0,8020.0,4870.0,2870.0,8270.0,9270.0,8770.0,3570.0,6440.0,6700.0,7000.0,4620.0,70630.0
Kolar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,5000.0,0.0,10000.0,5000.0,8000.0,0.0,8000.0,5000.0,5000.0,0.0,2500.0,58500.0
Kolar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2210.0,8150.0,2000.0,4600.0,4000.0,8500.0,5200.0,5130.0,4740.0,4700.0,2380.0,4060.0,55670.0
Kolar,16.1.1,Stock position of DPT vaccines,5. Total Stock,8020.0,4870.0,2870.0,8270.0,9270.0,8770.0,3570.0,6440.0,6700.0,7000.0,4620.0,3060.0,73460.0
Kolar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,6470.0,8710.0,17720.0,17720.0,10870.0,14820.0,14720.0,11020.0,8620.0,7340.0,7120.0,1490.0,126620.0
Kolar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,9000.0,27000.0,0.0,0.0,9000.0,6000.0,0.0,3000.0,3000.0,6000.0,0.0,6000.0,69000.0
Kolar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,6760.0,17990.0,0.0,6850.0,5050.0,6100.0,3700.0,5400.0,4280.0,6220.0,5630.0,5730.0,73710.0
Kolar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8710.0,17720.0,17720.0,10870.0,14820.0,14720.0,11020.0,8620.0,7340.0,7120.0,1490.0,1760.0,121910.0
Kolar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,22140.0,12440.0,59840.0,58840.0,43240.0,26740.0,21240.0,10140.0,16080.0,30620.0,22420.0,14420.0,338160.0
Kolar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,80000.0,0.0,0.0,0.0,10000.0,0.0,20000.0,27000.0,252000.0,225000.0,0.0,614000.0
Kolar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9700.0,32600.0,1000.0,15600.0,16500.0,15500.0,11100.0,14060.0,12460.0,260200.0,233000.0,9500.0,631220.0
Kolar,16.1.2,Stock position of OPV vaccines,5. Total Stock,12440.0,59840.0,58840.0,43240.0,26740.0,21240.0,10140.0,16080.0,30620.0,22420.0,14420.0,4920.0,320940.0
Kolar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,3730.0,9230.0,13310.0,11910.0,16410.0,21410.0,20210.0,13610.0,15640.0,12500.0,15190.0,9560.0,162710.0
Kolar,16.1.3,Stock position of TT vaccines,2. Stocks Received,12000.0,28000.0,0.0,15000.0,10000.0,12000.0,0.0,10000.0,5000.0,10000.0,0.0,0.0,102000.0
Kolar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6500.0,23920.0,1400.0,10500.0,5000.0,13200.0,6600.0,7970.0,8140.0,7310.0,5630.0,8210.0,104380.0
Kolar,16.1.3,Stock position of TT vaccines,5. Total Stock,9230.0,13310.0,11910.0,16410.0,21410.0,20210.0,13610.0,15640.0,12500.0,15190.0,9560.0,1350.0,160330.0
Kolar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,8900.0,2200.0,10700.0,10700.0,13100.0,18600.0,14600.0,11600.0,11300.0,12100.0,12300.0,7360.0,133460.0
Kolar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,30000.0,0.0,10000.0,10000.0,0.0,0.0,5000.0,5000.0,5000.0,0.0,0.0,65000.0
Kolar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6700.0,21500.0,0.0,7600.0,4500.0,4000.0,3000.0,5300.0,4200.0,4800.0,4940.0,5760.0,72300.0
Kolar,16.1.5,Stock position of BCG vaccines,5. Total Stock,2200.0,10700.0,10700.0,13100.0,18600.0,14600.0,11600.0,11300.0,12100.0,12300.0,7360.0,1600.0,126160.0
Kolar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2150.0,7400.0,5000.0,5000.0,5750.0,11000.0,7250.0,3400.0,3400.0,5650.0,6250.0,2250.0,64500.0
Kolar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,10000.0,10000.0,0.0,5000.0,10000.0,0.0,0.0,5000.0,5000.0,5000.0,0.0,5000.0,55000.0
Kolar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4750.0,12400.0,0.0,4250.0,4750.0,3750.0,3850.0,5000.0,2750.0,4400.0,4000.0,4800.0,54700.0
Kolar,16.1.6,Stock position of Measles vaccines,5. Total Stock,7400.0,5000.0,5000.0,5750.0,11000.0,7250.0,3400.0,3400.0,5650.0,6250.0,2250.0,2450.0,64800.0
Kolar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,6400.0,0.0,2400.0,2400.0,5000.0,1500.0,10000.0,2800.0,3300.0,4250.0,4900.0,550.0,43500.0
Kolar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,10000.0,0.0,10000.0,0.0,10000.0,0.0,5000.0,5000.0,5000.0,0.0,10000.0,55000.0
Kolar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,6400.0,7600.0,0.0,7400.0,3500.0,1500.0,7200.0,4500.0,4050.0,4350.0,4350.0,5200.0,56050.0
Kolar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,2400.0,2400.0,5000.0,1500.0,10000.0,2800.0,3300.0,4250.0,4900.0,550.0,5350.0,42450.0
Kolar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,4090.0,2850.0,6180.0,6180.0,5220.0,5220.0,5720.0,3120.0,3520.0,5500.0,6470.0,5020.0,59090.0
Kolar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,9000.0,0.0,0.0,2100.0,2500.0,0.0,2500.0,2500.0,2500.0,0.0,0.0,21100.0
Kolar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1240.0,5670.0,0.0,960.0,2100.0,2000.0,2600.0,2100.0,520.0,1530.0,1450.0,2020.0,22190.0
Kolar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2850.0,6180.0,6180.0,5220.0,5220.0,5720.0,3120.0,3520.0,5500.0,6470.0,5020.0,3000.0,58000.0
Kolar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,303.0,2553.0,753.0,553.0,4953.0,4453.0,4453.0,4253.0,3903.0,3603.0,2503.0,2303.0,34586.0
Kolar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,3000.0,0.0,0.0,4700.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7700.0
Kolar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,750.0,1800.0,200.0,300.0,500.0,0.0,200.0,350.0,300.0,1100.0,200.0,600.0,6300.0
Kolar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2553.0,753.0,553.0,4953.0,4453.0,4453.0,4253.0,3903.0,3603.0,2503.0,2303.0,1703.0,35986.0
Kolar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,17000.0,88740.0,45900.0,45900.0,45900.0,45060.0,45060.0,45060.0,43967.0,60000.0,110400.0,0.0,592987.0
Kolar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,75600.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60000.0,110400.0,0.0,38500.0,284500.0
Kolar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,3860.0,42840.0,0.0,0.0,840.0,0.0,0.0,1093.0,43967.0,60000.0,110400.0,0.0,263000.0
Kolar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,88740.0,45900.0,45900.0,45900.0,45060.0,45060.0,45060.0,43967.0,60000.0,110400.0,0.0,38500.0,614487.0
Kolar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,16000.0,9000.0,9000.0,8648.0,52.0,15052.0,102.0,57854.0
Kolar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,16000.0,9000.0,0.0,0.0,0.0,15000.0,0.0,10000.0,50000.0
Kolar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,352.0,8596.0,0.0,14950.0,0.0,39898.0
Kolar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,16000.0,9000.0,9000.0,8648.0,52.0,15052.0,102.0,10102.0,67956.0
Kolar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,4820.0,3940.0,1120.0,1120.0,1120.0,1060.0,1060.0,1060.0,1060.0,1060.0,1060.0,1060.0,19540.0
Kolar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,880.0,2820.0,0.0,0.0,60.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3760.0
Kolar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3940.0,1120.0,1120.0,1120.0,1060.0,1060.0,1060.0,1060.0,1060.0,1060.0,1060.0,1060.0,15780.0
Kolar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4750.0,2700.0,2400.0,2100.0,2100.0,7100.0,5000.0,5000.0,4700.0,4700.0,4700.0,4700.0,49950.0
Kolar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0
Kolar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,2050.0,300.0,300.0,0.0,0.0,2100.0,0.0,300.0,0.0,0.0,0.0,2000.0,7050.0
Kolar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,2700.0,2400.0,2100.0,2100.0,7100.0,5000.0,5000.0,4700.0,4700.0,4700.0,4700.0,2700.0,47900.0
Kolar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,790.0,790.0,790.0,790.0,3160.0
Kolar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,34000.0,0.0,0.0,0.0,0.0,34000.0
Kolar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,33210.0,0.0,0.0,0.0,0.0,33210.0
Kolar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,790.0,790.0,790.0,790.0,790.0,3950.0
Kolar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,11397.0,11117.0,8737.0,4937.0,4937.0,897.0,897.0,897.0,897.0,897.0,45610.0
Kolar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,11397.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,11397.0
Kolar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,280.0,2380.0,3800.0,0.0,4040.0,0.0,0.0,0.0,0.0,0.0,10500.0
Kolar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,11397.0,11117.0,8737.0,4937.0,4937.0,897.0,897.0,897.0,897.0,897.0,897.0,46507.0
Kolar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,1801.0,1801.0,1801.0,1801.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,303.0,7521.0
Kolar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,750.0,0.0,0.0,0.0,0.0,0.0,0.0,1200.0,0.0,1950.0
Kolar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,2549.0,0.0,0.0,0.0,0.0,0.0,0.0,899.0,303.0,3751.0
Kolar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1801.0,1801.0,1801.0,2.0,2.0,2.0,2.0,2.0,2.0,2.0,303.0,0.0,5720.0
Kolar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,7206.0,7206.0,7206.0,6306.0,5496.0,5496.0,5496.0,316.0,316.0,316.0,316.0,316.0,45992.0
Kolar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,135400.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,135400.0
Kolar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,900.0,136210.0,0.0,0.0,5180.0,0.0,0.0,0.0,0.0,0.0,142290.0
Kolar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,7206.0,7206.0,6306.0,5496.0,5496.0,5496.0,316.0,316.0,316.0,316.0,316.0,316.0,39102.0
Kolar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1910.0,2840.0,920.0,320.0,4700.0,2020.0,3300.0,600.0,1150.0,2910.0,4720.0,2780.0,28170.0
Kolar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,3300.0,0.0,6600.0,0.0,3300.0,0.0,3300.0,3300.0,3300.0,0.0,6600.0,32700.0
Kolar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2070.0,5220.0,600.0,2220.0,2680.0,2020.0,2700.0,2750.0,1540.0,1490.0,1940.0,2954.0,28184.0
Kolar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,2840.0,920.0,320.0,4700.0,2020.0,3300.0,600.0,1150.0,2910.0,4720.0,2780.0,6426.0,32686.0
Kolar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,5600.0,15600.0,18000.0,15000.0,4800.0,32200.0,48200.0,24200.0,21600.0,18000.0,50600.0,29900.0,283700.0
Kolar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,30000.0,48000.0,0.0,24000.0,48000.0,40000.0,0.0,24000.0,24000.0,60000.0,0.0,21600.0,319600.0
Kolar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,20000.0,45600.0,3000.0,34200.0,20600.0,24000.0,24000.0,26600.0,27600.0,27400.0,20700.0,29700.0,303400.0
Kolar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,15600.0,18000.0,15000.0,4800.0,32200.0,48200.0,24200.0,21600.0,18000.0,50600.0,29900.0,21800.0,299900.0
Kolar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1385.0,655.0,2440.0,2440.0,2340.0,2740.0,3140.0,1040.0,655.0,3725.0,3395.0,1265.0,25220.0
Kolar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,1200.0,4800.0,0.0,2400.0,2400.0,2400.0,0.0,2400.0,4800.0,2000.0,0.0,2400.0,24800.0
Kolar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0
Kolar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1930.0,3015.0,0.0,2500.0,2000.0,2000.0,2100.0,2785.0,1730.0,2330.0,2130.0,2560.0,25080.0
Kolar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,655.0,2440.0,2440.0,2340.0,2740.0,3140.0,1040.0,655.0,3725.0,3395.0,1265.0,1105.0,24940.0
Kolar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,1.0,,,,1.0
Kolar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,,1.0,1.0,,,,3.0
Kolar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kolar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,,1.0,1.0,,,,3.0
Kolar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,,,,1.0,,,,,3.0,1.0,8.0
Kolar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Kolar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,,,,1.0,,,,,3.0,1.0,8.0
Kolar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,3.0,3.0,1.0,2.0,1.0,,1.0,,3.0,2.0,4.0,3.0,23.0
Kolar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Kolar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,3.0,1.0,2.0,1.0,,1.0,,4.0,2.0,4.0,3.0,24.0
Kolar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,2.0,1.0,1.0,1.0,1.0,,,1.0,1.0,,,9.0
Kolar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,1.0,,,2.0
Kolar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,2.0,1.0,1.0,1.0,1.0,,,2.0,2.0,,,11.0
Kolar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,,,1.0,1.0,1.0,1.0,,5.0
Kolar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,,,1.0,1.0,1.0,1.0,,5.0
Kolar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kolar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Kolar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Kolar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,1.0,,,1.0
Kolar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Kolar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,1.0,,1.0,,,2.0
Kolar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Kolar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Kolar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,1.0,,,,,1.0
Kolar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,1.0,1.0,,,1.0,1.0,1.0,,2.0,1.0,,8.0
Kolar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,1.0,,,,1.0,,,,1.0,1.0,4.0
Kolar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,1.0,2.0,,,1.0,2.0,1.0,,2.0,2.0,1.0,12.0
Kolar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,1.0,,,,,1.0
Kolar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Kolar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,1.0,,1.0,,,,,1.0,1.0,,1.0,2.0,7.0
Kolar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,1.0,,1.0,,,2.0,1.0,,1.0,2.0,9.0
Kolar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,4.0,2.0,2.0,5.0,,2.0,1.0,1.0,3.0,1.0,23.0
Kolar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,1.0,1.0,1.0,2.0,4.0,1.0,,,1.0,2.0,1.0,17.0
Kolar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,2.0,5.0,3.0,4.0,9.0,1.0,2.0,1.0,2.0,5.0,2.0,40.0
Kolar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Kolar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,1.0,1.0,,3.0,3.0,2.0,3.0,5.0,4.0,8.0,1.0,35.0
Kolar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,4.0,7.0,4.0,2.0,3.0,7.0,11.0,9.0,10.0,20.0,6.0,88.0
Kolar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,9.0,5.0,8.0,4.0,5.0,7.0,9.0,14.0,14.0,14.0,28.0,7.0,124.0
Kolar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Kolar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Kolar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Kolar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Kolar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,1.0,,,1.0,,1.0,1.0,,1.0,,6.0
Kolar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,2.0,,,,,,1.0,,,,3.0
Kolar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,3.0,,,1.0,,1.0,2.0,,1.0,,10.0
Kolar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,4.0,1.0,,1.0,1.0,2.0,2.0,1.0,1.0,3.0,1.0,5.0,22.0
Kolar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,1.0,,2.0,,1.0,2.0,,1.0,2.0,9.0
Kolar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,4.0,1.0,,2.0,1.0,4.0,2.0,2.0,3.0,3.0,2.0,7.0,31.0
Kolar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Kolar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,7.0,11.0,14.0,15.0,12.0,16.0,10.0,20.0,19.0,16.0,21.0,10.0,171.0
Kolar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,18.0,10.0,23.0,9.0,16.0,23.0,18.0,28.0,28.0,32.0,25.0,27.0,257.0
Kolar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,25.0,21.0,37.0,24.0,28.0,39.0,28.0,48.0,47.0,48.0,46.0,38.0,429.0
Kolar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,1.0,,,,,1.0,2.0
Kolar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,,,1.0,2.0,3.0,7.0,4.0,4.0,1.0,2.0,1.0,1.0,26.0
Kolar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,7.0,3.0,3.0,6.0,4.0,8.0,8.0,8.0,5.0,6.0,8.0,5.0,71.0
Kolar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,7.0,3.0,4.0,8.0,7.0,15.0,13.0,12.0,6.0,8.0,9.0,7.0,99.0
Kolar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Kolar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Kolar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Kolar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Kolar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Kolar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Kolar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Kolar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Kolar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Kolar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Kolar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Kolar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Kolar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Kolar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Kolar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Kolar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,2.0,1.0,1.0,,1.0,2.0,1.0,1.0,,,9.0
Kolar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Kolar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,2.0,1.0,1.0,,1.0,2.0,1.0,1.0,,,9.0
Kolar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,1.0,2.0,3.0,,3.0,1.0,1.0,,,1.0,1.0,14.0
Kolar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,14.0,13.0,8.0,9.0,8.0,11.0,8.0,12.0,8.0,13.0,8.0,6.0,118.0
Kolar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,8.0,1.0,3.0,6.0,,1.0,2.0,5.0,2.0,5.0,2.0,36.0
Kolar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,16.0,22.0,11.0,15.0,14.0,14.0,10.0,15.0,13.0,15.0,14.0,9.0,168.0
Kolar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,,,,,,,,1.0,,,2.0
Kolar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,4.0,7.0,5.0,6.0,9.0,5.0,7.0,7.0,8.0,5.0,4.0,74.0
Kolar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,2.0,3.0,2.0,,3.0,2.0,2.0,,,3.0,1.0,19.0
Kolar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,9.0,6.0,10.0,7.0,6.0,12.0,7.0,9.0,7.0,9.0,8.0,5.0,95.0
Kolar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,1.0,,,,,1.0,,1.0,4.0
Kolar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,,,2.0,1.0,,1.0,,,,4.0
Kolar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,,,1.0,1.0,2.0
Kolar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,,,,1.0,2.0,1.0,,1.0,1.0,1.0,2.0,10.0
Kolar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,,,,,,,,,
Kolar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,6.0,2.0,2.0,5.0,6.0,12.0,6.0,14.0,9.0,8.0,5.0,8.0,83.0
Kolar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,7.0,16.0,6.0,6.0,4.0,6.0,6.0,10.0,4.0,8.0,8.0,5.0,86.0
Kolar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,13.0,18.0,8.0,11.0,10.0,18.0,12.0,24.0,13.0,16.0,13.0,13.0,169.0
Kolar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,1.0,,,,,1.0,,,,,3.0
Kolar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,6.0,2.0,3.0,3.0,4.0,1.0,9.0,6.0,8.0,8.0,4.0,7.0,61.0
Kolar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,8.0,11.0,9.0,10.0,8.0,10.0,16.0,9.0,11.0,12.0,7.0,9.0,120.0
Kolar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,15.0,13.0,13.0,13.0,12.0,11.0,25.0,16.0,19.0,20.0,11.0,16.0,184.0
Kolar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,,1.0,2.0,,,4.0,2.0,1.0,,,10.0
Kolar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,37.0,24.0,40.0,24.0,33.0,28.0,21.0,44.0,32.0,39.0,27.0,42.0,391.0
Kolar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,103.0,101.0,110.0,121.0,151.0,121.0,122.0,141.0,178.0,176.0,140.0,148.0,1612.0
Kolar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,140.0,125.0,150.0,146.0,186.0,149.0,143.0,189.0,212.0,216.0,167.0,190.0,2013.0
Koppal,1.1,Total number of pregnant women Registered for ANC,TOTAL,3016.0,2707.0,3031.0,2901.0,2629.0,3037.0,2785.0,3067.0,2664.0,2633.0,2677.0,2913.0,34060.0
Koppal,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2581.0,2304.0,2592.0,2468.0,2258.0,2626.0,2319.0,2552.0,2151.0,2131.0,2195.0,2405.0,28582.0
Koppal,1.2,Number of Pregnant women registered under JSY,TOTAL,2495.0,2353.0,2647.0,2528.0,2719.0,2642.0,2480.0,2511.0,2255.0,2138.0,2254.0,2445.0,29467.0
Koppal,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2802.0,2578.0,2553.0,2707.0,2581.0,2930.0,2522.0,2821.0,2553.0,2757.0,2663.0,2774.0,32241.0
Koppal,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1750.0,1798.0,1899.0,1819.0,1702.0,2167.0,1794.0,1858.0,1535.0,1415.0,1570.0,1702.0,21009.0
Koppal,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2815.0,2459.0,2972.0,2785.0,2540.0,2900.0,2685.0,2551.0,2533.0,2322.0,2223.0,2500.0,31285.0
Koppal,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1578.0,1401.0,1247.0,1236.0,2334.0,2630.0,3460.0,2282.0,1922.0,1725.0,453.0,184.0,20452.0
Koppal,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,90.0,57.0,79.0,190.0,213.0,102.0,107.0,103.0,115.0,106.0,118.0,71.0,1351.0
Koppal,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,6.0,7.0,11.0,9.0,20.0,43.0,15.0,15.0,27.0,21.0,15.0,194.0
Koppal,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,4000.0,3429.0,3964.0,4117.0,3289.0,4294.0,3068.0,3992.0,3700.0,3297.0,3685.0,3317.0,44152.0
Koppal,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,82.0,73.0,64.0,182.0,153.0,180.0,107.0,122.0,137.0,105.0,71.0,130.0,1406.0
Koppal,1.8,Number of pregnancy test kits used at SC level,TOTAL,160.0,210.0,194.0,178.0,205.0,238.0,243.0,275.0,210.0,244.0,181.0,259.0,2597.0
Koppal,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,25.0,37.0,40.0,31.0,30.0,38.0,52.0,45.0,38.0,41.0,42.0,36.0,455.0
Koppal,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,117.0,91.0,99.0,122.0,104.0,124.0,113.0,126.0,109.0,107.0,108.0,113.0,1333.0
Koppal,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,142.0,128.0,139.0,153.0,134.0,162.0,165.0,171.0,147.0,148.0,150.0,149.0,1788.0
Koppal,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,120.0,113.0,110.0,130.0,121.0,151.0,157.0,161.0,132.0,140.0,140.0,150.0,1625.0
Koppal,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,2.0,1.0,0.0,7.0,9.0,0.0,0.0,8.0,4.0,2.0,3.0,3.0,39.0
Koppal,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1916.0,1684.0,1643.0,1686.0,1797.0,1855.0,1972.0,1863.0,1874.0,1876.0,1817.0,1737.0,21720.0
Koppal,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,50.0,110.0,219.0,138.0,114.0,137.0,136.0,165.0,106.0,87.0,79.0,47.0,1388.0
Koppal,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,962.0,985.0,1281.0,1147.0,1110.0,1415.0,1047.0,1136.0,922.0,697.0,1145.0,1085.0,12932.0
Koppal,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,0.0,50.0,55.0
Koppal,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,135.0,150.0,145.0,120.0,139.0,128.0,175.0,124.0,107.0,118.0,119.0,138.0,1598.0
Koppal,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,38.0,28.0,7.0,6.0,1.0,4.0,4.0,0.0,3.0,8.0,14.0,25.0,138.0
Koppal,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,152.0,152.0,156.0,196.0,212.0,267.0,208.0,247.0,223.0,212.0,198.0,177.0,2400.0
Koppal,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,190.0,180.0,163.0,202.0,213.0,271.0,212.0,247.0,226.0,220.0,212.0,202.0,2538.0
Koppal,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,29.0,54.0,49.0,12.0,61.0,36.0,10.0,16.0,40.0,36.0,52.0,47.0,442.0
Koppal,4.1.1.a,Number of male live births,TOTAL,1082.0,1025.0,1017.0,1030.0,1042.0,1063.0,1175.0,1186.0,1041.0,1102.0,1106.0,1026.0,12895.0
Koppal,4.1.1.b,Number of female live births,TOTAL,1067.0,915.0,908.0,919.0,999.0,1036.0,1101.0,1040.0,1061.0,1044.0,983.0,972.0,12045.0
Koppal,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2149.0,1940.0,1925.0,1949.0,2041.0,2099.0,2276.0,2226.0,2102.0,2146.0,2089.0,1998.0,24940.0
Koppal,4.1.2,Number of still births,TOTAL,41.0,26.0,36.0,32.0,78.0,52.0,76.0,43.0,41.0,45.0,46.0,49.0,565.0
Koppal,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,48.0,45.0,50.0,56.0,48.0,65.0,35.0,37.0,47.0,41.0,46.0,43.0,561.0
Koppal,4.2.1,Number of Newborns weighed at birth,TOTAL,2004.0,1922.0,1920.0,1872.0,2029.0,2086.0,2273.0,2227.0,2115.0,2086.0,2057.0,1980.0,24571.0
Koppal,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,352.0,322.0,270.0,473.0,413.0,328.0,302.0,363.0,417.0,256.0,288.0,330.0,4114.0
Koppal,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1930.0,1856.0,1895.0,1812.0,2009.0,2048.0,2166.0,2169.0,2055.0,2093.0,2011.0,1935.0,23979.0
Koppal,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,9.0,14.0,19.0,14.0,13.0,18.0,8.0,16.0,15.0,12.0,9.0,16.0,163.0
Koppal,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,52.0,41.0,13.0,22.0,23.0,15.0,16.0,18.0,13.0,34.0,30.0,39.0,316.0
Koppal,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,77.0,92.0,136.0,175.0,208.0,299.0,245.0,184.0,151.0,149.0,161.0,188.0,2065.0
Koppal,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,138.0,147.0,168.0,211.0,244.0,332.0,269.0,218.0,179.0,195.0,200.0,243.0,2544.0
Koppal,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,393.0,284.0,271.0,530.0,699.0,623.0,645.0,628.0,397.0,398.0,387.0,321.0,5576.0
Koppal,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,26.0,23.0,21.0,17.0,37.0,37.0,17.0,23.0,35.0,28.0,26.0,19.0,309.0
Koppal,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,466.0,396.0,413.0,439.0,488.0,520.0,791.0,589.0,464.0,449.0,460.0,540.0,6015.0
Koppal,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,90.0,42.0,104.0,58.0,53.0,133.0,98.0,160.0,161.0,118.0,115.0,30.0,1162.0
Koppal,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1974.0,1745.0,1810.0,1796.0,1998.0,1918.0,1998.0,1926.0,1995.0,2152.0,2073.0,1846.0,23231.0
Koppal,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2462.0,2160.0,2373.0,2437.0,2576.0,2672.0,2511.0,2525.0,2498.0,2726.0,2460.0,2326.0,29726.0
Koppal,6.3,PNC maternal complications attended,TOTAL,47.0,77.0,35.0,25.0,18.0,17.0,20.0,27.0,18.0,23.0,26.0,9.0,342.0
Koppal,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,8.0,7.0,7.0,10.0,15.0,10.0,5.0,7.0,7.0,9.0,6.0,7.0,98.0
Koppal,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,3.0,4.0,8.0,7.0,4.0,1.0,2.0,8.0,1.0,3.0,5.0,51.0
Koppal,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,13.0,10.0,11.0,18.0,22.0,14.0,6.0,9.0,15.0,10.0,9.0,12.0,149.0
Koppal,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,5.0,2.0,9.0
Koppal,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,431.0,385.0,397.0,412.0,444.0,414.0,389.0,454.0,465.0,399.0,417.0,416.0,5023.0
Koppal,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,852.0,876.0,909.0,913.0,760.0,972.0,884.0,970.0,880.0,827.0,943.0,932.0,10718.0
Koppal,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1283.0,1261.0,1306.0,1325.0,1204.0,1386.0,1273.0,1424.0,1345.0,1226.0,1360.0,1348.0,15741.0
Koppal,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,0.0,3.0
Koppal,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,29.0,0.0,2.0,4.0,0.0,0.0,0.0,0.0,0.0,35.0
Koppal,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,29.0,0.0,2.0,4.0,0.0,0.0,0.0,0.0,0.0,35.0
Koppal,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,320.0,245.0,242.0,178.0,227.0,263.0,266.0,311.0,240.0,273.0,194.0,225.0,2984.0
Koppal,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,205.0,151.0,159.0,224.0,157.0,244.0,222.0,250.0,186.0,219.0,211.0,249.0,2477.0
Koppal,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,169.0,163.0,180.0,199.0,145.0,229.0,192.0,210.0,156.0,126.0,141.0,144.0,2054.0
Koppal,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,694.0,559.0,581.0,601.0,529.0,736.0,680.0,771.0,582.0,618.0,546.0,618.0,7515.0
Koppal,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,37.0,28.0,46.0,27.0,6.0,26.0,6.0,3.0,4.0,18.0,22.0,18.0,241.0
Koppal,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,87.0,60.0,89.0,78.0,65.0,47.0,48.0,57.0,60.0,59.0,28.0,63.0,741.0
Koppal,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,60.0,34.0,62.0,64.0,78.0,118.0,88.0,57.0,113.0,69.0,48.0,58.0,849.0
Koppal,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,184.0,122.0,197.0,169.0,149.0,191.0,142.0,117.0,177.0,146.0,98.0,139.0,1831.0
Koppal,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,8.0,9.0,5.0,3.0,2.0,3.0,2.0,9.0,3.0,6.0,2.0,11.0,63.0
Koppal,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,35.0,36.0,39.0,41.0,38.0,48.0,34.0,56.0,46.0,49.0,48.0,32.0,502.0
Koppal,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,43.0,45.0,44.0,44.0,40.0,51.0,36.0,65.0,49.0,55.0,50.0,43.0,565.0
Koppal,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,109.0,117.0,88.0,105.0,121.0,120.0,114.0,95.0,87.0,92.0,85.0,84.0,1217.0
Koppal,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,62.0,63.0,54.0,72.0,66.0,61.0,68.0,59.0,69.0,72.0,69.0,68.0,783.0
Koppal,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,32.0,22.0,37.0,31.0,30.0,29.0,28.0,13.0,14.0,31.0,19.0,19.0,305.0
Koppal,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,40.0,34.0,49.0,65.0,53.0,57.0,24.0,44.0,17.0,15.0,11.0,15.0,424.0
Koppal,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Koppal,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,243.0,236.0,228.0,273.0,270.0,267.0,234.0,211.0,187.0,210.0,184.0,186.0,2729.0
Koppal,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,22.0,9.0,8.0,740.0,36.0,37.0,46.0,9.0,9.0,7.0,11.0,12.0,946.0
Koppal,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,1.0,2.0,4.0,0.0,0.0,0.0,3.0,0.0,10.0
Koppal,9.06,Number of IUCD removals,TOTAL,95.0,63.0,42.0,60.0,24.0,58.0,46.0,58.0,57.0,51.0,41.0,47.0,642.0
Koppal,9.07,Number of Oral Pills cycles distributed,TOTAL,3452.0,1400.0,1428.0,922.0,818.0,1240.0,1305.0,1712.0,1420.0,1848.0,1771.0,2036.0,19352.0
Koppal,9.08,Number of Condom pieces distributed,TOTAL,28619.0,28105.0,30175.0,36915.0,34107.0,33695.0,34510.0,32245.0,31204.0,32690.0,29881.0,32834.0,384980.0
Koppal,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,2.0,1.0,2.0,8.0,44.0,8.0,31.0,9.0,9.0,9.0,125.0
Koppal,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,28.0,2.0,1.0,31.0
Koppal,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,3.0,3.0,1.0,3.0,0.0,3.0,2.0,2.0,4.0,1.0,1.0,23.0
Koppal,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,9.12,Number of Institutions having NSV trained doctors,TOTAL,14.0,10.0,10.0,7.0,10.0,11.0,11.0,15.0,11.0,13.0,10.0,11.0,-1.0
Koppal,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3053.0,2997.0,3012.0,2896.0,2851.0,3155.0,3010.0,3303.0,3012.0,2890.0,2808.0,2916.0,35903.0
Koppal,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,33.0,79.0,7.0,23.0,15.0,12.0,8.0,6.0,0.0,2.0,17.0,0.0,202.0
Koppal,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,45.0,74.0,5.0,26.0,16.0,18.0,9.0,6.0,0.0,2.0,18.0,1.0,220.0
Koppal,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,67.0,84.0,8.0,22.0,30.0,21.0,9.0,7.0,9.0,1.0,8.0,1.0,267.0
Koppal,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2418.0,2420.0,2740.0,2704.0,2366.0,2882.0,2454.0,2759.0,2669.0,2637.0,2429.0,2469.0,30947.0
Koppal,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2455.0,2327.0,2551.0,2850.0,2359.0,2688.0,2390.0,2427.0,2633.0,2618.0,2352.0,2554.0,30204.0
Koppal,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2513.0,2288.0,2514.0,2797.0,2439.0,2788.0,2428.0,2479.0,2386.0,2638.0,2344.0,2460.0,30074.0
Koppal,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2601.0,2360.0,2389.0,2436.0,2472.0,2625.0,2710.0,2628.0,2520.0,2476.0,2419.0,2340.0,29976.0
Koppal,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2412.0,2499.0,2702.0,2714.0,2371.0,2916.0,2435.0,2786.0,2670.0,2641.0,2439.0,2472.0,31057.0
Koppal,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2470.0,2397.0,2544.0,2852.0,2477.0,2695.0,2408.0,2444.0,2639.0,2634.0,2390.0,2552.0,30502.0
Koppal,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2515.0,2354.0,2499.0,2794.0,2450.0,2840.0,2423.0,2515.0,2409.0,2623.0,2397.0,2476.0,30295.0
Koppal,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1850.0,1673.0,1629.0,1645.0,1682.0,1781.0,1957.0,1786.0,1824.0,1828.0,1752.0,1613.0,21020.0
Koppal,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,15.0,21.0,7.0,20.0,15.0,14.0,7.0,7.0,0.0,21.0,42.0,12.0,181.0
Koppal,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,10.0,30.0,5.0,23.0,20.0,19.0,6.0,5.0,0.0,19.0,41.0,38.0,216.0
Koppal,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,11.0,36.0,20.0,16.0,22.0,20.0,1.0,6.0,0.0,20.0,38.0,21.0,211.0
Koppal,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2298.0,2321.0,2390.0,2793.0,2406.0,2828.0,2391.0,2353.0,2207.0,2294.0,2164.0,2314.0,28759.0
Koppal,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1913.0,1864.0,2213.0,2346.0,1977.0,2257.0,1871.0,2128.0,1862.0,1990.0,1730.0,2071.0,24222.0
Koppal,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1510.0,763.0,1671.0,2220.0,1832.0,2032.0,1635.0,916.0,1812.0,1912.0,1804.0,1869.0,19976.0
Koppal,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1164.0,1122.0,1178.0,1402.0,1200.0,1441.0,1216.0,1242.0,1128.0,1177.0,1118.0,1156.0,14544.0
Koppal,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1049.0,1071.0,1164.0,1330.0,1111.0,1295.0,1119.0,1136.0,1083.0,1075.0,1006.0,1114.0,13553.0
Koppal,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2213.0,2193.0,2342.0,2732.0,2311.0,2736.0,2335.0,2378.0,2211.0,2252.0,2124.0,2270.0,28097.0
Koppal,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2015.0,1994.0,2324.0,2430.0,2050.0,2361.0,1948.0,2187.0,1945.0,1830.0,1864.0,2024.0,24972.0
Koppal,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2028.0,1989.0,2321.0,2439.0,2049.0,2349.0,1946.0,2187.0,1945.0,1829.0,1858.0,2026.0,24966.0
Koppal,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,222.0,44.0,49.0,56.0,49.0,60.0,105.0,40.0,20.0,14.0,28.0,39.0,726.0
Koppal,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,375.0,383.0,385.0,335.0,369.0,518.0,357.0,381.0,303.0,377.0,390.0,352.0,4525.0
Koppal,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,329.0,339.0,351.0,327.0,358.0,430.0,288.0,330.0,274.0,365.0,339.0,323.0,4053.0
Koppal,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,704.0,722.0,736.0,662.0,727.0,948.0,645.0,711.0,577.0,742.0,729.0,675.0,8578.0
Koppal,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,432.0,430.0,625.0,1939.0,4196.0,4376.0,809.0,2113.0,2155.0,1489.0,1258.0,766.0,20588.0
Koppal,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,613.0,797.0,907.0,2133.0,4533.0,4736.0,1039.0,2732.0,2804.0,2162.0,1675.0,1027.0,25158.0
Koppal,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,707.0,988.0,1124.0,2045.0,3635.0,4369.0,1029.0,2545.0,2357.0,2018.0,1779.0,1082.0,23678.0
Koppal,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,2.0,1.0,2.0,0.0,1.0,2.0,4.0,4.0,4.0,0.0,21.0
Koppal,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,61.0,79.0,75.0,62.0,59.0,64.0,45.0,49.0,64.0,61.0,59.0,51.0,729.0
Koppal,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1175.0,1190.0,1197.0,1272.0,1244.0,1247.0,1247.0,1260.0,1187.0,1164.0,1174.0,1178.0,14535.0
Koppal,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1154.0,1175.0,1174.0,1231.0,1168.0,1219.0,1224.0,1227.0,1161.0,1139.0,1121.0,1139.0,14132.0
Koppal,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,882.0,795.0,815.0,889.0,846.0,872.0,836.0,830.0,836.0,798.0,767.0,791.0,9957.0
Koppal,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1203.0,548.0,1411.0,1761.0,1524.0,1562.0,1132.0,672.0,1423.0,1548.0,1472.0,1577.0,15833.0
Koppal,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2003.0,2104.0,2167.0,2405.0,2228.0,2390.0,2184.0,2257.0,2089.0,2192.0,2050.0,2101.0,26170.0
Koppal,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,103.0,428.0,63.0,1921.0,14342.0,253.0,35.0,21.0,32.0,35.0,39.0,926.0,18198.0
Koppal,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,99.0,336.0,22.0,2129.0,12074.0,117.0,102.0,26.0,30.0,22.0,32.0,1366.0,16355.0
Koppal,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,21.0,23.0,33.0,21.0,0.0,1.0,22.0,0.0,21.0,16.0,5.0,173.0
Koppal,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,408.0,364.0,390.0,393.0,531.0,456.0,418.0,450.0,441.0,304.0,379.0,299.0,4833.0
Koppal,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,0.0,11.0,14.0,0.0,2.0,0.0,1.0,1.0,0.0,0.0,0.0,30.0
Koppal,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,41.0,30.0,55.0,42.0,44.0,35.0,24.0,26.0,22.0,30.0,24.0,18.0,391.0
Koppal,13.1,Number of Patients operated for cataract,TOTAL,68.0,41.0,28.0,43.0,52.0,46.0,73.0,40.0,30.0,1.0,14.0,2.0,438.0
Koppal,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,65.0,41.0,28.0,43.0,52.0,46.0,73.0,40.0,30.0,1.0,14.0,2.0,435.0
Koppal,13.3,Number of School children detected with Refractive errors,TOTAL,13.0,7.0,1.0,0.0,13.0,10.0,0.0,99.0,121.0,183.0,43.0,58.0,548.0
Koppal,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,174.0,212.0,60.0,450.0
Koppal,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,35.0,25.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60.0
Koppal,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,15.0,10.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,25.0
Koppal,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,8.0,8.0,8.0,8.0,8.0,8.0,8.0,7.0,7.0,7.0,7.0,-1.0
Koppal,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,39.0,41.0,39.0,39.0,40.0,38.0,39.0,37.0,38.0,37.0,42.0,41.0,-1.0
Koppal,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,175.0,326.0,182.0,165.0,150.0,159.0,147.0,160.0,156.0,161.0,151.0,157.0,-1.0
Koppal,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,14.0,14.0,14.0,14.0,14.0,14.0,14.0,14.0,14.0,13.0,13.0,11.0,-1.0
Koppal,14.05,Number of RKS meetings held during the month,TOTAL,8.0,9.0,4.0,6.0,5.0,7.0,5.0,6.0,6.0,5.0,13.0,11.0,85.0
Koppal,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,20.0,18.0,18.0,19.0,19.0,21.0,20.0,23.0,24.0,22.0,21.0,23.0,-1.0
Koppal,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,237.0,195.0,176.0,190.0,226.0,206.0,191.0,221.0,161.0,166.0,181.0,160.0,2310.0
Koppal,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,9.0,9.0,7.0,7.0,7.0,8.0,8.0,8.0,7.0,7.0,7.0,-1.0
Koppal,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,4.0,56.0,42.0,4.0,4.0,4.0,4.0,6.0,6.0,40.0,76.0,34.0,-1.0
Koppal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,424.0,277.0,544.0,530.0,414.0,415.0,342.0,352.0,250.0,393.0,530.0,503.0,4974.0
Koppal,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2169.0,2157.0,2211.0,3233.0,2051.0,2305.0,2239.0,2340.0,1805.0,1589.0,2610.0,2559.0,27268.0
Koppal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,498.0,350.0,391.0,509.0,353.0,346.0,456.0,388.0,236.0,294.0,518.0,620.0,4959.0
Koppal,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5081.0,4947.0,5135.0,5541.0,4494.0,5129.0,4965.0,4775.0,4359.0,4249.0,5537.0,5264.0,59476.0
Koppal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,922.0,627.0,935.0,1039.0,767.0,761.0,798.0,740.0,486.0,687.0,1048.0,1123.0,9933.0
Koppal,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7250.0,7104.0,7346.0,8774.0,6545.0,7434.0,7204.0,7115.0,6164.0,5838.0,8147.0,7823.0,86744.0
Koppal,14.10.2.a,Number of death cases of Inpatient males,TOTAL,21.0,26.0,27.0,26.0,27.0,20.0,19.0,25.0,26.0,23.0,24.0,18.0,282.0
Koppal,14.10.2.b,Number of death cases of Inpatient females,TOTAL,20.0,16.0,9.0,18.0,12.0,18.0,16.0,20.0,18.0,11.0,12.0,20.0,190.0
Koppal,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,41.0,42.0,36.0,44.0,39.0,38.0,35.0,45.0,44.0,34.0,36.0,38.0,472.0
Koppal,14.11,In-Patient Head Count at midnight,TOTAL,10210.0,7938.0,8066.0,9849.0,8487.0,8534.0,7141.0,10083.0,7881.0,7670.0,8121.0,9449.0,103429.0
Koppal,14.12.1,OPD attendance (All),TOTAL,92708.0,91588.0,108521.0,102451.0,99956.0,105426.0,91531.0,99871.0,90976.0,86448.0,91468.0,84526.0,1145470.0
Koppal,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,164.0,110.0,136.0,220.0,207.0,307.0,234.0,292.0,250.0,135.0,238.0,222.0,2515.0
Koppal,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,9.0,32.0,17.0,17.0,16.0,29.0,18.0,13.0,21.0,8.0,19.0,23.0,222.0
Koppal,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,836.0,790.0,878.0,932.0,957.0,1044.0,971.0,1005.0,1118.0,1180.0,1129.0,1084.0,11924.0
Koppal,14.14.a,Number of patients given AYUSH treatment,TOTAL,9793.0,9542.0,10938.0,9837.0,9985.0,11220.0,10645.0,10296.0,11207.0,10937.0,8662.0,8151.0,121213.0
Koppal,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,116.0,104.0,62.0,107.0,61.0,1.0,217.0,57.0,63.0,54.0,124.0,102.0,1068.0
Koppal,14.14.c,Number of Adolescents counselled,TOTAL,659.0,719.0,902.0,793.0,784.0,790.0,635.0,834.0,801.0,703.0,745.0,682.0,9047.0
Koppal,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6324.0,5778.0,6918.0,6658.0,5142.0,6264.0,4675.0,6014.0,6260.0,5132.0,5858.0,5784.0,70807.0
Koppal,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,496.0,457.0,704.0,551.0,400.0,520.0,350.0,394.0,492.0,492.0,477.0,536.0,5869.0
Koppal,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1365.0,1474.0,1235.0,1764.0,1620.0,1643.0,1183.0,1463.0,1309.0,1334.0,1401.0,1136.0,16927.0
Koppal,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,38.0,37.0,45.0,41.0,42.0,45.0,41.0,37.0,38.0,14.0,27.0,27.0,432.0
Koppal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1406.0,1392.0,1395.0,1526.0,1276.0,1733.0,1202.0,1541.0,1390.0,1260.0,1541.0,1361.0,17023.0
Koppal,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,34.0,39.0,46.0,33.0,16.0,37.0,40.0,33.0,32.0,14.0,42.0,37.0,403.0
Koppal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3021.0,2871.0,3427.0,3252.0,2439.0,3127.0,2458.0,3502.0,2824.0,2724.0,2892.0,2744.0,35281.0
Koppal,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,6.0,9.0,2.0,4.0,5.0,3.0,10.0,8.0,2.0,6.0,3.0,59.0
Koppal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5792.0,5737.0,6057.0,6542.0,5335.0,6503.0,4843.0,6506.0,5523.0,5318.0,5834.0,5241.0,69231.0
Koppal,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,73.0,82.0,100.0,76.0,62.0,87.0,84.0,80.0,78.0,30.0,75.0,67.0,894.0
Koppal,15.2,Number of Widal tests conducted,Number tested,624.0,549.0,655.0,516.0,569.0,693.0,439.0,646.0,643.0,602.0,693.0,665.0,7294.0
Koppal,15.3.a,Number of VDRL tests conducted on males,Number tested,91.0,119.0,116.0,160.0,340.0,409.0,107.0,94.0,133.0,66.0,67.0,173.0,1875.0
Koppal,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,292.0,170.0,311.0,265.0,53.0,286.0,205.0,155.0,218.0,107.0,154.0,129.0,2345.0
Koppal,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2092.0,2005.0,2416.0,1887.0,1348.0,1826.0,1114.0,1679.0,1859.0,1666.0,1849.0,1839.0,21580.0
Koppal,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2475.0,2294.0,2843.0,2312.0,1741.0,2521.0,1426.0,1928.0,2210.0,1839.0,2070.0,2141.0,25800.0
Koppal,15.4.1,Number of blood smears examined for Malaria,TOTAL,24035.0,26030.0,26495.0,28540.0,27862.0,31390.0,25364.0,28132.0,24834.0,21467.0,22868.0,22659.0,309676.0
Koppal,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,33.0,59.0,1385.0,817.0,59.0,49.0,41.0,53.0,401.0,17.0,24.0,89.0,3027.0
Koppal,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,2.0,3.0,7.0,6.0,7.0,6.0,2.0,7.0,2.0,3.0,1.0,46.0
Koppal,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4500.0,1500.0,5500.0,8000.0,0.0,1500.0,8000.0,12000.0,10800.0,6690.0,3690.0,3690.0,65870.0
Koppal,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,6000.0,6000.0,0.0,15000.0,20000.0,5000.0,0.0,0.0,0.0,0.0,6000.0,58000.0
Koppal,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3000.0,2000.0,3500.0,8000.0,13500.0,13500.0,1000.0,1200.0,4110.0,3000.0,0.0,3000.0,55810.0
Koppal,16.1.1,Stock position of DPT vaccines,5. Total Stock,1500.0,5500.0,8000.0,0.0,1500.0,8000.0,12000.0,10800.0,6690.0,3690.0,3690.0,6690.0,68060.0
Koppal,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,11000.0,11000.0,14000.0,15500.0,8500.0,5000.0,6000.0,7000.0,3200.0,5960.0,4960.0,12460.0,104580.0
Koppal,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,10000.0,12000.0,10000.0,0.0,10000.0,10000.0,6000.0,0.0,10000.0,10000.0,10000.0,10000.0,98000.0
Koppal,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,10000.0,9000.0,8500.0,7000.0,13500.0,9000.0,5000.0,3800.0,7240.0,11000.0,2500.0,11500.0,98040.0
Koppal,16.1.1A,Stock Position of Pentavalent,5. Total Stock,11000.0,14000.0,15500.0,8500.0,5000.0,6000.0,7000.0,3200.0,5960.0,4960.0,12460.0,10960.0,104540.0
Koppal,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,22600.0,18600.0,21100.0,21100.0,3340.0,5340.0,6340.0,12340.0,1480.0,5980.0,4580.0,24180.0,146980.0
Koppal,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,20000.0,20000.0,1000.0,20000.0,20000.0,20000.0,0.0,19000.0,261810.0,274800.0,20000.0,686610.0
Koppal,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14000.0,17500.0,20000.0,18760.0,18000.0,19000.0,14000.0,10860.0,14500.0,263210.0,255200.0,16500.0,681530.0
Koppal,16.1.2,Stock position of OPV vaccines,5. Total Stock,18600.0,21100.0,21100.0,3340.0,5340.0,6340.0,12340.0,1480.0,5980.0,4580.0,24180.0,27680.0,152060.0
Koppal,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,15500.0,11500.0,16500.0,19500.0,1000.0,2000.0,2500.0,6000.0,1880.0,6730.0,7730.0,18230.0,109070.0
Koppal,16.1.3,Stock position of TT vaccines,2. Stocks Received,5000.0,14000.0,14000.0,0.0,14000.0,14000.0,15000.0,0.0,15000.0,14000.0,14000.0,14000.0,133000.0
Koppal,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.3,Stock position of TT vaccines,4. Stock Distributed,9000.0,9000.0,11000.0,18500.0,13000.0,13500.0,11500.0,4120.0,10150.0,13000.0,3500.0,13000.0,129270.0
Koppal,16.1.3,Stock position of TT vaccines,5. Total Stock,11500.0,16500.0,19500.0,1000.0,2000.0,2500.0,6000.0,1880.0,6730.0,7730.0,18230.0,19230.0,112800.0
Koppal,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,11500.0,12500.0,13500.0,12500.0,3500.0,4500.0,5500.0,8000.0,4650.0,3950.0,950.0,8000.0,89050.0
Koppal,16.1.5,Stock position of BCG vaccines,2. Stocks Received,10000.0,9000.0,9500.0,0.0,9500.0,10000.0,9500.0,0.0,8000.0,6000.0,9500.0,10000.0,91000.0
Koppal,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9000.0,8000.0,10500.0,9000.0,8500.0,9000.0,7000.0,3350.0,8700.0,9000.0,2450.0,8000.0,92500.0
Koppal,16.1.5,Stock position of BCG vaccines,5. Total Stock,12500.0,13500.0,12500.0,3500.0,4500.0,5500.0,8000.0,4650.0,3950.0,950.0,8000.0,10000.0,87550.0
Koppal,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,2750.0,7500.0,10000.0,9000.0,3500.0,6000.0,8500.0,10500.0,7485.0,5310.0,3310.0,9250.0,83105.0
Koppal,16.1.6,Stock position of Measles vaccines,2. Stocks Received,9000.0,7500.0,6000.0,0.0,8500.0,10000.0,6000.0,0.0,3000.0,4000.0,7500.0,13750.0,75250.0
Koppal,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4250.0,5000.0,7000.0,5500.0,6000.0,7500.0,4000.0,3015.0,5175.0,6000.0,1560.0,5750.0,60750.0
Koppal,16.1.6,Stock position of Measles vaccines,5. Total Stock,7500.0,10000.0,9000.0,3500.0,6000.0,8500.0,10500.0,7485.0,5310.0,3310.0,9250.0,17250.0,97605.0
Koppal,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,12500.0,13000.0,7500.0,6000.0,1000.0,0.0,5500.0,10000.0,3500.0,1500.0,60500.0
Koppal,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,15000.0,10000.0,0.0,7000.0,0.0,0.0,10000.0,10000.0,0.0,0.0,30000.0,82000.0
Koppal,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,2500.0,9500.0,5500.0,8500.0,5000.0,1000.0,4500.0,5500.0,6500.0,2000.0,7000.0,57500.0
Koppal,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,12500.0,13000.0,7500.0,6000.0,1000.0,0.0,5500.0,10000.0,3500.0,1500.0,24500.0,85000.0
Koppal,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,0.0,0.0,4000.0,5000.0,3000.0,6000.0,6000.0,5000.0,5000.0,3900.0,1500.0,1000.0,40400.0
Koppal,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,4000.0,4000.0,0.0,4500.0,3000.0,0.0,0.0,0.0,0.0,0.0,4000.0,19500.0
Koppal,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,0.0,0.0,3000.0,2000.0,1500.0,3000.0,1000.0,0.0,1100.0,2400.0,500.0,1000.0,15500.0
Koppal,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,0.0,4000.0,5000.0,3000.0,6000.0,6000.0,5000.0,5000.0,3900.0,1500.0,1000.0,4000.0,44400.0
Koppal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2500.0,2500.0,0.0,0.0,1350.0,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,14750.0
Koppal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,1800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0
Koppal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,2500.0,0.0,450.0,150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3100.0
Koppal,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2500.0,0.0,0.0,1350.0,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,1200.0,13450.0
Koppal,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,6000.0,6000.0,4000.0,4000.0,100800.0,50400.0,50400.0,50400.0,50400.0,160800.0,59280.0,22080.0,564560.0
Koppal,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,151200.0,0.0,0.0,0.0,0.0,160800.0,0.0,0.0,0.0,312000.0
Koppal,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,2000.0,0.0,54400.0,50400.0,0.0,0.0,0.0,50400.0,101520.0,37200.0,0.0,295920.0
Koppal,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,6000.0,4000.0,4000.0,100800.0,50400.0,50400.0,50400.0,50400.0,160800.0,59280.0,22080.0,22080.0,580640.0
Koppal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,1100.0,1100.0,7100.0,14400.0,6500.0,2000.0,32200.0
Koppal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,6000.0,7800.0,0.0,0.0,0.0,23800.0
Koppal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,8900.0,0.0,0.0,500.0,7900.0,4500.0,0.0,21800.0
Koppal,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,1100.0,1100.0,7100.0,14400.0,6500.0,2000.0,2000.0,34200.0
Koppal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,1600.0,250.0,250.0,250.0,250.0,250.0,200.0,200.0,3250.0
Koppal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3000.0
Koppal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1400.0,1350.0,0.0,0.0,0.0,0.0,50.0,0.0,0.0,2800.0
Koppal,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,1600.0,250.0,250.0,250.0,250.0,250.0,200.0,200.0,200.0,3450.0
Koppal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,3495.0,1595.0,1595.0,1195.0,9200.0,9200.0,9200.0,7200.0,7200.0,6200.0,6200.0,5000.0,67280.0
Koppal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Koppal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1900.0,0.0,400.0,1995.0,0.0,0.0,2000.0,0.0,1000.0,0.0,1200.0,1000.0,9495.0
Koppal,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1595.0,1595.0,1195.0,9200.0,9200.0,9200.0,7200.0,7200.0,6200.0,6200.0,5000.0,4000.0,67785.0
Koppal,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,3900.0,3900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7800.0
Koppal,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,3900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3900.0
Koppal,16.3.02,Stock Position of Gloves,5. Total Stock,3900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3900.0
Koppal,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,14800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14800.0
Koppal,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,14800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14800.0
Koppal,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2650.0,2650.0,2650.0,2650.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,11400.0
Koppal,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1394.0,1394.0
Koppal,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,2550.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1450.0,4000.0
Koppal,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,2650.0,2650.0,2650.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,100.0,44.0,8794.0
Koppal,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,19650.0,18450.0,16950.0,16950.0,9100.0,8700.0,6700.0,6300.0,4000.0,64608.0,23708.0,7808.0,202924.0
Koppal,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,67450.0,0.0,0.0,0.0,0.0,63008.0,0.0,0.0,0.0,130458.0
Koppal,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,1200.0,1500.0,0.0,75300.0,400.0,2000.0,400.0,2300.0,2400.0,40900.0,15900.0,0.0,142300.0
Koppal,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,18450.0,16950.0,16950.0,9100.0,8700.0,6700.0,6300.0,4000.0,64608.0,23708.0,7808.0,7808.0,191082.0
Koppal,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,11800.0,11800.0,11400.0,11800.0,8400.0,8300.0,8900.0,16000.0,14250.0,14050.0,14900.0,14900.0,146500.0
Koppal,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3600.0,3000.0,4000.0,0.0,3300.0,4000.0,9900.0,0.0,3300.0,4500.0,1000.0,13300.0,49900.0
Koppal,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3600.0,3400.0,3600.0,3400.0,3400.0,3400.0,2800.0,1750.0,3500.0,3650.0,1000.0,4000.0,37500.0
Koppal,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,11800.0,11400.0,11800.0,8400.0,8300.0,8900.0,16000.0,14250.0,14050.0,14900.0,14900.0,24200.0,158900.0
Koppal,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,62800.0,51000.0,81000.0,105000.0,73800.0,85800.0,52200.0,163400.0,133400.0,149400.0,119400.0,111400.0,1188600.0
Koppal,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,16200.0,60000.0,60000.0,0.0,48000.0,0.0,140000.0,0.0,36000.0,0.0,0.0,72000.0,432200.0
Koppal,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,28000.0,30000.0,36000.0,31200.0,36000.0,33600.0,28800.0,30000.0,20000.0,30000.0,8000.0,28000.0,339600.0
Koppal,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,51000.0,81000.0,105000.0,73800.0,85800.0,52200.0,163400.0,133400.0,149400.0,119400.0,111400.0,155400.0,1281200.0
Koppal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,11700.0,13600.0,10300.0,8100.0,4500.0,5300.0,1900.0,4300.0,2850.0,9850.0,6850.0,6050.0,85300.0
Koppal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,4000.0,0.0,0.0,0.0,4000.0,0.0,4800.0,0.0,9600.0,0.0,0.0,7200.0,29600.0
Koppal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Koppal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2100.0,3300.0,2200.0,3600.0,3200.0,3400.0,2400.0,1450.0,2600.0,3000.0,800.0,3000.0,31050.0
Koppal,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,13600.0,10300.0,8100.0,4500.0,5300.0,1900.0,4300.0,2850.0,9850.0,6850.0,6050.0,10250.0,83850.0
Koppal,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,3.0,,,,1.0,,1.0,,1.0,2.0,11.0
Koppal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,,,1.0,,,2.0,1.0,,5.0
Koppal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,1.0,1.0
Koppal,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,,,1.0,,,2.0,1.0,1.0,6.0
Koppal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,4.0,1.0,4.0,3.0,1.0,3.0,5.0,,,1.0,2.0,3.0,27.0
Koppal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,,1.0,,,,,,,1.0,,3.0
Koppal,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,5.0,1.0,4.0,4.0,1.0,3.0,5.0,,,1.0,3.0,3.0,30.0
Koppal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,6.0,5.0,2.0,4.0,2.0,,2.0,2.0,1.0,1.0,6.0,2.0,33.0
Koppal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,1.0,1.0,,1.0,1.0,2.0,,1.0,1.0,,3.0,12.0
Koppal,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,7.0,6.0,3.0,4.0,3.0,1.0,4.0,2.0,2.0,2.0,6.0,5.0,45.0
Koppal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,,2.0,3.0,2.0,,,1.0,1.0,1.0,1.0,3.0,18.0
Koppal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,2.0,,,1.0,,,,,3.0,1.0,8.0
Koppal,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,5.0,,4.0,3.0,2.0,1.0,,1.0,1.0,1.0,4.0,4.0,26.0
Koppal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,2.0,1.0,,1.0,,,1.0,,,,,,5.0
Koppal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,1.0,,1.0,,,,,,,2.0
Koppal,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,2.0,1.0,,2.0,,1.0,1.0,,,,,,7.0
Koppal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,1.0,,,,,,,,,,,1.0
Koppal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Koppal,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,1.0,,,,,,,,,,,1.0
Koppal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,,,,,,,,,,1.0
Koppal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Koppal,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,,,,,1.0,,,,,2.0
Koppal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Koppal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Koppal,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Koppal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,,2.0,2.0,6.0,,2.0,2.0,7.0,3.0,1.0,4.0,34.0
Koppal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,2.0,1.0,,2.0,2.0,1.0,2.0,1.0,,,12.0
Koppal,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,1.0,4.0,3.0,6.0,2.0,4.0,3.0,9.0,4.0,1.0,4.0,46.0
Koppal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Koppal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,1.0,,,2.0,,,1.0,,,,4.0
Koppal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,2.0,,,1.0,,,,,,,3.0
Koppal,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,1.0,,3.0,,,3.0,,,1.0,,,,8.0
Koppal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Koppal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,7.0,4.0,7.0,11.0,4.0,1.0,6.0,3.0,2.0,5.0,6.0,1.0,57.0
Koppal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,2.0,1.0,1.0,3.0,2.0,2.0,6.0,3.0,5.0,1.0,2.0,29.0
Koppal,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,8.0,6.0,9.0,12.0,7.0,3.0,8.0,9.0,5.0,10.0,7.0,3.0,87.0
Koppal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,2.0,,,,,,,,,1.0,1.0,4.0
Koppal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,7.0,7.0,5.0,7.0,10.0,5.0,8.0,6.0,9.0,11.0,11.0,7.0,93.0
Koppal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,30.0,24.0,28.0,28.0,25.0,39.0,26.0,33.0,30.0,35.0,28.0,28.0,354.0
Koppal,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,37.0,33.0,33.0,35.0,35.0,44.0,34.0,39.0,39.0,46.0,40.0,36.0,451.0
Koppal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Koppal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Koppal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Koppal,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,1.0,,,,,,1.0
Koppal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Koppal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,1.0,,3.0,,2.0,,,,,1.0,8.0
Koppal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,1.0,2.0,3.0,2.0,,,,8.0
Koppal,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,1.0,,3.0,1.0,4.0,3.0,2.0,,,1.0,17.0
Koppal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,1.0,,,,,,1.0
Koppal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,11.0,8.0,8.0,11.0,8.0,14.0,10.0,13.0,8.0,5.0,10.0,3.0,109.0
Koppal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,2.0,1.0,2.0,1.0,1.0,2.0,1.0,2.0,1.0,,1.0,14.0
Koppal,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,11.0,10.0,9.0,13.0,9.0,15.0,13.0,14.0,10.0,6.0,10.0,4.0,124.0
Koppal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,2.0,,1.0,,,,1.0,,,1.0,3.0,,8.0
Koppal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,23.0,20.0,20.0,30.0,23.0,14.0,19.0,18.0,31.0,32.0,31.0,14.0,275.0
Koppal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,29.0,27.0,21.0,21.0,19.0,34.0,23.0,29.0,23.0,29.0,27.0,12.0,294.0
Koppal,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,54.0,47.0,42.0,51.0,42.0,48.0,43.0,47.0,54.0,62.0,61.0,26.0,577.0
Koppal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,1.0,,,2.0,2.0,1.0,,,,,7.0
Koppal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,6.0,10.0,8.0,5.0,5.0,14.0,8.0,9.0,16.0,10.0,3.0,4.0,98.0
Koppal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,16.0,15.0,16.0,18.0,12.0,12.0,12.0,20.0,20.0,22.0,18.0,12.0,193.0
Koppal,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,23.0,25.0,25.0,23.0,17.0,28.0,22.0,30.0,36.0,32.0,21.0,16.0,298.0
Koppal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Koppal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Koppal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Koppal,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Koppal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Koppal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,1.0,,,,,1.0,,,,,1.0,3.0
Koppal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Koppal,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,1.0,,,,,1.0,,,,,1.0,3.0
Koppal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Koppal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,1.0,,,,,,,1.0,,,3.0
Koppal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Koppal,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,1.0,,,,,,,1.0,,,3.0
Koppal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Koppal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,2.0,1.0,,,,1.0,,1.0,,,,,5.0
Koppal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Koppal,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,2.0,1.0,,,,1.0,,1.0,,,,,5.0
Koppal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Koppal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Koppal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Koppal,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,1.0,,,,,,,,,,,1.0
Koppal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Koppal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,,2.0,1.0,1.0,1.0,,,,1.0,1.0,,9.0
Koppal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Koppal,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,,2.0,1.0,1.0,1.0,,,,1.0,1.0,,9.0
Koppal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,3.0,2.0,2.0,1.0,,2.0,1.0,2.0,,1.0,,14.0
Koppal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,21.0,24.0,19.0,13.0,11.0,16.0,17.0,7.0,11.0,11.0,13.0,9.0,172.0
Koppal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,4.0,6.0,,1.0,5.0,5.0,2.0,1.0,2.0,3.0,1.0,31.0
Koppal,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,22.0,31.0,27.0,15.0,13.0,21.0,24.0,10.0,14.0,13.0,17.0,10.0,217.0
Koppal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,2.0,,,,,1.0,,,4.0
Koppal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,14.0,8.0,5.0,10.0,13.0,13.0,16.0,9.0,13.0,16.0,11.0,8.0,136.0
Koppal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,1.0,5.0,,,2.0,,1.0,3.0,2.0,,2.0,19.0
Koppal,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,17.0,9.0,10.0,11.0,15.0,15.0,16.0,10.0,16.0,19.0,11.0,10.0,159.0
Koppal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,1.0,,,,,,2.0,,,1.0,5.0
Koppal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,2.0,3.0,,1.0,4.0,4.0,,2.0,1.0,4.0,1.0,23.0
Koppal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,1.0,,3.0,,1.0,,,5.0,3.0,,14.0
Koppal,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,4.0,5.0,,4.0,4.0,5.0,,4.0,6.0,7.0,2.0,42.0
Koppal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,,2.0,3.0,3.0,,1.0,1.0,2.0,,13.0
Koppal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,14.0,9.0,12.0,7.0,6.0,12.0,14.0,10.0,10.0,13.0,18.0,5.0,130.0
Koppal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,23.0,18.0,14.0,12.0,13.0,22.0,27.0,17.0,25.0,29.0,17.0,21.0,238.0
Koppal,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,38.0,27.0,26.0,19.0,21.0,37.0,44.0,27.0,36.0,43.0,37.0,26.0,381.0
Koppal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,3.0,,,,,1.0,,1.0,,3.0,1.0,,9.0
Koppal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,8.0,13.0,14.0,20.0,10.0,7.0,10.0,15.0,8.0,11.0,8.0,5.0,129.0
Koppal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,14.0,19.0,32.0,16.0,31.0,28.0,27.0,29.0,21.0,16.0,18.0,9.0,260.0
Koppal,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,25.0,32.0,46.0,36.0,41.0,36.0,37.0,45.0,29.0,30.0,27.0,14.0,398.0
Koppal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,5.0,3.0,3.0,6.0,3.0,5.0,2.0,2.0,,2.0,4.0,39.0
Koppal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,59.0,55.0,67.0,62.0,73.0,79.0,65.0,79.0,69.0,64.0,76.0,68.0,816.0
Koppal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,157.0,154.0,152.0,167.0,198.0,200.0,169.0,212.0,187.0,219.0,207.0,169.0,2191.0
Koppal,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,220.0,214.0,222.0,232.0,277.0,282.0,239.0,293.0,258.0,283.0,285.0,241.0,3046.0
Mandya,1.1,Total number of pregnant women Registered for ANC,TOTAL,2175.0,1853.0,2216.0,2022.0,2206.0,2328.0,2195.0,2250.0,1927.0,1892.0,1963.0,1804.0,24831.0
Mandya,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1722.0,1476.0,1723.0,1619.0,1773.0,1749.0,1687.0,1676.0,1375.0,1448.0,1439.0,1293.0,18980.0
Mandya,1.2,Number of Pregnant women registered under JSY,TOTAL,1905.0,1631.0,1955.0,1767.0,1873.0,1904.0,1888.0,1917.0,1677.0,1647.0,1680.0,1513.0,21357.0
Mandya,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1746.0,1802.0,1935.0,1890.0,1753.0,1897.0,1754.0,1860.0,1713.0,1635.0,1743.0,1807.0,21535.0
Mandya,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2386.0,2272.0,2906.0,2211.0,2083.0,2122.0,1975.0,2061.0,1859.0,1922.0,2173.0,2048.0,26018.0
Mandya,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2294.0,2496.0,2472.0,2234.0,1923.0,2220.0,2130.0,2118.0,2162.0,2053.0,2121.0,2239.0,26462.0
Mandya,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2056.0,1725.0,1825.0,1642.0,1898.0,1859.0,1770.0,2059.0,2114.0,1831.0,1195.0,1134.0,21108.0
Mandya,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,95.0,117.0,59.0,122.0,64.0,83.0,107.0,85.0,96.0,84.0,97.0,91.0,1100.0
Mandya,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,1.0,4.0,4.0,1.0,0.0,3.0,4.0,1.0,3.0,7.0,8.0,42.0
Mandya,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1916.0,1756.0,2108.0,2049.0,2054.0,2176.0,2420.0,2317.0,2469.0,2332.0,2475.0,2176.0,26248.0
Mandya,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,54.0,189.0,16.0,22.0,65.0,24.0,27.0,31.0,27.0,39.0,27.0,35.0,556.0
Mandya,1.8,Number of pregnancy test kits used at SC level,TOTAL,1476.0,1280.0,1416.0,1311.0,1341.0,1298.0,1352.0,1354.0,1352.0,1354.0,1212.0,1182.0,15928.0
Mandya,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Mandya,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,2.0,0.0,2.0,0.0,3.0,1.0,0.0,0.0,1.0,0.0,0.0,9.0
Mandya,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,2.0,0.0,2.0,0.0,3.0,2.0,0.0,0.0,1.0,0.0,0.0,11.0
Mandya,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,2.0,0.0,1.0,0.0,2.0,1.0,0.0,0.0,1.0,0.0,0.0,8.0
Mandya,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1081.0,1061.0,951.0,978.0,956.0,1006.0,1050.0,978.0,1015.0,997.0,1025.0,1015.0,12113.0
Mandya,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,29.0,30.0,17.0,29.0,22.0,23.0,24.0,19.0,30.0,24.0,21.0,18.0,286.0
Mandya,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1136.0,1500.0,1566.0,1336.0,1285.0,1217.0,1187.0,1596.0,1239.0,1282.0,1256.0,1141.0,15741.0
Mandya,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,250.0,222.0,160.0,0.0,1411.0,110.0,16.0,2235.0,538.0,329.0,1034.0,1025.0,7330.0
Mandya,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,698.0,783.0,784.0,683.0,665.0,673.0,578.0,627.0,607.0,707.0,702.0,619.0,8126.0
Mandya,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,249.0,236.0,220.0,252.0,210.0,233.0,209.0,220.0,210.0,228.0,239.0,245.0,2751.0
Mandya,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,249.0,236.0,220.0,252.0,210.0,233.0,209.0,220.0,210.0,228.0,239.0,245.0,2751.0
Mandya,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,331.0,342.0,435.0,401.0,401.0,430.0,264.0,291.0,268.0,300.0,365.0,332.0,4160.0
Mandya,4.1.1.a,Number of male live births,TOTAL,924.0,915.0,932.0,870.0,819.0,867.0,854.0,862.0,819.0,893.0,869.0,860.0,10484.0
Mandya,4.1.1.b,Number of female live births,TOTAL,845.0,916.0,796.0,779.0,793.0,792.0,760.0,728.0,790.0,809.0,856.0,776.0,9640.0
Mandya,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1769.0,1831.0,1728.0,1649.0,1612.0,1659.0,1614.0,1590.0,1609.0,1702.0,1725.0,1636.0,20124.0
Mandya,4.1.2,Number of still births,TOTAL,13.0,19.0,12.0,19.0,15.0,23.0,18.0,15.0,17.0,11.0,18.0,6.0,186.0
Mandya,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,81.0,102.0,110.0,91.0,82.0,114.0,99.0,96.0,113.0,100.0,115.0,98.0,1201.0
Mandya,4.2.1,Number of Newborns weighed at birth,TOTAL,1773.0,1831.0,1728.0,1659.0,1614.0,1674.0,1614.0,1590.0,1607.0,1702.0,1734.0,1636.0,20162.0
Mandya,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,194.0,193.0,225.0,186.0,112.0,141.0,231.0,223.0,157.0,193.0,154.0,155.0,2164.0
Mandya,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1571.0,1769.0,1620.0,1278.0,1508.0,1545.0,1538.0,1287.0,1476.0,1515.0,1518.0,1532.0,18157.0
Mandya,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,5.0
Mandya,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mandya,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,17.0,38.0,19.0,21.0,44.0,26.0,77.0,30.0,96.0,71.0,139.0,131.0,709.0
Mandya,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,17.0,38.0,19.0,26.0,44.0,26.0,78.0,30.0,96.0,71.0,139.0,131.0,715.0
Mandya,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,68.0,84.0,95.0,63.0,85.0,97.0,86.0,88.0,18.0,25.0,40.0,43.0,792.0
Mandya,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,70.0,108.0,122.0,94.0,118.0,112.0,103.0,88.0,41.0,76.0,62.0,63.0,1057.0
Mandya,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,11.0,20.0,18.0,15.0,27.0,9.0,23.0,21.0,50.0,12.0,48.0,44.0,298.0
Mandya,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,116.0,132.0,161.0,118.0,148.0,155.0,139.0,140.0,64.0,51.0,83.0,85.0,1392.0
Mandya,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,10.0,12.0,3.0,3.0,6.0,24.0,5.0,13.0,24.0,10.0,34.0,35.0,179.0
Mandya,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1734.0,1814.0,1676.0,1631.0,1532.0,1653.0,1581.0,1590.0,1607.0,1688.0,1713.0,1611.0,19830.0
Mandya,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2247.0,2220.0,1853.0,2074.0,2056.0,1930.0,1974.0,1965.0,1992.0,1986.0,2019.0,1830.0,24146.0
Mandya,6.3,PNC maternal complications attended,TOTAL,1.0,0.0,4.0,3.0,0.0,3.0,3.0,1.0,2.0,0.0,0.0,0.0,17.0
Mandya,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,27.0,11.0,18.0,20.0,20.0,35.0,36.0,29.0,29.0,31.0,33.0,35.0,324.0
Mandya,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,6.0,11.0,3.0,7.0,10.0,19.0,7.0,8.0,7.0,7.0,14.0,10.0,109.0
Mandya,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,33.0,22.0,21.0,27.0,30.0,54.0,43.0,37.0,36.0,38.0,47.0,45.0,433.0
Mandya,7.2,Number of MTPs conducted at Private Facilities,TOTAL,22.0,30.0,44.0,25.0,27.0,25.0,28.0,28.0,29.0,29.0,31.0,22.0,340.0
Mandya,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,595.0,540.0,539.0,550.0,547.0,543.0,464.0,560.0,491.0,497.0,520.0,489.0,6335.0
Mandya,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,773.0,979.0,867.0,916.0,1021.0,948.0,850.0,953.0,1254.0,829.0,867.0,892.0,11149.0
Mandya,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1368.0,1519.0,1406.0,1466.0,1568.0,1491.0,1314.0,1513.0,1745.0,1326.0,1387.0,1381.0,17484.0
Mandya,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,6.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15.0
Mandya,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,2.0
Mandya,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mandya,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,3.0
Mandya,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,172.0,209.0,132.0,186.0,166.0,148.0,110.0,161.0,128.0,71.0,106.0,111.0,1700.0
Mandya,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,74.0,46.0,53.0,53.0,43.0,59.0,62.0,60.0,39.0,51.0,35.0,39.0,614.0
Mandya,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,388.0,480.0,347.0,288.0,298.0,262.0,414.0,309.0,336.0,275.0,400.0,284.0,4081.0
Mandya,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,634.0,735.0,532.0,527.0,507.0,469.0,586.0,530.0,503.0,397.0,541.0,434.0,6395.0
Mandya,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,18.0,9.0,0.0,0.0,0.0,9.0,0.0,4.0,2.0,0.0,2.0,0.0,44.0
Mandya,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,63.0,62.0,52.0,43.0,33.0,26.0,36.0,38.0,63.0,22.0,69.0,32.0,539.0
Mandya,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,43.0,17.0,0.0,26.0,5.0,6.0,15.0,0.0,9.0,17.0,7.0,0.0,145.0
Mandya,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,49.0,33.0,44.0,44.0,28.0,25.0,46.0,42.0,38.0,41.0,62.0,38.0,490.0
Mandya,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,155.0,112.0,96.0,113.0,66.0,57.0,97.0,80.0,110.0,80.0,138.0,70.0,1174.0
Mandya,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,1.0,17.0,11.0,10.0,16.0,9.0,77.0,8.0,1.0,27.0,11.0,5.0,193.0
Mandya,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,8.0,0.0,6.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,14.0
Mandya,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12.0
Mandya,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,52.0,51.0,21.0,62.0,61.0,59.0,51.0,54.0,51.0,50.0,52.0,50.0,614.0
Mandya,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,60.0,51.0,39.0,62.0,61.0,59.0,51.0,54.0,51.0,50.0,52.0,50.0,640.0
Mandya,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,64.0,36.0,50.0,35.0,59.0,62.0,21.0,44.0,42.0,33.0,31.0,40.0,517.0
Mandya,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,224.0,200.0,223.0,284.0,214.0,229.0,199.0,193.0,173.0,172.0,156.0,132.0,2399.0
Mandya,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,179.0,170.0,168.0,245.0,174.0,183.0,175.0,209.0,207.0,233.0,200.0,187.0,2330.0
Mandya,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,15.0,10.0,22.0,37.0,19.0,19.0,17.0,21.0,18.0,14.0,23.0,13.0,228.0
Mandya,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,58.0,66.0,85.0,70.0,59.0,75.0,85.0,88.0,99.0,117.0,104.0,81.0,987.0
Mandya,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mandya,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,476.0,446.0,498.0,636.0,466.0,506.0,476.0,511.0,497.0,536.0,483.0,413.0,5944.0
Mandya,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,18.0,0.0,9.0,8.0,0.0,41.0,57.0,79.0,67.0,61.0,88.0,68.0,496.0
Mandya,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,36.0,38.0,16.0,27.0,13.0,36.0,40.0,16.0,20.0,20.0,28.0,45.0,335.0
Mandya,9.06,Number of IUCD removals,TOTAL,215.0,195.0,174.0,170.0,148.0,181.0,177.0,178.0,127.0,123.0,121.0,130.0,1939.0
Mandya,9.07,Number of Oral Pills cycles distributed,TOTAL,1530.0,1358.0,1287.0,995.0,1173.0,1125.0,1035.0,894.0,848.0,886.0,1287.0,2379.0,14797.0
Mandya,9.08,Number of Condom pieces distributed,TOTAL,15765.0,17397.0,15370.0,15143.0,15152.0,18579.0,18947.0,19654.0,19312.0,17551.0,17895.0,22678.0,213443.0
Mandya,9.09,Number of Centchroman (weekly) pills given,TOTAL,1.0,0.0,7.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0
Mandya,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,1.0,2.0,2.0,2.0,3.0,4.0,4.0,1.0,3.0,0.0,1.0,10.0,33.0
Mandya,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Mandya,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0,6.0
Mandya,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,9.12,Number of Institutions having NSV trained doctors,TOTAL,15.0,17.0,17.0,18.0,19.0,18.0,19.0,11.0,15.0,11.0,13.0,12.0,-1.0
Mandya,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1992.0,1889.0,1747.0,1922.0,1683.0,1812.0,1189.0,1766.0,1764.0,1725.0,1698.0,1786.0,20973.0
Mandya,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,2.0,0.0,40.0,0.0,0.0,1.0,0.0,0.0,43.0
Mandya,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mandya,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,1.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Mandya,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2298.0,2320.0,2299.0,2420.0,2058.0,2199.0,1992.0,2092.0,2205.0,1997.0,2037.0,1979.0,25896.0
Mandya,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2171.0,2019.0,2343.0,2453.0,2186.0,2305.0,1984.0,2031.0,2134.0,2061.0,1920.0,2105.0,25712.0
Mandya,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2173.0,2032.0,2127.0,2498.0,2258.0,2508.0,2129.0,1974.0,2078.0,2054.0,2034.0,2046.0,25911.0
Mandya,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1874.0,1764.0,1588.0,1825.0,1611.0,1675.0,1684.0,1638.0,1593.0,1586.0,1606.0,1645.0,20089.0
Mandya,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2298.0,2326.0,2298.0,2420.0,2048.0,2191.0,1992.0,2091.0,2195.0,2000.0,2037.0,1979.0,25875.0
Mandya,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2171.0,2020.0,2341.0,2455.0,2175.0,2293.0,1984.0,2031.0,2132.0,2059.0,1920.0,2102.0,25683.0
Mandya,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2173.0,2032.0,2130.0,2494.0,2254.0,2501.0,2132.0,1974.0,2078.0,2053.0,2034.0,2049.0,25904.0
Mandya,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1554.0,1622.0,1109.0,1590.0,1229.0,1310.0,1528.0,1480.0,1480.0,1472.0,1457.0,1536.0,17367.0
Mandya,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,20.0,20.0,34.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,74.0
Mandya,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,15.0,24.0,36.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,76.0
Mandya,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,24.0,22.0,37.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,85.0
Mandya,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2139.0,1996.0,2143.0,2212.0,1913.0,2261.0,2041.0,2089.0,2001.0,2109.0,2050.0,2086.0,25040.0
Mandya,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1902.0,1864.0,2023.0,2088.0,1814.0,2003.0,2021.0,2156.0,2024.0,1673.0,1806.0,1729.0,23103.0
Mandya,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,1904.0,1220.0,1548.0,1738.0,1804.0,2146.0,1920.0,2028.0,2013.0,2142.0,2039.0,2072.0,22574.0
Mandya,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1150.0,1082.0,1103.0,1168.0,975.0,1195.0,1068.0,1128.0,1067.0,1125.0,1092.0,1102.0,13255.0
Mandya,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,985.0,915.0,1043.0,1052.0,942.0,1078.0,967.0,961.0,936.0,984.0,953.0,1007.0,11823.0
Mandya,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2135.0,1997.0,2146.0,2220.0,1917.0,2273.0,2035.0,2089.0,2003.0,2109.0,2045.0,2109.0,25078.0
Mandya,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1924.0,1876.0,2109.0,2161.0,1856.0,2123.0,2010.0,2153.0,2013.0,1682.0,1799.0,1716.0,23422.0
Mandya,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1923.0,1875.0,2110.0,2154.0,1854.0,2122.0,2010.0,2153.0,2013.0,1682.0,1799.0,1716.0,23411.0
Mandya,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,10.0,3.0,3.0,6.0,32.0,0.0,3.0,8.0,2.0,6.0,0.0,73.0
Mandya,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1026.0,994.0,1123.0,1117.0,998.0,1106.0,1064.0,1126.0,1049.0,914.0,963.0,890.0,12370.0
Mandya,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,896.0,875.0,985.0,1046.0,871.0,1012.0,954.0,1015.0,959.0,769.0,829.0,826.0,11037.0
Mandya,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1922.0,1869.0,2108.0,2163.0,1869.0,2118.0,2018.0,2141.0,2008.0,1683.0,1792.0,1716.0,23407.0
Mandya,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,101.0,117.0,50.0,796.0,2868.0,6001.0,834.0,3996.0,1891.0,1460.0,484.0,2281.0,20879.0
Mandya,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,82.0,84.0,56.0,642.0,2748.0,5868.0,666.0,3576.0,1557.0,1544.0,422.0,2305.0,19550.0
Mandya,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,62.0,66.0,37.0,435.0,2959.0,6253.0,709.0,5236.0,1663.0,1565.0,557.0,2542.0,22084.0
Mandya,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,2.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0,0.0,7.0
Mandya,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mandya,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1121.0,1057.0,1090.0,1140.0,1080.0,1175.0,1110.0,1114.0,1186.0,1114.0,1131.0,1119.0,13437.0
Mandya,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1108.0,1044.0,1087.0,1134.0,1065.0,1161.0,1098.0,1105.0,1182.0,1104.0,1119.0,1104.0,13311.0
Mandya,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,888.0,862.0,836.0,903.0,848.0,909.0,847.0,855.0,929.0,849.0,851.0,852.0,10429.0
Mandya,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,1718.0,1275.0,1538.0,1817.0,1885.0,2037.0,1829.0,2013.0,2093.0,1887.0,1748.0,1640.0,21480.0
Mandya,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2114.0,1988.0,2131.0,2219.0,1967.0,2199.0,1943.0,2039.0,1937.0,2113.0,2191.0,2089.0,24930.0
Mandya,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,0.0,0.0,2.0,13642.0,22013.0,15.0,1.0,0.0,0.0,0.0,22112.0,15012.0,72797.0
Mandya,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,0.0,0.0,129.0,13111.0,20136.0,9.0,0.0,0.0,0.0,0.0,19793.0,15192.0,68370.0
Mandya,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,39.0,2.0,1.0,2.0,1.0,0.0,1.0,6.0,0.0,7.0,2.0,0.0,61.0
Mandya,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,457.0,452.0,421.0,404.0,456.0,414.0,428.0,387.0,379.0,376.0,443.0,376.0,4993.0
Mandya,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,2.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,0.0,99.0,0.0,103.0
Mandya,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,101.0,107.0,117.0,109.0,87.0,89.0,103.0,97.0,72.0,132.0,127.0,112.0,1253.0
Mandya,13.1,Number of Patients operated for cataract,TOTAL,159.0,123.0,136.0,40.0,91.0,111.0,140.0,102.0,160.0,99.0,115.0,113.0,1389.0
Mandya,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,159.0,123.0,136.0,40.0,91.0,111.0,140.0,102.0,160.0,99.0,115.0,113.0,1389.0
Mandya,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,6.0,14.0,18.0,27.0,1.0,70.0,31.0,129.0,87.0,182.0,565.0
Mandya,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,62.0,7.0,160.0,161.0,31.0,421.0
Mandya,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,6.0,7.0,6.0,8.0,7.0,8.0,7.0,7.0,7.0,7.0,-1.0
Mandya,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,29.0,27.0,27.0,30.0,32.0,29.0,30.0,28.0,29.0,28.0,25.0,26.0,-1.0
Mandya,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,373.0,365.0,369.0,366.0,365.0,363.0,363.0,380.0,353.0,364.0,356.0,360.0,-1.0
Mandya,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,8.0,6.0,7.0,7.0,8.0,7.0,7.0,8.0,10.0,9.0,8.0,-1.0
Mandya,14.05,Number of RKS meetings held during the month,TOTAL,7.0,7.0,6.0,3.0,5.0,6.0,3.0,3.0,6.0,21.0,19.0,22.0,108.0
Mandya,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,23.0,24.0,25.0,28.0,28.0,28.0,28.0,24.0,24.0,21.0,19.0,21.0,-1.0
Mandya,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,759.0,718.0,749.0,465.0,505.0,437.0,605.0,604.0,519.0,557.0,513.0,543.0,6974.0
Mandya,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,4.0,3.0,3.0,2.0,2.0,2.0,3.0,3.0,3.0,4.0,2.0,3.0,-1.0
Mandya,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,1.0,0.0,1.0,0.0,1.0,1.0,34.0,1.0,0.0,0.0,0.0,5.0,-1.0
Mandya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,998.0,1189.0,1834.0,1519.0,1771.0,1731.0,1843.0,1835.0,2266.0,2218.0,1870.0,2078.0,21152.0
Mandya,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3787.0,4824.0,6727.0,6635.0,7427.0,7706.0,5960.0,5988.0,6135.0,5936.0,6331.0,6276.0,73732.0
Mandya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,794.0,857.0,2511.0,1547.0,1634.0,1653.0,1361.0,1637.0,1820.0,1655.0,1487.0,1698.0,18654.0
Mandya,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5797.0,6480.0,8478.0,7084.0,7347.0,7499.0,7418.0,7452.0,7467.0,6996.0,7807.0,7603.0,87428.0
Mandya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1792.0,2046.0,4345.0,3066.0,3405.0,3384.0,3204.0,3472.0,4086.0,3873.0,3357.0,3776.0,39806.0
Mandya,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,9584.0,11304.0,15205.0,13719.0,14774.0,15205.0,13378.0,13440.0,13602.0,12932.0,14138.0,13879.0,161160.0
Mandya,14.10.2.a,Number of death cases of Inpatient males,TOTAL,77.0,92.0,66.0,59.0,80.0,78.0,85.0,84.0,94.0,95.0,83.0,86.0,979.0
Mandya,14.10.2.b,Number of death cases of Inpatient females,TOTAL,56.0,81.0,31.0,36.0,39.0,43.0,39.0,48.0,50.0,41.0,28.0,61.0,553.0
Mandya,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,133.0,173.0,97.0,95.0,119.0,121.0,124.0,132.0,144.0,136.0,111.0,147.0,1532.0
Mandya,14.11,In-Patient Head Count at midnight,TOTAL,42124.0,15893.0,19292.0,13991.0,16859.0,16798.0,15073.0,19051.0,19268.0,20116.0,20182.0,20614.0,239261.0
Mandya,14.12.1,OPD attendance (All),TOTAL,234669.0,229439.0,243856.0,246610.0,248566.0,255931.0,228736.0,238709.0,257627.0,245612.0,248463.0,248925.0,2927143.0
Mandya,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,842.0,858.0,1117.0,769.0,536.0,632.0,675.0,647.0,725.0,614.0,639.0,588.0,8642.0
Mandya,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,82.0,73.0,66.0,76.0,47.0,43.0,69.0,77.0,125.0,91.0,125.0,74.0,948.0
Mandya,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1080.0,1198.0,2309.0,1059.0,859.0,936.0,1056.0,1151.0,1095.0,853.0,1106.0,755.0,13457.0
Mandya,14.14.a,Number of patients given AYUSH treatment,TOTAL,4620.0,4252.0,4210.0,4472.0,3808.0,4016.0,3934.0,4960.0,4634.0,6072.0,5716.0,5642.0,56336.0
Mandya,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,3324.0,3381.0,3590.0,3828.0,3253.0,3420.0,3204.0,3764.0,3703.0,3950.0,3782.0,3850.0,43049.0
Mandya,14.14.c,Number of Adolescents counselled,TOTAL,1163.0,1149.0,1261.0,1203.0,1165.0,1261.0,1111.0,1252.0,1552.0,1381.0,1474.0,1410.0,15382.0
Mandya,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,14546.0,9249.0,22684.0,18455.0,17554.0,15688.0,14547.0,17527.0,16910.0,16534.0,11504.0,16296.0,191494.0
Mandya,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,1713.0,283.0,2222.0,2987.0,2831.0,2934.0,1972.0,1593.0,1447.0,444.0,473.0,1469.0,20368.0
Mandya,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2859.0,2554.0,2998.0,2977.0,2601.0,2807.0,2487.0,3160.0,3618.0,2528.0,2804.0,2818.0,34211.0
Mandya,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,21.0,38.0,27.0,127.0,29.0,43.0,38.0,38.0,34.0,13.0,6.0,18.0,432.0
Mandya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2538.0,1788.0,2246.0,1636.0,1545.0,1879.0,1779.0,2121.0,1910.0,1722.0,1279.0,1369.0,21812.0
Mandya,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,29.0,24.0,20.0,18.0,23.0,28.0,33.0,18.0,32.0,10.0,10.0,15.0,260.0
Mandya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3051.0,3123.0,2931.0,3171.0,2880.0,3130.0,3192.0,3616.0,2532.0,3077.0,2252.0,2078.0,35033.0
Mandya,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,9.0,12.0,0.0,2.0,1.0,6.0,6.0,8.0,3.0,2.0,2.0,2.0,53.0
Mandya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,8448.0,7465.0,8175.0,7784.0,7026.0,7816.0,7458.0,8897.0,8060.0,7327.0,6335.0,6265.0,91056.0
Mandya,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,59.0,74.0,47.0,147.0,53.0,77.0,77.0,64.0,69.0,25.0,18.0,35.0,745.0
Mandya,15.2,Number of Widal tests conducted,Number tested,2614.0,2461.0,2857.0,3125.0,3397.0,2772.0,2380.0,2753.0,2317.0,2928.0,2352.0,2934.0,32890.0
Mandya,15.3.a,Number of VDRL tests conducted on males,Number tested,490.0,398.0,794.0,775.0,591.0,533.0,562.0,781.0,719.0,477.0,277.0,287.0,6684.0
Mandya,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,839.0,452.0,1277.0,755.0,525.0,695.0,692.0,489.0,666.0,644.0,396.0,378.0,7808.0
Mandya,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2641.0,2548.0,2160.0,2715.0,2507.0,2774.0,2160.0,2902.0,1909.0,2408.0,1745.0,1667.0,28136.0
Mandya,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3970.0,3398.0,4231.0,4245.0,3623.0,4002.0,3414.0,4172.0,3294.0,3529.0,2418.0,2332.0,42628.0
Mandya,15.4.1,Number of blood smears examined for Malaria,TOTAL,18699.0,16994.0,22401.0,25297.0,24700.0,27304.0,19853.0,22579.0,22303.0,19080.0,20792.0,23005.0,263007.0
Mandya,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,1.0,2.0,404.0,6.0,10.0,7.0,0.0,2.0,4.0,3.0,3.0,0.0,442.0
Mandya,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,1.0
Mandya,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,4170.0,420.0,570.0,1610.0,2030.0,2610.0,2550.0,1150.0,4200.0,1200.0,1050.0,3450.0,25010.0
Mandya,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,4000.0,6000.0,10000.0,5000.0,10000.0,6000.0,12000.0,3000.0,5000.0,6000.0,5000.0,72000.0
Mandya,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,3750.0,3850.0,4960.0,9580.0,4420.0,10060.0,7400.0,8950.0,6000.0,5150.0,3600.0,3260.0,70980.0
Mandya,16.1.1,Stock position of DPT vaccines,5. Total Stock,420.0,570.0,1610.0,2030.0,2610.0,2550.0,1150.0,4200.0,1200.0,1050.0,3450.0,5190.0,26030.0
Mandya,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,11030.0,4480.0,3370.0,1490.0,3600.0,5200.0,4970.0,3670.0,5000.0,2870.0,1570.0,1800.0,49050.0
Mandya,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,6000.0,4000.0,9000.0,10000.0,5000.0,6000.0,16000.0,4000.0,6000.0,7000.0,8000.0,81000.0
Mandya,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,6550.0,7110.0,5880.0,6890.0,8400.0,5230.0,7300.0,14670.0,6130.0,7300.0,6770.0,5700.0,87930.0
Mandya,16.1.1A,Stock Position of Pentavalent,5. Total Stock,4480.0,3370.0,1490.0,3600.0,5200.0,4970.0,3670.0,5000.0,2870.0,1570.0,1800.0,4100.0,42120.0
Mandya,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,18420.0,9120.0,3360.0,6240.0,6340.0,5620.0,7380.0,2280.0,1480.0,2140.0,3860.0,13700.0,79940.0
Mandya,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,8000.0,16000.0,15000.0,15000.0,15000.0,12000.0,12000.0,12000.0,228000.0,233000.0,5000.0,571000.0
Mandya,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,9300.0,13760.0,13120.0,14900.0,15720.0,13240.0,17100.0,12800.0,11340.0,226280.0,223160.0,8340.0,579060.0
Mandya,16.1.2,Stock position of OPV vaccines,5. Total Stock,9120.0,3360.0,6240.0,6340.0,5620.0,7380.0,2280.0,1480.0,2140.0,3860.0,13700.0,10360.0,71880.0
Mandya,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,14990.0,9280.0,7840.0,2960.0,6190.0,8740.0,5860.0,1760.0,5650.0,3240.0,4330.0,3090.0,73930.0
Mandya,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,4000.0,3000.0,16000.0,18000.0,10000.0,10000.0,22000.0,8000.0,8000.0,5000.0,4000.0,108000.0
Mandya,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.3,Stock position of TT vaccines,4. Stock Distributed,5710.0,5440.0,7880.0,12770.0,15450.0,12880.0,14100.0,18110.0,10410.0,6910.0,6240.0,4890.0,120790.0
Mandya,16.1.3,Stock position of TT vaccines,5. Total Stock,9280.0,7840.0,2960.0,6190.0,8740.0,5860.0,1760.0,5650.0,3240.0,4330.0,3090.0,2200.0,61140.0
Mandya,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,9060.0,4890.0,4440.0,4400.0,4020.0,3700.0,3780.0,3370.0,3480.0,3170.0,1950.0,1310.0,47570.0
Mandya,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,4000.0,4000.0,4000.0,4000.0,3000.0,4000.0,4000.0,3000.0,2500.0,3000.0,3000.0,38500.0
Mandya,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,4170.0,4450.0,4040.0,4380.0,4320.0,2920.0,4410.0,3890.0,3310.0,3720.0,3640.0,3780.0,47030.0
Mandya,16.1.5,Stock position of BCG vaccines,5. Total Stock,4890.0,4440.0,4400.0,4020.0,3700.0,3780.0,3370.0,3480.0,3170.0,1950.0,1310.0,530.0,39040.0
Mandya,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6850.0,2055.0,985.0,1145.0,1570.0,3720.0,3615.0,1315.0,1635.0,2125.0,910.0,0.0,25925.0
Mandya,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,4000.0,5000.0,6000.0,8000.0,4000.0,4000.0,5000.0,5000.0,3000.0,4500.0,6000.0,54500.0
Mandya,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4795.0,5070.0,4840.0,5575.0,5850.0,4105.0,6300.0,4680.0,4510.0,4215.0,5410.0,4730.0,60080.0
Mandya,16.1.6,Stock position of Measles vaccines,5. Total Stock,2055.0,985.0,1145.0,1570.0,3720.0,3615.0,1315.0,1635.0,2125.0,910.0,0.0,1270.0,20345.0
Mandya,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,5875.0,2475.0,2445.0,25.0,30.0,4185.0,745.0,770.0,1600.0,4480.0,3325.0,3145.0,29100.0
Mandya,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,5000.0,0.0,5000.0,11830.0,0.0,5000.0,5000.0,10000.0,5000.0,5000.0,5000.0,56830.0
Mandya,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.7,Stock position of JE vaccines,4. Stock Distributed,3400.0,5030.0,2420.0,4995.0,7675.0,3440.0,4975.0,4170.0,7120.0,6155.0,5180.0,4920.0,59480.0
Mandya,16.1.7,Stock position of JE vaccines,5. Total Stock,2475.0,2445.0,25.0,30.0,4185.0,745.0,770.0,1600.0,4480.0,3325.0,3145.0,3225.0,26450.0
Mandya,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2050.0,1490.0,2880.0,1790.0,1670.0,610.0,1720.0,920.0,670.0,660.0,600.0,1940.0,17000.0
Mandya,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,2500.0,0.0,1000.0,0.0,2100.0,600.0,900.0,1000.0,1000.0,2500.0,1000.0,12600.0
Mandya,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,560.0,1110.0,1090.0,1120.0,1060.0,990.0,1400.0,1150.0,1010.0,1060.0,1160.0,1340.0,13050.0
Mandya,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,1490.0,2880.0,1790.0,1670.0,610.0,1720.0,920.0,670.0,660.0,600.0,1940.0,1600.0,16550.0
Mandya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,1700.0,1700.0,9600.0,0.0,14800.0
Mandya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,0.0,0.0,9600.0,0.0,0.0,11400.0
Mandya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0,0.0,1700.0,9600.0,0.0,11400.0
Mandya,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,1800.0,1700.0,1700.0,9600.0,0.0,0.0,14800.0
Mandya,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50400.0,50400.0,50400.0,60000.0,0.0,211200.0
Mandya,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,151200.0,50400.0,0.0,0.0,60000.0,0.0,0.0,261600.0
Mandya,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,151200.0,0.0,0.0,0.0,50400.0,60000.0,0.0,261600.0
Mandya,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,50400.0,50400.0,50400.0,60000.0,0.0,0.0,211200.0
Mandya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,16000.0,16000.0,12400.0,0.0,60400.0
Mandya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,0.0,12400.0,0.0,0.0,28400.0
Mandya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,12400.0,0.0,28400.0
Mandya,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,16000.0,16000.0,16000.0,12400.0,0.0,0.0,60400.0
Mandya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2504.0,0.0,2504.0
Mandya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2504.0,0.0,0.0,2504.0
Mandya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2504.0,0.0,2504.0
Mandya,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2504.0,0.0,0.0,2504.0
Mandya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15497.0,15497.0,30994.0
Mandya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15497.0,0.0,0.0,15497.0
Mandya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,15497.0,15497.0,15497.0,46491.0
Mandya,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,3331.0,3305.0,3280.0,3258.0,3234.0,913.0,888.0,864.0,839.0,813.0,788.0,2962.0,24475.0
Mandya,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2200.0,0.0,2200.0
Mandya,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,26.0,25.0,22.0,24.0,2321.0,25.0,24.0,25.0,26.0,25.0,26.0,2914.0,5483.0
Mandya,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,3305.0,3280.0,3258.0,3234.0,913.0,888.0,864.0,839.0,813.0,788.0,2962.0,48.0,21192.0
Mandya,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,6080.0,3070.0,2795.0,785.0,1375.0,2615.0,1135.0,905.0,0.0,1175.0,3035.0,1725.0,24695.0
Mandya,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,2000.0,0.0,3300.0,3300.0,0.0,3300.0,0.0,3300.0,3300.0,1000.0,13900.0,33400.0
Mandya,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3010.0,2275.0,2010.0,2710.0,2060.0,1480.0,3530.0,905.0,2125.0,1440.0,2310.0,2725.0,26580.0
Mandya,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,3070.0,2795.0,785.0,1375.0,2615.0,1135.0,905.0,0.0,1175.0,3035.0,1725.0,12900.0,31515.0
Mandya,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,84200.0,60600.0,79000.0,55200.0,28800.0,13900.0,7900.0,40900.0,14500.0,64100.0,39800.0,15450.0,504350.0
Mandya,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,40000.0,0.0,0.0,5000.0,10000.0,74000.0,0.0,72000.0,0.0,0.0,321600.0,522600.0
Mandya,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,23600.0,21600.0,23800.0,26400.0,19900.0,15600.0,41000.0,26400.0,22400.0,24300.0,24350.0,19700.0,289050.0
Mandya,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,60600.0,79000.0,55200.0,28800.0,13900.0,8300.0,40900.0,14500.0,64100.0,39800.0,15450.0,317350.0,737900.0
Mandya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,2790.0,1085.0,2670.0,1410.0,1330.0,140.0,880.0,7080.0,4890.0,11970.0,12335.0,12860.0,59440.0
Mandya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,2600.0,0.0,2400.0,0.0,2400.0,9600.0,0.0,9600.0,2400.0,2400.0,6400.0,37800.0
Mandya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mandya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1705.0,1015.0,1260.0,2480.0,1190.0,1660.0,3400.0,2190.0,2520.0,2035.0,1875.0,1915.0,23245.0
Mandya,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,1085.0,2670.0,1410.0,1330.0,140.0,880.0,7080.0,4890.0,11970.0,12335.0,12860.0,17345.0,73995.0
Mandya,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,3.0,,,,2.0,,4.0,4.0,5.0,3.0,2.0,1.0,24.0
Mandya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,2.0,2.0,,1.0,1.0,6.0,1.0,,,2.0,3.0,,18.0
Mandya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,2.0,2.0,4.0
Mandya,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,2.0,2.0,,1.0,1.0,6.0,1.0,,,2.0,5.0,2.0,22.0
Mandya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,4.0,5.0,2.0,1.0,2.0,5.0,4.0,3.0,5.0,2.0,1.0,4.0,38.0
Mandya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,1.0,,,3.0,1.0,,6.0
Mandya,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,4.0,6.0,2.0,1.0,2.0,5.0,5.0,3.0,5.0,5.0,2.0,4.0,44.0
Mandya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,4.0,,,,1.0,1.0,1.0,,2.0,1.0,10.0
Mandya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,2.0,,,,,,2.0,1.0,,,2.0,1.0,8.0
Mandya,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,2.0,,4.0,,,,3.0,2.0,1.0,,4.0,2.0,18.0
Mandya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,3.0,3.0,5.0,2.0,2.0,3.0,1.0,2.0,2.0,3.0,3.0,1.0,30.0
Mandya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,1.0,,,,2.0,1.0,1.0,2.0,2.0,2.0,3.0,15.0
Mandya,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,4.0,5.0,2.0,2.0,5.0,2.0,3.0,4.0,5.0,5.0,4.0,45.0
Mandya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,4.0,2.0,1.0,,2.0,,3.0,4.0,,,2.0,1.0,19.0
Mandya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,1.0,,,,,1.0
Mandya,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,4.0,2.0,1.0,,2.0,,3.0,5.0,,,2.0,1.0,20.0
Mandya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mandya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mandya,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Mandya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mandya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,,,,,,,,,1.0,,,2.0
Mandya,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,,,,1.0,,,2.0
Mandya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mandya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mandya,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mandya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,5.0,9.0,9.0,3.0,10.0,4.0,10.0,13.0,13.0,7.0,10.0,11.0,104.0
Mandya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,2.0,,2.0,3.0,3.0,1.0,,3.0,4.0,18.0
Mandya,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,5.0,9.0,9.0,5.0,10.0,6.0,13.0,16.0,14.0,7.0,13.0,15.0,122.0
Mandya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,1.0,,,,,,,,,,,1.0
Mandya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,1.0,,,1.0,1.0,2.0,,,,,,5.0
Mandya,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,,1.0,1.0,2.0,,,,,,6.0
Mandya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,1.0,,,1.0
Mandya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,7.0,2.0,1.0,3.0,5.0,1.0,3.0,1.0,3.0,2.0,3.0,33.0
Mandya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,2.0,1.0,,,2.0,1.0,4.0,1.0,2.0,3.0,18.0
Mandya,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,3.0,8.0,4.0,2.0,3.0,5.0,3.0,4.0,5.0,5.0,4.0,6.0,52.0
Mandya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,1.0,,,,,,,2.0
Mandya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,6.0,5.0,3.0,8.0,8.0,6.0,6.0,4.0,7.0,6.0,5.0,7.0,71.0
Mandya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,35.0,21.0,19.0,19.0,29.0,32.0,25.0,25.0,35.0,40.0,24.0,43.0,347.0
Mandya,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,41.0,26.0,22.0,27.0,38.0,39.0,31.0,29.0,42.0,46.0,29.0,50.0,420.0
Mandya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Mandya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Mandya,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,1.0,,,,1.0
Mandya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,1.0,,,,2.0
Mandya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,2.0,2.0,,1.0,,,4.0,,2.0,,,1.0,12.0
Mandya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,1.0,1.0,,,,2.0,,2.0,1.0,,3.0,12.0
Mandya,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,4.0,3.0,1.0,1.0,,1.0,6.0,,5.0,1.0,,4.0,26.0
Mandya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,3.0,5.0,4.0,5.0,3.0,,3.0,3.0,1.0,5.0,3.0,38.0
Mandya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,,,,1.0,1.0,,1.0,,2.0,,1.0,7.0
Mandya,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,4.0,3.0,5.0,4.0,6.0,4.0,,4.0,3.0,3.0,5.0,4.0,45.0
Mandya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,1.0,1.0,1.0,,,,4.0
Mandya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,48.0,39.0,32.0,44.0,44.0,35.0,34.0,39.0,44.0,52.0,48.0,38.0,497.0
Mandya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,82.0,49.0,62.0,54.0,60.0,59.0,69.0,58.0,78.0,75.0,78.0,54.0,778.0
Mandya,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,130.0,88.0,95.0,98.0,104.0,94.0,104.0,98.0,123.0,127.0,126.0,92.0,1279.0
Mandya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,1.0,,,2.0,1.0,,,,1.0,,,6.0
Mandya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,7.0,8.0,7.0,7.0,10.0,10.0,4.0,12.0,9.0,13.0,7.0,4.0,98.0
Mandya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,32.0,26.0,38.0,31.0,34.0,26.0,30.0,29.0,34.0,47.0,36.0,28.0,391.0
Mandya,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,40.0,35.0,45.0,38.0,46.0,37.0,34.0,41.0,43.0,61.0,43.0,32.0,495.0
Mandya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Mandya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mandya,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Mandya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,1.0,1.0
Mandya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mandya,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,1.0,1.0
Mandya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Mandya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mandya,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,,,,,,,,1.0
Mandya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,1.0,,,,,,,,,,,1.0
Mandya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mandya,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,1.0,,,,,,,,,,,1.0
Mandya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mandya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mandya,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mandya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,1.0,,,,,,1.0,2.0
Mandya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mandya,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,1.0,,,,,,1.0,2.0
Mandya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,3.0,,,1.0,,,4.0,2.0,1.0,4.0,1.0,,16.0
Mandya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,16.0,17.0,16.0,13.0,15.0,16.0,24.0,30.0,11.0,30.0,19.0,19.0,226.0
Mandya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,4.0,8.0,7.0,3.0,5.0,4.0,8.0,6.0,2.0,8.0,1.0,5.0,61.0
Mandya,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,23.0,25.0,23.0,17.0,20.0,20.0,36.0,38.0,14.0,42.0,21.0,24.0,303.0
Mandya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,5.0,2.0,1.0,1.0,1.0,1.0,1.0,,1.0,1.0,14.0
Mandya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,50.0,38.0,45.0,48.0,59.0,38.0,50.0,50.0,37.0,39.0,46.0,45.0,545.0
Mandya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,12.0,6.0,15.0,11.0,12.0,12.0,15.0,17.0,13.0,14.0,7.0,13.0,147.0
Mandya,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,62.0,44.0,65.0,61.0,72.0,51.0,66.0,68.0,51.0,53.0,54.0,59.0,706.0
Mandya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Mandya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,,1.0,2.0,,3.0,2.0,1.0,1.0,1.0,,11.0
Mandya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,1.0,,,,,2.0,1.0,2.0,1.0,,,8.0
Mandya,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,,1.0,2.0,,5.0,3.0,3.0,2.0,1.0,,19.0
Mandya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,2.0,,1.0,,,,1.0,,,5.0
Mandya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,18.0,18.0,13.0,20.0,16.0,13.0,14.0,16.0,11.0,20.0,21.0,25.0,205.0
Mandya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,31.0,42.0,48.0,38.0,36.0,49.0,35.0,32.0,41.0,62.0,46.0,30.0,490.0
Mandya,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,49.0,61.0,61.0,60.0,52.0,63.0,49.0,48.0,52.0,83.0,67.0,55.0,700.0
Mandya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,1.0,1.0,,3.0,1.0,,,,,7.0
Mandya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,17.0,13.0,21.0,22.0,28.0,26.0,32.0,21.0,20.0,20.0,22.0,12.0,254.0
Mandya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,50.0,48.0,47.0,55.0,60.0,73.0,57.0,75.0,65.0,65.0,58.0,56.0,709.0
Mandya,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,67.0,62.0,68.0,78.0,89.0,99.0,92.0,97.0,85.0,85.0,80.0,68.0,970.0
Mandya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,4.0,1.0,3.0,3.0,3.0,3.0,2.0,3.0,2.0,6.0,1.0,2.0,33.0
Mandya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,60.0,49.0,59.0,65.0,58.0,56.0,89.0,51.0,81.0,78.0,58.0,73.0,777.0
Mandya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,252.0,203.0,252.0,285.0,288.0,298.0,308.0,306.0,319.0,370.0,310.0,274.0,3465.0
Mandya,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,316.0,253.0,314.0,353.0,349.0,357.0,399.0,360.0,402.0,454.0,369.0,349.0,4275.0
Mysore,1.1,Total number of pregnant women Registered for ANC,TOTAL,3416.0,3286.0,3684.0,3416.0,3837.0,3721.0,3796.0,3900.0,3509.0,3505.0,3519.0,3295.0,42884.0
Mysore,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,3393.0,3262.0,3275.0,3099.0,3349.0,3808.0,3525.0,3504.0,3357.0,3413.0,2931.0,2941.0,39857.0
Mysore,1.2,Number of Pregnant women registered under JSY,TOTAL,2766.0,2806.0,2980.0,2916.0,3127.0,3143.0,3088.0,3149.0,2747.0,2703.0,2500.0,2484.0,34409.0
Mysore,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,5386.0,5969.0,4954.0,4783.0,5107.0,5009.0,4836.0,5137.0,4541.0,5311.0,5922.0,5743.0,62698.0
Mysore,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3806.0,3694.0,3798.0,3519.0,3520.0,4019.0,3508.0,3794.0,3404.0,3541.0,3147.0,3575.0,43325.0
Mysore,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3786.0,3861.0,4041.0,3888.0,3753.0,4167.0,3847.0,4084.0,3863.0,3909.0,3473.0,3631.0,46303.0
Mysore,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2847.0,3285.0,2380.0,2519.0,2533.0,2866.0,2825.0,3006.0,2817.0,2824.0,2710.0,2838.0,33450.0
Mysore,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,206.0,222.0,214.0,284.0,288.0,194.0,240.0,183.0,203.0,200.0,164.0,317.0,2715.0
Mysore,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,11.0,19.0,34.0,11.0,8.0,10.0,16.0,17.0,8.0,16.0,12.0,23.0,185.0
Mysore,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3063.0,3068.0,3960.0,3829.0,2982.0,3886.0,3356.0,3701.0,4452.0,3987.0,3504.0,3726.0,43514.0
Mysore,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,121.0,131.0,158.0,151.0,127.0,270.0,173.0,137.0,94.0,107.0,124.0,137.0,1730.0
Mysore,1.8,Number of pregnancy test kits used at SC level,TOTAL,343.0,430.0,433.0,379.0,410.0,449.0,383.0,470.0,426.0,584.0,612.0,559.0,5478.0
Mysore,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,2.0,1.0,0.0,1.0,0.0,1.0,6.0
Mysore,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,2.0,1.0,0.0,1.0,0.0,1.0,6.0
Mysore,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,1.0,0.0,1.0,6.0
Mysore,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2698.0,2696.0,2423.0,2439.0,2513.0,2471.0,2677.0,2548.0,2609.0,2618.0,2520.0,2535.0,30747.0
Mysore,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,412.0,413.0,241.0,578.0,295.0,253.0,334.0,942.0,146.0,201.0,162.0,81.0,4058.0
Mysore,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,228.0,225.0,333.0,208.0,235.0,279.0,414.0,387.0,596.0,456.0,341.0,341.0,4043.0
Mysore,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,2.0,0.0,0.0,28.0,12.0,4.0,28.0,0.0,2.0,18.0,94.0
Mysore,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,547.0,348.0,364.0,189.0,192.0,84.0,226.0,358.0,274.0,355.0,370.0,383.0,3690.0
Mysore,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,4.0,11.0,15.0,11.0,11.0,8.0,9.0,9.0,5.0,83.0
Mysore,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,13.0,16.0,9.0,11.0,17.0,19.0,10.0,13.0,7.0,5.0,8.0,15.0,143.0
Mysore,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,341.0,310.0,307.0,309.0,407.0,350.0,383.0,318.0,426.0,342.0,358.0,390.0,4241.0
Mysore,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,354.0,326.0,316.0,324.0,435.0,384.0,404.0,342.0,441.0,356.0,375.0,410.0,4467.0
Mysore,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,200.0,143.0,154.0,37.0,131.0,27.0,92.0,195.0,123.0,157.0,200.0,194.0,1653.0
Mysore,4.1.1.a,Number of male live births,TOTAL,1644.0,1534.0,1458.0,1448.0,1436.0,1464.0,1450.0,1415.0,1494.0,1506.0,1432.0,1463.0,17744.0
Mysore,4.1.1.b,Number of female live births,TOTAL,1572.0,1571.0,1342.0,1307.0,1350.0,1468.0,1472.0,1462.0,1316.0,1416.0,1390.0,1400.0,17066.0
Mysore,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3216.0,3105.0,2800.0,2755.0,2786.0,2932.0,2922.0,2877.0,2810.0,2922.0,2822.0,2863.0,34810.0
Mysore,4.1.2,Number of still births,TOTAL,76.0,79.0,42.0,71.0,52.0,52.0,79.0,71.0,61.0,58.0,68.0,56.0,765.0
Mysore,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,132.0,142.0,115.0,129.0,150.0,150.0,121.0,151.0,112.0,106.0,117.0,72.0,1497.0
Mysore,4.2.1,Number of Newborns weighed at birth,TOTAL,3191.0,3069.0,2764.0,2498.0,2701.0,2890.0,2894.0,2797.0,2800.0,2923.0,2840.0,2884.0,34251.0
Mysore,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,433.0,482.0,214.0,453.0,411.0,303.0,380.0,370.0,344.0,306.0,397.0,236.0,4329.0
Mysore,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,3228.0,3121.0,2781.0,2670.0,2632.0,2925.0,2857.0,2560.0,2810.0,2725.0,2597.0,2616.0,33522.0
Mysore,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,8.0,23.0,12.0,36.0,26.0,35.0,10.0,29.0,19.0,29.0,26.0,20.0,273.0
Mysore,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,4.0,5.0,3.0,2.0,9.0,11.0,5.0,0.0,0.0,4.0,7.0,9.0,59.0
Mysore,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,195.0,294.0,417.0,224.0,304.0,206.0,329.0,393.0,388.0,330.0,195.0,638.0,3913.0
Mysore,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,207.0,322.0,432.0,262.0,339.0,252.0,344.0,422.0,407.0,363.0,228.0,667.0,4245.0
Mysore,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,6.0,16.0,5.0,4.0,75.0,24.0,3.0,6.0,0.0,8.0,8.0,10.0,165.0
Mysore,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,431.0,503.0,595.0,611.0,656.0,663.0,491.0,550.0,316.0,255.0,370.0,372.0,5813.0
Mysore,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,46.0,61.0,29.0,61.0,70.0,71.0,40.0,55.0,56.0,54.0,51.0,63.0,657.0
Mysore,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1216.0,1316.0,1509.0,578.0,1239.0,1223.0,1267.0,1316.0,1554.0,1047.0,1187.0,1061.0,14513.0
Mysore,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,22.0,49.0,60.0,37.0,61.0,69.0,62.0,60.0,36.0,62.0,57.0,57.0,632.0
Mysore,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,3225.0,2763.0,2776.0,2754.0,2705.0,2701.0,2469.0,2701.0,2740.0,2866.0,2683.0,2903.0,33286.0
Mysore,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3030.0,2759.0,3295.0,2535.0,2652.0,3340.0,3347.0,2555.0,3638.0,3392.0,4176.0,4081.0,38800.0
Mysore,6.3,PNC maternal complications attended,TOTAL,38.0,33.0,36.0,29.0,81.0,70.0,68.0,37.0,28.0,44.0,38.0,154.0,656.0
Mysore,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,37.0,30.0,29.0,60.0,69.0,40.0,48.0,47.0,35.0,53.0,50.0,21.0,519.0
Mysore,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,28.0,33.0,31.0,20.0,34.0,16.0,12.0,29.0,12.0,22.0,22.0,12.0,271.0
Mysore,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,65.0,63.0,60.0,80.0,103.0,56.0,60.0,76.0,47.0,75.0,72.0,33.0,790.0
Mysore,7.2,Number of MTPs conducted at Private Facilities,TOTAL,46.0,62.0,54.0,16.0,59.0,93.0,31.0,54.0,29.0,44.0,50.0,93.0,631.0
Mysore,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,671.0,646.0,665.0,697.0,758.0,731.0,584.0,651.0,665.0,665.0,666.0,758.0,8157.0
Mysore,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,908.0,831.0,883.0,892.0,959.0,848.0,730.0,901.0,954.0,935.0,881.0,969.0,10691.0
Mysore,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1579.0,1477.0,1548.0,1589.0,1717.0,1579.0,1314.0,1552.0,1619.0,1600.0,1547.0,1727.0,18848.0
Mysore,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,60.0,25.0,0.0,0.0,0.0,9.0,2.0,8.0,1.0,8.0,10.0,123.0
Mysore,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mysore,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,1.0,1.0,0.0,1.0,1.0,0.0,2.0,1.0,2.0,10.0
Mysore,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,0.0,0.0,1.0,2.0,0.0,1.0,1.0,0.0,2.0,1.0,2.0,11.0
Mysore,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,1.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,7.0
Mysore,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,152.0,182.0,127.0,99.0,118.0,95.0,156.0,117.0,84.0,64.0,29.0,76.0,1299.0
Mysore,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,115.0,63.0,111.0,123.0,110.0,61.0,139.0,115.0,38.0,31.0,79.0,66.0,1051.0
Mysore,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,376.0,305.0,527.0,290.0,223.0,300.0,193.0,438.0,444.0,222.0,483.0,386.0,4187.0
Mysore,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,643.0,550.0,765.0,512.0,451.0,456.0,488.0,670.0,566.0,317.0,591.0,528.0,6537.0
Mysore,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,9.0,26.0,34.0,2.0,11.0,10.0,6.0,5.0,4.0,4.0,6.0,8.0,125.0
Mysore,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,52.0,52.0,64.0,26.0,54.0,45.0,68.0,67.0,55.0,36.0,41.0,59.0,619.0
Mysore,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,51.0,60.0,37.0,45.0,20.0,40.0,35.0,55.0,25.0,33.0,26.0,51.0,478.0
Mysore,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,253.0,208.0,251.0,196.0,174.0,199.0,233.0,326.0,395.0,137.0,248.0,262.0,2882.0
Mysore,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,356.0,320.0,352.0,267.0,248.0,284.0,336.0,448.0,475.0,206.0,315.0,372.0,3979.0
Mysore,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,43.0,12.0,16.0,1.0,15.0,1.0,1.0,6.0,5.0,0.0,1.0,6.0,107.0
Mysore,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,14.0,0.0,8.0,2.0,2.0,2.0,22.0,8.0,0.0,0.0,1.0,0.0,59.0
Mysore,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,2.0,2.0,1.0,1.0,5.0,5.0,3.0,5.0,3.0,1.0,4.0,4.0,36.0
Mysore,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,14.0,125.0,94.0,95.0,88.0,114.0,122.0,95.0,24.0,108.0,104.0,63.0,1046.0
Mysore,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,30.0,127.0,103.0,98.0,95.0,121.0,147.0,108.0,27.0,109.0,109.0,67.0,1141.0
Mysore,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,7.0,54.0,15.0,35.0,34.0,25.0,2.0,1.0,11.0,9.0,36.0,19.0,248.0
Mysore,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,139.0,134.0,134.0,109.0,116.0,126.0,140.0,125.0,138.0,122.0,135.0,113.0,1531.0
Mysore,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,241.0,238.0,287.0,227.0,221.0,272.0,230.0,235.0,259.0,210.0,219.0,248.0,2887.0
Mysore,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,24.0,15.0,28.0,26.0,21.0,32.0,30.0,19.0,31.0,16.0,21.0,18.0,281.0
Mysore,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,33.0,20.0,34.0,31.0,38.0,32.0,27.0,46.0,32.0,22.0,29.0,33.0,377.0
Mysore,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Mysore,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,437.0,407.0,483.0,393.0,396.0,462.0,427.0,425.0,460.0,370.0,404.0,412.0,5076.0
Mysore,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,23.0,51.0,56.0,31.0,33.0,52.0,47.0,64.0,40.0,44.0,8.0,21.0,470.0
Mysore,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,33.0,32.0,62.0,19.0,21.0,17.0,9.0,46.0,12.0,25.0,14.0,24.0,314.0
Mysore,9.06,Number of IUCD removals,TOTAL,239.0,260.0,318.0,300.0,292.0,391.0,235.0,248.0,202.0,264.0,200.0,202.0,3151.0
Mysore,9.07,Number of Oral Pills cycles distributed,TOTAL,6848.0,6646.0,6747.0,6086.0,7164.0,6779.0,5837.0,6224.0,5465.0,7149.0,6202.0,5763.0,76910.0
Mysore,9.08,Number of Condom pieces distributed,TOTAL,39722.0,38105.0,40356.0,40243.0,43465.0,41446.0,41647.0,43741.0,36337.0,41561.0,40376.0,38602.0,485601.0
Mysore,9.09,Number of Centchroman (weekly) pills given,TOTAL,2.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Mysore,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,48.0,19.0,22.0,129.0,143.0,132.0,11.0,98.0,34.0,236.0,9.0,16.0,897.0
Mysore,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mysore,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,4.0,7.0
Mysore,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mysore,9.12,Number of Institutions having NSV trained doctors,TOTAL,40.0,38.0,40.0,42.0,31.0,7.0,7.0,6.0,5.0,4.0,17.0,13.0,-1.0
Mysore,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3882.0,3592.0,3554.0,3121.0,3171.0,3514.0,3153.0,3383.0,3391.0,3743.0,3567.0,3554.0,41625.0
Mysore,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,387.0,219.0,125.0,101.0,56.0,33.0,111.0,0.0,65.0,0.0,0.0,0.0,1097.0
Mysore,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,1343.0,225.0,132.0,82.0,37.0,38.0,86.0,0.0,53.0,0.0,0.0,0.0,1996.0
Mysore,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,349.0,235.0,117.0,80.0,43.0,41.0,79.0,0.0,50.0,0.0,0.0,0.0,994.0
Mysore,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3500.0,3748.0,3897.0,3639.0,3430.0,3612.0,3401.0,4314.0,3410.0,3495.0,3446.0,3624.0,43516.0
Mysore,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3367.0,3570.0,3868.0,3640.0,3555.0,3671.0,3352.0,3497.0,3433.0,3478.0,3351.0,3658.0,42440.0
Mysore,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3433.0,3546.0,3737.0,3607.0,3571.0,3848.0,3413.0,3493.0,3467.0,3632.0,3304.0,3578.0,42629.0
Mysore,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3070.0,3085.0,3071.0,2652.0,2794.0,2864.0,2824.0,2889.0,2869.0,3086.0,2980.0,3090.0,35274.0
Mysore,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3565.0,3704.0,4533.0,3683.0,3278.0,3530.0,3336.0,3534.0,3372.0,3497.0,3449.0,3477.0,42958.0
Mysore,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3409.0,3445.0,3762.0,3619.0,3404.0,3465.0,3327.0,3480.0,3394.0,3409.0,3336.0,3542.0,41592.0
Mysore,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3464.0,3446.0,3948.0,3540.0,3505.0,3679.0,3316.0,3441.0,3422.0,3453.0,3279.0,3507.0,42000.0
Mysore,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2616.0,2543.0,2395.0,2347.0,2412.0,2508.0,2609.0,2443.0,2496.0,2864.0,2873.0,2703.0,30809.0
Mysore,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,475.0,520.0,375.0,190.0,136.0,305.0,217.0,213.0,189.0,132.0,122.0,291.0,3165.0
Mysore,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,469.0,471.0,312.0,185.0,126.0,254.0,186.0,192.0,180.0,86.0,80.0,245.0,2786.0
Mysore,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,474.0,467.0,312.0,190.0,116.0,288.0,199.0,217.0,198.0,85.0,72.0,178.0,2796.0
Mysore,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3436.0,3396.0,3534.0,3382.0,3460.0,3468.0,3144.0,3490.0,3409.0,3363.0,3499.0,3454.0,41035.0
Mysore,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2250.0,2273.0,2593.0,2434.0,2287.0,2348.0,2335.0,2467.0,2333.0,2176.0,2306.0,2281.0,28083.0
Mysore,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,0.0,7.0
Mysore,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1716.0,1731.0,1816.0,1811.0,1755.0,1863.0,1642.0,1781.0,1740.0,1680.0,1846.0,1826.0,21207.0
Mysore,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1626.0,1614.0,1656.0,1561.0,1582.0,1747.0,1532.0,1678.0,1635.0,1565.0,1642.0,1665.0,19503.0
Mysore,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3342.0,3345.0,3472.0,3372.0,3337.0,3610.0,3174.0,3459.0,3375.0,3245.0,3488.0,3491.0,40710.0
Mysore,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3110.0,3273.0,3521.0,3329.0,3190.0,3318.0,3156.0,3299.0,3229.0,3106.0,3114.0,3234.0,38879.0
Mysore,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3033.0,3254.0,3482.0,3292.0,3127.0,3293.0,3037.0,3266.0,3208.0,3103.0,3073.0,3165.0,38333.0
Mysore,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,322.0,201.0,274.0,306.0,236.0,218.0,233.0,162.0,122.0,56.0,100.0,89.0,2319.0
Mysore,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1064.0,1130.0,1253.0,1180.0,1117.0,1069.0,1030.0,1144.0,962.0,780.0,889.0,981.0,12599.0
Mysore,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1029.0,1065.0,1131.0,1049.0,1250.0,1026.0,968.0,1079.0,895.0,768.0,842.0,887.0,11989.0
Mysore,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2093.0,2195.0,2384.0,2229.0,2367.0,2095.0,1998.0,2223.0,1857.0,1548.0,1731.0,1868.0,24588.0
Mysore,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,424.0,578.0,525.0,10087.0,10097.0,6600.0,654.0,1081.0,530.0,363.0,399.0,205.0,31543.0
Mysore,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,411.0,668.0,462.0,10020.0,10810.0,6910.0,680.0,1733.0,1105.0,647.0,336.0,218.0,34000.0
Mysore,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,330.0,504.0,306.0,9605.0,9723.0,6863.0,743.0,1582.0,1114.0,599.0,405.0,242.0,32016.0
Mysore,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Mysore,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Mysore,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1325.0,1352.0,1340.0,1324.0,1327.0,1358.0,1333.0,1331.0,1379.0,1360.0,1323.0,1318.0,16070.0
Mysore,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1268.0,1299.0,1306.0,1281.0,1269.0,1293.0,1263.0,1270.0,1317.0,1285.0,1244.0,1257.0,15352.0
Mysore,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1035.0,1081.0,1110.0,1097.0,1102.0,1078.0,1089.0,1067.0,1107.0,1046.0,1006.0,1045.0,12863.0
Mysore,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2824.0,3048.0,2937.0,3673.0,5607.0,3153.0,2793.0,2954.0,3220.0,3168.0,4018.0,3757.0,41152.0
Mysore,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,214.0,232.0,194.0,11524.0,20486.0,518.0,146.0,68.0,188.0,1051.0,14768.0,2713.0,52102.0
Mysore,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,186.0,185.0,242.0,11842.0,18146.0,484.0,135.0,40.0,47.0,1015.0,13590.0,2358.0,48270.0
Mysore,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,11.0,21.0,69.0,7.0,15.0,2.0,17.0,12.0,6.0,6.0,13.0,3.0,182.0
Mysore,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,355.0,431.0,265.0,365.0,416.0,339.0,313.0,313.0,313.0,361.0,307.0,386.0,4164.0
Mysore,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,5.0,39.0,48.0,7.0,3.0,4.0,15.0,9.0,6.0,10.0,0.0,16.0,162.0
Mysore,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,214.0,137.0,140.0,307.0,535.0,284.0,238.0,164.0,172.0,278.0,113.0,179.0,2761.0
Mysore,13.1,Number of Patients operated for cataract,TOTAL,103.0,45.0,209.0,28.0,6.0,17.0,66.0,54.0,49.0,100.0,51.0,66.0,794.0
Mysore,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,74.0,45.0,178.0,28.0,6.0,17.0,64.0,54.0,49.0,100.0,51.0,66.0,732.0
Mysore,13.3,Number of School children detected with Refractive errors,TOTAL,4.0,0.0,3.0,21.0,39.0,140.0,30.0,1567.0,110.0,131.0,99.0,15.0,2159.0
Mysore,13.4,Number of children provided free glasses,TOTAL,16.0,0.0,0.0,5.0,0.0,5.0,13.0,42.0,33.0,135.0,102.0,263.0,614.0
Mysore,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,8.0,10.0,10.0,11.0,15.0,12.0,7.0,10.0,12.0,11.0,11.0,-1.0
Mysore,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,48.0,43.0,41.0,43.0,32.0,29.0,38.0,34.0,32.0,29.0,34.0,28.0,-1.0
Mysore,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,563.0,484.0,560.0,608.0,580.0,592.0,566.0,577.0,636.0,644.0,625.0,626.0,-1.0
Mysore,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,6.0,8.0,11.0,10.0,8.0,8.0,8.0,8.0,9.0,9.0,-1.0
Mysore,14.05,Number of RKS meetings held during the month,TOTAL,35.0,37.0,44.0,29.0,29.0,27.0,22.0,27.0,32.0,29.0,46.0,54.0,411.0
Mysore,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,50.0,46.0,46.0,46.0,37.0,40.0,42.0,38.0,39.0,41.0,41.0,34.0,-1.0
Mysore,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,498.0,409.0,466.0,345.0,451.0,305.0,310.0,390.0,369.0,462.0,568.0,529.0,5102.0
Mysore,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,9.0,7.0,8.0,9.0,9.0,7.0,9.0,11.0,10.0,10.0,10.0,-1.0
Mysore,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,14.0,11.0,17.0,6.0,16.0,20.0,6.0,2.0,4.0,3.0,4.0,5.0,-1.0
Mysore,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,1336.0,1665.0,1274.0,1322.0,1591.0,1105.0,1016.0,969.0,1194.0,1362.0,1517.0,1317.0,15668.0
Mysore,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3322.0,3210.0,4697.0,2208.0,3157.0,2760.0,2614.0,2444.0,2294.0,2042.0,5081.0,4869.0,38698.0
Mysore,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,1016.0,1264.0,952.0,1017.0,1143.0,938.0,709.0,842.0,1125.0,1022.0,1236.0,1025.0,12289.0
Mysore,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,6981.0,7122.0,5808.0,5869.0,5925.0,7164.0,6352.0,6364.0,6406.0,5863.0,7879.0,7940.0,79673.0
Mysore,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,2352.0,2929.0,2226.0,2339.0,2734.0,2043.0,1725.0,1811.0,2319.0,2384.0,2753.0,2342.0,27957.0
Mysore,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,10303.0,10332.0,10505.0,8077.0,9082.0,9924.0,8966.0,8808.0,8700.0,7905.0,12960.0,12809.0,118371.0
Mysore,14.10.2.a,Number of death cases of Inpatient males,TOTAL,66.0,69.0,69.0,54.0,69.0,68.0,74.0,56.0,78.0,64.0,205.0,221.0,1093.0
Mysore,14.10.2.b,Number of death cases of Inpatient females,TOTAL,52.0,45.0,38.0,45.0,106.0,70.0,32.0,55.0,54.0,52.0,137.0,152.0,838.0
Mysore,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,118.0,114.0,107.0,99.0,175.0,138.0,106.0,111.0,132.0,116.0,342.0,373.0,1931.0
Mysore,14.11,In-Patient Head Count at midnight,TOTAL,21732.0,23576.0,20106.0,22448.0,23122.0,21152.0,19867.0,19828.0,10814.0,11742.0,22016.0,20544.0,236947.0
Mysore,14.12.1,OPD attendance (All),TOTAL,215275.0,217695.0,237394.0,237304.0,240934.0,248681.0,202873.0,234920.0,226447.0,216773.0,265923.0,272175.0,2816394.0
Mysore,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1107.0,1164.0,917.0,1104.0,849.0,539.0,727.0,516.0,795.0,675.0,1685.0,1396.0,11474.0
Mysore,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,254.0,4.0,257.0,191.0,34.0,85.0,101.0,170.0,122.0,96.0,364.0,195.0,1873.0
Mysore,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,374.0,596.0,294.0,420.0,338.0,305.0,234.0,413.0,308.0,243.0,520.0,513.0,4558.0
Mysore,14.14.a,Number of patients given AYUSH treatment,TOTAL,718.0,576.0,1379.0,967.0,1107.0,1238.0,875.0,1067.0,2193.0,1955.0,2056.0,2650.0,16781.0
Mysore,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,727.0,901.0,1141.0,805.0,852.0,1067.0,670.0,968.0,1813.0,1816.0,2056.0,2466.0,15282.0
Mysore,14.14.c,Number of Adolescents counselled,TOTAL,196.0,279.0,245.0,245.0,229.0,273.0,190.0,215.0,291.0,280.0,332.0,380.0,3155.0
Mysore,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,17834.0,15486.0,16720.0,15671.0,13217.0,15734.0,12990.0,16607.0,12311.0,9993.0,16538.0,16472.0,179573.0
Mysore,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,665.0,735.0,693.0,742.0,731.0,685.0,641.0,480.0,467.0,421.0,657.0,643.0,7560.0
Mysore,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,3406.0,3199.0,3613.0,3301.0,3160.0,3569.0,2630.0,3243.0,3038.0,2752.0,3940.0,3413.0,39264.0
Mysore,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,36.0,32.0,85.0,39.0,73.0,25.0,35.0,50.0,84.0,34.0,25.0,67.0,585.0
Mysore,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1509.0,1928.0,1941.0,1810.0,1570.0,1901.0,1453.0,1652.0,1638.0,1648.0,2062.0,2011.0,21123.0
Mysore,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,14.0,17.0,31.0,28.0,63.0,21.0,22.0,26.0,37.0,20.0,21.0,28.0,328.0
Mysore,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3541.0,3518.0,3709.0,3320.0,2971.0,3560.0,2672.0,3378.0,3000.0,3012.0,3228.0,2885.0,38794.0
Mysore,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,24.0,23.0,112.0,21.0,184.0,51.0,25.0,44.0,37.0,18.0,9.0,67.0,615.0
Mysore,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,8456.0,8645.0,9263.0,8431.0,7701.0,9030.0,6755.0,8273.0,7676.0,7412.0,9230.0,8309.0,99181.0
Mysore,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,74.0,72.0,228.0,88.0,320.0,97.0,82.0,120.0,158.0,72.0,55.0,162.0,1528.0
Mysore,15.2,Number of Widal tests conducted,Number tested,1485.0,1419.0,1976.0,1834.0,2160.0,1850.0,1237.0,1506.0,1524.0,1259.0,1925.0,2025.0,20200.0
Mysore,15.3.a,Number of VDRL tests conducted on males,Number tested,477.0,149.0,147.0,266.0,223.0,398.0,165.0,101.0,144.0,74.0,325.0,143.0,2612.0
Mysore,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,273.0,267.0,291.0,282.0,338.0,404.0,220.0,318.0,166.0,213.0,342.0,274.0,3388.0
Mysore,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2242.0,1991.0,2485.0,2151.0,1975.0,2491.0,1912.0,2494.0,2509.0,2561.0,1803.0,2297.0,26911.0
Mysore,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2992.0,2407.0,2923.0,2699.0,2536.0,3293.0,2297.0,2913.0,2819.0,2848.0,2470.0,2714.0,32911.0
Mysore,15.4.1,Number of blood smears examined for Malaria,TOTAL,29317.0,29196.0,32851.0,31153.0,29212.0,30593.0,25791.0,28478.0,31554.0,25762.0,28379.0,30866.0,353152.0
Mysore,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,388.0,4.0,2.0,451.0,152.0,197.0,6.0,4.0,4.0,1.0,289.0,10.0,1508.0
Mysore,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,2.0,1.0,0.0,0.0,1.0,0.0,0.0,2.0,0.0,1.0,0.0,8.0
Mysore,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,10290.0,50000.0,27710.0,43990.0,14590.0,62240.0,13960.0,0.0,76590.0,80300.0,87650.0,74540.0,541860.0
Mysore,16.1.1,Stock position of DPT vaccines,2. Stocks Received,50000.0,,60000.0,50000.0,80000.0,0.0,0.0,100000.0,30000.0,20000.0,0.0,30000.0,420000.0
Mysore,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,10290.0,22290.0,43720.0,79400.0,32350.0,48280.0,13960.0,23410.0,26290.0,12650.0,13110.0,16010.0,341760.0
Mysore,16.1.1,Stock position of DPT vaccines,5. Total Stock,50000.0,27710.0,43990.0,14590.0,62240.0,13960.0,0.0,76590.0,80300.0,87650.0,74540.0,88530.0,620100.0
Mysore,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,94960.0,127560.0,104180.0,116310.0,144880.0,165590.0,130980.0,114020.0,121530.0,118560.0,128930.0,108690.0,1476190.0
Mysore,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,60000.0,,60000.0,60000.0,45000.0,0.0,0.0,51000.0,30000.0,30000.0,0.0,18000.0,354000.0
Mysore,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,27400.0,23380.0,47870.0,31430.0,24290.0,34610.0,16960.0,43490.0,32970.0,19630.0,20240.0,44910.0,367180.0
Mysore,16.1.1A,Stock Position of Pentavalent,5. Total Stock,127560.0,104180.0,116310.0,144880.0,165590.0,130980.0,114020.0,121530.0,118560.0,128930.0,108690.0,81780.0,1463010.0
Mysore,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,327340.0,335700.0,291720.0,205540.0,190840.0,215840.0,132980.0,76200.0,79600.0,70220.0,48120.0,31840.0,2005940.0
Mysore,16.1.2,Stock position of OPV vaccines,2. Stocks Received,40000.0,,0.0,61500.0,75000.0,0.0,0.0,60000.0,81000.0,420000.0,410000.0,99000.0,1246500.0
Mysore,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,31640.0,43980.0,86180.0,76200.0,50000.0,82860.0,56780.0,56600.0,90380.0,442100.0,426280.0,46660.0,1489660.0
Mysore,16.1.2,Stock position of OPV vaccines,5. Total Stock,335700.0,291720.0,205540.0,190840.0,215840.0,132980.0,76200.0,79600.0,70220.0,48120.0,31840.0,84180.0,1762780.0
Mysore,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,157560.0,188080.0,161230.0,159680.0,121560.0,179700.0,107520.0,73080.0,142830.0,127440.0,131420.0,120520.0,1670620.0
Mysore,16.1.3,Stock position of TT vaccines,2. Stocks Received,60000.0,,60000.0,70000.0,120000.0,0.0,0.0,120500.0,35000.0,30000.0,0.0,60000.0,555500.0
Mysore,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.3,Stock position of TT vaccines,4. Stock Distributed,29480.0,26850.0,61550.0,108120.0,61860.0,72180.0,34440.0,50750.0,50390.0,26020.0,10900.0,40960.0,573500.0
Mysore,16.1.3,Stock position of TT vaccines,5. Total Stock,188080.0,161230.0,159680.0,121560.0,179700.0,107520.0,73080.0,142830.0,127440.0,131420.0,120520.0,139560.0,1652620.0
Mysore,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,94960.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,94960.0
Mysore,16.1.4,Stock position of DT vaccines,2. Stocks Received,60000.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,60000.0
Mysore,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Mysore,16.1.4,Stock position of DT vaccines,4. Stock Distributed,27400.0,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,27400.0
Mysore,16.1.4,Stock position of DT vaccines,5. Total Stock,127560.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,127560.0
Mysore,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,99360.0,79730.0,66410.0,66580.0,70350.0,125430.0,104930.0,90050.0,110510.0,117260.0,111120.0,98150.0,1139880.0
Mysore,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,,30000.0,20000.0,70000.0,0.0,0.0,40000.0,30000.0,10000.0,0.0,20000.0,220000.0
Mysore,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,19630.0,13320.0,29830.0,16230.0,14920.0,20500.0,14880.0,19540.0,23250.0,16140.0,12970.0,28780.0,229990.0
Mysore,16.1.5,Stock position of BCG vaccines,5. Total Stock,79730.0,66410.0,66580.0,70350.0,125430.0,104930.0,90050.0,110510.0,117260.0,111120.0,98150.0,89370.0,1129890.0
Mysore,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,17165.0,51295.0,31105.0,54190.0,54440.0,69885.0,42640.0,24725.0,40365.0,43660.0,58610.0,44580.0,532660.0
Mysore,16.1.6,Stock position of Measles vaccines,2. Stocks Received,50000.0,,50000.0,30000.0,35000.0,0.0,0.0,40000.0,30000.0,30000.0,0.0,30000.0,295000.0
Mysore,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,15870.0,20190.0,26915.0,29750.0,19555.0,27245.0,17915.0,24360.0,26705.0,15050.0,14030.0,31515.0,269100.0
Mysore,16.1.6,Stock position of Measles vaccines,5. Total Stock,51295.0,31105.0,54190.0,54440.0,69885.0,42640.0,24725.0,40365.0,43660.0,58610.0,44580.0,43065.0,558560.0
Mysore,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Mysore,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,,,5000.0
Mysore,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Mysore,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,,0.0,0.0,0.0,0.0,0.0,5000.0,0.0,0.0,,,5000.0
Mysore,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,23280.0,35610.0,28460.0,24530.0,18910.0,15040.0,4590.0,740.0,23410.0,34000.0,32900.0,26730.0,268200.0
Mysore,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,15000.0,,0.0,0.0,0.0,0.0,0.0,30000.0,20000.0,5000.0,0.0,10000.0,80000.0
Mysore,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,2670.0,7150.0,3930.0,5620.0,3870.0,10450.0,3850.0,7330.0,9410.0,6100.0,6170.0,10390.0,76940.0
Mysore,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,35610.0,28460.0,24530.0,18910.0,15040.0,4590.0,740.0,23410.0,34000.0,32900.0,26730.0,26340.0,271260.0
Mysore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2570.0,2320.0,2120.0,820.0,2370.0,1620.0,1370.0,1370.0,820.0,165.0,5915.0,5890.0,27350.0
Mysore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,6000.0,0.0,500.0,8900.0
Mysore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,250.0,200.0,1300.0,850.0,750.0,250.0,200.0,550.0,655.0,250.0,25.0,1100.0,6380.0
Mysore,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2320.0,2120.0,820.0,2370.0,1620.0,1370.0,1170.0,820.0,165.0,5915.0,5890.0,5290.0,29870.0
Mysore,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,17300.0,17300.0,,17300.0,137760.0,137760.0,78760.0,63260.0,63260.0,47760.0,47760.0,47760.0,675980.0
Mysore,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,,,120960.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,120960.0
Mysore,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,,500.0,0.0,59000.0,15500.0,0.0,15500.0,0.0,0.0,0.0,90500.0
Mysore,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,17300.0,17300.0,0.0,137760.0,137760.0,78760.0,63260.0,63260.0,47760.0,47760.0,47760.0,47760.0,706440.0
Mysore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,540.0,540.0,,510.0,380.0,330.0,30.0,0.0,11560.0,2980.0,2560.0,2370.0,21800.0
Mysore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,0.0,0.0,16000.0,0.0,0.0,0.0,0.0,16000.0
Mysore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,30.0,,130.0,0.0,300.0,30.0,4440.0,8580.0,420.0,190.0,280.0,14400.0
Mysore,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,540.0,510.0,0.0,380.0,380.0,30.0,0.0,11560.0,2980.0,2560.0,2370.0,2090.0,23400.0
Mysore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,900.0,660.0,,600.0,540.0,540.0,540.0,360.0,240.0,60.0,7060.0,6060.0,17560.0
Mysore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,7000.0,0.0,0.0,7000.0
Mysore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,240.0,60.0,,60.0,0.0,0.0,180.0,120.0,180.0,0.0,1000.0,4000.0,5840.0
Mysore,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,660.0,600.0,0.0,540.0,540.0,540.0,360.0,240.0,60.0,7060.0,6060.0,2060.0,18720.0
Mysore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,5815.0,4815.0,4815.0,4315.0,9315.0,8315.0,8315.0,7315.0,7315.0,6315.0,10230.0,10230.0,87110.0
Mysore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,4915.0,0.0,0.0,9915.0
Mysore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,1000.0,0.0,500.0,0.0,1000.0,0.0,1000.0,0.0,1000.0,1000.0,0.0,1000.0,6500.0
Mysore,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,4815.0,4815.0,4315.0,9315.0,8315.0,8315.0,7315.0,7315.0,6315.0,10230.0,10230.0,9230.0,90525.0
Mysore,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,4050.0,3550.0,2550.0,2550.0,1900.0,1550.0,10825.0,10325.0,9550.0,9250.0,56100.0
Mysore,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,4200.0,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,14200.0
Mysore,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,150.0,500.0,375.0,650.0,650.0,350.0,725.0,500.0,775.0,300.0,400.0,5375.0
Mysore,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,4050.0,3550.0,3175.0,1900.0,1900.0,1550.0,10825.0,10325.0,9550.0,9250.0,8850.0,64925.0
Mysore,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,,,,0.0,0.0,0.0,0.0,,,,,0.0
Mysore,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,,,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,,180000.0,31000.0,20000.0,7000.0,1500.0,0.0,500.0,,,,240000.0
Mysore,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,,149000.0,11000.0,13000.0,5500.0,1000.0,0.0,500.0,,,,180000.0
Mysore,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,31000.0,20000.0,7000.0,1500.0,500.0,0.0,0.0,0.0,0.0,0.0,60000.0
Mysore,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,,,,0.0,0.0,0.0,0.0,0.0,6250.0,6250.0,6100.0,18600.0
Mysore,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,,,,0.0,0.0,0.0,0.0,6250.0,0.0,0.0,0.0,6250.0
Mysore,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,,,,0.0,0.0,0.0,0.0,0.0,0.0,150.0,3000.0,3150.0
Mysore,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6250.0,6250.0,6100.0,3100.0,21700.0
Mysore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,1625.0,47279.0,46329.0,15079.0,13579.0,13029.0,11779.0,11579.0,0.0,9779.0,9029.0,8629.0,187715.0
Mysore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,46404.0,,0.0,0.0,0.0,0.0,0.0,0.0,10729.0,0.0,0.0,0.0,57133.0
Mysore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,750.0,950.0,31250.0,1500.0,550.0,1250.0,200.0,850.0,950.0,750.0,400.0,800.0,40200.0
Mysore,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,47279.0,46329.0,15079.0,13579.0,13029.0,11779.0,11579.0,10729.0,9779.0,9029.0,8629.0,7829.0,204648.0
Mysore,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,,,41380.0,0.0,0.0,0.0,0.0,0.0,,,,41380.0
Mysore,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,,,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Mysore,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,,,21350.0,0.0,0.0,0.0,0.0,0.0,,,,21350.0
Mysore,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,20030.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,20030.0
Mysore,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,256580.0,236580.0,204180.0,41380.0,20030.0,34718.0,31618.0,31218.0,29118.0,139942.0,135142.0,131842.0,1292348.0
Mysore,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,,0.0,0.0,17288.0,0.0,0.0,0.0,117224.0,0.0,0.0,0.0,134512.0
Mysore,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,20000.0,32400.0,162800.0,21350.0,2600.0,3100.0,400.0,2100.0,6400.0,4800.0,3300.0,50300.0,309550.0
Mysore,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,236580.0,204180.0,41380.0,20030.0,34718.0,31618.0,31218.0,29118.0,139942.0,135142.0,131842.0,81542.0,1117310.0
Mysore,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,24560.0,6410.0,4600.0,11260.0,11930.0,3670.0,1710.0,450.0,3620.0,14850.0,10810.0,5290.0,99160.0
Mysore,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,,17300.0,19000.0,0.0,0.0,0.0,9000.0,16500.0,0.0,0.0,0.0,61800.0
Mysore,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,18150.0,1810.0,10640.0,18330.0,8260.0,1960.0,1260.0,5830.0,5270.0,4040.0,5520.0,5030.0,86100.0
Mysore,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,6410.0,4600.0,11260.0,11930.0,3670.0,1710.0,450.0,3620.0,14850.0,10810.0,5290.0,260.0,74860.0
Mysore,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,206100.0,161100.0,137900.0,136100.0,43500.0,113300.0,50300.0,27500.0,69900.0,106700.0,129500.0,95300.0,1277200.0
Mysore,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,,72000.0,48000.0,96000.0,0.0,0.0,70000.0,72000.0,54000.0,0.0,66000.0,478000.0
Mysore,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,45000.0,23200.0,73800.0,140600.0,26200.0,63000.0,22800.0,27600.0,35200.0,31200.0,34200.0,33000.0,555800.0
Mysore,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,161100.0,137900.0,136100.0,43500.0,113300.0,50300.0,27500.0,69900.0,106700.0,129500.0,95300.0,128300.0,1199400.0
Mysore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,13750.0,6500.0,6400.0,8550.0,1650.0,21800.0,10300.0,9750.0,6900.0,12500.0,12400.0,11400.0,121900.0
Mysore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,,12000.0,9600.0,24000.0,0.0,0.0,0.0,12000.0,0.0,0.0,0.0,57600.0
Mysore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Mysore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,7250.0,100.0,9850.0,16500.0,3850.0,11500.0,550.0,2850.0,6400.0,100.0,1000.0,1350.0,61300.0
Mysore,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,6500.0,6400.0,8550.0,1650.0,21800.0,10300.0,9750.0,6900.0,12500.0,12400.0,11400.0,10050.0,118200.0
Mysore,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,23.0,32.0,33.0,24.0,30.0,28.0,,1.0,,,1.0,1.0,173.0
Mysore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,4.0,1.0,,3.0,,,,1.0,,,1.0,2.0,12.0
Mysore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,1.0,,,,,1.0,,2.0,,5.0
Mysore,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,4.0,2.0,,4.0,,,,1.0,1.0,,3.0,2.0,17.0
Mysore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,1.0,1.0,,,1.0,2.0,1.0,,1.0,,9.0
Mysore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Mysore,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,1.0,1.0,,,1.0,2.0,1.0,,1.0,,9.0
Mysore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,,1.0,,,,1.0,1.0,,,,1.0,4.0
Mysore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,,,,1.0,,1.0,,,,,,3.0
Mysore,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,1.0,,1.0,,2.0,1.0,,,,1.0,7.0
Mysore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,4.0,3.0,9.0,12.0,6.0,,2.0,,2.0,2.0,4.0,48.0
Mysore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,2.0,,,2.0,5.0,,,,,,2.0,4.0,15.0
Mysore,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,6.0,4.0,3.0,11.0,17.0,6.0,,2.0,,2.0,4.0,8.0,63.0
Mysore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,4.0,5.0,1.0,1.0,,1.0,,,2.0,1.0,14.0,16.0,45.0
Mysore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,,,,1.0,,,,,2.0,4.0
Mysore,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,5.0,5.0,1.0,1.0,,1.0,1.0,,2.0,1.0,14.0,18.0,49.0
Mysore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mysore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mysore,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Mysore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,1.0,1.0
Mysore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mysore,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,1.0,1.0
Mysore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Mysore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Mysore,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Mysore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,7.0,4.0,7.0,11.0,24.0,26.0,,2.0,3.0,,1.0,11.0,96.0
Mysore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,,,1.0,,2.0,,1.0,,,,,5.0
Mysore,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,8.0,4.0,7.0,12.0,24.0,28.0,,3.0,3.0,,1.0,11.0,101.0
Mysore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,3.0,,1.0,,,,,1.0,5.0
Mysore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,3.0,,5.0,,,,,,8.0
Mysore,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,6.0,,6.0,,,,,1.0,13.0
Mysore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,2.0,2.0,2.0,2.0,1.0,4.0,3.0,2.0,1.0,3.0,,24.0
Mysore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,2.0,2.0,4.0,,2.0,2.0,2.0,2.0,1.0,1.0,1.0,21.0
Mysore,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,4.0,4.0,4.0,6.0,2.0,3.0,6.0,5.0,4.0,2.0,4.0,1.0,45.0
Mysore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,1.0,,,1.0,,,,1.0,,,,,3.0
Mysore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,9.0,7.0,10.0,9.0,10.0,4.0,4.0,6.0,8.0,4.0,11.0,6.0,88.0
Mysore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,28.0,17.0,22.0,20.0,27.0,25.0,28.0,32.0,42.0,40.0,37.0,30.0,348.0
Mysore,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,38.0,24.0,32.0,30.0,37.0,29.0,32.0,39.0,50.0,44.0,48.0,36.0,439.0
Mysore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,1.0,,1.0
Mysore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Mysore,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,1.0,,,,,,,,,1.0,,2.0
Mysore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,1.0,,,,,,,,1.0,2.0
Mysore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,,,1.0,1.0,1.0,,1.0,,,1.0,1.0,7.0
Mysore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,,,,1.0,,,,,,1.0,,3.0
Mysore,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,2.0,,,2.0,2.0,1.0,,1.0,,,2.0,2.0,12.0
Mysore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,,4.0,4.0,1.0,3.0,1.0,2.0,2.0,4.0,3.0,2.0,28.0
Mysore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,1.0,1.0,,,1.0,,,,,,,4.0
Mysore,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,1.0,5.0,4.0,1.0,4.0,1.0,2.0,2.0,4.0,3.0,2.0,32.0
Mysore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,1.0,3.0,,,,,,5.0
Mysore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,29.0,40.0,42.0,33.0,30.0,44.0,38.0,34.0,48.0,46.0,54.0,46.0,484.0
Mysore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,37.0,45.0,54.0,41.0,54.0,65.0,48.0,49.0,55.0,78.0,51.0,54.0,631.0
Mysore,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,66.0,85.0,97.0,74.0,84.0,110.0,89.0,83.0,103.0,124.0,105.0,100.0,1120.0
Mysore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,,1.0,,,,,,1.0,,,3.0
Mysore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,6.0,7.0,3.0,3.0,12.0,8.0,12.0,9.0,8.0,13.0,6.0,9.0,96.0
Mysore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,18.0,22.0,15.0,22.0,16.0,19.0,32.0,28.0,27.0,35.0,21.0,26.0,281.0
Mysore,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,25.0,29.0,18.0,26.0,28.0,27.0,44.0,37.0,35.0,49.0,27.0,35.0,380.0
Mysore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Mysore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Mysore,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,1.0,,,1.0
Mysore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,2.0,2.0
Mysore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Mysore,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,2.0,2.0
Mysore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,1.0,,,,,,,2.0,,4.0
Mysore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Mysore,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,1.0,,,,,,,2.0,,4.0
Mysore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Mysore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Mysore,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Mysore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Mysore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Mysore,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Mysore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Mysore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,1.0,1.0,1.0,2.0,1.0,2.0,1.0,,,,,,9.0
Mysore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Mysore,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,1.0,1.0,1.0,2.0,1.0,2.0,1.0,,,,,,9.0
Mysore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,,,,,2.0,,,2.0,1.0,3.0,8.0
Mysore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,17.0,24.0,21.0,14.0,18.0,25.0,21.0,16.0,14.0,20.0,21.0,14.0,225.0
Mysore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,4.0,8.0,4.0,4.0,6.0,4.0,4.0,5.0,4.0,1.0,4.0,51.0
Mysore,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,20.0,28.0,29.0,18.0,22.0,31.0,27.0,20.0,19.0,26.0,23.0,21.0,284.0
Mysore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,2.0,1.0,,,1.0,1.0,1.0,,,1.0,,8.0
Mysore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,35.0,32.0,28.0,28.0,22.0,29.0,35.0,32.0,41.0,23.0,29.0,23.0,357.0
Mysore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,6.0,6.0,3.0,1.0,5.0,4.0,8.0,4.0,8.0,6.0,4.0,3.0,58.0
Mysore,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,42.0,40.0,32.0,29.0,27.0,34.0,44.0,37.0,49.0,29.0,34.0,26.0,423.0
Mysore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,,,,,,,,,1.0,2.0
Mysore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,3.0,3.0,,,2.0,2.0,3.0,1.0,3.0,1.0,,,18.0
Mysore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,,1.0,2.0,2.0,2.0,,,,,2.0,10.0
Mysore,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,4.0,,1.0,4.0,4.0,5.0,1.0,3.0,1.0,,3.0,30.0
Mysore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,,,1.0,,,,,,,,1.0,3.0
Mysore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,17.0,18.0,18.0,26.0,14.0,19.0,18.0,13.0,22.0,17.0,22.0,17.0,221.0
Mysore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,21.0,24.0,33.0,31.0,39.0,42.0,31.0,29.0,28.0,43.0,30.0,52.0,403.0
Mysore,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,39.0,42.0,51.0,58.0,53.0,61.0,49.0,42.0,50.0,60.0,52.0,70.0,627.0
Mysore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,,,,2.0,,,1.0,1.0,,,,5.0
Mysore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,23.0,26.0,19.0,24.0,32.0,27.0,32.0,23.0,32.0,22.0,23.0,26.0,309.0
Mysore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,46.0,69.0,81.0,45.0,76.0,89.0,73.0,78.0,69.0,57.0,75.0,70.0,828.0
Mysore,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,70.0,95.0,100.0,69.0,110.0,116.0,105.0,102.0,102.0,79.0,98.0,96.0,1142.0
Mysore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,8.0,5.0,4.0,5.0,1.0,4.0,4.0,7.0,4.0,2.0,1.0,3.0,48.0
Mysore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,70.0,53.0,67.0,70.0,74.0,95.0,66.0,76.0,76.0,70.0,68.0,82.0,867.0
Mysore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,269.0,209.0,249.0,242.0,266.0,325.0,264.0,285.0,271.0,258.0,262.0,226.0,3126.0
Mysore,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,347.0,267.0,320.0,317.0,341.0,424.0,334.0,368.0,351.0,330.0,331.0,311.0,4041.0
Raichur,1.1,Total number of pregnant women Registered for ANC,TOTAL,4320.0,3753.0,4334.0,3923.0,3829.0,4010.0,3800.0,4536.0,4170.0,4085.0,4013.0,4259.0,49032.0
Raichur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2917.0,2589.0,3030.0,2553.0,2700.0,2792.0,2570.0,3127.0,2741.0,2669.0,2774.0,2917.0,33379.0
Raichur,1.2,Number of Pregnant women registered under JSY,TOTAL,3397.0,2942.0,3430.0,2973.0,2950.0,3125.0,2876.0,3333.0,3007.0,3061.0,3168.0,3192.0,37454.0
Raichur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3469.0,3042.0,2865.0,2706.0,3824.0,3289.0,2673.0,3034.0,2895.0,3216.0,3090.0,3232.0,37335.0
Raichur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3241.0,3113.0,3283.0,2913.0,3176.0,3520.0,3075.0,3297.0,3202.0,3458.0,2738.0,3040.0,38056.0
Raichur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,4123.0,3989.0,4596.0,4230.0,4530.0,4807.0,4191.0,4587.0,4383.0,4587.0,3627.0,4545.0,52195.0
Raichur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2023.0,1858.0,1180.0,984.0,841.0,1430.0,1188.0,1849.0,1290.0,1336.0,1012.0,2136.0,17127.0
Raichur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,138.0,139.0,132.0,165.0,123.0,171.0,191.0,213.0,78.0,239.0,155.0,138.0,1882.0
Raichur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,4.0,34.0,24.0,33.0,20.0,16.0,14.0,18.0,14.0,17.0,17.0,10.0,221.0
Raichur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1521.0,1379.0,1997.0,1695.0,2000.0,2125.0,1792.0,1842.0,1950.0,1688.0,2036.0,2693.0,22718.0
Raichur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,183.0,138.0,102.0,84.0,100.0,153.0,140.0,168.0,156.0,183.0,155.0,135.0,1697.0
Raichur,1.8,Number of pregnancy test kits used at SC level,TOTAL,269.0,380.0,446.0,401.0,416.0,430.0,396.0,396.0,362.0,371.0,360.0,285.0,4512.0
Raichur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,42.0,31.0,46.0,31.0,32.0,50.0,48.0,36.0,43.0,47.0,45.0,24.0,475.0
Raichur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,69.0,69.0,73.0,72.0,67.0,67.0,62.0,56.0,54.0,39.0,34.0,40.0,702.0
Raichur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,111.0,100.0,119.0,103.0,99.0,117.0,110.0,92.0,97.0,86.0,79.0,64.0,1177.0
Raichur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,90.0,75.0,71.0,81.0,68.0,75.0,74.0,72.0,71.0,52.0,58.0,46.0,833.0
Raichur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,20.0,30.0,27.0,24.0,19.0,19.0,19.0,16.0,33.0,23.0,19.0,10.0,259.0
Raichur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,2119.0,1956.0,2218.0,2041.0,2287.0,2190.0,2308.0,2290.0,2126.0,2085.0,2021.0,2023.0,25664.0
Raichur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,244.0,329.0,306.0,174.0,205.0,271.0,148.0,199.0,206.0,257.0,276.0,253.0,2868.0
Raichur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,1221.0,1629.0,1681.0,1668.0,1816.0,1676.0,1389.0,1377.0,1230.0,1221.0,1142.0,1749.0,17799.0
Raichur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,582.0,473.0,99.0,354.0,111.0,589.0,122.0,532.0,162.0,205.0,202.0,540.0,3971.0
Raichur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,837.0,688.0,735.0,1015.0,716.0,719.0,796.0,580.0,841.0,730.0,675.0,654.0,8986.0
Raichur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,8.0,5.0,6.0,0.0,6.0,5.0,8.0,9.0,8.0,6.0,1.0,0.0,62.0
Raichur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,124.0,165.0,136.0,149.0,179.0,146.0,150.0,137.0,195.0,156.0,140.0,183.0,1860.0
Raichur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,132.0,170.0,142.0,149.0,185.0,151.0,158.0,146.0,203.0,162.0,141.0,183.0,1922.0
Raichur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,66.0,12.0,58.0,114.0,59.0,67.0,65.0,172.0,174.0,156.0,143.0,232.0,1318.0
Raichur,4.1.1.a,Number of male live births,TOTAL,1512.0,1439.0,1581.0,1775.0,1580.0,1551.0,1664.0,1524.0,1577.0,1584.0,1434.0,1430.0,18651.0
Raichur,4.1.1.b,Number of female live births,TOTAL,1512.0,1291.0,1441.0,1479.0,1495.0,1446.0,1531.0,1409.0,1447.0,1392.0,1299.0,1283.0,17025.0
Raichur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3024.0,2730.0,3022.0,3254.0,3075.0,2997.0,3195.0,2933.0,3024.0,2976.0,2733.0,2713.0,35676.0
Raichur,4.1.2,Number of still births,TOTAL,73.0,54.0,57.0,59.0,62.0,86.0,53.0,57.0,50.0,59.0,72.0,36.0,718.0
Raichur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,43.0,39.0,39.0,98.0,34.0,54.0,35.0,50.0,31.0,32.0,43.0,42.0,540.0
Raichur,4.2.1,Number of Newborns weighed at birth,TOTAL,2843.0,2700.0,2872.0,3206.0,3049.0,2944.0,3165.0,2825.0,3019.0,2958.0,2697.0,2521.0,34799.0
Raichur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,310.0,242.0,332.0,333.0,321.0,342.0,392.0,450.0,337.0,353.0,277.0,359.0,4048.0
Raichur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2807.0,2666.0,2818.0,3193.0,3014.0,2937.0,3159.0,2804.0,2971.0,2783.0,2689.0,2515.0,34356.0
Raichur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,12.0,6.0,37.0,2.0,1.0,7.0,14.0,29.0,24.0,7.0,12.0,15.0,166.0
Raichur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,71.0,77.0,100.0,70.0,34.0,24.0,24.0,20.0,25.0,66.0,5.0,3.0,519.0
Raichur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,285.0,322.0,301.0,302.0,336.0,263.0,327.0,377.0,364.0,257.0,212.0,269.0,3615.0
Raichur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,368.0,405.0,438.0,374.0,371.0,294.0,365.0,426.0,413.0,330.0,229.0,287.0,4300.0
Raichur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,5.0,1.0,10.0,0.0,8.0,3.0,9.0,8.0,10.0,13.0,16.0,83.0
Raichur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,387.0,368.0,393.0,360.0,442.0,366.0,425.0,467.0,355.0,445.0,449.0,476.0,4933.0
Raichur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,79.0,65.0,83.0,50.0,66.0,71.0,47.0,57.0,35.0,38.0,83.0,90.0,764.0
Raichur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,895.0,713.0,938.0,516.0,927.0,851.0,849.0,994.0,757.0,897.0,817.0,774.0,9928.0
Raichur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,63.0,66.0,101.0,65.0,59.0,76.0,88.0,90.0,114.0,125.0,94.0,105.0,1046.0
Raichur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1955.0,1444.0,2076.0,1831.0,1714.0,1991.0,2085.0,2450.0,2678.0,2438.0,2210.0,2462.0,25334.0
Raichur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2198.0,1962.0,1868.0,1950.0,1923.0,2008.0,2071.0,2595.0,2093.0,2347.0,2164.0,2011.0,25190.0
Raichur,6.3,PNC maternal complications attended,TOTAL,13.0,21.0,157.0,19.0,58.0,58.0,28.0,37.0,18.0,17.0,18.0,26.0,470.0
Raichur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,9.0,9.0,4.0,46.0,13.0,10.0,14.0,8.0,12.0,9.0,17.0,12.0,163.0
Raichur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,2.0,4.0,10.0,12.0,5.0,8.0,6.0,28.0,4.0,18.0,14.0,10.0,121.0
Raichur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,11.0,13.0,14.0,58.0,18.0,18.0,20.0,36.0,16.0,27.0,31.0,22.0,284.0
Raichur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,0.0,0.0,5.0,4.0,6.0,0.0,0.0,0.0,0.0,3.0,0.0,2.0,20.0
Raichur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,389.0,470.0,432.0,417.0,409.0,471.0,383.0,416.0,437.0,472.0,424.0,426.0,5146.0
Raichur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,568.0,668.0,642.0,614.0,478.0,615.0,556.0,626.0,635.0,733.0,592.0,619.0,7346.0
Raichur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,957.0,1138.0,1074.0,1031.0,887.0,1086.0,939.0,1042.0,1072.0,1205.0,1016.0,1045.0,12492.0
Raichur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,12.0,0.0,30.0,0.0,0.0,0.0,0.0,0.0,10.0,48.0,0.0,0.0,100.0
Raichur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
Raichur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Raichur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,30.0
Raichur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,275.0,321.0,456.0,310.0,316.0,313.0,293.0,301.0,340.0,303.0,312.0,184.0,3724.0
Raichur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,171.0,139.0,235.0,178.0,184.0,193.0,179.0,249.0,125.0,178.0,200.0,144.0,2175.0
Raichur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,284.0,299.0,359.0,291.0,266.0,288.0,292.0,436.0,321.0,330.0,330.0,324.0,3820.0
Raichur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,730.0,759.0,1050.0,779.0,766.0,794.0,764.0,986.0,786.0,811.0,842.0,652.0,9719.0
Raichur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,68.0,41.0,21.0,20.0,17.0,0.0,9.0,3.0,16.0,20.0,17.0,19.0,251.0
Raichur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,29.0,0.0,0.0,26.0,0.0,0.0,0.0,0.0,25.0,18.0,29.0,127.0
Raichur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,6.0,7.0,8.0,4.0,6.0,4.0,7.0,5.0,7.0,4.0,5.0,6.0,69.0
Raichur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,15.0,10.0,4.0,14.0,8.0,13.0,8.0,23.0,21.0,34.0,44.0,24.0,218.0
Raichur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,21.0,46.0,12.0,18.0,40.0,17.0,15.0,28.0,28.0,63.0,67.0,59.0,414.0
Raichur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,22.0,15.0,17.0,11.0,2.0,0.0,4.0,2.0,0.0,26.0,0.0,30.0,129.0
Raichur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Raichur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,2.0,1.0,1.0,0.0,0.0,2.0,0.0,2.0,0.0,0.0,8.0
Raichur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,1.0,0.0,0.0,0.0,7.0,2.0,2.0,0.0,3.0,5.0,3.0,27.0,50.0
Raichur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,3.0,0.0,2.0,1.0,8.0,2.0,2.0,2.0,3.0,7.0,3.0,27.0,60.0
Raichur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,13.0,2.0,0.0,10.0,13.0,0.0,0.0,5.0,0.0,11.0,23.0,0.0,77.0
Raichur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,81.0,78.0,97.0,105.0,65.0,90.0,77.0,87.0,78.0,89.0,68.0,83.0,998.0
Raichur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,49.0,49.0,56.0,45.0,32.0,40.0,39.0,35.0,38.0,29.0,34.0,43.0,489.0
Raichur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,62.0,11.0,7.0,10.0,2.0,3.0,1.0,3.0,6.0,5.0,0.0,0.0,110.0
Raichur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,33.0,42.0,45.0,6.0,26.0,29.0,27.0,13.0,26.0,140.0,52.0,174.0,613.0
Raichur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Raichur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,225.0,180.0,205.0,166.0,125.0,162.0,144.0,138.0,148.0,263.0,154.0,300.0,2210.0
Raichur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,54.0,76.0,73.0,69.0,62.0,47.0,39.0,33.0,43.0,67.0,68.0,44.0,675.0
Raichur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,18.0,14.0,13.0,77.0,8.0,2.0,12.0,8.0,15.0,36.0,18.0,20.0,241.0
Raichur,9.06,Number of IUCD removals,TOTAL,122.0,76.0,45.0,66.0,71.0,82.0,52.0,57.0,69.0,70.0,55.0,44.0,809.0
Raichur,9.07,Number of Oral Pills cycles distributed,TOTAL,2181.0,1082.0,748.0,793.0,935.0,4451.0,874.0,713.0,576.0,592.0,417.0,690.0,14052.0
Raichur,9.08,Number of Condom pieces distributed,TOTAL,10236.0,9550.0,9346.0,9446.0,10680.0,7842.0,9305.0,12305.0,9878.0,12226.0,10569.0,9186.0,120569.0
Raichur,9.09,Number of Centchroman (weekly) pills given,TOTAL,3.0,0.0,350.0,8.0,0.0,0.0,8.0,50.0,0.0,0.0,0.0,0.0,419.0
Raichur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,10.0,4.0,14.0,30.0,32.0,28.0,49.0,20.0,45.0,36.0,54.0,23.0,345.0
Raichur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Raichur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,9.12,Number of Institutions having NSV trained doctors,TOTAL,25.0,25.0,20.0,29.0,27.0,21.0,25.0,26.0,28.0,29.0,36.0,26.0,-1.0
Raichur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,4225.0,3934.0,4550.0,4208.0,4340.0,4447.0,4461.0,5065.0,4400.0,4323.0,3697.0,4436.0,52086.0
Raichur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,17.0,2.0,119.0,18.0,54.0,5.0,0.0,17.0,0.0,11.0,19.0,6.0,268.0
Raichur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,23.0,3.0,73.0,57.0,63.0,4.0,5.0,18.0,5.0,8.0,0.0,2.0,261.0
Raichur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,28.0,7.0,72.0,13.0,65.0,28.0,2.0,29.0,6.0,22.0,0.0,21.0,293.0
Raichur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3646.0,3744.0,4341.0,4089.0,3948.0,4238.0,4153.0,4632.0,4410.0,3966.0,3405.0,4046.0,48618.0
Raichur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3697.0,3605.0,3903.0,3996.0,3870.0,4190.0,3979.0,4238.0,4361.0,3841.0,3473.0,3857.0,47010.0
Raichur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3699.0,3653.0,3948.0,3788.0,3979.0,4351.0,4179.0,4357.0,4314.0,4169.0,3784.0,4177.0,48398.0
Raichur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2933.0,2635.0,2820.0,2959.0,3250.0,3197.0,3187.0,3255.0,3022.0,2963.0,2663.0,2695.0,35579.0
Raichur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3633.0,3738.0,4259.0,4110.0,3874.0,4154.0,3994.0,4626.0,4542.0,3924.0,3404.0,4006.0,48264.0
Raichur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3647.0,3547.0,3815.0,4075.0,3842.0,4098.0,3834.0,4237.0,4323.0,3825.0,3439.0,3856.0,46538.0
Raichur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3798.0,3573.0,3917.0,3810.0,3917.0,4304.0,4007.0,4356.0,4293.0,4090.0,3567.0,4101.0,47733.0
Raichur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2017.0,1747.0,2052.0,2276.0,2672.0,2315.0,2597.0,2513.0,2709.0,2375.0,2155.0,2519.0,27947.0
Raichur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,21.0,124.0,68.0,171.0,71.0,80.0,78.0,221.0,114.0,51.0,11.0,29.0,1039.0
Raichur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,19.0,78.0,14.0,71.0,68.0,80.0,67.0,208.0,124.0,49.0,7.0,25.0,810.0
Raichur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,44.0,99.0,73.0,80.0,74.0,93.0,68.0,256.0,134.0,58.0,23.0,34.0,1036.0
Raichur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3373.0,3302.0,3809.0,3820.0,3800.0,4160.0,3789.0,3954.0,3863.0,3427.0,3239.0,4372.0,44908.0
Raichur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2821.0,2772.0,3340.0,3899.0,3555.0,3757.0,3316.0,3649.0,3526.0,3090.0,2717.0,4015.0,40457.0
Raichur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2344.0,1970.0,1901.0,3377.0,3432.0,3304.0,3107.0,3164.0,3899.0,3326.0,3088.0,4170.0,37082.0
Raichur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1855.0,1894.0,1860.0,1891.0,1899.0,2061.0,1879.0,1875.0,1835.0,1764.0,1666.0,2196.0,22675.0
Raichur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1744.0,1697.0,1750.0,1777.0,1758.0,2051.0,1781.0,1863.0,1705.0,1577.0,1543.0,2040.0,21286.0
Raichur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3599.0,3591.0,3610.0,3668.0,3657.0,4112.0,3660.0,3738.0,3540.0,3341.0,3209.0,4236.0,43961.0
Raichur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,3176.0,3004.0,3428.0,4014.0,3656.0,3857.0,3440.0,3773.0,3570.0,3162.0,2697.0,4011.0,41788.0
Raichur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,3152.0,2941.0,3371.0,3999.0,3643.0,3861.0,3299.0,3780.0,3537.0,3156.0,2687.0,3976.0,41402.0
Raichur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,116.0,118.0,62.0,38.0,43.0,88.0,31.0,85.0,107.0,41.0,61.0,99.0,889.0
Raichur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1320.0,1494.0,932.0,1324.0,1031.0,1053.0,784.0,957.0,812.0,888.0,690.0,1018.0,12303.0
Raichur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1220.0,1352.0,896.0,1277.0,963.0,991.0,763.0,916.0,795.0,754.0,680.0,967.0,11574.0
Raichur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,2540.0,2846.0,1828.0,2601.0,1994.0,2044.0,1547.0,1873.0,1607.0,1642.0,1370.0,1985.0,23877.0
Raichur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,1113.0,1078.0,1201.0,1759.0,2146.0,1952.0,1319.0,2351.0,1983.0,1433.0,1633.0,2169.0,20137.0
Raichur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,3055.0,854.0,1110.0,1821.0,2293.0,2497.0,1343.0,2380.0,2010.0,1610.0,1524.0,2001.0,22498.0
Raichur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,1402.0,783.0,905.0,1303.0,1749.0,1613.0,1092.0,2216.0,1568.0,1512.0,1530.0,1637.0,17310.0
Raichur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,6.0,8.0,3.0,3.0,4.0,1.0,4.0,25.0,3.0,8.0,10.0,3.0,78.0
Raichur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,4.0,8.0,3.0,2.0,5.0,19.0,20.0,12.0,12.0,8.0,6.0,99.0
Raichur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1593.0,1560.0,1604.0,1589.0,1608.0,1645.0,1627.0,1567.0,1570.0,1584.0,1596.0,1619.0,19162.0
Raichur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1479.0,1430.0,1491.0,1519.0,1565.0,1588.0,1559.0,1520.0,1536.0,1503.0,1301.0,1547.0,18038.0
Raichur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,999.0,955.0,982.0,986.0,954.0,957.0,919.0,951.0,903.0,944.0,797.0,965.0,11312.0
Raichur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,2233.0,1609.0,1304.0,2979.0,2776.0,2645.0,2311.0,2822.0,2984.0,3174.0,1939.0,2710.0,29486.0
Raichur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3251.0,3180.0,3701.0,3549.0,4388.0,3859.0,3495.0,3599.0,3648.0,3391.0,3131.0,3992.0,43184.0
Raichur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,680.0,475.0,599.0,2064.0,10841.0,699.0,742.0,698.0,443.0,600.0,431.0,520.0,18792.0
Raichur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,472.0,124.0,138.0,1620.0,10231.0,342.0,490.0,184.0,136.0,177.0,140.0,250.0,14304.0
Raichur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,39.0,32.0,12.0,19.0,10.0,11.0,9.0,5.0,6.0,9.0,49.0,41.0,242.0
Raichur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,474.0,448.0,308.0,316.0,530.0,368.0,356.0,447.0,459.0,371.0,445.0,392.0,4914.0
Raichur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,36.0,1.0,1.0,0.0,8.0,3.0,0.0,6.0,0.0,1.0,0.0,17.0,73.0
Raichur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,90.0,97.0,76.0,68.0,61.0,64.0,93.0,117.0,114.0,99.0,155.0,99.0,1133.0
Raichur,13.1,Number of Patients operated for cataract,TOTAL,839.0,1000.0,915.0,838.0,777.0,613.0,569.0,636.0,551.0,527.0,679.0,966.0,8910.0
Raichur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,839.0,991.0,915.0,838.0,777.0,613.0,569.0,636.0,550.0,527.0,679.0,965.0,8899.0
Raichur,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,18.0,33.0,40.0,55.0,0.0,84.0,139.0,128.0,18.0,0.0,515.0
Raichur,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0,23.0,8.0,0.0,62.0
Raichur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,10.0,10.0,10.0,6.0,11.0,10.0,11.0,10.0,12.0,12.0,13.0,12.0,-1.0
Raichur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,43.0,43.0,43.0,44.0,45.0,43.0,43.0,46.0,44.0,46.0,46.0,46.0,-1.0
Raichur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,391.0,393.0,423.0,416.0,612.0,490.0,492.0,432.0,458.0,402.0,512.0,537.0,-1.0
Raichur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,8.0,5.0,9.0,7.0,9.0,8.0,7.0,7.0,10.0,9.0,-1.0
Raichur,14.05,Number of RKS meetings held during the month,TOTAL,14.0,14.0,12.0,13.0,8.0,14.0,14.0,21.0,15.0,15.0,10.0,17.0,167.0
Raichur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,33.0,30.0,30.0,27.0,30.0,31.0,36.0,39.0,33.0,38.0,39.0,36.0,-1.0
Raichur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,307.0,182.0,203.0,237.0,250.0,176.0,233.0,217.0,224.0,190.0,259.0,333.0,2811.0
Raichur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,10.0,10.0,10.0,8.0,8.0,9.0,10.0,9.0,9.0,10.0,10.0,12.0,-1.0
Raichur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,6.0,39.0,26.0,4.0,3.0,3.0,3.0,3.0,3.0,-1.0
Raichur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,693.0,566.0,641.0,695.0,805.0,718.0,893.0,632.0,609.0,547.0,671.0,735.0,8205.0
Raichur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3021.0,2505.0,3606.0,2622.0,2408.0,2394.0,2179.0,2706.0,1932.0,2450.0,2876.0,2970.0,31669.0
Raichur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,781.0,515.0,545.0,649.0,742.0,809.0,1331.0,554.0,1171.0,527.0,688.0,561.0,8873.0
Raichur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,5183.0,4547.0,5672.0,5583.0,4930.0,4948.0,5129.0,4652.0,4901.0,4182.0,4284.0,4398.0,58409.0
Raichur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1474.0,1081.0,1186.0,1344.0,1547.0,1527.0,2224.0,1186.0,1780.0,1074.0,1359.0,1296.0,17078.0
Raichur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,8204.0,7052.0,9278.0,8205.0,7338.0,7342.0,7308.0,7358.0,6833.0,6632.0,7160.0,7368.0,90078.0
Raichur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,64.0,57.0,56.0,54.0,70.0,82.0,61.0,71.0,71.0,111.0,75.0,70.0,842.0
Raichur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,53.0,38.0,44.0,40.0,44.0,51.0,64.0,52.0,52.0,34.0,40.0,22.0,534.0
Raichur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,117.0,95.0,100.0,94.0,114.0,133.0,125.0,123.0,123.0,145.0,115.0,92.0,1376.0
Raichur,14.11,In-Patient Head Count at midnight,TOTAL,16673.0,14842.0,17104.0,18342.0,17510.0,17174.0,18181.0,17790.0,20192.0,18476.0,17667.0,19006.0,212957.0
Raichur,14.12.1,OPD attendance (All),TOTAL,89480.0,86354.0,93656.0,85276.0,97546.0,114240.0,104447.0,100017.0,88514.0,92389.0,95573.0,100325.0,1147817.0
Raichur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1084.0,473.0,486.0,476.0,451.0,412.0,909.0,461.0,543.0,446.0,370.0,383.0,6494.0
Raichur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,73.0,49.0,89.0,88.0,72.0,26.0,44.0,67.0,41.0,44.0,65.0,40.0,698.0
Raichur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,943.0,1631.0,1855.0,1632.0,1650.0,1454.0,1388.0,1538.0,1446.0,1291.0,1061.0,1181.0,17070.0
Raichur,14.14.a,Number of patients given AYUSH treatment,TOTAL,12642.0,9644.0,12652.0,12807.0,13935.0,15190.0,14782.0,14947.0,13533.0,13296.0,8790.0,9291.0,151509.0
Raichur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,244.0,6.0,4.0,223.0,127.0,19.0,279.0,273.0,245.0,47.0,15.0,40.0,1522.0
Raichur,14.14.c,Number of Adolescents counselled,TOTAL,185.0,237.0,273.0,298.0,235.0,256.0,203.0,213.0,209.0,203.0,221.0,206.0,2739.0
Raichur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,6171.0,7594.0,8448.0,7890.0,7504.0,9377.0,8882.0,9044.0,8046.0,8060.0,8636.0,9135.0,98787.0
Raichur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,425.0,432.0,466.0,420.0,407.0,521.0,375.0,458.0,391.0,424.0,418.0,399.0,5136.0
Raichur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1309.0,1402.0,1619.0,1910.0,1825.0,1506.0,1253.0,1448.0,1335.0,1611.0,1581.0,1632.0,18431.0
Raichur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,47.0,51.0,58.0,58.0,49.0,58.0,45.0,50.0,40.0,27.0,44.0,61.0,588.0
Raichur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1353.0,1607.0,1415.0,1700.0,1551.0,1773.0,1815.0,1745.0,2212.0,1777.0,1414.0,1641.0,20003.0
Raichur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,46.0,51.0,53.0,62.0,21.0,41.0,36.0,43.0,46.0,20.0,32.0,40.0,491.0
Raichur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2836.0,2812.0,3229.0,3447.0,2830.0,3468.0,2694.0,3182.0,3203.0,3480.0,3074.0,3535.0,37790.0
Raichur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,4.0,5.0,10.0,4.0,3.0,1.0,3.0,5.0,3.0,5.0,2.0,51.0
Raichur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5498.0,5821.0,6263.0,7057.0,6206.0,6747.0,5762.0,6375.0,6750.0,6868.0,6069.0,6808.0,76224.0
Raichur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,99.0,106.0,116.0,130.0,74.0,102.0,82.0,96.0,91.0,50.0,81.0,103.0,1130.0
Raichur,15.2,Number of Widal tests conducted,Number tested,961.0,1019.0,982.0,1265.0,1502.0,2086.0,1521.0,1756.0,1237.0,1497.0,1358.0,1390.0,16574.0
Raichur,15.3.a,Number of VDRL tests conducted on males,Number tested,51.0,45.0,131.0,193.0,102.0,38.0,14.0,17.0,362.0,350.0,37.0,56.0,1396.0
Raichur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,79.0,73.0,77.0,190.0,37.0,61.0,51.0,26.0,23.0,172.0,10.0,169.0,968.0
Raichur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1379.0,1670.0,1429.0,1304.0,1122.0,1584.0,1385.0,1487.0,1368.0,1470.0,1563.0,1722.0,17483.0
Raichur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1509.0,1788.0,1637.0,1687.0,1261.0,1683.0,1450.0,1530.0,1753.0,1992.0,1610.0,1947.0,19847.0
Raichur,15.4.1,Number of blood smears examined for Malaria,TOTAL,17969.0,17815.0,20831.0,20602.0,21662.0,24144.0,17546.0,20576.0,18027.0,16121.0,15453.0,17169.0,227915.0
Raichur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,20.0,14.0,20.0,14.0,24.0,12.0,12.0,52.0,9.0,9.0,2.0,26.0,214.0
Raichur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,6.0,1.0,4.0,2.0,15.0,4.0,7.0,32.0,10.0,2.0,0.0,19.0,102.0
Raichur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,14000.0,10000.0,8000.0,8400.0,9400.0,9400.0,11400.0,10900.0,9400.0,7700.0,4800.0,4900.0,108300.0
Raichur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,5000.0,0.0,5000.0,5000.0,10000.0,8000.0,2000.0,3000.0,5000.0,5000.0,2000.0,10000.0,60000.0
Raichur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,9000.0,2000.0,4600.0,4000.0,10000.0,6000.0,2500.0,4500.0,6700.0,7900.0,1900.0,9900.0,69000.0
Raichur,16.1.1,Stock position of DPT vaccines,5. Total Stock,10000.0,8000.0,8400.0,9400.0,9400.0,11400.0,10900.0,9400.0,7700.0,4800.0,4900.0,5000.0,99300.0
Raichur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,24310.0,25300.0,18300.0,21400.0,26400.0,26600.0,27600.0,8800.0,7300.0,12000.0,10000.0,9100.0,217110.0
Raichur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,13500.0,0.0,13000.0,12000.0,15000.0,9000.0,0.0,5000.0,14000.0,15000.0,7000.0,12000.0,115500.0
Raichur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,12510.0,7000.0,9900.0,7000.0,14800.0,8000.0,18800.0,6500.0,9300.0,17000.0,7900.0,14800.0,133510.0
Raichur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,25300.0,18300.0,21400.0,26400.0,26600.0,27600.0,8800.0,7300.0,12000.0,10000.0,9100.0,6300.0,199100.0
Raichur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,23300.0,25380.0,2380.0,21980.0,16980.0,14980.0,12980.0,15980.0,21980.0,13980.0,6980.0,0.0,176900.0
Raichur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,23000.0,0.0,25000.0,22000.0,26000.0,18000.0,23000.0,30000.0,15000.0,15000.0,5000.0,26000.0,228000.0
Raichur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,20920.0,23000.0,5400.0,27000.0,28000.0,20000.0,20000.0,24000.0,23000.0,22000.0,11980.0,26000.0,251300.0
Raichur,16.1.2,Stock position of OPV vaccines,5. Total Stock,25380.0,2380.0,21980.0,16980.0,14980.0,12980.0,15980.0,21980.0,13980.0,6980.0,0.0,0.0,153600.0
Raichur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,8200.0,5570.0,1070.0,11170.0,11970.0,12170.0,8170.0,2170.0,6970.0,5170.0,2270.0,7370.0,82270.0
Raichur,16.1.3,Stock position of TT vaccines,2. Stocks Received,10000.0,12000.0,16000.0,20000.0,18000.0,15000.0,10000.0,15000.0,18000.0,18000.0,20000.0,18000.0,190000.0
Raichur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,12630.0,16500.0,5900.0,19200.0,17800.0,19000.0,16000.0,10200.0,19800.0,20900.0,14900.0,16900.0,189730.0
Raichur,16.1.3,Stock position of TT vaccines,5. Total Stock,5570.0,1070.0,11170.0,11970.0,12170.0,8170.0,2170.0,6970.0,5170.0,2270.0,7370.0,8470.0,82540.0
Raichur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.4,Stock position of DT vaccines,2. Stocks Received,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,,,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3750.0,5750.0,1850.0,5470.0,3670.0,4870.0,1970.0,2170.0,2770.0,3570.0,2570.0,3570.0,41980.0
Raichur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,8000.0,5000.0,8000.0,8000.0,8000.0,6000.0,8000.0,8000.0,8000.0,8000.0,6000.0,6000.0,87000.0
Raichur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,6000.0,8900.0,4380.0,9800.0,6800.0,8900.0,7800.0,7400.0,7200.0,9000.0,5000.0,8500.0,89680.0
Raichur,16.1.5,Stock position of BCG vaccines,5. Total Stock,5750.0,1850.0,5470.0,3670.0,4870.0,1970.0,2170.0,2770.0,3570.0,2570.0,3570.0,1070.0,39300.0
Raichur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,23890.0,24880.0,15280.0,14030.0,8530.0,290.0,890.0,1090.0,2190.0,2690.0,3490.0,5290.0,102540.0
Raichur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,5000.0,1000.0,0.0,10000.0,4000.0,10000.0,10000.0,10000.0,7000.0,7000.0,69000.0
Raichur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4010.0,9600.0,6250.0,6500.0,8240.0,9400.0,3800.0,8900.0,9500.0,9200.0,5200.0,8200.0,88800.0
Raichur,16.1.6,Stock position of Measles vaccines,5. Total Stock,24880.0,15280.0,14030.0,8530.0,290.0,890.0,1090.0,2190.0,2690.0,3490.0,5290.0,4090.0,82740.0
Raichur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,6625.0,4625.0,0.0,8000.0,0.0,0.0,0.0,0.0,15400.0,9400.0,5400.0,8200.0,57650.0
Raichur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,5000.0,10000.0,10000.0,7500.0,2500.0,10000.0,30000.0,0.0,0.0,10000.0,5000.0,90000.0
Raichur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,2000.0,9625.0,2000.0,18000.0,7500.0,2500.0,10000.0,14600.0,6000.0,4000.0,7200.0,6900.0,90325.0
Raichur,16.1.7,Stock position of JE vaccines,5. Total Stock,4625.0,0.0,8000.0,0.0,0.0,0.0,0.0,15400.0,9400.0,5400.0,8200.0,6300.0,57325.0
Raichur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9020.0,12850.0,8850.0,11050.0,10050.0,13150.0,16150.0,13150.0,13150.0,14350.0,16150.0,16250.0,154170.0
Raichur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,4500.0,0.0,4500.0,3000.0,5100.0,5000.0,0.0,0.0,3000.0,5000.0,3000.0,5000.0,38100.0
Raichur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,670.0,4000.0,2300.0,4000.0,2000.0,2000.0,3000.0,0.0,1800.0,3200.0,2900.0,3500.0,29370.0
Raichur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,12850.0,8850.0,11050.0,10050.0,13150.0,16150.0,13150.0,13150.0,14350.0,16150.0,16250.0,17750.0,162900.0
Raichur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,5600.0,5000.0,4200.0,3200.0,2400.0,2400.0,2100.0,2100.0,2100.0,2100.0,2100.0,2100.0,35400.0
Raichur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,600.0,800.0,1000.0,800.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,1000.0,4500.0
Raichur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,5000.0,4200.0,3200.0,2400.0,2400.0,2100.0,2100.0,2100.0,2100.0,2100.0,2100.0,1100.0,30900.0
Raichur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,60480.0,30480.0,10480.0,10480.0,4480.0,4480.0,3880.0,0.0,0.0,0.0,0.0,0.0,124760.0
Raichur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,12000.0,12000.0
Raichur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,30000.0,20000.0,0.0,6000.0,0.0,600.0,3880.0,0.0,0.0,0.0,0.0,12000.0,72480.0
Raichur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,30480.0,10480.0,10480.0,4480.0,4480.0,3880.0,0.0,0.0,0.0,0.0,0.0,0.0,64280.0
Raichur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0
Raichur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2000.0,2000.0
Raichur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,3840.0,3840.0,3840.0,3840.0,3240.0,3240.0,3040.0,3040.0,3040.0,1540.0,1540.0,1540.0,35580.0
Raichur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,600.0,500.0,200.0,0.0,0.0,1500.0,0.0,0.0,0.0,2800.0
Raichur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,3840.0,3840.0,3840.0,3240.0,2740.0,3040.0,3040.0,3040.0,1540.0,1540.0,1540.0,1540.0,32780.0
Raichur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,4015.0,3115.0,2115.0,915.0,915.0,215.0,3715.0,3615.0,3615.0,1615.0,615.0,0.0,24465.0
Raichur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,4500.0,0.0,0.0,0.0,0.0,0.0,4550.0,9050.0
Raichur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,,,,,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,900.0,1000.0,1200.0,0.0,700.0,1000.0,100.0,0.0,2000.0,1000.0,615.0,1300.0,9815.0
Raichur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,3115.0,2115.0,915.0,915.0,215.0,3715.0,3615.0,3615.0,1615.0,615.0,0.0,3250.0,23700.0
Raichur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.02,Stock Position of Gloves,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.02,Stock Position of Gloves,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.02,Stock Position of Gloves,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,,0.0,,0.0,150.0,,0.0,0.0,0.0,0.0,0.0,0.0,150.0
Raichur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,,0.0,,0.0,100.0,,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Raichur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,50.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,50.0
Raichur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,,0.0,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,5850.0,650.0,0.0,1500.0,0.0,0.0,0.0,4000.0,8800.0,3800.0,0.0,0.0,24600.0
Raichur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,3000.0,6000.0,0.0,0.0,0.0,6000.0,9300.0,0.0,0.0,3300.0,3300.0,30900.0
Raichur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,5200.0,3650.0,4500.0,1500.0,0.0,0.0,2000.0,4500.0,5000.0,3800.0,3300.0,3300.0,36750.0
Raichur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,650.0,0.0,1500.0,0.0,0.0,0.0,4000.0,8800.0,3800.0,0.0,0.0,0.0,18750.0
Raichur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,53800.0,5800.0,193800.0,159800.0,89800.0,59800.0,44800.0,40800.0,128800.0,108000.0,87800.0,72800.0,1045800.0
Raichur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,202000.0,0.0,0.0,0.0,0.0,8000.0,108000.0,0.0,0.0,0.0,3600.0,321600.0
Raichur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,48000.0,14000.0,34000.0,70000.0,30000.0,15000.0,12000.0,20000.0,28000.0,20200.0,15000.0,72300.0,378500.0
Raichur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,5800.0,193800.0,159800.0,89800.0,59800.0,44800.0,40800.0,128800.0,100800.0,87800.0,72800.0,4100.0,988900.0
Raichur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5300.0,3700.0,13400.0,11000.0,8200.0,6700.0,5700.0,7500.0,13800.0,12300.0,10400.0,8400.0,106400.0
Raichur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,12000.0,0.0,0.0,0.0,0.0,3000.0,7800.0,0.0,0.0,0.0,0.0,22800.0
Raichur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,,,,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Raichur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1600.0,2300.0,2400.0,2800.0,1500.0,1000.0,1200.0,1500.0,1500.0,1900.0,2000.0,1500.0,21200.0
Raichur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,3700.0,13400.0,11000.0,8200.0,6700.0,5700.0,7500.0,13800.0,12300.0,10400.0,8400.0,6900.0,108000.0
Raichur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,2.0,2.0,1.0,4.0,2.0,5.0,3.0,,2.0,,,23.0
Raichur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,4.0,4.0,4.0,1.0,7.0,4.0,7.0,7.0,3.0,14.0,2.0,1.0,58.0
Raichur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,1.0,4.0,1.0,,1.0,2.0,,,,,9.0
Raichur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,4.0,4.0,5.0,5.0,8.0,4.0,8.0,9.0,3.0,14.0,2.0,1.0,67.0
Raichur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,15.0,10.0,16.0,16.0,12.0,15.0,25.0,17.0,11.0,12.0,5.0,4.0,158.0
Raichur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,5.0,,2.0,1.0,,2.0,,1.0,,1.0,,,12.0
Raichur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,20.0,10.0,18.0,17.0,12.0,17.0,25.0,18.0,11.0,13.0,5.0,4.0,170.0
Raichur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,17.0,6.0,12.0,18.0,11.0,19.0,30.0,12.0,15.0,32.0,11.0,7.0,190.0
Raichur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,6.0,,2.0,2.0,,1.0,4.0,4.0,1.0,2.0,,,22.0
Raichur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,23.0,6.0,14.0,20.0,11.0,20.0,34.0,16.0,16.0,34.0,11.0,7.0,212.0
Raichur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,14.0,2.0,6.0,8.0,2.0,,9.0,10.0,4.0,2.0,1.0,3.0,61.0
Raichur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,4.0,,2.0,,,,5.0,6.0,,1.0,,,18.0
Raichur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,18.0,2.0,8.0,8.0,2.0,,14.0,16.0,4.0,3.0,1.0,3.0,79.0
Raichur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,8.0,1.0,3.0,10.0,2.0,4.0,8.0,3.0,1.0,4.0,2.0,1.0,47.0
Raichur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,1.0,,,2.0,,,2.0,,,,1.0,1.0,7.0
Raichur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,9.0,1.0,3.0,12.0,2.0,4.0,10.0,3.0,1.0,4.0,3.0,2.0,54.0
Raichur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Raichur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Raichur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Raichur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,3.0,,,1.0,2.0,1.0,1.0,3.0,,1.0,,1.0,13.0
Raichur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,1.0,1.0,,,,,,,,,,,2.0
Raichur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,4.0,1.0,,1.0,2.0,1.0,1.0,3.0,,1.0,,1.0,15.0
Raichur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Raichur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,1.0,,,,,,,,,,,1.0
Raichur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,1.0,,,,,,,,,,,1.0
Raichur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,15.0,1.0,8.0,4.0,,4.0,12.0,5.0,6.0,7.0,4.0,1.0,67.0
Raichur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,6.0,2.0,4.0,7.0,7.0,2.0,3.0,2.0,4.0,2.0,1.0,3.0,43.0
Raichur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,21.0,3.0,12.0,11.0,7.0,6.0,15.0,7.0,10.0,9.0,5.0,4.0,110.0
Raichur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,2.0,1.0,,,,,,,,,3.0
Raichur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Raichur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,2.0,1.0,,,,,,1.0,,,4.0
Raichur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,1.0,,,,,,,,1.0,,,,2.0
Raichur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,11.0,5.0,5.0,8.0,6.0,2.0,8.0,1.0,6.0,4.0,4.0,4.0,64.0
Raichur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,3.0,1.0,4.0,3.0,1.0,4.0,4.0,3.0,3.0,1.0,6.0,,33.0
Raichur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,15.0,6.0,9.0,11.0,7.0,6.0,12.0,4.0,10.0,5.0,10.0,4.0,99.0
Raichur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,1.0,1.0,,,2.0,,,,,,,4.0
Raichur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,5.0,3.0,4.0,1.0,5.0,3.0,2.0,8.0,7.0,8.0,4.0,54.0
Raichur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,5.0,8.0,6.0,6.0,5.0,8.0,7.0,11.0,9.0,10.0,9.0,19.0,103.0
Raichur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,9.0,14.0,10.0,10.0,6.0,15.0,10.0,13.0,17.0,17.0,17.0,23.0,161.0
Raichur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Raichur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Raichur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,1.0,,,1.0
Raichur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Raichur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,1.0,,1.0,2.0,,2.0,,2.0,2.0,10.0
Raichur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,,,,1.0,1.0,,,2.0,4.0
Raichur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,1.0,,1.0,2.0,1.0,3.0,,3.0,4.0,15.0
Raichur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Raichur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,5.0,6.0,5.0,3.0,5.0,5.0,7.0,5.0,5.0,2.0,4.0,54.0
Raichur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,1.0,1.0,,1.0,1.0,1.0,,,1.0,1.0,1.0,1.0,9.0
Raichur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,7.0,6.0,6.0,5.0,6.0,5.0,7.0,6.0,6.0,3.0,5.0,65.0
Raichur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,,,1.0,1.0,,,,1.0,4.0
Raichur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,21.0,14.0,27.0,11.0,11.0,17.0,24.0,21.0,14.0,15.0,27.0,8.0,210.0
Raichur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,22.0,13.0,8.0,8.0,14.0,11.0,11.0,11.0,10.0,16.0,22.0,10.0,156.0
Raichur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,43.0,27.0,36.0,19.0,25.0,28.0,36.0,33.0,24.0,31.0,49.0,19.0,370.0
Raichur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,1.0,,1.0,1.0,1.0,,,1.0,,,6.0
Raichur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,11.0,1.0,5.0,6.0,12.0,16.0,4.0,9.0,13.0,4.0,12.0,8.0,101.0
Raichur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,9.0,12.0,6.0,5.0,7.0,12.0,5.0,6.0,12.0,15.0,18.0,11.0,118.0
Raichur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,21.0,13.0,12.0,11.0,20.0,29.0,10.0,15.0,25.0,20.0,30.0,19.0,225.0
Raichur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Raichur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Raichur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Raichur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,2.0,1.0,1.0,1.0,,,1.0,,,,7.0
Raichur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Raichur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,2.0,1.0,1.0,1.0,,,1.0,,,,7.0
Raichur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,2.0,,1.0,,,,,,,1.0,1.0,6.0
Raichur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Raichur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,2.0,,1.0,,,,,,,1.0,1.0,6.0
Raichur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,1.0,3.0,,,,,,,1.0,,7.0
Raichur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Raichur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,1.0,3.0,,,,,,,1.0,,7.0
Raichur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Raichur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Raichur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Raichur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Raichur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,1.0,1.0,1.0,1.0,1.0,2.0,,1.0,,,,10.0
Raichur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Raichur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,1.0,1.0,1.0,1.0,1.0,2.0,,1.0,,,,10.0
Raichur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,,2.0,,1.0,,2.0,1.0,3.0,1.0,2.0,1.0,13.0
Raichur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,21.0,14.0,16.0,10.0,12.0,12.0,23.0,17.0,17.0,13.0,14.0,16.0,185.0
Raichur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,2.0,2.0,1.0,1.0,,2.0,2.0,1.0,5.0,1.0,2.0,2.0,21.0
Raichur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,23.0,16.0,19.0,11.0,13.0,14.0,27.0,19.0,25.0,15.0,18.0,19.0,219.0
Raichur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,,1.0,,,,1.0,,,1.0,3.0
Raichur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,7.0,10.0,14.0,9.0,7.0,17.0,19.0,14.0,7.0,5.0,7.0,11.0,127.0
Raichur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,,,1.0,1.0,,2.0,,1.0,3.0,1.0,3.0,3.0,15.0
Raichur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,7.0,10.0,15.0,10.0,8.0,19.0,19.0,15.0,11.0,6.0,10.0,15.0,145.0
Raichur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,2.0,1.0,2.0,1.0,,,,2.0,9.0
Raichur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,4.0,2.0,2.0,1.0,5.0,1.0,2.0,1.0,,1.0,,19.0
Raichur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,3.0,,1.0,1.0,1.0,4.0,,10.0
Raichur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,4.0,2.0,2.0,3.0,9.0,3.0,4.0,2.0,1.0,5.0,2.0,38.0
Raichur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,1.0,1.0,1.0,1.0,,,,1.0,,1.0,6.0
Raichur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,4.0,4.0,4.0,2.0,1.0,1.0,4.0,5.0,6.0,4.0,9.0,8.0,52.0
Raichur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,3.0,1.0,3.0,4.0,4.0,3.0,4.0,8.0,5.0,5.0,4.0,3.0,47.0
Raichur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,7.0,5.0,8.0,7.0,6.0,5.0,8.0,13.0,11.0,10.0,13.0,12.0,105.0
Raichur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,2.0,,,,1.0,,,,3.0,,,6.0
Raichur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,9.0,15.0,9.0,7.0,15.0,10.0,12.0,16.0,22.0,20.0,17.0,19.0,171.0
Raichur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,16.0,16.0,13.0,10.0,16.0,19.0,18.0,16.0,16.0,21.0,18.0,16.0,195.0
Raichur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,25.0,33.0,22.0,17.0,31.0,30.0,30.0,32.0,38.0,44.0,35.0,35.0,372.0
Raichur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,2.0,2.0,2.0,5.0,3.0,4.0,1.0,,,3.0,4.0,26.0
Raichur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,46.0,40.0,32.0,53.0,47.0,51.0,44.0,57.0,61.0,44.0,43.0,32.0,550.0
Raichur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,99.0,100.0,80.0,99.0,128.0,168.0,112.0,152.0,144.0,142.0,123.0,113.0,1460.0
Raichur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,145.0,142.0,114.0,154.0,180.0,222.0,160.0,210.0,205.0,186.0,169.0,149.0,2036.0
Ramanagar,1.1,Total number of pregnant women Registered for ANC,TOTAL,1277.0,1175.0,1343.0,1311.0,1484.0,1419.0,1243.0,1410.0,1261.0,1183.0,1149.0,1185.0,15440.0
Ramanagar,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,932.0,888.0,936.0,978.0,1010.0,1014.0,898.0,999.0,965.0,827.0,817.0,876.0,11140.0
Ramanagar,1.2,Number of Pregnant women registered under JSY,TOTAL,1055.0,999.0,1142.0,1062.0,1128.0,1248.0,1027.0,1198.0,1082.0,1031.0,996.0,986.0,12954.0
Ramanagar,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1507.0,1457.0,1505.0,1460.0,1558.0,1729.0,1491.0,1575.0,1344.0,1478.0,1418.0,1223.0,17745.0
Ramanagar,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1165.0,1179.0,1369.0,1268.0,1398.0,1508.0,1127.0,1419.0,1273.0,1165.0,1236.0,1235.0,15342.0
Ramanagar,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1288.0,1248.0,1317.0,1347.0,1434.0,1644.0,1308.0,1444.0,1460.0,1317.0,1277.0,1260.0,16344.0
Ramanagar,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,927.0,816.0,625.0,1285.0,940.0,1192.0,1415.0,1192.0,1102.0,1309.0,837.0,1164.0,12804.0
Ramanagar,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,30.0,61.0,28.0,34.0,42.0,57.0,63.0,38.0,38.0,27.0,48.0,54.0,520.0
Ramanagar,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,6.0,0.0,0.0,1.0,5.0,6.0,4.0,11.0,5.0,0.0,1.0,0.0,39.0
Ramanagar,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,635.0,659.0,820.0,941.0,919.0,901.0,712.0,970.0,903.0,821.0,926.0,936.0,10143.0
Ramanagar,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,28.0,19.0,21.0,33.0,36.0,35.0,28.0,34.0,22.0,29.0,46.0,30.0,361.0
Ramanagar,1.8,Number of pregnancy test kits used at SC level,TOTAL,71.0,47.0,61.0,80.0,69.0,101.0,85.0,96.0,111.0,151.0,138.0,66.0,1076.0
Ramanagar,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,5.0,2.0,2.0,4.0,4.0,2.0,1.0,1.0,0.0,1.0,1.0,2.0,25.0
Ramanagar,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,1.0,2.0,0.0,2.0,2.0,1.0,4.0,0.0,0.0,1.0,2.0,2.0,17.0
Ramanagar,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,6.0,4.0,2.0,6.0,6.0,3.0,5.0,1.0,0.0,2.0,3.0,4.0,42.0
Ramanagar,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,5.0,3.0,3.0,6.0,5.0,3.0,5.0,0.0,0.0,2.0,3.0,4.0,39.0
Ramanagar,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,4.0,2.0,6.0,17.0
Ramanagar,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,438.0,431.0,447.0,392.0,415.0,386.0,430.0,442.0,419.0,437.0,433.0,459.0,5129.0
Ramanagar,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,214.0,96.0,136.0,161.0,145.0,178.0,139.0,185.0,185.0,231.0,153.0,182.0,2005.0
Ramanagar,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,183.0,174.0,173.0,363.0,280.0,303.0,371.0,487.0,452.0,435.0,278.0,329.0,3828.0
Ramanagar,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,28.0,11.0,5.0,17.0,0.0,0.0,0.0,0.0,0.0,61.0
Ramanagar,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,386.0,456.0,410.0,445.0,411.0,461.0,363.0,418.0,469.0,322.0,414.0,405.0,4960.0
Ramanagar,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0,9.0,4.0,7.0,13.0,41.0
Ramanagar,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,81.0,85.0,67.0,61.0,77.0,73.0,106.0,79.0,88.0,89.0,121.0,95.0,1022.0
Ramanagar,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,81.0,85.0,67.0,61.0,77.0,73.0,110.0,83.0,97.0,93.0,128.0,108.0,1063.0
Ramanagar,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,139.0,122.0,100.0,67.0,110.0,116.0,107.0,123.0,139.0,50.0,133.0,88.0,1294.0
Ramanagar,4.1.1.a,Number of male live births,TOTAL,420.0,442.0,453.0,417.0,435.0,457.0,414.0,433.0,482.0,388.0,429.0,414.0,5184.0
Ramanagar,4.1.1.b,Number of female live births,TOTAL,417.0,444.0,403.0,421.0,394.0,387.0,380.0,424.0,401.0,370.0,436.0,460.0,4937.0
Ramanagar,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,837.0,886.0,856.0,838.0,829.0,844.0,794.0,857.0,883.0,758.0,865.0,874.0,10121.0
Ramanagar,4.1.2,Number of still births,TOTAL,3.0,6.0,3.0,10.0,3.0,6.0,6.0,4.0,5.0,3.0,4.0,2.0,55.0
Ramanagar,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,25.0,20.0,30.0,46.0,38.0,35.0,19.0,35.0,16.0,18.0,42.0,35.0,359.0
Ramanagar,4.2.1,Number of Newborns weighed at birth,TOTAL,846.0,851.0,832.0,838.0,825.0,837.0,794.0,860.0,875.0,738.0,865.0,881.0,10042.0
Ramanagar,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,96.0,69.0,73.0,64.0,64.0,73.0,52.0,83.0,69.0,78.0,66.0,97.0,884.0
Ramanagar,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,824.0,840.0,804.0,833.0,828.0,855.0,802.0,854.0,874.0,742.0,849.0,857.0,9962.0
Ramanagar,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Ramanagar,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,2.0,0.0,5.0
Ramanagar,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,36.0,27.0,8.0,7.0,7.0,27.0,34.0,11.0,4.0,28.0,35.0,34.0,258.0
Ramanagar,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,36.0,27.0,8.0,7.0,7.0,27.0,34.0,14.0,4.0,28.0,37.0,35.0,264.0
Ramanagar,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,0.0,0.0,0.0,13.0,20.0,45.0,4.0,22.0,22.0,13.0,12.0,10.0,161.0
Ramanagar,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,141.0,138.0,96.0,204.0,152.0,115.0,104.0,96.0,93.0,58.0,90.0,153.0,1440.0
Ramanagar,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,8.0,3.0,5.0,5.0,6.0,6.0,11.0,4.0,3.0,0.0,3.0,5.0,59.0
Ramanagar,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,303.0,204.0,207.0,278.0,182.0,217.0,263.0,149.0,97.0,76.0,85.0,271.0,2332.0
Ramanagar,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,27.0,30.0,13.0,17.0,31.0,28.0,26.0,8.0,14.0,17.0,12.0,11.0,234.0
Ramanagar,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,694.0,901.0,814.0,666.0,671.0,805.0,614.0,873.0,658.0,689.0,849.0,856.0,9090.0
Ramanagar,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,818.0,1157.0,1040.0,845.0,943.0,1054.0,896.0,1112.0,927.0,912.0,974.0,1052.0,11730.0
Ramanagar,6.3,PNC maternal complications attended,TOTAL,2.0,3.0,0.0,7.0,2.0,1.0,3.0,3.0,8.0,12.0,4.0,8.0,53.0
Ramanagar,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,10.0,12.0,19.0,14.0,20.0,13.0,5.0,9.0,7.0,10.0,12.0,12.0,143.0
Ramanagar,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,5.0,3.0,4.0,4.0,3.0,1.0,2.0,1.0,0.0,2.0,4.0,1.0,30.0
Ramanagar,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,15.0,15.0,23.0,18.0,23.0,14.0,7.0,10.0,7.0,12.0,16.0,13.0,173.0
Ramanagar,7.2,Number of MTPs conducted at Private Facilities,TOTAL,2.0,10.0,9.0,19.0,9.0,15.0,2.0,13.0,12.0,2.0,2.0,5.0,100.0
Ramanagar,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,197.0,159.0,213.0,345.0,275.0,291.0,144.0,165.0,257.0,368.0,344.0,346.0,3104.0
Ramanagar,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,297.0,254.0,319.0,466.0,422.0,400.0,211.0,224.0,409.0,439.0,442.0,440.0,4323.0
Ramanagar,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,494.0,413.0,532.0,811.0,697.0,691.0,355.0,389.0,666.0,807.0,786.0,786.0,7427.0
Ramanagar,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,7.0,7.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,15.0
Ramanagar,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Ramanagar,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Ramanagar,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,286.0,378.0,393.0,367.0,247.0,260.0,302.0,365.0,292.0,264.0,280.0,369.0,3803.0
Ramanagar,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,286.0,378.0,393.0,367.0,247.0,260.0,302.0,365.0,292.0,264.0,280.0,369.0,3803.0
Ramanagar,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,0.0,0.0,0.0,4.0
Ramanagar,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,0.0,3.0
Ramanagar,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,2.0
Ramanagar,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,136.0,22.0,41.0,17.0,24.0,48.0,5.0,5.0,1.0,3.0,1.0,26.0,329.0
Ramanagar,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,136.0,22.0,41.0,17.0,24.0,48.0,5.0,5.0,4.0,3.0,2.0,27.0,334.0
Ramanagar,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,4.0,1.0,3.0,19.0,0.0,0.0,4.0,17.0,26.0,17.0,14.0,9.0,114.0
Ramanagar,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0,4.0,3.0,9.0
Ramanagar,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,9.0,12.0,8.0,8.0,7.0,24.0,30.0,18.0,30.0,17.0,20.0,1.0,184.0
Ramanagar,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,9.0,12.0,8.0,8.0,7.0,24.0,30.0,18.0,31.0,18.0,24.0,4.0,193.0
Ramanagar,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,18.0,30.0,16.0,35.0,41.0,39.0,16.0,0.0,12.0,3.0,0.0,11.0,221.0
Ramanagar,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,95.0,110.0,107.0,105.0,102.0,112.0,89.0,115.0,90.0,80.0,65.0,84.0,1154.0
Ramanagar,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,53.0,50.0,66.0,68.0,54.0,58.0,55.0,52.0,40.0,70.0,48.0,45.0,659.0
Ramanagar,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,11.0,7.0,9.0,15.0,5.0,7.0,4.0,13.0,7.0,10.0,8.0,4.0,100.0
Ramanagar,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,36.0,43.0,37.0,29.0,23.0,34.0,30.0,35.0,26.0,31.0,27.0,30.0,381.0
Ramanagar,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Ramanagar,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,195.0,210.0,219.0,217.0,184.0,211.0,178.0,215.0,163.0,191.0,148.0,163.0,2294.0
Ramanagar,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,4.0,5.0,8.0,5.0,14.0,30.0,10.0,17.0,6.0,6.0,8.0,14.0,127.0
Ramanagar,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,37.0,21.0,9.0,14.0,18.0,18.0,14.0,19.0,11.0,2.0,8.0,5.0,176.0
Ramanagar,9.06,Number of IUCD removals,TOTAL,121.0,110.0,100.0,98.0,89.0,93.0,92.0,110.0,107.0,115.0,84.0,59.0,1178.0
Ramanagar,9.07,Number of Oral Pills cycles distributed,TOTAL,2033.0,2328.0,2217.0,2135.0,2171.0,2083.0,2110.0,2138.0,2063.0,2317.0,3822.0,2244.0,27661.0
Ramanagar,9.08,Number of Condom pieces distributed,TOTAL,41530.0,26856.0,24852.0,26062.0,26515.0,28617.0,26868.0,28444.0,32613.0,31603.0,23667.0,36136.0,353763.0
Ramanagar,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,61.0,93.0,70.0,50.0,48.0,114.0,42.0,48.0,43.0,32.0,54.0,36.0,691.0
Ramanagar,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,1.0,1.0,1.0,0.0,1.0,5.0,0.0,0.0,0.0,0.0,0.0,9.0
Ramanagar,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Ramanagar,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,9.12,Number of Institutions having NSV trained doctors,TOTAL,11.0,13.0,10.0,12.0,12.0,15.0,10.0,10.0,15.0,14.0,9.0,8.0,-1.0
Ramanagar,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1180.0,1284.0,1179.0,1221.0,1167.0,1156.0,1076.0,1305.0,1276.0,1224.0,1308.0,1304.0,14680.0
Ramanagar,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,139.0,184.0,152.0,182.0,159.0,135.0,132.0,92.0,24.0,6.0,2.0,0.0,1207.0
Ramanagar,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,147.0,161.0,145.0,143.0,172.0,167.0,105.0,93.0,30.0,7.0,4.0,0.0,1174.0
Ramanagar,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,144.0,173.0,147.0,162.0,163.0,147.0,113.0,80.0,27.0,10.0,1.0,0.0,1167.0
Ramanagar,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1149.0,1243.0,1272.0,1368.0,1190.0,1279.0,1209.0,1369.0,1332.0,1360.0,1235.0,1296.0,15302.0
Ramanagar,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1139.0,1142.0,1321.0,1258.0,1293.0,1290.0,1155.0,1347.0,1331.0,1268.0,1179.0,1338.0,15061.0
Ramanagar,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1078.0,1072.0,1179.0,1235.0,1201.0,1396.0,1200.0,1257.0,1337.0,1347.0,1184.0,1222.0,14708.0
Ramanagar,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,895.0,851.0,855.0,853.0,824.0,871.0,836.0,879.0,912.0,779.0,887.0,878.0,10320.0
Ramanagar,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1261.0,1354.0,1375.0,1542.0,1334.0,1362.0,1286.0,1537.0,1330.0,1358.0,1232.0,1296.0,16267.0
Ramanagar,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1247.0,1248.0,1345.0,1393.0,1448.0,1389.0,1219.0,1476.0,1342.0,1267.0,1177.0,1334.0,15885.0
Ramanagar,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1189.0,1198.0,1292.0,1382.0,1358.0,1482.0,1256.0,1297.0,1347.0,1356.0,1189.0,1230.0,15576.0
Ramanagar,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,688.0,787.0,829.0,827.0,814.0,813.0,795.0,849.0,887.0,743.0,858.0,864.0,9754.0
Ramanagar,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,52.0,78.0,115.0,173.0,212.0,129.0,152.0,111.0,39.0,14.0,5.0,5.0,1085.0
Ramanagar,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,42.0,71.0,120.0,138.0,220.0,125.0,128.0,105.0,52.0,13.0,6.0,5.0,1025.0
Ramanagar,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,49.0,78.0,117.0,151.0,193.0,123.0,121.0,98.0,47.0,13.0,3.0,0.0,993.0
Ramanagar,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1164.0,1218.0,1329.0,1285.0,1259.0,1391.0,1197.0,1292.0,1246.0,1241.0,1261.0,1224.0,15107.0
Ramanagar,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,737.0,835.0,897.0,1007.0,962.0,1072.0,931.0,1154.0,989.0,956.0,947.0,968.0,11455.0
Ramanagar,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11.0,0.0,0.0,11.0
Ramanagar,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,597.0,580.0,659.0,625.0,638.0,638.0,558.0,649.0,623.0,628.0,654.0,651.0,7500.0
Ramanagar,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,520.0,568.0,601.0,562.0,509.0,600.0,520.0,603.0,554.0,541.0,578.0,570.0,6726.0
Ramanagar,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1117.0,1148.0,1260.0,1187.0,1147.0,1238.0,1078.0,1252.0,1177.0,1169.0,1232.0,1221.0,14226.0
Ramanagar,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1053.0,1057.0,1183.0,1213.0,1086.0,1276.0,1083.0,1290.0,1164.0,1076.0,1017.0,1024.0,13522.0
Ramanagar,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1055.0,1044.0,1157.0,1195.0,1061.0,1241.0,1079.0,1291.0,1169.0,1074.0,1020.0,1021.0,13407.0
Ramanagar,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,107.0,134.0,202.0,211.0,120.0,159.0,140.0,165.0,129.0,103.0,85.0,87.0,1642.0
Ramanagar,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,174.0,159.0,172.0,163.0,279.0,262.0,203.0,269.0,244.0,230.0,279.0,301.0,2735.0
Ramanagar,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,155.0,129.0,167.0,149.0,237.0,250.0,185.0,257.0,222.0,217.0,270.0,273.0,2511.0
Ramanagar,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,329.0,288.0,339.0,312.0,516.0,512.0,388.0,526.0,466.0,447.0,549.0,574.0,5246.0
Ramanagar,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,83.0,89.0,89.0,501.0,2205.0,6965.0,359.0,620.0,643.0,335.0,221.0,113.0,12223.0
Ramanagar,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,58.0,33.0,63.0,297.0,1602.0,6439.0,341.0,564.0,718.0,289.0,102.0,73.0,10579.0
Ramanagar,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,69.0,74.0,32.0,203.0,1858.0,7120.0,483.0,808.0,557.0,249.0,107.0,121.0,11681.0
Ramanagar,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,3.0,1.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0
Ramanagar,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Ramanagar,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,516.0,513.0,528.0,584.0,575.0,573.0,502.0,550.0,578.0,513.0,517.0,570.0,6519.0
Ramanagar,10.4.2,Number of Immunisation sessions held during the month,TOTAL,468.0,468.0,483.0,536.0,516.0,545.0,464.0,513.0,527.0,473.0,469.0,470.0,5932.0
Ramanagar,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,336.0,297.0,343.0,335.0,346.0,338.0,352.0,353.0,352.0,307.0,314.0,295.0,3968.0
Ramanagar,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6.0,6.0
Ramanagar,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1114.0,1126.0,1234.0,1227.0,1230.0,1257.0,1063.0,1157.0,1169.0,1151.0,1287.0,1347.0,14362.0
Ramanagar,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,24.0,17.0,68.0,341.0,12307.0,809.0,30.0,11.0,12.0,57.0,929.0,4424.0,19029.0
Ramanagar,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,11.0,0.0,0.0,310.0,12538.0,26.0,37.0,0.0,0.0,45.0,1263.0,3880.0,18110.0
Ramanagar,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,2.0,4.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,8.0,0.0,5.0,23.0
Ramanagar,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,212.0,267.0,207.0,222.0,348.0,332.0,189.0,263.0,234.0,244.0,272.0,276.0,3066.0
Ramanagar,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,1.0
Ramanagar,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,20.0,48.0,35.0,31.0,40.0,22.0,24.0,41.0,37.0,36.0,20.0,36.0,390.0
Ramanagar,13.1,Number of Patients operated for cataract,TOTAL,65.0,48.0,34.0,27.0,27.0,48.0,39.0,64.0,7.0,10.0,33.0,11.0,413.0
Ramanagar,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,61.0,23.0,34.0,22.0,30.0,17.0,8.0,41.0,7.0,10.0,26.0,11.0,290.0
Ramanagar,13.3,Number of School children detected with Refractive errors,TOTAL,0.0,0.0,0.0,11.0,10.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,29.0
Ramanagar,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,8.0,0.0,8.0
Ramanagar,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,9.0,8.0,10.0,5.0,8.0,6.0,6.0,6.0,5.0,5.0,7.0,7.0,-1.0
Ramanagar,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,13.0,14.0,11.0,15.0,15.0,16.0,14.0,13.0,13.0,18.0,17.0,17.0,-1.0
Ramanagar,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,239.0,231.0,313.0,376.0,260.0,298.0,265.0,271.0,256.0,252.0,278.0,271.0,-1.0
Ramanagar,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,5.0,7.0,3.0,5.0,5.0,4.0,3.0,3.0,4.0,4.0,4.0,-1.0
Ramanagar,14.05,Number of RKS meetings held during the month,TOTAL,15.0,7.0,9.0,9.0,11.0,9.0,9.0,11.0,10.0,18.0,16.0,14.0,138.0
Ramanagar,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,20.0,21.0,22.0,24.0,28.0,27.0,25.0,24.0,24.0,29.0,32.0,31.0,-1.0
Ramanagar,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,68.0,115.0,108.0,93.0,104.0,106.0,87.0,85.0,104.0,106.0,82.0,131.0,1189.0
Ramanagar,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,6.0,5.0,5.0,3.0,6.0,7.0,7.0,4.0,5.0,5.0,5.0,4.0,-1.0
Ramanagar,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,3.0,3.0,3.0,95.0,3.0,4.0,3.0,3.0,3.0,3.0,3.0,3.0,-1.0
Ramanagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,230.0,206.0,180.0,339.0,222.0,214.0,148.0,224.0,288.0,158.0,205.0,260.0,2674.0
Ramanagar,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,755.0,1150.0,1357.0,1219.0,1049.0,1107.0,796.0,974.0,1129.0,916.0,952.0,1129.0,12533.0
Ramanagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,158.0,219.0,169.0,281.0,250.0,207.0,189.0,210.0,292.0,191.0,257.0,240.0,2663.0
Ramanagar,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,1583.0,1782.0,2055.0,1580.0,1604.0,1792.0,1428.0,1835.0,1455.0,1406.0,1356.0,1828.0,19704.0
Ramanagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,388.0,425.0,349.0,620.0,472.0,421.0,337.0,434.0,580.0,349.0,462.0,500.0,5337.0
Ramanagar,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,2338.0,2932.0,3412.0,2799.0,2653.0,2899.0,2224.0,2809.0,2584.0,2322.0,2308.0,2957.0,32237.0
Ramanagar,14.10.2.a,Number of death cases of Inpatient males,TOTAL,7.0,3.0,15.0,10.0,11.0,14.0,5.0,16.0,13.0,11.0,13.0,7.0,125.0
Ramanagar,14.10.2.b,Number of death cases of Inpatient females,TOTAL,5.0,6.0,7.0,4.0,5.0,6.0,5.0,7.0,4.0,3.0,6.0,5.0,63.0
Ramanagar,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,12.0,9.0,22.0,14.0,16.0,20.0,10.0,23.0,17.0,14.0,19.0,12.0,188.0
Ramanagar,14.11,In-Patient Head Count at midnight,TOTAL,4357.0,4482.0,4623.0,4628.0,4127.0,3763.0,3046.0,3594.0,3141.0,3306.0,3493.0,4002.0,46562.0
Ramanagar,14.12.1,OPD attendance (All),TOTAL,107793.0,99326.0,102107.0,114363.0,113804.0,104129.0,108997.0,115653.0,108080.0,109214.0,138552.0,135395.0,1357413.0
Ramanagar,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,369.0,368.0,301.0,183.0,272.0,222.0,230.0,231.0,242.0,180.0,263.0,420.0,3281.0
Ramanagar,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,33.0,49.0,33.0,13.0,14.0,10.0,37.0,27.0,0.0,8.0,18.0,57.0,299.0
Ramanagar,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,112.0,99.0,120.0,122.0,92.0,131.0,93.0,139.0,96.0,85.0,156.0,119.0,1364.0
Ramanagar,14.14.a,Number of patients given AYUSH treatment,TOTAL,3783.0,3874.0,2278.0,3545.0,2102.0,2170.0,2079.0,2495.0,1885.0,2848.0,2269.0,2695.0,32023.0
Ramanagar,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1052.0,1077.0,1335.0,1241.0,1154.0,1218.0,867.0,2125.0,997.0,1524.0,947.0,1102.0,14639.0
Ramanagar,14.14.c,Number of Adolescents counselled,TOTAL,191.0,154.0,126.0,140.0,156.0,181.0,138.0,134.0,96.0,137.0,188.0,147.0,1788.0
Ramanagar,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,3605.0,3796.0,4005.0,4104.0,5622.0,3627.0,2614.0,3250.0,2771.0,2682.0,3908.0,3340.0,43324.0
Ramanagar,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,102.0,53.0,54.0,131.0,86.0,75.0,47.0,59.0,73.0,97.0,107.0,61.0,945.0
Ramanagar,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1378.0,1376.0,1687.0,1515.0,1388.0,1700.0,1179.0,1719.0,1569.0,1517.0,1424.0,1624.0,18076.0
Ramanagar,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,7.0,12.0,14.0,10.0,6.0,8.0,10.0,7.0,17.0,6.0,19.0,15.0,131.0
Ramanagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,907.0,1035.0,1021.0,1113.0,970.0,1105.0,849.0,987.0,1060.0,931.0,1015.0,1100.0,12093.0
Ramanagar,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,3.0,9.0,7.0,6.0,11.0,9.0,3.0,6.0,10.0,3.0,5.0,3.0,75.0
Ramanagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1599.0,1398.0,1682.0,1724.0,1743.0,1781.0,1429.0,1754.0,1567.0,1631.0,1604.0,1065.0,18977.0
Ramanagar,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,1.0,8.0,3.0,3.0,1.0,0.0,1.0,1.0,4.0,12.0,3.0,42.0
Ramanagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,3884.0,3809.0,4390.0,4352.0,4101.0,4586.0,3457.0,4460.0,4196.0,4079.0,4043.0,3789.0,49146.0
Ramanagar,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,15.0,22.0,29.0,19.0,20.0,18.0,13.0,14.0,28.0,13.0,36.0,21.0,248.0
Ramanagar,15.2,Number of Widal tests conducted,Number tested,607.0,507.0,794.0,1188.0,975.0,904.0,503.0,742.0,704.0,533.0,867.0,1104.0,9428.0
Ramanagar,15.3.a,Number of VDRL tests conducted on males,Number tested,80.0,99.0,97.0,184.0,102.0,95.0,155.0,84.0,78.0,82.0,180.0,82.0,1318.0
Ramanagar,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,127.0,120.0,122.0,178.0,224.0,151.0,96.0,228.0,152.0,103.0,189.0,124.0,1814.0
Ramanagar,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,732.0,627.0,840.0,873.0,909.0,902.0,651.0,845.0,818.0,705.0,914.0,843.0,9659.0
Ramanagar,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,939.0,846.0,1059.0,1235.0,1235.0,1148.0,902.0,1157.0,1048.0,890.0,1283.0,1049.0,12791.0
Ramanagar,15.4.1,Number of blood smears examined for Malaria,TOTAL,8631.0,9224.0,10761.0,11064.0,9693.0,11957.0,8992.0,11070.0,10404.0,10406.0,10112.0,11763.0,124077.0
Ramanagar,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,2.0,0.0,3.0,6.0,0.0,3.0,179.0,1.0,0.0,1.0,0.0,0.0,195.0
Ramanagar,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Ramanagar,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,1200.0,2010.0,0.0,0.0,1000.0,1000.0,0.0,8000.0,4000.0,2000.0,6000.0,4500.0,29710.0
Ramanagar,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2500.0,0.0,2500.0,5000.0,15000.0,15000.0,8000.0,0.0,0.0,5000.0,0.0,,53000.0
Ramanagar,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1690.0,2010.0,2500.0,4000.0,10500.0,10500.0,0.0,4000.0,2000.0,1000.0,1500.0,1500.0,41200.0
Ramanagar,16.1.1,Stock position of DPT vaccines,5. Total Stock,2010.0,0.0,0.0,1000.0,5500.0,5500.0,8000.0,4000.0,2000.0,6000.0,4500.0,3000.0,41510.0
Ramanagar,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,5030.0,8080.0,2780.0,4700.0,6700.0,6700.0,5200.0,7200.0,6200.0,2200.0,6200.0,5200.0,66190.0
Ramanagar,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,6000.0,0.0,9000.0,9000.0,6000.0,6000.0,3000.0,3000.0,0.0,6000.0,0.0,,48000.0
Ramanagar,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,2950.0,5300.0,7080.0,7000.0,5500.0,5500.0,3000.0,4000.0,5000.0,2000.0,1000.0,4100.0,52430.0
Ramanagar,16.1.1A,Stock Position of Pentavalent,5. Total Stock,8080.0,2780.0,4700.0,6700.0,7200.0,7200.0,5200.0,6200.0,1200.0,6200.0,5200.0,1100.0,61760.0
Ramanagar,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,2100.0,8280.0,1640.0,480.0,7580.0,7580.0,1580.0,6080.0,9000.0,1300.0,300.0,12300.0,58220.0
Ramanagar,16.1.2,Stock position of OPV vaccines,2. Stocks Received,10000.0,0.0,10000.0,15000.0,0.0,0.0,10000.0,9000.0,0.0,5000.0,9000.0,,68000.0
Ramanagar,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,3820.0,6640.0,11160.0,7900.0,7500.0,7500.0,5500.0,6080.0,8000.0,6000.0,2000.0,5000.0,77100.0
Ramanagar,16.1.2,Stock position of OPV vaccines,5. Total Stock,8280.0,1640.0,480.0,7580.0,80.0,80.0,6080.0,9000.0,1000.0,300.0,7300.0,7300.0,49120.0
Ramanagar,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,4550.0,9700.0,4080.0,7050.0,7050.0,7050.0,3550.0,9550.0,13550.0,10550.0,13050.0,11050.0,100780.0
Ramanagar,16.1.3,Stock position of TT vaccines,2. Stocks Received,8000.0,0.0,5000.0,5000.0,15000.0,15000.0,10000.0,10000.0,0.0,5000.0,0.0,,73000.0
Ramanagar,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.3,Stock position of TT vaccines,4. Stock Distributed,2850.0,5620.0,2030.0,5000.0,12000.0,12000.0,4000.0,6000.0,3000.0,2500.0,2000.0,4500.0,61500.0
Ramanagar,16.1.3,Stock position of TT vaccines,5. Total Stock,9700.0,4080.0,7050.0,7050.0,10050.0,10050.0,9550.0,13550.0,10550.0,13050.0,11050.0,6550.0,112280.0
Ramanagar,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,2100.0,4060.0,2980.0,1440.0,2440.0,2440.0,1000.0,4000.0,4500.0,2000.0,4000.0,3000.0,33960.0
Ramanagar,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4500.0,0.0,2500.0,4000.0,2000.0,2000.0,3000.0,3000.0,0.0,3000.0,0.0,,24000.0
Ramanagar,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2540.0,1080.0,4040.0,3000.0,3500.0,4440.0,2000.0,2500.0,2500.0,1000.0,1000.0,3000.0,30600.0
Ramanagar,16.1.5,Stock position of BCG vaccines,5. Total Stock,4060.0,2980.0,1440.0,2440.0,940.0,0.0,2000.0,4500.0,2000.0,4000.0,3000.0,0.0,27360.0
Ramanagar,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,1530.0,4940.0,1840.0,3260.0,3760.0,3760.0,3000.0,6000.0,8000.0,5500.0,8000.0,7000.0,56590.0
Ramanagar,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,0.0,5000.0,5000.0,0.0,0.0,3000.0,5000.0,0.0,5000.0,0.0,,28000.0
Ramanagar,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,1590.0,3100.0,3580.0,4500.0,2760.0,2760.0,2000.0,3000.0,1500.0,2500.0,2000.0,2500.0,31790.0
Ramanagar,16.1.6,Stock position of Measles vaccines,5. Total Stock,4940.0,1840.0,3260.0,3760.0,1000.0,1000.0,4000.0,8000.0,6500.0,8000.0,6000.0,4500.0,52800.0
Ramanagar,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,1350.0,3350.0,2300.0,2250.0,2250.0,2250.0,250.0,2250.0,2250.0,1750.0,3750.0,3750.0,27750.0
Ramanagar,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,0.0,1500.0,0.0,0.0,0.0,2500.0,0.0,0.0,2500.0,0.0,,9500.0
Ramanagar,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1000.0,1050.0,1550.0,0.0,1500.0,1500.0,500.0,0.0,500.0,500.0,0.0,2000.0,10100.0
Ramanagar,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3350.0,2300.0,2250.0,2250.0,750.0,750.0,2250.0,2250.0,1750.0,3750.0,3750.0,1750.0,27150.0
Ramanagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,,600.0
Ramanagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,600.0,0.0,0.0,600.0
Ramanagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1165.0,665.0,0.0,0.0,,1830.0
Ramanagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1000.0,500.0,0.0,0.0,,1500.0
Ramanagar,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,165.0,165.0,0.0,0.0,0.0,330.0
Ramanagar,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Ramanagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,8000.0,8000.0,5000.0,3000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,,25000.0
Ramanagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,0.0,3000.0,2000.0,2000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,7000.0
Ramanagar,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,8000.0,5000.0,3000.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,18000.0
Ramanagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,4800.0,4800.0,4800.0,4800.0,2400.0,2400.0,0.0,0.0,0.0,2400.0,0.0,,26400.0
Ramanagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,0.0,2400.0,600.0,600.0,0.0,0.0,0.0,0.0,4800.0,,8400.0
Ramanagar,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,4800.0,4800.0,4800.0,2400.0,1800.0,1800.0,0.0,0.0,0.0,2400.0,-4800.0,0.0,18000.0
Ramanagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,5000.0,5000.0,4000.0,2000.0,1000.0,1000.0,0.0,0.0,0.0,2000.0,0.0,,20000.0
Ramanagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,0.0
Ramanagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,1000.0,2000.0,1000.0,1000.0,1000.0,0.0,0.0,0.0,0.0,0.0,,6000.0
Ramanagar,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,5000.0,4000.0,2000.0,1000.0,0.0,0.0,0.0,0.0,0.0,2000.0,0.0,0.0,14000.0
Ramanagar,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,,,,,,,,1.0
Ramanagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,,,,,,,,
Ramanagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramanagar,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,,,,,,,,
Ramanagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,,,,2.0,1.0,,,,,,1.0,4.0
Ramanagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramanagar,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,,,,2.0,1.0,,,,,,1.0,4.0
Ramanagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,,1.0,,,,,,,,,,2.0,3.0
Ramanagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramanagar,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,,1.0,,,,,,,,,,2.0,3.0
Ramanagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,,,1.0,,1.0,,,1.0,,3.0
Ramanagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Ramanagar,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,,,1.0,,1.0,,,1.0,,3.0
Ramanagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,1.0,,,,,3.0,1.0,,1.0,,,6.0
Ramanagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramanagar,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,1.0,,,,,3.0,1.0,,1.0,,,6.0
Ramanagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramanagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramanagar,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Ramanagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramanagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Ramanagar,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,1.0,,,,,,,,1.0
Ramanagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Ramanagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Ramanagar,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Ramanagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,2.0,1.0,1.0,2.0,2.0,,2.0,1.0,1.0,1.0,1.0,16.0
Ramanagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,1.0,,,,1.0,,,,,1.0,,4.0
Ramanagar,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,3.0,3.0,1.0,1.0,2.0,3.0,,2.0,1.0,1.0,2.0,1.0,20.0
Ramanagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,1.0,,,,1.0
Ramanagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,1.0,,1.0,,,,,,,,2.0
Ramanagar,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,1.0,,1.0,,,,1.0,,,,3.0
Ramanagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,1.0,4.0,,,2.0,,1.0,4.0,2.0,1.0,,16.0
Ramanagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,2.0,1.0,2.0,1.0,1.0,,1.0,1.0,2.0,,2.0,13.0
Ramanagar,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,1.0,3.0,5.0,2.0,1.0,3.0,,2.0,5.0,4.0,1.0,2.0,29.0
Ramanagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,3.0,5.0,4.0,7.0,5.0,8.0,7.0,2.0,2.0,4.0,8.0,6.0,61.0
Ramanagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,28.0,18.0,27.0,34.0,32.0,35.0,30.0,33.0,28.0,31.0,41.0,18.0,355.0
Ramanagar,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,31.0,23.0,31.0,41.0,37.0,43.0,37.0,35.0,30.0,35.0,49.0,24.0,416.0
Ramanagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Ramanagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,1.0,1.0
Ramanagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,,,,,,,1.0,,3.0,4.0
Ramanagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,,,2.0,2.0,,,,,,,4.0
Ramanagar,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,,,,2.0,2.0,,,,1.0,,4.0,9.0
Ramanagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,2.0,1.0,1.0,,,1.0,,,,,2.0,9.0
Ramanagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,,,,,,,,,,1.0,1.0
Ramanagar,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,2.0,1.0,1.0,,,1.0,,,,,3.0,10.0
Ramanagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,23.0,24.0,31.0,27.0,24.0,28.0,19.0,20.0,23.0,22.0,30.0,31.0,302.0
Ramanagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,36.0,26.0,36.0,34.0,38.0,40.0,45.0,37.0,46.0,47.0,40.0,44.0,469.0
Ramanagar,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,59.0,50.0,67.0,61.0,62.0,68.0,64.0,57.0,69.0,69.0,70.0,75.0,771.0
Ramanagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,6.0,5.0,6.0,5.0,2.0,10.0,4.0,3.0,7.0,8.0,8.0,5.0,69.0
Ramanagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,28.0,22.0,28.0,18.0,20.0,28.0,20.0,21.0,19.0,22.0,30.0,21.0,277.0
Ramanagar,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,34.0,27.0,34.0,23.0,22.0,38.0,24.0,24.0,26.0,30.0,38.0,26.0,346.0
Ramanagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Ramanagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Ramanagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Ramanagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Ramanagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,1.0,,,,1.0
Ramanagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Ramanagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,,,,,1.0,,,,1.0,2.0
Ramanagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Ramanagar,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,,,,,1.0,,,,1.0,2.0
Ramanagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,1.0,1.0,,,,4.0,1.0,1.0,1.0,3.0,1.0,15.0
Ramanagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,13.0,16.0,14.0,12.0,11.0,11.0,10.0,21.0,21.0,16.0,15.0,168.0
Ramanagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,5.0,5.0,11.0,5.0,1.0,2.0,7.0,5.0,1.0,3.0,9.0,4.0,58.0
Ramanagar,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,15.0,19.0,28.0,19.0,13.0,13.0,22.0,16.0,23.0,25.0,28.0,20.0,241.0
Ramanagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,2.0,,,,,,,,,,1.0,,3.0
Ramanagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,17.0,19.0,21.0,22.0,21.0,15.0,23.0,18.0,11.0,19.0,22.0,17.0,225.0
Ramanagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,4.0,3.0,1.0,3.0,5.0,5.0,6.0,11.0,4.0,5.0,7.0,57.0
Ramanagar,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,22.0,23.0,24.0,23.0,24.0,20.0,28.0,24.0,22.0,23.0,28.0,24.0,285.0
Ramanagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Ramanagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,1.0,2.0,1.0,,,2.0,,,1.0,2.0,1.0,11.0
Ramanagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,1.0,1.0,,,1.0,,1.0,,,,4.0
Ramanagar,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,1.0,1.0,3.0,2.0,,,3.0,,1.0,1.0,2.0,1.0,15.0
Ramanagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,1.0,,,,2.0,3.0,1.0,1.0,,8.0
Ramanagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,12.0,10.0,14.0,16.0,8.0,13.0,16.0,20.0,13.0,15.0,20.0,20.0,177.0
Ramanagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,23.0,14.0,20.0,22.0,25.0,19.0,25.0,29.0,33.0,37.0,34.0,27.0,308.0
Ramanagar,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,35.0,24.0,34.0,39.0,33.0,32.0,41.0,51.0,49.0,53.0,55.0,47.0,493.0
Ramanagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,1.0,,,,,1.0,,,,,1.0,3.0
Ramanagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,13.0,13.0,5.0,16.0,13.0,11.0,10.0,4.0,16.0,10.0,10.0,19.0,140.0
Ramanagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,23.0,26.0,17.0,17.0,27.0,26.0,15.0,36.0,30.0,34.0,28.0,35.0,314.0
Ramanagar,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,36.0,40.0,22.0,33.0,40.0,37.0,26.0,40.0,46.0,44.0,38.0,55.0,457.0
Ramanagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,1.0,2.0,3.0,1.0,2.0,1.0,,,1.0,,1.0,12.0
Ramanagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,42.0,32.0,38.0,37.0,42.0,49.0,42.0,39.0,48.0,58.0,50.0,44.0,521.0
Ramanagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,144.0,115.0,142.0,145.0,160.0,165.0,152.0,152.0,182.0,156.0,163.0,162.0,1838.0
Ramanagar,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,186.0,148.0,182.0,185.0,203.0,216.0,195.0,191.0,230.0,215.0,213.0,207.0,2371.0
Shimoga,1.1,Total number of pregnant women Registered for ANC,TOTAL,2169.0,1931.0,2398.0,2415.0,2511.0,2629.0,2235.0,2455.0,2142.0,2130.0,1962.0,2156.0,27133.0
Shimoga,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1770.0,1609.0,1963.0,2018.0,2115.0,2181.0,1863.0,2037.0,1784.0,1789.0,1591.0,1747.0,22467.0
Shimoga,1.2,Number of Pregnant women registered under JSY,TOTAL,1818.0,1613.0,2011.0,1972.0,2096.0,2120.0,1798.0,1995.0,1741.0,1725.0,1591.0,1733.0,22213.0
Shimoga,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2299.0,2307.0,2432.0,2232.0,2282.0,2299.0,2087.0,1993.0,1911.0,1942.0,1910.0,2004.0,25698.0
Shimoga,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1733.0,1590.0,1778.0,1922.0,2150.0,2084.0,1886.0,2080.0,1695.0,1587.0,1725.0,1656.0,21886.0
Shimoga,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2117.0,2168.0,2307.0,2462.0,2626.0,2518.0,2558.0,2841.0,2515.0,2143.0,2150.0,2252.0,28657.0
Shimoga,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1688.0,1527.0,1385.0,1622.0,1382.0,1056.0,1100.0,1035.0,857.0,981.0,921.0,885.0,14439.0
Shimoga,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,76.0,67.0,66.0,114.0,185.0,227.0,173.0,278.0,78.0,86.0,304.0,110.0,1764.0
Shimoga,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,24.0,20.0,29.0,26.0,40.0,29.0,21.0,17.0,21.0,19.0,41.0,19.0,306.0
Shimoga,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,2381.0,3277.0,2485.0,2657.0,2870.0,4704.0,3200.0,3638.0,2570.0,2958.0,2017.0,3298.0,36055.0
Shimoga,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,163.0,105.0,133.0,118.0,251.0,195.0,154.0,221.0,98.0,135.0,274.0,173.0,2020.0
Shimoga,1.8,Number of pregnancy test kits used at SC level,TOTAL,272.0,316.0,316.0,355.0,367.0,408.0,325.0,392.0,302.0,363.0,418.0,460.0,4294.0
Shimoga,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,0.0,1.0,1.0,0.0,1.0,1.0,1.0,1.0,1.0,1.0,2.0,3.0,13.0
Shimoga,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,2.0,2.0,3.0,2.0,8.0,2.0,6.0,0.0,1.0,1.0,2.0,0.0,29.0
Shimoga,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,2.0,3.0,4.0,2.0,9.0,3.0,7.0,1.0,2.0,2.0,4.0,3.0,42.0
Shimoga,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,2.0,3.0,4.0,2.0,8.0,3.0,5.0,1.0,1.0,0.0,5.0,3.0,37.0
Shimoga,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,1.0,0.0,0.0,0.0,1.0,6.0,0.0,0.0,0.0,0.0,0.0,1.0,9.0
Shimoga,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1674.0,1723.0,1681.0,1694.0,1580.0,1601.0,1540.0,1635.0,1617.0,1610.0,1784.0,1686.0,19825.0
Shimoga,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,503.0,582.0,507.0,484.0,475.0,534.0,540.0,583.0,537.0,594.0,595.0,573.0,6507.0
Shimoga,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,946.0,1017.0,1087.0,1053.0,975.0,1018.0,940.0,1049.0,1033.0,1100.0,919.0,1100.0,12237.0
Shimoga,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,72.0,72.0,30.0,43.0,40.0,72.0,41.0,40.0,44.0,38.0,32.0,61.0,585.0
Shimoga,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,697.0,700.0,674.0,806.0,766.0,574.0,579.0,649.0,650.0,607.0,652.0,602.0,7956.0
Shimoga,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,532.0,612.0,587.0,602.0,607.0,544.0,497.0,514.0,565.0,557.0,586.0,623.0,6826.0
Shimoga,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,532.0,612.0,587.0,602.0,607.0,544.0,497.0,514.0,565.0,557.0,586.0,623.0,6826.0
Shimoga,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,281.0,297.0,268.0,308.0,269.0,244.0,249.0,256.0,265.0,264.0,323.0,227.0,3251.0
Shimoga,4.1.1.a,Number of male live births,TOTAL,1183.0,1244.0,1187.0,1253.0,1207.0,1105.0,1072.0,1160.0,1154.0,1138.0,1265.0,1136.0,14104.0
Shimoga,4.1.1.b,Number of female live births,TOTAL,1192.0,1173.0,1175.0,1257.0,1155.0,1072.0,1061.0,1131.0,1122.0,1090.0,1183.0,1156.0,13767.0
Shimoga,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2375.0,2417.0,2362.0,2510.0,2362.0,2177.0,2133.0,2291.0,2276.0,2228.0,2448.0,2292.0,27871.0
Shimoga,4.1.2,Number of still births,TOTAL,10.0,14.0,6.0,7.0,7.0,7.0,6.0,3.0,11.0,5.0,9.0,8.0,93.0
Shimoga,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,145.0,89.0,128.0,145.0,165.0,183.0,121.0,103.0,89.0,91.0,117.0,120.0,1496.0
Shimoga,4.2.1,Number of Newborns weighed at birth,TOTAL,2373.0,2416.0,2360.0,2506.0,2360.0,2174.0,2088.0,2215.0,2250.0,2183.0,2253.0,2289.0,27467.0
Shimoga,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,121.0,146.0,108.0,169.0,155.0,156.0,146.0,171.0,138.0,146.0,313.0,141.0,1910.0
Shimoga,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2373.0,2415.0,2359.0,2507.0,2348.0,2170.0,2111.0,2007.0,2275.0,2226.0,2440.0,2292.0,27523.0
Shimoga,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,6.0,6.0,2.0,2.0,4.0,0.0,4.0,3.0,4.0,3.0,6.0,2.0,42.0
Shimoga,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,2.0,1.0,1.0,2.0,5.0,6.0,1.0,1.0,0.0,1.0,0.0,22.0
Shimoga,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,47.0,76.0,90.0,77.0,43.0,59.0,45.0,69.0,53.0,42.0,59.0,53.0,713.0
Shimoga,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,55.0,84.0,93.0,80.0,49.0,64.0,55.0,73.0,58.0,45.0,66.0,55.0,777.0
Shimoga,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,78.0,114.0,63.0,7.0,4.0,4.0,3.0,67.0,7.0,9.0,0.0,26.0,382.0
Shimoga,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1107.0,1217.0,1112.0,1236.0,1139.0,1118.0,1135.0,1190.0,1155.0,1208.0,1196.0,1189.0,14002.0
Shimoga,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,50.0,23.0,30.0,27.0,40.0,32.0,22.0,23.0,21.0,35.0,32.0,26.0,361.0
Shimoga,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1059.0,1032.0,971.0,1014.0,1033.0,1088.0,1040.0,1380.0,1312.0,1295.0,1167.0,1116.0,13507.0
Shimoga,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,212.0,236.0,245.0,255.0,196.0,238.0,311.0,178.0,221.0,229.0,211.0,177.0,2709.0
Shimoga,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1907.0,1799.0,1850.0,2043.0,1920.0,1531.0,1762.0,1907.0,1652.0,1433.0,1364.0,1934.0,21102.0
Shimoga,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,2621.0,2518.0,2474.0,2539.0,2399.0,2271.0,2359.0,2431.0,2194.0,2382.0,2592.0,2753.0,29533.0
Shimoga,6.3,PNC maternal complications attended,TOTAL,104.0,82.0,83.0,3.0,7.0,38.0,3.0,4.0,5.0,5.0,8.0,117.0,459.0
Shimoga,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,31.0,29.0,35.0,45.0,57.0,48.0,27.0,28.0,21.0,35.0,27.0,29.0,412.0
Shimoga,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,11.0,5.0,8.0,3.0,1.0,5.0,5.0,6.0,4.0,7.0,18.0,11.0,84.0
Shimoga,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,42.0,34.0,43.0,48.0,58.0,53.0,32.0,34.0,25.0,42.0,45.0,40.0,496.0
Shimoga,7.2,Number of MTPs conducted at Private Facilities,TOTAL,55.0,37.0,35.0,40.0,55.0,73.0,21.0,41.0,50.0,47.0,43.0,44.0,541.0
Shimoga,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,419.0,421.0,548.0,446.0,375.0,408.0,350.0,450.0,407.0,382.0,486.0,349.0,5041.0
Shimoga,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,1058.0,1096.0,1115.0,1011.0,1086.0,1142.0,952.0,1050.0,1119.0,1148.0,889.0,1010.0,12676.0
Shimoga,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1477.0,1517.0,1663.0,1457.0,1461.0,1550.0,1302.0,1500.0,1526.0,1530.0,1375.0,1359.0,17717.0
Shimoga,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,132.0,150.0,92.0,82.0,77.0,128.0,76.0,86.0,101.0,178.0,86.0,131.0,1319.0
Shimoga,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Shimoga,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,2.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0
Shimoga,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,2.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5.0
Shimoga,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,50.0,43.0,36.0,23.0,34.0,60.0,30.0,49.0,29.0,26.0,16.0,39.0,435.0
Shimoga,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,104.0,101.0,95.0,31.0,94.0,97.0,88.0,121.0,78.0,83.0,63.0,74.0,1029.0
Shimoga,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,300.0,339.0,315.0,194.0,108.0,227.0,300.0,284.0,236.0,232.0,181.0,207.0,2923.0
Shimoga,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,454.0,483.0,446.0,248.0,236.0,384.0,418.0,454.0,343.0,341.0,260.0,320.0,4387.0
Shimoga,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,42.0,28.0,22.0,29.0,36.0,22.0,78.0,62.0,67.0,15.0,17.0,15.0,433.0
Shimoga,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,148.0,156.0,124.0,150.0,56.0,115.0,107.0,147.0,136.0,137.0,134.0,155.0,1565.0
Shimoga,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,148.0,156.0,124.0,150.0,56.0,115.0,107.0,147.0,136.0,137.0,134.0,155.0,1565.0
Shimoga,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,45.0,60.0,47.0,50.0,53.0,33.0,43.0,23.0,36.0,46.0,38.0,38.0,512.0
Shimoga,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,9.0,0.0,0.0,10.0
Shimoga,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,176.0,195.0,199.0,188.0,182.0,179.0,151.0,199.0,183.0,176.0,189.0,174.0,2191.0
Shimoga,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,176.0,195.0,199.0,188.0,182.0,179.0,151.0,199.0,184.0,185.0,189.0,174.0,2201.0
Shimoga,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,45.0,56.0,36.0,32.0,23.0,37.0,55.0,46.0,54.0,27.0,58.0,72.0,541.0
Shimoga,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,151.0,179.0,148.0,158.0,180.0,182.0,177.0,185.0,168.0,149.0,127.0,163.0,1967.0
Shimoga,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,140.0,132.0,152.0,181.0,145.0,172.0,135.0,154.0,159.0,133.0,163.0,174.0,1840.0
Shimoga,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,25.0,19.0,34.0,19.0,21.0,19.0,23.0,23.0,21.0,20.0,16.0,13.0,253.0
Shimoga,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,73.0,114.0,122.0,85.0,76.0,79.0,57.0,59.0,92.0,58.0,72.0,77.0,964.0
Shimoga,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Shimoga,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,389.0,444.0,456.0,443.0,422.0,452.0,392.0,421.0,440.0,360.0,378.0,427.0,5024.0
Shimoga,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,17.0,14.0,27.0,13.0,28.0,11.0,28.0,11.0,15.0,30.0,25.0,21.0,240.0
Shimoga,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,37.0,46.0,51.0,67.0,78.0,71.0,78.0,95.0,94.0,69.0,63.0,63.0,812.0
Shimoga,9.06,Number of IUCD removals,TOTAL,289.0,230.0,330.0,313.0,160.0,258.0,201.0,196.0,193.0,188.0,149.0,146.0,2653.0
Shimoga,9.07,Number of Oral Pills cycles distributed,TOTAL,6630.0,7580.0,8184.0,6606.0,5801.0,6419.0,6000.0,6005.0,6361.0,5547.0,5765.0,5707.0,76605.0
Shimoga,9.08,Number of Condom pieces distributed,TOTAL,39587.0,41924.0,40662.0,40208.0,42493.0,40905.0,42991.0,41917.0,42197.0,40263.0,39053.0,48692.0,500892.0
Shimoga,9.09,Number of Centchroman (weekly) pills given,TOTAL,220.0,408.0,184.0,170.0,30.0,5.0,108.0,11.0,0.0,0.0,0.0,0.0,1136.0
Shimoga,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,6.0,18.0,4.0,15.0,6.0,21.0,9.0,14.0,11.0,13.0,9.0,246.0,372.0
Shimoga,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.11.2.b,Number of failures following female sterilization,TOTAL,2.0,2.0,2.0,1.0,0.0,1.0,0.0,0.0,0.0,1.0,0.0,0.0,9.0
Shimoga,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Shimoga,9.12,Number of Institutions having NSV trained doctors,TOTAL,27.0,31.0,33.0,24.0,23.0,28.0,32.0,34.0,33.0,35.0,35.0,34.0,-1.0
Shimoga,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2275.0,2236.0,2320.0,2261.0,2098.0,2083.0,2108.0,2169.0,2044.0,2024.0,2200.0,2261.0,26079.0
Shimoga,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,13.0,0.0,0.0,0.0,0.0,12.0,1.0,0.0,0.0,2.0,0.0,28.0
Shimoga,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,12.0,0.0,0.0,0.0,0.0,12.0,0.0,0.0,0.0,0.0,0.0,24.0
Shimoga,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,3.0,24.0,0.0,0.0,0.0,0.0,16.0,0.0,0.0,0.0,5.0,0.0,48.0
Shimoga,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2442.0,2638.0,2555.0,2581.0,2278.0,2448.0,2263.0,2411.0,2265.0,2239.0,2275.0,2406.0,28801.0
Shimoga,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2156.0,2328.0,2732.0,2839.0,2360.0,2567.0,2293.0,2536.0,2360.0,2263.0,2246.0,2510.0,29190.0
Shimoga,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2288.0,2165.0,2574.0,2899.0,2708.0,2709.0,2481.0,2655.0,2477.0,2440.0,2301.0,2553.0,30250.0
Shimoga,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,2115.0,2067.0,1821.0,1966.0,1844.0,1975.0,1934.0,2054.0,1961.0,1939.0,2035.0,2121.0,23832.0
Shimoga,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2412.0,2592.0,2654.0,2611.0,2324.0,2364.0,2206.0,2312.0,2213.0,2155.0,2200.0,2320.0,28363.0
Shimoga,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2147.0,2312.0,2922.0,2811.0,2364.0,2480.0,2258.0,2442.0,2326.0,2177.0,2170.0,2432.0,28841.0
Shimoga,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2279.0,2155.0,2875.0,2864.0,2697.0,2660.0,2414.0,2564.0,2439.0,2361.0,2226.0,2480.0,30014.0
Shimoga,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1867.0,1793.0,1451.0,1813.0,1463.0,1847.0,1810.0,1773.0,1821.0,1757.0,1866.0,2046.0,21307.0
Shimoga,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,2.0,4.0,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,8.0
Shimoga,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,1.0,10.0,0.0,0.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0
Shimoga,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,1.0,6.0,0.0,0.0,2.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,10.0
Shimoga,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2281.0,2133.0,2383.0,2463.0,2161.0,2460.0,2250.0,2495.0,2439.0,2568.0,2440.0,2589.0,28662.0
Shimoga,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1547.0,1579.0,1983.0,2045.0,1869.0,1987.0,1977.0,2194.0,1991.0,1834.0,1912.0,1944.0,22862.0
Shimoga,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1199.0,1108.0,1204.0,1234.0,1111.0,1261.0,1147.0,1314.0,1221.0,1315.0,1218.0,1311.0,14643.0
Shimoga,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1079.0,1019.0,1158.0,1163.0,995.0,1139.0,1026.0,1128.0,1115.0,1167.0,1136.0,1195.0,13320.0
Shimoga,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2278.0,2127.0,2362.0,2397.0,2106.0,2400.0,2173.0,2442.0,2336.0,2482.0,2354.0,2506.0,27963.0
Shimoga,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1742.0,1787.0,2251.0,2307.0,2125.0,2340.0,2182.0,2499.0,2220.0,2063.0,2155.0,2113.0,25784.0
Shimoga,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1739.0,1789.0,2243.0,2300.0,2134.0,2329.0,2188.0,2492.0,2212.0,2053.0,2143.0,2123.0,25745.0
Shimoga,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,253.0,229.0,246.0,281.0,276.0,261.0,302.0,291.0,270.0,244.0,258.0,221.0,3132.0
Shimoga,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,123.0,106.0,152.0,136.0,132.0,144.0,157.0,184.0,143.0,146.0,122.0,203.0,1748.0
Shimoga,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,113.0,82.0,119.0,129.0,116.0,129.0,128.0,167.0,154.0,147.0,118.0,199.0,1601.0
Shimoga,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,236.0,188.0,271.0,265.0,248.0,273.0,285.0,351.0,297.0,293.0,240.0,402.0,3349.0
Shimoga,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,135.0,115.0,189.0,2084.0,1705.0,2358.0,485.0,4802.0,3841.0,2100.0,1084.0,984.0,19882.0
Shimoga,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,107.0,116.0,148.0,2064.0,1719.0,2766.0,363.0,4963.0,4193.0,2341.0,1255.0,767.0,20802.0
Shimoga,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,132.0,98.0,258.0,1804.0,1737.0,2166.0,215.0,5663.0,4773.0,2537.0,978.0,648.0,21009.0
Shimoga,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,7.0,2.0,1.0,3.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,17.0
Shimoga,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,9.0,6.0,11.0,5.0,9.0,8.0,9.0,7.0,11.0,4.0,5.0,92.0
Shimoga,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1362.0,1335.0,1337.0,1351.0,1330.0,1338.0,1367.0,1361.0,1345.0,1328.0,1323.0,1305.0,16082.0
Shimoga,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1230.0,1222.0,1224.0,1239.0,1216.0,1205.0,1229.0,1237.0,1221.0,1208.0,1187.0,1187.0,14605.0
Shimoga,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,889.0,842.0,841.0,843.0,850.0,859.0,835.0,844.0,856.0,851.0,856.0,856.0,10222.0
Shimoga,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,0.0,0.0,4.0
Shimoga,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2289.0,1991.0,2279.0,2713.0,2227.0,2677.0,2190.0,2421.0,2271.0,2485.0,2497.0,2592.0,28632.0
Shimoga,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,5.0,9.0,290.0,7527.0,4457.0,432.0,134.0,97.0,68.0,136.0,2989.0,6411.0,22555.0
Shimoga,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,2.0,16.0,263.0,7720.0,4165.0,535.0,122.0,68.0,68.0,117.0,2375.0,7320.0,22771.0
Shimoga,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,7.0,6.0,0.0,1.0,34.0,8.0,1.0,4.0,0.0,0.0,2.0,8.0,71.0
Shimoga,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,969.0,1159.0,1055.0,925.0,936.0,1040.0,1016.0,896.0,894.0,830.0,928.0,974.0,11622.0
Shimoga,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,1.0,1.0,1.0,0.0,3.0,1.0,1.0,1.0,4.0,13.0,0.0,0.0,26.0
Shimoga,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,186.0,169.0,261.0,314.0,317.0,432.0,309.0,335.0,337.0,247.0,235.0,234.0,3376.0
Shimoga,13.1,Number of Patients operated for cataract,TOTAL,54.0,128.0,61.0,61.0,48.0,100.0,38.0,107.0,37.0,101.0,47.0,105.0,887.0
Shimoga,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,85.0,128.0,61.0,61.0,48.0,237.0,38.0,159.0,37.0,101.0,46.0,49.0,1050.0
Shimoga,13.3,Number of School children detected with Refractive errors,TOTAL,7.0,7.0,6.0,7.0,16.0,12.0,5.0,42.0,9.0,20.0,33.0,44.0,208.0
Shimoga,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,29.0,29.0
Shimoga,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,9.0,12.0,12.0,12.0,14.0,14.0,14.0,15.0,14.0,12.0,17.0,-1.0
Shimoga,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,24.0,24.0,26.0,25.0,21.0,19.0,22.0,23.0,29.0,29.0,27.0,32.0,-1.0
Shimoga,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,459.0,492.0,453.0,475.0,465.0,570.0,499.0,553.0,558.0,616.0,555.0,581.0,-1.0
Shimoga,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,11.0,14.0,17.0,15.0,15.0,17.0,18.0,18.0,17.0,18.0,15.0,17.0,-1.0
Shimoga,14.05,Number of RKS meetings held during the month,TOTAL,16.0,22.0,30.0,35.0,29.0,25.0,25.0,27.0,31.0,34.0,37.0,39.0,350.0
Shimoga,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,41.0,39.0,46.0,46.0,44.0,45.0,43.0,51.0,54.0,48.0,53.0,55.0,-1.0
Shimoga,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,400.0,481.0,430.0,373.0,398.0,384.0,331.0,396.0,352.0,395.0,442.0,357.0,4739.0
Shimoga,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,12.0,13.0,17.0,16.0,16.0,16.0,17.0,17.0,17.0,17.0,17.0,16.0,-1.0
Shimoga,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,5.0,3.0,3.0,5.0,6.0,6.0,2.0,3.0,6.0,3.0,3.0,4.0,-1.0
Shimoga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,929.0,928.0,879.0,941.0,1087.0,1017.0,765.0,807.0,800.0,678.0,885.0,950.0,10666.0
Shimoga,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,4886.0,4806.0,5499.0,4681.0,4925.0,5398.0,4738.0,4975.0,4813.0,4479.0,5251.0,5705.0,60156.0
Shimoga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,777.0,853.0,757.0,814.0,871.0,894.0,740.0,775.0,672.0,579.0,781.0,873.0,9386.0
Shimoga,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,7472.0,7469.0,7989.0,6954.0,6750.0,7336.0,7042.0,7393.0,6831.0,6710.0,8078.0,9035.0,89059.0
Shimoga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1706.0,1781.0,1636.0,1755.0,1958.0,1911.0,1505.0,1582.0,1472.0,1257.0,1666.0,1823.0,20052.0
Shimoga,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,12358.0,12275.0,13488.0,11635.0,11675.0,12734.0,11780.0,12368.0,11644.0,11189.0,13329.0,14740.0,149215.0
Shimoga,14.10.2.a,Number of death cases of Inpatient males,TOTAL,76.0,78.0,92.0,94.0,108.0,107.0,105.0,111.0,158.0,104.0,109.0,99.0,1241.0
Shimoga,14.10.2.b,Number of death cases of Inpatient females,TOTAL,42.0,46.0,35.0,61.0,48.0,72.0,246.0,62.0,36.0,59.0,49.0,50.0,806.0
Shimoga,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,118.0,124.0,127.0,155.0,156.0,179.0,351.0,173.0,194.0,163.0,158.0,149.0,2047.0
Shimoga,14.11,In-Patient Head Count at midnight,TOTAL,16801.0,19279.0,17595.0,39008.0,30728.0,31204.0,36768.0,33271.0,32025.0,32226.0,33992.0,30869.0,353766.0
Shimoga,14.12.1,OPD attendance (All),TOTAL,194523.0,204375.0,235499.0,225083.0,236325.0,243348.0,205684.0,231003.0,227076.0,202558.0,212311.0,204820.0,2622605.0
Shimoga,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,794.0,850.0,905.0,817.0,563.0,674.0,700.0,732.0,867.0,780.0,1022.0,787.0,9491.0
Shimoga,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,51.0,35.0,69.0,101.0,99.0,66.0,283.0,69.0,37.0,14.0,42.0,35.0,901.0
Shimoga,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,1082.0,1077.0,1288.0,1127.0,1214.0,1492.0,1508.0,1093.0,1307.0,1176.0,1198.0,1288.0,14850.0
Shimoga,14.14.a,Number of patients given AYUSH treatment,TOTAL,3572.0,3503.0,4228.0,4525.0,4156.0,5570.0,4003.0,4370.0,2995.0,4084.0,4791.0,5302.0,51099.0
Shimoga,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1686.0,1633.0,1816.0,1773.0,1755.0,1790.0,1688.0,1708.0,1587.0,1787.0,1605.0,1647.0,20475.0
Shimoga,14.14.c,Number of Adolescents counselled,TOTAL,1050.0,1266.0,1006.0,1643.0,1269.0,1214.0,1047.0,1077.0,1123.0,1085.0,1451.0,1330.0,14561.0
Shimoga,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,11168.0,10344.0,12391.0,12011.0,11879.0,13239.0,11006.0,10722.0,10756.0,10793.0,10970.0,12055.0,137334.0
Shimoga,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,716.0,748.0,649.0,634.0,644.0,725.0,578.0,526.0,513.0,496.0,563.0,587.0,7379.0
Shimoga,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1453.0,1547.0,1708.0,1780.0,1643.0,2097.0,1367.0,1638.0,1717.0,1562.0,1542.0,1543.0,19597.0
Shimoga,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,11.0,7.0,8.0,11.0,20.0,16.0,5.0,9.0,9.0,12.0,12.0,12.0,132.0
Shimoga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1402.0,1182.0,1374.0,1261.0,1147.0,1391.0,1227.0,1319.0,1251.0,1094.0,1228.0,1263.0,15139.0
Shimoga,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,9.0,7.0,13.0,5.0,16.0,13.0,5.0,13.0,14.0,69.0,7.0,14.0,185.0
Shimoga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1623.0,2243.0,2429.0,2396.0,2225.0,2697.0,1787.0,2453.0,2290.0,2232.0,2024.0,1950.0,26349.0
Shimoga,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,3.0,2.0,14.0,4.0,25.0,4.0,0.0,3.0,2.0,9.0,3.0,1.0,70.0
Shimoga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4478.0,4972.0,5511.0,5437.0,5015.0,6185.0,4381.0,5410.0,5258.0,4888.0,4794.0,4756.0,61085.0
Shimoga,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,23.0,16.0,35.0,20.0,61.0,33.0,10.0,25.0,25.0,90.0,22.0,27.0,387.0
Shimoga,15.2,Number of Widal tests conducted,Number tested,1174.0,1283.0,1584.0,1633.0,1723.0,1629.0,900.0,1159.0,929.0,790.0,1317.0,1616.0,15737.0
Shimoga,15.3.a,Number of VDRL tests conducted on males,Number tested,138.0,67.0,51.0,85.0,83.0,153.0,68.0,104.0,46.0,78.0,84.0,116.0,1073.0
Shimoga,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,328.0,192.0,202.0,360.0,290.0,162.0,136.0,377.0,81.0,166.0,210.0,287.0,2791.0
Shimoga,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1926.0,1380.0,1626.0,1519.0,1425.0,1937.0,1216.0,1602.0,1693.0,1209.0,1375.0,1430.0,18338.0
Shimoga,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,2392.0,1639.0,1879.0,1964.0,1798.0,2252.0,1420.0,2083.0,1820.0,1453.0,1669.0,1833.0,22202.0
Shimoga,15.4.1,Number of blood smears examined for Malaria,TOTAL,14585.0,14868.0,17550.0,18577.0,18313.0,18318.0,12965.0,14985.0,15943.0,14755.0,16107.0,17273.0,194239.0
Shimoga,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,12.0,15.0,28.0,13.0,21.0,22.0,11.0,11.0,10.0,8.0,4.0,5.0,160.0
Shimoga,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,0.0,1.0,1.0,2.0,5.0,1.0,1.0,1.0,1.0,0.0,1.0,15.0
Shimoga,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,20450.0,18450.0,15750.0,11250.0,5220.0,10720.0,15720.0,19720.0,20220.0,17120.0,21520.0,21220.0,197360.0
Shimoga,16.1.1,Stock position of DPT vaccines,2. Stocks Received,0.0,0.0,3000.0,3000.0,8000.0,17000.0,10000.0,10000.0,8000.0,5000.0,0.0,0.0,64000.0
Shimoga,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,2000.0,2700.0,7500.0,9030.0,2500.0,12000.0,6000.0,9500.0,11100.0,600.0,300.0,5900.0,69130.0
Shimoga,16.1.1,Stock position of DPT vaccines,5. Total Stock,18450.0,15750.0,11250.0,5220.0,10720.0,15720.0,19720.0,20220.0,17120.0,21520.0,21220.0,15320.0,192230.0
Shimoga,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,12950.0,7450.0,12450.0,12950.0,15750.0,10220.0,14500.0,17500.0,11000.0,10500.0,10500.0,13000.0,148770.0
Shimoga,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,0.0,10000.0,5000.0,10000.0,3000.0,10000.0,10000.0,2000.0,2000.0,5000.0,9000.0,7000.0,73000.0
Shimoga,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,5500.0,5000.0,4500.0,7200.0,8530.0,5720.0,7000.0,8500.0,2500.0,5000.0,6500.0,8100.0,74050.0
Shimoga,16.1.1A,Stock Position of Pentavalent,5. Total Stock,7450.0,12450.0,12950.0,15750.0,10220.0,14500.0,17500.0,11000.0,10500.0,10500.0,13000.0,11900.0,147720.0
Shimoga,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,27560.0,16060.0,19360.0,23800.0,25300.0,8100.0,17800.0,19300.0,15800.0,14800.0,13920.0,26240.0,228040.0
Shimoga,16.1.2,Stock position of OPV vaccines,2. Stocks Received,,20000.0,20000.0,20000.0,0.0,20000.0,20000.0,15000.0,15000.0,214000.0,228000.0,15000.0,587000.0
Shimoga,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11500.0,16700.0,15560.0,18500.0,17200.0,10300.0,18500.0,18500.0,16000.0,214880.0,215680.0,28500.0,601820.0
Shimoga,16.1.2,Stock position of OPV vaccines,5. Total Stock,16060.0,19360.0,23800.0,25300.0,8100.0,17800.0,19300.0,15800.0,14800.0,13920.0,26240.0,12740.0,213220.0
Shimoga,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,16100.0,11600.0,10900.0,16900.0,11700.0,18700.0,9200.0,11900.0,15000.0,12500.0,13500.0,20000.0,168000.0
Shimoga,16.1.3,Stock position of TT vaccines,2. Stocks Received,0.0,5000.0,15000.0,6000.0,15000.0,5000.0,20000.0,15000.0,20000.0,5000.0,10000.0,10000.0,126000.0
Shimoga,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.3,Stock position of TT vaccines,4. Stock Distributed,4500.0,5700.0,9000.0,11200.0,8000.0,14500.0,17300.0,11900.0,22500.0,4000.0,3500.0,6000.0,118100.0
Shimoga,16.1.3,Stock position of TT vaccines,5. Total Stock,11600.0,10900.0,16900.0,11700.0,18700.0,9200.0,11900.0,15000.0,12500.0,13500.0,20000.0,24000.0,175900.0
Shimoga,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,12550.0,9050.0,9500.0,8900.0,11400.0,9400.0,10200.0,12200.0,11900.0,11400.0,9400.0,9900.0,125800.0
Shimoga,16.1.5,Stock position of BCG vaccines,2. Stocks Received,0.0,4000.0,4000.0,8000.0,3000.0,3000.0,5000.0,3000.0,2000.0,2000.0,5000.0,5000.0,44000.0
Shimoga,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3500.0,3550.0,4600.0,5500.0,5000.0,2200.0,3000.0,3300.0,2500.0,4000.0,4500.0,4000.0,45650.0
Shimoga,16.1.5,Stock position of BCG vaccines,5. Total Stock,9050.0,9500.0,8900.0,11400.0,9400.0,10200.0,12200.0,11900.0,11400.0,9400.0,9900.0,10900.0,124150.0
Shimoga,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,8250.0,4500.0,5100.0,8500.0,13000.0,8500.0,13780.0,14000.0,14250.0,12250.0,9500.0,14500.0,126130.0
Shimoga,16.1.6,Stock position of Measles vaccines,2. Stocks Received,0.0,5000.0,5000.0,7000.0,6000.0,10000.0,6000.0,5000.0,2000.0,3000.0,10000.0,10000.0,69000.0
Shimoga,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,3750.0,4400.0,1600.0,2500.0,10500.0,4720.0,5780.0,4750.0,4000.0,5750.0,5000.0,17000.0,69750.0
Shimoga,16.1.6,Stock position of Measles vaccines,5. Total Stock,4500.0,5100.0,8500.0,13000.0,8500.0,13780.0,14000.0,14250.0,12250.0,9500.0,14500.0,7500.0,125380.0
Shimoga,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5040.0,3740.0,1840.0,1040.0,290.0,1690.0,390.0,2790.0,3390.0,2590.0,590.0,4090.0,27480.0
Shimoga,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,3000.0,0.0,3000.0,2000.0,0.0,0.0,5000.0,5000.0,18000.0
Shimoga,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1300.0,1900.0,800.0,750.0,1600.0,1300.0,600.0,1400.0,800.0,2000.0,1500.0,1000.0,14950.0
Shimoga,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,3740.0,1840.0,1040.0,290.0,1690.0,390.0,2790.0,3390.0,2590.0,590.0,4090.0,8090.0,30530.0
Shimoga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,2850.0,2850.0,2850.0,2850.0,6150.0,6150.0,6150.0,6150.0,5950.0,5950.0,4750.0,1750.0,54400.0
Shimoga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,4800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4800.0
Shimoga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,1500.0,0.0,0.0,0.0,200.0,0.0,1200.0,3000.0,600.0,6500.0
Shimoga,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,2850.0,2850.0,2850.0,6150.0,6150.0,6150.0,6150.0,5950.0,5950.0,4750.0,1750.0,1150.0,52700.0
Shimoga,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,34910.0,34910.0,34910.0,34910.0,60710.0,30470.0,9830.0,9830.0,4790.0,1290.0,1290.0,1290.0,259140.0
Shimoga,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,60480.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,60480.0
Shimoga,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,34680.0,30240.0,20640.0,0.0,5040.0,3500.0,0.0,0.0,0.0,94100.0
Shimoga,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,34910.0,34910.0,34910.0,60710.0,30470.0,9830.0,9830.0,4790.0,1290.0,1290.0,1290.0,1290.0,225520.0
Shimoga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,17000.0,12800.0,8800.0,3300.0,3200.0,3200.0,1200.0,49500.0
Shimoga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,17000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,17000.0
Shimoga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,4200.0,4000.0,5500.0,100.0,0.0,2000.0,1200.0,17000.0
Shimoga,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,17000.0,12800.0,8800.0,3300.0,3200.0,3200.0,1200.0,0.0,49500.0
Shimoga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Shimoga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Shimoga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Shimoga,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Shimoga,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3100.0,0.0,0.0,5600.0,7200.0,2000.0,0.0,2300.0,3300.0,1600.0,1300.0,2800.0,29200.0
Shimoga,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,800.0,6600.0,6600.0,0.0,0.0,2300.0,3300.0,0.0,3300.0,3300.0,6600.0,32800.0
Shimoga,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3100.0,800.0,1000.0,5000.0,5200.0,2000.0,0.0,2300.0,1700.0,3600.0,1800.0,3900.0,30400.0
Shimoga,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,0.0,5600.0,7200.0,2000.0,0.0,2300.0,3300.0,1600.0,1300.0,2800.0,5500.0,31600.0
Shimoga,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,34000.0,19000.0,1200.0,16200.0,95200.0,71200.0,49400.0,27200.0,2400.0,0.0,72000.0,52600.0,440400.0
Shimoga,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,0.0,24000.0,120000.0,0.0,0.0,0.0,0.0,0.0,96000.0,0.0,0.0,240000.0
Shimoga,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,15000.0,17800.0,9000.0,41000.0,24000.0,21800.0,22200.0,24800.0,2400.0,24000.0,19400.0,28800.0,250200.0
Shimoga,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,19000.0,1200.0,16200.0,95200.0,71200.0,49400.0,27200.0,2400.0,0.0,72000.0,52600.0,23800.0,430200.0
Shimoga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,4250.0,4250.0,3050.0,4450.0,3850.0,2950.0,2950.0,2950.0,2550.0,2550.0,4850.0,4650.0,43300.0
Shimoga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,2400.0,0.0,0.0,0.0,0.0,0.0,0.0,3300.0,1550.0,0.0,7250.0
Shimoga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Shimoga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,1200.0,1000.0,600.0,900.0,0.0,0.0,400.0,0.0,1000.0,1750.0,500.0,7350.0
Shimoga,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,4250.0,3050.0,4450.0,3850.0,2950.0,2950.0,2950.0,2550.0,2550.0,4850.0,4650.0,4150.0,43200.0
Shimoga,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,1.0,1.0,1.0,1.0,1.0,,,8.0,14.0
Shimoga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,11.0,17.0,14.0,9.0,17.0,12.0,12.0,20.0,4.0,5.0,22.0,13.0,156.0
Shimoga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,1.0,,,1.0,,,,,1.0,,1.0,4.0
Shimoga,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,11.0,18.0,14.0,9.0,18.0,12.0,12.0,20.0,4.0,6.0,22.0,14.0,160.0
Shimoga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,14.0,5.0,15.0,24.0,4.0,7.0,13.0,4.0,19.0,7.0,8.0,,120.0
Shimoga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,1.0,,1.0,,1.0,,,1.0,,1.0,,,5.0
Shimoga,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,15.0,5.0,16.0,24.0,5.0,7.0,13.0,5.0,19.0,8.0,8.0,,125.0
Shimoga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,1.0,4.0,,2.0,5.0,2.0,,,7.0,,7.0,29.0
Shimoga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,2.0,1.0,,1.0,,,1.0,,,2.0,,,7.0
Shimoga,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,2.0,4.0,1.0,2.0,5.0,3.0,,,9.0,,7.0,36.0
Shimoga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,2.0,2.0,1.0,5.0,3.0,1.0,5.0,2.0,3.0,1.0,,25.0
Shimoga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,2.0,3.0,3.0,3.0,,,,1.0,,1.0,13.0
Shimoga,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,2.0,4.0,4.0,8.0,6.0,1.0,5.0,2.0,4.0,1.0,1.0,38.0
Shimoga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,1.0,,,,,,,1.0,,2.0
Shimoga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shimoga,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,1.0,,,,,,,1.0,,2.0
Shimoga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shimoga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shimoga,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Shimoga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,1.0,1.0,,,,,3.0
Shimoga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shimoga,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,,,1.0,1.0,,,,,3.0
Shimoga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Shimoga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Shimoga,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Shimoga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,2.0,1.0,6.0,2.0,3.0,,3.0,1.0,2.0,6.0,4.0,31.0
Shimoga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,1.0,2.0,,,1.0,1.0,,1.0,1.0,1.0,1.0,2.0,11.0
Shimoga,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,4.0,1.0,6.0,3.0,4.0,,4.0,2.0,3.0,7.0,6.0,42.0
Shimoga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Shimoga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,,,,,,,,,1.0
Shimoga,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,,,,,,,,1.0,2.0
Shimoga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,2.0,7.0,3.0,3.0,1.0,3.0,2.0,5.0,,2.0,1.0,,29.0
Shimoga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,,,1.0,2.0,1.0,2.0,2.0,1.0,1.0,2.0,2.0,,14.0
Shimoga,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,7.0,4.0,5.0,2.0,5.0,4.0,6.0,1.0,4.0,3.0,,43.0
Shimoga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,7.0,4.0,5.0,12.0,9.0,10.0,7.0,8.0,5.0,6.0,7.0,7.0,87.0
Shimoga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,34.0,31.0,35.0,37.0,49.0,40.0,31.0,52.0,31.0,42.0,40.0,41.0,463.0
Shimoga,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,41.0,35.0,40.0,49.0,58.0,50.0,38.0,60.0,36.0,48.0,47.0,48.0,550.0
Shimoga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Shimoga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,1.0,,,1.0
Shimoga,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,1.0,,,1.0
Shimoga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,1.0,,1.0
Shimoga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,4.0,2.0,2.0,,1.0,3.0,1.0,1.0,1.0,1.0,19.0
Shimoga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,2.0,,2.0,1.0,,2.0,2.0,1.0,,,,12.0
Shimoga,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,4.0,4.0,4.0,3.0,,3.0,5.0,2.0,1.0,2.0,1.0,32.0
Shimoga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Shimoga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,4.0,3.0,,3.0,1.0,1.0,1.0,4.0,,2.0,4.0,3.0,26.0
Shimoga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,2.0,1.0,,1.0,1.0,1.0,1.0,,,2.0,10.0
Shimoga,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,4.0,4.0,2.0,4.0,1.0,3.0,2.0,5.0,1.0,2.0,4.0,5.0,37.0
Shimoga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,2.0,,,,1.0,,1.0,4.0
Shimoga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,50.0,40.0,44.0,53.0,60.0,50.0,46.0,43.0,52.0,49.0,55.0,49.0,591.0
Shimoga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,71.0,62.0,67.0,103.0,90.0,107.0,86.0,99.0,93.0,110.0,88.0,88.0,1064.0
Shimoga,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,121.0,102.0,111.0,156.0,150.0,159.0,132.0,142.0,145.0,160.0,143.0,138.0,1659.0
Shimoga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,1.0,,,,,1.0,,1.0,1.0,,2.0,7.0
Shimoga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,10.0,7.0,11.0,19.0,11.0,17.0,9.0,14.0,12.0,16.0,10.0,18.0,154.0
Shimoga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,50.0,41.0,47.0,66.0,59.0,77.0,74.0,64.0,80.0,71.0,86.0,48.0,763.0
Shimoga,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,61.0,49.0,58.0,85.0,70.0,94.0,84.0,78.0,93.0,88.0,96.0,68.0,924.0
Shimoga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Shimoga,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Shimoga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Shimoga,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Shimoga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,2.0,1.0,,,1.0,,,2.0,7.0
Shimoga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Shimoga,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,2.0,1.0,,,1.0,,,2.0,7.0
Shimoga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,1.0,,,1.0
Shimoga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Shimoga,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,1.0,,,1.0
Shimoga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Shimoga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Shimoga,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,1.0,,,,,,,1.0
Shimoga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Shimoga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,4.0,1.0,3.0,1.0,1.0,,2.0,,3.0,,1.0,,16.0
Shimoga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Shimoga,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,4.0,1.0,3.0,1.0,1.0,,2.0,,3.0,,1.0,,16.0
Shimoga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,2.0,2.0,2.0,,,,,,,2.0,1.0,1.0,10.0
Shimoga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,8.0,20.0,10.0,12.0,10.0,16.0,16.0,14.0,16.0,13.0,16.0,14.0,165.0
Shimoga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,1.0,6.0,5.0,3.0,3.0,3.0,1.0,4.0,5.0,9.0,7.0,3.0,50.0
Shimoga,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,11.0,28.0,17.0,15.0,13.0,19.0,17.0,18.0,21.0,24.0,24.0,18.0,225.0
Shimoga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,,,,,1.0,1.0,,1.0,,4.0
Shimoga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,14.0,17.0,23.0,29.0,29.0,18.0,16.0,28.0,19.0,15.0,19.0,16.0,243.0
Shimoga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,6.0,3.0,1.0,5.0,2.0,8.0,7.0,4.0,10.0,,3.0,50.0
Shimoga,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,15.0,23.0,27.0,30.0,34.0,20.0,24.0,36.0,24.0,25.0,20.0,19.0,297.0
Shimoga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,1.0,,1.0,,,,,,,,,2.0
Shimoga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,2.0,,1.0,2.0,,2.0,,3.0,1.0,2.0,1.0,,14.0
Shimoga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,1.0,1.0,,,,1.0,,1.0,,2.0,1.0,7.0
Shimoga,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,2.0,2.0,3.0,,2.0,1.0,3.0,2.0,2.0,3.0,1.0,23.0
Shimoga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,2.0,,,,1.0,,,2.0,,2.0,7.0
Shimoga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,14.0,13.0,18.0,34.0,22.0,13.0,23.0,19.0,22.0,14.0,18.0,21.0,231.0
Shimoga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,16.0,22.0,21.0,40.0,21.0,22.0,43.0,29.0,40.0,38.0,36.0,24.0,352.0
Shimoga,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,30.0,35.0,41.0,74.0,43.0,35.0,67.0,48.0,62.0,54.0,54.0,47.0,590.0
Shimoga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,1.0,2.0,1.0,,1.0,,2.0,,1.0,1.0,1.0,1.0,11.0
Shimoga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,29.0,13.0,30.0,23.0,20.0,15.0,32.0,15.0,25.0,24.0,9.0,16.0,251.0
Shimoga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,28.0,40.0,31.0,48.0,38.0,32.0,22.0,25.0,33.0,33.0,27.0,30.0,387.0
Shimoga,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,58.0,55.0,62.0,71.0,59.0,47.0,56.0,40.0,59.0,58.0,37.0,47.0,649.0
Shimoga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,3.0,1.0,4.0,1.0,3.0,1.0,4.0,4.0,2.0,24.0
Shimoga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,41.0,36.0,71.0,70.0,58.0,113.0,72.0,86.0,83.0,63.0,116.0,73.0,882.0
Shimoga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,99.0,85.0,115.0,119.0,170.0,182.0,152.0,168.0,177.0,156.0,145.0,144.0,1712.0
Shimoga,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,140.0,121.0,187.0,192.0,229.0,299.0,225.0,257.0,261.0,223.0,265.0,219.0,2618.0
Tumkur,1.1,Total number of pregnant women Registered for ANC,TOTAL,3230.0,3112.0,3529.0,3299.0,2989.0,3463.0,3032.0,3208.0,3347.0,3127.0,2980.0,3100.0,38416.0
Tumkur,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,2606.0,2456.0,2794.0,2607.0,2408.0,2690.0,2403.0,2531.0,2604.0,2435.0,2364.0,2426.0,30324.0
Tumkur,1.2,Number of Pregnant women registered under JSY,TOTAL,2910.0,2777.0,3104.0,2904.0,2632.0,3027.0,2719.0,2982.0,2911.0,2754.0,2653.0,2783.0,34156.0
Tumkur,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,3044.0,2260.0,2628.0,2611.0,2609.0,3076.0,2697.0,2705.0,2828.0,2809.0,2944.0,2751.0,32962.0
Tumkur,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,3402.0,3033.0,3035.0,2831.0,3138.0,3164.0,2870.0,3487.0,3154.0,3172.0,2995.0,3099.0,37380.0
Tumkur,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,3574.0,3701.0,4070.0,3625.0,3981.0,3633.0,3644.0,4166.0,4083.0,3701.0,3688.0,3675.0,45541.0
Tumkur,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,2128.0,2261.0,2174.0,2062.0,2056.0,2666.0,2336.0,2240.0,2197.0,2090.0,2168.0,1901.0,26279.0
Tumkur,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,201.0,188.0,81.0,58.0,58.0,65.0,79.0,121.0,78.0,80.0,56.0,60.0,1125.0
Tumkur,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,1.0,1.0,2.0,39.0,2.0,0.0,22.0,0.0,3.0,1.0,1.0,75.0
Tumkur,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,3679.0,4458.0,3818.0,3569.0,3300.0,3132.0,3257.0,4639.0,3512.0,3265.0,3283.0,3218.0,43130.0
Tumkur,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,339.0,152.0,104.0,162.0,82.0,73.0,99.0,70.0,124.0,91.0,76.0,83.0,1455.0
Tumkur,1.8,Number of pregnancy test kits used at SC level,TOTAL,243.0,241.0,248.0,257.0,265.0,300.0,246.0,262.0,254.0,258.0,232.0,299.0,3105.0
Tumkur,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,2.0,1.0,3.0,5.0,1.0,6.0,4.0,4.0,8.0,2.0,4.0,5.0,45.0
Tumkur,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,15.0,12.0,14.0,10.0,15.0,19.0,9.0,12.0,10.0,11.0,4.0,6.0,137.0
Tumkur,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,17.0,13.0,17.0,15.0,16.0,25.0,13.0,16.0,18.0,13.0,8.0,11.0,182.0
Tumkur,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,18.0,14.0,17.0,15.0,16.0,15.0,9.0,13.0,18.0,8.0,8.0,7.0,158.0
Tumkur,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,1.0,0.0,1.0,0.0,3.0
Tumkur,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1752.0,1566.0,1636.0,1643.0,1686.0,1636.0,1588.0,1651.0,1552.0,1474.0,1563.0,1613.0,19360.0
Tumkur,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,50.0,42.0,21.0,1.0,2.0,2.0,7.0,3.0,0.0,12.0,4.0,17.0,161.0
Tumkur,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,608.0,561.0,761.0,628.0,521.0,690.0,339.0,408.0,505.0,492.0,300.0,277.0,6090.0
Tumkur,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,0.0,0.0,20.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,18.0,43.0
Tumkur,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,1297.0,1204.0,1429.0,1190.0,1444.0,1298.0,1297.0,1293.0,1292.0,1353.0,1410.0,1329.0,15836.0
Tumkur,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,521.0,509.0,570.0,559.0,611.0,643.0,485.0,632.0,535.0,479.0,555.0,578.0,6677.0
Tumkur,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,521.0,509.0,570.0,559.0,611.0,643.0,485.0,632.0,535.0,479.0,555.0,578.0,6677.0
Tumkur,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,872.0,666.0,891.0,714.0,953.0,783.0,900.0,849.0,789.0,792.0,819.0,702.0,9730.0
Tumkur,4.1.1.a,Number of male live births,TOTAL,1583.0,1407.0,1527.0,1516.0,1673.0,1587.0,1436.0,1520.0,1462.0,1516.0,1570.0,1529.0,18326.0
Tumkur,4.1.1.b,Number of female live births,TOTAL,1473.0,1371.0,1552.0,1325.0,1478.0,1396.0,1477.0,1494.0,1399.0,1312.0,1416.0,1442.0,17135.0
Tumkur,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,3056.0,2778.0,3079.0,2841.0,3151.0,2983.0,2913.0,3014.0,2861.0,2828.0,2986.0,2971.0,35461.0
Tumkur,4.1.2,Number of still births,TOTAL,22.0,13.0,21.0,15.0,8.0,18.0,18.0,12.0,14.0,16.0,14.0,7.0,178.0
Tumkur,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,110.0,79.0,109.0,147.0,70.0,124.0,73.0,70.0,63.0,89.0,67.0,86.0,1087.0
Tumkur,4.2.1,Number of Newborns weighed at birth,TOTAL,3057.0,2777.0,3074.0,2838.0,3106.0,2894.0,2853.0,3006.0,2852.0,2754.0,2985.0,2948.0,35144.0
Tumkur,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,267.0,210.0,199.0,193.0,210.0,233.0,260.0,362.0,360.0,267.0,244.0,259.0,3064.0
Tumkur,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,2395.0,2750.0,3025.0,2820.0,3055.0,2947.0,2831.0,2980.0,2807.0,2784.0,2920.0,2802.0,34116.0
Tumkur,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,1.0,0.0,0.0,0.0,6.0,0.0,0.0,0.0,2.0,0.0,0.0,9.0
Tumkur,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Tumkur,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,410.0,395.0,416.0,382.0,401.0,450.0,372.0,454.0,407.0,344.0,387.0,411.0,4829.0
Tumkur,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,412.0,396.0,416.0,382.0,401.0,456.0,372.0,454.0,407.0,346.0,387.0,411.0,4840.0
Tumkur,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,5.0,4.0,2.0,4.0,2.0,2.0,4.0,2.0,3.0,4.0,1.0,5.0,38.0
Tumkur,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,1003.0,874.0,437.0,506.0,545.0,545.0,504.0,576.0,502.0,409.0,420.0,478.0,6799.0
Tumkur,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,46.0,81.0,32.0,50.0,39.0,77.0,69.0,96.0,42.0,29.0,21.0,26.0,608.0
Tumkur,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,1268.0,1067.0,618.0,541.0,644.0,629.0,712.0,659.0,584.0,579.0,547.0,557.0,8405.0
Tumkur,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,140.0,105.0,100.0,99.0,91.0,101.0,87.0,76.0,73.0,56.0,66.0,72.0,1066.0
Tumkur,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1942.0,1799.0,2098.0,1674.0,1883.0,1306.0,1886.0,1822.0,1771.0,2168.0,2250.0,1828.0,22427.0
Tumkur,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,3108.0,2973.0,3093.0,2595.0,2662.0,3091.0,2772.0,3001.0,2913.0,3072.0,3208.0,3052.0,35540.0
Tumkur,6.3,PNC maternal complications attended,TOTAL,4.0,9.0,2.0,35.0,4.0,13.0,4.0,15.0,8.0,2.0,0.0,13.0,109.0
Tumkur,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,41.0,25.0,30.0,24.0,23.0,33.0,15.0,27.0,15.0,17.0,17.0,18.0,285.0
Tumkur,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,6.0,16.0,27.0,12.0,12.0,12.0,10.0,7.0,11.0,9.0,7.0,20.0,149.0
Tumkur,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,47.0,41.0,57.0,36.0,35.0,45.0,25.0,34.0,26.0,26.0,24.0,38.0,434.0
Tumkur,7.2,Number of MTPs conducted at Private Facilities,TOTAL,21.0,18.0,20.0,46.0,8.0,20.0,18.0,11.0,10.0,13.0,8.0,8.0,201.0
Tumkur,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,481.0,481.0,519.0,504.0,477.0,434.0,391.0,606.0,522.0,503.0,592.0,498.0,6008.0
Tumkur,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,902.0,941.0,905.0,953.0,846.0,829.0,705.0,927.0,917.0,909.0,1039.0,903.0,10776.0
Tumkur,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1383.0,1422.0,1424.0,1457.0,1323.0,1263.0,1096.0,1533.0,1439.0,1412.0,1631.0,1401.0,16784.0
Tumkur,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0,3.0,0.0,2.0,2.0,12.0
Tumkur,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,1.0,1.0,4.0,0.0,6.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0,17.0
Tumkur,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,1.0,2.0,5.0,0.0,6.0,1.0,1.0,3.0,3.0,0.0,2.0,5.0,29.0
Tumkur,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,189.0,215.0,181.0,169.0,168.0,173.0,109.0,157.0,43.0,21.0,50.0,61.0,1536.0
Tumkur,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,8.0,19.0,12.0,16.0,16.0,0.0,23.0,0.0,0.0,0.0,0.0,94.0
Tumkur,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,336.0,236.0,265.0,224.0,162.0,242.0,216.0,246.0,260.0,328.0,319.0,401.0,3235.0
Tumkur,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,525.0,459.0,465.0,405.0,346.0,431.0,325.0,426.0,303.0,349.0,369.0,462.0,4865.0
Tumkur,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,8.0,10.0,2.0,34.0,0.0,8.0,0.0,0.0,0.0,1.0,1.0,0.0,64.0
Tumkur,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,18.0,25.0,13.0,23.0,12.0,16.0,5.0,16.0,12.0,11.0,22.0,12.0,185.0
Tumkur,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,75.0,102.0,90.0,54.0,36.0,59.0,35.0,46.0,37.0,98.0,68.0,46.0,746.0
Tumkur,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,93.0,127.0,103.0,77.0,48.0,75.0,40.0,62.0,49.0,109.0,90.0,58.0,931.0
Tumkur,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,26.0,21.0,37.0,3.0,2.0,28.0,23.0,18.0,15.0,66.0,69.0,234.0,542.0
Tumkur,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,19.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,19.0
Tumkur,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,121.0,164.0,182.0,177.0,182.0,210.0,170.0,206.0,222.0,238.0,207.0,161.0,2240.0
Tumkur,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,121.0,164.0,201.0,177.0,182.0,210.0,170.0,206.0,222.0,238.0,207.0,161.0,2259.0
Tumkur,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,183.0,147.0,184.0,242.0,147.0,176.0,132.0,164.0,164.0,228.0,236.0,86.0,2089.0
Tumkur,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,206.0,211.0,221.0,221.0,170.0,181.0,179.0,194.0,169.0,164.0,132.0,134.0,2182.0
Tumkur,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,337.0,346.0,337.0,383.0,322.0,286.0,276.0,313.0,316.0,290.0,273.0,269.0,3748.0
Tumkur,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,3.0,6.0,8.0,16.0,5.0,7.0,5.0,3.0,6.0,8.0,6.0,3.0,76.0
Tumkur,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,146.0,128.0,159.0,126.0,107.0,134.0,129.0,135.0,112.0,119.0,80.0,92.0,1467.0
Tumkur,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Tumkur,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,692.0,691.0,725.0,746.0,604.0,608.0,589.0,645.0,603.0,581.0,491.0,498.0,7473.0
Tumkur,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,13.0,20.0,17.0,18.0,20.0,26.0,9.0,14.0,11.0,16.0,15.0,22.0,201.0
Tumkur,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,49.0,45.0,73.0,74.0,28.0,73.0,19.0,103.0,129.0,61.0,81.0,35.0,770.0
Tumkur,9.06,Number of IUCD removals,TOTAL,260.0,162.0,158.0,265.0,239.0,151.0,183.0,200.0,176.0,138.0,154.0,178.0,2264.0
Tumkur,9.07,Number of Oral Pills cycles distributed,TOTAL,5122.0,4674.0,4808.0,5480.0,5506.0,4385.0,4603.0,4930.0,4707.0,5124.0,4728.0,5041.0,59108.0
Tumkur,9.08,Number of Condom pieces distributed,TOTAL,41958.0,40024.0,41865.0,42949.0,41702.0,44281.0,42582.0,43088.0,43698.0,43295.0,44061.0,43234.0,512737.0
Tumkur,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Tumkur,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,9.12,Number of Institutions having NSV trained doctors,TOTAL,23.0,21.0,27.0,21.0,29.0,25.0,20.0,18.0,19.0,22.0,20.0,14.0,-1.0
Tumkur,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,3481.0,3108.0,2959.0,3293.0,3173.0,3339.0,3116.0,3347.0,3124.0,3013.0,3094.0,2949.0,37996.0
Tumkur,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,3715.0,3924.0,3954.0,3758.0,3452.0,3765.0,3543.0,3900.0,3775.0,3784.0,3752.0,3685.0,45007.0
Tumkur,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,3551.0,3499.0,4057.0,3719.0,3575.0,3765.0,3427.0,3805.0,3872.0,3787.0,3689.0,3802.0,44548.0
Tumkur,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,3746.0,3432.0,3826.0,3833.0,3656.0,3784.0,3609.0,3895.0,3635.0,3919.0,3815.0,3730.0,44880.0
Tumkur,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,3135.0,2663.0,3112.0,2618.0,2771.0,2633.0,2422.0,2870.0,2727.0,2705.0,2855.0,2796.0,33307.0
Tumkur,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,3707.0,3925.0,3953.0,3769.0,3452.0,3765.0,3532.0,3881.0,3775.0,3782.0,3739.0,3682.0,44962.0
Tumkur,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,3543.0,3498.0,4056.0,3722.0,3572.0,3765.0,3420.0,3747.0,3872.0,3785.0,3677.0,3808.0,44465.0
Tumkur,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,3735.0,3432.0,3821.0,3813.0,3660.0,3784.0,3588.0,3876.0,3635.0,3926.0,3805.0,3720.0,44795.0
Tumkur,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,2959.0,2138.0,2195.0,2243.0,2703.0,2477.0,2315.0,2733.0,2628.0,2617.0,2770.0,2700.0,30478.0
Tumkur,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,3441.0,3426.0,3602.0,3515.0,3322.0,3568.0,3286.0,3506.0,3431.0,3620.0,3617.0,3637.0,41971.0
Tumkur,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,2932.0,2643.0,3296.0,2997.0,2804.0,3036.0,2830.0,3079.0,3074.0,2921.0,2797.0,3125.0,35534.0
Tumkur,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1706.0,1739.0,1794.0,1739.0,1613.0,1729.0,1700.0,1672.0,1713.0,1858.0,1834.0,1776.0,20873.0
Tumkur,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1494.0,1562.0,1659.0,1529.0,1478.0,1596.0,1440.0,1464.0,1565.0,1659.0,1548.0,1542.0,18536.0
Tumkur,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,3200.0,3301.0,3453.0,3268.0,3091.0,3325.0,3140.0,3136.0,3278.0,3517.0,3382.0,3318.0,39409.0
Tumkur,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,2992.0,2861.0,3368.0,3124.0,2879.0,3230.0,2873.0,3104.0,3244.0,3017.0,2850.0,3136.0,36678.0
Tumkur,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,2992.0,2845.0,3360.0,3117.0,2873.0,3220.0,2868.0,3109.0,3243.0,3018.0,2850.0,3126.0,36621.0
Tumkur,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,393.0,198.0,223.0,128.0,67.0,67.0,104.0,19.0,14.0,27.0,57.0,41.0,1338.0
Tumkur,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,376.0,191.0,207.0,108.0,62.0,64.0,80.0,18.0,18.0,29.0,56.0,35.0,1244.0
Tumkur,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,769.0,389.0,430.0,236.0,129.0,131.0,184.0,37.0,32.0,56.0,113.0,76.0,2582.0
Tumkur,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,94.0,77.0,46.0,1691.0,6836.0,10988.0,203.0,3543.0,2270.0,429.0,742.0,400.0,27319.0
Tumkur,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,57.0,50.0,13.0,1787.0,6903.0,11223.0,95.0,3294.0,2253.0,538.0,836.0,359.0,27408.0
Tumkur,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,13.0,2.0,3.0,1356.0,6326.0,13837.0,159.0,3263.0,2721.0,952.0,9713.0,237.0,38582.0
Tumkur,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Tumkur,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,3.0
Tumkur,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1867.0,1881.0,1861.0,2002.0,2027.0,2001.0,2022.0,2014.0,2098.0,2036.0,2106.0,2123.0,24038.0
Tumkur,10.4.2,Number of Immunisation sessions held during the month,TOTAL,1595.0,1634.0,1636.0,1746.0,1725.0,1717.0,1692.0,1701.0,1732.0,1656.0,1714.0,1748.0,20296.0
Tumkur,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,1271.0,1257.0,1260.0,1312.0,1261.0,1272.0,1256.0,1268.0,1274.0,1224.0,1261.0,1282.0,15198.0
Tumkur,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,3136.0,3053.0,3148.0,3288.0,3632.0,3460.0,3108.0,3260.0,3311.0,3440.0,3678.0,3657.0,40171.0
Tumkur,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,305.0,96.0,113.0,2761.0,48625.0,262.0,170.0,64.0,85.0,99.0,13851.0,9316.0,75747.0
Tumkur,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,6.0,5.0,3.0,2438.0,49972.0,29.0,5.0,0.0,4.0,4.0,12633.0,9591.0,74690.0
Tumkur,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,5.0,3.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,5.0,14.0
Tumkur,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,169.0,171.0,131.0,104.0,79.0,79.0,78.0,77.0,84.0,77.0,108.0,140.0,1297.0
Tumkur,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0
Tumkur,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,19.0,39.0,23.0,61.0,49.0,99.0,62.0,41.0,22.0,36.0,59.0,71.0,581.0
Tumkur,13.1,Number of Patients operated for cataract,TOTAL,159.0,202.0,186.0,184.0,254.0,174.0,148.0,176.0,201.0,174.0,192.0,141.0,2191.0
Tumkur,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,159.0,202.0,186.0,184.0,254.0,174.0,142.0,173.0,201.0,174.0,192.0,141.0,2182.0
Tumkur,13.3,Number of School children detected with Refractive errors,TOTAL,100.0,77.0,101.0,101.0,123.0,111.0,81.0,121.0,90.0,67.0,52.0,208.0,1232.0
Tumkur,13.4,Number of children provided free glasses,TOTAL,13.0,0.0,6.0,12.0,12.0,5.0,5.0,13.0,16.0,21.0,10.0,225.0,338.0
Tumkur,13.5,Number of eyes collected through eye donation,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tumkur,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tumkur,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,13.0,12.0,11.0,12.0,13.0,12.0,11.0,10.0,13.0,11.0,16.0,13.0,-1.0
Tumkur,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,48.0,48.0,50.0,49.0,52.0,48.0,43.0,48.0,45.0,46.0,47.0,44.0,-1.0
Tumkur,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,627.0,568.0,542.0,510.0,540.0,528.0,519.0,544.0,518.0,542.0,531.0,542.0,-1.0
Tumkur,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,7.0,8.0,8.0,8.0,11.0,8.0,9.0,9.0,11.0,8.0,11.0,10.0,-1.0
Tumkur,14.05,Number of RKS meetings held during the month,TOTAL,31.0,26.0,30.0,31.0,27.0,25.0,22.0,18.0,24.0,29.0,37.0,45.0,345.0
Tumkur,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,38.0,35.0,39.0,37.0,50.0,43.0,35.0,40.0,40.0,43.0,43.0,36.0,-1.0
Tumkur,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,559.0,558.0,527.0,426.0,507.0,425.0,457.0,491.0,469.0,490.0,536.0,478.0,5923.0
Tumkur,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,10.0,12.0,13.0,14.0,11.0,10.0,11.0,12.0,12.0,14.0,11.0,-1.0
Tumkur,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,6.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,4.0,5.0,5.0,4.0,-1.0
Tumkur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,511.0,423.0,633.0,445.0,402.0,440.0,572.0,347.0,353.0,374.0,457.0,473.0,5430.0
Tumkur,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2905.0,2667.0,2945.0,2155.0,2203.0,1952.0,1871.0,2033.0,2033.0,1848.0,2494.0,2341.0,27447.0
Tumkur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,515.0,495.0,910.0,400.0,490.0,587.0,732.0,313.0,578.0,591.0,477.0,639.0,6727.0
Tumkur,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4790.0,4652.0,5166.0,4641.0,4939.0,4345.0,4011.0,4462.0,3808.0,3503.0,4249.0,4662.0,53228.0
Tumkur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1026.0,918.0,1543.0,845.0,892.0,1027.0,1304.0,660.0,931.0,965.0,934.0,1112.0,12157.0
Tumkur,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7695.0,7319.0,8111.0,6796.0,7142.0,6297.0,5882.0,6495.0,5841.0,5351.0,6743.0,7003.0,80675.0
Tumkur,14.10.2.a,Number of death cases of Inpatient males,TOTAL,64.0,62.0,59.0,42.0,71.0,72.0,39.0,88.0,63.0,70.0,71.0,51.0,752.0
Tumkur,14.10.2.b,Number of death cases of Inpatient females,TOTAL,37.0,52.0,31.0,36.0,24.0,37.0,29.0,30.0,38.0,36.0,37.0,29.0,416.0
Tumkur,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,101.0,114.0,90.0,78.0,95.0,109.0,68.0,118.0,101.0,106.0,108.0,80.0,1168.0
Tumkur,14.11,In-Patient Head Count at midnight,TOTAL,11367.0,11371.0,16135.0,14153.0,14247.0,12865.0,11744.0,11596.0,11748.0,11859.0,14082.0,11521.0,152688.0
Tumkur,14.12.1,OPD attendance (All),TOTAL,185462.0,191175.0,242086.0,246929.0,269147.0,262252.0,196971.0,235593.0,231325.0,225058.0,254089.0,260232.0,2800319.0
Tumkur,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1376.0,1370.0,958.0,882.0,982.0,920.0,812.0,954.0,929.0,884.0,929.0,785.0,11781.0
Tumkur,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,54.0,69.0,47.0,47.0,76.0,64.0,62.0,46.0,32.0,57.0,111.0,38.0,703.0
Tumkur,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,354.0,279.0,134.0,135.0,247.0,170.0,199.0,198.0,281.0,318.0,259.0,276.0,2850.0
Tumkur,14.14.a,Number of patients given AYUSH treatment,TOTAL,4005.0,3852.0,4389.0,4374.0,5124.0,4216.0,4187.0,4642.0,4084.0,4906.0,4158.0,4704.0,52641.0
Tumkur,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,1127.0,1163.0,1373.0,1574.0,1538.0,1551.0,1176.0,1407.0,1105.0,1152.0,1221.0,1175.0,15562.0
Tumkur,14.14.c,Number of Adolescents counselled,TOTAL,433.0,349.0,483.0,529.0,546.0,502.0,551.0,494.0,445.0,610.0,878.0,678.0,6498.0
Tumkur,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,10184.0,9633.0,9391.0,9033.0,9781.0,10029.0,8222.0,9267.0,8500.0,9617.0,9730.0,9153.0,112540.0
Tumkur,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,574.0,548.0,372.0,406.0,356.0,395.0,347.0,417.0,477.0,376.0,314.0,351.0,4933.0
Tumkur,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2722.0,2910.0,3378.0,3058.0,3519.0,3754.0,2607.0,2960.0,3518.0,3220.0,3396.0,3186.0,38228.0
Tumkur,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,34.0,38.0,38.0,32.0,40.0,36.0,46.0,34.0,35.0,39.0,35.0,34.0,441.0
Tumkur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,2162.0,2353.0,3158.0,2543.0,3065.0,3104.0,2278.0,2477.0,3240.0,2347.0,2603.0,2548.0,31878.0
Tumkur,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,43.0,33.0,37.0,26.0,31.0,29.0,31.0,27.0,28.0,29.0,20.0,27.0,361.0
Tumkur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,3935.0,4012.0,4775.0,3867.0,4381.0,4681.0,3138.0,3631.0,4396.0,3725.0,3758.0,3604.0,47903.0
Tumkur,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,6.0,5.0,7.0,5.0,4.0,5.0,0.0,2.0,3.0,1.0,1.0,4.0,43.0
Tumkur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,8819.0,9275.0,11311.0,9468.0,10965.0,11539.0,8023.0,9068.0,11154.0,9292.0,9757.0,9338.0,118009.0
Tumkur,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,83.0,76.0,82.0,63.0,75.0,70.0,77.0,63.0,66.0,69.0,56.0,65.0,845.0
Tumkur,15.2,Number of Widal tests conducted,Number tested,2013.0,1367.0,1608.0,2727.0,2677.0,3657.0,2232.0,2350.0,2074.0,1892.0,2941.0,2669.0,28207.0
Tumkur,15.3.a,Number of VDRL tests conducted on males,Number tested,199.0,153.0,180.0,141.0,176.0,400.0,162.0,159.0,162.0,143.0,203.0,259.0,2337.0
Tumkur,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,354.0,312.0,442.0,334.0,266.0,634.0,302.0,272.0,221.0,391.0,401.0,393.0,4322.0
Tumkur,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,2731.0,2494.0,2590.0,2635.0,2551.0,2628.0,2014.0,2494.0,2467.0,2377.0,2598.0,2491.0,30070.0
Tumkur,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,3284.0,2959.0,3212.0,3110.0,2993.0,3662.0,2478.0,2925.0,2850.0,2911.0,3202.0,3143.0,36729.0
Tumkur,15.4.1,Number of blood smears examined for Malaria,TOTAL,42326.0,42927.0,49512.0,52183.0,49759.0,54057.0,40444.0,44784.0,39656.0,40334.0,49499.0,46018.0,551499.0
Tumkur,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,6.0,3.0,4.0,4.0,2.0,0.0,2.0,0.0,2.0,2.0,2.0,33.0
Tumkur,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,2.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0
Tumkur,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,670.0,3000.0,5870.0,5020.0,3890.0,32200.0,18770.0,24270.0,14820.0,11640.0,4460.0,4640.0,129250.0
Tumkur,16.1.1,Stock position of DPT vaccines,2. Stocks Received,10000.0,10000.0,10000.0,20000.0,35000.0,0.0,12000.0,0.0,0.0,0.0,5000.0,5000.0,107000.0
Tumkur,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,7670.0,7130.0,10850.0,21130.0,6690.0,13430.0,6500.0,9450.0,3180.0,7180.0,4820.0,5200.0,103230.0
Tumkur,16.1.1,Stock position of DPT vaccines,5. Total Stock,3000.0,5870.0,5020.0,3890.0,32200.0,18770.0,24270.0,14820.0,11640.0,4460.0,4640.0,4440.0,133020.0
Tumkur,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3750.0,3250.0,5970.0,8540.0,3240.0,6660.0,8530.0,15430.0,3180.0,6280.0,1480.0,4780.0,71090.0
Tumkur,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,12000.0,15000.0,12000.0,6000.0,9000.0,12000.0,15000.0,0.0,12000.0,6000.0,12000.0,9000.0,120000.0
Tumkur,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,12500.0,12280.0,9430.0,11300.0,5580.0,10130.0,8100.0,12250.0,8900.0,10800.0,8700.0,11780.0,121750.0
Tumkur,16.1.1A,Stock Position of Pentavalent,5. Total Stock,3250.0,5970.0,8540.0,3240.0,6660.0,8530.0,15430.0,3180.0,6280.0,1480.0,4780.0,2000.0,69340.0
Tumkur,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,42720.0,28720.0,20210.0,13810.0,8710.0,24450.0,17500.0,25400.0,900.0,500.0,2440.0,25640.0,211000.0
Tumkur,16.1.2,Stock position of OPV vaccines,2. Stocks Received,0.0,20000.0,20000.0,20000.0,28500.0,25000.0,25000.0,0.0,27000.0,389500.0,400000.0,18000.0,973000.0
Tumkur,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,3090.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3090.0
Tumkur,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,14000.0,25420.0,26400.0,25100.0,12760.0,31950.0,17100.0,24500.0,27400.0,387560.0,376800.0,16020.0,985010.0
Tumkur,16.1.2,Stock position of OPV vaccines,5. Total Stock,28720.0,20210.0,13810.0,8710.0,24450.0,17500.0,25400.0,900.0,500.0,2440.0,25640.0,27620.0,195900.0
Tumkur,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,14460.0,16310.0,8280.0,5020.0,670.0,19480.0,16500.0,15800.0,3440.0,3970.0,4590.0,6340.0,114860.0
Tumkur,16.1.3,Stock position of TT vaccines,2. Stocks Received,16000.0,8000.0,7500.0,20000.0,37000.0,20000.0,10000.0,0.0,10000.0,15000.0,10000.0,12000.0,165500.0
Tumkur,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.3,Stock position of TT vaccines,4. Stock Distributed,14150.0,16030.0,10760.0,24350.0,18280.0,22980.0,10700.0,12360.0,9470.0,14380.0,8250.0,8700.0,170410.0
Tumkur,16.1.3,Stock position of TT vaccines,5. Total Stock,16310.0,8280.0,5020.0,670.0,19390.0,16500.0,15800.0,3440.0,3970.0,4590.0,6340.0,9640.0,109950.0
Tumkur,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,7220.0,13500.0,4320.0,1090.0,5550.0,20950.0,12950.0,11790.0,5150.0,4590.0,450.0,5000.0,92560.0
Tumkur,16.1.5,Stock position of BCG vaccines,2. Stocks Received,14000.0,0.0,4000.0,10000.0,5000.0,14000.0,4000.0,0.0,5000.0,5000.0,10000.0,4000.0,75000.0
Tumkur,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,7720.0,9180.0,7230.0,5540.0,3600.0,8000.0,5160.0,6640.0,5560.0,9140.0,5450.0,5770.0,78990.0
Tumkur,16.1.5,Stock position of BCG vaccines,5. Total Stock,13500.0,4320.0,1090.0,5550.0,6950.0,26950.0,11790.0,5150.0,4590.0,450.0,5000.0,3230.0,88570.0
Tumkur,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,12815.0,7940.0,4585.0,2610.0,4755.0,5650.0,8225.0,13490.0,6340.0,4075.0,1935.0,3905.0,76325.0
Tumkur,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,5000.0,5000.0,10000.0,5000.0,10000.0,10000.0,0.0,5000.0,5000.0,10000.0,10000.0,80000.0
Tumkur,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,9875.0,8355.0,6975.0,7855.0,4105.0,7425.0,4735.0,7150.0,7265.0,7140.0,8030.0,7435.0,86345.0
Tumkur,16.1.6,Stock position of Measles vaccines,5. Total Stock,7940.0,4585.0,2610.0,4755.0,5650.0,8225.0,13490.0,6340.0,4075.0,1935.0,3905.0,6470.0,69980.0
Tumkur,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.7,Stock position of JE vaccines,4. Stock Distributed,,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2940.0,7440.0,5990.0,1790.0,5790.0,5290.0,3790.0,2850.0,1790.0,600.0,3890.0,330.0,42490.0
Tumkur,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,6000.0,0.0,0.0,6000.0,0.0,0.0,0.0,0.0,200.0,5000.0,0.0,5000.0,22200.0
Tumkur,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,1500.0,1450.0,4200.0,2000.0,500.0,1500.0,940.0,1060.0,1390.0,1710.0,3560.0,2620.0,22430.0
Tumkur,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,7440.0,5990.0,1790.0,5790.0,5290.0,3790.0,2850.0,1790.0,600.0,3890.0,330.0,2710.0,42260.0
Tumkur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1150.0,1150.0,1000.0,300.0,1950.0,1950.0,2550.0,1050.0,1050.0,1050.0,1050.0,0.0,14250.0
Tumkur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,2650.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2650.0
Tumkur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,150.0,700.0,1000.0,0.0,0.0,1500.0,0.0,0.0,0.0,1050.0,0.0,4400.0
Tumkur,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,1150.0,1000.0,300.0,1950.0,1950.0,1950.0,1050.0,1050.0,1050.0,1050.0,0.0,0.0,12500.0
Tumkur,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,32280.0,32280.0,2280.0,0.0,32940.0,11840.0,147890.0,132740.0,107540.0,82290.0,21390.0,21390.0,624860.0
Tumkur,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,100540.0,0.0,151200.0,0.0,0.0,0.0,0.0,0.0,0.0,251740.0
Tumkur,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,30000.0,2280.0,67600.0,0.0,15150.0,15150.0,25200.0,25250.0,60900.0,0.0,0.0,241530.0
Tumkur,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,32280.0,2280.0,0.0,32940.0,32940.0,147890.0,132740.0,107540.0,82290.0,21390.0,21390.0,21390.0,635070.0
Tumkur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,450.0,450.0,100.0,0.0,0.0,0.0,9000.0,8000.0,7000.0,2000.0,0.0,0.0,27000.0
Tumkur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,10000.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0
Tumkur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,350.0,100.0,0.0,0.0,1000.0,1000.0,1000.0,5000.0,2000.0,0.0,0.0,10450.0
Tumkur,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,450.0,100.0,0.0,0.0,0.0,9000.0,8000.0,7000.0,2000.0,0.0,0.0,0.0,26550.0
Tumkur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,6950.0,6450.0,6450.0,4950.0,4950.0,4850.0,4850.0,4850.0,2350.0,2350.0,1850.0,1850.0,52700.0
Tumkur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1500.0,0.0,100.0,0.0,0.0,2500.0,0.0,500.0,0.0,0.0,4600.0
Tumkur,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,6950.0,6450.0,4950.0,4950.0,4850.0,4850.0,4850.0,2350.0,2350.0,1850.0,1850.0,1850.0,48100.0
Tumkur,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,136900.0,0.0,0.0,0.0,0.0,0.0,0.0,136900.0
Tumkur,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,1566900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1566900.0
Tumkur,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,1430000.0,136900.0,0.0,0.0,0.0,0.0,0.0,0.0,1566900.0
Tumkur,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,136900.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,136900.0
Tumkur,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,195608.0,163459.0,359067.0
Tumkur,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,391808.0,97951.0,388499.0,878258.0
Tumkur,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,196200.0,130100.0,516499.0,842799.0
Tumkur,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,195608.0,163459.0,35459.0,394526.0
Tumkur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Tumkur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Tumkur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Tumkur,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,4010.0,4010.0,2160.0,1530.0,,,,0.0,0.0,0.0,0.0,98.0,11808.0
Tumkur,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Tumkur,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,,,,0.0,0.0,0.0,0.0,,0.0
Tumkur,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,1850.0,630.0,1530.0,,,,0.0,0.0,,0.0,,4010.0
Tumkur,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,4010.0,2160.0,1530.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,98.0,7798.0
Tumkur,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,195640.0,195640.0,159640.0,94640.0,100616.0,30968.0,30968.0,30968.0,98020.0,98020.0,98020.0,64620.0,1197760.0
Tumkur,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,28976.0,38352.0,0.0,67052.0,67052.0,0.0,0.0,0.0,0.0,201432.0
Tumkur,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,36000.0,65000.0,23000.0,108000.0,0.0,0.0,0.0,0.0,0.0,33400.0,30200.0,295600.0
Tumkur,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,195640.0,159640.0,94640.0,100616.0,30968.0,30968.0,98020.0,98020.0,98020.0,98020.0,64620.0,34420.0,1103592.0
Tumkur,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1900.0,1000.0,350.0,150.0,2650.0,1550.0,3950.0,1200.0,500.0,1800.0,600.0,2750.0,18400.0
Tumkur,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,0.0,0.0,6600.0,0.0,6600.0,0.0,0.0,6600.0,0.0,6600.0,0.0,29400.0
Tumkur,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,3900.0,650.0,200.0,4100.0,1100.0,4200.0,2750.0,700.0,5300.0,1200.0,4450.0,2750.0,31300.0
Tumkur,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,1000.0,350.0,150.0,2650.0,1550.0,3950.0,1200.0,500.0,1800.0,600.0,2750.0,0.0,16500.0
Tumkur,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,27100.0,43500.0,12700.0,17300.0,9300.0,22400.0,21000.0,35800.0,5200.0,2000.0,7200.0,10100.0,213600.0
Tumkur,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,30000.0,25000.0,25000.0,28800.0,36000.0,33000.0,30000.0,0.0,24000.0,0.0,36000.0,0.0,267800.0
Tumkur,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,13600.0,55800.0,20400.0,36800.0,22900.0,34400.0,15200.0,30600.0,27200.0,38000.0,33100.0,6000.0,334000.0
Tumkur,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,43500.0,12700.0,17300.0,9300.0,22400.0,21000.0,35800.0,5200.0,2000.0,-36000.0,10100.0,4100.0,147400.0
Tumkur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,1440.0,390.0,3100.0,1700.0,1400.0,1400.0,700.0,550.0,100.0,1900.0,1700.0,3150.0,17530.0
Tumkur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,5000.0,0.0,0.0,0.0,0.0,0.0,0.0,2400.0,0.0,2400.0,0.0,9800.0
Tumkur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Tumkur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,1050.0,2290.0,1400.0,300.0,550.0,700.0,150.0,450.0,600.0,200.0,950.0,1800.0,10440.0
Tumkur,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,390.0,3100.0,1700.0,1400.0,850.0,700.0,550.0,100.0,1900.0,1700.0,3150.0,1350.0,16890.0
Tumkur,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,1.0,3.0,6.0,5.0,5.0,2.0,6.0,7.0,1.0,8.0,3.0,4.0,51.0
Tumkur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,3.0,2.0,,1.0,2.0,,,1.0,1.0,2.0,,12.0
Tumkur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,2.0,,,,,,,2.0
Tumkur,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,3.0,2.0,,1.0,4.0,,,1.0,1.0,2.0,,14.0
Tumkur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,3.0,2.0,1.0,1.0,,3.0,1.0,4.0,7.0,2.0,1.0,,25.0
Tumkur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,1.0,,,,,,,,,,,1.0
Tumkur,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,3.0,3.0,1.0,1.0,,3.0,1.0,4.0,7.0,2.0,1.0,,26.0
Tumkur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,8.0,3.0,10.0,5.0,5.0,5.0,7.0,4.0,1.0,4.0,5.0,58.0
Tumkur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,1.0,,,,,,,,2.0,,3.0
Tumkur,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,8.0,4.0,10.0,5.0,5.0,5.0,7.0,4.0,1.0,6.0,5.0,61.0
Tumkur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,4.0,2.0,1.0,1.0,1.0,4.0,1.0,3.0,4.0,6.0,,2.0,29.0
Tumkur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,1.0,,,1.0,1.0,,3.0,,,6.0
Tumkur,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,4.0,2.0,1.0,2.0,1.0,4.0,2.0,4.0,4.0,9.0,,2.0,35.0
Tumkur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,4.0,1.0,2.0,2.0,4.0,5.0,5.0,2.0,2.0,1.0,2.0,4.0,34.0
Tumkur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,1.0,,1.0,,,,1.0,,3.0
Tumkur,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,4.0,1.0,2.0,2.0,5.0,5.0,6.0,2.0,2.0,1.0,3.0,4.0,37.0
Tumkur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tumkur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tumkur,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Tumkur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,1.0,,,,,,,1.0,,,,,2.0
Tumkur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,1.0,,,,,,,,1.0
Tumkur,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,1.0,,,,1.0,,,1.0,,,,,3.0
Tumkur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Tumkur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Tumkur,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Tumkur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,6.0,2.0,3.0,4.0,4.0,7.0,9.0,8.0,3.0,7.0,5.0,4.0,62.0
Tumkur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,1.0,,,,2.0,,,,,3.0
Tumkur,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,6.0,2.0,3.0,5.0,4.0,7.0,9.0,10.0,3.0,7.0,5.0,4.0,65.0
Tumkur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,,,1.0,,2.0
Tumkur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,2.0,1.0,,1.0,,,1.0,,,2.0,,,7.0
Tumkur,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,2.0,1.0,,1.0,1.0,,1.0,,,2.0,1.0,,9.0
Tumkur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,7.0,7.0,4.0,3.0,5.0,4.0,5.0,4.0,5.0,4.0,7.0,6.0,61.0
Tumkur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,5.0,4.0,2.0,3.0,9.0,2.0,5.0,2.0,3.0,2.0,4.0,43.0
Tumkur,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,9.0,12.0,8.0,5.0,8.0,13.0,7.0,9.0,7.0,7.0,9.0,10.0,104.0
Tumkur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,,,,,,,,1.0,,2.0
Tumkur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,15.0,11.0,20.0,15.0,13.0,24.0,14.0,13.0,17.0,13.0,13.0,14.0,182.0
Tumkur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,77.0,60.0,53.0,62.0,69.0,72.0,76.0,73.0,97.0,82.0,90.0,66.0,877.0
Tumkur,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,92.0,71.0,74.0,77.0,82.0,96.0,90.0,86.0,114.0,95.0,104.0,80.0,1061.0
Tumkur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,1.0,,,1.0,,,,,,,,,2.0
Tumkur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Tumkur,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,,1.0,,,,,,,,,2.0
Tumkur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,1.0,2.0,1.0,,,1.0,2.0,1.0,,3.0,1.0,12.0
Tumkur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,,1.0,1.0,1.0,,,,1.0,,1.0,,5.0
Tumkur,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,3.0,2.0,1.0,,1.0,2.0,2.0,,4.0,1.0,17.0
Tumkur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,4.0,3.0,3.0,5.0,7.0,1.0,2.0,2.0,5.0,3.0,6.0,44.0
Tumkur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,,1.0,,1.0,,1.0,,,,3.0,1.0,7.0
Tumkur,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,4.0,4.0,3.0,6.0,7.0,2.0,2.0,2.0,5.0,6.0,7.0,51.0
Tumkur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,1.0,,,1.0,1.0,2.0,5.0
Tumkur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,35.0,49.0,49.0,48.0,52.0,69.0,50.0,47.0,48.0,53.0,62.0,55.0,617.0
Tumkur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,93.0,84.0,87.0,87.0,112.0,105.0,87.0,100.0,100.0,105.0,107.0,100.0,1167.0
Tumkur,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,128.0,133.0,136.0,135.0,164.0,174.0,138.0,147.0,148.0,159.0,170.0,157.0,1789.0
Tumkur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,1.0,1.0,1.0,,,,,,2.0,1.0,,6.0
Tumkur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,10.0,12.0,9.0,12.0,12.0,13.0,23.0,12.0,8.0,14.0,14.0,17.0,156.0
Tumkur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,44.0,39.0,44.0,55.0,51.0,70.0,44.0,70.0,58.0,64.0,49.0,47.0,635.0
Tumkur,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,54.0,52.0,54.0,68.0,63.0,83.0,67.0,82.0,66.0,80.0,64.0,64.0,797.0
Tumkur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Tumkur,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Tumkur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,1.0,,,,,,1.0,,,,,,2.0
Tumkur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Tumkur,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,1.0,,,,,,1.0,,,,,,2.0
Tumkur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,1.0,,,,,,,1.0,,,,,2.0
Tumkur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Tumkur,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,1.0,,,,,,,1.0,,,,,2.0
Tumkur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,1.0,,,,,1.0,,,,,,3.0
Tumkur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Tumkur,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,1.0,,,,,1.0,,,,,,3.0
Tumkur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,1.0,,,,1.0
Tumkur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Tumkur,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,1.0,,,,1.0
Tumkur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Tumkur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,2.0,1.0,,,,,3.0,4.0,1.0,2.0,,1.0,14.0
Tumkur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Tumkur,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,2.0,1.0,,,,,3.0,4.0,1.0,2.0,,1.0,14.0
Tumkur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,1.0,,1.0,3.0,,,1.0,,1.0,1.0,9.0
Tumkur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,19.0,33.0,28.0,24.0,24.0,31.0,32.0,21.0,30.0,27.0,20.0,27.0,316.0
Tumkur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,12.0,11.0,8.0,13.0,8.0,7.0,9.0,12.0,13.0,13.0,11.0,12.0,129.0
Tumkur,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,31.0,45.0,37.0,37.0,33.0,41.0,41.0,33.0,44.0,40.0,32.0,40.0,454.0
Tumkur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,1.0,,1.0,,,2.0,,1.0,,1.0,,,6.0
Tumkur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,29.0,25.0,18.0,22.0,14.0,20.0,23.0,17.0,14.0,20.0,24.0,20.0,246.0
Tumkur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,2.0,2.0,6.0,8.0,3.0,5.0,2.0,5.0,9.0,5.0,3.0,3.0,53.0
Tumkur,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,32.0,27.0,25.0,30.0,17.0,27.0,25.0,23.0,23.0,26.0,27.0,23.0,305.0
Tumkur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,1.0,,,,,,,,,,,,1.0
Tumkur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,5.0,4.0,2.0,3.0,1.0,4.0,3.0,,2.0,,1.0,2.0,27.0
Tumkur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,4.0,,1.0,1.0,,3.0,2.0,2.0,2.0,,1.0,1.0,17.0
Tumkur,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,10.0,4.0,3.0,4.0,1.0,7.0,5.0,2.0,4.0,,2.0,3.0,45.0
Tumkur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,1.0,1.0,1.0,2.0,,1.0,1.0,,,1.0,2.0,,10.0
Tumkur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,31.0,24.0,28.0,32.0,33.0,36.0,19.0,20.0,20.0,27.0,23.0,19.0,312.0
Tumkur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,69.0,45.0,68.0,55.0,61.0,76.0,57.0,76.0,58.0,79.0,71.0,49.0,764.0
Tumkur,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,101.0,70.0,97.0,89.0,94.0,113.0,77.0,96.0,78.0,107.0,96.0,68.0,1086.0
Tumkur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,,,1.0,1.0,2.0,,1.0,,,1.0,,8.0
Tumkur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,18.0,17.0,29.0,27.0,29.0,22.0,22.0,37.0,21.0,29.0,22.0,19.0,292.0
Tumkur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,57.0,67.0,64.0,69.0,70.0,98.0,67.0,75.0,87.0,101.0,65.0,83.0,903.0
Tumkur,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,77.0,84.0,93.0,97.0,100.0,122.0,89.0,113.0,108.0,130.0,88.0,102.0,1203.0
Tumkur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,3.0,1.0,7.0,2.0,4.0,5.0,5.0,7.0,4.0,10.0,7.0,4.0,59.0
Tumkur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,42.0,50.0,44.0,32.0,44.0,60.0,49.0,43.0,66.0,54.0,58.0,55.0,597.0
Tumkur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,171.0,110.0,151.0,196.0,195.0,214.0,194.0,232.0,217.0,236.0,238.0,186.0,2340.0
Tumkur,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,216.0,161.0,202.0,230.0,243.0,279.0,248.0,282.0,287.0,300.0,303.0,245.0,2996.0
Udupi,1.1,Total number of pregnant women Registered for ANC,TOTAL,1386.0,1208.0,1463.0,1298.0,1261.0,1382.0,1171.0,1463.0,1231.0,1242.0,1295.0,1207.0,15607.0
Udupi,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1212.0,1030.0,1230.0,1097.0,1071.0,1213.0,1027.0,1276.0,1138.0,1117.0,1147.0,1056.0,13614.0
Udupi,1.2,Number of Pregnant women registered under JSY,TOTAL,857.0,777.0,922.0,791.0,805.0,937.0,802.0,915.0,791.0,768.0,814.0,776.0,9955.0
Udupi,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,1249.0,1356.0,1235.0,1119.0,1612.0,1409.0,1432.0,1511.0,1399.0,1629.0,1650.0,1491.0,17092.0
Udupi,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1243.0,1312.0,1406.0,1321.0,1272.0,1262.0,1119.0,1259.0,1026.0,1220.0,1129.0,1047.0,14616.0
Udupi,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1001.0,1142.0,1118.0,1333.0,1502.0,1278.0,1259.0,1195.0,1068.0,1267.0,1209.0,1113.0,14485.0
Udupi,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1444.0,1313.0,1337.0,1217.0,1117.0,1795.0,1702.0,1607.0,1649.0,1629.0,1582.0,1713.0,18105.0
Udupi,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,83.0,100.0,115.0,90.0,92.0,91.0,87.0,64.0,139.0,60.0,112.0,74.0,1107.0
Udupi,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,0.0,3.0,3.0,5.0,3.0,2.0,0.0,0.0,0.0,1.0,3.0,4.0,24.0
Udupi,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1126.0,1171.0,1407.0,1309.0,1379.0,1481.0,1254.0,1294.0,1387.0,1243.0,1370.0,1543.0,15964.0
Udupi,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,35.0,39.0,54.0,34.0,22.0,32.0,26.0,35.0,55.0,53.0,28.0,40.0,453.0
Udupi,1.8,Number of pregnancy test kits used at SC level,TOTAL,239.0,196.0,210.0,278.0,241.0,297.0,265.0,261.0,292.0,309.0,265.0,386.0,3239.0
Udupi,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,1.0,0.0,1.0,3.0,1.0,0.0,0.0,2.0,3.0,1.0,3.0,0.0,15.0
Udupi,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,0.0,0.0,2.0,3.0,1.0,1.0,1.0,4.0,0.0,1.0,3.0,2.0,18.0
Udupi,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,1.0,0.0,3.0,6.0,2.0,1.0,1.0,6.0,3.0,2.0,6.0,2.0,33.0
Udupi,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,1.0,1.0,3.0,4.0,2.0,0.0,1.0,4.0,0.0,2.0,3.0,2.0,23.0
Udupi,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,2.0,3.0,0.0,1.0,0.0,0.0,5.0,0.0,9.0,1.0,1.0,22.0
Udupi,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,467.0,463.0,421.0,414.0,392.0,395.0,423.0,427.0,425.0,362.0,371.0,420.0,4980.0
Udupi,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,1.0,4.0,0.0,1.0,4.0,0.0,7.0,2.0,1.0,1.0,0.0,85.0,106.0
Udupi,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,402.0,614.0,803.0,541.0,536.0,571.0,596.0,655.0,483.0,451.0,548.0,595.0,6795.0
Udupi,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,25.0,17.0,24.0,18.0,37.0,22.0,16.0,19.0,16.0,24.0,18.0,12.0,248.0
Udupi,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Udupi,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,726.0,825.0,868.0,681.0,688.0,697.0,774.0,803.0,559.0,692.0,701.0,668.0,8682.0
Udupi,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,194.0,208.0,173.0,191.0,167.0,163.0,180.0,175.0,194.0,168.0,158.0,172.0,2143.0
Udupi,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,194.0,208.0,173.0,191.0,167.0,163.0,180.0,175.0,194.0,168.0,158.0,172.0,2143.0
Udupi,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,417.0,456.0,472.0,394.0,401.0,403.0,475.0,402.0,287.0,366.0,239.0,205.0,4517.0
Udupi,4.1.1.a,Number of male live births,TOTAL,603.0,654.0,650.0,560.0,579.0,595.0,620.0,634.0,487.0,564.0,576.0,582.0,7104.0
Udupi,4.1.1.b,Number of female live births,TOTAL,592.0,634.0,627.0,549.0,513.0,516.0,595.0,608.0,502.0,497.0,501.0,530.0,6664.0
Udupi,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1195.0,1288.0,1277.0,1109.0,1092.0,1111.0,1215.0,1242.0,989.0,1061.0,1077.0,1112.0,13768.0
Udupi,4.1.2,Number of still births,TOTAL,6.0,8.0,16.0,12.0,4.0,10.0,5.0,4.0,4.0,3.0,8.0,14.0,94.0
Udupi,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,93.0,156.0,74.0,107.0,77.0,126.0,111.0,72.0,58.0,109.0,115.0,91.0,1189.0
Udupi,4.2.1,Number of Newborns weighed at birth,TOTAL,1185.0,1281.0,1272.0,1109.0,1101.0,1106.0,1216.0,1236.0,989.0,1060.0,1076.0,1103.0,13734.0
Udupi,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,107.0,117.0,156.0,138.0,116.0,102.0,131.0,150.0,80.0,93.0,122.0,114.0,1426.0
Udupi,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1127.0,1290.0,1136.0,1115.0,1084.0,1045.0,1199.0,1246.0,941.0,1073.0,1095.0,1084.0,13435.0
Udupi,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4.0,4.0
Udupi,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,88.0,103.0,118.0,101.0,95.0,95.0,87.0,93.0,104.0,90.0,87.0,78.0,1139.0
Udupi,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,88.0,103.0,118.0,101.0,95.0,95.0,87.0,93.0,104.0,90.0,87.0,82.0,1143.0
Udupi,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,274.0,328.0,302.0,237.0,411.0,302.0,516.0,222.0,175.0,415.0,262.0,115.0,3559.0
Udupi,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,473.0,277.0,541.0,287.0,433.0,267.0,426.0,238.0,274.0,330.0,288.0,261.0,4095.0
Udupi,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,1.0,2.0,11.0,21.0,10.0,7.0,6.0,3.0,1.0,7.0,2.0,72.0,143.0
Udupi,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,260.0,257.0,356.0,219.0,302.0,247.0,290.0,227.0,222.0,384.0,329.0,231.0,3324.0
Udupi,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,39.0,50.0,66.0,52.0,76.0,87.0,79.0,56.0,61.0,69.0,58.0,92.0,785.0
Udupi,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1020.0,1203.0,1053.0,916.0,923.0,938.0,1114.0,822.0,903.0,912.0,901.0,1005.0,11710.0
Udupi,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1401.0,1343.0,1436.0,1273.0,1274.0,1273.0,1397.0,1266.0,1408.0,1223.0,1245.0,1378.0,15917.0
Udupi,6.3,PNC maternal complications attended,TOTAL,43.0,4.0,43.0,13.0,15.0,19.0,9.0,13.0,4.0,12.0,12.0,8.0,195.0
Udupi,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,3.0,3.0,2.0,3.0,5.0,2.0,6.0,3.0,5.0,6.0,5.0,47.0
Udupi,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,3.0,1.0,0.0,1.0,2.0,5.0,4.0,3.0,3.0,0.0,4.0,26.0
Udupi,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,6.0,4.0,2.0,4.0,7.0,7.0,10.0,6.0,8.0,6.0,9.0,73.0
Udupi,7.2,Number of MTPs conducted at Private Facilities,TOTAL,71.0,108.0,74.0,65.0,54.0,84.0,71.0,64.0,49.0,79.0,72.0,52.0,843.0
Udupi,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,232.0,172.0,145.0,120.0,136.0,189.0,137.0,132.0,103.0,213.0,161.0,139.0,1879.0
Udupi,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,277.0,256.0,316.0,344.0,342.0,423.0,263.0,238.0,261.0,311.0,310.0,326.0,3667.0
Udupi,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,509.0,428.0,461.0,464.0,478.0,612.0,400.0,370.0,364.0,524.0,471.0,465.0,5546.0
Udupi,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,14.0,0.0,0.0,0.0,0.0,15.0
Udupi,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,1.0,1.0,0.0,2.0,0.0,1.0,2.0,1.0,1.0,0.0,0.0,9.0
Udupi,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,1.0,1.0,0.0,2.0,0.0,1.0,2.0,1.0,1.0,0.0,0.0,9.0
Udupi,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,2.0,1.0,0.0,5.0
Udupi,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,56.0,54.0,24.0,25.0,48.0,29.0,22.0,21.0,16.0,16.0,6.0,17.0,334.0
Udupi,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,56.0,54.0,24.0,25.0,48.0,29.0,22.0,21.0,16.0,16.0,6.0,17.0,334.0
Udupi,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,80.0,43.0,47.0,81.0,33.0,52.0,50.0,56.0,34.0,35.0,24.0,65.0,600.0
Udupi,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,9.0,6.0,0.0,13.0,0.0,7.0,9.0,0.0,7.0,7.0,6.0,64.0
Udupi,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,0.0,67.0,54.0,0.0,78.0,77.0,0.0,70.0,0.0,51.0,66.0,2.0,465.0
Udupi,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,0.0,76.0,60.0,0.0,91.0,77.0,7.0,79.0,0.0,58.0,73.0,8.0,529.0
Udupi,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,325.0,386.0,400.0,362.0,361.0,370.0,409.0,403.0,386.0,392.0,351.0,292.0,4437.0
Udupi,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,5.0,2.0,1.0,0.0,2.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,11.0
Udupi,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,140.0,138.0,93.0,126.0,122.0,129.0,162.0,119.0,117.0,128.0,136.0,78.0,1488.0
Udupi,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,145.0,140.0,94.0,126.0,124.0,129.0,162.0,119.0,117.0,129.0,136.0,78.0,1499.0
Udupi,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,133.0,140.0,141.0,130.0,168.0,137.0,110.0,80.0,94.0,116.0,122.0,77.0,1448.0
Udupi,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,17.0,11.0,9.0,34.0,14.0,21.0,12.0,15.0,14.0,8.0,11.0,12.0,178.0
Udupi,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,64.0,54.0,70.0,82.0,57.0,55.0,46.0,57.0,39.0,47.0,51.0,36.0,658.0
Udupi,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,12.0,12.0,14.0,14.0,13.0,12.0,11.0,15.0,18.0,9.0,11.0,6.0,147.0
Udupi,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,64.0,95.0,96.0,120.0,115.0,130.0,153.0,109.0,102.0,71.0,88.0,138.0,1281.0
Udupi,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Udupi,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,157.0,172.0,189.0,250.0,199.0,218.0,222.0,196.0,173.0,135.0,161.0,192.0,2264.0
Udupi,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,45.0,74.0,81.0,107.0,107.0,111.0,143.0,93.0,88.0,66.0,83.0,162.0,1160.0
Udupi,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,308.0,412.0,443.0,476.0,427.0,447.0,418.0,444.0,417.0,396.0,406.0,395.0,4989.0
Udupi,9.06,Number of IUCD removals,TOTAL,105.0,131.0,134.0,96.0,80.0,94.0,109.0,108.0,101.0,112.0,92.0,91.0,1253.0
Udupi,9.07,Number of Oral Pills cycles distributed,TOTAL,3727.0,3280.0,3300.0,3367.0,3287.0,3234.0,3593.0,3503.0,3510.0,3641.0,3385.0,3658.0,41485.0
Udupi,9.08,Number of Condom pieces distributed,TOTAL,44091.0,44168.0,47186.0,47477.0,45932.0,48774.0,49545.0,46930.0,44007.0,46464.0,43413.0,45965.0,553952.0
Udupi,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,11.0,6.0,8.0,10.0,15.0,6.0,11.0,7.0,8.0,9.0,5.0,8.0,104.0
Udupi,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,1.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Udupi,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Udupi,9.11.2.b,Number of failures following female sterilization,TOTAL,1.0,1.0,0.0,1.0,0.0,2.0,0.0,0.0,2.0,0.0,1.0,3.0,11.0
Udupi,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,9.12,Number of Institutions having NSV trained doctors,TOTAL,28.0,26.0,26.0,35.0,31.0,30.0,31.0,28.0,29.0,28.0,29.0,30.0,-1.0
Udupi,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,1410.0,1414.0,1352.0,1256.0,1141.0,1199.0,1301.0,1347.0,1026.0,1120.0,1153.0,1146.0,14865.0
Udupi,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,281.0,214.0,209.0,293.0,62.0,180.0,37.0,97.0,45.0,150.0,70.0,60.0,1698.0
Udupi,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,202.0,132.0,177.0,324.0,67.0,134.0,42.0,88.0,41.0,127.0,57.0,44.0,1435.0
Udupi,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,198.0,128.0,167.0,229.0,79.0,109.0,40.0,81.0,46.0,116.0,48.0,50.0,1291.0
Udupi,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,1253.0,1316.0,1226.0,1359.0,1281.0,1254.0,1248.0,1334.0,1135.0,1364.0,1194.0,1102.0,15066.0
Udupi,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1121.0,1201.0,1226.0,1509.0,1311.0,1319.0,1250.0,1213.0,1109.0,1308.0,1341.0,1220.0,15128.0
Udupi,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1079.0,1024.0,1168.0,1366.0,1393.0,1397.0,1250.0,1284.0,1025.0,1249.0,1279.0,1310.0,14824.0
Udupi,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1296.0,1321.0,1285.0,1100.0,1103.0,1095.0,1214.0,1233.0,1003.0,1061.0,1086.0,1116.0,13913.0
Udupi,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1496.0,1572.0,1424.0,1374.0,1082.0,1174.0,1028.0,1116.0,1270.0,1273.0,1030.0,971.0,14810.0
Udupi,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1307.0,1337.0,1391.0,1554.0,1136.0,1183.0,1064.0,1029.0,1188.0,1270.0,1157.0,1075.0,14691.0
Udupi,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1249.0,1117.0,1335.0,1373.0,1264.0,1255.0,1059.0,1106.0,1098.0,1155.0,1097.0,1146.0,14254.0
Udupi,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,490.0,544.0,973.0,637.0,804.0,657.0,784.0,653.0,758.0,499.0,628.0,853.0,8280.0
Udupi,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,260.0,202.0,138.0,139.0,91.0,128.0,33.0,119.0,114.0,113.0,63.0,33.0,1433.0
Udupi,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,208.0,116.0,159.0,187.0,109.0,180.0,39.0,61.0,63.0,93.0,49.0,24.0,1288.0
Udupi,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,169.0,125.0,127.0,103.0,141.0,102.0,23.0,68.0,69.0,68.0,45.0,36.0,1076.0
Udupi,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1274.0,1262.0,1274.0,1345.0,1321.0,1205.0,1255.0,1253.0,1243.0,1416.0,1386.0,1271.0,15505.0
Udupi,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,793.0,919.0,957.0,1165.0,1019.0,894.0,1078.0,1041.0,906.0,1103.0,938.0,930.0,11743.0
Udupi,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,606.0,571.0,560.0,600.0,568.0,552.0,606.0,571.0,535.0,636.0,616.0,568.0,6989.0
Udupi,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,526.0,528.0,499.0,564.0,548.0,514.0,559.0,494.0,582.0,646.0,591.0,552.0,6603.0
Udupi,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1132.0,1099.0,1059.0,1164.0,1116.0,1066.0,1165.0,1065.0,1117.0,1282.0,1207.0,1120.0,13592.0
Udupi,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1037.0,1116.0,1251.0,1267.0,1164.0,1129.0,1284.0,1149.0,1150.0,1192.0,1096.0,1141.0,13976.0
Udupi,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1027.0,1116.0,1245.0,1261.0,1159.0,1126.0,1280.0,1155.0,1102.0,1232.0,1084.0,1141.0,13928.0
Udupi,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,112.0,245.0,184.0,211.0,50.0,224.0,120.0,96.0,120.0,134.0,171.0,66.0,1733.0
Udupi,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,279.0,246.0,278.0,305.0,258.0,283.0,316.0,276.0,325.0,292.0,277.0,295.0,3430.0
Udupi,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,255.0,253.0,278.0,269.0,244.0,308.0,275.0,264.0,288.0,291.0,261.0,271.0,3257.0
Udupi,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,534.0,499.0,556.0,574.0,502.0,591.0,591.0,540.0,613.0,583.0,538.0,566.0,6687.0
Udupi,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,191.0,276.0,189.0,765.0,818.0,828.0,280.0,711.0,679.0,573.0,836.0,119.0,6265.0
Udupi,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,101.0,129.0,106.0,759.0,813.0,846.0,182.0,733.0,625.0,503.0,924.0,105.0,5826.0
Udupi,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,15.0,46.0,33.0,699.0,839.0,810.0,27.0,999.0,1004.0,480.0,686.0,26.0,5664.0
Udupi,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,1.0,0.0,4.0,1.0,0.0,2.0,0.0,4.0,0.0,2.0,0.0,0.0,14.0
Udupi,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,1.0
Udupi,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,3.0,7.0,5.0,1.0,4.0,3.0,3.0,6.0,2.0,3.0,6.0,1.0,44.0
Udupi,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,657.0,673.0,666.0,719.0,655.0,720.0,690.0,674.0,684.0,669.0,663.0,617.0,8087.0
Udupi,10.4.2,Number of Immunisation sessions held during the month,TOTAL,652.0,663.0,658.0,718.0,646.0,682.0,693.0,672.0,683.0,663.0,659.0,610.0,7999.0
Udupi,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,422.0,417.0,412.0,454.0,415.0,437.0,437.0,425.0,455.0,439.0,445.0,408.0,5166.0
Udupi,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,982.0,1173.0,1111.0,1127.0,1522.0,1017.0,1065.0,999.0,983.0,1127.0,1228.0,1257.0,13591.0
Udupi,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,19.0,13.0,8.0,143.0,14166.0,19.0,13.0,38.0,43.0,68.0,7556.0,4661.0,26747.0
Udupi,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,13.0,3.0,3.0,126.0,15095.0,2.0,3.0,0.0,4.0,2.0,7726.0,5953.0,28930.0
Udupi,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,9.0,9.0,4.0,4.0,2.0,7.0,7.0,13.0,3.0,10.0,8.0,4.0,80.0
Udupi,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,597.0,758.0,746.0,753.0,570.0,486.0,445.0,459.0,1109.0,586.0,572.0,437.0,7518.0
Udupi,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,10.0,12.0,15.0,22.0,7.0,9.0,11.0,6.0,12.0,3.0,6.0,9.0,122.0
Udupi,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,163.0,198.0,155.0,237.0,375.0,308.0,190.0,189.0,197.0,213.0,211.0,144.0,2580.0
Udupi,13.1,Number of Patients operated for cataract,TOTAL,298.0,356.0,151.0,425.0,129.0,150.0,423.0,444.0,492.0,119.0,377.0,358.0,3722.0
Udupi,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,298.0,356.0,151.0,425.0,129.0,150.0,422.0,415.0,492.0,119.0,377.0,358.0,3692.0
Udupi,13.3,Number of School children detected with Refractive errors,TOTAL,62.0,51.0,65.0,111.0,131.0,1625.0,488.0,81.0,124.0,127.0,180.0,38.0,3083.0
Udupi,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,3.0,0.0,0.0,0.0,49.0,0.0,27.0,6.0,0.0,42.0,127.0
Udupi,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,6.0,6.0,7.0,6.0,8.0,5.0,5.0,5.0,7.0,6.0,5.0,6.0,-1.0
Udupi,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,15.0,19.0,15.0,19.0,19.0,23.0,24.0,19.0,18.0,15.0,16.0,21.0,-1.0
Udupi,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,354.0,313.0,341.0,350.0,341.0,351.0,326.0,326.0,324.0,340.0,348.0,359.0,-1.0
Udupi,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,8.0,10.0,7.0,7.0,8.0,8.0,8.0,9.0,8.0,8.0,7.0,-1.0
Udupi,14.05,Number of RKS meetings held during the month,TOTAL,5.0,14.0,16.0,14.0,8.0,11.0,9.0,11.0,14.0,15.0,21.0,22.0,160.0
Udupi,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,30.0,32.0,33.0,35.0,35.0,36.0,34.0,30.0,31.0,31.0,30.0,30.0,-1.0
Udupi,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,247.0,325.0,247.0,438.0,280.0,267.0,224.0,220.0,252.0,201.0,266.0,349.0,3316.0
Udupi,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,5.0,5.0,6.0,4.0,7.0,4.0,4.0,4.0,6.0,7.0,6.0,7.0,-1.0
Udupi,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,14.0,10.0,13.0,8.0,12.0,19.0,22.0,9.0,13.0,9.0,13.0,13.0,-1.0
Udupi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,898.0,853.0,1586.0,1641.0,2029.0,1906.0,1583.0,688.0,763.0,1466.0,1567.0,1435.0,16415.0
Udupi,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,3297.0,3604.0,7401.0,7163.0,7405.0,7333.0,6967.0,3279.0,3483.0,6566.0,6235.0,6165.0,68898.0
Udupi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,829.0,834.0,1212.0,1342.0,1678.0,1444.0,1251.0,645.0,730.0,1197.0,1305.0,1044.0,13511.0
Udupi,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4566.0,5056.0,7236.0,7087.0,6907.0,7300.0,7282.0,4517.0,4557.0,6758.0,7169.0,6610.0,75045.0
Udupi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1727.0,1687.0,2798.0,2983.0,3707.0,3350.0,2834.0,1333.0,1493.0,2663.0,2872.0,2479.0,29926.0
Udupi,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,7863.0,8660.0,14637.0,14250.0,14312.0,14633.0,14249.0,7796.0,8040.0,13324.0,13404.0,12775.0,143943.0
Udupi,14.10.2.a,Number of death cases of Inpatient males,TOTAL,69.0,67.0,131.0,159.0,170.0,173.0,141.0,56.0,59.0,175.0,158.0,165.0,1523.0
Udupi,14.10.2.b,Number of death cases of Inpatient females,TOTAL,40.0,31.0,80.0,73.0,82.0,99.0,84.0,34.0,40.0,89.0,84.0,63.0,799.0
Udupi,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,109.0,98.0,211.0,232.0,252.0,272.0,225.0,90.0,99.0,264.0,242.0,228.0,2322.0
Udupi,14.11,In-Patient Head Count at midnight,TOTAL,11776.0,12381.0,12711.0,15731.0,15536.0,13495.0,14283.0,8409.0,11341.0,15996.0,13855.0,12043.0,157557.0
Udupi,14.12.1,OPD attendance (All),TOTAL,153384.0,160206.0,231277.0,246682.0,249329.0,247672.0,219994.0,156678.0,164366.0,210299.0,224293.0,205127.0,2469307.0
Udupi,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,1363.0,1679.0,3367.0,3314.0,2967.0,3267.0,3296.0,1481.0,1513.0,3002.0,2903.0,2747.0,30899.0
Udupi,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,13.0,11.0,17.0,10.0,17.0,22.0,9.0,6.0,13.0,6.0,10.0,6.0,140.0
Udupi,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,819.0,1131.0,1788.0,1676.0,1741.0,1682.0,1757.0,823.0,863.0,1583.0,1499.0,1230.0,16592.0
Udupi,14.14.a,Number of patients given AYUSH treatment,TOTAL,2079.0,2700.0,4528.0,4949.0,3199.0,4740.0,3900.0,2231.0,2176.0,2857.0,5704.0,3829.0,42892.0
Udupi,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2655.0,2507.0,3078.0,3047.0,3141.0,3088.0,2664.0,2686.0,2284.0,2793.0,3148.0,1579.0,32670.0
Udupi,14.14.c,Number of Adolescents counselled,TOTAL,327.0,313.0,261.0,411.0,404.0,271.0,330.0,392.0,353.0,292.0,390.0,232.0,3976.0
Udupi,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,11432.0,11801.0,29186.0,34287.0,34143.0,34606.0,33338.0,15973.0,15673.0,32859.0,33378.0,31945.0,318621.0
Udupi,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,239.0,204.0,782.0,875.0,885.0,900.0,812.0,284.0,330.0,845.0,809.0,1093.0,8058.0
Udupi,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,1947.0,1941.0,2826.0,2857.0,2701.0,2997.0,2636.0,2445.0,2292.0,3027.0,3157.0,3036.0,31862.0
Udupi,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,34.0,25.0,82.0,60.0,43.0,65.0,61.0,75.0,36.0,60.0,58.0,57.0,656.0
Udupi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1090.0,1440.0,1558.0,1700.0,1632.0,1814.0,1672.0,1422.0,1438.0,1591.0,1893.0,1846.0,19096.0
Udupi,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,14.0,20.0,35.0,40.0,18.0,36.0,28.0,28.0,13.0,25.0,24.0,30.0,311.0
Udupi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,1327.0,1386.0,1524.0,1514.0,1597.0,1664.0,1391.0,1517.0,1361.0,1406.0,1470.0,1503.0,17660.0
Udupi,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,2.0,1.0,3.0,11.0,8.0,3.0,1.0,34.0,11.0,11.0,0.0,2.0,87.0
Udupi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4364.0,4767.0,5908.0,6071.0,5930.0,6475.0,5699.0,5384.0,5091.0,6024.0,6520.0,6385.0,68618.0
Udupi,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,50.0,46.0,120.0,111.0,69.0,104.0,90.0,137.0,60.0,96.0,82.0,89.0,1054.0
Udupi,15.2,Number of Widal tests conducted,Number tested,1090.0,1302.0,1763.0,2266.0,2585.0,2611.0,1909.0,1419.0,1516.0,1887.0,2121.0,1046.0,21515.0
Udupi,15.3.a,Number of VDRL tests conducted on males,Number tested,114.0,103.0,81.0,136.0,195.0,479.0,200.0,95.0,227.0,207.0,164.0,147.0,2148.0
Udupi,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,223.0,138.0,228.0,450.0,416.0,233.0,476.0,148.0,121.0,446.0,405.0,462.0,3746.0
Udupi,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1071.0,1030.0,1336.0,1073.0,999.0,1264.0,1017.0,1033.0,970.0,834.0,803.0,967.0,12397.0
Udupi,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1408.0,1271.0,1645.0,1659.0,1610.0,1976.0,1693.0,1276.0,1318.0,1487.0,1372.0,1576.0,18291.0
Udupi,15.4.1,Number of blood smears examined for Malaria,TOTAL,10870.0,12880.0,18643.0,20183.0,19723.0,22057.0,14600.0,16224.0,16009.0,13599.0,14407.0,14452.0,193647.0
Udupi,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,156.0,437.0,404.0,449.0,455.0,407.0,368.0,291.0,261.0,196.0,145.0,127.0,3696.0
Udupi,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,14.0,20.0,37.0,58.0,67.0,46.0,54.0,43.0,24.0,27.0,35.0,32.0,457.0
Udupi,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,810.0,3440.0,4660.0,9880.0,5280.0,6830.0,8240.0,7360.0,8150.0,6300.0,4500.0,2510.0,67960.0
Udupi,16.1.1,Stock position of DPT vaccines,2. Stocks Received,4000.0,4000.0,12500.0,0.0,5000.0,5000.0,0.0,2000.0,0.0,0.0,,,32500.0
Udupi,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1370.0,2780.0,7280.0,4600.0,3450.0,3590.0,880.0,1210.0,1850.0,1800.0,1990.0,1620.0,32420.0
Udupi,16.1.1,Stock position of DPT vaccines,5. Total Stock,3440.0,4660.0,9880.0,5280.0,6830.0,8240.0,7360.0,8150.0,6300.0,4500.0,2510.0,890.0,68040.0
Udupi,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,3720.0,7490.0,6100.0,6560.0,3210.0,2790.0,4930.0,5890.0,5660.0,3260.0,3740.0,3640.0,56990.0
Udupi,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,7540.0,2000.0,3000.0,0.0,3000.0,6000.0,3000.0,3000.0,0.0,3000.0,3000.0,2000.0,35540.0
Udupi,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,3770.0,3390.0,2540.0,3350.0,3420.0,3860.0,2040.0,3230.0,2400.0,2520.0,3100.0,3300.0,36920.0
Udupi,16.1.1A,Stock Position of Pentavalent,5. Total Stock,7490.0,6100.0,6560.0,3210.0,2790.0,4930.0,5890.0,5660.0,3260.0,3740.0,3640.0,2340.0,55610.0
Udupi,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,680.0,15100.0,10300.0,10480.0,4480.0,660.0,2320.0,4360.0,14000.0,3740.0,3840.0,4720.0,74680.0
Udupi,16.1.2,Stock position of OPV vaccines,2. Stocks Received,25480.0,5000.0,10000.0,0.0,0.0,12000.0,12000.0,14000.0,0.0,8000.0,4800.0,5000.0,96280.0
Udupi,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,11060.0,9800.0,9820.0,6000.0,3820.0,10340.0,9960.0,4360.0,10260.0,7900.0,3920.0,5640.0,92880.0
Udupi,16.1.2,Stock position of OPV vaccines,5. Total Stock,15100.0,10300.0,10480.0,4480.0,660.0,2320.0,4360.0,14000.0,3740.0,3840.0,4720.0,4080.0,78080.0
Udupi,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,160.0,10290.0,11210.0,10010.0,2970.0,7610.0,10110.0,9330.0,10310.0,40.0,4140.0,6490.0,82670.0
Udupi,16.1.3,Stock position of TT vaccines,2. Stocks Received,16410.0,8000.0,10000.0,0.0,12500.0,12000.0,2500.0,7500.0,0.0,12500.0,8000.0,5000.0,94410.0
Udupi,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.3,Stock position of TT vaccines,4. Stock Distributed,6280.0,7080.0,11200.0,7040.0,7860.0,9500.0,3280.0,6520.0,10270.0,8400.0,5650.0,6700.0,89780.0
Udupi,16.1.3,Stock position of TT vaccines,5. Total Stock,10290.0,11210.0,10010.0,2970.0,7610.0,10110.0,9330.0,10310.0,40.0,4140.0,6490.0,4790.0,87300.0
Udupi,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,3280.0,4130.0,4120.0,4970.0,4410.0,4840.0,6340.0,4520.0,4660.0,3280.0,4000.0,2390.0,50940.0
Udupi,16.1.5,Stock position of BCG vaccines,2. Stocks Received,3000.0,3000.0,4000.0,0.0,2000.0,3000.0,0.0,3000.0,0.0,2000.0,,2000.0,22000.0
Udupi,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,2150.0,3010.0,3150.0,560.0,1570.0,1500.0,1820.0,2860.0,1380.0,1280.0,1610.0,2440.0,23330.0
Udupi,16.1.5,Stock position of BCG vaccines,5. Total Stock,4130.0,4120.0,4970.0,4410.0,4840.0,6340.0,4520.0,4660.0,3280.0,4000.0,2390.0,1950.0,49610.0
Udupi,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,0.0,3850.0,2980.0,5085.0,1765.0,2630.0,2680.0,3025.0,3985.0,180.0,2625.0,2180.0,30985.0
Udupi,16.1.6,Stock position of Measles vaccines,2. Stocks Received,8000.0,3000.0,5000.0,0.0,3000.0,3000.0,2000.0,4000.0,0.0,5000.0,2000.0,2000.0,37000.0
Udupi,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,4150.0,3870.0,2895.0,3320.0,2135.0,2950.0,1655.0,3040.0,3805.0,2555.0,2445.0,2775.0,35595.0
Udupi,16.1.6,Stock position of Measles vaccines,5. Total Stock,3850.0,2980.0,5085.0,1765.0,2630.0,2680.0,3025.0,3985.0,180.0,2625.0,2180.0,1405.0,32390.0
Udupi,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,2860.0,2620.0,1180.0,930.0,790.0,410.0,1030.0,780.0,3460.0,2610.0,2200.0,1520.0,20390.0
Udupi,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,0.0,30.0,0.0,60.0,160.0,920.0,0.0,3000.0,0.0,0.0,,1000.0,5170.0
Udupi,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,240.0,1470.0,250.0,200.0,540.0,300.0,250.0,320.0,850.0,410.0,680.0,620.0,6130.0
Udupi,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,2620.0,1180.0,930.0,790.0,410.0,1030.0,780.0,3460.0,2610.0,2200.0,1520.0,1900.0,19430.0
Udupi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,1195.0,960.0,1735.0,1160.0,660.0,1665.0,1140.0,840.0,585.0,285.0,35.0,2950.0,13210.0
Udupi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,1200.0,0.0,0.0,1200.0,0.0,0.0,0.0,0.0,0.0,3000.0,,5400.0
Udupi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,235.0,425.0,575.0,500.0,195.0,525.0,300.0,255.0,300.0,250.0,85.0,950.0,4595.0
Udupi,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,960.0,1735.0,1160.0,660.0,1665.0,1140.0,840.0,585.0,285.0,35.0,2950.0,2000.0,14015.0
Udupi,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,162200.0,139960.0,117280.0,89560.0,215560.0,191200.0,139960.0,123580.0,100480.0,74440.0,40420.0,104620.0,1499260.0
Udupi,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,151200.0,0.0,0.0,0.0,0.0,0.0,,85200.0,,236400.0
Udupi,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,22240.0,22680.0,27720.0,25200.0,24360.0,51240.0,16380.0,23100.0,26040.0,34020.0,21000.0,18080.0,312060.0
Udupi,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,139960.0,117280.0,89560.0,215560.0,191200.0,139960.0,123580.0,100480.0,74440.0,40420.0,104620.0,86540.0,1423600.0
Udupi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,,10000.0
Udupi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10000.0,,10000.0
Udupi,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,,5000.0
Udupi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5000.0,,5000.0
Udupi,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,500.0,500.0,500.0,200.0,700.0,700.0,700.0,700.0,700.0,700.0,700.0,500.0,7100.0
Udupi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,,,500.0
Udupi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,200.0,,500.0
Udupi,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,500.0,500.0,200.0,700.0,700.0,700.0,700.0,700.0,700.0,700.0,500.0,500.0,7100.0
Udupi,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,32282.0,21162.0,,53444.0
Udupi,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,32282.0,0.0,,,32282.0
Udupi,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,11120.0,21162.0,,32282.0
Udupi,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,32282.0,21162.0,0.0,0.0,53444.0
Udupi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Udupi,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,,100.0,100.0,100.0,100.0,100.0,100.0,85.0,14.0,699.0
Udupi,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,500.0,0.0,0.0,0.0,0.0,0.0,0.0,734.0,,1234.0
Udupi,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,400.0,0.0,0.0,0.0,0.0,0.0,15.0,805.0,10.0,1230.0
Udupi,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,100.0,100.0,100.0,100.0,100.0,100.0,85.0,14.0,4.0,703.0
Udupi,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,,23300.0,67596.0,26196.0,0.0,0.0,,,,117092.0
Udupi,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,66500.0,67596.0,0.0,0.0,0.0,,,,,134096.0
Udupi,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,,,,,0.0
Udupi,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,43200.0,23300.0,41400.0,26196.0,0.0,,,,,134096.0
Udupi,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,23300.0,67596.0,26196.0,0.0,0.0,0.0,0.0,0.0,0.0,117092.0
Udupi,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,3160.0,7390.0,8400.0,9940.0,9190.0,7090.0,5390.0,4870.0,6570.0,5870.0,1930.0,4480.0,74280.0
Udupi,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,6000.0,3000.0,3300.0,,0.0,0.0,0.0,3300.0,0.0,0.0,3300.0,3300.0,22200.0
Udupi,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1770.0,1990.0,1760.0,750.0,2100.0,1700.0,520.0,1600.0,700.0,3940.0,750.0,660.0,18240.0
Udupi,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,7390.0,8400.0,9940.0,9190.0,7090.0,5390.0,4870.0,6570.0,5870.0,1930.0,4480.0,7120.0,78240.0
Udupi,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,7830.0,20730.0,24200.0,15450.0,5300.0,4150.0,1250.0,13400.0,15510.0,4010.0,6620.0,9140.0,127590.0
Udupi,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,24000.0,9600.0,4800.0,,12000.0,7200.0,19200.0,14000.0,0.0,16800.0,10000.0,7200.0,124800.0
Udupi,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,11100.0,6130.0,13550.0,10150.0,13150.0,10100.0,7050.0,11890.0,11500.0,14190.0,7480.0,7350.0,123640.0
Udupi,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,20730.0,24200.0,15450.0,5300.0,4150.0,1250.0,13400.0,15510.0,4010.0,6620.0,9140.0,8990.0,128750.0
Udupi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,7000.0,7000.0,6800.0,2300.0,2200.0,2200.0,2200.0,2200.0,2200.0,2200.0,1400.0,1200.0,38900.0
Udupi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,0.0,,,0.0
Udupi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,,0.0,0.0,0.0,0.0,0.0,,,,0.0
Udupi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,200.0,4500.0,100.0,0.0,0.0,0.0,0.0,0.0,800.0,200.0,600.0,6400.0
Udupi,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,7000.0,6800.0,2300.0,2200.0,2200.0,2200.0,2200.0,2200.0,2200.0,1400.0,1200.0,600.0,32500.0
Udupi,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,1.0,,,,1.0,,,,,2.0
Udupi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,2.0,1.0,1.0,3.0,,1.0,1.0,1.0,,,4.0,15.0
Udupi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udupi,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,2.0,1.0,1.0,3.0,,1.0,1.0,1.0,,,4.0,15.0
Udupi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,,1.0,,1.0,3.0,1.0,1.0,2.0,2.0,,2.0,4.0,17.0
Udupi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Udupi,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,,1.0,,1.0,3.0,1.0,1.0,2.0,2.0,,2.0,4.0,17.0
Udupi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,,,2.0,,1.0,,1.0,1.0,1.0,,1.0,8.0
Udupi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,1.0,,,,,,1.0
Udupi,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,,,2.0,,1.0,1.0,1.0,1.0,1.0,,1.0,9.0
Udupi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,,2.0,,1.0,2.0,,,,,1.0,6.0
Udupi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,1.0,,,,1.0
Udupi,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,,,,2.0,,1.0,2.0,,1.0,,,1.0,7.0
Udupi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udupi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udupi,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,,,,,,,,,,,,,
Udupi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udupi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udupi,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Udupi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udupi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udupi,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,,,,,,,,
Udupi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Udupi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Udupi,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Udupi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,,,,1.0,3.0,2.0,,,,,,,6.0
Udupi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,,,,1.0,,1.0,,1.0,1.0,4.0
Udupi,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,,,,1.0,3.0,2.0,1.0,,1.0,,1.0,1.0,10.0
Udupi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,1.0,,,1.0
Udupi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,1.0,1.0,,1.0,,,,,,3.0
Udupi,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,1.0,1.0,,1.0,,,1.0,,,4.0
Udupi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,3.0,5.0,1.0,5.0,4.0,5.0,4.0,4.0,1.0,2.0,5.0,43.0
Udupi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,2.0,2.0,6.0,3.0,2.0,,2.0,,1.0,4.0,1.0,,23.0
Udupi,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,6.0,5.0,11.0,4.0,7.0,4.0,7.0,4.0,5.0,5.0,3.0,5.0,66.0
Udupi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,1.0,2.0,,2.0,,,,,1.0,,6.0
Udupi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,2.0,3.0,13.0,11.0,15.0,10.0,9.0,4.0,1.0,7.0,7.0,8.0,90.0
Udupi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,21.0,16.0,24.0,39.0,25.0,31.0,39.0,19.0,13.0,30.0,20.0,25.0,302.0
Udupi,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,23.0,19.0,38.0,52.0,40.0,43.0,48.0,23.0,14.0,37.0,28.0,33.0,398.0
Udupi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,1.0,,,1.0,1.0,,,,,,3.0
Udupi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,1.0,,,,1.0,,,,,,,,2.0
Udupi,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,1.0,,1.0,,1.0,1.0,1.0,,,,,,5.0
Udupi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Udupi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,,3.0,5.0,4.0,1.0,,,1.0,2.0,,16.0
Udupi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,1.0,1.0,,2.0,1.0,1.0,1.0,1.0,2.0,,2.0,1.0,13.0
Udupi,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,1.0,1.0,1.0,5.0,6.0,5.0,2.0,1.0,2.0,1.0,4.0,1.0,30.0
Udupi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,1.0,,,,,,,,,,1.0
Udupi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,3.0,5.0,4.0,7.0,4.0,6.0,3.0,,6.0,4.0,3.0,48.0
Udupi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,2.0,1.0,1.0,,,2.0,,1.0,,1.0,2.0,1.0,11.0
Udupi,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,5.0,4.0,7.0,4.0,7.0,6.0,6.0,4.0,,7.0,6.0,4.0,60.0
Udupi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,1.0,,2.0,,,,,,,,3.0
Udupi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,14.0,18.0,24.0,31.0,27.0,30.0,31.0,25.0,19.0,41.0,29.0,29.0,318.0
Udupi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,94.0,79.0,120.0,124.0,130.0,132.0,97.0,124.0,92.0,121.0,105.0,95.0,1313.0
Udupi,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,108.0,97.0,145.0,155.0,159.0,162.0,128.0,149.0,111.0,162.0,134.0,124.0,1634.0
Udupi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,1.0,,1.0,3.0,1.0,,,,,,,,6.0
Udupi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,7.0,9.0,9.0,7.0,21.0,16.0,8.0,10.0,5.0,17.0,8.0,10.0,127.0
Udupi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,31.0,32.0,43.0,33.0,39.0,46.0,29.0,25.0,27.0,33.0,44.0,34.0,416.0
Udupi,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,39.0,41.0,53.0,43.0,61.0,62.0,37.0,35.0,32.0,50.0,52.0,44.0,549.0
Udupi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Udupi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Udupi,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Udupi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,,,,,,
Udupi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Udupi,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,,,,,,
Udupi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,1.0,,,,,1.0,1.0,,,,1.0,4.0
Udupi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Udupi,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,1.0,,,,,1.0,1.0,,,,1.0,4.0
Udupi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Udupi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Udupi,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Udupi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,1.0,1.0,,,1.0,,,,,,3.0
Udupi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Udupi,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,1.0,1.0,,,1.0,,,,,,3.0
Udupi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,,1.0,,,,1.0,1.0,4.0
Udupi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Udupi,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,,1.0,,,,1.0,1.0,4.0
Udupi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,1.0,,3.0,1.0,,,,1.0,,7.0
Udupi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,7.0,11.0,20.0,17.0,14.0,14.0,16.0,13.0,6.0,16.0,15.0,13.0,162.0
Udupi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,6.0,5.0,6.0,9.0,9.0,6.0,4.0,14.0,1.0,7.0,7.0,6.0,80.0
Udupi,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,13.0,17.0,26.0,27.0,23.0,23.0,21.0,27.0,7.0,23.0,23.0,19.0,249.0
Udupi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,,1.0,,1.0,,1.0,,,,,3.0
Udupi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,13.0,14.0,17.0,20.0,21.0,12.0,10.0,14.0,13.0,16.0,15.0,13.0,178.0
Udupi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,5.0,10.0,3.0,6.0,3.0,6.0,6.0,7.0,6.0,8.0,6.0,5.0,71.0
Udupi,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,18.0,24.0,20.0,27.0,24.0,19.0,16.0,22.0,19.0,24.0,21.0,18.0,252.0
Udupi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Udupi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,,,3.0,1.0,,1.0,1.0,1.0,,,,,7.0
Udupi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,4.0,2.0,,,,1.0,7.0
Udupi,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,,,3.0,1.0,,1.0,5.0,3.0,,,,1.0,14.0
Udupi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,,,,1.0,2.0,1.0,1.0,,2.0,2.0,1.0,10.0
Udupi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,9.0,8.0,27.0,37.0,35.0,43.0,30.0,16.0,16.0,34.0,23.0,21.0,299.0
Udupi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,27.0,30.0,47.0,57.0,50.0,61.0,51.0,29.0,21.0,68.0,52.0,43.0,536.0
Udupi,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,36.0,38.0,74.0,94.0,86.0,106.0,82.0,46.0,37.0,104.0,77.0,65.0,845.0
Udupi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,,1.0,1.0,,,1.0,,,,,,3.0
Udupi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,12.0,9.0,21.0,21.0,26.0,15.0,28.0,23.0,17.0,14.0,22.0,13.0,221.0
Udupi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,28.0,28.0,54.0,59.0,57.0,66.0,50.0,37.0,36.0,46.0,70.0,41.0,572.0
Udupi,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,40.0,37.0,76.0,81.0,83.0,81.0,79.0,60.0,53.0,60.0,92.0,54.0,796.0
Udupi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,,,,,,1.0,2.0,,4.0
Udupi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,14.0,10.0,16.0,12.0,15.0,10.0,19.0,21.0,14.0,12.0,13.0,13.0,169.0
Udupi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,43.0,54.0,74.0,71.0,101.0,87.0,78.0,91.0,66.0,98.0,70.0,69.0,902.0
Udupi,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,57.0,64.0,91.0,83.0,116.0,97.0,97.0,112.0,80.0,111.0,85.0,82.0,1075.0
Uttara Kannada,1.1,Total number of pregnant women Registered for ANC,TOTAL,1884.0,1531.0,1966.0,1935.0,1942.0,2139.0,1855.0,2068.0,1781.0,1846.0,1712.0,1710.0,22369.0
Uttara Kannada,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1572.0,1325.0,1631.0,1594.0,1661.0,1838.0,1600.0,1764.0,1540.0,1515.0,1402.0,1388.0,18830.0
Uttara Kannada,1.2,Number of Pregnant women registered under JSY,TOTAL,1348.0,1131.0,1430.0,1361.0,1397.0,1593.0,1378.0,1484.0,1286.0,1320.0,1221.0,1248.0,16197.0
Uttara Kannada,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2508.0,2210.0,2031.0,2151.0,1936.0,1967.0,2165.0,1730.0,2007.0,2205.0,1539.0,1993.0,24442.0
Uttara Kannada,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,1525.0,1410.0,1665.0,1620.0,1824.0,1940.0,1787.0,1868.0,1570.0,1604.0,1474.0,1457.0,19744.0
Uttara Kannada,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,1868.0,1677.0,1770.0,1823.0,1856.0,2039.0,2048.0,2020.0,1945.0,1790.0,1669.0,1570.0,22075.0
Uttara Kannada,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,1808.0,1523.0,1649.0,1532.0,1558.0,1633.0,1141.0,1194.0,1186.0,1356.0,1062.0,983.0,16625.0
Uttara Kannada,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,40.0,43.0,41.0,36.0,42.0,62.0,62.0,42.0,46.0,55.0,33.0,53.0,555.0
Uttara Kannada,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,3.0,3.0,5.0,3.0,4.0,9.0,4.0,6.0,4.0,5.0,7.0,6.0,59.0
Uttara Kannada,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1367.0,1416.0,1608.0,1779.0,1668.0,1411.0,1126.0,1734.0,1423.0,1424.0,1400.0,1323.0,17679.0
Uttara Kannada,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,45.0,41.0,105.0,41.0,44.0,37.0,36.0,42.0,89.0,63.0,59.0,69.0,671.0
Uttara Kannada,1.8,Number of pregnancy test kits used at SC level,TOTAL,464.0,400.0,430.0,403.0,439.0,487.0,377.0,463.0,449.0,591.0,497.0,516.0,5516.0
Uttara Kannada,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,6.0,6.0,3.0,5.0,5.0,6.0,9.0,5.0,8.0,4.0,6.0,2.0,65.0
Uttara Kannada,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,6.0,1.0,2.0,2.0,4.0,2.0,1.0,2.0,6.0,3.0,4.0,2.0,35.0
Uttara Kannada,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,12.0,7.0,5.0,7.0,9.0,8.0,10.0,7.0,14.0,7.0,10.0,4.0,100.0
Uttara Kannada,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,12.0,5.0,6.0,4.0,8.0,7.0,8.0,6.0,13.0,8.0,10.0,3.0,90.0
Uttara Kannada,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,2.0,2.0,1.0,0.0,6.0
Uttara Kannada,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1225.0,1216.0,1126.0,1013.0,953.0,942.0,1004.0,1016.0,985.0,989.0,1095.0,1169.0,12733.0
Uttara Kannada,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,226.0,180.0,245.0,196.0,119.0,136.0,140.0,215.0,220.0,174.0,22.0,42.0,1915.0
Uttara Kannada,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,791.0,679.0,847.0,673.0,736.0,922.0,657.0,894.0,774.0,875.0,866.0,950.0,9664.0
Uttara Kannada,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,10.0,4.0,3.0,0.0,12.0,10.0,10.0,25.0,44.0,25.0,85.0,228.0
Uttara Kannada,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,955.0,854.0,945.0,990.0,848.0,795.0,1041.0,916.0,915.0,830.0,827.0,859.0,10775.0
Uttara Kannada,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,257.0,283.0,254.0,196.0,217.0,196.0,236.0,224.0,206.0,206.0,237.0,243.0,2755.0
Uttara Kannada,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,257.0,283.0,254.0,196.0,217.0,196.0,236.0,224.0,206.0,206.0,237.0,243.0,2755.0
Uttara Kannada,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,341.0,264.0,297.0,307.0,278.0,235.0,352.0,314.0,290.0,188.0,254.0,261.0,3381.0
Uttara Kannada,4.1.1.a,Number of male live births,TOTAL,1124.0,1073.0,1078.0,1001.0,951.0,881.0,1054.0,976.0,916.0,969.0,986.0,1051.0,12060.0
Uttara Kannada,4.1.1.b,Number of female live births,TOTAL,1070.0,1003.0,991.0,1000.0,882.0,873.0,997.0,955.0,991.0,861.0,931.0,1002.0,11556.0
Uttara Kannada,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,2194.0,2076.0,2069.0,2001.0,1833.0,1754.0,2051.0,1931.0,1907.0,1830.0,1917.0,2053.0,23616.0
Uttara Kannada,4.1.2,Number of still births,TOTAL,11.0,11.0,20.0,14.0,6.0,13.0,24.0,17.0,12.0,13.0,23.0,21.0,185.0
Uttara Kannada,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,206.0,221.0,160.0,184.0,182.0,168.0,186.0,170.0,163.0,160.0,143.0,132.0,2075.0
Uttara Kannada,4.2.1,Number of Newborns weighed at birth,TOTAL,2195.0,1987.0,2067.0,2008.0,1827.0,1755.0,2045.0,1869.0,1925.0,1822.0,1821.0,2051.0,23372.0
Uttara Kannada,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,224.0,290.0,224.0,250.0,243.0,328.0,242.0,240.0,235.0,234.0,323.0,276.0,3109.0
Uttara Kannada,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1995.0,1849.0,1898.0,1939.0,1751.0,1525.0,1809.0,1697.0,1769.0,1657.0,1891.0,1893.0,21673.0
Uttara Kannada,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,0.0,0.0,7.0,1.0,5.0,6.0,0.0,9.0,1.0,7.0,7.0,9.0,52.0
Uttara Kannada,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Uttara Kannada,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,92.0,98.0,68.0,78.0,53.0,73.0,57.0,73.0,88.0,67.0,75.0,91.0,913.0
Uttara Kannada,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,92.0,98.0,75.0,79.0,58.0,79.0,57.0,82.0,89.0,74.0,82.0,101.0,966.0
Uttara Kannada,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,155.0,55.0,60.0,35.0,65.0,61.0,46.0,123.0,135.0,106.0,82.0,84.0,1007.0
Uttara Kannada,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,292.0,219.0,172.0,158.0,135.0,172.0,173.0,265.0,230.0,181.0,134.0,130.0,2261.0
Uttara Kannada,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,22.0,59.0,22.0,9.0,185.0,20.0,15.0,14.0,16.0,19.0,62.0,21.0,464.0
Uttara Kannada,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,190.0,303.0,282.0,186.0,220.0,195.0,107.0,255.0,198.0,358.0,162.0,147.0,2603.0
Uttara Kannada,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,68.0,22.0,15.0,24.0,18.0,15.0,26.0,23.0,27.0,19.0,18.0,20.0,295.0
Uttara Kannada,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1671.0,1557.0,1446.0,1425.0,1358.0,1453.0,1625.0,1616.0,1612.0,1450.0,1523.0,1531.0,18267.0
Uttara Kannada,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1626.0,1605.0,1520.0,1615.0,1540.0,1462.0,1505.0,1466.0,1606.0,1396.0,1764.0,1880.0,18985.0
Uttara Kannada,6.3,PNC maternal complications attended,TOTAL,11.0,47.0,30.0,14.0,4.0,4.0,6.0,9.0,20.0,26.0,33.0,25.0,229.0
Uttara Kannada,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,46.0,55.0,39.0,36.0,43.0,54.0,39.0,48.0,46.0,30.0,38.0,40.0,514.0
Uttara Kannada,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,4.0,13.0,16.0,15.0,2.0,5.0,2.0,7.0,13.0,21.0,9.0,7.0,114.0
Uttara Kannada,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,50.0,68.0,55.0,51.0,45.0,59.0,41.0,55.0,59.0,51.0,47.0,47.0,628.0
Uttara Kannada,7.2,Number of MTPs conducted at Private Facilities,TOTAL,88.0,96.0,66.0,95.0,79.0,56.0,92.0,70.0,76.0,64.0,47.0,62.0,891.0
Uttara Kannada,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,458.0,398.0,408.0,426.0,395.0,398.0,377.0,433.0,322.0,366.0,411.0,330.0,4722.0
Uttara Kannada,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,675.0,639.0,665.0,674.0,667.0,707.0,658.0,700.0,580.0,568.0,654.0,594.0,7781.0
Uttara Kannada,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,1133.0,1037.0,1073.0,1100.0,1062.0,1105.0,1035.0,1133.0,902.0,934.0,1065.0,924.0,12503.0
Uttara Kannada,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,1.0,1.0,1.0,27.0,0.0,0.0,3.0,0.0,2.0,2.0,16.0,2.0,55.0
Uttara Kannada,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,2.0,0.0,0.0,7.0,3.0,1.0,5.0,2.0,1.0,1.0,2.0,1.0,25.0
Uttara Kannada,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,2.0,0.0,0.0,7.0,3.0,1.0,5.0,2.0,1.0,1.0,2.0,1.0,25.0
Uttara Kannada,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0
Uttara Kannada,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,9.0,20.0,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,31.0
Uttara Kannada,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,11.0,15.0,8.0,4.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,38.0
Uttara Kannada,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,280.0,267.0,222.0,165.0,137.0,292.0,211.0,206.0,216.0,164.0,300.0,184.0,2644.0
Uttara Kannada,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,300.0,302.0,232.0,169.0,137.0,292.0,211.0,206.0,216.0,164.0,300.0,184.0,2713.0
Uttara Kannada,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,20.0,16.0,10.0,11.0,6.0,7.0,23.0,12.0,5.0,2.0,7.0,7.0,126.0
Uttara Kannada,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,4.0,4.0,4.0,2.0,3.0,5.0,1.0,2.0,0.0,3.0,5.0,3.0,36.0
Uttara Kannada,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,82.0,82.0,92.0,81.0,70.0,83.0,64.0,92.0,73.0,83.0,65.0,53.0,920.0
Uttara Kannada,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,86.0,86.0,96.0,83.0,73.0,88.0,65.0,94.0,73.0,86.0,70.0,56.0,956.0
Uttara Kannada,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,39.0,46.0,16.0,34.0,25.0,28.0,27.0,32.0,19.0,17.0,34.0,17.0,334.0
Uttara Kannada,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,2.0
Uttara Kannada,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,144.0,128.0,148.0,131.0,136.0,116.0,128.0,162.0,113.0,120.0,128.0,119.0,1573.0
Uttara Kannada,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,144.0,128.0,148.0,131.0,136.0,116.0,128.0,162.0,115.0,120.0,128.0,119.0,1575.0
Uttara Kannada,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,38.0,44.0,36.0,47.0,50.0,35.0,60.0,46.0,51.0,75.0,27.0,49.0,558.0
Uttara Kannada,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,32.0,34.0,30.0,63.0,34.0,39.0,56.0,49.0,53.0,44.0,15.0,14.0,463.0
Uttara Kannada,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,61.0,69.0,86.0,103.0,70.0,77.0,70.0,84.0,84.0,68.0,81.0,54.0,907.0
Uttara Kannada,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,1.0,4.0,1.0,0.0,2.0,5.0,3.0,3.0,0.0,1.0,9.0,8.0,37.0
Uttara Kannada,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,47.0,55.0,47.0,56.0,50.0,48.0,23.0,51.0,50.0,56.0,44.0,61.0,588.0
Uttara Kannada,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Uttara Kannada,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,141.0,162.0,164.0,222.0,156.0,169.0,152.0,187.0,187.0,169.0,149.0,137.0,1995.0
Uttara Kannada,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,30.0,4.0,21.0,42.0,12.0,5.0,21.0,1.0,3.0,2.0,15.0,14.0,170.0
Uttara Kannada,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,67.0,52.0,72.0,76.0,55.0,66.0,65.0,59.0,61.0,52.0,43.0,40.0,708.0
Uttara Kannada,9.06,Number of IUCD removals,TOTAL,134.0,117.0,154.0,102.0,98.0,112.0,82.0,143.0,99.0,119.0,96.0,64.0,1320.0
Uttara Kannada,9.07,Number of Oral Pills cycles distributed,TOTAL,3774.0,4169.0,3570.0,3675.0,3718.0,3356.0,3250.0,3530.0,3283.0,4044.0,3513.0,2670.0,42552.0
Uttara Kannada,9.08,Number of Condom pieces distributed,TOTAL,33469.0,33826.0,33056.0,33151.0,34556.0,32657.0,35549.0,34200.0,31591.0,34155.0,37202.0,34688.0,408100.0
Uttara Kannada,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,15.0,2.0,25.0,29.0,99.0,31.0,33.0,22.0,28.0,72.0,30.0,19.0,405.0
Uttara Kannada,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,1.0,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,2.0
Uttara Kannada,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,1.0,1.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0
Uttara Kannada,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,2.0,0.0,4.0
Uttara Kannada,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,9.12,Number of Institutions having NSV trained doctors,TOTAL,18.0,18.0,16.0,22.0,23.0,17.0,18.0,17.0,12.0,13.0,13.0,11.0,-1.0
Uttara Kannada,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2189.0,2046.0,1989.0,2014.0,1820.0,1935.0,1938.0,1966.0,1923.0,1747.0,1897.0,2021.0,23485.0
Uttara Kannada,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,31.0,22.0,35.0,6.0,51.0,74.0,5.0,32.0,7.0,6.0,0.0,0.0,269.0
Uttara Kannada,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,26.0,39.0,33.0,3.0,65.0,197.0,5.0,23.0,9.0,7.0,0.0,1.0,408.0
Uttara Kannada,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,28.0,30.0,37.0,5.0,78.0,45.0,13.0,19.0,5.0,5.0,0.0,0.0,265.0
Uttara Kannada,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2059.0,2149.0,2292.0,2120.0,1939.0,2053.0,1823.0,1994.0,2020.0,1939.0,1843.0,1817.0,24048.0
Uttara Kannada,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,1933.0,1885.0,2152.0,2232.0,2060.0,1993.0,1717.0,1948.0,1953.0,1946.0,1823.0,1939.0,23581.0
Uttara Kannada,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,1871.0,1790.0,1947.0,2102.0,2173.0,2037.0,1766.0,1819.0,1938.0,1854.0,1783.0,1876.0,22956.0
Uttara Kannada,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1880.0,1764.0,1773.0,1643.0,1514.0,1593.0,1734.0,1761.0,1591.0,1457.0,1648.0,1672.0,20030.0
Uttara Kannada,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,1960.0,2115.0,2286.0,2173.0,1939.0,2054.0,1826.0,1983.0,2023.0,1949.0,1844.0,1766.0,23918.0
Uttara Kannada,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,1821.0,1856.0,2138.0,2254.0,2065.0,1982.0,1716.0,1939.0,1950.0,1943.0,1820.0,1932.0,23416.0
Uttara Kannada,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,1753.0,1769.0,1908.0,2127.0,2171.0,2006.0,1757.0,1853.0,1937.0,1893.0,1779.0,1870.0,22823.0
Uttara Kannada,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,1307.0,1324.0,1459.0,1244.0,1217.0,1207.0,1277.0,1334.0,1170.0,1193.0,1375.0,1357.0,15464.0
Uttara Kannada,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,28.0,16.0,19.0,14.0,50.0,8.0,1.0,25.0,8.0,17.0,0.0,25.0,211.0
Uttara Kannada,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,21.0,9.0,17.0,17.0,52.0,0.0,2.0,16.0,9.0,8.0,0.0,24.0,175.0
Uttara Kannada,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,20.0,21.0,27.0,21.0,76.0,5.0,6.0,23.0,9.0,7.0,0.0,25.0,240.0
Uttara Kannada,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,1815.0,1715.0,1869.0,1853.0,1761.0,1824.0,1662.0,1884.0,1813.0,1924.0,1882.0,1929.0,21931.0
Uttara Kannada,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,1316.0,1287.0,1689.0,1625.0,1603.0,1752.0,1540.0,1842.0,1629.0,1563.0,1642.0,1597.0,19085.0
Uttara Kannada,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,2.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,3.0
Uttara Kannada,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,873.0,794.0,953.0,877.0,849.0,884.0,833.0,910.0,911.0,907.0,933.0,984.0,10708.0
Uttara Kannada,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,856.0,781.0,874.0,820.0,831.0,860.0,784.0,886.0,890.0,929.0,929.0,901.0,10341.0
Uttara Kannada,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,1729.0,1575.0,1827.0,1697.0,1680.0,1744.0,1617.0,1796.0,1801.0,1836.0,1862.0,1885.0,21049.0
Uttara Kannada,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1585.0,1449.0,1868.0,1798.0,1831.0,1904.0,1743.0,2005.0,1771.0,1668.0,1688.0,1634.0,20944.0
Uttara Kannada,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1584.0,1439.0,1862.0,1793.0,1836.0,1909.0,1734.0,1998.0,1774.0,1664.0,1680.0,1635.0,20908.0
Uttara Kannada,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,123.0,119.0,123.0,127.0,98.0,58.0,109.0,108.0,96.0,96.0,44.0,70.0,1171.0
Uttara Kannada,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,246.0,210.0,278.0,208.0,234.0,210.0,161.0,220.0,218.0,197.0,186.0,164.0,2532.0
Uttara Kannada,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,195.0,182.0,230.0,183.0,218.0,208.0,155.0,187.0,191.0,160.0,138.0,131.0,2178.0
Uttara Kannada,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,441.0,392.0,508.0,391.0,452.0,418.0,316.0,407.0,409.0,357.0,324.0,295.0,4710.0
Uttara Kannada,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,437.0,379.0,550.0,1416.0,1571.0,2322.0,964.0,4815.0,2966.0,1881.0,1666.0,1398.0,20365.0
Uttara Kannada,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,166.0,175.0,296.0,699.0,1354.0,2473.0,586.0,5435.0,2632.0,1564.0,1357.0,1155.0,17892.0
Uttara Kannada,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,158.0,204.0,521.0,1029.0,1373.0,3136.0,852.0,5187.0,3346.0,1419.0,970.0,1862.0,20057.0
Uttara Kannada,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,1.0,3.0,0.0,1.0,0.0,1.0,0.0,0.0,0.0,0.0,6.0
Uttara Kannada,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,2.0,0.0,4.0,9.0,4.0,2.0,5.0,4.0,3.0,1.0,3.0,2.0,39.0
Uttara Kannada,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,929.0,936.0,911.0,962.0,938.0,974.0,940.0,932.0,940.0,904.0,901.0,904.0,11171.0
Uttara Kannada,10.4.2,Number of Immunisation sessions held during the month,TOTAL,893.0,874.0,890.0,937.0,879.0,920.0,915.0,910.0,913.0,886.0,882.0,891.0,10790.0
Uttara Kannada,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,675.0,673.0,681.0,696.0,680.0,692.0,686.0,713.0,704.0,700.0,644.0,605.0,8149.0
Uttara Kannada,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,1690.0,1587.0,1684.0,1630.0,1866.0,1635.0,1498.0,1657.0,1587.0,1820.0,1832.0,1862.0,20348.0
Uttara Kannada,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,416.0,164.0,238.0,824.0,12821.0,1015.0,118.0,153.0,107.0,143.0,4978.0,3523.0,24500.0
Uttara Kannada,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,248.0,30.0,49.0,820.0,11521.0,829.0,33.0,21.0,20.0,65.0,4991.0,3251.0,21878.0
Uttara Kannada,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,10.0,3.0,10.0,1.0,24.0,16.0,1.0,6.0,5.0,9.0,6.0,19.0,110.0
Uttara Kannada,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,1980.0,1879.0,2134.0,2378.0,2395.0,2077.0,2069.0,2139.0,1911.0,1722.0,2141.0,2119.0,24944.0
Uttara Kannada,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,3.0,12.0,11.0,3.0,2.0,5.0,3.0,3.0,3.0,1.0,1.0,0.0,47.0
Uttara Kannada,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,142.0,116.0,201.0,183.0,265.0,188.0,148.0,123.0,93.0,39.0,159.0,126.0,1783.0
Uttara Kannada,13.1,Number of Patients operated for cataract,TOTAL,398.0,438.0,340.0,489.0,200.0,300.0,325.0,439.0,338.0,262.0,351.0,289.0,4169.0
Uttara Kannada,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,398.0,438.0,355.0,489.0,200.0,299.0,325.0,435.0,338.0,262.0,351.0,289.0,4179.0
Uttara Kannada,13.3,Number of School children detected with Refractive errors,TOTAL,75.0,36.0,49.0,134.0,220.0,108.0,51.0,144.0,256.0,135.0,177.0,119.0,1504.0
Uttara Kannada,13.4,Number of children provided free glasses,TOTAL,20.0,9.0,7.0,158.0,86.0,24.0,20.0,50.0,61.0,24.0,28.0,13.0,500.0
Uttara Kannada,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,17.0,16.0,16.0,16.0,17.0,16.0,15.0,17.0,17.0,15.0,14.0,15.0,-1.0
Uttara Kannada,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,11.0,16.0,11.0,16.0,15.0,13.0,12.0,12.0,12.0,12.0,13.0,11.0,-1.0
Uttara Kannada,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,550.0,573.0,618.0,614.0,683.0,638.0,607.0,636.0,691.0,794.0,916.0,1165.0,-1.0
Uttara Kannada,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,12.0,12.0,13.0,15.0,14.0,14.0,12.0,12.0,13.0,14.0,10.0,13.0,-1.0
Uttara Kannada,14.05,Number of RKS meetings held during the month,TOTAL,7.0,6.0,18.0,13.0,12.0,12.0,7.0,10.0,9.0,13.0,18.0,15.0,140.0
Uttara Kannada,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,28.0,33.0,31.0,36.0,34.0,37.0,34.0,31.0,28.0,33.0,27.0,29.0,-1.0
Uttara Kannada,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,443.0,373.0,319.0,294.0,350.0,295.0,285.0,238.0,266.0,272.0,301.0,302.0,3738.0
Uttara Kannada,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,14.0,13.0,14.0,15.0,12.0,13.0,13.0,13.0,11.0,11.0,9.0,10.0,-1.0
Uttara Kannada,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,22.0,20.0,20.0,20.0,19.0,18.0,14.0,15.0,19.0,16.0,13.0,15.0,-1.0
Uttara Kannada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,603.0,812.0,610.0,660.0,770.0,636.0,596.0,629.0,498.0,644.0,696.0,702.0,7856.0
Uttara Kannada,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,2112.0,2499.0,2535.0,2284.0,3576.0,2132.0,1980.0,2286.0,1849.0,1797.0,1786.0,1901.0,26737.0
Uttara Kannada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,697.0,568.0,552.0,595.0,686.0,588.0,562.0,516.0,475.0,561.0,655.0,594.0,7049.0
Uttara Kannada,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,4062.0,4383.0,4678.0,4371.0,3824.0,4261.0,4109.0,4444.0,4082.0,3765.0,4057.0,3953.0,49989.0
Uttara Kannada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1300.0,1380.0,1162.0,1255.0,1456.0,1224.0,1158.0,1145.0,973.0,1205.0,1351.0,1296.0,14905.0
Uttara Kannada,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,6174.0,6882.0,7213.0,6655.0,7400.0,6393.0,6089.0,6730.0,5931.0,5562.0,5843.0,5854.0,76726.0
Uttara Kannada,14.10.2.a,Number of death cases of Inpatient males,TOTAL,52.0,43.0,54.0,39.0,48.0,56.0,52.0,42.0,92.0,49.0,41.0,33.0,601.0
Uttara Kannada,14.10.2.b,Number of death cases of Inpatient females,TOTAL,37.0,22.0,35.0,22.0,28.0,23.0,21.0,25.0,128.0,32.0,30.0,17.0,420.0
Uttara Kannada,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,89.0,65.0,89.0,61.0,76.0,79.0,73.0,67.0,220.0,81.0,71.0,50.0,1021.0
Uttara Kannada,14.11,In-Patient Head Count at midnight,TOTAL,11883.0,14167.0,15337.0,13625.0,15938.0,12346.0,11943.0,12467.0,12315.0,11728.0,12780.0,11923.0,156452.0
Uttara Kannada,14.12.1,OPD attendance (All),TOTAL,150918.0,157985.0,177392.0,180011.0,169661.0,179721.0,152023.0,165439.0,148345.0,188754.0,182323.0,173764.0,2026336.0
Uttara Kannada,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,923.0,837.0,740.0,763.0,667.0,700.0,873.0,779.0,684.0,738.0,725.0,759.0,9188.0
Uttara Kannada,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,146.0,89.0,147.0,119.0,69.0,54.0,121.0,103.0,56.0,107.0,103.0,97.0,1211.0
Uttara Kannada,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,953.0,1047.0,1171.0,830.0,851.0,754.0,857.0,834.0,823.0,835.0,757.0,695.0,10407.0
Uttara Kannada,14.14.a,Number of patients given AYUSH treatment,TOTAL,3707.0,3997.0,3829.0,3899.0,4459.0,4238.0,3549.0,3560.0,3721.0,3956.0,2964.0,1930.0,43809.0
Uttara Kannada,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,2574.0,2421.0,1523.0,2469.0,2280.0,1246.0,2039.0,1444.0,1224.0,1323.0,2088.0,1248.0,21879.0
Uttara Kannada,14.14.c,Number of Adolescents counselled,TOTAL,268.0,257.0,271.0,292.0,295.0,259.0,222.0,263.0,300.0,341.0,301.0,293.0,3362.0
Uttara Kannada,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,7808.0,7883.0,8524.0,9861.0,8009.0,9271.0,9166.0,9485.0,8168.0,8588.0,9838.0,9104.0,105705.0
Uttara Kannada,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,141.0,206.0,254.0,445.0,126.0,169.0,286.0,200.0,228.0,233.0,220.0,195.0,2703.0
Uttara Kannada,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,2013.0,1847.0,2082.0,1990.0,2118.0,2241.0,1926.0,2074.0,1888.0,2176.0,2170.0,2098.0,24623.0
Uttara Kannada,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,15.0,18.0,11.0,86.0,18.0,10.0,9.0,11.0,109.0,14.0,17.0,20.0,338.0
Uttara Kannada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1516.0,1548.0,1591.0,1351.0,1508.0,1507.0,1326.0,1731.0,1430.0,1588.0,1469.0,1476.0,18041.0
Uttara Kannada,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,15.0,10.0,11.0,142.0,13.0,9.0,11.0,14.0,102.0,12.0,9.0,13.0,361.0
Uttara Kannada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2073.0,1976.0,2264.0,2034.0,2398.0,2639.0,1979.0,2466.0,1841.0,2630.0,2120.0,2167.0,26587.0
Uttara Kannada,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,1.0,18.0,2.0,116.0,0.0,0.0,2.0,0.0,110.0,25.0,23.0,9.0,306.0
Uttara Kannada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,5602.0,5371.0,5937.0,5375.0,6024.0,6387.0,5231.0,6271.0,5159.0,6394.0,5759.0,5741.0,69251.0
Uttara Kannada,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,31.0,46.0,24.0,344.0,31.0,19.0,22.0,25.0,321.0,51.0,49.0,42.0,1005.0
Uttara Kannada,15.2,Number of Widal tests conducted,Number tested,880.0,821.0,1337.0,1508.0,1282.0,1315.0,1784.0,1283.0,945.0,1467.0,1247.0,1403.0,15272.0
Uttara Kannada,15.3.a,Number of VDRL tests conducted on males,Number tested,125.0,247.0,181.0,175.0,128.0,117.0,183.0,176.0,128.0,178.0,154.0,199.0,1991.0
Uttara Kannada,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,252.0,197.0,235.0,311.0,224.0,228.0,335.0,237.0,168.0,281.0,151.0,225.0,2844.0
Uttara Kannada,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,1446.0,1391.0,1618.0,1468.0,1529.0,1853.0,1443.0,1679.0,1557.0,1418.0,1206.0,1332.0,17940.0
Uttara Kannada,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1823.0,1835.0,2034.0,1954.0,1881.0,2198.0,1961.0,2092.0,1853.0,1877.0,1511.0,1756.0,22775.0
Uttara Kannada,15.4.1,Number of blood smears examined for Malaria,TOTAL,12695.0,12404.0,15397.0,15497.0,14503.0,15090.0,12498.0,14701.0,13264.0,12126.0,13676.0,13507.0,165358.0
Uttara Kannada,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,14.0,15.0,34.0,18.0,31.0,39.0,29.0,26.0,18.0,15.0,9.0,9.0,257.0
Uttara Kannada,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,1.0,2.0,0.0,1.0,1.0,3.0,5.0,2.0,0.0,1.0,0.0,0.0,16.0
Uttara Kannada,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,800.0,1000.0,650.0,650.0,650.0,3550.0,500.0,790.0,1230.0,580.0,1080.0,1200.0,12680.0
Uttara Kannada,16.1.1,Stock position of DPT vaccines,2. Stocks Received,2000.0,2500.0,3500.0,7000.0,12000.0,3000.0,1800.0,5000.0,3500.0,4000.0,6000.0,2000.0,52300.0
Uttara Kannada,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,1800.0,2850.0,3500.0,7000.0,9100.0,6050.0,1510.0,4560.0,4150.0,3500.0,5880.0,1050.0,50950.0
Uttara Kannada,16.1.1,Stock position of DPT vaccines,5. Total Stock,1000.0,650.0,650.0,650.0,3550.0,500.0,790.0,1230.0,580.0,1080.0,1200.0,2150.0,14030.0
Uttara Kannada,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,1690.0,810.0,540.0,140.0,240.0,1100.0,100.0,160.0,480.0,100.0,590.0,1100.0,7050.0
Uttara Kannada,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,7000.0,6500.0,5000.0,8000.0,7000.0,3000.0,4500.0,5800.0,3500.0,5500.0,6000.0,4000.0,65800.0
Uttara Kannada,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,7880.0,6770.0,5400.0,7900.0,6140.0,4000.0,4440.0,5480.0,3880.0,5010.0,5490.0,3920.0,66310.0
Uttara Kannada,16.1.1A,Stock Position of Pentavalent,5. Total Stock,810.0,540.0,140.0,240.0,1100.0,100.0,160.0,480.0,100.0,590.0,1100.0,1180.0,6540.0
Uttara Kannada,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,8720.0,6470.0,1470.0,1770.0,3070.0,1070.0,870.0,1370.0,120.0,140.0,180.0,800.0,26050.0
Uttara Kannada,16.1.2,Stock position of OPV vaccines,2. Stocks Received,6000.0,9000.0,10500.0,14000.0,14000.0,16500.0,12500.0,8000.0,13000.0,8000.0,15000.0,10000.0,136500.0
Uttara Kannada,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,8250.0,14000.0,10200.0,12700.0,16000.0,16700.0,12000.0,9250.0,12980.0,7960.0,14380.0,9300.0,143720.0
Uttara Kannada,16.1.2,Stock position of OPV vaccines,5. Total Stock,6470.0,1470.0,1770.0,3070.0,1070.0,870.0,1370.0,120.0,140.0,180.0,800.0,1500.0,18830.0
Uttara Kannada,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,300.0,1350.0,170.0,0.0,0.0,500.0,1300.0,1780.0,2090.0,2140.0,2260.0,2630.0,14520.0
Uttara Kannada,16.1.3,Stock position of TT vaccines,2. Stocks Received,3000.0,4000.0,0.0,10000.0,10000.0,11500.0,7000.0,7500.0,14090.0,8000.0,6000.0,1000.0,82090.0
Uttara Kannada,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.3,Stock position of TT vaccines,4. Stock Distributed,1950.0,5180.0,170.0,10000.0,9500.0,10700.0,6520.0,7190.0,14040.0,7880.0,5630.0,2110.0,80870.0
Uttara Kannada,16.1.3,Stock position of TT vaccines,5. Total Stock,1350.0,170.0,0.0,0.0,500.0,1300.0,1780.0,2090.0,2140.0,2260.0,2630.0,1520.0,15740.0
Uttara Kannada,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,260.0,410.0,0.0,300.0,2900.0,2400.0,700.0,920.0,730.0,0.0,670.0,370.0,9660.0
Uttara Kannada,16.1.5,Stock position of BCG vaccines,2. Stocks Received,4000.0,0.0,7000.0,6000.0,2500.0,2500.0,2500.0,2500.0,1000.0,2000.0,3000.0,2000.0,35000.0
Uttara Kannada,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,3850.0,410.0,6700.0,3400.0,3000.0,4200.0,2280.0,2690.0,1730.0,1330.0,3300.0,2100.0,34990.0
Uttara Kannada,16.1.5,Stock position of BCG vaccines,5. Total Stock,410.0,0.0,300.0,2900.0,2400.0,700.0,920.0,730.0,0.0,670.0,370.0,270.0,9670.0
Uttara Kannada,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,3910.0,2225.0,1220.0,470.0,1120.0,600.0,500.0,415.0,780.0,250.0,230.0,0.0,11720.0
Uttara Kannada,16.1.6,Stock position of Measles vaccines,2. Stocks Received,1000.0,3000.0,4000.0,5000.0,3000.0,4000.0,3000.0,5000.0,6080.0,3000.0,2500.0,5500.0,45080.0
Uttara Kannada,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,2685.0,4005.0,4750.0,4350.0,3520.0,4100.0,3085.0,4635.0,6610.0,3020.0,2730.0,4955.0,48445.0
Uttara Kannada,16.1.6,Stock position of Measles vaccines,5. Total Stock,2225.0,1220.0,470.0,1120.0,600.0,500.0,415.0,780.0,250.0,230.0,0.0,545.0,8355.0
Uttara Kannada,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,5300.0,6050.0,2250.0,900.0,450.0,800.0,700.0,880.0,780.0,780.0,1070.0,530.0,20490.0
Uttara Kannada,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,1000.0,500.0,1500.0,1000.0,1000.0,500.0,600.0,600.0,600.0,500.0,500.0,1000.0,9300.0
Uttara Kannada,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,3800.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3800.0
Uttara Kannada,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,250.0,500.0,2850.0,1450.0,650.0,600.0,420.0,700.0,600.0,210.0,1040.0,930.0,10200.0
Uttara Kannada,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,6050.0,2250.0,900.0,450.0,800.0,700.0,880.0,780.0,780.0,1070.0,530.0,600.0,15790.0
Uttara Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,28650.0,28650.0,28650.0,13530.0,164730.0,164730.0,210090.0,275610.0,265530.0,271530.0,50970.0,50970.0,1553640.0
Uttara Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,151200.0,0.0,75600.0,126000.0,0.0,6000.0,0.0,0.0,0.0,358800.0
Uttara Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,15120.0,0.0,0.0,30240.0,60480.0,10080.0,0.0,220560.0,0.0,5040.0,341520.0
Uttara Kannada,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,28650.0,28650.0,13530.0,164730.0,164730.0,210090.0,275610.0,265530.0,271530.0,50970.0,50970.0,45930.0,1570920.0
Uttara Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1111.0,1111.0,1111.0,1111.0,911.0,911.0,16911.0,12911.0,11911.0,27711.0,10911.0,10911.0,97532.0
Uttara Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,16000.0,0.0,0.0,15800.0,0.0,0.0,0.0,31800.0
Uttara Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,200.0,0.0,0.0,4000.0,1000.0,0.0,16800.0,0.0,0.0,22000.0
Uttara Kannada,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,1111.0,1111.0,1111.0,911.0,911.0,16911.0,12911.0,11911.0,27711.0,10911.0,10911.0,10911.0,107332.0
Uttara Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Uttara Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,100.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,100.0
Uttara Kannada,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,15315.0,15315.0,15315.0,14315.0,14315.0,14315.0,14315.0,11115.0,10915.0,10915.0,10915.0,8415.0,155480.0
Uttara Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,0.0,0.0,1000.0,0.0,0.0,0.0,3200.0,200.0,0.0,0.0,2500.0,0.0,6900.0
Uttara Kannada,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,15315.0,15315.0,14315.0,14315.0,14315.0,14315.0,11115.0,10915.0,10915.0,10915.0,8415.0,8415.0,148580.0
Uttara Kannada,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11870.0,11870.0
Uttara Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11870.0,0.0,11870.0
Uttara Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11540.0,11540.0
Uttara Kannada,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,11870.0,330.0,12200.0
Uttara Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1100.0,0.0,1100.0
Uttara Kannada,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1100.0,0.0,1100.0
Uttara Kannada,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,0.0,0.0,0.0,0.0,3412.0,3412.0,3412.0,3412.0,3412.0,2612.0,800.0,0.0,20472.0
Uttara Kannada,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,0.0,67256.0,0.0,0.0,0.0,0.0,0.0,67196.0,0.0,0.0,134452.0
Uttara Kannada,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,0.0,0.0,0.0,63844.0,0.0,0.0,0.0,0.0,800.0,69008.0,800.0,0.0,134452.0
Uttara Kannada,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,0.0,0.0,0.0,3412.0,3412.0,3412.0,3412.0,3412.0,2612.0,800.0,0.0,0.0,20472.0
Uttara Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,200.0,400.0,0.0,0.0,0.0,100.0,0.0,4980.0,680.0,480.0,3300.0,4500.0,14640.0
Uttara Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,3000.0,3000.0,0.0,2050.0,3300.0,1000.0,6680.0,0.0,0.0,4950.0,3700.0,6600.0,34280.0
Uttara Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,2800.0,3400.0,0.0,2050.0,3200.0,1100.0,1700.0,4300.0,200.0,2130.0,2500.0,2300.0,25680.0
Uttara Kannada,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,400.0,0.0,0.0,0.0,100.0,0.0,4980.0,680.0,480.0,3300.0,4500.0,8800.0,23240.0
Uttara Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,600.0,600.0,0.0,0.0,1200.0,1200.0,1500.0,13100.0,9100.0,5100.0,21600.0,8600.0,62600.0
Uttara Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,10000.0,15000.0,0.0,21600.0,24000.0,2700.0,80000.0,0.0,0.0,21600.0,17100.0,61200.0,253200.0
Uttara Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,10000.0,15600.0,0.0,20400.0,24000.0,2400.0,68400.0,4000.0,4000.0,5100.0,30100.0,43200.0,227200.0
Uttara Kannada,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,600.0,0.0,0.0,1200.0,1200.0,1500.0,13100.0,9100.0,5100.0,21600.0,8600.0,26600.0,88600.0
Uttara Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,0.0,0.0,0.0,0.0,200.0,400.0,1600.0,3600.0,3000.0,1800.0,2300.0,3700.0,16600.0
Uttara Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,2000.0,2400.0,600.0,2400.0,2400.0,4800.0,2400.0,0.0,0.0,2400.0,1700.0,9600.0,30700.0
Uttara Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Uttara Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,2000.0,2400.0,600.0,2200.0,2200.0,3600.0,400.0,600.0,1200.0,1900.0,300.0,1000.0,18400.0
Uttara Kannada,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,0.0,0.0,0.0,200.0,400.0,1600.0,3600.0,3000.0,1800.0,2300.0,3700.0,12300.0,28900.0
Uttara Kannada,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,2.0,1.0,1.0,1.0,,,,,1.0,1.0,,,7.0
Uttara Kannada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,1.0,,,,1.0,,1.0,,,1.0,,2.0,6.0
Uttara Kannada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,1.0,,,,,,,1.0
Uttara Kannada,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,1.0,,,,1.0,1.0,1.0,,,1.0,,2.0,7.0
Uttara Kannada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,,1.0,,1.0,,1.0,2.0,,6.0,4.0,,17.0
Uttara Kannada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Uttara Kannada,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,,1.0,,1.0,,1.0,2.0,,6.0,4.0,,17.0
Uttara Kannada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,2.0,4.0,,2.0,2.0,1.0,1.0,2.0,3.0,,2.0,,19.0
Uttara Kannada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,1.0,1.0,,1.0,,,1.0,,,,,,4.0
Uttara Kannada,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,3.0,5.0,,3.0,2.0,1.0,2.0,2.0,3.0,,2.0,,23.0
Uttara Kannada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,,,1.0,,3.0,,1.0,2.0,1.0,3.0,,1.0,12.0
Uttara Kannada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,1.0,,,,,,,,,1.0,,,2.0
Uttara Kannada,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,1.0,,3.0,,1.0,2.0,1.0,4.0,,1.0,14.0
Uttara Kannada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,,,,1.0,,1.0,1.0,,,,4.0
Uttara Kannada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttara Kannada,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,,,,1.0,,1.0,1.0,,,,4.0
Uttara Kannada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Uttara Kannada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttara Kannada,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Uttara Kannada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,,,,1.0,,,,,,,1.0
Uttara Kannada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttara Kannada,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,,,,1.0,,,,,,,1.0
Uttara Kannada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Uttara Kannada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Uttara Kannada,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Uttara Kannada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,2.0,1.0,,,2.0,2.0,,,3.0,1.0,3.0,,14.0
Uttara Kannada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,1.0,,,1.0,,1.0,,1.0,,1.0,,5.0
Uttara Kannada,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,2.0,2.0,,,3.0,2.0,1.0,,4.0,1.0,4.0,,19.0
Uttara Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,,,,,,,,1.0,1.0
Uttara Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,,,,,,,,,,,1.0,1.0
Uttara Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,4.0,1.0,2.0,,4.0,2.0,1.0,2.0,,1.0,4.0,2.0,23.0
Uttara Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,1.0,,,2.0,3.0,,,,2.0,,2.0,11.0
Uttara Kannada,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,5.0,2.0,2.0,,6.0,5.0,1.0,2.0,,3.0,4.0,4.0,34.0
Uttara Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Uttara Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,5.0,,7.0,,5.0,4.0,2.0,4.0,2.0,5.0,2.0,4.0,40.0
Uttara Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,9.0,8.0,15.0,18.0,19.0,25.0,22.0,13.0,19.0,24.0,22.0,13.0,207.0
Uttara Kannada,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,14.0,8.0,22.0,18.0,25.0,29.0,24.0,17.0,21.0,29.0,24.0,17.0,248.0
Uttara Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,1.0,,,,,,,,1.0
Uttara Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,1.0,,,,,,,,1.0
Uttara Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,1.0,,,,,,,,1.0
Uttara Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,1.0,2.0,2.0,,,2.0,6.0,2.0,1.0,2.0,,,18.0
Uttara Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,2.0,1.0,2.0,1.0,,,1.0,,,,1.0,,8.0
Uttara Kannada,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,3.0,3.0,4.0,1.0,1.0,2.0,7.0,2.0,1.0,2.0,1.0,,27.0
Uttara Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,1.0,,1.0,,2.0
Uttara Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,3.0,2.0,,1.0,1.0,2.0,,1.0,1.0,2.0,2.0,4.0,19.0
Uttara Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,,1.0,1.0,1.0,,,,,1.0,1.0,6.0
Uttara Kannada,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,3.0,3.0,,2.0,2.0,3.0,,1.0,2.0,2.0,4.0,5.0,27.0
Uttara Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,28.0,37.0,29.0,36.0,41.0,43.0,34.0,40.0,39.0,26.0,32.0,25.0,410.0
Uttara Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,93.0,78.0,76.0,75.0,91.0,105.0,88.0,104.0,81.0,101.0,85.0,94.0,1071.0
Uttara Kannada,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,121.0,115.0,105.0,111.0,132.0,148.0,122.0,144.0,120.0,127.0,117.0,119.0,1481.0
Uttara Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,,1.0,,,,,2.0
Uttara Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,8.0,8.0,7.0,12.0,7.0,11.0,7.0,7.0,7.0,9.0,11.0,7.0,101.0
Uttara Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,57.0,50.0,44.0,73.0,67.0,64.0,62.0,69.0,48.0,77.0,61.0,53.0,725.0
Uttara Kannada,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,65.0,58.0,51.0,85.0,74.0,76.0,69.0,77.0,55.0,86.0,72.0,60.0,828.0
Uttara Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Uttara Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,1.0,,,,,,,1.0
Uttara Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,1.0,,,,,,,1.0
Uttara Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,,,,,,,,,,
Uttara Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,,,,,,,,,,,,,
Uttara Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,1.0,,,,,,,,,1.0
Uttara Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,1.0,,,,,,,,,1.0
Uttara Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,,,1.0,,,1.0,2.0,,,1.0,,5.0
Uttara Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Uttara Kannada,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,,,1.0,,,1.0,2.0,,,1.0,,5.0
Uttara Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,1.0,3.0,1.0,,,,4.0,2.0,1.0,1.0,2.0,,15.0
Uttara Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,12.0,15.0,10.0,14.0,7.0,15.0,16.0,14.0,6.0,9.0,8.0,6.0,132.0
Uttara Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,7.0,7.0,5.0,5.0,2.0,2.0,4.0,4.0,2.0,2.0,8.0,2.0,50.0
Uttara Kannada,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,20.0,25.0,16.0,19.0,9.0,17.0,24.0,20.0,9.0,12.0,18.0,8.0,197.0
Uttara Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,1.0,,,,,,1.0,,,,,2.0
Uttara Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,18.0,9.0,16.0,13.0,4.0,12.0,10.0,14.0,9.0,13.0,10.0,11.0,139.0
Uttara Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,3.0,2.0,1.0,3.0,2.0,2.0,1.0,1.0,2.0,2.0,5.0,4.0,28.0
Uttara Kannada,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,21.0,12.0,17.0,16.0,6.0,14.0,11.0,16.0,11.0,15.0,15.0,15.0,169.0
Uttara Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,,,,,,,,,,
Uttara Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,1.0,,1.0,,1.0,,,,3.0,1.0,,,7.0
Uttara Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,1.0,,2.0,1.0,1.0,,,,,,1.0,1.0,7.0
Uttara Kannada,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,2.0,,3.0,1.0,2.0,,,,3.0,1.0,1.0,1.0,14.0
Uttara Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,1.0,,,,,,,,2.0
Uttara Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,15.0,5.0,11.0,13.0,14.0,18.0,13.0,5.0,13.0,16.0,10.0,12.0,145.0
Uttara Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,25.0,36.0,39.0,20.0,31.0,33.0,23.0,13.0,29.0,27.0,28.0,14.0,318.0
Uttara Kannada,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,40.0,42.0,50.0,33.0,46.0,51.0,36.0,18.0,42.0,43.0,38.0,26.0,465.0
Uttara Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,,2.0,1.0,,,,,,,,,,3.0
Uttara Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,17.0,8.0,8.0,15.0,26.0,16.0,19.0,13.0,15.0,21.0,14.0,15.0,187.0
Uttara Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,31.0,31.0,30.0,40.0,37.0,41.0,28.0,37.0,35.0,49.0,38.0,36.0,433.0
Uttara Kannada,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,48.0,41.0,39.0,55.0,63.0,57.0,47.0,50.0,50.0,70.0,52.0,51.0,623.0
Uttara Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,1.0,,2.0,3.0,1.0,1.0,1.0,1.0,2.0,,,2.0,14.0
Uttara Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,33.0,18.0,35.0,30.0,28.0,37.0,30.0,34.0,38.0,28.0,31.0,20.0,362.0
Uttara Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,138.0,112.0,130.0,175.0,150.0,172.0,157.0,153.0,171.0,195.0,185.0,141.0,1879.0
Uttara Kannada,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,172.0,130.0,167.0,208.0,179.0,210.0,188.0,188.0,211.0,223.0,216.0,163.0,2255.0
Yadgir,1.1,Total number of pregnant women Registered for ANC,TOTAL,2859.0,2710.0,3234.0,3400.0,2978.0,3091.0,2704.0,2982.0,2764.0,2781.0,2764.0,2824.0,35091.0
Yadgir,1.1.1,Of which Number registered within first trimester (within 12 weeks),TOTAL,1811.0,1622.0,1905.0,1943.0,1855.0,1884.0,1885.0,1908.0,1811.0,1803.0,1792.0,1774.0,21993.0
Yadgir,1.2,Number of Pregnant women registered under JSY,TOTAL,2188.0,2140.0,2573.0,2487.0,2294.0,2417.0,2339.0,2432.0,2195.0,2188.0,2142.0,2401.0,27796.0
Yadgir,1.3,Number of pregnant women received 3 ANC check ups during pregnancy,TOTAL,2487.0,2129.0,2798.0,2948.0,2712.0,2948.0,2730.0,3074.0,2943.0,3103.0,2976.0,2644.0,33492.0
Yadgir,1.4.1,Number of pregnant women given TT1 during current pregnancy,TOTAL,2821.0,2642.0,3224.0,3062.0,3010.0,2988.0,2804.0,3220.0,2854.0,2867.0,2806.0,2852.0,35150.0
Yadgir,1.4.2,Number of pregnant women given TT2 or Booster during current pregnancy,TOTAL,2934.0,2680.0,3005.0,3037.0,3263.0,3277.0,2970.0,3089.0,2931.0,2909.0,3002.0,2917.0,36014.0
Yadgir,1.5,Total number of pregnant women given 100 IFA tablets,TOTAL,3013.0,2821.0,3163.0,2948.0,2640.0,2358.0,2393.0,2511.0,2554.0,2440.0,2080.0,2017.0,30938.0
Yadgir,1.6.1,Number of new cases of Hypertension (BP>140/90) detected in Pregnant women at the institution,TOTAL,53.0,37.0,78.0,72.0,70.0,86.0,90.0,103.0,161.0,78.0,67.0,65.0,960.0
Yadgir,1.6.2,Number of Eclampsia cases managed during delivery,TOTAL,5.0,5.0,15.0,9.0,2.0,1.0,3.0,4.0,4.0,1.0,11.0,2.0,62.0
Yadgir,1.7.1,Number of Pregnant women with anaemia i.e. Hb level<11 (tested cases),TOTAL,1804.0,1586.0,1986.0,2131.0,1900.0,1729.0,1660.0,1605.0,1922.0,1846.0,1686.0,2148.0,22003.0
Yadgir,1.7.2,Number of Pregnant women having severe anaemia (Hb<7) treated at institution,TOTAL,56.0,35.0,131.0,72.0,45.0,62.0,42.0,58.0,30.0,29.0,242.0,50.0,852.0
Yadgir,1.8,Number of pregnancy test kits used at SC level,TOTAL,147.0,106.0,140.0,147.0,203.0,168.0,167.0,162.0,132.0,79.0,45.0,93.0,1589.0
Yadgir,2.1.1.a,Number of deliveries conducted at Home and attended by trained SBA(i.e. Doctor or Nurse or ANM),TOTAL,52.0,53.0,46.0,64.0,70.0,73.0,63.0,64.0,36.0,28.0,14.0,30.0,593.0
Yadgir,2.1.1.b,Number of deliveries conducted at Home and attended by non trained SBA (i.e. trained TBA or Relatives etc.),TOTAL,6.0,6.0,15.0,10.0,13.0,17.0,15.0,15.0,37.0,38.0,25.0,29.0,226.0
Yadgir,2.1.1.c,Total number of deliveries conducted at Home and attended by trained or non-trained SBA (i.e. sum of 2.1.1.a and 2.1.1.b),TOTAL,58.0,59.0,61.0,74.0,83.0,90.0,78.0,79.0,73.0,66.0,39.0,59.0,819.0
Yadgir,2.1.2,Number of newborns visited within 24 hours of delivery for deliveries conducted at home,TOTAL,51.0,53.0,56.0,56.0,79.0,72.0,71.0,72.0,61.0,57.0,37.0,48.0,713.0
Yadgir,2.1.3,Number of mothers paid JSY incentive for deliveries conducted at home,TOTAL,3.0,6.0,5.0,3.0,3.0,1.0,1.0,33.0,5.0,5.0,5.0,2.0,72.0
Yadgir,2.2,Deliveries conducted at Public Institutions (Including C-Sections),TOTAL,1633.0,1376.0,1599.0,1601.0,1725.0,1767.0,1540.0,1702.0,1644.0,1450.0,1440.0,1455.0,18932.0
Yadgir,2.2.1,"Out of 2.2, Number discharged under 48 hours of delivery",TOTAL,333.0,271.0,341.0,334.0,333.0,358.0,337.0,253.0,835.0,719.0,757.0,614.0,5485.0
Yadgir,2.2.2.a,Number of mothers paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,411.0,355.0,460.0,420.0,477.0,721.0,794.0,656.0,485.0,648.0,505.0,484.0,6416.0
Yadgir,2.2.2.b,Number of ASHAs paid JSY Incentive for deliveries conducted at Public Institutions,TOTAL,0.0,2.0,0.0,2.0,44.0,18.0,6.0,58.0,36.0,47.0,12.0,22.0,247.0
Yadgir,2.2.2.c,Number of cases of deliveries conducted at Public Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,2.3,Deliveries conducted at Private Institutions (Including C-Sections),TOTAL,191.0,33.0,214.0,229.0,233.0,129.0,124.0,127.0,137.0,143.0,209.0,214.0,1983.0
Yadgir,2.3.1.a,Number of mothers paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,2.3.1.b,Number of ASHAs paid JSY Incentive for deliveries conducted at accredited Private Institutions,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,2.3.1.c,Number of cases of deliveries conducted at accredited Private Institutions where JSY incentive was paid to ANMs or AWWs [only for High Performing States (HPS)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,3.1.1,Number of Caesarean (C-Section) deliveries performed at PHCs (Primary Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,3.1.2,Number of Caesarean (C-Section) deliveries performed at CHCs (Community Health Centre),TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,3.1.3,Number of Caesarean (C-Section) deliveries performed at SDHs (Sub-divisional Hospital) or DHs (District Hospital),TOTAL,18.0,4.0,19.0,4.0,16.0,16.0,12.0,20.0,19.0,7.0,32.0,23.0,190.0
Yadgir,3.1.4,Number of Caesarean (C-Section) deliveries performed at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,3.1.5,"Total Number of Caesarean (C-Section) deliveries performed at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 3.1.1 to 3.1.4)",TOTAL,18.0,4.0,19.0,4.0,16.0,16.0,12.0,20.0,19.0,7.0,32.0,23.0,190.0
Yadgir,3.2,No. of C-section deliveries performed at Private facilities,TOTAL,17.0,2.0,41.0,29.0,21.0,17.0,10.0,14.0,15.0,25.0,22.0,15.0,228.0
Yadgir,4.1.1.a,Number of male live births,TOTAL,1036.0,773.0,947.0,952.0,1067.0,1021.0,879.0,971.0,958.0,879.0,858.0,942.0,11283.0
Yadgir,4.1.1.b,Number of female live births,TOTAL,831.0,689.0,918.0,938.0,983.0,948.0,863.0,937.0,898.0,872.0,816.0,852.0,10545.0
Yadgir,4.1.1.c,Total number of male and female live births (4.1.1.a and 4.1.1.b),TOTAL,1867.0,1462.0,1865.0,1890.0,2050.0,1969.0,1742.0,1908.0,1856.0,1751.0,1674.0,1794.0,21828.0
Yadgir,4.1.2,Number of still births,TOTAL,17.0,16.0,19.0,25.0,9.0,13.0,20.0,19.0,14.0,12.0,13.0,12.0,189.0
Yadgir,4.1.3,Number of Abortions (spontaneous or induced),TOTAL,21.0,22.0,26.0,72.0,49.0,19.0,52.0,38.0,16.0,51.0,30.0,25.0,421.0
Yadgir,4.2.1,Number of Newborns weighed at birth,TOTAL,1718.0,1431.0,1653.0,1895.0,2000.0,1972.0,1681.0,1856.0,1859.0,1572.0,1640.0,1695.0,20972.0
Yadgir,4.2.2,Number of Newborns having weight less than 2.5 kg,TOTAL,156.0,150.0,356.0,178.0,177.0,236.0,181.0,200.0,166.0,147.0,193.0,180.0,2320.0
Yadgir,4.3,Number of Newborns breast fed within 1 hour of birth,TOTAL,1808.0,1265.0,1802.0,1885.0,1967.0,1909.0,1592.0,1824.0,1780.0,1619.0,1582.0,1691.0,20724.0
Yadgir,5.1.1,Number of cases of pregnant women with Obstetric Complications and attended at PHCs,TOTAL,250.0,59.0,58.0,92.0,111.0,70.0,66.0,284.0,124.0,258.0,92.0,286.0,1750.0
Yadgir,5.1.2,Number of cases of pregnant women with Obstetric Complications and attended at CHCs,TOTAL,76.0,2.0,4.0,4.0,5.0,18.0,0.0,13.0,0.0,10.0,0.0,20.0,152.0
Yadgir,5.1.3,Number of cases of pregnant women with Obstetric Complications and attended at SDHs or DHs,TOTAL,146.0,89.0,99.0,140.0,126.0,92.0,77.0,100.0,64.0,100.0,319.0,193.0,1545.0
Yadgir,5.1.4,Number of cases of pregnant women with Obstetric Complications and attended at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,5.1.5,"Number of cases of pregnant women with Obstetric Complications and attended at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 5.1.1 to 5.1.4)",TOTAL,472.0,150.0,161.0,236.0,242.0,180.0,143.0,397.0,188.0,368.0,411.0,499.0,3447.0
Yadgir,5.2,Number of cases of pregnant women with Obstetric Complications and attended at Private facilities,TOTAL,44.0,29.0,44.0,52.0,53.0,62.0,55.0,46.0,62.0,128.0,75.0,107.0,757.0
Yadgir,5.3.1,Number of cases of complicated pregnancies treated with IV antibiotics,TOTAL,431.0,170.0,197.0,250.0,238.0,333.0,363.0,188.0,206.0,192.0,167.0,200.0,2935.0
Yadgir,5.3.2,Number of cases of complicated pregnancies treated with IV Antihypertensive/Magsulph injection,TOTAL,38.0,39.0,24.0,19.0,33.0,37.0,28.0,36.0,44.0,24.0,9.0,44.0,375.0
Yadgir,5.3.3,Number of cases of complicated pregnancies treated with IV Oxytocis,TOTAL,343.0,276.0,297.0,430.0,293.0,509.0,439.0,450.0,447.0,409.0,689.0,408.0,4990.0
Yadgir,5.3.4,Number of cases of complicated pregnancies treated with Blood Transfusion,TOTAL,67.0,89.0,99.0,135.0,115.0,92.0,72.0,90.0,65.0,93.0,63.0,121.0,1101.0
Yadgir,6.1,Women getting post partum check-up within 48 hours after delivery,TOTAL,1400.0,1297.0,1445.0,1267.0,1347.0,1351.0,1253.0,1569.0,1403.0,1224.0,1109.0,1147.0,15812.0
Yadgir,6.2,Women getting a post partum check up between 48 hours and 14 days after delivery,TOTAL,1039.0,882.0,1015.0,1031.0,1120.0,982.0,908.0,1055.0,1080.0,867.0,898.0,947.0,11824.0
Yadgir,6.3,PNC maternal complications attended,TOTAL,15.0,19.0,16.0,27.0,101.0,37.0,15.0,7.0,19.0,99.0,14.0,13.0,382.0
Yadgir,7.1.1,Number of MTPs conducted at Public Institutions up to 12 weeks of pregnancy,TOTAL,4.0,6.0,5.0,4.0,4.0,3.0,9.0,2.0,0.0,2.0,2.0,4.0,45.0
Yadgir,7.1.2,Number of MTPs conducted at Public Institutions for more than 12 weeks of pregnancy,TOTAL,0.0,2.0,0.0,2.0,0.0,4.0,0.0,2.0,1.0,3.0,0.0,1.0,15.0
Yadgir,7.1.3,Total number of MTPs conducted at Public Institutions (sum of items 7.1.1 and 7.1.2),TOTAL,4.0,8.0,5.0,6.0,4.0,7.0,9.0,4.0,1.0,5.0,2.0,5.0,60.0
Yadgir,7.2,Number of MTPs conducted at Private Facilities,TOTAL,6.0,8.0,53.0,36.0,35.0,26.0,32.0,19.0,13.0,28.0,19.0,13.0,288.0
Yadgir,8.1.a,Number of new cases of RTI/STI in males for which treatment was initiated,TOTAL,261.0,225.0,290.0,265.0,270.0,256.0,191.0,239.0,213.0,273.0,188.0,248.0,2919.0
Yadgir,8.1.b,Number of new cases of RTI/STI in females for which treatment was initiated,TOTAL,542.0,440.0,496.0,472.0,403.0,384.0,294.0,391.0,449.0,402.0,396.0,456.0,5125.0
Yadgir,8.1.c,Total number of new cases of RTI/STI in males and females for which treatment was initiated (sum of items 8.1.a and 8.1.b),TOTAL,803.0,665.0,786.0,737.0,673.0,640.0,485.0,630.0,662.0,675.0,584.0,704.0,8044.0
Yadgir,8.2,Number of suspected RTI/STI cases for whom wet mount test was conducted,TOTAL,0.0,0.0,0.0,4.0,0.0,0.0,5.0,19.0,36.0,16.0,0.0,0.0,80.0
Yadgir,9.1.1.a,Number of NSV (No Scalpel Vasectomy) or Conventional Vasectomy conducted at PHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.1.1.b,Number of NSV or Conventional Vasectomy conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.1.1.c,Number of NSV or Conventional Vasectomy conducted at SDHs or DHs,TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0
Yadgir,9.1.1.d,Number of NSV or Conventional Vasectomy conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,9.1.1.e,"Total Number of NSV or Conventional Vasectomy conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.1.1.a to 9.1.1.d)",TOTAL,0.0,0.0,1.0,0.0,0.0,0.0,1.0,1.0,0.0,0.0,0.0,0.0,3.0
Yadgir,9.1.2,Number of NSV or Conventional Vasectomy conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.2.1.a,Number of Laparoscopic sterilizations conducted at PHCs,TOTAL,63.0,77.0,27.0,38.0,56.0,71.0,44.0,102.0,91.0,0.0,77.0,57.0,703.0
Yadgir,9.2.1.b,Number of Laparoscopic sterilizations conducted at CHCs,TOTAL,108.0,137.0,102.0,103.0,135.0,118.0,138.0,98.0,110.0,106.0,178.0,244.0,1577.0
Yadgir,9.2.1.c,Number of Laparoscopic sterilizations conducted at SDHs or DHs,TOTAL,348.0,201.0,365.0,350.0,210.0,338.0,188.0,330.0,334.0,270.0,347.0,322.0,3603.0
Yadgir,9.2.1.d,Number of Laparoscopic sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,9.2.1.e,"Total Number of Laparoscopic sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.2.1.a to 9.2.1.d)",TOTAL,519.0,415.0,494.0,491.0,401.0,527.0,370.0,530.0,535.0,376.0,602.0,623.0,5883.0
Yadgir,9.2.2,Number of Laparoscopic sterilizations conducted at Private facilities,TOTAL,0.0,0.0,0.0,0.0,9.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,9.0
Yadgir,9.3.1.a,Number of Mini-lap sterilizations conducted at PHCs,TOTAL,0.0,0.0,24.0,0.0,20.0,24.0,0.0,31.0,23.0,31.0,0.0,0.0,153.0
Yadgir,9.3.1.b,Number of Mini-lap sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.3.1.c,Number of Mini-lap sterilizations conducted at SDHs or DHs,TOTAL,82.0,67.0,69.0,89.0,41.0,79.0,82.0,52.0,78.0,73.0,36.0,54.0,802.0
Yadgir,9.3.1.d,Number of Mini-lap sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,9.3.1.e,"Total Number of Mini-lap sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.3.1.a to 9.3.1.d)",TOTAL,82.0,67.0,93.0,89.0,61.0,103.0,82.0,83.0,101.0,104.0,36.0,54.0,955.0
Yadgir,9.3.2,Number of Mini-lap sterilizations conducted at Private facilities,TOTAL,0.0,0.0,4.0,1.0,0.0,8.0,4.0,4.0,4.0,2.0,1.0,5.0,33.0
Yadgir,9.4.1.a,Number of Post-Partum sterilizations conducted at PHCs,TOTAL,0.0,0.0,5.0,0.0,0.0,0.0,0.0,0.0,0.0,7.0,0.0,0.0,12.0
Yadgir,9.4.1.b,Number of Post-Partum sterilizations conducted at CHCs,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.4.1.c,Number of Post-Partum sterilizations conducted at SDHs or DHs,TOTAL,0.0,4.0,5.0,5.0,9.0,8.0,6.0,5.0,3.0,3.0,20.0,0.0,68.0
Yadgir,9.4.1.d,Number of Post-Partum sterilizations conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,9.4.1.e,"Total Number of Post-Partum sterilizations conducted at Public facilities i.e. PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.4.1.a to 9.4.1.d)",TOTAL,0.0,4.0,10.0,5.0,9.0,8.0,6.0,5.0,3.0,10.0,20.0,0.0,80.0
Yadgir,9.4.2,Number of Post-Partum sterilizations conducted at Private facilities,TOTAL,4.0,1.0,0.0,7.0,0.0,9.0,5.0,2.0,0.0,4.0,4.0,0.0,36.0
Yadgir,9.5.1.a,Number of IUCD Insertions conducted at SCs,TOTAL,40.0,34.0,22.0,35.0,17.0,27.0,28.0,34.0,22.0,43.0,44.0,44.0,390.0
Yadgir,9.5.1.b,Number of IUCD Insertions conducted at PHCs,TOTAL,86.0,85.0,62.0,77.0,70.0,56.0,44.0,64.0,52.0,61.0,60.0,55.0,772.0
Yadgir,9.5.1.c,Number of IUCD Insertions conducted at CHCs,TOTAL,5.0,9.0,7.0,8.0,4.0,3.0,2.0,6.0,3.0,5.0,7.0,2.0,61.0
Yadgir,9.5.1.d,Number of IUCD Insertions conducted at SDHs or DHs,TOTAL,44.0,6.0,47.0,13.0,14.0,53.0,37.0,55.0,36.0,37.0,36.0,12.0,390.0
Yadgir,9.5.1.e,Number of IUCD Insertions conducted at other State owned public institutions,TOTAL,,,,,,,,,,,,,
Yadgir,9.5.1.f,"Total Number of IUCD Insertions conducted at Public facilities i.e. SC, PHC, CHC, SDH, DH and other State owned public institutions (sum of items from 9.5.1.a to 9.5.1.e)",TOTAL,175.0,134.0,138.0,133.0,105.0,139.0,111.0,159.0,113.0,146.0,147.0,113.0,1613.0
Yadgir,9.5.1A,"Out of above total, Post Partum (within 48 hours of delivery) IUCD insertions",TOTAL,6.0,8.0,0.0,5.0,2.0,2.0,0.0,1.0,4.0,10.0,3.0,0.0,41.0
Yadgir,9.5.2,Number of IUCD Insertions conducted at Private facilities,TOTAL,5.0,5.0,2.0,5.0,3.0,2.0,4.0,6.0,4.0,9.0,8.0,2.0,55.0
Yadgir,9.06,Number of IUCD removals,TOTAL,85.0,36.0,50.0,50.0,62.0,31.0,18.0,40.0,26.0,35.0,35.0,61.0,529.0
Yadgir,9.07,Number of Oral Pills cycles distributed,TOTAL,4601.0,2240.0,2388.0,2614.0,2654.0,2457.0,2333.0,2317.0,2285.0,2245.0,2301.0,2479.0,30914.0
Yadgir,9.08,Number of Condom pieces distributed,TOTAL,24297.0,23452.0,24098.0,24258.0,26185.0,24798.0,23326.0,21667.0,23239.0,24615.0,25081.0,23843.0,288859.0
Yadgir,9.09,Number of Centchroman (weekly) pills given,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,2.0
Yadgir,9.10,Number of Emergency Contraceptive Pills distributed,TOTAL,0.0,2.0,2.0,3.0,2.0,3.0,258.0,4.0,5.0,3.0,5.0,5.0,292.0
Yadgir,9.11.1.a,Number of cases of complications following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.11.1.b,Number of cases of complications following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,1.0,1.0
Yadgir,9.11.2.a,Number of failures following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.11.2.b,Number of failures following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,1.0,0.0,0.0,0.0,2.0,1.0,1.0,5.0
Yadgir,9.11.3.a,Number of deaths following male sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.11.3.b,Number of deaths following female sterilization,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,9.12,Number of Institutions having NSV trained doctors,TOTAL,19.0,19.0,19.0,20.0,18.0,4.0,6.0,5.0,36.0,36.0,36.0,28.0,-1.0
Yadgir,10.1.01,Number of Infants (0 to 11 months old)received BCG immunisation,TOTAL,2542.0,2332.0,3031.0,3002.0,2902.0,2858.0,2982.0,3322.0,3166.0,2995.0,2855.0,2691.0,34678.0
Yadgir,10.1.02,Number of Infants (0 to 11 months old) received DPT1 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,210.0,210.0,18.0,187.0,625.0
Yadgir,10.1.03,Number of Infants (0 to 11 months old) received DPT2 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,181.0,198.0,2.0,202.0,583.0
Yadgir,10.1.04,Number of Infants (0 to 11 months old) received DPT3 immunisation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,196.0,190.0,2.0,205.0,593.0
Yadgir,10.1.04A,Number of Infants (0 to 11 months old) received Pentavalent1 immunisation,TOTAL,2524.0,2377.0,2925.0,2836.0,2754.0,2766.0,2489.0,2846.0,2746.0,2490.0,2698.0,2285.0,31736.0
Yadgir,10.1.04B,Number of Infants (0 to 11 months old) received Pentavalent2 immunisation,TOTAL,2682.0,2342.0,2716.0,2622.0,2657.0,2730.0,2393.0,2618.0,2537.0,2427.0,2590.0,2274.0,30588.0
Yadgir,10.1.04C,Number of Infants (0 to 11 months old) received Pentavalent3 immunisation,TOTAL,2663.0,2465.0,2770.0,2694.0,2675.0,2790.0,2503.0,2655.0,2518.0,2358.0,2733.0,2245.0,31069.0
Yadgir,10.1.05,Number of Infants (0 to 11 months old) received OPV 0 (Birth Dose),TOTAL,1701.0,1786.0,2013.0,2051.0,2067.0,2124.0,1939.0,2017.0,1917.0,1855.0,1816.0,1782.0,23068.0
Yadgir,10.1.06,Number of Infants (0 to 11 months old) received OPV1 (First Dose),TOTAL,2517.0,2362.0,2906.0,2847.0,2782.0,2679.0,2504.0,2830.0,2750.0,2694.0,2689.0,2462.0,32022.0
Yadgir,10.1.07,Number of Infants (0 to 11 months old) received OPV2 (Second Dose),TOTAL,2682.0,2295.0,2718.0,2622.0,2677.0,2650.0,2405.0,2619.0,2726.0,2622.0,2578.0,2476.0,31070.0
Yadgir,10.1.08,Number of Infants (0 to 11 months old) received OPV3 (Third Dose),TOTAL,2632.0,2444.0,2755.0,2691.0,2684.0,2709.0,2530.0,2657.0,2846.0,2554.0,2725.0,2428.0,31655.0
Yadgir,10.1.09A,Number of Infants (upto 48 hrs of age) received Hepatitis-B0 immunisation,TOTAL,995.0,1273.0,1401.0,1309.0,1226.0,1430.0,1232.0,1353.0,1171.0,1225.0,1218.0,1298.0,15131.0
Yadgir,10.1.09,Number of Infants (0 to 11 months old) received Hepatitis-B1 immunisation,TOTAL,0.0,31.0,13.0,15.0,0.0,0.0,9.0,0.0,48.0,43.0,59.0,20.0,238.0
Yadgir,10.1.10,Number of Infants (0 to 11 months old) received Hepatitis-B2 immunisation,TOTAL,0.0,32.0,11.0,13.0,0.0,0.0,10.0,0.0,44.0,35.0,32.0,14.0,191.0
Yadgir,10.1.11,Number of Infants (0 to 11 months old) received Hepatitis-B3 immunisation,TOTAL,0.0,33.0,10.0,11.0,0.0,13.0,31.0,1.0,30.0,30.0,25.0,11.0,195.0
Yadgir,10.1.12,Number of Infants (0 to 11 months old) received Measles immunisation (First Dose),TOTAL,2352.0,2326.0,2457.0,2557.0,2529.0,2443.0,2245.0,2425.0,2470.0,2526.0,2734.0,2471.0,29535.0
Yadgir,10.1.12B,Number of Infants (more than 16 months old) received Measles immunisation (Second Dose),TOTAL,786.0,622.0,734.0,929.0,869.0,989.0,818.0,1158.0,1063.0,973.0,952.0,938.0,10831.0
Yadgir,10.1A,No. of Children aged 9 to 12 months who received JE 1st dose,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,16.0,0.0,16.0
Yadgir,10.1.13.a,Total number of male children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1159.0,1135.0,1171.0,1265.0,1181.0,1199.0,1093.0,1151.0,1210.0,1273.0,1399.0,1235.0,14471.0
Yadgir,10.1.13.b,Total number of female children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,1133.0,1121.0,1171.0,1232.0,1212.0,1156.0,1096.0,1147.0,1165.0,1226.0,1296.0,1240.0,14195.0
Yadgir,10.1.13.c,Total number of children (9 to 11 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month (sum of items 10.1.13.a and 10.1.13.b),TOTAL,2292.0,2256.0,2342.0,2497.0,2393.0,2355.0,2189.0,2298.0,2375.0,2499.0,2695.0,2475.0,28666.0
Yadgir,10.2.1,Number of Infants (more than 16 months old) received DPT Booster dose,TOTAL,1688.0,1628.0,1722.0,1734.0,1854.0,1934.0,1762.0,1890.0,1979.0,1936.0,2012.0,1968.0,22107.0
Yadgir,10.2.2,Number of Infants (more than 16 months old) received OPV Booster dose,TOTAL,1680.0,1626.0,1722.0,1739.0,1858.0,1944.0,1762.0,1877.0,1950.0,1911.0,2007.0,1939.0,22015.0
Yadgir,10.2.3,"Number of Infants (more than 16 months old) received Measles, Mumps, Rubella (MMR) Vaccination",TOTAL,374.0,458.0,373.0,453.0,474.0,559.0,668.0,569.0,564.0,545.0,558.0,481.0,6076.0
Yadgir,10.3.1.a,Total number of male children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,738.0,751.0,776.0,750.0,779.0,775.0,712.0,844.0,818.0,807.0,796.0,874.0,9420.0
Yadgir,10.3.1.b,Total number of female children (12 to 23 months old) fully immunised (BCG+DPT123/Pentavalent123+OPV123+Measles) during the month,TOTAL,724.0,738.0,785.0,764.0,788.0,754.0,673.0,825.0,761.0,797.0,782.0,862.0,9253.0
Yadgir,10.3.1.c,Total number of children (12 to 23 months old) fully immunised (BCG+DPT123+OPV123/Pentavalent123+Measles) during the month (sum of items 10.3.1.a and 10.3.1.b),TOTAL,1462.0,1489.0,1561.0,1514.0,1567.0,1529.0,1385.0,1669.0,1579.0,1604.0,1578.0,1736.0,18673.0
Yadgir,10.3.2,Number of children (more than 5 years old) given DT5,TOTAL,222.0,188.0,313.0,1376.0,3921.0,4629.0,982.0,1855.0,1184.0,1123.0,745.0,240.0,16778.0
Yadgir,10.3.3,Number of children (more than 10 years old) given TT10,TOTAL,549.0,436.0,545.0,1963.0,4095.0,5449.0,994.0,2686.0,1597.0,1879.0,988.0,474.0,21655.0
Yadgir,10.3.4,Number of children (more than 16 years old) given TT16,TOTAL,640.0,761.0,725.0,2440.0,2923.0,5046.0,1016.0,2418.0,1950.0,1545.0,895.0,664.0,21023.0
Yadgir,10.3.5.a,Number of cases of Abscess reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,13.0,2.0,0.0,0.0,15.0
Yadgir,10.3.5.b,Number of cases of Death reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,10.3.5.c,Number of cases of other complications reported following immunisation [Adverse Event Following Immunisation (AEFI)],TOTAL,8.0,9.0,4.0,0.0,0.0,0.0,0.0,0.0,35.0,0.0,37.0,45.0,138.0
Yadgir,10.4.1,Number of Immunisation sessions planned to be held during the month,TOTAL,1032.0,911.0,983.0,974.0,943.0,1012.0,951.0,1011.0,1042.0,1020.0,1012.0,966.0,11857.0
Yadgir,10.4.2,Number of Immunisation sessions held during the month,TOTAL,976.0,890.0,938.0,946.0,909.0,985.0,927.0,986.0,1019.0,992.0,988.0,931.0,11487.0
Yadgir,10.4.3,Number of Immunisation sessions held during the month where ASHAs were present,TOTAL,669.0,671.0,659.0,677.0,673.0,706.0,677.0,690.0,700.0,690.0,680.0,651.0,8143.0
Yadgir,10.5.1,Number of children (more than 16 months old) received Japanese Encephalitis (JE) vaccination,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,11.1.1,Number of children (9 months to 5 years old) administered 1st dose of Vitamin A (Dose-1),TOTAL,2253.0,2191.0,2348.0,2324.0,2348.0,2372.0,2238.0,2465.0,2580.0,2512.0,2453.0,2339.0,28423.0
Yadgir,11.1.2,Number of children (9 months to 5 years old) were administered 5th dose of Vitamin A (Dose-5),TOTAL,230.0,278.0,249.0,207.0,375.0,178.0,229.0,491.0,315.0,330.0,178.0,407.0,3467.0
Yadgir,11.1.3,Number of children (9 months to 5 years old) administered 9th dose of Vitamin A (Dose-9),TOTAL,76.0,60.0,110.0,104.0,254.0,144.0,285.0,286.0,257.0,221.0,108.0,312.0,2217.0
Yadgir,12.1,Number of cases of Diptheria reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,12.2,Number of cases of Pertusis reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,12.3,Number of cases of Tetanus neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,12.4,Number of cases of Tetanus other than neonatarum reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,12.5,Number of cases of Polio reported in children below 5 years of age,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,12.6,Number of cases of Measles reported in children below 5 years of age,TOTAL,4.0,0.0,0.0,2.0,1.0,0.0,16.0,13.0,11.0,10.0,28.0,4.0,89.0
Yadgir,12.7,Number of cases of Diarrhoea and Dehydration reported in children below 5 years of age,TOTAL,550.0,591.0,567.0,640.0,691.0,636.0,676.0,635.0,590.0,546.0,594.0,527.0,7243.0
Yadgir,12.8,Number of cases of Malaria reported in children below 5 years of age,TOTAL,0.0,0.0,2.0,30.0,30.0,16.0,1.0,44.0,9.0,36.0,7.0,6.0,181.0
Yadgir,12.9,Number of children below 5 years of age admitted with Respiratory Infections,TOTAL,66.0,50.0,30.0,68.0,106.0,108.0,85.0,55.0,101.0,121.0,113.0,89.0,992.0
Yadgir,13.1,Number of Patients operated for cataract,TOTAL,30.0,6.0,2.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,309.0,350.0
Yadgir,13.2,Number of Intraocular Lens(IOL) implantations,TOTAL,30.0,6.0,0.0,3.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,39.0
Yadgir,13.3,Number of School children detected with Refractive errors,TOTAL,3.0,2.0,0.0,0.0,0.0,0.0,0.0,2.0,0.0,0.0,0.0,3.0,10.0
Yadgir,13.4,Number of children provided free glasses,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3.0,3.0
Yadgir,13.5,Number of eyes collected through eye donation,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,13.6,Number of eyes utilised for corneal transplant,TOTAL,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,14.01,Number of CHC or SDH or DH functioning as First Referral units (FRUs),TOTAL,8.0,5.0,8.0,11.0,10.0,10.0,9.0,9.0,10.0,9.0,8.0,6.0,-1.0
Yadgir,14.02,Number of PHCs functioning 24X7 with atleast 3 Staff Nurses,TOTAL,38.0,38.0,39.0,38.0,37.0,38.0,39.0,37.0,36.0,37.0,38.0,38.0,-1.0
Yadgir,14.03,Number of Anganwadi centres reported to have conducted VHNDs,TOTAL,158.0,160.0,159.0,169.0,184.0,188.0,156.0,200.0,158.0,320.0,154.0,175.0,-1.0
Yadgir,14.04,Number of facilities having a Rogi Kalyan Samiti (RKS),TOTAL,8.0,5.0,8.0,11.0,10.0,10.0,9.0,9.0,10.0,10.0,10.0,8.0,-1.0
Yadgir,14.05,Number of RKS meetings held during the month,TOTAL,13.0,12.0,9.0,11.0,11.0,14.0,14.0,11.0,13.0,10.0,10.0,13.0,141.0
Yadgir,14.06,Number of facilities having Ambulance services (Assured Referral Services),TOTAL,34.0,27.0,31.0,33.0,30.0,32.0,33.0,33.0,34.0,35.0,35.0,34.0,-1.0
Yadgir,14.07,Total Number of times the Ambulance was used for transporting patients during the month,TOTAL,129.0,115.0,107.0,176.0,134.0,182.0,125.0,105.0,107.0,143.0,206.0,127.0,1656.0
Yadgir,14.08,Number of Institutions having Operational Sick New Born and Child Care Units (SNCU),TOTAL,9.0,4.0,7.0,9.0,7.0,8.0,7.0,8.0,8.0,9.0,9.0,7.0,-1.0
Yadgir,14.09,Number of functional Laproscopes in CHC/SDH/DH,TOTAL,19.0,39.0,24.0,4.0,38.0,2.0,64.0,2.0,3.0,38.0,38.0,212.0,-1.0
Yadgir,14.10.1.a,Number of male patients admitted (Inpatients) during the month,1. Children,576.0,333.0,413.0,398.0,383.0,572.0,409.0,492.0,733.0,671.0,589.0,693.0,6262.0
Yadgir,14.10.1.a,Number of male patients admitted (Inpatients) during the month,2. Adults,1758.0,1549.0,1902.0,1638.0,1732.0,2580.0,1451.0,2288.0,2214.0,1693.0,2130.0,2265.0,23200.0
Yadgir,14.10.1.b,Number of female patients (Inpatients) admitted during the month,1. Children,548.0,301.0,364.0,367.0,358.0,510.0,345.0,442.0,765.0,706.0,632.0,792.0,6130.0
Yadgir,14.10.1.b,Number of female patients (Inpatients) admitted during the month,2. Adults,3621.0,3056.0,4214.0,3583.0,3623.0,4756.0,2755.0,4481.0,4361.0,3959.0,4101.0,4406.0,46916.0
Yadgir,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),1. Children,1124.0,634.0,777.0,765.0,741.0,1082.0,754.0,934.0,1498.0,1377.0,1221.0,1485.0,12392.0
Yadgir,14.10.1.c,Total number of patients admitted (Inpatients) during the month (sum of items 14.10.1.a and 14.10.1.b),2. Adults,5379.0,4605.0,6116.0,5221.0,5355.0,7336.0,4206.0,6769.0,6575.0,5652.0,6231.0,6671.0,70116.0
Yadgir,14.10.2.a,Number of death cases of Inpatient males,TOTAL,2.0,4.0,3.0,7.0,5.0,3.0,8.0,6.0,9.0,8.0,6.0,13.0,74.0
Yadgir,14.10.2.b,Number of death cases of Inpatient females,TOTAL,4.0,3.0,3.0,1.0,0.0,4.0,2.0,3.0,3.0,3.0,5.0,3.0,34.0
Yadgir,14.10.2.c,Number of cases of death of Inpatients (sum of items 14.10.2.a and 14.10.2.b),TOTAL,6.0,7.0,6.0,8.0,5.0,7.0,10.0,9.0,12.0,11.0,11.0,16.0,108.0
Yadgir,14.11,In-Patient Head Count at midnight,TOTAL,5178.0,4568.0,4645.0,5406.0,5022.0,4286.0,4533.0,5980.0,4422.0,5163.0,4683.0,5923.0,59809.0
Yadgir,14.12.1,OPD attendance (All),TOTAL,59934.0,55698.0,64061.0,69259.0,77126.0,66561.0,72658.0,74716.0,70061.0,63768.0,64303.0,68219.0,806364.0
Yadgir,14.13.1,Number of major operations carried out using general or spinal anaesthesia,TOTAL,24.0,42.0,56.0,997.0,31.0,31.0,57.0,26.0,24.0,519.0,533.0,34.0,2374.0
Yadgir,14.13.1A,"Out of 14.13.1,Gynecology- Hysterectomy surgeries",TOTAL,0.0,2.0,0.0,0.0,0.0,0.0,62.0,1.0,0.0,0.0,0.0,0.0,65.0
Yadgir,14.13.2,Number of minor operations carried out without anaesthesia or using local anaesthesia,TOTAL,261.0,241.0,267.0,269.0,245.0,233.0,173.0,234.0,209.0,47.0,179.0,189.0,2547.0
Yadgir,14.14.a,Number of patients given AYUSH treatment,TOTAL,8297.0,4747.0,8204.0,6686.0,7374.0,6465.0,5551.0,10139.0,9767.0,8631.0,9386.0,8829.0,94076.0
Yadgir,14.14.b,Number of patients on whom Dental Procedure was conducted,TOTAL,609.0,543.0,1162.0,258.0,223.0,258.0,219.0,228.0,183.0,227.0,218.0,198.0,4326.0
Yadgir,14.14.c,Number of Adolescents counselled,TOTAL,73.0,86.0,146.0,92.0,109.0,146.0,148.0,262.0,298.0,159.0,169.0,94.0,1782.0
Yadgir,15.1.1.a,Number of Haemoglobin (Hb) tests conducted,TOTAL,4434.0,3994.0,6438.0,5624.0,4614.0,5370.0,4155.0,5382.0,4944.0,5140.0,4922.0,4915.0,59932.0
Yadgir,15.1.1.b,"Out of the total number of Hb tests conducted, number of cases having Hb less than 7gm/dl",TOTAL,158.0,154.0,332.0,242.0,181.0,219.0,222.0,135.0,110.0,133.0,138.0,126.0,2150.0
Yadgir,15.1.2.a,Number of HIV tests conducted on males,1. Number tested,905.0,711.0,990.0,877.0,852.0,831.0,593.0,791.0,790.0,734.0,957.0,816.0,9847.0
Yadgir,15.1.2.a,Number of HIV tests conducted on males,2. Number Positive,28.0,6.0,22.0,24.0,13.0,11.0,8.0,9.0,10.0,4.0,14.0,16.0,165.0
Yadgir,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),1. Number tested,1344.0,975.0,1269.0,1151.0,1168.0,1328.0,737.0,1288.0,982.0,987.0,1329.0,1649.0,14207.0
Yadgir,15.1.2.b,Number of HIV tests conducted on Female-Non ANC (i.e. non pregnant females),2. Number Positive,20.0,7.0,12.0,13.0,11.0,13.0,9.0,11.0,10.0,5.0,15.0,18.0,144.0
Yadgir,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),1. Number tested,2577.0,2068.0,3082.0,2608.0,2400.0,2551.0,2014.0,2505.0,2438.0,2114.0,2352.0,2518.0,29227.0
Yadgir,15.1.2.c,Number of HIV tests conducted on Female with ANC (i.e. pregnant females),2. Number Positive,5.0,1.0,6.0,2.0,2.0,1.0,0.0,1.0,3.0,0.0,7.0,5.0,33.0
Yadgir,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),1. Number tested,4826.0,3754.0,5341.0,4636.0,4420.0,4710.0,3344.0,4584.0,4210.0,3835.0,4638.0,4983.0,53281.0
Yadgir,15.1.2.d,Total number of HIV tests conducted (sum of items 15.1.2.a to 15.1.2.c),2. Number Positive,53.0,14.0,40.0,39.0,26.0,25.0,17.0,21.0,23.0,9.0,36.0,39.0,342.0
Yadgir,15.2,Number of Widal tests conducted,Number tested,272.0,260.0,435.0,543.0,560.0,382.0,276.0,587.0,460.0,314.0,314.0,452.0,4855.0
Yadgir,15.3.a,Number of VDRL tests conducted on males,Number tested,75.0,16.0,66.0,12.0,4.0,4.0,68.0,8.0,16.0,4.0,2.0,1.0,276.0
Yadgir,15.3.b,Number of VDRL tests conducted on Female-Non ANC (i.e. non pregnant females),Number tested,187.0,312.0,430.0,107.0,76.0,383.0,160.0,76.0,52.0,85.0,47.0,293.0,2208.0
Yadgir,15.3.c,Number of VDRL tests conducted on Female with ANC (i.e. pregnant females),Number tested,896.0,547.0,1057.0,1067.0,823.0,896.0,772.0,1321.0,1020.0,1039.0,888.0,1080.0,11406.0
Yadgir,15.3.d,Total number of VDRL tests conducted (sum of items 15.3.a to 15.3.c),Number tested,1158.0,875.0,1553.0,1186.0,903.0,1283.0,1000.0,1405.0,1088.0,1128.0,937.0,1374.0,13890.0
Yadgir,15.4.1,Number of blood smears examined for Malaria,TOTAL,8978.0,7475.0,11064.0,11037.0,10935.0,11675.0,8337.0,10612.0,9806.0,8645.0,9137.0,9234.0,116935.0
Yadgir,15.4.2,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Vivax",TOTAL,6.0,5.0,6.0,10.0,10.0,23.0,18.0,6.0,8.0,4.0,2.0,7.0,105.0
Yadgir,15.4.3,"Out of blood smears examined for malaria, number of blood smears tested positive for Plasmodium Falciparum",TOTAL,0.0,0.0,0.0,1.0,0.0,0.0,0.0,0.0,0.0,3.0,0.0,0.0,4.0
Yadgir,16.1.1,Stock position of DPT vaccines,1. Balance From Previous Month,7500.0,8000.0,12000.0,12000.0,3000.0,3000.0,4000.0,1000.0,6000.0,9000.0,8000.0,12000.0,85500.0
Yadgir,16.1.1,Stock position of DPT vaccines,2. Stocks Received,7000.0,6000.0,5000.0,0.0,7000.0,13000.0,0.0,7000.0,4000.0,0.0,5000.0,0.0,54000.0
Yadgir,16.1.1,Stock position of DPT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.1,Stock position of DPT vaccines,4. Stock Distributed,6500.0,2000.0,5000.0,9000.0,7000.0,12000.0,3000.0,2000.0,1000.0,1000.0,2000.0,4000.0,54500.0
Yadgir,16.1.1,Stock position of DPT vaccines,5. Total Stock,8000.0,12000.0,12000.0,3000.0,3000.0,4000.0,1000.0,6000.0,9000.0,8000.0,11000.0,8000.0,85000.0
Yadgir,16.1.1A,Stock Position of Pentavalent,1. Balance From Previous Month,11500.0,10000.0,12000.0,12000.0,6000.0,10000.0,13000.0,10000.0,6500.0,9500.0,5500.0,4500.0,110500.0
Yadgir,16.1.1A,Stock Position of Pentavalent,2. Stocks Received,10000.0,5000.0,10000.0,0.0,10000.0,15000.0,0.0,4000.0,11000.0,0.0,5000.0,0.0,70000.0
Yadgir,16.1.1A,Stock Position of Pentavalent,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.1A,Stock Position of Pentavalent,4. Stock Distributed,11500.0,3000.0,10000.0,6000.0,6000.0,12000.0,3000.0,7500.0,8000.0,4000.0,6000.0,2600.0,79600.0
Yadgir,16.1.1A,Stock Position of Pentavalent,5. Total Stock,10000.0,12000.0,12000.0,6000.0,10000.0,13000.0,10000.0,6500.0,9500.0,5500.0,4500.0,1900.0,100900.0
Yadgir,16.1.2,Stock position of OPV vaccines,1. Balance From Previous Month,9000.0,4500.0,16000.0,16000.0,0.0,0.0,10000.0,0.0,0.0,8000.0,620.0,620.0,64740.0
Yadgir,16.1.2,Stock position of OPV vaccines,2. Stocks Received,15000.0,17000.0,16000.0,0.0,19000.0,31000.0,0.0,8000.0,32000.0,239560.0,4000.0,19000.0,400560.0
Yadgir,16.1.2,Stock position of OPV vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.2,Stock position of OPV vaccines,4. Stock Distributed,19500.0,5500.0,16000.0,16000.0,19000.0,21000.0,10000.0,8000.0,24000.0,246940.0,4000.0,18000.0,407940.0
Yadgir,16.1.2,Stock position of OPV vaccines,5. Total Stock,4500.0,16000.0,16000.0,0.0,0.0,10000.0,0.0,0.0,8000.0,620.0,620.0,1620.0,57360.0
Yadgir,16.1.3,Stock position of TT vaccines,1. Balance From Previous Month,7500.0,2500.0,15500.0,16500.0,1000.0,2000.0,8000.0,1000.0,4000.0,14000.0,7000.0,11000.0,90000.0
Yadgir,16.1.3,Stock position of TT vaccines,2. Stocks Received,12000.0,15000.0,15000.0,0.0,13000.0,24000.0,0.0,12000.0,24000.0,0.0,12000.0,7000.0,134000.0
Yadgir,16.1.3,Stock position of TT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.3,Stock position of TT vaccines,4. Stock Distributed,17000.0,2000.0,14000.0,15500.0,12000.0,18000.0,7000.0,9000.0,14000.0,7000.0,8000.0,11000.0,134500.0
Yadgir,16.1.3,Stock position of TT vaccines,5. Total Stock,2500.0,15500.0,16500.0,1000.0,2000.0,8000.0,1000.0,4000.0,14000.0,7000.0,11000.0,7000.0,89500.0
Yadgir,16.1.4,Stock position of DT vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.4,Stock position of DT vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.4,Stock position of DT vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.4,Stock position of DT vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.4,Stock position of DT vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.5,Stock position of BCG vaccines,1. Balance From Previous Month,6500.0,5000.0,11000.0,10500.0,1500.0,1500.0,5500.0,0.0,500.0,7000.0,2000.0,1000.0,52000.0
Yadgir,16.1.5,Stock position of BCG vaccines,2. Stocks Received,8000.0,8000.0,7000.0,0.0,8000.0,14000.0,0.0,8000.0,16000.0,0.0,6000.0,8000.0,83000.0
Yadgir,16.1.5,Stock position of BCG vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.5,Stock position of BCG vaccines,4. Stock Distributed,9500.0,2000.0,7500.0,9000.0,8000.0,10000.0,5500.0,7500.0,9500.0,5000.0,7000.0,8500.0,89000.0
Yadgir,16.1.5,Stock position of BCG vaccines,5. Total Stock,5000.0,11000.0,10500.0,1500.0,1500.0,5500.0,0.0,500.0,7000.0,2000.0,1000.0,500.0,46000.0
Yadgir,16.1.6,Stock position of Measles vaccines,1. Balance From Previous Month,6500.0,6250.0,7750.0,8250.0,1500.0,5500.0,8750.0,5750.0,4250.0,4750.0,2750.0,2750.0,64750.0
Yadgir,16.1.6,Stock position of Measles vaccines,2. Stocks Received,5000.0,3000.0,5000.0,0.0,7000.0,8000.0,0.0,3000.0,5000.0,0.0,4000.0,3000.0,43000.0
Yadgir,16.1.6,Stock position of Measles vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.6,Stock position of Measles vaccines,4. Stock Distributed,5250.0,1500.0,4500.0,6750.0,3000.0,4750.0,3000.0,4500.0,4500.0,2500.0,3500.0,4000.0,47750.0
Yadgir,16.1.6,Stock position of Measles vaccines,5. Total Stock,6250.0,7750.0,8250.0,1500.0,5500.0,8750.0,5750.0,4250.0,4750.0,2250.0,3250.0,1750.0,60000.0
Yadgir,16.1.7,Stock position of JE vaccines,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.7,Stock position of JE vaccines,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.7,Stock position of JE vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.7,Stock position of JE vaccines,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.7,Stock position of JE vaccines,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.8,Stock position of Hepatitis B vaccines,1. Balance From Previous Month,9500.0,9500.0,10700.0,12500.0,3500.0,7300.0,14800.0,9700.0,9700.0,9700.0,9700.0,3900.0,110500.0
Yadgir,16.1.8,Stock position of Hepatitis B vaccines,2. Stocks Received,3000.0,1200.0,3000.0,0.0,5000.0,9000.0,0.0,0.0,0.0,0.0,3000.0,0.0,24200.0
Yadgir,16.1.8,Stock position of Hepatitis B vaccines,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.1.8,Stock position of Hepatitis B vaccines,4. Stock Distributed,3000.0,0.0,1200.0,9000.0,1200.0,1500.0,5100.0,0.0,0.0,0.0,8800.0,2400.0,32200.0
Yadgir,16.1.8,Stock position of Hepatitis B vaccines,5. Total Stock,9500.0,10700.0,12500.0,3500.0,7300.0,14800.0,9700.0,9700.0,9700.0,9700.0,3900.0,1500.0,102500.0
Yadgir,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),1. Balance From Previous Month,3300.0,3300.0,9300.0,2100.0,2100.0,2100.0,2100.0,100.0,100.0,100.0,100.0,100.0,24800.0
Yadgir,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),2. Stocks Received,0.0,6000.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6000.0
Yadgir,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),4. Stock Distributed,0.0,0.0,7200.0,0.0,0.0,0.0,2000.0,0.0,0.0,0.0,0.0,0.0,9200.0
Yadgir,16.2.1,Stock Position of IU 380 A (to be used for Family Planning),5. Total Stock,3300.0,9300.0,2100.0,2100.0,2100.0,2100.0,100.0,100.0,100.0,100.0,100.0,100.0,21600.0
Yadgir,16.2.2,Stock Position of Condoms (to be used for Family Planning),1. Balance From Previous Month,10980.0,10980.0,41220.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,63180.0
Yadgir,16.2.2,Stock Position of Condoms (to be used for Family Planning),2. Stocks Received,0.0,30240.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,30240.0
Yadgir,16.2.2,Stock Position of Condoms (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.2.2,Stock Position of Condoms (to be used for Family Planning),4. Stock Distributed,0.0,0.0,41220.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,41220.0
Yadgir,16.2.2,Stock Position of Condoms (to be used for Family Planning),5. Total Stock,10980.0,41220.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,52200.0
Yadgir,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),1. Balance From Previous Month,300.0,300.0,300.0,300.0,300.0,300.0,300.0,0.0,0.0,0.0,0.0,0.0,2100.0
Yadgir,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,300.0,0.0,0.0,0.0,0.0,0.0,300.0
Yadgir,16.2.3,Stock Position of Oral Contraceptive (to be used for Family Planning),5. Total Stock,300.0,300.0,300.0,300.0,300.0,300.0,0.0,0.0,0.0,0.0,0.0,0.0,1800.0
Yadgir,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),1. Balance From Previous Month,1143.0,1143.0,4983.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,7269.0
Yadgir,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),2. Stocks Received,0.0,3840.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3840.0
Yadgir,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),4. Stock Distributed,0.0,0.0,4983.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,4983.0
Yadgir,16.2.4,Stock Position of Emergency Contraceptive (to be used for Family Planning),5. Total Stock,1143.0,4983.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6126.0
Yadgir,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),1. Balance From Previous Month,2300.0,1500.0,7764.0,6464.0,3964.0,3564.0,2864.0,2864.0,1600.0,1600.0,1200.0,300.0,35984.0
Yadgir,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),2. Stocks Received,0.0,6664.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,6664.0
Yadgir,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),4. Stock Distributed,800.0,400.0,1300.0,2500.0,400.0,700.0,0.0,1264.0,0.0,400.0,1000.0,200.0,8964.0
Yadgir,16.2.5,Stock Position of Tubal Rings (to be used for Family Planning),5. Total Stock,1500.0,7764.0,6464.0,3964.0,3564.0,2864.0,2864.0,1600.0,1600.0,1200.0,200.0,100.0,33684.0
Yadgir,16.3.01,Stock Position of Oxytocin Injection,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.01,Stock Position of Oxytocin Injection,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.01,Stock Position of Oxytocin Injection,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.01,Stock Position of Oxytocin Injection,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.01,Stock Position of Oxytocin Injection,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.02,Stock Position of Gloves,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.02,Stock Position of Gloves,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.02,Stock Position of Gloves,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.02,Stock Position of Gloves,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.02,Stock Position of Gloves,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.03,Stock Position of MVA Syringes,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.03,Stock Position of MVA Syringes,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.03,Stock Position of MVA Syringes,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.03,Stock Position of MVA Syringes,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.03,Stock Position of MVA Syringes,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.04,Stock Position of Fluconazole Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.04,Stock Position of Fluconazole Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.04,Stock Position of Fluconazole Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.04,Stock Position of Fluconazole Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.04,Stock Position of Fluconazole Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.05,Stock Position of Blood Transfusion Sets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.05,Stock Position of Blood Transfusion Sets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.05,Stock Position of Blood Transfusion Sets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.05,Stock Position of Blood Transfusion Sets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.05,Stock Position of Blood Transfusion Sets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.06,Stock Position of Gluteraldehyde solution of 2% concentration,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.07,Stock Position of IFA Tablets,1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.07,Stock Position of IFA Tablets,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.07,Stock Position of IFA Tablets,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.07,Stock Position of IFA Tablets,4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.07,Stock Position of IFA Tablets,5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.08,Stock Position of IFA Syrup (Paediatric),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.08,Stock Position of IFA Syrup (Paediatric),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10750.0,0.0,0.0,0.0,10750.0
Yadgir,16.3.08,Stock Position of IFA Syrup (Paediatric),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.08,Stock Position of IFA Syrup (Paediatric),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,10750.0,0.0,0.0,0.0,10750.0
Yadgir,16.3.08,Stock Position of IFA Syrup (Paediatric),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),1. Balance From Previous Month,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),4. Stock Distributed,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.09,Stock Position of Paediatrics Antibiotics (Cotrimaxozole and Injectable Gentamicin),5. Total Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.10,Stock Position of Vitamin A solution,1. Balance From Previous Month,2150.0,1150.0,1150.0,1150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,5600.0
Yadgir,16.3.10,Stock Position of Vitamin A solution,2. Stocks Received,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.10,Stock Position of Vitamin A solution,3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.10,Stock Position of Vitamin A solution,4. Stock Distributed,1000.0,0.0,0.0,1150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,2150.0
Yadgir,16.3.10,Stock Position of Vitamin A solution,5. Total Stock,1150.0,1150.0,1150.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,3450.0
Yadgir,16.3.11,Stock of ORS (New WHO formulation),1. Balance From Previous Month,793.0,693.0,693.0,108293.0,18993.0,18993.0,39455.0,28005.0,21555.0,21555.0,21555.0,21555.0,302138.0
Yadgir,16.3.11,Stock of ORS (New WHO formulation),2. Stocks Received,0.0,0.0,107600.0,0.0,0.0,26012.0,0.0,0.0,0.0,0.0,0.0,0.0,133612.0
Yadgir,16.3.11,Stock of ORS (New WHO formulation),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.3.11,Stock of ORS (New WHO formulation),4. Stock Distributed,100.0,0.0,0.0,89300.0,0.0,5550.0,11450.0,6450.0,0.0,0.0,2300.0,2300.0,117450.0
Yadgir,16.3.11,Stock of ORS (New WHO formulation),5. Total Stock,693.0,693.0,108293.0,18993.0,18993.0,39455.0,28005.0,21555.0,21555.0,21555.0,19255.0,19255.0,318300.0
Yadgir,16.4.1,Stock Position of 0.1 ml Syringes(AD),1. Balance From Previous Month,1000.0,0.0,6600.0,0.0,0.0,0.0,4400.0,0.0,0.0,0.0,0.0,0.0,12000.0
Yadgir,16.4.1,Stock Position of 0.1 ml Syringes(AD),2. Stocks Received,0.0,6600.0,0.0,0.0,0.0,6600.0,0.0,0.0,3300.0,0.0,3300.0,3300.0,23100.0
Yadgir,16.4.1,Stock Position of 0.1 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.4.1,Stock Position of 0.1 ml Syringes(AD),4. Stock Distributed,1000.0,0.0,6600.0,0.0,0.0,2200.0,4400.0,0.0,3300.0,0.0,3300.0,3300.0,24100.0
Yadgir,16.4.1,Stock Position of 0.1 ml Syringes(AD),5. Total Stock,0.0,6600.0,0.0,0.0,0.0,4400.0,0.0,0.0,0.0,0.0,0.0,0.0,11000.0
Yadgir,16.4.2,Stock Position of 0.5 ml Syringes(AD),1. Balance From Previous Month,100.0,100.0,84100.0,0.0,0.0,0.0,5000.0,0.0,0.0,2400.0,0.0,0.0,91700.0
Yadgir,16.4.2,Stock Position of 0.5 ml Syringes(AD),2. Stocks Received,0.0,84000.0,0.0,0.0,0.0,8000.0,0.0,8000.0,8000.0,0.0,7200.0,3600.0,118800.0
Yadgir,16.4.2,Stock Position of 0.5 ml Syringes(AD),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.4.2,Stock Position of 0.5 ml Syringes(AD),4. Stock Distributed,0.0,0.0,84100.0,0.0,0.0,3000.0,5000.0,8000.0,5600.0,2400.0,7200.0,3600.0,118900.0
Yadgir,16.4.2,Stock Position of 0.5 ml Syringes(AD),5. Total Stock,100.0,84100.0,0.0,0.0,0.0,5000.0,0.0,0.0,2400.0,0.0,0.0,0.0,91600.0
Yadgir,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),1. Balance From Previous Month,100.0,100.0,4900.0,0.0,0.0,0.0,2400.0,1700.0,1700.0,1700.0,1700.0,1700.0,16000.0
Yadgir,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),2. Stocks Received,0.0,4800.0,0.0,0.0,0.0,3000.0,0.0,0.0,0.0,0.0,0.0,0.0,7800.0
Yadgir,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),3. Unusable Stock,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0,0.0
Yadgir,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),4. Stock Distributed,0.0,0.0,4900.0,0.0,0.0,600.0,700.0,0.0,0.0,0.0,0.0,0.0,6200.0
Yadgir,16.4.3,Stock Position of 5.0 ml Syringes(Disposable),5. Total Stock,100.0,4900.0,0.0,0.0,0.0,2400.0,1700.0,1700.0,1700.0,1700.0,1700.0,1700.0,17600.0
Yadgir,17.1,Number of cases of Infant deaths within 24 hrs of birth,TOTAL,,,,,,,,,,2.0,,,2.0
Yadgir,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,1. Up to 1 Weeks of Birth,,,,,,1.0,,,,,,,1.0
Yadgir,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Yadgir,17.2.1,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Sepsis,3. Total,,,,,,1.0,,,,,,,1.0
Yadgir,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,1. Up to 1 Weeks of Birth,2.0,1.0,2.0,1.0,,1.0,,1.0,1.0,2.0,1.0,,12.0
Yadgir,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,2. Between 1 week & 4 weeks of birth,,,,,1.0,,,,,,,,1.0
Yadgir,17.2.2,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being Asphyxia,3. Total,2.0,1.0,2.0,1.0,1.0,1.0,,1.0,1.0,2.0,1.0,,13.0
Yadgir,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,1. Up to 1 Weeks of Birth,1.0,1.0,,,,2.0,,2.0,1.0,,1.0,1.0,9.0
Yadgir,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,2. Between 1 week & 4 weeks of birth,,,,,,,,,,,,,
Yadgir,17.2.3,Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being LBW,3. Total,1.0,1.0,,,,2.0,,2.0,1.0,,1.0,1.0,9.0
Yadgir,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",1. Up to 1 Weeks of Birth,1.0,,,,,1.0,,,1.0,1.0,,,4.0
Yadgir,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",2. Between 1 week & 4 weeks of birth,,,,,,,,,2.0,,,,2.0
Yadgir,17.2.4,"Number of cases of Infant deaths 24 hours to 4 weeks of birth with the probable cause being other than Sepsis, Asphyxia and LBW",3. Total,1.0,,,,,1.0,,,3.0,1.0,,,6.0
Yadgir,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,1. Between 1 month and 11 months,1.0,,1.0,,,,1.0,,1.0,,,,4.0
Yadgir,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,2. Between 1 year & 5 years,,,,,,,,,,,,,
Yadgir,17.3.1,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Pneumonia,3. Total,1.0,,1.0,,,,1.0,,1.0,,,,4.0
Yadgir,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,1. Between 1 month and 11 months,,,,,,,,,,,,,
Yadgir,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,2. Between 1 year & 5 years,,,,,,,,,,,,,
Yadgir,17.3.2,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Diarrhoea,3. Total,,,,,,,,,,,,,
Yadgir,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,1. Between 1 month and 11 months,,,1.0,1.0,3.0,,,,,,,,5.0
Yadgir,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,2. Between 1 year & 5 years,,,,1.0,1.0,,1.0,,,,,,3.0
Yadgir,17.3.3,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Fever related,3. Total,,,1.0,2.0,4.0,,1.0,,,,,,8.0
Yadgir,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,1. Between 1 month and 11 months,,,,,,,,,,,,,
Yadgir,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,2. Between 1 year & 5 years,,,,,,,,,,,,,
Yadgir,17.3.4,Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being Measles,3. Total,,,,,,,,,,,,,
Yadgir,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",1. Between 1 month and 11 months,1.0,1.0,1.0,2.0,1.0,2.0,4.0,3.0,2.0,1.0,,,18.0
Yadgir,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",2. Between 1 year & 5 years,,,,2.0,,1.0,2.0,2.0,2.0,,,1.0,10.0
Yadgir,17.3.5,"Number of cases of Infant or Child deaths between 1 month to 5 years of age with the probable cause being other than Pneumonia, Diarrhoea, Fever related and Measles",3. Total,1.0,1.0,1.0,4.0,1.0,3.0,6.0,5.0,4.0,1.0,,1.0,28.0
Yadgir,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,2. 15-55 yrs.,,,,,1.0,,,,1.0,,,,2.0
Yadgir,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,3. Above 55 yrs.,,2.0,,1.0,,,,,,,,,3.0
Yadgir,17.4.1,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Diarrhoeal diseases,4. Total,,2.0,,1.0,1.0,,,,1.0,,,,5.0
Yadgir,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,1. 6-14 yrs,,1.0,,,,,,,,,,,1.0
Yadgir,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,2. 15-55 yrs.,1.0,2.0,2.0,1.0,4.0,1.0,2.0,1.0,2.0,3.0,3.0,1.0,23.0
Yadgir,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,3. Above 55 yrs.,1.0,2.0,,,,1.0,,,,2.0,1.0,,7.0
Yadgir,17.4.2,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Tuberculosis,4. Total,2.0,5.0,2.0,1.0,4.0,2.0,2.0,1.0,2.0,5.0,4.0,1.0,31.0
Yadgir,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,1. 6-14 yrs,,,,,,,,,,,1.0,1.0,2.0
Yadgir,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,2. 15-55 yrs.,4.0,,2.0,1.0,,1.0,1.0,2.0,3.0,4.0,1.0,,19.0
Yadgir,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,3. Above 55 yrs.,1.0,2.0,3.0,5.0,1.0,2.0,4.0,,4.0,7.0,3.0,3.0,35.0
Yadgir,17.4.3,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Respiratory diseases including infections,4. Total,5.0,2.0,5.0,6.0,1.0,3.0,5.0,2.0,7.0,11.0,5.0,4.0,56.0
Yadgir,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,2. 15-55 yrs.,,,,,,,,,,,,,
Yadgir,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,3. Above 55 yrs.,,,,,,,,,,,,,
Yadgir,17.4.4,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Malaria,4. Total,,,,,,,,,,,,,
Yadgir,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,1. 6-14 yrs,,,,,,1.0,,,,,,,1.0
Yadgir,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,2. 15-55 yrs.,,,1.0,,,,,,,1.0,,,2.0
Yadgir,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,3. Above 55 yrs.,,1.0,,,,,,,,,,,1.0
Yadgir,17.4.5,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being other Fever related,4. Total,,1.0,1.0,,,1.0,,,,1.0,,,4.0
Yadgir,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,2. 15-55 yrs.,2.0,6.0,2.0,,,1.0,1.0,,1.0,1.0,,,14.0
Yadgir,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,3. Above 55 yrs.,,1.0,1.0,,,,,,,,,1.0,3.0
Yadgir,17.4.6,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being HIV/AIDS,4. Total,2.0,7.0,3.0,,,1.0,1.0,,1.0,1.0,,1.0,17.0
Yadgir,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,2. 15-55 yrs.,5.0,3.0,5.0,4.0,8.0,8.0,3.0,8.0,3.0,12.0,8.0,7.0,74.0
Yadgir,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,3. Above 55 yrs.,2.0,3.0,4.0,3.0,9.0,3.0,3.0,1.0,5.0,3.0,6.0,3.0,45.0
Yadgir,17.4.7,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Heart disease or related to Hypertension,4. Total,7.0,6.0,9.0,7.0,17.0,11.0,6.0,9.0,8.0,15.0,14.0,10.0,119.0
Yadgir,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,1. 6-14 yrs,,,,,,1.0,1.0,,,,,,2.0
Yadgir,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,2. 15-55 yrs.,4.0,,2.0,1.0,1.0,2.0,,3.0,1.0,,,1.0,15.0
Yadgir,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,3. Above 55 yrs.,9.0,3.0,6.0,4.0,5.0,4.0,,1.0,4.0,8.0,9.0,8.0,61.0
Yadgir,17.4.8,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Neurological disease including strokes,4. Total,13.0,3.0,8.0,5.0,6.0,7.0,1.0,4.0,5.0,8.0,9.0,9.0,78.0
Yadgir,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,2. 15-49 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,3. Above 49 yrs.,,,,,,,,,,,,,
Yadgir,17.4.9(a),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Abortion,4. Total,,,,,,,,,,,,,
Yadgir,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,2. 15-49 yrs,,,,,,,,1.0,,,,,1.0
Yadgir,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,3. Above 49 yrs.,,,,,,,,,,,,,
Yadgir,17.4.9(b),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Obstructed or prolonged labour,4. Total,,,,,,,,1.0,,,,,1.0
Yadgir,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,2. 15-49 yrs,,,,1.0,,,,,,,,1.0,2.0
Yadgir,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,3. Above 49 yrs.,,,,,,,,,,,,,
Yadgir,17.4.9(c),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Severe hypertesnion or fits,4. Total,,,,1.0,,,,,,,,1.0,2.0
Yadgir,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,2. 15-49 yrs,1.0,,,,,,,,,,,,1.0
Yadgir,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,3. Above 49 yrs.,,,,,,,,,,,,,
Yadgir,17.4.9(d),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being Bleeding,4. Total,1.0,,,,,,,,,,,,1.0
Yadgir,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,2. 15-49 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,3. Above 49 yrs.,,,,,,,,,,,,,
Yadgir,17.4.9(e),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being High Fever,4. Total,,,,,,,,,,,,,
Yadgir,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,1. 6-14 yrs,,,,,,,,,,,,,
Yadgir,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,2. 15-49 yrs,,2.0,1.0,,1.0,1.0,1.0,,,,,,6.0
Yadgir,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,3. Above 49 yrs.,,,,,,,,,,,,,
Yadgir,17.4.9(f),Number of cases of Maternal deaths (age 15-49 years) with the probable cause being other causes (excluding abortion; obstructed or prolonged labour; severe hypertension or fits;,4. Total,,2.0,1.0,,1.0,1.0,1.0,,,,,,6.0
Yadgir,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,1. 6-14 yrs,,1.0,,2.0,,2.0,1.0,1.0,,,,1.0,8.0
Yadgir,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,2. 15-55 yrs.,5.0,11.0,10.0,7.0,1.0,6.0,7.0,8.0,9.0,4.0,10.0,10.0,88.0
Yadgir,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,3. Above 55 yrs.,3.0,2.0,1.0,2.0,,1.0,1.0,1.0,,1.0,3.0,2.0,17.0
Yadgir,17.4.10,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Trauma or Accidents or Burn cases,4. Total,8.0,14.0,11.0,11.0,1.0,9.0,9.0,10.0,9.0,5.0,13.0,13.0,113.0
Yadgir,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,1. 6-14 yrs,,,1.0,1.0,,3.0,,,,,,3.0,8.0
Yadgir,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,2. 15-55 yrs.,5.0,3.0,5.0,4.0,5.0,7.0,1.0,4.0,6.0,6.0,4.0,6.0,56.0
Yadgir,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,3. Above 55 yrs.,1.0,1.0,1.0,,1.0,1.0,1.0,4.0,1.0,,,1.0,12.0
Yadgir,17.4.11,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being suicide,4. Total,6.0,4.0,7.0,5.0,6.0,11.0,2.0,8.0,7.0,6.0,4.0,10.0,76.0
Yadgir,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,1. 6-14 yrs,,,,1.0,2.0,,,,1.0,,,,4.0
Yadgir,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,2. 15-55 yrs.,4.0,2.0,2.0,,1.0,2.0,2.0,,,1.0,,2.0,16.0
Yadgir,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,3. Above 55 yrs.,,,,,,,,,1.0,,,,1.0
Yadgir,17.4.12,Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Animal bites and stings,4. Total,4.0,2.0,2.0,1.0,3.0,2.0,2.0,,2.0,1.0,,2.0,21.0
Yadgir,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,1. 6-14 yrs,,1.0,,,1.0,1.0,,,1.0,,1.0,,5.0
Yadgir,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,2. 15-55 yrs.,5.0,2.0,1.0,1.0,1.0,2.0,,2.0,5.0,4.0,2.0,1.0,26.0
Yadgir,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,3. Above 55 yrs.,4.0,,1.0,,1.0,1.0,,2.0,3.0,1.0,4.0,1.0,18.0
Yadgir,17.4.13(a),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Acute disease,4. Total,9.0,3.0,2.0,1.0,3.0,4.0,,4.0,9.0,5.0,7.0,2.0,49.0
Yadgir,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,1. 6-14 yrs,2.0,1.0,,,1.0,,,,1.0,,,,5.0
Yadgir,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,2. 15-55 yrs.,2.0,,,3.0,1.0,3.0,,3.0,2.0,3.0,1.0,2.0,20.0
Yadgir,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,3. Above 55 yrs.,1.0,,,3.0,8.0,3.0,,,4.0,1.0,,,20.0
Yadgir,17.4.13(b),Number of cases of Adolescent or Adult deaths (age 6 years & above) with the probable cause being Known Chronic disease,4. Total,5.0,1.0,,6.0,10.0,6.0,,3.0,7.0,4.0,1.0,2.0,45.0
Yadgir,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,1. 6-14 yrs,,,1.0,,1.0,2.0,,2.0,1.0,2.0,1.0,,10.0
Yadgir,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,2. 15-55 yrs.,31.0,36.0,35.0,22.0,31.0,38.0,38.0,29.0,34.0,45.0,22.0,18.0,379.0
Yadgir,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,3. Above 55 yrs.,72.0,80.0,89.0,65.0,104.0,113.0,103.0,131.0,103.0,106.0,93.0,100.0,1159.0
Yadgir,17.4.13(c),Number of cases of Adolescent or Adult deaths (age 6 years & above) where the cause was not known,4. Total,103.0,116.0,125.0,87.0,136.0,153.0,141.0,162.0,138.0,153.0,116.0,118.0,1548.0
